Authors,Author(s) ID,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Affiliations,Authors with affiliations,Abstract,Author Keywords,Index Keywords,Molecular Sequence Numbers,Chemicals/CAS,Tradenames,Manufacturers,Funding Details,Funding Text 1,Funding Text 2,Funding Text 3,References,Correspondence Address,Editors,Sponsors,Publisher,Conference name,Conference date,Conference location,Conference code,ISSN,ISBN,CODEN,PubMed ID,Language of Original Document,Abbreviated Source Title,Document Type,Publication Stage,Access Type,Source,EID
"Buitrago D., Codó L., Illa R., de Jorge P., Battistini F., Flores O., Bayarri G., Royo R., Del Pino M., Heath S., Hospital A., Gelpí J.L., Heath I.B., Orozco M.","57196032996;55882083800;57211122456;57211122288;35193719000;43260979100;57211122515;24176373200;57210955894;57211122650;15831739300;35517522400;57211121981;7102809158;","Nucleosome Dynamics: a new tool for the dynamic analysis of nucleosome positioning",2019,"Nucleic acids research","47","18",,"9511","9523",,,"10.1093/nar/gkz759","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072718217&doi=10.1093%2fnar%2fgkz759&partnerID=40&md5=3660be87fe9cfc5417e0e6428d0e0e19","Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Barcelona Supercomputing Center (BSC), Jordi Girona 31; Centro Nacional de Análisis Genómico (CNAG-CRG), Centre de Regulacio Genómico (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain; Departament de Bioquímica i Biomedicina. Facultat de Biologia, Universitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain","Buitrago, D., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Codó, L., Barcelona Supercomputing Center (BSC), Jordi Girona 31; Illa, R., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; de Jorge, P., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Battistini, F., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Flores, O., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Bayarri, G., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Royo, R., Barcelona Supercomputing Center (BSC), Jordi Girona 31; Del Pino, M., Barcelona Supercomputing Center (BSC), Jordi Girona 31; Heath, S., Centro Nacional de Análisis Genómico (CNAG-CRG), Centre de Regulacio Genómico (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain; Hospital, A., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Gelpí, J.L., Barcelona Supercomputing Center (BSC), Jordi Girona 31, Departament de Bioquímica i Biomedicina. Facultat de Biologia, Universitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain; Heath, I.B., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10, Barcelona, 08028, Spain, Departament de Bioquímica i Biomedicina. Facultat de Biologia, Universitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain","We present Nucleosome Dynamics, a suite of programs integrated into a virtual research environment and created to define nucleosome architecture and dynamics from noisy experimental data. The package allows both the definition of nucleosome architectures and the detection of changes in nucleosomal organization due to changes in cellular conditions. Results are displayed in the context of genomic information thanks to different visualizers and browsers, allowing the user a holistic, multidimensional view of the genome/transcriptome. The package shows good performance for both locating equilibrium nucleosome architecture and nucleosome dynamics and provides abundant useful information in several test cases, where experimental data on nucleosome position (and for some cases expression level) have been collected for cells under different external conditions (cell cycle phase, yeast metabolic cycle progression, changes in nutrients or difference in MNase digestion level). Nucleosome Dynamics is a free software and is provided under several distribution models. © The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.",,,,,,,,,,,,,,,"NLM (Medline)",,,,,13624962,,,"31504766","English","Nucleic Acids Res.",Article,"Final",Open Access,Scopus,2-s2.0-85072718217
"Andrio P., Hospital A., Conejero J., Jordá L., Del Pino M., Codo L., Soiland-Reyes S., Goble C., Lezzi D., Badia R.M., Orozco M., Gelpi J.L.","55203611300;15831739300;55224212200;57210964415;57210955894;55882083800;24774024500;7004072716;22334444700;6603994224;7102809158;35517522400;","BioExcel Building Blocks, a software library for interoperable biomolecular simulation workflows",2019,"Scientific data","6","1",,"169","",,,"10.1038/s41597-019-0177-4","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072039100&doi=10.1038%2fs41597-019-0177-4&partnerID=40&md5=3c124072616ac81ffb1da87daa137004","Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, Barcelona, 08028, Spain; School of Computer Science, University of Manchester, Manchester, United Kingdom; Department Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain","Andrio, P., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Hospital, A., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, Barcelona, 08028, Spain; Conejero, J., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Jordá, L., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Del Pino, M., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Codo, L., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Soiland-Reyes, S., School of Computer Science, University of Manchester, Manchester, United Kingdom; Goble, C., School of Computer Science, University of Manchester, Manchester, United Kingdom; Lezzi, D., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Badia, R.M., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Baldiri Reixac 10, Barcelona, 08028, Spain, Department Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain; Gelpi, J.L., Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain, Department Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain","In the recent years, the improvement of software and hardware performance has made biomolecular simulations a mature tool for the study of biological processes. Simulation length and the size and complexity of the analyzed systems make simulations both complementary and compatible with other bioinformatics disciplines. However, the characteristics of the software packages used for simulation have prevented the adoption of the technologies accepted in other bioinformatics fields like automated deployment systems, workflow orchestration, or the use of software containers. We present here a comprehensive exercise to bring biomolecular simulations to the ""bioinformatics way of working"". The exercise has led to the development of the BioExcel Building Blocks (BioBB) library. BioBB's are built as Python wrappers to provide an interoperable architecture. BioBB's have been integrated in a chain of usual software management tools to generate data ontologies, documentation, installation packages, software containers and ways of integration with workflow managers, that make them usable in most computational environments.",,,,,,,,,,,,,,,"NLM (Medline)",,,,,20524463,,,"31506435","English","Sci Data",Article,"Final",Open Access,Scopus,2-s2.0-85072039100
"Ison J., Ienasescu H., Chmura P., Rydza E., Menager H., Kalaš M., Schwammle V., Gruning B., Beard N., Lopez R., Duvaud S., Stockinger H., Persson B., Vařekova R.S., Raček T., Vondrašek J., Peterson H., Salumets A., Jonassen I., Hooft R., Nyronen T., Valencia A., Capella S., Gelpi J., Zambelli F., Savakis B., Leskošek B., Rapacki K., Blanchet C., Jimenez R., Oliveira A., Vriend G., Collin O., Van Helden J., Løngreen P., Brunak Sø.","7005978055;55990801400;56521679100;56521739200;8921913600;36192875600;22935691900;37088461600;57190048977;7401491151;6507114857;56227877100;55914729200;57208041614;57189056284;6603730744;18134080900;57210394739;56268152000;6603607988;6602986464;57199730465;35335928400;35517522400;55893989700;57189330372;55599291600;6507206595;35972291700;24481270200;56898444700;7006556611;55325352600;7003886643;57190047248;7005477388;","The bio.tools registry of software tools and data resources for the life sciences",2019,"Genome Biology","20","1", 164,"","",,1,"10.1186/s13059-019-1772-6","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070536381&doi=10.1186%2fs13059-019-1772-6&partnerID=40&md5=f6110a25f5f779e36c1196574cb1d999","National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2200, Denmark; Hub de Bioinformatique et de Biostatistiques, Institut Pasteur, C3BI USR, 3756 IP CNRS, Paris, France; Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, N-5020, Norway; Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Campusvej 55, Odense, 5230, Denmark; Department of Computer Science, Albert-Ludwigs-University Freiburg, Georges-Kohler-Allee 106, Freiburg, 79110, Germany; School of Computer Science, University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom; EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom; SIB Swiss Institute of Bioinformatics, Quartier Sorge-Batiment Amphipole, Lausanne, CH-1015, Switzerland; Bioinformatics Infrastructure for Life Sciences, Science for Life Laboratory, Dept of Cell and Molecular Biology, Uppsala, S-75124, Sweden; CEITEC-Central European Institute of Technology, Masaryk University Brno, Kamenice 5, Brno-Bohunice, 625 00, Czech Republic; Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo namesti 2, Prague, 160 00, Czech Republic; ELIXIR-EE, Institute of Computer Science, University of Tartu. J Liivi 2, Tartu, Estonia; Dutch Techcentre for Life Sciences, Jaarbeursplein 6, Utrecht, AL  3521, Netherlands; CSC-IT Center for Science, PO BOX 405, Espoo, FI-02101, Finland; Barcelona Supercomputing Centre (BSC), Barcelona, 08034, Spain; Institucio Catalana de Recerca i Estudis Avancats (ICREA), Pg. Lluls Companys 23, Barcelona, 08010, Spain; Department of Biochemistry and Molecular Biomedicine, University of Barcelona, INB / BSC-CNS, Barcelona, Spain; Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (CNR), via Amendola 165/A, Bari, Italy; Department of Biosciences, University of Milano, Via Celoria 26, Milan, Italy; Biomedical Sciences Research Centre, Alexander Fleming 34 Al. Fleming Str, Vari, 16672, Greece; Faculty of Medicine / ELIXIR-SI, University of Ljubljana, Vrazov trg 2, Ljubljana, SI-1000, Slovenia; CNRS, UMS 3601, Institut Francais de Bioinformatique, IFB-core, 2 rue Gaston Cremieux, Evry, F-91000, France; ELIXIR-Hub, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom; INESC-ID / Instituto Superior Tecnico, R. Alves Redol 9, Lisbon, Portugal; Radboud University Medical Centre, CMBI, Postbus 9101, Nijmegen, 6500 HB, Netherlands; Plateforme GenOuest Univ Rennes, Inria, CNRS, IRISA, Rennes, F-35000, France; Aix-Marseille Univ, INSERM, Lab. Theory and Approaches of Genome Complexity (TAGC), Marseille, France; Department of Bio and Health Informatics, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark","Ison, J., National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark; Ienasescu, H., National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark; Chmura, P., Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2200, Denmark; Rydza, E., Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2200, Denmark; Menager, H., Hub de Bioinformatique et de Biostatistiques, Institut Pasteur, C3BI USR, 3756 IP CNRS, Paris, France; Kalaš, M., Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, N-5020, Norway; Schwammle, V., Department of Biochemistry and Molecular Biology, VILLUM Center for Bioanalytical Sciences, University of Southern Denmark, Campusvej 55, Odense, 5230, Denmark; Gruning, B., Department of Computer Science, Albert-Ludwigs-University Freiburg, Georges-Kohler-Allee 106, Freiburg, 79110, Germany; Beard, N., School of Computer Science, University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom; Lopez, R., EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom; Duvaud, S., SIB Swiss Institute of Bioinformatics, Quartier Sorge-Batiment Amphipole, Lausanne, CH-1015, Switzerland; Stockinger, H., SIB Swiss Institute of Bioinformatics, Quartier Sorge-Batiment Amphipole, Lausanne, CH-1015, Switzerland; Persson, B., Bioinformatics Infrastructure for Life Sciences, Science for Life Laboratory, Dept of Cell and Molecular Biology, Uppsala, S-75124, Sweden; Vařekova, R.S., CEITEC-Central European Institute of Technology, Masaryk University Brno, Kamenice 5, Brno-Bohunice, 625 00, Czech Republic; Raček, T., CEITEC-Central European Institute of Technology, Masaryk University Brno, Kamenice 5, Brno-Bohunice, 625 00, Czech Republic; Vondrašek, J., Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo namesti 2, Prague, 160 00, Czech Republic; Peterson, H., ELIXIR-EE, Institute of Computer Science, University of Tartu. J Liivi 2, Tartu, Estonia; Salumets, A., ELIXIR-EE, Institute of Computer Science, University of Tartu. J Liivi 2, Tartu, Estonia; Jonassen, I., Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, N-5020, Norway; Hooft, R., Dutch Techcentre for Life Sciences, Jaarbeursplein 6, Utrecht, AL  3521, Netherlands; Nyronen, T., CSC-IT Center for Science, PO BOX 405, Espoo, FI-02101, Finland; Valencia, A., Barcelona Supercomputing Centre (BSC), Barcelona, 08034, Spain, Institucio Catalana de Recerca i Estudis Avancats (ICREA), Pg. Lluls Companys 23, Barcelona, 08010, Spain; Capella, S., Barcelona Supercomputing Centre (BSC), Barcelona, 08034, Spain; Gelpi, J., Barcelona Supercomputing Centre (BSC), Barcelona, 08034, Spain, Department of Biochemistry and Molecular Biomedicine, University of Barcelona, INB / BSC-CNS, Barcelona, Spain; Zambelli, F., Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Research Council (CNR), via Amendola 165/A, Bari, Italy, Department of Biosciences, University of Milano, Via Celoria 26, Milan, Italy; Savakis, B., Biomedical Sciences Research Centre, Alexander Fleming 34 Al. Fleming Str, Vari, 16672, Greece; Leskošek, B., Faculty of Medicine / ELIXIR-SI, University of Ljubljana, Vrazov trg 2, Ljubljana, SI-1000, Slovenia; Rapacki, K., National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark; Blanchet, C., CNRS, UMS 3601, Institut Francais de Bioinformatique, IFB-core, 2 rue Gaston Cremieux, Evry, F-91000, France; Jimenez, R., ELIXIR-Hub, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom; Oliveira, A., INESC-ID / Instituto Superior Tecnico, R. Alves Redol 9, Lisbon, Portugal; Vriend, G., Radboud University Medical Centre, CMBI, Postbus 9101, Nijmegen, 6500 HB, Netherlands; Collin, O., Plateforme GenOuest Univ Rennes, Inria, CNRS, IRISA, Rennes, F-35000, France; Van Helden, J., Aix-Marseille Univ, INSERM, Lab. Theory and Approaches of Genome Complexity (TAGC), Marseille, France; Løngreen, P., National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark; Brunak, Sø., Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DK-2200, Denmark, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, Kongens Lyngby, DK-2800, Denmark","Bioinformaticians and biologists rely increasingly upon workflows for the flexible utilization of the many life science tools that are needed to optimally convert data into knowledge. We outline a pan-European enterprise to provide a catalogue (https://bio.tools) of tools and databases that can be used in these workflows. bio.tools not only lists where to find resources, but also provides a wide variety of practical information. © 2019 The Author(s).",,"article; biologist; biomedicine; human; publication; software; workflow; letter",,,,,"Horizon 2020 Framework Programme, H2020: 676559

Danish Agency for Science and Higher Education, FI","We acknowledge with gratitude the support of our funders: The Danish Ministry of Higher Education and Science; ELIXIR-EXCELERATE under the European Union’s Horizon 2020 research and innovation programme (grant agreement number 676559).",,,"Lesk, A.M., Sequence analysis in molecular biology; Treasure trove or trivial pursuit (1988) Trends Biochem Sci, 13 (10), p. 410. , 10.1016/0968-0004(88)90198-3; Park, Y.M., Squizzato, S., Buso, N., Gur, T., Lopez, R., The EBI search engine: EBI search as a service-making biological data accessible for all (2017) Nucleic Acids Research, 45 (W1), pp. W545-W549. , 1:CAS:528:DC%2BC1cXhs1aitro%3D; O'Connor, B.D., The Dockstore: Enabling modular, community-focused sharing of Docker-based genomics tools and workflows (2017) F1000Research, 6, p. 52. , 10.12688/f1000research.10137.1 28344774 5333608; Artimo, P., Jonnalagedda, M., Arnold, K., Baratin, D., Csardi, G., De Castro, E., Duvaud, S., Stockinger, H., ExPASy: SIB bioinformatics resource portal (2012) Nucleic Acids Research, 40 (W1), pp. W597-W603. , 1:CAS:528:DC%2BC3sXjtVCqu7c%3D; Ison, J., Rapacki, K., Menager, H., Kalaš, M., Rydza, E., Chmura, P., Anthon, C., Brunak, S., Tools and data services registry: A community effort to document bioinformatics resources (2015) Nucleic Acids Research, 44 (D1), pp. D38-D47; Ison, J., Kalas, M., Jonassen, I., Bolser, D., Uludag, M., McWilliam, H., Malone, J., Rice, P., EDAM: An ontology of bioinformatics operations, types of data and identifiers, topics and formats (2013) Bioinformatics, 29 (10), pp. 1325-1332. , 1:CAS:528:DC%2BC3sXnvV2msbk%3D; Wise, J., De Barron, A.G., Splendiani, A., Balali-Mood, B., Vasant, D., Little, E., Mellino, G., Hedley, V., Implementation and relevance of FAIR data principles in biopharmaceutical R&D (2019) Drug Discovery Today, 24 (4), pp. 933-938; Palmblad, M., Automated workflow composition in mass spectrometry-based proteomics (2018) Bioinformatics, 35 (4), pp. 656-664. , 10.1093/bioinformatics/bty646 6378944; Brancotte, B., A reusable tree-based web-visualization to browse EDAM ontology, and contribute to it (2018) J Open Source Software, 3 (27), p. 698. , 10.21105/joss.00698; Da Veiga Leprevost, F., Gruning, B.A., Alves Aflitos, S., Rost, H.L., Uszkoreit, J., Barsnes, H., Vaudel, M., Perez-Riverol, Y., BioContainers: An open-source and community-driven framework for software standardization (2017) Bioinformatics, 33 (16), pp. 2580-2582. , 1:CAS:528:DC%2BC1cXitFOnt73L; Hillion, K.-H., Using bio.tools to generate and annotate workbench tool descriptions (2017) F1000Research, 6, p. 2074. , 10.12688/f1000research.12974.1; Afgan, E., Baker, D., Batut, B., Van Den Beek, M., Bouvier, D., Čech, M., Chilton, J., Blankenberg, D., The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update (2018) Nucleic Acids Research, 46 (W1), pp. W537-W544. , 1:CAS:528:DC%2BC1MXosVyrur8%3D; Linden, M., Common ELIXIR Service for Researcher Authentication and Authorisation (2018) F1000Res, 7, p. 1199. , 10.12688/f1000research.15161.1; Larcombe, L., ELIXIR-UK role in bioinformatics training at the National Level and across ELIXIR (2017) F1000Research, 6, p. 952. , 10.12688/f1000research.11837.1; McQuilton, P., Gonzalez-Beltran, A., Rocca-Serra, P., Thurston, M., Lister, A., Maguire, E., Sansone, S.-A., BioSharing: Curated and crowd-sourced metadata standards, databases and data policies in the life sciences (2016) Database, 2016, p. baw075","Ison, J.; National Life Science Supercomputing Center, Technical University of Denmark, Building 208, Denmark; email: jison@bioinformatics.dtu.dk",,,"BioMed Central Ltd.",,,,,14747596,,GNBLF,"31405382","English","Genome Biol.",Article,"Final",Open Access,Scopus,2-s2.0-85070536381
"Aterido A., Cañete J.D., Tornero J., Ferrándiz C., Pinto J.A., Gratacós J., Queiró R., Montilla C., Torre-Alonso J.C., Pérez-Venegas J.J., Fernández Nebro A., Muñoz-Fernández S., González C.M., Roig D., Zarco P., Erra A., Rodríguez J., Castañeda S., Rubio E., Salvador G., Díaz-Torné C., Blanco R., Willisch Domínguez A., Mosquera J.A., Vela P., Sánchez-Fernández S.A., Corominas H., Ramírez J., De La Cueva P., Fonseca E., Fernández E., Puig L., Dauden E., Sánchez-Carazo J.L., López-Estebaranz J.L., Moreno D., Vanaclocha F., Herrera E., Blanco F., Fernándeza Gutiérrez B., González A., Pérez-García C., Alperia López M., Olivé Marques A., Martíneza Taboada V., González-Álvaro I., Sanmartí R., Tomás Roura C., García-Montero A.C., Bonàs-Guarch S., Mercader J.M., Torrents D., Codó L., Gelpí J.L., López-Corbeto M., Pluma A., López-Lasanta M., Tortosa R., Palau N., Absher D., Myers R., Marsal S., Julià A.","56239671200;7003746360;36151354800;7005892900;56883759100;23469245300;6603878341;12782882100;6603460831;55338747000;57195363279;7004546711;36064831900;6602407204;7006771455;16678368700;57209135380;6701750483;56529071700;7003510663;12779759300;7102430622;26538402100;8055295800;7004528221;55986702400;6602373022;55794210400;15043904600;34975078800;55933326900;7101770587;7003438085;9233529000;6603673238;57207745958;6603052674;7103001516;7102243071;57206906476;55455325800;10739123700;57206906499;6507172289;57206907636;57200864474;7004460755;57205129593;6603714021;55548527500;56473714000;6603452371;55882083800;35517522400;57151370100;57200277397;23035265100;55933194400;54412813600;57198406019;7403700738;57210770007;57210878792;","Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis",2019,"Annals of the Rheumatic Diseases","78","3",,"355","364",,4,"10.1136/annrheumdis-2018-214158X","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058700955&doi=10.1136%2fannrheumdis-2018-214158X&partnerID=40&md5=29ab04d836b434888beeaed0678303f5","Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, Barcelona, Spain; Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Mexico; Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Rheumatology Department, Complejo Hospitalario Juan Canalejo, A Coruna, Spain; Rheumatology Department, Hospital Parc Tauli, Sabadell, Spain; Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Rheumatology Department, Hospital Virgen de la Vega, Salamanca, Spain; Rheumatology Department, Hospital Monte Naranco, Oviedo, Spain; Rheumatology Department, Hospital de Jerez de la Frontera, Cadiz, Spain; Rheumatology Department, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Malaga, Spain; Rheumatology Department, Hospital Universitario Infanta Sofia, Universidad Europea, Madrid, Spain; Rheumatology Department, Hospital Universitario Gregorio Maranon, Madrid, Spain; Rheumatology Department, Hospital Moises Broggi, Barcelona, Spain; Rheumatology Department, Hospital Universitario Fundacion Alcorcon, Madrid, Spain; Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain; Rheumatology Department, Hospital Universitario la Princesa, IIS la Princesa, Madrid, Spain; Rheumatology Department, Centro de Salud Virgen de Los Reyes, Sevilla, Spain; Rheumatology Department, Hospital Universitario Mutua de Terrassa, Terrassa, Spain; Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Rheumatology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain; Rheumatology Department, Complexo Hospitalario de Ourense, Ourense, Spain; Rheumatology Department, Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain; Rheumatology Department, Hospital General Universitario de Alicante, Alicante, Spain; Rheumatology Department, Hospital la Mancha Centro, Alcazar de San Juan, Spain; Rheumatology Department, Hospital Dos de Maig, Barcelona, Spain; Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain; Dermatology Department, Complejo Hospitalario Universitario de A Coruna, A Coruna, Spain; Dermatology Department, Hospital Universitario de Salamanca, Salamanca, Spain; Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Dermatology Department, Hospital Universitario la Princesa, IIS la Princesa, Madrid, Spain; Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; Dermatology Department, Hospital Universitario Fundacion Alcorcon, Madrid, Spain; Dermatology Department, Hospital Virgen Macarena, Sevilla, Spain; Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Dermatology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain; Rheumatology Department, INIBIC-Hospital, Universitario A Coruna, A Coruna, Spain; Rheumatology Department, Hospital Clinico San Carlos, IDISSC, Madrid, Spain; Instituto de Investigacion Sanitaria Hospital Clinico, Universitario de Santiago, Santiago de Compostela, Spain; Rheumatology Department, Parc de Salut Mar Barcelona, Barcelona, Spain; Rheumatology Department, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, Spain; Rheumatology Department, Hospital Comarcal d'Amposta, Tarragona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Barcelona Supercomputing Centre (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain; Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain; Life Sciences Department, Barcelona Supercomputing Centre, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States","Aterido, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain; Cañete, J.D., Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, Barcelona, Spain; Tornero, J., Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Mexico; Ferrándiz, C., Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Pinto, J.A., Rheumatology Department, Complejo Hospitalario Juan Canalejo, A Coruna, Spain; Gratacós, J., Rheumatology Department, Hospital Parc Tauli, Sabadell, Spain; Queiró, R., Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Montilla, C., Rheumatology Department, Hospital Virgen de la Vega, Salamanca, Spain; Torre-Alonso, J.C., Rheumatology Department, Hospital Monte Naranco, Oviedo, Spain; Pérez-Venegas, J.J., Rheumatology Department, Hospital de Jerez de la Frontera, Cadiz, Spain; Fernández Nebro, A., Rheumatology Department, Instituto de Investigacion Biomedica de Malaga, Hospital Regional Universitario de Malaga, Malaga, Spain; Muñoz-Fernández, S., Rheumatology Department, Hospital Universitario Infanta Sofia, Universidad Europea, Madrid, Spain; González, C.M., Rheumatology Department, Hospital Universitario Gregorio Maranon, Madrid, Spain; Roig, D., Rheumatology Department, Hospital Moises Broggi, Barcelona, Spain; Zarco, P., Rheumatology Department, Hospital Universitario Fundacion Alcorcon, Madrid, Spain; Erra, A., Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Rodríguez, J., Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain; Castañeda, S., Rheumatology Department, Hospital Universitario la Princesa, IIS la Princesa, Madrid, Spain; Rubio, E., Rheumatology Department, Centro de Salud Virgen de Los Reyes, Sevilla, Spain; Salvador, G., Rheumatology Department, Hospital Universitario Mutua de Terrassa, Terrassa, Spain; Díaz-Torné, C., Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Blanco, R., Rheumatology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain; Willisch Domínguez, A., Rheumatology Department, Complexo Hospitalario de Ourense, Ourense, Spain; Mosquera, J.A., Rheumatology Department, Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain; Vela, P., Rheumatology Department, Hospital General Universitario de Alicante, Alicante, Spain; Sánchez-Fernández, S.A., Rheumatology Department, Hospital la Mancha Centro, Alcazar de San Juan, Spain; Corominas, H., Rheumatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, Rheumatology Department, Hospital Dos de Maig, Barcelona, Spain; Ramírez, J., Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, Barcelona, Spain; De La Cueva, P., Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain; Fonseca, E., Dermatology Department, Complejo Hospitalario Universitario de A Coruna, A Coruna, Spain; Fernández, E., Dermatology Department, Hospital Universitario de Salamanca, Salamanca, Spain; Puig, L., Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Dauden, E., Dermatology Department, Hospital Universitario la Princesa, IIS la Princesa, Madrid, Spain; Sánchez-Carazo, J.L., Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; López-Estebaranz, J.L., Dermatology Department, Hospital Universitario Fundacion Alcorcon, Madrid, Spain; Moreno, D., Dermatology Department, Hospital Virgen Macarena, Sevilla, Spain; Vanaclocha, F., Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Herrera, E., Dermatology Department, Hospital Universitario Virgen de la Victoria, Malaga, Spain; Blanco, F., Rheumatology Department, INIBIC-Hospital, Universitario A Coruna, A Coruna, Spain; Fernándeza Gutiérrez, B., Rheumatology Department, Hospital Clinico San Carlos, IDISSC, Madrid, Spain; González, A., Instituto de Investigacion Sanitaria Hospital Clinico, Universitario de Santiago, Santiago de Compostela, Spain; Pérez-García, C., Rheumatology Department, Parc de Salut Mar Barcelona, Barcelona, Spain; Alperia López, M., Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Olivé Marques, A., Rheumatology Department, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, Spain; Martíneza Taboada, V., Rheumatology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain; González-Álvaro, I., Rheumatology Department, Hospital Universitario la Princesa, IIS la Princesa, Madrid, Spain; Sanmartí, R., Rheumatology Department, Hospital Clinic de Barcelona and IDIBAPS, Barcelona, Spain; Tomás Roura, C., Rheumatology Department, Hospital Comarcal d'Amposta, Tarragona, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Bonàs-Guarch, S., Barcelona Supercomputing Centre (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain; Mercader, J.M., Barcelona Supercomputing Centre (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain; Torrents, D., Barcelona Supercomputing Centre (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain, Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain; Codó, L., Life Sciences Department, Barcelona Supercomputing Centre, Barcelona, Spain; Gelpí, J.L., Life Sciences Department, Barcelona Supercomputing Centre, Barcelona, Spain; López-Corbeto, M., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Pluma, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Palau, N., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States; Myers, R., HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States; Marsal, S., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Julià, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain","Objective Psoriatic arthritis (PsA) is a chronic inflammatory arthritis affecting up to 30% of patients with psoriasis (Ps). To date, most of the known risk loci for PsA are shared with Ps, and identifying disease-specific variation has proven very challenging. The objective of the present study was to identify genetic variation specific for PsA. Methods We performed a genome-wide association study in a cohort of 835 patients with PsA and 1558 controls from Spain. Genetic association was tested at the single marker level and at the pathway level. Meta-analysis was performed with a case-control cohort of 2847 individuals from North America. To confirm the specificity of the genetic associations with PsA, we tested the associated variation using a purely cutaneous psoriasis cohort (PsC, n=614) and a rheumatoid arthritis cohort (RA, n=1191). Using network and drug-repurposing analyses, we further investigated the potential of the PsA-specific associations to guide the development of new drugs in PsA. Results We identified a new PsA risk single-nucleotide polymorphism at B3GNT2 locus (p=1.10e-08). At the pathway level, we found 14 genetic pathways significantly associated with PsA (p FDR <0.05). From these, the glycosaminoglycan (GAG) metabolism pathway was confirmed to be disease-specific after comparing the PsA cohort with the cohorts of patients with PsC and RA. Finally, we identified candidate drug targets in the GAG metabolism pathway as well as new PsA indications for approved drugs. Conclusion These findings provide insights into the biological mechanisms that are specific for PsA and could contribute to develop more effective therapies. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.","drug repurposing; genetics; genome-wide association study; glycosaminoglycan; psoriatic arthritis","glycosaminoglycan; Article; B3GNT2 gene; biological activity; case control study; cohort analysis; controlled study; disease association; disease marker; drug indication; drug targeting; gene; gene locus; genetic association; genetic identification; genetic risk; genetic variation; genome-wide association study; glycosaminoglycan metabolism; human; major clinical study; meta analysis; North America; priority journal; psoriasis; psoriatic arthritis; rheumatoid arthritis; risk assessment; risk factor; signal transduction; single nucleotide polymorphism; Spain; therapy effect; transcriptomics",,,,,"Generalitat de Catalunya

Krembil Foundation

Canadian Institutes of Health Research

Helene Morgan Babcock and Alfred Babcock Memorial Scholarship Trust

Ministerio de Economía y Competitividad: iPT-010000-2010-36, Pse-010000-2006-6

European Regional Development Fund: 00587","Funding This study was funded by the spanish Ministry of economy and Competitiveness (grant numbers: Pse-010000-2006-6 and iPT-010000-2010-36, cofunded by the european Regional Development Fund). This work was also sponsored by the ’agència de Gestió d’ajuts Universitaris i de Recerca’ (aGaUR, Fi-DGR2016, grant number: 00587), which is supported by the ’secretaria d’Universitats i Recerca’ (economy and Knowledge Department, Generalitat de Catalunya) and cofunded by the european social Fund. The obtention of the GWas data from the Psa case-control cohort from north american population was supported by grants from the niH, the Canadian institutes of Health Research, the Krembil Foundation, the Babcock Memorial Trust, the Barbara and neal Henschel Charitable Foundation and the ann arbor Veterans affairs Hospital. The study sponsors had no role in the collection, analysis or interpretation of the data",,,"Ibrahim, G., Waxman, R., Helliwell, P.S., The prevalence of psoriatic arthritis in people with psoriasis (2009) Arthritis Rheum, 61, pp. 1373-1378; Chandran, V., Raychaudhuri, S.P., Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis (2010) J Autoimmun, 34, pp. J314-J321; Rosen, C.F., Mussani, F., Chandran, V., Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone (2012) Rheumatology, 51, pp. 571-576; Ritchlin, C.T., Colbert, R.A., Gladman, D.D., Psoriatic Arthritis (2017) N Engl J Med, 376, pp. 957-970; Bhalerao, J., Bowcock, A.M., The genetics of psoriasis: A complex disorder of the skin and immune system (1998) Hum Mol Genet, 7, pp. 1537-1545; Chandran, V., Schentag, C.T., Brockbank, J.E., Familial aggregation of psoriatic arthritis (2009) Ann Rheum Dis, 68, pp. 664-667; Elder, J.T., Nair, R.P., Guo, S.W., The genetics of psoriasis (1994) Arch Dermatol, 130, pp. 216-224; Gladman, D.D., Farewell, V.T., Pellett, F., HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs (2003) Hum Immunol, 64, pp. 887-889; Strange, A., Capon, F., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) Nat Genet, 42, pp. 985-990. , Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2; Tsoi, L.C., Spain, S.L., Ellinghaus, E., Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci (2015) Nat Commun, 6, p. 7001; Tsoi, L.C., Spain, S.L., Knight, J., Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (2012) Nat Genet, 44, pp. 1341-1348; Yin, X., Low, H.Q., Wang, L., Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility (2015) Nat Commun, 6, p. 6916; Yin, X., Wineinger, N.E., Cheng, H., Common variants explain a large fraction of the variability in the liability to psoriasis in a Han Chinese population (2014) BMC Genomics, 15, p. 87; Zuo, X., Sun, L., Yin, X., Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis (2015) Nat Commun, 6, p. 6793; Stuart, P.E., Nair, R.P., Tsoi, L.C., Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture (2015) Am J Hum Genet, 97, pp. 816-836; Bowes, J., Budu-Aggrey, A., Huffmeier, U., Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis (2015) Nat Commun, 6, p. 6046; Liu, Y., Helms, C., Liao, W., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci (2008) PLoS Genet, 4, p. e1000041; Hüffmeier, U., Uebe, S., Ekici, A.B., Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis (2010) Nat Genet, 42, pp. 996-999; Ellinghaus, E., Stuart, P.E., Ellinghaus, D., Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL (2012) J Invest Dermatol, 132, pp. 1133-1140; Julià, A., Pinto, J.A., Gratacós, J., A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk (2015) Ann Rheum Dis, 74, pp. 1875-1881; Apel, M., Uebe, S., Bowes, J., Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis (2013) Arthritis Rheum, 65, pp. 1224-1231; Bowes, J., Loehr, S., Budu-Aggrey, A., PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: Evidence for a further PsA-specific risk locus (2015) Ann Rheum Dis, 74, pp. 1882-1885; Chen, H., Poon, A., Yeung, C., A genetic risk score combining ten psoriasis risk loci improves disease prediction (2011) PLoS One, 6, p. e19454; Manolio, T.A., Collins, F.S., Cox, N.J., Finding the missing heritability of complex diseases (2009) Nature, 461, pp. 747-753; Du, Y., Xie, J., Chang, W., Genome-wide association studies: Inherent limitations and future challenges (2012) Front Med, 6, pp. 444-450; Wang, K., Li, M., Hakonarson, H., Analysing biological pathways in genome-wide association studies (2010) Nat Rev Genet, 11, pp. 843-854; De Leeuw, C.A., Neale, B.M., Heskes, T., The statistical properties of gene-set analysis (2016) Nat Rev Genet, 17, pp. 353-364; Wu, M.C., Kraft, P., Epstein, M.P., Powerful SNP-set analysis for case-control genomewide association studies (2010) Am J Hum Genet, 86, pp. 929-942; Aterido, A., Julià, A., Ferrándiz, C., Genome-wide pathway analysis identifies genetic pathways associated with psoriasis (2016) J Invest Dermatol, 136, pp. 593-602; Aterido, A., Julià, A., Carreira, P., Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus (2017) Arthritis Res Ther, 19, p. 138; Julià, A., Tortosa, R., Hernanz, J.M., Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes (2012) Hum Mol Genet, 21, pp. 4549-4557; Taylor, W., Gladman, D., Helliwell, P., Classification criteria for psoriatic arthritis: Development of new criteria from a large international study (2006) Arthritis Rheum, 54, pp. 2665-2673; Howie, B., Marchini, J., Stephens, M., Genotype imputation with thousands of genomes (2011) G3, 1, pp. 457-470; Abecasis, G.R., Auton, A., An integrated map of genetic variation from 1, 092 human genomes (2012) Nature, 491, pp. 56-65. , 1000 Genomes Project Consortium; Julià, A., Blanco, F., Fernández-Gutierrez, B., Identification of IRX1 as a risk locus for rheumatoid factor positivity in rheumatoid arthritis in a genome-wide association study (2016) Arthritis Rheumatol, 68, pp. 1384-1391; Jia, X., Han, B., Onengut-Gumuscu, S., Imputing amino acid polymorphisms in human leukocyte antigens (2013) PLoS One, 8, p. e64683; Marchini, J., Howie, B., Myers, S., A new multipoint method for genome-wide association studies by imputation of genotypes (2007) Nat Genet, 39, pp. 906-913; Bowes, J., Ashcroft, J., Dand, N., Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis (2017) Ann Rheum Dis, 76, pp. 1774-1779; Okada, Y., Han, B., Tsoi, L.C., Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes (2014) Am J Hum Genet, 95, pp. 162-172; Willer, C.J., Li, Y., Abecasis, G.R., METAL: Fast and efficient meta-analysis of genomewide association scans (2010) Bioinformatics, 26, pp. 2190-2191; Ramanan, V.K., Shen, L., Moore, J.H., Pathway analysis of genomic data: Concepts, methods, and prospects for future development (2012) Trends Genet, 28, pp. 323-332; Edwards, Y.J., Beecham, G.W., Scott, W.K., Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach (2011) PLoS One, 6, p. e16917; Chen, D., Enroth, S., Ivansson, E., Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection (2014) Hum Mol Genet, 23, pp. 6047-6060; Barrett, T., Wilhite, S.E., Ledoux, P., NCBI GEO: Archive for functional genomics data sets-update (2013) Nucleic Acids Res, 41, pp. D991-D995. , (Database issue); Langfelder, P., Horvath, S., WGCNA: An R package for weighted correlation network analysis (2008) BMC Bioinformatics, 9, p. 559; Pollock, R.A., Abji, F., Liang, K., Gene expression differences between psoriasis patients with and without inflammatory arthritis (2015) J Invest Dermatol, 135, pp. 620-623; Hahn, M.W., Kern, A.D., Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks (2005) Mol Biol Evol, 22, pp. 803-806; Togayachi, A., Kozono, Y., Ishida, H., Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activation (2007) Proc Natl Acad Sci U S A, 104, pp. 15829-15834; Ward, L.D., Kellis, M., HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants (2012) Nucleic Acids Res, 40, pp. D930-D934. , (Database issue); The Genotype-Tissue Expression (GTEx) project (2013) Nat Genet, 45, pp. 580-585. , GTEx Consortium; Okada, Y., Terao, C., Ikari, K., Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population (2012) Nat Genet, 44, pp. 511-516; Reveille, J.D., Sims, A.M., Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci (2010) Nat Genet, 42, pp. 123-127. , A ustralo-Anglo-American Spondyloarthritis Consortium (TASC); Togayachi, A., Kozono, Y., Kuno, A., Beta3GnT2 (B3GNT2), a major polylactosamine synthase: Analysis of B3GNT2-deficient mice (2010) Methods Enzymol, 479, pp. 185-204; Wang, K., Li, M., Bucan, M., Pathway-based approaches for analysis of genomewide association studies (2007) Am J Hum Genet, 81, pp. 1278-1283; Gulati, K., Poluri, K.M., Mechanistic and therapeutic overview of glycosaminoglycans: The unsung heroes of biomolecular signaling (2016) Glycoconj J, 33, pp. 1-17; Schett, G., Coates, L.C., Ash, Z.R., Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Traditional views, novel insights gained from TNF blockade, and concepts for the future (2011) Arthritis Res Ther, 13, p. S4; Caterson, B., Flannery, C.R., Hughes, C.E., Mechanisms involved in cartilage proteoglycan catabolism (2000) Matrix Biol, 19, pp. 333-344; Afratis, N., Gialeli, C., Nikitovic, D., Glycosaminoglycans: Key players in cancer cell biology and treatment (2012) Febs J, 279, pp. 1177-1197; Hansen, C., Otto, E., Kuhlemann, K., Glycosaminoglycans in autoimmunity (1996) Clin Exp Rheumatol, 14, pp. S59-67; Arner, E.C., Hughes, C.E., Decicco, C.P., Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase (1998) Osteoarthritis Cartilage, 6, pp. 214-228; Van Den Boom, R., Van Der Harst, M.R., Brommer, H., Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1 (2005) Equine Vet J, 37, pp. 19-25; Patterson, A.M., Cartwright, A., David, G., Differential expression of syndecans and glypicans in chronically inflamed synovium (2008) Ann Rheum Dis, 67, pp. 592-601; Elkayam, O., Yaron, I., Shirazi, I., Serum levels of hyaluronic acid in patients with psoriatic arthritis (2000) Clin Rheumatol, 19, pp. 455-457; Sugimoto, K., Iizawa, T., Harada, H., Cartilage degradation independent of MMP/ aggrecanases (2004) Osteoarthritis Cartilage, 12, pp. 1006-1014; Baker, K.F., Isaacs, J.D., Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis (2018) Ann Rheum Dis, 77, pp. 175-187; Kundu-Raychaudhuri, S., Abria, C., Raychaudhuri, S.P., IL-9, a local growth factor for synovial T cells in inflammatory arthritis (2016) Cytokine, 79, pp. 45-51; Colucci, S., Brunetti, G., Cantatore, F.P., Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis (2007) J Pathol, 212, pp. 47-55; Gibbs, J.B., Mechanism-based target identification and drug discovery in cancer research (2000) Science, 287, pp. 1969-1973; Okada, Y., Wu, D., Trynka, G., Genetics of rheumatoid arthritis contributes to biology and drug discovery (2014) Nature, 506, pp. 376-381; Francesconi, M., Lehner, B., The effects of genetic variation on gene expression dynamics during development (2014) Nature, 505, pp. 208-211; Van Der Wijst, M.G.P., Brugge, H., De Vries, D.H., Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs (2018) Nat Genet, 50, pp. 493-497; Fairfax, B.P., Humburg, P., Makino, S., Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression (2014) Science, 343, p. 1246949; Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., The NIH Roadmap Epigenomics Mapping Consortium (2010) Nat Biotechnol, 28, pp. 1045-1048","Julià, A.; Rheumatology Research Group, Vall d'Hebron Research InstituteSpain; email: toni.julia@vhir.org",,,"BMJ Publishing Group",,,,,00034967,,ARDIA,"30552173","English","Ann. Rheum. Dis.",Article,"Final",,Scopus,2-s2.0-85058700955
"Delgado J., Naro D., Llorente S., Gelpi J.L., Royo R.","8349341200;57194139939;8349341100;35517522400;24176373200;","Metadata to describe genomic information",2018,"Studies in Health Technology and Informatics","247",,,"621","625",,,"10.3233/978-1-61499-852-5-621","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046543160&doi=10.3233%2f978-1-61499-852-5-621&partnerID=40&md5=3171cbafe0fc4408e62a2f22e132bd2c","DMAG, DAC, Universitat Politècnica de Catalunya (UPC), Spain; Barcelona Supercomputing Center (BSC), Spain; Dept. Biochemistry and Molecular Biomedicine, Univ. of Barcelona (UB), Spain","Delgado, J., DMAG, DAC, Universitat Politècnica de Catalunya (UPC), Spain; Naro, D., DMAG, DAC, Universitat Politècnica de Catalunya (UPC), Spain, Dept. Biochemistry and Molecular Biomedicine, Univ. of Barcelona (UB), Spain; Llorente, S., DMAG, DAC, Universitat Politècnica de Catalunya (UPC), Spain; Gelpi, J.L., Barcelona Supercomputing Center (BSC), Spain, Dept. Biochemistry and Molecular Biomedicine, Univ. of Barcelona (UB), Spain; Royo, R., Barcelona Supercomputing Center (BSC), Spain","Interoperable metadata is key for the management of genomic information. We propose a flexible approach that we contribute to the standardization by ISO/IEC of a new format for efficient and secure compressed storage and transmission of genomic information. © 2018 European Federation for Medical Informatics (EFMI) and IOS Press.","Genomic Information; Interoperability; Metadata; Representation","conference paper; metadata; standardization; storage; genomics; Genomics; Metadata",,,,,"TEC2015-67774-2-R, TEC2015-67774-C2-1-R","This work is partly supported by the Spanish Government (GenCom, TEC2015-67774-C2-1-R and TEC2015-67774-2-R). We also thank the EGA team for their valuable comments.",,,"EGA, , https://ega-archive.org/; Genomic Standards Consortium, , http://gensc.org/; NCBI, , https://www.ncbi.nlm.nih.gov/; Sequence Alignment / Map (SAM) Format Specification, , https://samtools.github.io/hts-specs/; Delgado, J., Protecting privacy of genomic information (2017) Studies in Health Technology and Informatics, 235, pp. 318-322; MPEG, , https://mpeg.chiariglione.org/; MPEG-, , https://mpeg.chiariglione.org/standards/mpeg-g, G; Read Domain XML 1.5 Metadata Format, , https://www.ebi.ac.uk/ena/submit/read-xml-format-1-5; (2016) Joint Call for Proposals for Genomic Information Compression and Storage, , ISO/IEC JTC 1/SC 29/WG 11 ISO/TC 276/WG 5 MPEG2016/N16320, June; (2017) Transport and Storage of Genomic Information, , MPEG, ISO/IEC CD 23092-1, November; (2017) Coding of Genomic Information, , MPEG, ISO/IEC CD 23092-2, November; (2018) Genomic Information Metadata and APIs, , MPEG, ISO/IEC CD 23092-3, February; Cock, P., The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants (2010) Nucleir Acids Research, 38 (6). , April; https://www.elixir-europe.org/platforms/data/core-data-resources",,"Klein G.O.Karlsson D.Moen A.Ugon A.",,"IOS Press","40th Medical Informatics in Europe Conference, MIE 2018","24 April 2018 through 26 April 2018",,136052,09269630,9781614998518,,"29678035","English","Stud. Health Technol. Informatics",Conference Paper,"Final",,Scopus,2-s2.0-85046543160
"López-Ferrando V., Gazzo A., De La Cruz X., Orozco M., Gelpí J.L.","57194828762;57190015726;6603686486;7102809158;35517522400;","PMut: A web-based tool for the annotation of pathological variants on proteins, 2017 update",2017,"Nucleic Acids Research","45","W1",,"W222","W228",,17,"10.1093/nar/gkx313","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85023197268&doi=10.1093%2fnar%2fgkx313&partnerID=40&md5=9a9864c0cbfe8a3a769c2b50ae7a6824","Barcelona Supercomputing Center (BSC), Barcelona, Spain; Joint Program BSC-CRG-IRB Research Program for Computational Biology, Barcelona, Spain; Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain; Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain; Barcelona, ICREA, Spain; Dept. of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain; Interuniversity Institute for Bioinformatics, ULB-VUB, Brussels, Brussels, 1050, Belgium","López-Ferrando, V., Barcelona Supercomputing Center (BSC), Barcelona, Spain, Joint Program BSC-CRG-IRB Research Program for Computational Biology, Barcelona, Spain; Gazzo, A., Joint Program BSC-CRG-IRB Research Program for Computational Biology, Barcelona, Spain, Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Interuniversity Institute for Bioinformatics, ULB-VUB, Brussels, Brussels, 1050, Belgium; De La Cruz, X., Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain, Barcelona, ICREA, Spain; Orozco, M., Joint Program BSC-CRG-IRB Research Program for Computational Biology, Barcelona, Spain, Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Dept. of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain; Gelpí, J.L., Barcelona Supercomputing Center (BSC), Barcelona, Spain, Joint Program BSC-CRG-IRB Research Program for Computational Biology, Barcelona, Spain, Dept. of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, Spain","We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.",,"access to information; accuracy; Article; classifier; cross validation; data processing; data repository; Mendelian pathological mutation; mutation; mutational analysis; online system; pathology prediction; prediction; predictive value; priority journal; protein analysis; protein database; quality control; receiver operating characteristic; sensitivity and specificity; sequence analysis; software; validation process; web based tool; diseases; genetics; human; Internet; mutation; protein; Disease; Humans; Internet; Mutation; Proteins; Software",,"protein, 67254-75-5; Proteins","PMut",,,,,,"Collins, F.S., Brooks, L.D., Chakravarti, A., A DNA polymorphism discovery resource for research on human genetic variation (1998) Genome Res., 8, pp. 1229-1231; Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Shaw, N., Kalyanaraman, N., Characterization of single-nucleotide polymorphisms in coding regions of human genes (1999) Nat. Genet., 22, pp. 231-238; Fernald, G.H., Capriotti, E., Daneshjou, R., Karczewski, K.J., Altman, R.B., Bioinformatics challenges for personalized medicine (2011) Bioinformatics (Oxford, England), 27, pp. 1741-1748; Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Leal, S.M., A second generation human haplotype map of over 3.1 million SNPs (2007) Nature, 449, pp. 851-861; Wang, D.G., Fan, J.B., Siao, C.J., Berno, A., Young, P., Sapolsky, R., Ghandour, G., Spencer, J., Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome (1998) Science (New York, N.Y.), 280, pp. 1077-1082; Cotton, R.G., Auerbach, A.D., Axton, M., Barash, C.I., Berkovic, S.F., Brookes, A.J., Burn, J., Flicek, P., GENETICS. The human variome project (2008) Science (New York, N.Y.), 322, pp. 861-862; Abecasis, G.R., Altshuler, D., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E., McVean, G.A., A map of human genome variation from population-scale sequencing (2010) Nature, 467, pp. 1061-1073; Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls (2007) Nature, 447, pp. 661-678; Sherry, S.T., Ward, M.H., Kholodov, M., Baker, J., Phan, L., Smigielski, E.M., Sirotkin, K., DbSNP: The NCBI database of genetic variation (2001) Nucleic Acids Res., 29, pp. 308-311; Yip, Y.L., Famiglietti, M., Gos, A., Duek, P.D., David, F.P., Gateau, A., Bairoch, A., Annotating single amino acid polymorphisms in the UniProt/Swiss-Prot knowledgebase (2008) Hum. Mut., 29, pp. 361-366; Stenson, P.D., Mort, M., Ball, E.V., Shaw, K., Phillips, A., Cooper, D.N., The Human Gene Mutation Database: Building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine (2014) Hum. Genet., 133, pp. 1-9; Landrum, M.J., Lee, J.M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hoover, J., ClinVar: Public archive of interpretations of clinically relevant variants (2016) Nucleic Acids Res., 44, pp. D862-D868; Karchin, R., Next generation tools for the annotation of human SNPs (2009) Brief. Bioinform., 10, pp. 35-52; Mooney, S., Bioinformatics approaches and resources for single nucleotide polymorphism functional analysis (2005) Brief. Bioinform., 6, pp. 44-56; Tavtigian, S.V., Greenblatt, M.S., Lesueur, F., Byrnes, G.B., In silico analysis of missense substitutions using sequence-Alignment based methods (2008) Hum. Mut., 29, pp. 1327-1336; Ferrer-Costa, C., Gelpi, J.L., Zamakola, L., Parraga, I., De La Cruz, X., Orozco, M., PMUT: A web-based tool for the annotation of pathological mutations on proteins (2005) Bioinformatics (Oxford, England), 21, pp. 3176-3178; Bromberg, Y., Yachdav, G., Rost, B., SNAP predicts effect of mutations on protein function (2008) Bioinformatics (Oxford, England), 24, pp. 2397-2398; Ng, P.C., Henikoff, S., SIFT: Predicting amino acid changes that affect protein function (2003) Nucleic Acids Res., 31, pp. 3812-3814; Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S., Sunyaev, S.R., A method and server for predicting damaging missense mutations (2010) Nat. Methods, 7, pp. 248-249; Choi, Y., Chan, A.P., PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels (2015) Bioinformatics (Oxford, England), 31, pp. 2745-2747; Chun, S., Fay, J.C., Identification of deleterious mutations within three human genomes (2009) Genome Res., 19, pp. 1553-1561; Reva, B., Antipin, Y., Sander, C., Predicting the functional impact of protein mutations: Application to cancer genomics (2011) Nucleic Acids Res., 39, p. e118; Thomas, P.D., Kejariwal, A., Coding single-nucleotide polymorphisms associated with complex vs. Mendelian disease: Evolutionary evidence for differences in molecular effects (2004) Proc. Natl. Acad. Sci. U.S.A., 101, pp. 15398-15403; Shihab, H.A., Gough, J., Cooper, D.N., Stenson, P.D., Barker, G.L., Edwards, K.J., Day, I.N., Gaunt, T.R., Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models (2013) Hum. Mut., 34, pp. 57-65; Niroula, A., Urolagin, S., Vihinen, M., PON-P2: Prediction method for fast and reliable identification of harmful variants (2015) PLoS One, 10, p. e0117380; Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V.E., Kinzler, K.W., Vogelstein, B., Karchin, R., Cancer-specific high-Throughput annotation of somatic mutations: Computational prediction of driver missense mutations (2009) Cancer Res., 69, pp. 6660-6667; Kaminker, J.S., Zhang, Y., Watanabe, C., Zhang, Z., CanPredict: A computational tool for predicting cancer-Associated missense mutations (2007) Nucleic Acids Res., 35, pp. W595-W598; Wainreb, G., Ashkenazy, H., Bromberg, Y., Starovolsky-Shitrit, A., Haliloglu, T., Ruppin, E., Avraham, K.B., Ben-Tal, N., MuD: An interactive web server for the prediction of non-neutral substitutions using protein structural data (2010) Nucleic Acids Res., 38, pp. W523-W528; Kircher, M., Witten, D.M., Jain, P., Oroak, B.J., Cooper, G.M., Shendure, J., A general framework for estimating the relative pathogenicity of human genetic variants (2014) Nat. Genet., 46, pp. 310-315; Calabrese, R., Capriotti, E., Fariselli, P., Martelli, P.L., Casadio, R., Functional annotations improve the predictive score of human disease-related mutations in proteins (2009) Hum. Mut., 30, pp. 1237-1244; Capriotti, E., Arbiza, L., Casadio, R., Dopazo, J., Dopazo, H., Marti-Renom, M.A., Use of estimated evolutionary strength at the codon level improves the prediction of disease-related protein mutations in humans (2008) Hum. Mut., 29, pp. 198-204; Karchin, R., Diekhans, M., Kelly, L., Thomas, D.J., Pieper, U., Eswar, N., Haussler, D., Sali, A., LS-SNP: Large-scale annotation of coding non-synonymous SNPs based on multiple information sources (2005) Bioinformatics (Oxford, England), 21, pp. 2814-2820; Yue, P., Melamud, E., Moult, J., SNPs3D: Candidate gene and SNP selection for association studies (2006) BMC Bioinformatics, 7, p. 166; Dong, C., Wei, P., Jian, X., Gibbs, R., Boerwinkle, E., Wang, K., Liu, X., Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies (2015) Hum. Mol. Genet., 24, pp. 2125-2137; Schwarz, J.M., Rodelsperger, C., Schuelke, M., Seelow, D., MutationTaster evaluates disease-causing potential of sequence alterations (2010) Nat. Methods, 7, pp. 575-576; Jagadeesh, K.A., Wenger, A.M., Berger, M.J., Guturu, H., Stenson, P.D., Cooper, D.N., Bernstein, J.A., Bejerano, G., M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity (2016) Nat. Genet., 48, pp. 1581-1586; Gonzalez-Perez, A., Lopez-Bigas, N., Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel (2011) Am. J. Hum. Genet., 88, pp. 440-449; Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M.C., Estreicher, A., Gasteiger, E., Martin, M.J., Phan, I., The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 (2003) Nucleic Acids Res., 31, pp. 365-370; Suzek, B.E., Wang, Y., Huang, H., McGarvey, P.B., Wu, C.H., UniRef clusters: A comprehensive and scalable alternative for improving sequence similarity searches (2015) Bioinformatics (Oxford, England), 31, pp. 926-932; Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J., Gapped BLAST and PSI-BLAST: A new generation of protein database search programs (1997) Nucleic Acids Res., 25, pp. 3389-3402; Lassmann, T., Sonnhammer, E.L., Kalign-An accurate and fast multiple sequence alignment algorithm (2005) BMC Bioinformatics, 6, p. 298; Breiman, L., Random forests (2001) Mach. Learn., 45, pp. 5-32; Wang, K., Li, M., Hakonarson, H., ANNOVAR: Functional annotation of genetic variants from high-Throughput sequencing data (2010) Nucleic Acids Res., 38, p. e164; UniProt: The universal protein knowledgebase (2017) Nucleic Acids Res., 45, pp. D158-D169. , Uniprot; Berman, H., Henrick, K., Nakamura, H., Markley, J.L., The worldwide protein data bank (wwPDB): Ensuring a single, uniform archive of PDB data (2007) Nucleic Acids Res., 35, pp. D301-D303; Aken, B.L., Achuthan, P., Akanni, W., Amode, M.R., Bernsdorff, F., Bhai, J., Billis, K., Clapham, P., Ensembl 2017 (2017) Nucleic Acids Res., 45, pp. D635-D642; Finn, R.D., Coggill, P., Eberhardt, R.Y., Eddy, S.R., Mistry, J., Mitchell, A.L., Potter, S.C., Sangrador-Vegas, A., The Pfam protein families database: Towards a more sustainable future (2016) Nucleic Acids Res., 44, pp. D279-D285; Mitchell, A., Chang, H.Y., Daugherty, L., Fraser, M., Hunter, S., Lopez, R., McAnulla, C., Pesseat, S., The InterPro protein families database: The classification resource after 15 years (2015) Nucleic Acids Res., 43, pp. D213-D221; Mosca, R., Ceol, A., Aloy, P., Interactome3D: Adding structural details to protein networks (2013) Nat. Methods, 10, pp. 47-53","Gelpí, J.L.; Barcelona Supercomputing Center (BSC)Spain; email: gelpi@ub.edu",,,"Oxford University Press",,,,,03051048,,NARHA,"28453649","English","Nucleic Acids Res.",Article,"Final",Open Access,Scopus,2-s2.0-85023197268
"Aterido A., Julià A., Carreira P., Blanco R., López-Longo J.J., Venegas J.J.P., Olivé, Andreu J.L., Aguirre-Zamorano M., Vela P., Nolla J.M., Marenco-de la Fuente J.L., Zea A., Pego J.M., Freire M., Díez E., López-Lasanta M., López-Corbeto M., Palau N., Tortosa R., Gelpí J.L., Absher D., Myers R.M., Fernández-Nebro A., Marsal S.","56239671200;57210878792;55192600900;7102430622;56517079000;55338747000;7005738781;7103245648;6507662740;7004528221;7005300918;6505456136;6603779330;55678364500;7102299230;56519429800;23035265100;57151370100;54412813600;55933194400;35517522400;57198406019;7403700738;57195363279;6603356384;","Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus",2017,"Arthritis Research and Therapy","19","1", 138,"","",,8,"10.1186/s13075-017-1345-6","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021052889&doi=10.1186%2fs13075-017-1345-6&partnerID=40&md5=b5c0442e377afb4efb44cda9bb100be1","Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; Universitat Pompeu Fabra, Department of Experimental and Health Sciences, Barcelona, 08005, Spain; Hospital Universitario 12 de Octubre, Rheumatology Department, Madrid, 28041, Spain; Hospital Universitario Marqués de Valdecilla, Rheumatology Department, Santander, 39008, Spain; Hospital Universitario Gregorio Marañón, Rheumatology Department, Madrid, 28007, Spain; Hospital del SAS de Jerez de la Frontera, Rheumatology Department, Cádiz, 11407, Spain; Hospital Universitari Germans Trias i Pujol, Rheumatology Department, Badalona, 08916, Spain; Hospital Universitario Puerta de Hierro, Rheumatology Department, Madrid, 28222, Spain; Hospital Universitario Reina Sofía, Rheumatology Department, Córdoba, 14004, Spain; Hospital General Universitario de Alicante, Rheumatology Department, Alicante, 03010, Spain; Hospital Universitari de Bellvitge, Rheumatology Department, Barcelona, 08907, Spain; Hospital de Valme, Rheumatology Department, Sevilla, 41014, Spain; Hospital Universitario Ramón y Cajal, Rheumatology Department, Madrid, 28034, Spain; Instituto de Investigación Biomédica de Vigo, Ourense y Pontevedra, 36204, Spain; Hospital Universitario A Coruña, Rheumatology Department, A Coruña, 15006, Spain; Hospital Complejo Asistencial Universitario de León, Rheumatology Department, León, 24001, Spain; Life Sciences, Barcelona Supercomputing Centre, Barcelona, 08034, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, AL  35806, United States; Hospital Regional Universitario de Málaga, Rheumatology Department, Málaga, 29010, Spain; Universidad de Málaga, Instituto de Investigación Biomédica de Málaga, Málaga, 29010, Spain","Aterido, A., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain, Universitat Pompeu Fabra, Department of Experimental and Health Sciences, Barcelona, 08005, Spain; Julià, A., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; Carreira, P., Hospital Universitario 12 de Octubre, Rheumatology Department, Madrid, 28041, Spain; Blanco, R., Hospital Universitario Marqués de Valdecilla, Rheumatology Department, Santander, 39008, Spain; López-Longo, J.J., Hospital Universitario Gregorio Marañón, Rheumatology Department, Madrid, 28007, Spain; Venegas, J.J.P., Hospital del SAS de Jerez de la Frontera, Rheumatology Department, Cádiz, 11407, Spain; Olivé, Hospital Universitari Germans Trias i Pujol, Rheumatology Department, Badalona, 08916, Spain; Andreu, J.L., Hospital Universitario Puerta de Hierro, Rheumatology Department, Madrid, 28222, Spain; Aguirre-Zamorano, M., Hospital Universitario Reina Sofía, Rheumatology Department, Córdoba, 14004, Spain; Vela, P., Hospital General Universitario de Alicante, Rheumatology Department, Alicante, 03010, Spain; Nolla, J.M., Hospital Universitari de Bellvitge, Rheumatology Department, Barcelona, 08907, Spain; Marenco-de la Fuente, J.L., Hospital de Valme, Rheumatology Department, Sevilla, 41014, Spain; Zea, A., Hospital Universitario Ramón y Cajal, Rheumatology Department, Madrid, 28034, Spain; Pego, J.M., Instituto de Investigación Biomédica de Vigo, Ourense y Pontevedra, 36204, Spain; Freire, M., Hospital Universitario A Coruña, Rheumatology Department, A Coruña, 15006, Spain; Díez, E., Hospital Complejo Asistencial Universitario de León, Rheumatology Department, León, 24001, Spain; López-Lasanta, M., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; López-Corbeto, M., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; Palau, N., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; Tortosa, R., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Centre, Barcelona, 08034, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, AL  35806, United States; Myers, R.M., HudsonAlpha Institute for Biotechnology, Huntsville, AL  35806, United States; Fernández-Nebro, A., Hospital Regional Universitario de Málaga, Rheumatology Department, Málaga, 29010, Spain, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga, Málaga, 29010, Spain; Marsal, S., Vall d'Hebron Research Institute, Rheumatology Research Group, Barcelona, 08035, Spain","Background: Systemic lupus erythematosus (SLE) is a genetically complex rheumatic disease characterized by heterogeneous clinical manifestations of unknown etiology. Recent studies have suggested the existence of a genetic basis for SLE heterogeneity. The objective of the present study was to identify new genetic variation associated with the clinically relevant phenotypes in SLE. Methods: A two-stage pathway-based approach was used to identify the genetic variation associated with the main clinical phenotypes in SLE. In the discovery stage, 482 SLE patients were genotyped using Illumina Human Quad610 microarrays. Association between 798 reference genetic pathways from the Molecular Signatures Database and 11 SLE phenotypes was tested using the set-based method implemented in PLINK software. Pathways significantly associated after multiple test correction were subsequently tested for replication in an independent cohort of 425 SLE patients. Using an in silico approach, we analyzed the functional effects of common SLE therapies on the replicated genetic pathways. The association of known SLE risk variants with the development of the clinical phenotypes was also analyzed. Results: In the discovery stage, we found a significant association between the vascular endothelial growth factor (VEGF) pathway and oral ulceration (P value for false discovery rate (P FDR) &lt; 0.05), and between the negative regulation signaling pathway of retinoic acid inducible gene-I/melanoma differentiation associated gene 5 and the production of antinuclear antibodies (P FDR &lt; 0.05). In the replication stage, we validated the association between the VEGF pathway and oral ulceration. Therapies commonly used to treat mucocutaneous phenotypes in SLE were found to strongly influence VEGF pathway gene expression (P = 4.60e-4 to 5.38e-14). Analysis of known SLE risk loci identified a strong association between PTPN22 and the risk of hematologic disorder and with the development of antinuclear antibodies. Conclusions: The present study has identified VEGF genetic pathway association with the risk of oral ulceration in SLE. New therapies targeting the VEGF pathway could be more effective in reducing the severity of this phenotype. These findings represent a first step towards the understanding of the genetic basis of phenotype heterogeneity in SLE. © 2017 The Author(s).","Clinical phenotypes; Genetics; Genome-wide pathway analysis; Oral ulceration; Systemic lupus erythematosus","antinuclear antibody; betamethasone valerate; diphencyprone; imiquimod; interferon induced helicase C domain containing protein 1; non receptor protein tyrosine phosphatase 22; pimecrolimus; retinoic acid inducible protein I; vasculotropin; vasculotropin A; VEGFA protein, human; adolescent; adult; antibody production; Article; cohort analysis; computer analysis; controlled study; disease severity; female; gene expression regulation; gene locus; genetic association; genetic risk; genetic variability; genome-wide association study; genotype phenotype correlation; human; major clinical study; male; molecular pathology; mouth ulcer; phenotypic variation; PTPN22 gene; signal transduction; single nucleotide polymorphism; systemic lupus erythematosus; complication; genetic predisposition; genetic variation; genetics; genome-wide association study; genotype; mouth ulcer; pathology; phenotype; systemic lupus erythematosus; Adult; Female; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Humans; Lupus Erythematosus, Systemic; Male; Oral Ulcer; Phenotype; Vascular Endothelial Growth Factor A",,"betamethasone valerate, 2152-44-5, 57654-97-4; diphencyprone, 886-38-4; imiquimod, 99011-02-6; interferon induced helicase C domain containing protein 1; pimecrolimus, 137071-32-0; RNA helicase; vasculotropin, 127464-60-2; vasculotropin A, 489395-96-2; Vascular Endothelial Growth Factor A; VEGFA protein, human",,,,,,,"Danchenko, N., Satia, J.A., Anthony, M.S., Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden (2006) Lupus, 15 (5), pp. 308-318; Lisnevskaia, L., Murphy, G., Isenberg, D., Systemic lupus erythematosus (2014) Lancet, 384 (9957), pp. 1878-1888; Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Winchester, R.J., The 1982 revised criteria for the classification of systemic lupus erythematosus (1982) Arthritis Rheum, 25 (11), pp. 1271-1277; Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Nath, S.K., Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci (2008) Nat Genet, 40 (2), pp. 204-210; Bentham, J., Morris, D.L., Cunninghame Graham, D.S., Pinder, C.L., Tombleson, P., Behrens, T.W., Martin, J., Chen, L., Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus (2015) Nat Genet, 47 (12), pp. 1457-1464; Olson, J.M., Song, Y., Dudek, D.M., Moser, K.L., Kelly, J.A., Bruner, G.R., Downing, K.J., Harley, J.B., A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity (2002) Genes Immun, 3, pp. S5-S12; Ceccarelli, F., Perricone, C., Borgiani, P., Ciccacci, C., Rufini, S., Cipriano, E., Alessandri, C., Novelli, G., Genetic factors in systemic lupus erythematosus: contribution to disease phenotype (2015) J Immunol Res, 2015, p. 745647; Azevêdo, S.J., Addobbati, C., Sandrin-Garcia, P., Crovella, S., Systemic lupus erythematosus: old and new susceptibility genes versus clinical manifestations (2014) Curr Genomics, 15 (1), pp. 52-65; Sanchez, E., Nadig, A., Richardson, B.C., Freedman, B.I., Kaufman, K.M., Kelly, J.A., Niewold, T.B., Ziegler, J.T., Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus (2011) Ann Rheum Dis, 70 (10), pp. 1752-1757; Taylor, K.E., Remmers, E.F., Lee, A.T., Ortmann, W.A., Plenge, R.M., Tian, C., Chung, S.A., Kao, A.H., Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus (2008) PLoS Genet, 4 (5); Robinson, M.R., Wray, N.R., Visscher, P.M., Explaining additional genetic variation in complex traits (2014) Trends Genet, 30 (4), pp. 124-132; Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., McCarthy, M.I., Chakravarti, A., Finding the missing heritability of complex diseases (2009) Nature, 461 (7265), pp. 747-753; Du, Y., Xie, J., Chang, W., Han, Y., Cao, G., Genome-wide association studies: inherent limitations and future challenges (2012) Front Med, 6 (4), pp. 444-450; Johnson, R.C., Nelson, G.W., Troyer, J.L., Lautenberger, J.A., Kessing, B.D., Winkler, C.A., O'Brien, S.J., Accounting for multiple comparisons in a genome-wide association study (GWAS) (2010) BMC Genomics, 11, p. 724; Zhang, K., Cui, S., Chang, S., Zhang, L., Wang, J., i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study (2010) Nucleic Acids Res, 38 (WEB SERVER ISSUE), pp. W90-W95; Gui, H., Li, M., Sham, P.C., Cherny, S.S., Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's disease dataset (2011) BMC Res Notes, 4, p. 386; Ramanan, V.K., Shen, L., Moore, J.H., Saykin, A.J., Pathway analysis of genomic data: concepts, methods, and prospects for future development (2012) Trends Genet, 28 (7), pp. 323-332; Wu, M.C., Kraft, P., Epstein, M.P., Taylor, D.M., Chanock, S.J., Hunter, D.J., Lin, X., Powerful SNP-set analysis for case-control genome-wide association studies (2010) Am J Hum Genet, 86 (6), pp. 929-942; Chen, D., Enroth, S., Ivansson, E., Gyllensten, U., Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection (2014) Hum Mol Genet, 23 (22), pp. 6047-6060; Aterido, A., Julia, A., Ferrandiz, C., Puig, L., Fonseca, E., Fernandez-Lopez, E., Dauden, E., Moreno-Ramirez, D., Genome-wide pathway analysis identifies genetic pathways associated with psoriasis (2016) J Invest Dermatol, 136 (3), pp. 593-602; Julia, A., Tortosa, R., Hernanz, J.M., Canete, J.D., Fonseca, E., Ferrandiz, C., Unamuno, P., Sanmarti, R., Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes (2012) Hum Mol Genet, 21 (20), pp. 4549-4557; Yu, C., Gershwin, M.E., Chang, C., Diagnostic criteria for systemic lupus erythematosus: a critical review (2014) J Autoimmun, 48-49, pp. 10-13; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Daly, M.J., PLINK: a tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81 (3), pp. 559-575; Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nat Genet, 38 (8), pp. 904-909; Marchini, J., Howie, B., Myers, S., McVean, G., Donnelly, P., A new multipoint method for genome-wide association studies by imputation of genotypes (2007) Nat Genet, 39 (7), pp. 906-913; Willer, C.J., Li, Y., Abecasis, G.R., METAL: fast and efficient meta-analysis of genomewide association scans (2010) Bioinformatics, 26 (17), pp. 2190-2191; Wang, K., Li, M., Hakonarson, H., Analysing biological pathways in genome-wide association studies (2010) Nat Rev Genet, 11 (12), pp. 843-854; Leeuw, C.A., Neale, B.M., Heskes, T., Posthuma, D., The statistical properties of gene-set analysis (2016) Nat Rev Genet, 17 (6), pp. 353-364; Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdottir, H., Tamayo, P., Mesirov, J.P., Molecular signatures database (MSigDB) 3.0 (2011) Bioinformatics, 27, pp. 1739-1740; Edwards, Y.J., Beecham, G.W., Scott, W.K., Khuri, S., Bademci, G., Tekin, D., Martin, E.R., ffrench-Mullen, J., Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach (2011) PLoS One, 6 (2); Lesiak, A., Narbutt, J., Kobos, J., Kordek, R., Sysa-Jedrzejowska, A., Norval, M., Wozniacka, A., Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis (2009) Clin Exp Dermatol, 34 (5), pp. 570-575; Chang, A.Y., Werth, V.P., Treatment of cutaneous lupus (2011) Curr Rheumatol Rep, 13 (4), pp. 300-307; Khandpur, S., Sharma, V.K., Sumanth, K., Topical immunomodulators in dermatology (2004) J Postgrad Med, 50 (2), pp. 131-139; Ihaka, R., Gentleman, G., R: A language for data analysis and graphics (1996) J Comput Graph Stat, 5 (5), pp. 299-314; Shibuya, M., Claesson-Welsh, L., Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis (2006) Exp Cell Res, 312 (5), pp. 549-560; Ferrara, N., Vascular endothelial growth factor: basic science and clinical progress (2004) Endocr Rev, 25 (4), pp. 581-611; Sakly, N., Mirshahi, P., Ducros, E., Soria, J., Ghedira, I., Mirshahi, M., Angiogenic activity in sera of patients with systemic lupus erythematosus (2009) Lupus, 18 (8), pp. 705-712; Walchner, M., Meurer, M., Plewig, G., Messer, G., Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus (2000) Int J Dermatol, 39 (5), pp. 383-388; Cuadrado, M.J., Karim, Y., Sanna, G., Smith, E., Khamashta, M.A., Hughes, G.R., Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens (2005) Am J Med, 118 (3), pp. 246-250; Kuryliszyn-Moskal, A., Klimiuk, P.A., Sierakowski, S., Ciolkiewicz, M., Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities (2007) Arch Immunol Ther Exp (Warsz), 55, pp. 179-185; Moneib, H.A., Salem, S.A., Aly, D.G., Khedr, H.T., Wafaey, H.A., Hassan, H.E., Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations (2012) J Dermatol, 39 (1), p. 52; Mustafa, M.B., Porter, S.R., Smoller, B.R., Sitaru, C., Oral mucosal manifestations of autoimmune skin diseases (2015) Autoimmun Rev, 14 (10), pp. 930-951; Khatibi, M., Shakoorpour, A.H., Jahromi, Z.M., Ahmadzadeh, A., The prevalence of oral mucosal lesions and related factors in 188 patients with systemic lupus erythematosus (2012) Lupus, 21 (12), pp. 1312-1315; Munoz-Corcuera, M., Esparza-Gomez, G., Gonzalez-Moles, M.A., Bascones-Martinez, A., Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers (2009) Clin Exp Dermatol, 34, pp. 456-461; Arbiser, J.L., Johnson, D., Cohen, C., Brown, L.F., High-level expression of vascular endothelial growth factor and its receptors in an aphthous ulcer (2003) J Cutan Med Surg, 7 (3), pp. 225-228; Jacobson, J.M., Greenspan, J.S., Spritzler, J., Ketter, N., Fahey, J.L., Jackson, J.B., Fox, L., MacPhail, L.A., Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group (1997) N Engl J Med, 336 (21), pp. 1487-1493; Grinspan, D., Significant response of oral aphthosis to thalidomide treatment (1985) J Am Acad Dermatol, 12 (1 PART. 1), pp. 85-90; Urman, J.D., Lowenstein, M.B., Abeles, M., Weinstein, A., Oral mucosal ulceration in systemic lupus erythematosus (1978) Arthritis Rheum, 21 (1), pp. 58-61; Parodi, A., Massone, C., Cacciapuoti, M., Aragone, M.G., Bondavalli, P., Cattarini, G., Rebora, A., Measuring the activity of the disease in patients with cutaneous lupus erythematosus (2000) Br J Dermatol, 142 (3), pp. 457-460; Taylor, J., Glenny, A.M., Walsh, T., Brocklehurst, P., Riley, P., Gorodkin, R., Pemberton, M.N., Interventions for the management of oral ulcers in Behcet's disease (2014) Cochrane Database Syst Rev, 9; Yalcin, B., Arda, N., Tezel, G.G., Erman, M., Alli, N., Expressions of vascular endothelial growth factor and CD34 in oral aphthous lesions of Behcet's disease (2006) Anal Quant Cytol Histol, 28 (6), pp. 303-306; Brozovic, S., Vucicevic-Boras, V., Mravak-Stipetic, M., Jukic, S., Kleinheinz, J., Lukac, J., Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration (2002) J Oral Pathol Med, 31 (2), pp. 106-108; Kim, Y.S., Park, S.W., Kim, M.H., Jang, E.J., Park, J.S., Park, S.J., Baik, H.W., Hahm, K.B., Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers (2008) J Gastroenterol Hepatol, 23, pp. S131-S139; Namjou, B., Kim-Howard, X., Sun, C., Adler, A., Chung, S.A., Kaufman, K.M., Kelly, J.A., Scofield, R.H., PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes (2013) PLoS One, 8 (8); Khatri, P., Sirota, M., Butte, A.J., Ten years of pathway analysis: current approaches and outstanding challenges (2012) PLoS Comput Biol, 8 (2); The ENCODE (ENCyclopedia Of DNA Elements) Project (2004) Science, 306 (5696), pp. 636-640","Julià, A.; Vall d'Hebron Research Institute, Rheumatology Research GroupSpain; email: toni.julia@vhir.org",,,"BioMed Central Ltd.",,,,,14786354,,ARTRC,"28619073","English","Arthritis Res. Ther.",Article,"Final",Open Access,Scopus,2-s2.0-85021052889
"Hospital A., Candotti M., Gelpí J.L., Orozco M.","15831739300;36058488900;35517522400;7102809158;","The Multiple Roles of Waters in Protein Solvation",2017,"Journal of Physical Chemistry B","121","15",,"3636","3643",,9,"10.1021/acs.jpcb.6b09676","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020201582&doi=10.1021%2facs.jpcb.6b09676&partnerID=40&md5=ea5e294c66e06b8f0da440874402b4dc","Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, 08028, Spain; Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain","Hospital, A., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Candotti, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Gelpí, J.L., Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, 08028, Spain, Barcelona Supercomputing Center (BSC), Jordi Girona 29, Barcelona, 08034, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Department of Biochemistry and Molecular Biomedicine, University of Barcelona, Barcelona, 08028, Spain","Extensive molecular dynamics (MD) simulations have been used to characterize the multiple roles of water in solvating different types of proteins under different environmental conditions. We analyzed a small set of proteins, representative of the most prevalent meta-folds under native conditions, in the presence of crowding agents, and at high temperature with or without high concentration of urea. We considered also a protein in the unfolded state as characterized by NMR and atomistic MD simulations. Our results outline the main characteristics of the hydration environment of proteins and illustrate the dramatic plasticity of water, and its chameleonic ability to stabilize proteins under a variety of conditions. © 2017 American Chemical Society.",,"Molecular dynamics; Urea; Environmental conditions; High temperature; MD simulation; Molecular dynamics simulations; Proteins; protein; urea; water; chemistry; molecular dynamics; nuclear magnetic resonance spectroscopy; protein stability; solubility; temperature; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Protein Stability; Proteins; Solubility; Temperature; Urea; Water",,"protein, 67254-75-5; urea, 57-13-6; water, 7732-18-5; Proteins; Urea; Water",,,"Instituto Nacional de Perinatología, INPer: H2020, GA 676559, BioExcel GA 675728

Institució Catalana de Recerca i Estudis Avançats, ICREA

Ministerio de Economía y Competitividad, MINECO: BIO2015/64802-R, GA SEV-2015-050","The authors thank INB (Instituto Nacional de Bioinform?tica) for support in this project. Additional funding to this project comes from H2020 (BioExcel GA 675728, Elixir-Excelerate GA 676559) and the Spanish MINECO (BIO2015/64802-R) funding agencies. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain, GA SEV-2015-050). M.O. is an ICREA Academia researcher.",,,"Kuntz, I.D., Kauzmann, W., Hydration of Proteins and Polypeptides (1974) Adv. Protein Chem., 28, pp. 239-345; Quiocho, F.A., Wilson, D.K., Vyas, N.K., Substrate Specificity and Affinity of a Protein Modulated by Bound Water Molecules (1989) Nature, 340, pp. 404-407; Gerwert, K., Freier, E., Wolf, S., The Role of Protein-Bound Water Molecules in Microbial Rhodopsins (2014) Biochim. Biophys. Acta, Bioenerg., 1837, pp. 606-613; Bhat, T.N., Bentley, G.A., Boulot, G., Greene, M.I., Tello, D., Dall'Acqua, W., Souchon, H., Poljak, R.J., Bound Water Molecules and Conformational Stabilization Help Mediate an Antigen-Antibody Association (1994) Proc. Natl. Acad. Sci. U. S. A., 91, pp. 1089-1093; Smith, K.J., Reid, S.W., Harlos, K., McMichael, A.J., Stuart, D.I., Bell, J.I., Jones, E.Y., Bound Water Structure and Polymorphic Amino Acids Act Together to Allow the Binding of Different Peptides to MHC Class i HLA-B53 (1996) Immunity, 4, pp. 215-228; Bagchi, B., Water Dynamics in the Hydration Layer Around Proteins and Micelles (2005) Chem. Rev., 105, pp. 3197-3219; Ball, P., Water as an Active Constituent in Cell Biology (2008) Chem. Rev., 108, pp. 74-108; Fogarty, A.C., Duboué-Dijon, E., Sterpone, F., Hynes, J.T., Laage, D., Biomolecular Hydration Dynamics: A Jump Model Perspective (2013) Chem. Soc. Rev., 42, pp. 5672-5683; Halle, B., Protein Hydration Dynamics in Solution: A Critical Survey (2004) Philos. Trans. R. Soc., B, 359, pp. 1207-1223; Brooks, C.L., Karplus, M., Pettitt, B.M., (1988) Proteins: A Theoretical Perspective of Dynamics, Structure, and Thermodynamics, , Wiley: New York; Chichester, U.K; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of Folded Proteins (1977) Nature, 267, pp. 585-590; Bizzarri, A.R., Cannistraro, S., Molecular Dynamics of Water at the Protein-Solvent Interface (2002) J. Phys. Chem. B, 106, pp. 6617-6633; Pal, S., Bandyopadhyay, S., Importance of Protein Conformational Motions and Electrostatic Anchoring Sites on the Dynamics and Hydrogen Bond Properties of Hydration Water (2013) Langmuir, 29, pp. 1162-1173; Pizzitutti, F., Marchi, M., Sterpone, F., Rossky, P.J., How Protein Surfaces Induce Anomalous Dynamics of Hydration Water (2007) J. Phys. Chem. B, 111, pp. 7584-7590; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., Hospital, A., Gelpí, J.L., Orozco, M., A Consensus View of Protein Dynamics (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 796-801; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Pérez, A., Carrillo, O., Repchevsky, D., MoDEL (Molecular Dynamics Extended Library): A Database of Atomistic Molecular Dynamics Trajectories (2010) Structure, 18, pp. 1399-1409; Makarov, V.A., Andrews, B.K., Smith, P.E., Pettitt, B.M., Residence Times of Water Molecules in the Hydration Sites of Myoglobin (2000) Biophys. J., 79, pp. 2966-2974; García, A.E., Hummer, G., Water Penetration and Escape in Proteins (2000) Proteins: Struct., Funct., Genet., 38, pp. 261-272; Kaieda, S., Halle, B., Internal Water and Microsecond Dynamics in Myoglobin (2013) J. Phys. Chem. B, 117, pp. 14676-14687; Ball, P., Water as a Biomolecule (2008) ChemPhysChem, 9, pp. 2677-2685; Fogarty, A.C., Laage, D., Water Dynamics in Protein Hydration Shells: The Molecular Origins of the Dynamical Perturbation (2014) J. Phys. Chem. B, 118, pp. 7715-7729; Qvist, J., Ortega, G., Tadeo, X., Millet, O., Halle, B., Hydration Dynamics of a Halophilic Protein in Folded and Unfolded States (2012) J. Phys. Chem. B, 116, pp. 3436-3444; Candotti, M., Orozco, M., The Differential Response of Proteins to Macromolecular Crowding (2016) PLoS Comput. Biol., 12, p. e1005040; King, J.T., Arthur, E.J., Brooks, C.L., Kubarych, K.J., Crowding Induced Collective Hydration of Biological Macromolecules over Extended Distances (2014) J. Am. Chem. Soc., 136, pp. 188-194; Samanta, N., Luong, T.Q., Das Mahanta, D., Mitra, R.K., Havenith, M., Effect of Short Chain Poly(ethylene glycol)s on the Hydration Structure and Dynamics around Human Serum Albumin (2016) Langmuir, 32, pp. 831-837; Modig, K., Kurian, E., Prendergast, F.G., Halle, B., Water and Urea Interactions with the Native and Unfolded Forms of a Beta-Barrel Protein (2003) Protein Sci., 12, pp. 2768-2781; Sterpone, F., Stirnemann, G., Laage, D., Magnitude and Molecular Origin of Water Slowdown next to a Protein (2012) J. Am. Chem. Soc., 134, pp. 4116-4119; Candotti, M., Esteban-Martín, S., Salvatella, X., Orozco, M., Toward an Atomistic Description of the Urea-Denatured State of Proteins (2013) Proc. Natl. Acad. Sci. U. S. A., 110, pp. 5933-5938; Candotti, M., Pérez, A., Ferrer-Costa, C., Rueda, M., Meyer, T., Gelpí, J.L., Orozco, M., Exploring Early Stages of the Chemical Unfolding of Proteins at the Proteome Scale (2013) PLoS Comput. Biol., 9, p. e1003393; Murzin, A.G., Brenner, S.E., Hubbard, T., Chothia, C., SCOP: A Structural Classification of Proteins Database for the Investigation of Sequences and Structures (1995) J. Mol. Biol., 247, pp. 536-540; Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., Gelpí, J.L., MDWeb and MDMoby: An Integrated Web-Based Platform for Molecular Dynamics Simulations (2012) Bioinformatics, 28, pp. 1278-1279; Darden, T., York, D., Pedersen, L., Particle Mesh Ewald: An N·log(N) Method for Ewald Sums in Large Systems (1993) J. Chem. Phys., 98, pp. 10089-10092; Ryckaert, J.-P., Ciccotti, G., Berendsen, H.J.C., Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of N-Alkanes (1977) J. Comput. Phys., 23, pp. 327-341; Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepeis, J.L., Dror, R.O., Shaw, D.E., Improved Side-Chain Torsion Potentials for the Amber ff99sb Protein Force Field (2010) Proteins: Struct., Funct., Genet., 78, pp. 1950-1958; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of Simple Potential Functions for Simulating Liquid Water (1983) J. Chem. Phys., 79, pp. 926-935; Fischer, J., Paschek, D., Geiger, A., Sadowski, G., Modeling of Aqueous Poly(Oxyethylene) Solutions: 1. Atomistic Simulations (2008) J. Phys. Chem. B, 112, pp. 2388-2398; Case, D.A., Betz, R.M., Botello-Smith, W., Cerutti, D.S., Cheatham, T.E., III, Darden, T.A., Duke, R.E., Goetz, A.W., (2016) AMBER 2016, , University of California: San Francisco, CA; Abraham, M.J., Murtola, T., Schulz, R., Páll, S., Smith, J.C., Hess, B., Lindahl, E., GROMACS: High Performance Molecular Simulations Through Multi-Level Parallelism from Laptops to Supercomputers (2015) SoftwareX, 12, pp. 19-25; Roe, D.R., Cheatham, T.E., PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data (2013) J. Chem. Theory Comput., 9, pp. 3084-3095; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., Cicin-Sain, D., Orozco, M., FlexServ: An Integrated Tool for the Analysis of Protein Flexibility (2009) Bioinformatics, 25, pp. 1709-1710; Schröder, C., Rudas, T., Boresch, S., Steinhauser, O., Simulation Studies of the Protein-Water Interface. I. Properties at the Molecular Resolution (2006) J. Chem. Phys., 124, p. 234907; Hubbard, S., Thornton, J., (1993) NACCESS Computer Program, , University College London: London; Williams, M.A., Goodfellow, J.M., Thornton, J.M., Buried Waters and Internal Cavities in Monomeric Proteins (1994) Protein Sci., 3, pp. 1224-1235; Juranić, N., Likić, V.A., Prendergast, F.G., Macura, S., Protein-Solvent Hydrogen Bonding Studied by NMR 1JNC' Coupling Constant Determination and Molecular Dynamics Simulations (1996) J. Am. Chem. Soc., 118, pp. 7859-7860; Petukhov, M., Rychkov, G., Firsov, L., Serrano, L., H-bonding in Protein Hydration Revisited (2004) Protein Sci., 13, pp. 2120-2129; Brotzakis, Z.F., Groot, C.C., Brandeburgo, W.H., Bakker, H.J., Bolhuis, P.G., Dynamics of Hydration Water around Native and Misfolded α-Lactalbumin (2016) J. Phys. Chem. B, 120, pp. 4756-4766; Hertz, H., (1973) Water: A Comprehensive Treatise, Vol. 3, , Franks, F. Plenum Press: New York; Mills, R., Self-diffusion in Normal and Heavy Water in the Range 1-45° (1973) J. Phys. Chem., 77, pp. 685-688","Gelpí, J.L.; Joint BSC-IRB Research Program in Computational Biology, Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Spain; email: gelpi@ub.edu",,,"American Chemical Society",,,,,15206106,,JPCBF,"28059510","English","J Phys Chem B",Article,"Final",,Scopus,2-s2.0-85020201582
"Pinheiro S., Soteras I., Gelpí J.L., Dehez F., Chipot C., Luque F.J., Curutchet C.","57194023219;6505871837;35517522400;6507092475;7003715790;23025357900;9737651900;","Structural and energetic study of cation-π-cation interactions in proteins",2017,"Physical Chemistry Chemical Physics","19","15",,"9849","9861",,6,"10.1039/c6cp08448f","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020012211&doi=10.1039%2fc6cp08448f&partnerID=40&md5=dd1350eb8e0b7f2452902d18bb791457","Departament de Farmacia i Tecnologia Farmaceutica i Fisicoquimica and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain; Departament de Nutricio, Ciencies de l'Alimentacio i Gastronomia and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Santa Coloma de Gramenet, Spain; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Spain; Laboratoire International Associé Centre National de la Recherche Scientifique, University of Illinois at Urbana-Champaign, Unité Mixte de Recherche No. 7565, Université de Lorraine, Vandoeuvre-lès-Nancy cedex, France; Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United States","Pinheiro, S., Departament de Farmacia i Tecnologia Farmaceutica i Fisicoquimica and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain; Soteras, I., Departament de Nutricio, Ciencies de l'Alimentacio i Gastronomia and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Santa Coloma de Gramenet, Spain; Gelpí, J.L., Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Spain; Dehez, F., Laboratoire International Associé Centre National de la Recherche Scientifique, University of Illinois at Urbana-Champaign, Unité Mixte de Recherche No. 7565, Université de Lorraine, Vandoeuvre-lès-Nancy cedex, France; Chipot, C., Laboratoire International Associé Centre National de la Recherche Scientifique, University of Illinois at Urbana-Champaign, Unité Mixte de Recherche No. 7565, Université de Lorraine, Vandoeuvre-lès-Nancy cedex, France, Beckman Institute for Advanced Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United States; Luque, F.J., Departament de Nutricio, Ciencies de l'Alimentacio i Gastronomia and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Santa Coloma de Gramenet, Spain; Curutchet, C., Departament de Farmacia i Tecnologia Farmaceutica i Fisicoquimica and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Barcelona, Spain","Cation-π interactions of aromatic rings and positively charged groups are among the most important interactions in structural biology. The role and energetic characteristics of these interactions are well established. However, the occurrence of cation-π-cation interactions is an unexpected motif, which raises intriguing questions about its functional role in proteins. We present a statistical analysis of the occurrence, composition and geometrical preferences of cation-π-cation interactions identified in a set of non-redundant protein structures taken from the Protein Data Bank. Our results demonstrate that this structural motif is observed at a small, albeit non-negligible frequency in proteins, and suggest a preference to establish cation-π-cation motifs with Trp, followed by Tyr and Phe. Furthermore, we have found that cation-π-cation interactions tend to be highly conserved, which supports their structural or functional role. Finally, we have performed an energetic analysis of a representative subset of cation-π-cation complexes combining quantum-chemical and continuum solvation calculations. Our results point out that the protein environment can strongly screen the cation-cation repulsion, leading to an attractive interaction in 64% of the complexes analyzed. Together with the high degree of conservation observed, these results suggest a potential stabilizing role in the protein fold, as demonstrated recently for a miniature protein (Craven et al., J. Am. Chem. Soc. 2016, 138, 1543). From a computational point of view, the significant contribution of non-additive three-body terms challenges the suitability of standard additive force fields for describing cation-π-cation motifs in molecular simulations. © 2017 the Owner Societies.",,"cation; growth hormone receptor; metal; phenylalanine; protein; tryptophan; chemistry; human; metabolism; protein tertiary structure; quantum theory; thermodynamics; Cations; Humans; Metals; Phenylalanine; Protein Structure, Tertiary; Proteins; Quantum Theory; Receptors, Somatotropin; Thermodynamics; Tryptophan",,"phenylalanine, 3617-44-5, 63-91-2; protein, 67254-75-5; tryptophan, 6912-86-3, 73-22-3; Cations; Metals; Phenylalanine; Proteins; Receptors, Somatotropin; Tryptophan",,,,,,,"Campbell, E., Kaltenbach, M., Correy, G.J., Carr, P.D., Porebski, B.T., Livingstone, E.K., Afriat-Jurnou, L., Jackson, C.J., (2016) Nat. Chem. Biol., 12, pp. 944-950; Kiss, G., Çelebi-Ölçüm, N., Moretti, R., Baker, D., Houk, K.N., (2013) Angew. Chem., Int. Ed., 52, pp. 5700-5725; Kries, H., Blomberg, R., Hilvert, D., (2013) Curr. Opin. Chem. Biol., 17, pp. 221-228; Dougherty, D.A., (1996) Science, 271, pp. 163-168; Ma, J.C., Dougherty, D.A., (1997) Chem. Rev., 97, pp. 1303-1324; Cubero, E., Luque, F.J., Orozco, M., (1998) Proc. Natl. Acad. Sci. U. S. A., 95, pp. 5976-5980; Minoux, H., Chipot, C., (1999) J. Am. Chem. Soc., 121, pp. 10366-10372; Riley, K.E., Pitoňák, M., Jurečka, P., Hobza, P., (2010) Chem. Rev., 110, pp. 5023-5063; Alkorta, I., Blanco, F., Deyà, P.M., Elguero, J., Estarellas, C., Frontera, A., Quiñonero, D., (2010) Theor. Chem. Acc., 126, pp. 1-14; Frontera, A., Quiñonero, D., Deyà, P.M., (2011) Wiley Interdiscip. Rev.: Comput. Mol. Sci., 1, pp. 440-459; Dougherty, D.A., (2013) Acc. Chem. Res., 46, pp. 885-893; Mahadevi, A.S., Sastry, G.N., (2013) Chem. Rev., 113, pp. 2100-2138; Sherrill, C.D., (2013) Acc. Chem. Res., 46, pp. 1020-1028; Fiol, J.J., Barceló-Oliver, M., Tasada, A., Frontera, A., Terrón, À., García-Raso, Á., (2013) Coord. Chem. Rev., 257, pp. 2705-2715; Clark, T., Politzer, P., Murray, J.S., (2015) Wiley Interdiscip. Rev.: Comput. Mol. Sci., 5, pp. 169-177; Bauzá, A., Mooibroek, T.J., Frontera, A., (2015) ChemPhysChem, 16, pp. 2496-2517; Kolář, M.H., Hobza, P., (2016) Chem. Rev., 116, pp. 5155-5187; Mahadevi, A.S., Sastry, G.N., (2016) Chem. Rev., 116, pp. 2775-2825; Andrić, J.M., Misini-Ignjatović, M.Z., Murray, J.S., Politzer, P., Zarić, S.D., (2016) ChemPhysChem, 17, pp. 2035-2042; Rodríguez-Sanz, A.A., Cabaleiro-Lago, E.M., Rodríguez-Otero, J., (2014) Phys. Chem. Chem. Phys., 16, pp. 22499-22512; Rapp, C., Goldberger, E., Tishbi, N., Kirshenbaum, R., (2014) Proteins: Struct., Funct., Bioinf., 82, pp. 1494-1502; Vijay, D., Sastry, G.N., (2008) Phys. Chem. Chem. Phys., 10, pp. 582-590; Emenike, B.U., Bey, S.N., Spinelle, R.A., Jones, J.T., Yoo, B., Zeller, M., (2016) Phys. Chem. Chem. Phys., 18, pp. 30940-30945; Cieplak, P., Dupradeau, F.-Y.Y., Duan, Y., Wang, J.M., (2009) J. Phys.: Condens. Matter, 21, p. 333102; Luque, F.J., Dehez, F., Chipot, C., Orozco, M., (2011) Wiley Interdiscip. Rev.: Comput. Mol. Sci., 1, pp. 844-854; Soteras, I., Curutchet, C., Bidon-Chanal, A., Dehez, F., Ángyán, J.G., Orozco, M., Chipot, C., Luque, F.J., (2007) J. Chem. Theory Comput., 3, pp. 1901-1913; Dehez, F., Ángyán, J.G., Gutiérrez, I.S., Luque, F.J., Schulten, K., Chipot, C., (2007) J. Chem. Theory Comput., 3, pp. 1914-1926; Soteras, I., Orozco, M., Luque, F.J., (2008) Phys. Chem. Chem. Phys., 10, pp. 2616-2624; Archambault, F., Chipot, C., Soteras, I., Luque, F.J., Schulten, K., Dehez, F., (2009) J. Chem. Theory Comput., 5, pp. 3022-3031; Ansorg, K., Tafipolsky, M., Engels, B., (2013) J. Phys. Chem. B, 117, pp. 10093-10102; Caldwell, J.W., Kollman, P.A., (1995) J. Am. Chem. Soc., 117, pp. 4177-4178; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., (2000) Nucleic Acids Res., 28, pp. 235-242; Biot, C., Wintjens, R., Rooman, M., (2004) J. Am. Chem. Soc., 126, pp. 6220-6221; Quiñonero, D., Frontera, A., Garau, C., Ballester, P., Costa, A., Deyà, P.M., (2006) ChemPhysChem, 7, pp. 2487-2491; Reddy, A.S., Vijay, D., Sastry, G.M., Sastry, G.N., (2006) J. Phys. Chem. B, 110, pp. 2479-2481; Frontera, A., Quiñonero, D., Costa, A., Ballester, P., Deyà, P.M., (2007) New J. Chem., 31, pp. 556-560; Li, Q., Li, W., Cheng, J., Gong, B., Sun, J., (2008) J. Mol. Struct.: THEOCHEM, 867, pp. 107-110; Escudero, D., Frontera, A., Quiñonero, D., Deyà, P.M., (2008) Chem. Phys. Lett., 456, pp. 257-261; Estarellas, C., Frontera, A., Quiñonero, D., Deyà, P.M., (2009) Chem. Phys. Lett., 479, pp. 316-320; Vijay, D., Sastry, G.N., (2010) Chem. Phys. Lett., 485, pp. 235-242; Li, R., Li, Q., Cheng, J., Liu, Z., Li, W., (2011) ChemPhysChem, 12, pp. 2289-2295; Campo-Cacharrón, A., Cabaleiro-Lago, E.M., Carrazana-García, J.A., Rodríguez-Otero, J., (2014) J. Comput. Chem., 35, pp. 1290-1301; Craven, T.W., Cho, M.-K., Traaseth, N.J., Bonneau, R., Kirshenbaum, K., (2016) J. Am. Chem. Soc., 138, pp. 1543-1550; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Pérez, A., Carrillo, O., Orozco, M., (2010) Structure, 18, pp. 1399-1409; Olsson, M.H.M., Søndergaard, C.R., Rostkowski, M., Jensen, J.H., (2011) J. Chem. Theory Comput., 7, pp. 525-537; Søndergaard, C.R., Olsson, M.H.M., Rostkowski, M., Jensen, J.H., (2011) J. Chem. Theory Comput., 7, pp. 2284-2295; Landau, M., Mayrose, I., Rosenberg, Y., Glaser, F., Martz, E., Pupko, T., Ben-Tal, N., (2005) Nucleic Acids Res., 33, pp. W299-W302; Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., Ben-Tal, N., (2016) Nucleic Acids Res., 44, pp. W344-W350; Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Fox, D.J., (2009) Gaussian 09, Revision A.2., , Gaussian Inc., Wallingford CT; Grimme, S., (2003) J. Chem. Phys., 118, pp. 9095-9102; Truhlar, D.G., (1998) Chem. Phys. Lett., 294, pp. 45-48; Boys, S., Bernardi, F., (1970) Mol. Phys., 19, pp. 553-566; Curutchet, C., Orozco, M., Luque, F.J., (2001) J. Comput. Chem., 22, pp. 1180-1193; Curutchet, C., Bidon-Chanal, A., Soteras, I., Orozco, M., Luque, F.J., (2005) J. Phys. Chem. B, 109, pp. 3565-3574; Soteras, I., Curutchet, C., Bidon-Chanal, A., Orozco, M., Luque, F.J., (2005) THEOCHEM, 727, pp. 29-40; Case, D.A., Darden, T.A., Cheatham, I.T.E., Simmerling, C.L., Wang, J., Duke, R.E., Luo, R., Kollman, P.A., (2012) AMBER 12, , University of California, San Francisco; Onufriev, A., Bashford, D., Case, D.A., (2004) Proteins: Struct., Funct., Bioinf., 55, pp. 383-394; Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., Simmerling, C., (2006) Proteins: Struct., Funct., Bioinf., 65, pp. 712-725; Bayly, C.I., Cieplak, P., Cornell, W., Kollman, P.A., (1993) J. Phys. Chem., 97, pp. 10269-10280; Mason, P.E., Neilson, G.W., Dempsey, C.E., Barnes, A.C., Cruickshank, J.M., (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 4557-4561; Grossfield, A., Ren, P., Ponder, J.W., (2003) J. Am. Chem. Soc., 125, pp. 15671-15682; Jiao, D., King, C., Grossfield, A., Darden, T.A., Ren, P., (2006) J. Phys. Chem. B, 110, pp. 18553-18559; Liu, J., Kelly, C.P., Goren, A.C., Marenich, A.V., Cramer, C.J., Truhlar, D.G., Zhan, C.-G., (2010) J. Chem. Theory Comput., 6, pp. 1109-1117; Trinquier, G., Sanejouand, Y.H., (1998) Protein Eng., Des. Sel., 11, pp. 153-169; Khan, H.M., Grauffel, C., Broer, R., Mackerell, A.D., Havenith, R.W.A., Reuter, N., (2016) J. Chem. Theory Comput., 12, pp. 5585-5595; Lemkul, J.A., Huang, J., Roux, B., Mackerell, A.D., (2016) Chem. Rev., 116, pp. 4983-5013; Shi, Y., Xia, Z., Zhang, J., Best, R., Wu, C., Ponder, J.W., Ren, P., (2013) J. Chem. Theory Comput., 9, pp. 4046-4063; Warshel, A., Sharma, P.K., Kato, M., Parson, W.W., (2006) Biochim. Biophys. Acta, Proteins Proteomics, 1764, pp. 1647-1676; Inoue, Y., Sugio, S., Andzelm, J., Nakamura, N., (1998) J. Phys. Chem. A, 102, pp. 646-648; Norrby, P.-O., Liljefors, T., (1999) J. Am. Chem. Soc., 121, pp. 2303-2306; Zarić, S.D., Popović, D.M., Knapp, E.-W., (2000) Chemistry, 6, pp. 3935-3942; Thompson, S.E., Smithrud, D.B., (2002) J. Am. Chem. Soc., 124, pp. 442-449; Dvornikovs, V., Smithrud, D.B., (2002) J. Org. Chem., 67, pp. 2160-2167; Anderson, M.A., Ogbay, B., Arimoto, R., Sha, W., Kisselev, O.G., Cistola, D.P., Marshall, G.R., (2006) J. Am. Chem. Soc., 128, pp. 7531-7541; Mitra, M., Manna, P., Seth, S.K., Das, A., Meredith, J., Helliwell, M., Bauzá, A., Mukhopadhyay, S., (2013) CrystEngComm, 15, pp. 686-696","Curutchet, C.; Departament de Farmacia i Tecnologia Farmaceutica i Fisicoquimica and Institut de Biomedicina, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de BarcelonaSpain; email: carles.curutchet@ub.edu",,,"Royal Society of Chemistry",,,,,14639076,,PPCPF,"28352893","English","Phys. Chem. Chem. Phys.",Article,"Final",,Scopus,2-s2.0-85020012211
"Jiménez R.C., Kuzak M., Alhamdoosh M., Barker M., Batut B., Borg M., Capella-Gutierrez S., Chue Hong N., Cook M., Corpas M., Flannery M., Garcia L., Gelpí J.L., Gladman S., Goble C., González Ferreiro M., Gonzalez-Beltran A., Griffin P.C., Grüning B., Hagberg J., Holub P., Hooft R., Ison J., Katz D.S., Leskošek B., López Gómez F., Oliveira L.J., Mellor D., Mosbergen R., Mulder N., Perez-Riverol Y., Pergl R., Pichler H., Pope B., Sanz F., Schneider M.V., Stodden V., Suchecki R., Svobodová Vařeková R., Talvik H.-A., Todorov I., Treloar A., Tyagi S., van Gompel M., Vaughan D., Via A., Wang X., Watson-Haigh N.S., Crouch S.","24481270200;14325240700;42760903200;57192395945;56176768300;57194974096;35335928400;57191382381;57207168831;24448006700;57194972163;50261456800;35517522400;55221967000;7004072716;57194977622;23396745000;26664597700;37088461600;57192404893;8935314200;6603607988;7005978055;49661664400;55599291600;57194976860;57193360895;57204300656;55612506500;7102238454;24598095700;26633154200;7005305909;7005597341;7102263897;7404064011;15623425400;36705161900;16235290700;35241373100;7102462913;22939397700;8099398400;55511076000;55249764800;6602979457;57194979102;26538313800;7006761235;","Four simple recommendations to encourage best practices in research software",2017,"F1000Research","6",, 876,"","",,13,"10.12688/f1000research.11407.1","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85024481292&doi=10.12688%2ff1000research.11407.1&partnerID=40&md5=20b68fb6104b9977f825f909fc34acaa","ELIXIR Hub, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Netherlands eScience Center, Science Park 140, Amsterdam, 1098 XG, Netherlands; CSL Limited, Bio21 Institute, 30 Flemington Road, Parkville, VIC  3010, Australia; National eResearch Collaboration Tools and ResourcesVIC  3010, Australia; ELIXIR-DE and de.NBI, Bioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany; ELIXIR-SE, National Bioinformatics Infrastructure Sweden (NBIS), Scilifelab, Department of Biochemistry and Biophysics (DBB), Stockholm University, Stockholm, Sweden; ELIXIR-ES, Spanish National Bioinformatics Institute (INB), Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández Almagro 3, Madrid, 28029, Spain; Software Sustainability Institute, JCMB, University of Edinburgh, Edinburgh, EH9 3FD, United Kingdom; Repositive Ltd, Future Business Centre, Cambridge, United Kingdom; EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Barcelona Supercomputing Center, Barcelona, 08034, Spain; Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona, Barcelona, 08028, Spain; ELIXIR-UK, Software Sustainability Institute, School of Computer Science, University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom; Oxford e-Research Centre, University of Oxford, Oxford, United Kingdom; BBMRI-ERIC, Neue Stiftingtalstraße 2/B/6, Graz, 8010, Austria; Dutch TechCenter for Life Sciences and ELIXIR-NL, Utrecht, Netherlands; ELIXIR-DK, Technical University of Denmark, Denmark, Denmark; National Center for Supercomputing Applications, University of Illinois at Urbana-Champaign, Urbana, IL, United States; School of Information Sciences, University of Illinois Urbana Champaign, Urbana, IL, United States; Department of Electrical and Computer Engineering, University of Illinois Urbana Champaign, Urbana, IL, United States; Department of Computer Science, University of Illinois Urbana Champaign, Urbana, IL, United States; ELIXIR-SI, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; DETI/IEETA, University of Aveiro, Aveiro, Portugal; Center for Open Science, Charlottesville, VA, United States; Stemformatics, University of Melbourne, Melbourne, Australia; Computational Biology Division, Department of Integrative Biomedical Sciences, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; ELIXIR-CZ, Faculty of Information Technology, Czech Technical University in Prague, Prague, Czech Republic; BBMRI.at, Alpen-Adria-University Klagenfurt, Klagenfurt, Austria; GRIB, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; School of Agriculture, Food and Wine, University of Adelaide, Adelaide, Australia; Central European Institute of Technology (CEITEC), Brno, Czech Republic; National Centre for Biomolecular Research, Masaryk University, Brno, Czech Republic; ELIXIR-EE, Institute of Computer Science, University of Tartu, Tartu, Estonia; Science and Technologies Facilities Council, Swindon, United Kingdom; Australian National Data Service, Melbourne, Australia; Australian Genome Research Facility Ltd., Melbourne, Australia; Centre for Language and Speech Technology, Radboud University Nijmegen, Nijmegen, Netherlands; IBPM-CNR, Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy; Faculty of Information Technology, Monash UniversityVIC, Australia; Software Sustainability Institute, Web and Internet Science, University of Southampton, Southampton, United Kingdom","Jiménez, R.C., ELIXIR Hub, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Kuzak, M., Netherlands eScience Center, Science Park 140, Amsterdam, 1098 XG, Netherlands; Alhamdoosh, M., CSL Limited, Bio21 Institute, 30 Flemington Road, Parkville, VIC  3010, Australia; Barker, M., National eResearch Collaboration Tools and ResourcesVIC  3010, Australia; Batut, B., ELIXIR-DE and de.NBI, Bioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany; Borg, M., ELIXIR-SE, National Bioinformatics Infrastructure Sweden (NBIS), Scilifelab, Department of Biochemistry and Biophysics (DBB), Stockholm University, Stockholm, Sweden; Capella-Gutierrez, S., ELIXIR-ES, Spanish National Bioinformatics Institute (INB), Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández Almagro 3, Madrid, 28029, Spain; Chue Hong, N., Software Sustainability Institute, JCMB, University of Edinburgh, Edinburgh, EH9 3FD, United Kingdom; Cook, M., ELIXIR Hub, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Corpas, M., Repositive Ltd, Future Business Centre, Cambridge, United Kingdom; Flannery, M., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; Garcia, L., EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Gelpí, J.L., Barcelona Supercomputing Center, Barcelona, 08034, Spain, Department of Biochemistry and Molecular Biomedicine, Universitat de Barcelona, Barcelona, 08028, Spain; Gladman, S., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; Goble, C., ELIXIR-UK, Software Sustainability Institute, School of Computer Science, University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom; González Ferreiro, M., EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Gonzalez-Beltran, A., Oxford e-Research Centre, University of Oxford, Oxford, United Kingdom; Griffin, P.C., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; Grüning, B., ELIXIR-DE and de.NBI, Bioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany; Hagberg, J., ELIXIR-SE, National Bioinformatics Infrastructure Sweden (NBIS), Scilifelab, Department of Biochemistry and Biophysics (DBB), Stockholm University, Stockholm, Sweden; Holub, P., BBMRI-ERIC, Neue Stiftingtalstraße 2/B/6, Graz, 8010, Austria; Hooft, R., Dutch TechCenter for Life Sciences and ELIXIR-NL, Utrecht, Netherlands; Ison, J., ELIXIR-DK, Technical University of Denmark, Denmark, Denmark; Katz, D.S., National Center for Supercomputing Applications, University of Illinois at Urbana-Champaign, Urbana, IL, United States, School of Information Sciences, University of Illinois Urbana Champaign, Urbana, IL, United States, Department of Electrical and Computer Engineering, University of Illinois Urbana Champaign, Urbana, IL, United States, Department of Computer Science, University of Illinois Urbana Champaign, Urbana, IL, United States; Leskošek, B., ELIXIR-SI, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; López Gómez, F., ELIXIR Hub, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Oliveira, L.J., DETI/IEETA, University of Aveiro, Aveiro, Portugal; Mellor, D., Center for Open Science, Charlottesville, VA, United States; Mosbergen, R., Stemformatics, University of Melbourne, Melbourne, Australia; Mulder, N., Computational Biology Division, Department of Integrative Biomedical Sciences, Institute for Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Perez-Riverol, Y., EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Pergl, R., ELIXIR-CZ, Faculty of Information Technology, Czech Technical University in Prague, Prague, Czech Republic; Pichler, H., BBMRI.at, Alpen-Adria-University Klagenfurt, Klagenfurt, Austria; Pope, B., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; Sanz, F., GRIB, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, Barcelona, Spain; Schneider, M.V., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia; Stodden, V., School of Information Sciences, University of Illinois Urbana Champaign, Urbana, IL, United States; Suchecki, R., School of Agriculture, Food and Wine, University of Adelaide, Adelaide, Australia; Svobodová Vařeková, R., Central European Institute of Technology (CEITEC), Brno, Czech Republic, National Centre for Biomolecular Research, Masaryk University, Brno, Czech Republic; Talvik, H.-A., ELIXIR-EE, Institute of Computer Science, University of Tartu, Tartu, Estonia; Todorov, I., Science and Technologies Facilities Council, Swindon, United Kingdom; Treloar, A., Australian National Data Service, Melbourne, Australia; Tyagi, S., EMBL Australia Bioinformatics Resource, Lab-14, The University of Melbourne, 700 Swanston St, Parkville, VIC  3053, Australia, Australian Genome Research Facility Ltd., Melbourne, Australia; van Gompel, M., Centre for Language and Speech Technology, Radboud University Nijmegen, Nijmegen, Netherlands; Vaughan, D., EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, United Kingdom; Via, A., IBPM-CNR, Department of Biochemical Sciences, Sapienza University of Rome, Rome, Italy; Wang, X., Faculty of Information Technology, Monash UniversityVIC, Australia; Watson-Haigh, N.S., School of Agriculture, Food and Wine, University of Adelaide, Adelaide, Australia; Crouch, S., Software Sustainability Institute, Web and Internet Science, University of Southampton, Southampton, United Kingdom","Scientific research relies on computer software, yet software is not always developed following practices that ensure its quality and sustainability. This manuscript does not aim to propose new software development best practices, but rather to provide simple recommendations that encourage the adoption of existing best practices. Software development best practices promote better quality software, and better quality software improves the reproducibility and reusability of research. These recommendations are designed around Open Source values, and provide practical suggestions that contribute to making research software and its source code more discoverable, reusable and transparent. This manuscript is aimed at developers, but also at organisations, projects, journals and funders that can increase the quality and sustainability of research software by encouraging the adoption of these recommendations. © 2017 Jiménez RC et al.","Best practices; Code; FAIR; Guidelines; Open Science; Open Source; Quality; Recommendations; Software; Sustainability","adoption; organization; practice guideline; publication; reproducibility; software",,,,,,,,,"Artaza, H., Chue Hong, N., Manuel, C., Top 10 metrics for life science software good practices (2016) F1000Res, 5. , 27635232, 5007752, pii: ELIXIR-2000; Brase, J., Datacite - A Global Registration Agency for Research Data SSRN Electronic Journal, , n.d; Corpas, M., Jimenez, R., Carbon, S.J., BioJS: an open source standard for biological visualisation - its status in 2014 (2014) F1000Res, 3, p. 55. , 25075290, 4103492; Crouch, S., Chue Hong, N., Hettrick, S., The Software Sustainability Institute: Changing Research Software Attitudes and Practices (2013) Computing in Science & Engineering, 15 (6), pp. 74-80; DagstuhlEAS/draft-Manifesto (2017) GitHub, , Reference Source; Eijssen, L., Evelo, C., Kok, R., The Dutch Techcentre for Life Sciences: Enabling data-intensive life science research in the Netherlands [version 2; referees: 2 approved, 1 approved with reservations] (2016) F1000Res, 4, p. 33. , 26913186, 4743138; Fogel, K., Producing Open Source Software: How to Run a Successful Free Software Project (2005), Reference Source, O'Reilly Media, Inc; Gilb, T., Principles of Software Engineering Management (1988), Reference Source, Addison-Wesley Professional; Goble, C., Better Software, Better Research (2014) IEEE Internet Computing, 18 (5), pp. 4-8; Gómez, J., García, L.J., Salazar, G.A., BioJS: An Open Source JavaScript Framework for Biological Data Visualization (2013) Bioinformatics, 29 (8), pp. 1103-1104. , 23435069, 3624812; Hannay, J.E., MacLeod, C., Singer, J., How Do Scientists Develop and Use Scientific Software? (2009) 2009 ICSE Workshop on Software Engineering for Computational Science and Engineering; Henry, V.J., Bandrowski, A.E., Pepin, A.S., OMICtools: An Informative Directory for Multi-Omic Data Analysis (2014) Database (Oxford), 2014. , 25024350, 4095679, pii: bau069; Hettrick, S., Antonioletti, M., Carr, L., UK Research Software Survey 2014 (2016), Accessed November 27; Ince, D.C., Hatton, L., Graham-Cumming, J., The Case for Open Computer Programs (2012) Nature, 482 (7386), pp. 485-488. , 22358837; Ison, J., Rapacki, K., Ménager, H., Tools and Data Services Registry: A Community Effort to Document Bioinformatics Resources (2016) Nucleic Acids Res, 44 (D1), pp. D38-47. , 26538599, 4702812; Leprevost, F.V., Barbosar, V.C., Francisco, E.L., On best practices in the development of bioinformatics software (2014) Front Genet, 5, p. 199. , 25071829, 4078907; List, M., Ebert, P., Albrecht, F., Ten Simple Rules for Developing Usable Software in Computational Biology (2017) PLoS Comput Biol, 13 (1). , 28056032, 5215831; McKiernan, E.C., Bourne, P.E., Brown, C.T., How open science helps researchers succeed (2016) eLife, 5. , 27387362, 4973366, pii: e16800; Mulgan, G., Steinberg, T., Salem, O., Wide Open: Open Source Methods and Their Future Potential (2005), Reference Source, Demos Medical Publishing; Nosek, B.A., Alter, G., Banks, G.C., SCIENTIFIC STANDARDS. Promoting an open research culture (2015) Science. American Association for the Advancement of Science, 348 (6242), pp. 1422-1425. , 26113702, 4550299; Perez-Riverol, Y., Gatto, L., Wang, R., Ten Simple Rules for Taking Advantage of Git and GitHub (2016) PLoS Comput Biol, 12 (7). , 27415786, 4945047; Perez-Riverol, Y., Wang, R., Hermjakob, H., Open source libraries and frameworks for mass spectrometry based proteomics: a developer's perspective (2014) Biochim Biophys Acta, 1844 (1), pp. 63-76. , 23467006, 3898926; Popp, K.M., Best Practices for Commercial Use of Open Source Software: Business Models, Processes and Tools for Managing Open Source Software (2015) BoD - Books on Demand, , Reference Source; Prlić, A., Procter, J.B., Ten simple rules for the open development of scientific software (2012) PLoS Comput Biol, 8 (12). , 23236269, 3516539; Smith, A.M., Katz, D.S., Niemeyer, K.E., Software Citation Principles (2016) PeerJ Comput Sci, 2; Wilkinson, M.D., Dumontier, M., Aalbersberg, I.J., The FAIR Guiding Principles for scientific data management and stewardship (2016) Sci Data, 3, p. 160018. , 26978244, 4792175; Wilson, G., Aruliah, D.A., Brown, C.T., Best practices for scientific computing (2014) PLoS Biol, 12 (1). , 24415924, 3886731; Wilson, G., Bryan, J., Cranston, K., Good Enough Practices in Scientific Computing (2016), Reference Source; Wilson, G., Software Carpentry: lessons learned [version 1; referees: 3 approved] (2014) F1000Res, 3, p. 62. , 24715981, 3976103","Jiménez, R.C.; ELIXIR Hub, Wellcome Genome CampusUnited Kingdom; email: rafael.jimenez@elixir-europe.org",,,"Faculty of 1000 Ltd",,,,,20461402,,,,"English","F1000 Res.",Article,"Final",Open Access,Scopus,2-s2.0-85024481292
"Julià A., Vinaixa M., Domènech E., Fernández-Nebro A., Cañete J.D., Ferrándiz C., Tornero J., Gisbert J.P., Nos P., Casbas A.G., Puig L., González-Álvaro I., Pinto-Tasende J.A., Blanco R., Rodríguez M.A., Beltran A., Correig X., Marsal S., Fernández E., Sanmartí R., Gratacós J., Martínez-Taboada V.M., Gomollón F., Daudén E., Maymó J., Queiró R., Longo F.J.L., Garcia- Planella E., Carazo J.L.S., Alperi-López M., Montilla C., Pérez-Venegas J.J., Fernández-Gutiérrez B., Mendoza J.L., López Estebaranz J.L., Olivé A., Torre-Alonso J.C., Barreiro-de Acosta M., Ramírez D.M., Corominas H., Muñoz-Fernández S., Andreu J.L., Muñoz F., de la Cueva P., Erra A., González C.M., Aguirre-Zamorano M.A., Vera M., Vanaclocha F., Roig D., Vela P., Saro C., Herrera E., Zarco P., Nolla J.M., Esteve M., Marenco de la Fuente J.L., Pego-Reigosa J.M., García-Sánchez V., Panés J., Fonseca E., Blanco F., Rodríguez-Moreno J., Carreira P., Ramírez J., ávila G., Codó L., Gelpí J.L., García-Montero A.C., Palau N., López-Lasanta M., Tortosa R., Alonso A.","57210878792;8309283300;55403162200;57195363279;7003746360;7005892900;36151354800;56240616000;7004378444;30367504900;7101770587;7003841482;57210846883;7102430622;57201839711;57211127953;56212707200;6603356384;55933326900;7004460755;23469245300;7003889422;36854127900;7003438085;6602416727;6603878341;56844680100;6507483158;23049315100;24553621900;12782882100;55338747000;6701926209;7102491741;6603673238;7005738781;6603460831;16240700200;56884019300;6602373022;7004546711;7103245648;7103206318;15043904600;16678368700;36064831900;6507662740;55347520400;6603052674;6602407204;7004528221;6603201272;7103001516;7006771455;7005300918;7006785161;6505456136;23111754100;23467027100;55857704800;34975078800;7102243071;6603940765;55192600900;55794210400;55545844500;55882083800;35517522400;6603714021;54412813600;23035265100;55933194400;36150353900;","Urine metabolome profiling of immune-mediated inflammatory diseases",2016,"BMC Medicine","14","1", 133,"","",,21,"10.1186/s12916-016-0681-8","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84986253441&doi=10.1186%2fs12916-016-0681-8&partnerID=40&md5=ec0242fe769bfbe209b79e4f1b8b429f","Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; Hospital Parc Taulí, Sabadell, Spain; Hospital Universitario Marqués de Valdecilla, Santander, Spain; CIBERehd, Madrid, Spain; Hospital Clínico Universitario, Zaragoza, Spain; Hospital Universitario de la Princesa and IIS-IP, Madrid, Spain; Hospital del Mar, Barcelona, Spain; Hospital Universitario Central de Asturias, Asturias, Spain; Hospital Gregorio Marañón, Madrid, Spain; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Hospital General Universitario, Valencia, Spain; Hospital de Jerez de la Frontera, Cádiz, Spain; Hospital Clínico San Carlos, IDISSC, Madrid, Spain; Hospital Universitario Fundación Alcorcón, Madrid, Spain; Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Hospital Monte Naranco, Oviedo, Spain; Hospital Clínico Universitario, Santiago de Compostela, Spain; Hospital Virgen de la Macarena, Sevilla, Spain; Hospital Moisès Broggi, Barcelona, Spain; Hospital Universitario Infanta Sofía, Madrid, Spain; Hospital Universitario Puerta de Hierro, Madrid, Spain; Complejo Hospitalario de León, León, Spain; Hospital Universitario Infanta Leonor, Madrid, Spain; Hospital Sant Rafael, Barcelona, Spain; Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain; Hospital Universitario Doce de Octubre, Madrid, Spain; Hospital General de Alicante, Alicante, Spain; Hospital de Cabueñes, Gijón, Spain; Hospital Virgen de la Victoria, Málaga, Spain; Hospital Universitari de Bellvitge, Barcelona, Spain; Hospital Universitari Mútua de Terrassa, Barcelona, Spain; Hospital del Valme, Sevilla, Spain; Hospital do Meixoeiro, Vigo, Spain; Complejo Hospitalario Juan Canalejo, INIBIC, A Coruña, Spain; Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Centre for Omic Sciences, COS-DEEEA-URV-IISPV, Reus, Spain; Metabolomics Platform, CIBERDEM, Reus, Spain; Universidad de Málaga, UGC Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Málaga, Spain; Hospital Universitario Guadalajara, Guadalajara, Spain; Hospital la Fe, Valencia, Spain","Julià, A., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Vinaixa, M., Centre for Omic Sciences, COS-DEEEA-URV-IISPV, Reus, Spain, Metabolomics Platform, CIBERDEM, Reus, Spain; Domènech, E., CIBERehd, Madrid, Spain, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Fernández-Nebro, A., Universidad de Málaga, UGC Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Málaga, Spain; Cañete, J.D., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; Ferrándiz, C., CIBERehd, Madrid, Spain; Tornero, J., Hospital Universitario Guadalajara, Guadalajara, Spain; Gisbert, J.P., CIBERehd, Madrid, Spain, Hospital Universitario de la Princesa and IIS-IP, Madrid, Spain; Nos, P., CIBERehd, Madrid, Spain, Hospital la Fe, Valencia, Spain; Casbas, A.G., CIBERehd, Madrid, Spain, Hospital General de Alicante, Alicante, Spain; Puig, L., Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; González-Álvaro, I., Hospital Universitario de la Princesa and IIS-IP, Madrid, Spain; Pinto-Tasende, J.A., Complejo Hospitalario Juan Canalejo, INIBIC, A Coruña, Spain; Blanco, R., Hospital Universitario Marqués de Valdecilla, Santander, Spain; Rodríguez, M.A., Centre for Omic Sciences, COS-DEEEA-URV-IISPV, Reus, Spain, Metabolomics Platform, CIBERDEM, Reus, Spain; Beltran, A., Centre for Omic Sciences, COS-DEEEA-URV-IISPV, Reus, Spain, Metabolomics Platform, CIBERDEM, Reus, Spain; Correig, X., Centre for Omic Sciences, COS-DEEEA-URV-IISPV, Reus, Spain, Metabolomics Platform, CIBERDEM, Reus, Spain; Marsal, S., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Fernández, E., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; Sanmartí, R., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; Gratacós, J., Hospital Parc Taulí, Sabadell, Spain; Martínez-Taboada, V.M., Hospital Universitario Marqués de Valdecilla, Santander, Spain; Gomollón, F., CIBERehd, Madrid, Spain, Hospital Clínico Universitario, Zaragoza, Spain; Daudén, E., Hospital Universitario de la Princesa and IIS-IP, Madrid, Spain; Maymó, J., Hospital del Mar, Barcelona, Spain; Queiró, R., Hospital Universitario Central de Asturias, Asturias, Spain; Longo, F.J.L., Hospital Gregorio Marañón, Madrid, Spain; Garcia- Planella, E., Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Carazo, J.L.S., Hospital General Universitario, Valencia, Spain; Alperi-López, M., Hospital Universitario Central de Asturias, Asturias, Spain; Montilla, C., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; Pérez-Venegas, J.J., Hospital de Jerez de la Frontera, Cádiz, Spain; Fernández-Gutiérrez, B., Hospital Clínico San Carlos, IDISSC, Madrid, Spain; Mendoza, J.L., Hospital Clínico San Carlos, IDISSC, Madrid, Spain; López Estebaranz, J.L., Hospital Universitario Fundación Alcorcón, Madrid, Spain; Olivé, A., Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Torre-Alonso, J.C., Hospital Monte Naranco, Oviedo, Spain; Barreiro-de Acosta, M., Hospital Clínico Universitario, Santiago de Compostela, Spain; Ramírez, D.M., Hospital Virgen de la Macarena, Sevilla, Spain; Corominas, H., Hospital Moisès Broggi, Barcelona, Spain; Muñoz-Fernández, S., Hospital Universitario Infanta Sofía, Madrid, Spain; Andreu, J.L., Hospital Universitario Puerta de Hierro, Madrid, Spain; Muñoz, F., Complejo Hospitalario de León, León, Spain; de la Cueva, P., Hospital Universitario Infanta Leonor, Madrid, Spain; Erra, A., Hospital Sant Rafael, Barcelona, Spain; González, C.M., Hospital Gregorio Marañón, Madrid, Spain; Aguirre-Zamorano, M.A., Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain; Vera, M., Hospital Universitario Puerta de Hierro, Madrid, Spain; Vanaclocha, F., Hospital Universitario Doce de Octubre, Madrid, Spain; Roig, D., Hospital Moisès Broggi, Barcelona, Spain; Vela, P., Hospital General de Alicante, Alicante, Spain; Saro, C., Hospital de Cabueñes, Gijón, Spain; Herrera, E., Hospital Virgen de la Victoria, Málaga, Spain; Zarco, P., Hospital Universitario Fundación Alcorcón, Madrid, Spain; Nolla, J.M., Hospital Universitari de Bellvitge, Barcelona, Spain; Esteve, M., Hospital Universitari Mútua de Terrassa, Barcelona, Spain; Marenco de la Fuente, J.L., Hospital del Valme, Sevilla, Spain; Pego-Reigosa, J.M., Hospital do Meixoeiro, Vigo, Spain; García-Sánchez, V., Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, Spain; Panés, J., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain, CIBERehd, Madrid, Spain; Fonseca, E., Complejo Hospitalario Juan Canalejo, INIBIC, A Coruña, Spain; Blanco, F., Complejo Hospitalario Juan Canalejo, INIBIC, A Coruña, Spain; Rodríguez-Moreno, J., Hospital Universitari de Bellvitge, Barcelona, Spain; Carreira, P., Hospital Universitario Doce de Octubre, Madrid, Spain; Ramírez, J., Hospital Clínic de Barcelona and IDIBAPS, Barcelona, Spain; ávila, G., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Codó, L., Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Palau, N., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain; Alonso, A., Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain","Background: Immune-mediated inflammatory diseases (IMIDs) are a group of complex and prevalent diseases where disease diagnostic and activity monitoring is highly challenging. The determination of the metabolite profiles of biological samples is becoming a powerful approach to identify new biomarkers of clinical utility. In order to identify new metabolite biomarkers of diagnosis and disease activity, we have performed the first large-scale profiling of the urine metabolome of the six most prevalent IMIDs: rheumatoid arthritis, psoriatic arthritis, psoriasis, systemic lupus erythematosus, Crohn's disease, and ulcerative colitis. Methods: Using nuclear magnetic resonance, we analyzed the urine metabolome in a discovery cohort of 1210 patients and 100 controls. Within each IMID, two patient subgroups were recruited representing extreme disease activity (very high vs. very low). Metabolite association analysis with disease diagnosis and disease activity was performed using multivariate linear regression in order to control for the effects of clinical, epidemiological, or technical variability. After multiple test correction, the most significant metabolite biomarkers were validated in an independent cohort of 1200 patients and 200 controls. Results: In the discovery cohort, we identified 28 significant associations between urine metabolite levels and disease diagnosis and three significant metabolite associations with disease activity (P FDR &lt; 0.05). Using the validation cohort, we validated 26 of the diagnostic associations and all three metabolite associations with disease activity (P FDR &lt; 0.05). Combining all diagnostic biomarkers using multivariate classifiers we obtained a good disease prediction accuracy in all IMIDs and particularly high in inflammatory bowel diseases. Several of the associated metabolites were found to be commonly altered in multiple IMIDs, some of which can be considered as hub biomarkers. The analysis of the metabolic reactions connecting the IMID-associated metabolites showed an over-representation of citric acid cycle, phenylalanine, and glycine-serine metabolism pathways. Conclusions: This study shows that urine is a source of biomarkers of clinical utility in IMIDs. We have found that IMIDs show similar metabolic changes, particularly between clinically similar diseases and we have found, for the first time, the presence of hub metabolites. These findings represent an important step in the development of more efficient and less invasive diagnostic and disease monitoring methods in IMIDs. © 2016 The Author(s).","Autoimmune diseases; Disease activity; Inflammatory diseases; Metabolomics; Urine biomarkers","corticosteroid; etanercept; glycine; ibuprofen; infliximab; leflunomide; mesalazine; methotrexate; paracetamol; phenylalanine; serine; biological marker; amino acid metabolism; Article; citric acid cycle; classifier; cohort analysis; controlled study; Crohn disease; disease activity; disease association; disease marker; disease severity; human; immune mediated inflammatory disease; immunopathogenesis; inflammatory disease; linear regression analysis; major clinical study; metabolite; metabolome; multivariate analysis; nuclear magnetic resonance imaging; prediction; psoriasis; psoriatic arthritis; rheumatoid arthritis; systemic lupus erythematosus; ulcerative colitis; urinalysis; urine level; validation process; autoimmune disease; case control study; complication; Crohn disease; inflammation; metabolism; metabolomics; nuclear magnetic resonance spectroscopy; procedures; psoriasis; rheumatoid arthritis; systemic lupus erythematosus; ulcerative colitis; urine; Arthritis, Rheumatoid; Autoimmune Diseases; Biomarkers; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Humans; Inflammation; Lupus Erythematosus, Systemic; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Psoriasis",,"etanercept, 185243-69-0, 200013-86-1; glycine, 56-40-6, 6000-43-7, 6000-44-8; ibuprofen, 15687-27-1, 79261-49-7, 31121-93-4, 527688-20-6; infliximab, 170277-31-3; leflunomide, 75706-12-6; mesalazine, 89-57-6; methotrexate, 15475-56-6, 59-05-2, 7413-34-5; paracetamol, 103-90-2; phenylalanine, 3617-44-5, 63-91-2; serine, 56-45-1, 6898-95-9; Biomarkers",,,,,,,"Burisch, J., Jess, T., Martinato, M., Lakatos, P.L., The burden of inflammatory bowel disease in Europe (2013) J Crohns Colitis, 7 (4), pp. 322-337; Chandran, V., Raychaudhuri, S.P., Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis (2010) J Autoimmun, 34 (3), pp. J314-J321; Ferrándiz, C., Bordas, García P, Puig S, Pujol R, Smandía A. Prevalence of psoriasis in Spain (Epiderma Project: phase I) (2001) J Eur Acad Dermatol Venereol, 15 (1), pp. 20-23; Shapira, Y., Agmon-Levin, N., Shoenfeld, Y., Geoepidemiology of autoimmune rheumatic diseases (2010) Nat Rev Rheumatol, 6 (8), pp. 468-476; Rosman, Z., Shoenfeld, Y., Zandman-Goddard, G., Biologic therapy for autoimmune diseases: an update (2013) BMC Med., 11, p. 88; Cooper, G.S., Stroehla, B.C., The epidemiology of autoimmune diseases (2003) Autoimmun Rev, 2 (3), pp. 119-125; Eaton, W.W., Rose, N.R., Kalaydjian, A., Pedersen, M.G., Mortensen, P.B., Epidemiology of autoimmune diseases in Denmark (2007) J Autoimmun, 29 (1), pp. 1-9; Youinou, P., Pers, J.-O., Gershwin, M.E., Shoenfeld, Y., Geo-epidemiology and autoimmunity (2010) J Autoimmun, 34 (3), pp. J163-J167; Hehlgans, T., Pfeffer, K., The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games (2005) Immunology, 115 (1), pp. 1-20; Anaya, J.-M., Common mechanisms of autoimmune diseases (the autoimmune tautology) (2012) Autoimmun Rev, 11 (11), pp. 781-784; Hanauer, S.B., Positioning biologic agents in the treatment of Crohn's disease (2009) Inflamm Bowel Dis, 15 (10), pp. 1570-1582; Scarpa, R., Altomare, G., Marchesoni, A., Balato, N., Matucci Cerinic, M., Lotti, T., Olivieri, I., Valesini, G., Psoriatic disease: concepts and implications (2010) J Eur Acad Dermatol Venereol, 24 (6), pp. 627-630; Emery, P., Breedveld, F.C., Hall, S., Durez, P., Chang, D.J., Robertson, D., Singh, A., Freundlich, B., Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial (2008) Lancet, 372 (9636), pp. 375-382; Singh, J.A., Furst, D.E., Bharat, A., Curtis, J.R., Kavanaugh, A.F., Kremer, J.M., Moreland, L.W., Beukelman, T., 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis (2012) Arthritis Care Res, 64 (5), pp. 625-639; Smolen, J.S., Han, C., Heijde, D., Emery, P., Bathon, J.M., Keystone, E., Kalden, J.R., Baker, D., Infliximab treatment maintains employability in patients with early rheumatoid arthritis (2006) Arthritis Rheum, 54 (3), pp. 716-722; Kooij, S.M., Cessie, S., Goekoop-Ruiterman, Y.P.M., Vries-Bouwstra, J.K., Zeben, D., Kerstens, P.J.S.M., Hazes, J.M.W., Dijkmans, B.A.C., Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis (2009) Ann Rheum Dis, 68 (7), pp. 1153-1158; Schoepfer, A.M., Dehlavi, M.-A., Fournier, N., Safroneeva, E., Straumann, A., Pittet, V., Peyrin-Biroulet, L., Vavricka, S.R., Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate (2013) Am J Gastroenterol, 108 (11), pp. 1744-1753; Bakker, M.F., Cavet, G., Jacobs, J.W.G., Bijlsma, J.W.J., Haney, D.J., Shen, Y., Hesterberg, L.K., Roon, J.A.G., Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study (2012) Ann Rheum Dis, 71 (10), pp. 1692-1697; Uhlig, T., Kvien, T.K., Pincus, T., Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis (2009) Ann Rheum Dis, 68 (6), pp. 972-975; Castro-Santos, P., Laborde, C.M., Diaz-Pena, R., Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers (2015) Clin Exp Rheumatol., 8, p. 8; Huang, H., Vangay, P., McKinlay, C.E., Knights, D., Multi-omics analysis of inflammatory bowel disease (2014) Immunol Lett, 162 (2), pp. 62-68; Villanova, F., Meglio, P., Nestle, F.O., Biomarkers in psoriasis and psoriatic arthritis (2013) Ann Rheum Dis, 72, pp. 2104-2110; Thongboonkerd, V., Urinary proteomics: towards biomarker discovery, diagnostics and prognostics (2008) Mol Biosyst, 4 (8), pp. 810-815; Zhang, A., Sun, H., Wu, X., Wang, X., Urine metabolomics (2012) Clin Chim Acta., 414, pp. 65-69; Patti, G.J., Yanes, O., Siuzdak, G., Innovation: Metabolomics: the apogee of the omics trilogy (2012) Nat Rev Mol Cell Biol, 13 (4), pp. 263-269; Collino, S., Martin, F.-P., Rezzi, S., Clinical metabolomics paves the way towards future healthcare strategies (2013) Br J Clin Pharmacol, 75 (3), pp. 619-629; Zhang, A., Sun, H., Wang, P., Han, Y., Wang, X., Modern analytical techniques in metabolomics analysis (2012) Analyst, 137 (2), pp. 293-300; Preter, V., Verbeke, K., Metabolomics as a diagnostic tool in gastroenterology (2013) World J Gastrointest Pharmacol Ther, 4 (4), pp. 97-107; Julià, A., Alonso, A., Marsal, S., Metabolomics in rheumatic diseases (2014) Int J Clin Rheumatol, 9 (4), pp. 353-369; Julià, A., Domènech, E., Ricart, E., Tortosa, R., García-Sánchez, V., Gisbert, J.P., Nos Mateu, P., Mendoza, J.L., A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300 (2013) Gut, 62 (10), pp. 1440-1445; Julià, A., Tortosa, R., Hernanz, J.M., Cañete, J.D., Fonseca, E., Ferrándiz, C., Unamuno, P., Sanmartí, R., Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes (2012) Hum Mol Genet, 21 (20), pp. 4549-4557; Alonso, A., Domènech, E., Julià, A., Panés, J., García-Sánchez, V., Mateu, P.N., Gutiérrez, A., Garcia-Planella, E., Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study (2015) Gastroenterology, 148 (4), pp. 794-805; Alonso, A., Rodríguez, M.A., Vinaixa, M., Tortosa, R., Correig, X., Julià, A., Marsal, S., Focus: A Robust Workflow for One-Dimensional NMR Spectral Analysis (2013) Anal Chem, 86 (2), pp. 1160-1169; Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Dong, E., HMDB 3.0-The Human Metabolome Database in 2013 (2013) Nucleic Acids Res, 41 (DATABASE ISSUE), pp. D801-D807; Menni, C., Kastenmüller, G., Petersen, A.K., Bell, J.T., Psatha, M., Tsai, P.-C., Gieger, C., John, S., Metabolomic markers reveal novel pathways of ageing and early development in human populations (2013) Int J Epidemiol, 42 (4), pp. 1111-1119; Shah, S.H., Hauser, E.R., Bain, J.R., Muehlbauer, M.J., Haynes, C., Stevens, R.D., Wenner, B.R., Ginsburg, G., High heritability of metabolomic profiles in families burdened with premature cardiovascular disease (2009) Mol Syst Biol., 5, p. 258; Wang-Sattler, R., Yu, Z., Herder, C., Messias, A.C., Floegel, A., He, Y., Heim, K., Thorand, B., Novel biomarkers for pre-diabetes identified by metabolomics (2012) Mol Syst Biol., 8, p. 615; Alonso, A., Marsal, S., Julià, A., Analytical methods in untargeted metabolomics: state of the art in 2015 (2015) Front Bioeng Biotechnol., 3, p. 23; Posma, J.M., Robinette, S.L., Holmes, E., Nicholson, J.K., MetaboNetworks, an interactive Matlab-based toolbox for creating, customizing and exploring sub-networks from KEGG (2014) Bioinformatics, 30 (6), pp. 893-895; Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., Tanabe, M., KEGG for integration and interpretation of large-scale molecular data sets (2012) Nucleic Acids Res, 40 (DATABASE ISSUE), pp. D109-D114; Elliott, P., Posma, J.M., Chan, Q., Garcia-Perez, I., Wijeyesekera, A., Bictash, M., Ebbels, T.M., Horn, L., Urinary metabolic signatures of human adiposity (2015) Sci Transl Med, 7 (285). , 285ra62; Bouatra, S., Aziat, F., Mandal, R., Guo, A.C., Wilson, M.R., Knox, C., Bjorndahl, T.C., Liu, P., The human urine metabolome (2013) PLoS One, 8 (9), p. e73076; Gronwald, W., Klein, M.S., Zeltner, R., Schulze, B.-D., Reinhold, S.W., Deutschmann, M., Immervoll, A.-K., Eckardt, K.-U., Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine (2011) Kidney Int, 79 (11), pp. 1244-1253; Kang, S.-M., Park, J.-C., Shin, M.-J., Lee, H., Oh, J., Ryu, D.H., Hwang, G.-S., Chung, J.H., 1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure (2011) Clin Biochem, 44 (4), pp. 293-299; Armitage, E.G., Barbas, C., Metabolomics in cancer biomarker discovery: current trends and future perspectives (2014) J Pharm Biomed Anal., 87, pp. 1-11; Duarte, I.F., Diaz, S.O., Gil, A.M., NMR metabolomics of human blood and urine in disease research (2014) J Pharm Biomed Anal., 93, pp. 17-26; Mastrangelo, A., Armitage, E.G., García, A., Barbas, C., Metabolomics as a tool for drug discovery and personalised medicine. A Review (2014) Curr Top Med Chem, 14 (23), pp. 2627-2636; Infantino, V., Iacobazzi, V., Menga, A., Avantaggiati, M.L., Palmieri, F., A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation (2014) Biochim Biophys Acta, 1839 (11), pp. 1217-1225; Dawiskiba, T., Deja, S., Mulak, A., Zabek, A., Jawień, E., Pawełka, D., Banasik, M., Kaliszewski, K., Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases (2014) World J Gastroenterol, 20 (1), pp. 163-174; Stephens, N.S., Siffledeen, J., Su, X., Murdoch, T.B., Fedorak, R.N., Slupsky, C.M., Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy (2013) J Crohns Colitis, 7 (2), pp. e42-e48; Jiang, M., Chen, T., Feng, H., Zhang, Y., Li, L., Zhao, A., Niu, X., Zhan, J., Serum metabolic signatures of four types of human arthritis (2013) J Proteome Res, 12 (8), pp. 3769-3779; Ouyang, X., Dai, Y., Wen, J.L., Wang, L.X., 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus (2011) Lupus, 20 (13), pp. 1411-1420; Cho, J.H., Gregersen, P.K., Genomics and the multifactorial nature of human autoimmune disease (2011) N Engl J Med, 365 (17), pp. 1612-1623; Cotsapas, C., Voight, B.F., Rossin, E., Lage, K., Neale, B.M., Wallace, C., Abecasis, G.R., Cho, J., Pervasive sharing of genetic effects in autoimmune disease (2011) PLoS Genet, 7 (8), p. e1002254; Li, Y., Begovich, A.B., Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis (2009) Semin Immunol, 21 (6), pp. 318-327; Sirota, M., Schaub, M.A., Batzoglou, S., Robinson, W.H., Butte, A.J., Autoimmune disease classification by inverse association with SNP alleles (2009) PLoS Genet, 5 (12), p. e1000792; Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., Lee, J.C., Anderson, C.A., Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (2012) Nature, 491 (7422), pp. 119-124; Liu, Y., Helms, C., Liao, W., Zaba, L.C., Duan, S., Gardner, J., Wise, C., Pullinger, C.R., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci (2008) PLoS Genet, 4 (4), p. e1000041; Hébert, H.L., Ali, F.R., Bowes, J., Griffiths, C.E.M., Barton, A., Warren, R.B., Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy (2012) Br J Dermatol, 166 (3), pp. 474-482; Márquez, A., Vidal-Bralo, L., Rodríguez-Rodríguez, L., González-Gay, M.A., Balsa, A., González-Álvaro, I., Carreira, P., García-Hernández, F.J., A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus (2016) Ann Rheum Dis.; McGettrick, A.F., O'Neill, L.A.J., How metabolism generates signals during innate immunity and inflammation (2013) J Biol Chem, 288 (32), pp. 22893-22898; Jansson, J., Willing, B., Lucio, M., Fekete, A., Dicksved, J., Halfvarson, J., Tysk, C., Schmitt-Kopplin, P., Metabolomics reveals metabolic biomarkers of Crohn's disease (2009) PLoS One, 4 (7), p. e6386; Wang, W., Wu, Z., Dai, Z., Yang, Y., Wang, J., Wu, G., Glycine metabolism in animals and humans: implications for nutrition and health (2013) Amino Acids, 45 (3), pp. 463-477; Baumgart, M., Dogan, B., Rishniw, M., Weitzman, G., Bosworth, B., Yantiss, R., Orsi, R.H., Kim, S.G., Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum (2007) ISME J, 1 (5), pp. 403-418; Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases (2007) Proc Natl Acad Sci, 104 (34), pp. 13780-13785; Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Zhang, M., Symbiotic gut microbes modulate human metabolic phenotypes (2008) Proc Natl Acad Sci, 105 (6), pp. 2117-2122; Machiels, K., Joossens, M., Sabino, J., Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Verbeke, K., A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis (2014) Gut, 63 (8), pp. 1275-1283; Schicho, R., Shaykhutdinov, R., Ngo, J., Nazyrova, A., Schneider, C., Panaccione, R., Kaplan, G.G., Storr, M., Quantitative metabolomic profiling of serum, plasma, and urine by 1H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals (2012) J Proteome Res, 11 (6), pp. 3344-3357; Williams, H.R.T., Cox, I.J., Walker, D.G., North, B.V., Patel, V.M., Marshall, S.E., Jewell, D.P., Teare, J.P., Characterization of inflammatory bowel disease with urinary metabolic profiling (2009) Am J Gastroenterol, 104 (6), pp. 1435-1444; Xia, J., Broadhurst, D.I., Wilson, M., Wishart, D.S., Translational biomarker discovery in clinical metabolomics: an introductory tutorial (2013) Metabolomics, 9 (2), pp. 280-299; Harvey, R.F., Bradshaw, J.M., A simple index of Crohn's-disease activity (1980) Lancet, 315 (8167), p. 514; Lichtiger, S., Present, D.H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., Hanauer, S., Cyclosporine in severe ulcerative colitis refractory to steroid therapy (1994) N Engl J Med, 330 (26), pp. 1841-1845; Prevoo, M.L.L., Hof, M.A., Kuper, H.H., Leeuwen, M.A., Putte, L.B.A., Riel, P.L.C.M., Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis (1995) Arthritis Rheum, 38 (1), pp. 44-48; Fredriksson, T., Pettersson, U., Severe psoriasis--oral therapy with a new retinoid (1978) Dermatologica, 157 (4), pp. 238-244; Petri, M., Kim, M.Y., Kalunian, K.C., Grossman, J., Hahn, B.H., Sammaritano, L.R., Lockshin, M., Askanase, A.D., Combined oral contraceptives in women with systemic lupus erythematosus (2005) N Engl J Med, 353 (24), pp. 2550-2558; Hay, E.M., Bacon, P.A., Gordon, C., Isenberg, D.A., Maddison, P., Snaith, M.L., Symmons, D.P.M., Zoma, A., The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus (1993) QJM, 86 (7), pp. 447-458","Julià, A.; Rheumatology Research Group, Vall d'Hebron Hospital Research InstituteSpain; email: toni.julia@vhir.org",,,"BioMed Central Ltd.",,,,,17417015,,,"27609333","English","BMC Med.",Article,"Final",Open Access,Scopus,2-s2.0-84986253441
"Julià A., Blanco F., Fernández-Gutierrez B., González A., Cañete J.D., Maymó J., Alperi-López M., Olivè A., Corominas H., Martínez-Taboada V., González-Álvaro I., Fernandez-Nebro A., Erra A., Sánchez-Fernández S., Alonso A., López-Lasanta M., Tortosa R., Codó L., Lluis Gelpi J., García-Montero A.C., Bertranpetit J., Absher D., Myers R.M., Tornero J., Marsal S.","57210878792;7102243071;6701926209;55455325800;7003746360;6602416727;24553621900;7005738781;6602373022;7003889422;7003841482;57195363279;16678368700;55986702400;36150353900;23035265100;55933194400;55882083800;35517522400;6603714021;7005566413;57198406019;7403700738;36151354800;6603356384;","Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study",2016,"Arthritis and Rheumatology","68","6",,"1384","1391",,5,"10.1002/art.39591","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971216371&doi=10.1002%2fart.39591&partnerID=40&md5=d88f72a6747a1a3a22cd99fe1b08c435","Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Instituto de Investigación Biomédica de A Coruña, Hospital Universitario A Coruña, A Coruña, Spain; Hospital Clínico San Carlos, Madrid, Spain; Instituto de Investigación Sanitaria, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain; Hospital Clínic de Barcelona, Barcelona, Spain; Hospital Del Mar, Barcelona, Barcelona, Spain; Hospital Universitario, Central de Asturias, Oviedo, Spain; Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Hospital Moisès Broggi, Barcelona, Spain; Hospital Universitario Marqués de Valdecilla, Santander, Spain; Hospital Universitario la Princesa, IIS Princesa, Madrid, Spain; Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain; Hospital Sant Rafael, Barcelona, Spain; Hospital General la Mancha Centro, Ciudad Real, Spain; Barcelona Supercomputing Center, Barcelona, Spain; National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain; National Genotyping Center, Pompeu Fabra University, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States; Hospital Universitario de Guadalajara, Guadalajara, Spain","Julià, A., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Blanco, F., Instituto de Investigación Biomédica de A Coruña, Hospital Universitario A Coruña, A Coruña, Spain; Fernández-Gutierrez, B., Hospital Clínico San Carlos, Madrid, Spain; González, A., Instituto de Investigación Sanitaria, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain; Cañete, J.D., Hospital Clínic de Barcelona, Barcelona, Spain; Maymó, J., Hospital Del Mar, Barcelona, Barcelona, Spain; Alperi-López, M., Hospital Universitario, Central de Asturias, Oviedo, Spain; Olivè, A., Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Corominas, H., Hospital Moisès Broggi, Barcelona, Spain; Martínez-Taboada, V., Hospital Universitario Marqués de Valdecilla, Santander, Spain; González-Álvaro, I., Hospital Universitario la Princesa, IIS Princesa, Madrid, Spain; Fernandez-Nebro, A., Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain; Erra, A., Hospital Sant Rafael, Barcelona, Spain; Sánchez-Fernández, S., Hospital General la Mancha Centro, Ciudad Real, Spain; Alonso, A., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain; López-Lasanta, M., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Tortosa, R., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Codó, L., Barcelona Supercomputing Center, Barcelona, Spain; Lluis Gelpi, J., Barcelona Supercomputing Center, Barcelona, Spain; García-Montero, A.C., National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain; Bertranpetit, J., National Genotyping Center, Pompeu Fabra University, Barcelona, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States; Myers, R.M., HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States; Tornero, J., Hospital Universitario de Guadalajara, Guadalajara, Spain; Marsal, S., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Barcelona, 08035, Spain","Objective Rheumatoid factor (RF) is a well-established diagnostic and prognostic biomarker in rheumatoid arthritis (RA). However, â20% of RA patients are negative for this anti-IgG antibody. To date, only variation at the HLA-DRB1 gene has been associated with the presence of RF. This study was undertaken to identify additional genetic variants associated with RF positivity. Methods A genome-wide association study (GWAS) for RF positivity was performed using an Illumina Quad610 genotyping platform. A total of 937 RF-positive and 323 RF-negative RA patients were genotyped for &gt;550,000 single-nucleotide polymorphisms (SNPs). Association testing was performed using an allelic chi-square test implemented in Plink software. An independent cohort of 472 RF-positive and 190 RF-negative RA patients was used to validate the most significant findings. Results In the discovery stage, a SNP in the IRX1 locus on chromosome 5p15.3 (SNP rs1502644) showed a genome-wide significant association with RF positivity (P = 4.13 × 10-8, odds ratio [OR] 0.37 [95% confidence interval (95% CI) 0.26-0.53]). In the validation stage, the association of IRX1 with RF was replicated in an independent group of RA patients (P = 0.034, OR 0.58 [95% CI 0.35-0.97] and combined P = 1.14 × 10-8, OR 0.43 [95% CI 0.32-0.58]). Conclusion To our knowledge, this is the first GWAS of RF positivity in RA. Variation at the IRX1 locus on chromosome 5p15.3 is associated with the presence of RF. Our findings indicate that IRX1 and HLA-DRB1 are the strongest genetic factors for RF production in RA. © 2016, American College of Rheumatology.",,"chemokine receptor CCR6; chemokine receptor CXCR5; HLA DRB1 antigen; interferon consensus sequence binding protein; iroquois protein family 1; rheumatoid factor; transcription factor RUNX1; unclassified drug; homeodomain protein; IRX1 protein, human; rheumatoid factor; transcription factor; Article; B lymphocyte; B lymphocyte differentiation; chromosome 5p; chromosome 6; cohort analysis; controlled study; gene expression profiling; gene frequency; gene locus; genetic association; genetic marker; genetic variability; genetic variation; genome-wide association study; genotype; human; major clinical study; multicenter study; priority journal; rheumatoid arthritis; single nucleotide polymorphism; genetic variation; genetics; rheumatoid arthritis; risk; Arthritis, Rheumatoid; Genetic Loci; Genetic Variation; Genome-Wide Association Study; Genotype; Homeodomain Proteins; Humans; Polymorphism, Single Nucleotide; Rheumatoid Factor; Risk; Transcription Factors",,"chemokine receptor CCR6, 287981-77-5; rheumatoid factor, 9009-79-4; Homeodomain Proteins; IRX1 protein, human; Rheumatoid Factor; Transcription Factors",,,,,,,"Firestein, G.S., Evolving concepts of rheumatoid arthritis (2003) Nature, 423, pp. 356-361; Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis (1988) Arthritis Rheum, 31, pp. 315-324; MacGregor, A.J., Ollier, W.E., Venkovsky, J., Mageed, R.A., Carthy, D., Silman, A.J., Rheumatoid factor isotypes in monozygotic and dizygotic twins discordant for rheumatoid arthritis (1995) J Rheumatol, 22, pp. 2203-2207; Olsen, N.J., Callahan, L.F., Brooks, R.H., Nance, E.P., Kaye, J.J., Stastny, P., Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis (1988) Am J Med, 84, pp. 257-264; Rose, H.M., Ragan, C., Pearce, E., Lipman, M.O., Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis (1948) Proc Soc Exp Biol Med, 68, pp. 1-6; Waaler, E., On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles (1940) Acta Pathol Microbiol Scand, 17, pp. 172-188; Dorner, T., Egerer, K., Feist, E., Burmester, G.R., Rheumatoid factor revisited (2004) Curr Opin Rheumatol, 16, pp. 246-253; Newkirk, M.M., Rheumatoid factors: Host resistance or autoimmunity? (2002) Clin Immunol, 104, pp. 1-13; Masi, A.T., Maldonado-Cocco, J.A., Kaplan, S.B., Feigenbaum, S.L., Chandler, R.W., Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome (1976) Semin Arthritis Rheum, 4, pp. 299-326; Goronzy, J.J., Matteson, E.L., Fulbright, J.W., Warrington, K.J., Chang-Miller, A., Hunder, G.G., Prognostic markers of radiographic progression in early rheumatoid arthritis (2004) Arthritis Rheum, 50, pp. 43-54; Bukhari, M., Lunt, M., Harrison, B.J., Scott, D.G., Symmons, D.P., Silman, A.J., Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: Results from the Norfolk Arthritis Register Study, a large inception cohort (2002) Arthritis Rheum, 46, pp. 906-912; Quartuccio, L., Fabris, M., Salvin, S., Atzeni, F., Saracco, M., Benucci, M., Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis (2009) Rheumatology (Oxford), 48, pp. 1557-1559; Klaasen, R., Cantaert, T., Wijbrandts, C.A., Teitsma, C., Gerlag, D.M., Out, T.A., The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: An exploratory study (2011) Rheumatology (Oxford), 50, pp. 1487-1493; Nielen, M.M., Van Schaardenburg, D., Reesink, H.W., Van De Stadt, R.J., Van Der Horst-Bruinsma, I.E., De Koning, M.H., Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors (2004) Arthritis Rheum, 50, pp. 380-386; Rantapaa-Dahlqvist, S., De Jong, B.A., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis (2003) Arthritis Rheum, 48, pp. 2741-2749; Laurent, L., Anquetil, F., Clavel, C., Ndongo-Thiam, N., Offer, G., Miossec, P., IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritis-specific immune complexes containing anticitrullinated protein antibodies (2015) Ann Rheum Dis, 74, pp. 1425-1431; Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Genetics of rheumatoid arthritis contributes to biology and drug discovery (2014) Nature, 506, pp. 376-381; Lundstrom, E., Kallberg, H., Alfredsson, L., Klareskog, L., Padyukov, L., Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important (2009) Arthritis Rheum, 60, pp. 1597-1603; Padyukov, L., Seielstad, M., Ong, R.T., Ding, B., Ronnelid, J., Seddighzadeh, M., A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis (2011) Ann Rheum Dis, 70, pp. 259-265; Klareskog, L., Catrina, A.I., Paget, S., Rheumatoid arthritis (2009) Lancet, 373, pp. 659-672; Bossini-Castillo, L., De Kovel, C., Kallberg, H., Van 'T Slot, R., Italiaander, A., Coenen, M., A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides (2015) Ann Rheum Dis, 74, p. e15; Julia, A., Domenech, E., Chaparro, M., Garcia-Sanchez, V., Gomollon, F., Panes, J., A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis (2014) Hum Mol Genet, 23, pp. 6927-6934; Arnett, F.C., Revised criteria for the classification of rheumatoid arthritis (1989) Bull Rheum Dis, 38, pp. 1-6; Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nat Genet, 38, pp. 904-909; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., PLINK: A toolset for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81, pp. 559-575; Purcell, S., Cherny, S.S., Sham, P.C., Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits (2003) Bioinformatics, 19, pp. 149-150; Delaneau, O., Zagury, J.F., Marchini, J., Improved whole-chromosome phasing for disease and population genetic studies (2013) Nat Methods, 10, pp. 5-6; Howie, B., Marchini, J., Stephens, M., Genotype imputation with thousands of genomes (2011) G3 (Bethesda), 1, pp. 457-470; Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., An integrated map of genetic variation from 1,092 human genomes (2012) Nature, 491, pp. 56-65; Kassambara, A., Reme, T., Jourdan, M., Fest, T., Hose, D., Tarte, K., GenomicScape: An easy-to-use web tool for gene expression data analysis: Application to investigate the molecular events in the differentiation of B cells into plasma cells (2015) PLoS Comput Biol, 11, p. e1004077; Jourdan, M., Cren, M., Robert, N., Bollore, K., Fest, T., Duperray, C., IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors (2014) Leukemia, 28, pp. 1647-1656; Gomez-Skarmeta, J.L., Modolell, J., Iroquois genes: Genomic organization and function in vertebrate neural development (2002) Curr Opin Genet Dev, 12, pp. 403-408; Ovsyannikova, I.G., Kennedy, R.B., O'Byrne, M., Jacobson, R.M., Pankratz, V.S., Poland, G.A., Genome-wide association study of antibody response to smallpox vaccine (2012) Vaccine, 30, pp. 4182-4189; Carotta, S., Willis, S.N., Hasbold, J., Inouye, M., Pang, S.H., Emslie, D., The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation (2014) J Exp Med, 211, pp. 2169-2181; Kitanaka, A., Mano, H., Conley, M.E., Campana, D., Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells (1998) Blood, 91, pp. 940-948; Legler, D.F., Loetscher, M., Roos, R.S., Clark-Lewis, I., Baggiolini, M., Moser, B., B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5 (1998) J Exp Med, 187, pp. 655-660; Elgueta, R., Marks, E., Nowak, E., Menezes, S., Benson, M., Raman, V.S., CCR6-dependent positioning of memory B cells is essential for their ability to mount a recall response to antigen (2015) J Immunol, 194, pp. 505-513; Takenaka, K., Fukami, K., Otsuki, M., Nakamura, Y., Kataoka, Y., Wada, M., Role of phospholipase C-L2, a novel phospholipase C-like protein that lacks lipase activity, in B-cell receptor signaling (2003) Mol Cell Biol, 23, pp. 7329-7338; Hecht, C., Englbrecht, M., Rech, J., Schmidt, S., Araujo, E., Engelke, K., Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA (2015) Ann Rheum Dis, 74, pp. 2151-2156; Van Steenbergen, H.W., Ajeganova, S., Forslind, K., Svensson, B., Van Der Helm-Van Mil, A.H., The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis (2015) Ann Rheum Dis, 74, p. e3; Padyukov, L., Seielstad, M., Ong, R.T., Ding, B., Ronnelid, J., Seddighzadeh, M., A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis (2011) Ann Rheum Dis, 70, pp. 259-265; Criswell, L.A., Chen, W.V., Jawaheer, D., Lum, R.F., Wener, M.H., Gu, X., Dissecting the heterogeneity of rheumatoid arthritis through linkage analysis of quantitative traits (2007) Arthritis Rheum, 56, pp. 58-68; Mukhopadhyay, N., Halder, I., Bhattacharjee, S., Weeks, D.E., Two-dimensional linkage analyses of rheumatoid arthritis (2007) BMC Proc, 1, p. S68; Oh, C., A Bayesian genome-wide linkage analysis of quantitative traits for rheumatoid arthritis via perfect sampling (2007) BMC Proc, 1, p. S110; Hirschhorn, J.N., Daly, M.J., Genome-wide association studies for common diseases and complex traits (2005) Nat Rev Genet, 6, pp. 95-108; Terao, C., Ohmura, K., Ikari, K., Kawaguchi, T., Takahashi, M., Setoh, K., Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population (2014) Arthritis Care Res (Hoboken), 66, pp. 1818-1827. , on behalf of the Nagahama Study Group; McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P., Genome-wide association studies for complex traits: Consensus, uncertainty and challenges (2008) Nat Rev Genet, 9, pp. 356-369; Bukhari, M., Lunt, M., Harrison, B.J., Scott, D.G., Symmons, D.P., Silman, A.J., Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: Results from the Norfolk Arthritis Register Study, a large inception cohort (2002) Arthritis Rheum, 46, pp. 906-912; Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M., Smoller, J.W., Pleiotropy in complex traits: Challenges and strategies (2013) Nat Rev Genet, 14, pp. 483-495","Marsal, S.; Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Passeig de la Vall d'Hebron, 119-129, Spain; email: sara.marsal@vhir.org",,,"John Wiley and Sons Inc.",,,,,23265191,,,"26815016","English","Arthritis Rheum.",Article,"Final",,Scopus,2-s2.0-84971216371
"Julià A., González I., Fernández-Nebro A., Blanco F., Rodriguez L., González A., Cañete J.D., Maymó J., Alperi-López M., Olivé A., Corominas H., Martínez-Taboada V., Erra A., Sánchez-Fernández S., Alonso A., Lopez-Lasanta M., Tortosa R., Codó L., Gelpi J.L., García-Montero A.C., Bertranpetit J., Absher D., Bridges S.L., Jr., Myers R.M., Tornero J., Marsal S.","57210878792;55442971400;57195363279;7102243071;26324085100;55455325800;7003746360;6602416727;24553621900;7005738781;6602373022;7003889422;16678368700;55986702400;36150353900;23035265100;55933194400;55882083800;35517522400;6603714021;7005566413;57198406019;7006956774;7403700738;36151354800;6603356384;","A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis",2016,"Rheumatology (United Kingdom)","55","6",,"1106","1111",,3,"10.1093/rheumatology/kew035","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84974817803&doi=10.1093%2frheumatology%2fkew035&partnerID=40&md5=30708d5a037ab409f7ba441cf6ecc0d6","Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain; Rheumatology Department, Hospital Universitario La Princesa. IIS La Princesa, Madrid, Spain; UGC Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain; Rheumatology Department, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain; Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain; Instituto de Investigación Sanitaria-Hospital Clínico Universitario de Santiago, Rheumatology Unit, Santiago de Compostela, Spain; Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Rheumatology Department, Hospital del Mar, Barcelona, Spain; Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Rheumatology Department, Hospital Universitari Germans Trias i Pujol, Spain; Rheumatology Department, Hospital Moisè s Broggi, Barcelona, Spain; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Rheumatology Department, Hospital General La Mancha Centro, Ciudad Real, Spain; Life Sciences, Barcelona Supercomputing Centre, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Nacional Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; Hudson Alpha Institute for Biotechnology, Abshers lab, Huntsville, Spain; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, United States; Hudson Alpha Institute for Biotechnology, Myers lab, Huntsville, AL, United States; Rheumatology Department, Hospital Universitario De Guadalajara, Guadalajara, Spain","Julià, A., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain; González, I., Rheumatology Department, Hospital Universitario La Princesa. IIS La Princesa, Madrid, Spain; Fernández-Nebro, A., UGC Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain; Blanco, F., Rheumatology Department, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain; Rodriguez, L., Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain; González, A., Instituto de Investigación Sanitaria-Hospital Clínico Universitario de Santiago, Rheumatology Unit, Santiago de Compostela, Spain; Cañete, J.D., Rheumatology Department, Hospital Clínic de Barcelona, Barcelona, Spain; Maymó, J., Rheumatology Department, Hospital del Mar, Barcelona, Spain; Alperi-López, M., Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Olivé, A., Rheumatology Department, Hospital Universitari Germans Trias i Pujol, Spain; Corominas, H., Rheumatology Department, Hospital Moisè s Broggi, Barcelona, Spain; Martínez-Taboada, V., Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Erra, A., Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Sánchez-Fernández, S., Rheumatology Department, Hospital General La Mancha Centro, Ciudad Real, Spain; Alonso, A., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain; Lopez-Lasanta, M., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain; Tortosa, R., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain; Codó, L., Life Sciences, Barcelona Supercomputing Centre, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Gelpi, J.L., Life Sciences, Barcelona Supercomputing Centre, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Bertranpetit, J., Nacional Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; Absher, D., Hudson Alpha Institute for Biotechnology, Abshers lab, Huntsville, Spain; Bridges, S.L., Jr., Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, United States; Myers, R.M., Hudson Alpha Institute for Biotechnology, Myers lab, Huntsville, AL, United States; Tornero, J., Rheumatology Department, Hospital Universitario De Guadalajara, Guadalajara, Spain; Marsal, S., Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain","Objective. RA patients with serum ACPA have a strong and specific genetic background. The objective of the study was to identify new susceptibility genes for ACPA-positive RA using a genome-wide association approach. Methods. A total of 924 ACPA-positive RA patients with joint damage in hands and/or feet, and 1524 healthy controls were genotyped in 582 591 single-nucleotide polymorphisms (SNPs) in the discovery phase. In the validation phase, the most significant SNPs in the genome-wide association study representing new candidate loci for RA were tested in an independent cohort of 863 ACPA-positive patients with joint damage and 1152 healthy controls. All individuals from the discovery and validation cohorts were Caucasian and of Southern European ancestry. Results. In the discovery phase, 60 loci not previously associated with RA risk showed evidence for association at P<5±10±4 and were tested for replication in the validation cohort. A total of 12 loci were replicated at the nominal level (P<0.05, same direction of effect as in the discovery phase). When combining the discovery and validation cohorts, an intronic SNP in the Solute Carrier family 8 gene (SLC8A3) was found to be associated with ACPA-positive RA at a genome-wide level of significance RA [odds ratio (95% CI): 1.42 (1.25, 1.6), Pcombined = 3.19±10±8]. Conclusions. SLC8A3 was identified as a new risk locus for ACPA-positive RA. This study demonstrates the advantage of analysing relevant subsets of RA patients to identify new genetic risk variants. © The Author 2016.","Anti-citrullinated protein antibodies; Genetic risk; Genome-wide association study; Joint erosions; Rheumatoid arthritis","carrier proteins and binding proteins; citrullinated protein antibody; protein antibody; solute carrier family 8 member 3 protein; unclassified drug; autoantibody; cyclic citrullinated peptide; cyclopeptide; SLC38A3 protein, human; sodium calcium exchange protein; Article; case control study; Caucasian; chromosome 14q; cohort analysis; controlled study; gene locus; genetic association; genetic risk; genetic susceptibility; genetic variation; genome-wide association study; genomics; genotype; human; human cell; major clinical study; priority journal; rheumatoid arthritis; risk assessment; single nucleotide polymorphism; Southern European; adult; blood; female; genetic predisposition; genetics; genome-wide association study; immunology; male; middle aged; rheumatoid arthritis; risk factor; Adult; Arthritis, Rheumatoid; Autoantibodies; Case-Control Studies; European Continental Ancestry Group; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Peptides, Cyclic; Polymorphism, Single Nucleotide; Risk Factors; Sodium-Calcium Exchanger",,"Autoantibodies; cyclic citrullinated peptide; Peptides, Cyclic; SLC38A3 protein, human; Sodium-Calcium Exchanger",,,,,,,"Okada, Y., Wu, D., Trynka, G., Genetics of rheumatoid arthritis contributes to biology and drug discovery (2014) Nature, 506, pp. 376-381; Kurreeman, F., Liao, K., Chibnik, L., Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records (2011) Am J Hum Genet, 88, pp. 57-69; Padyukov, L., Seielstad, M., Ong, R.T., A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis (2011) Ann Rheum Dis, 70, pp. 259-265; Raychaudhuri, S., Sandor, C., Stahl, E.A., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis (2012) Nat Genet, 44, pp. 291-296; Kim, K., Bang, S.Y., Lee, H.S., High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci (2015) Ann Rheum Dis, 74; van der Heijde, D.M., Joint erosions and patients with early rheumatoid arthritis (1995) Br J Rheumatol, 34, pp. 74-78; Julia, A., Domenech, E., Chaparro, M., A genome-wide association study identifies a novel locus at 6q22.1associated with ulcerative colitis (2014) Hum Mol Genet, 23, pp. 6927-6934; Rosenbloom, K.R., Armstrong, J., Barber, G.P., The UCSC Genome Browser database: 2015 update (2015) Nucleic Acids Res, 43 (DATABASE ISSUE), pp. D670-D681; Lytton, J., Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport (2007) Biochem J, 406, pp. 365-382; Staiano, R.I., Granata, F., Secondo, A., Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes (2009) Eur J Immunol, 39, pp. 1405-1418; Firestein, G.S., Evolving concepts of rheumatoid arthritis (2003) Nature, 423, pp. 356-361; Stains, J.P., Weber, J.A., Gay, C.V., Expression of Na+/Ca2+ exchanger isoforms (NCX1 and NCX3) and plasma membrane Ca2+ ATPase during osteoblast differentiation (2002) J Cell Biochem, 84, pp. 625-635; Sosnoski, D.M., Gay, C.V., NCX3 is a major functional isoform of the sodium-calcium exchanger in osteoblasts (2008) J Cell Biochem, 103, pp. 1101-1110; Viatte, S., Plant, D., Bowes, J., Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients (2011) Ann Rheum Dis, 71, pp. 1984-1990; Bossini-Castillo, L., de Kovel, C., Kallberg, H., A genomewide association study of rheumatoid arthritis without antibodies against citrullinated peptides (2015) Ann Rheum Dis, 74; Knevel, R., Klein, K., Somers, K., Identification of a genetic variant for joint damage progression in autoantibodypositive rheumatoid arthritis (2014) Ann Rheum Dis, 73, pp. 2038-2046; Thal, M.A., Carvalho, T.L., He, T., Ebf1-mediated downregulation of Id2 and Id3 is essential for specification of the B cell lineage (2009) Proc Natl Acad Sci U S A, 106, pp. 552-557; Nordmark, G., Kristjansdottir, G., Theander, E., Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjogren's syndrome (2011) Genes Immun, 12, pp. 100-109","Marsal, S.; Grup de Recerca de Reumatologia, Vall d'Hebron Hospital Research Institute, Pg Vall Hebron 119-129, Spain; email: sara.marsal@vhir.org",,,"Oxford University Press",,,,,14620324,,RUMAF,"26983453","English","Rheumatology",Article,"Final",Open Access,Scopus,2-s2.0-84974817803
"Dans P.D., Danilane L., Ivani I., Drsata T., Lankas F., Hospital A., Walther J., Pujagut R.I., Battistini F., Gelpi J.L., Lavery R., Orozco M.","25931363700;57189464169;36545032500;55344475800;6602967732;15831739300;56959973100;57189471601;35193719000;35517522400;7005788982;7102809158;","Long-timescale dynamics of the Drew-Dickerson dodecamer",2016,"Nucleic Acids Research","44","9",,"4052","4066",,38,"10.1093/nar/gkw264","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971229282&doi=10.1093%2fnar%2fgkw264&partnerID=40&md5=722742495da7d23fc65a33be7e78683f","Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; School of Chemistry, University of East Anglia, Norwich, NR47TJ, United Kingdom; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam 2, Prague, 16610, Czech Republic; Laboratory of Informatics and Chemistry, University of Chemistry and Technology Prague, Prague, 16628, Czech Republic; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, 08028, Spain; Bases Moleculaires et Structurales des Systemes Infectieux, Universite Lyon i, CNRS, 7 Passage du Vercors, Lyon, 69367, France","Dans, P.D., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Danilane, L., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, School of Chemistry, University of East Anglia, Norwich, NR47TJ, United Kingdom; Ivani, I., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Drsata, T., Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam 2, Prague, 16610, Czech Republic; Lankas, F., Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo nam 2, Prague, 16610, Czech Republic, Laboratory of Informatics and Chemistry, University of Chemistry and Technology Prague, Prague, 16628, Czech Republic; Hospital, A., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Walther, J., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Pujagut, R.I., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Battistini, F., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain; Gelpi, J.L., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, 08028, Spain; Lavery, R., Bases Moleculaires et Structurales des Systemes Infectieux, Universite Lyon i, CNRS, 7 Passage du Vercors, Lyon, 69367, France; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, IRB, Research Program in Computational Biology, Baldiri Reixac 10-12, Barcelona, 08028, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, 08028, Spain","We present a systematic study of the long-timescale dynamics of the Drew-Dickerson dodecamer (DDD: d(CGCGAATTGCGC)2) a prototypical B-DNA duplex. Using our newly parameterized PARMBSC1 force field, we describe the conformational landscape of DDD in a variety of ionic environments from minimal salt to 2 M Na+Cl- or K+Cl-. The sensitivity of the simulations to the use of different solvent and ion models is analyzed in detail using multi-microsecond simulations. Finally, an extended (10 μs) simulation is used to characterize slow and infrequent conformational changes in DDD, leading to the identification of previously uncharacterized conformational states of this duplex which can explain biologically relevant conformational transitions. With a total of more than 43 μs of unrestrained molecular dynamics simulation, this study is the most extensive investigation of the dynamics of the most prototypical DNA duplex. © 2016 The Author(s).",,"DNA B; double stranded DNA; Drew Dickerson dodecamer; potassium chloride; sodium chloride; unclassified drug; DNA B; Article; concentration response; conformational transition; controlled study; DNA conformation; DNA determination; force field; ionic strength; molecular dynamics; physical parameters; priority journal; radiation scattering; solvent effect; chemistry; conformation; molecular model; ultrastructure; DNA, B-Form; Models, Molecular; Molecular Dynamics Simulation; Nucleic Acid Conformation; Potassium Chloride; Sodium Chloride",,"potassium chloride, 7447-40-7; sodium chloride, 7647-14-5; DNA, B-Form; Potassium Chloride; Sodium Chloride",,,"European Research Council

14-21893S

BFU2014-61670-EXP, BIO2012-32868

Instituto Nacional de Técnica Aeroespacial

ANR-12-BSV5-0017-01, ERC SimDNA","MINECOSevero OchoaAward of Excellence (Government of Spain) (to IRB Barcelona); Spanish Ministry of Science [BIO2012-32868, BFU2014-61670-EXP to M.O.]; Catalan SGR (to M.O.); Instituto Nacional de Bioinform?tica (to M.O.); European Research Council (ERC SimDNA) (to M.O.); H2020 program (MuG and BioExcel projects) (to M.O.); Czech Republic Grant Agency [14-21893S to T.D., F.L.]; ANR grant CHROME [ANR-12-BSV5-0017-01 to R.L.]. Funding for open access charge: European Research Council (ERC SimDNA).",,,"Hud, N.V., (2008) Nucleic Acid-Metal Ion Interactions. Biomolecular Sciences, , The Royal Society of Chemistry, Cambridge; Geggier, S., Vologodskii, A., Sequence dependence of DNA bending rigidity (2010) Proc. Natl. Acad. Sci. U.S.A., 107, pp. 15421-15426; Huguet, J.M., Bizarro, C.V., Forns, N., Smith, S.B., Bustamante, C., Ritort, F., Single-molecule derivation of salt dependent base-pair free energies in DNA (2010) Proc. Natl. Acad. Sci. U.S.A., 107, pp. 15431-15436; Heng, J.B., Aksimentiev, A., Ho, C., Marks, P., Grinkova, Y.V., Sligar, S., Schulten, K., Timp, G., The electromechanics of DNA in a synthetic nanopore (2006) Biophys. J., 90, pp. 1098-1106; Strick, T.R., Dessinges, M.-N., Charvin, G., Dekker, N.H., Allemand, J.-F., Bensimon, D., Croquette, V., Stretching of macromolecules and proteins (2003) Reports Prog. Phys., 66, pp. 1-45; Prez, A., Lankas, F., Luque, F.J., Orozco, M., Towards a molecular dynamics consensus view of B-DNA flexibility (2008) Nucleic Acids Res., 36, pp. 2379-2394; Drsata, T., Prez, A., Orozco, M., Morozov, A.V., Sponer, J., Lankas, F., Structure, stiffness and substates of the dickerson-drew dodecamer (2013) J. Chem. Theory Comput., 9, pp. 707-721; Pasi, M., Maddocks, J.H., Beveridge, D., Bishop, T.C., Case, D.A., Cheatham, T., Dans, P.D., Laughton, C., ABC: A systematic microsecond molecular dynamics study of tetranucleotide sequence effects in B-DNA (2014) Nucleic Acids Res., 42, pp. 12272-12283; Lankas, F., Sponer, J., Hobza, P., Langowski, J., Sequence-dependent elastic properties of DNA (2000) J. Mol. Biol., 299, pp. 695-709; Drsata, T., Lankas, F., Multiscale modelling of DNA mechanics (2015) J. Phys. Condens. Matter, 27, p. 323102; Prez, A., Luque, F.J., Orozco, M., Frontiers in molecular dynamics simulations of DNA (2012) Acc. Chem. Res., 45, pp. 196-205; Arcella, A., Dreyer, J., Ippoliti, E., Ivani, I., Portella, G., Gabelica, V., Carloni, P., Orozco, M., Structure and dynamics of oligonucleotides in the gas phase (2015) Angew. Chem. Int. Ed. Engl., 54, pp. 467-471; Portella, G., Germann, M.W., Hud, N.V., Orozco, M., MD and NMR analyses of choline and TMA binding to duplex DNA: On the origins of aberrant sequence-dependent stability by alkyl cations in aqueous and water-free solvents (2014) J. Am. Chem. Soc., 136, pp. 3075-3086; Arcella, A., Portella, G., Collepardo-Guevara, R., Chakraborty, D., Wales, D.J., Orozco, M., Structure and properties of DNA in apolar solvents (2014) J. Phys. Chem. B, 118, pp. 8540-8548; Dans, P.D., Walther, J., Gmez, H., Orozco, M., Multiscale simulation of DNA (2016) Curr. Opin. Struct. Biol., 37, pp. 29-45; Sponer, J., Cang, X., Cheatham, T.E., Molecular dynamics simulations of G-DNA and perspectives on the simulation of nucleic acid structures (2012) Methods, 57, pp. 25-39; Sim, A.Y.L., Minary, P., Levitt, M., Modeling nucleic acids (2012) Curr. Opin. Struct. Biol., 22, pp. 273-278; Vrnai, P., Zakrzewska, K., DNA and its counterions: A molecular dynamics study (2004) Nucleic Acids Res., 32, pp. 4269-4280; Prez, A., Marchn, I., Svozil, D., Sponer, J., Cheatham, T.E., Laughton, C.A., Orozco, M., Refinement of the AMBER force field for nucleic acids: Improving the description of alpha/gamma conformers (2007) Biophys. J., 92, pp. 3817-3829; Ivani, I., Dans, P.D., Noy, A., Prez, A., Faustino, I., Hospital, A., Walther, J., Balaceanu, A., Parmbsc1: A refined force field for DNA simulations (2015) Nat. Methods, 13, pp. 55-58; Drew, H.R., Wing, R.M., Takano, T., Broka, C., Tanaka, S., Itakura, K., Dickerson, R.E., Structure of a B-DNA dodecamer: Conformation and dynamics (1981) Proc. Natl. Acad. Sci. U.S.A., 78, pp. 2179-2183; Prez, A., Luque, F.J., Orozco, M., Dynamics of B-DNA on the microsecond time scale (2007) J. Am. Chem. Soc., 129, pp. 14739-14745; Trieb, M., Rauch, C., Wellenzohn, B., Wibowo, F., Loerting, T., Liedl, K.R., Dynamics of DNA: B i and B II Phosphate Backbone Transitions (2004) J. Phys. Chem. B, 108, pp. 2470-2476; Arnott, S., Hukins, D.W., Optimised parameters for A-DNA and B-DNA (1972) Biochem. Biophys. Res. Commun., 47, pp. 1504-1509; Howerton, S., Sines, C., VanDerveer, D., Williams, L.D., Locating monovalent cations in the grooves of B-DNA (2001) Biochemistry, 40, pp. 10023-10031; Smith, D.E., Dang, L.X., Computer simulations of NaCl association in polarizable water (1994) J. Chem. Phys., 100, pp. 3757-3766; Joung, I.S., Cheatham, T.E., Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations (2008) J. Phys. Chem. B, 112, pp. 9020-9041; Jensen, K.P., Jorgensen, W.L., Halide, ammonium, alkali metal ion parameters for modeling aqueous solutions (2006) J. Chem. Theory Comput., 2, pp. 1499-1509; Beglov, D., Roux, B., Finite representation of an infinite bulk system: Solvent boundary potential for computer simulations (1994) J. Chem. Phys., 100, pp. 9050-9063; Shields, G.C., Laughton, C.A., Orozco, M., Molecular dynamics simulations of the d(T) triple helix (1997) J. Am. Chem. Soc., 119, pp. 7463-7469; Berendsen, H.J.C., Postma, J.P.M., Van Gunsteren, W.F., DiNola, A., Haak, J.R., (1984) Molecular Dynamics with Coupling to An External Bath, 81, pp. 3684-3690; Mor, A., Ziv, G., Levy, Y., Simulations of proteins with inhomogeneous degrees of freedom: The effect of thermostats (2008) J. Comput. Chem., 29, pp. 1992-1998; Nos, S., Klein, M.L., Constant pressure molecular dynamics for molecular systems (2006) Mol. Phys., 50, pp. 1055-1076; Ryckaert, J.-P., Ciccotti, G., Berendsen, H.J., Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J. Comput. Phys., 23, pp. 327-341; Darden, T., York, D., Pedersen, L., Particle mesh Ewald: An Nog(N) method for Ewald sums in large systems (1993) J. Chem. Phys., 98, pp. 10089-10092; Salomon-Ferrer, R., Gtz, A.W., Poole, D., Le Grand, S., Walker, R.C., Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald (2013) J. Chem. Theory Comput., 9, pp. 3878-3888; Case, D.A., Babin, V., Berryman, J.T., Betz, R.M., Cai, Q., Cerutti, D.S., Cheatham, T.E., III, Gohlke, H., (2014) AMBER, , University of California, San Francisco; Roe, D.R., Cheatham, T.E., PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data (2013) J. Chem. Theory Comput., 9, pp. 3084-3095; Hospital, A., Faustino, I., Collepardo-Guevara, R., Gonzlez, C., Gelp, J.L., Orozco, M., NAFlex: A web server for the study of nucleic acid flexibility (2013) Nucleic Acids Res., 41, pp. W47-W55; Lavery, R., Moakher, M., Maddocks, J.H., Petkeviciute, D., Zakrzewska, K., Conformational analysis of nucleic acids revisited: Curves+ (2009) Nucleic Acids Res., 37, pp. 5917-5929; Zuo, X., Cui, G., Merz, K.M., Zhang, L., Lewis, F.D., Tiede, D.M., X-ray diffraction fingerprinting of DNA structure in solution for quantitative evaluation of molecular dynamics simulation (2006) Proc. Natl. Acad. Sci. U.S.A., 103, pp. 3534-3539; Park, S., Bardhan, J.P., Roux, B., Makowski, L., Simulated X-ray scattering of protein solutions using explicit-solvent models (2009) J. Chem. Phys., 130, p. 134114; Nguyen, H.T., Pabit, S.A., Meisburger, S.P., Pollack, L., Case, D.A., Accurate small and wide angle X-ray scattering profiles from atomic models of proteins and nucleic acids (2014) J. Chem. Phys., 141, pp. 22-508; Zuo, X., Tiede, D.M., Resolving conflicting crystallographic and NMR models for solution-state DNA with solution X-ray diffraction (2005) J. Am. Chem. Soc., 127, pp. 16-17; Lavery, R., Maddocks, J.H., Pasi, M., Zakrzewska, K., Analyzing ion distributions around DNA (2014) Nucleic Acids Res., 42, pp. 8138-8149; Dans, P.D., Faustino, I., Battistini, F., Zakrzewska, K., Lavery, R., Orozco, M., Unraveling the sequence-dependent polymorphic behavior of d(CpG) steps in B-DNA (2014) Nucleic Acids Res., 42, pp. 11304-11320; Pasi, M., Maddocks, J.H., Lavery, R., Analyzing ion distributions around DNA: Sequence-dependence of potassium ion distributions from microsecond molecular dynamics (2015) Nucleic Acids Res., 43, pp. 2412-2423; Schlitter, J., Estimation of absolute and relative entropies of macromolecules using the covariance matrix (1993) Chem. Phys. Lett., 215, pp. 617-621; Ricioaei, I., Karplus, M., On the calculation of entropy from covariance matrices of the atomic fluctuations (2001) J. Chem. Phys., 115, pp. 6289-6292; Hess, B., Similarities between principal components of protein dynamics and random diffusion (2000) Phys. Rev. E. Stat. Phys. Plasmas. Fluids. Relat. Interdiscip. Topics, 62, pp. 8438-8448; Prez, A., Blas, J.R., Rueda, M., Lpez-Bes, J.M., Dela Cruz, X., Orozco, M., Exploring the essential dynamics of B-DNA (2005) J. Chem. Theory Comput., 1, pp. 790-800; Orozco, M., Prez, A., Noy, A., Luque, F.J., Theoretical methods for the simulation of nucleic acids (2003) Chem. Soc. Rev., 32, pp. 350-364; Noy, A., Golestanian, R., Length Scale Dependence of DNA Mechanical Properties (2012) Phys. Rev. Lett., 109, p. 228101; Zheng, G., Czapla, L., Srinivasan, A.R., Olson, W.K., How stiff is DNA Phys (2010) Chem. Chem. Phys., 12, pp. 1399-1406; Mecklin, C.J., Shapiro-wilk test for normality (2007) Encyclopedia of Measurement and Statistics, pp. 884-887. , Salkind, NJ and Rasmussen, K (eds SAGE Publications, Inc Thousand Oaks; (2013) R: A Language and Environment for Statistical Computing, , R Core Team R Foundation for Statistical Computing, Vienna; Wickham, H., (2009) Ggplot2, , Springer, NY; Humphrey, W., Dalke, A., Schulten, K., VMD: Visual molecular dynamics (1996) J. Mol. Graph., 14, pp. 33-38; Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., Ferrin, T.E., UCSF Chimera-a visualization system for exploratory research and analysis (2004) J. Comput. Chem., 25, pp. 1605-1612; Savelyev, A., MacKerell, A.D., Differential impact of the monovalent ions Li(+), Na(+), K(+), Rb(+) on DNA conformational properties (2015) J. Phys. Chem. Lett., 6, pp. 212-216; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J. Chem. Phys., 79, pp. 926-935; Berendsen, H.J.C., Grigera, J.R., Straatsma, T.P., The missing term in effective pair potentials (1987) J. Phys. Chem., 91, pp. 6269-6271; Noy, A., Soteras, I., Luque, F.J., Orozco, M., The impact of monovalent ion force field model in nucleic acids simulations (2009) Phys. Chem. Chem. Phys., 11, pp. 10596-10607; Prez, A., Luque, F.J., Orozco, M., Frontiers in molecular dynamics simulations of DNA (2012) Acc. Chem. Res., 45, pp. 196-205; Savelyev, A., MacKerell, A.D., Differential impact of the monovalent ions Li+, Na+, K+, Rb+ on DNA conformational properties (2015) J. Phys. Chem. Lett., 6, pp. 212-216; Levitt, M., The birth of computational structural biology (2001) Nat. Struct. Biol., 8, pp. 392-393; Bixon, M., Lifson, S., Potential functions and conformations in cycloalkanes (1967) Tetrahedron, 23, pp. 769-784; Mazur, A.K., Maaloum, M., Atomic force microscopy study of DNA flexibility on short length scales: Smooth bending versus kinking (2014) Nucleic Acids Res., 42, pp. 14006-14012; Noy, A., Golestanian, R., The chirality of DNA: Elasticity cross-terms at base-pair level including A-tracts and the influence of ionic strength (2010) J. Phys. Chem. B, 114, pp. 8022-8031; De Leeuw, S.W., Perram, J.W., Smith, E.R., Simulation of electrostatic systems in periodic boundary conditions I. Lattice sums and dielectric constants (1980) Proc. R. Soc. A Math. Phys. Eng. Sci., 373, pp. 27-56; Sagui, C., Darden, T.A., Molecular dynamics simulations of biomolecules: Long-range electrostatic effects (1999) Annu. Rev. Biophys. Biomol. Struct., 28, pp. 155-179; Shui, X., McFail-Isom, L., Hu, G.G., Williams, L.D., The B-DNA dodecamer at high resolution reveals a spine of water on sodium (1998) Biochemistry, 37, pp. 8341-8355; Shui, X., Sines, C.C., McFail-Isom, L., VanDerveer, D., Williams, L.D., Structure of the potassium form of CGCGAATTCGCG: DNA deformation by electrostatic collapse around inorganic cations (1998) Biochemistry, 37, pp. 16877-16887; Drew, H., Samson, S., Dickerson, R.E., Structure of a B-DNA dodecamer at 16 K (1982) Proc. Natl. Acad. Sci. U.S.A., 79, pp. 4040-4044; Westhof, E., Re-refinement of the B-dodecamer d(CGCGAATTCGCG) with a comparative analysis of the solvent in it and in the Z-hexamer d(5BrCG5BrCG5BrCG) (1987) J. Biomol. Struct. Dyn., 5, pp. 581-600; Holbrook, S., Dickerson, R., Kim, S.-H., Anisotropic thermal-parameter refinement of the DNA dodecamer CGCGAATTCGCG by the segmented rigid-body method (1985) Acta Crystallogr. B, 41, pp. 255-262; Wu, Z., Delaglio, F., Tjandra, N., Zhurkin, V., Bax, A., Overall structure and sugar dynamics of a DNA dodecamer from homo-and heteronuclear dipolar couplings and (31)P chemical shift anisotropy (2003) J. Biomol. Nmr, 26, pp. 297-315; Varnai, P., Alpha/gamma transitions in the B-DNA backbone (2002) Nucleic Acids Res., 30, pp. 5398-5406; Tian, Y., Kayatta, M., Shultis, K., Gonzalez, A., Mueller, L.J., Hatcher, M.E., 31P NMR investigation of backbone dynamics in DNA binding sites (2009) J. Phys. Chem. B, 113, pp. 2596-2603; Schwieters, C.D., Clore, G.M., A physical picture of atomic motions within the Dickerson DNA dodecamer in solution derived from joint ensemble refinement against NMR and large-angle X-ray scattering data (2007) Biochemistry, 46, pp. 1152-1166; Dans, P.D., Prez, A., Faustino, I., Lavery, R., Orozco, M., Exploring polymorphisms in B-DNA helical conformations (2012) Nucleic Acids Res., 40, pp. 10668-10678; Schwarz, G., Annals, T., Mar, N., Estimating the dimension of a model (1978) Ann. Stat., 6, pp. 461-464; Djuranovic, D., Hartmann, B., DNA fine structure and dynamics in crystals and in solution: The impact of BI/BII backbone conformations (2004) Biopolymers, 73, pp. 356-368; Wecker, K., The role of the phosphorus BI-BII transition in protein-DNA recognition: The NF-kappaB complex (2002) Nucleic Acids Res., 30, pp. 4452-4459; Madhumalar, A., Bansal, M., Sequence preference for BI/BII conformations in DNA: MD and crystal structure data analysis (2005) J. Biomol. Struct. Dyn., 23, pp. 13-27; Frederick, C.A., Williams, L.D., Ughetto, G., Van Der Marel, G.A., Van Boom, J.H., Rich, A., Wang, A.H.J., Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin (1990) Biochemistry, 29, pp. 2538-2549; Fei, J., Ha, T., Watching DNA breath one molecule at a time (2013) Proc. Natl. Acad. Sci. U.S.A., 110, pp. 17173-17174; Cubero, E., Sherer, E.C., Luque, F.J., Orozco, M., Laughton, C.A., Observation of spontaneous base pair breathing events in the molecular dynamics simulation of a difluorotoluene-containing DNA oligonucleotide (1999) J. Am. Chem. Soc., 121, pp. 8653-8654; Zgarbov, M., Otyepka, M., Sponer, J., Lankas, F., Jurecka, P., Base pair fraying in molecular dynamics simulations of DNA and RNA (2014) J. Chem. Theory Comput., 10, pp. 3177-3189; Leontis, N.B., Stombaugh, J., Westhof, E., The non-Watson-Crick base pairs and their associated isostericity matrices (2002) Nucleic Acids Res., 30, pp. 3497-3531; Galindo-Murillo, R., Roe, D.R., Cheatham, T.E., On the absence of intrahelical DNA dynamics on the-s to ms timescale (2014) Nat. Commun., 5, p. 5152; Galindo-Murillo, R., Roe, D.R., Cheatham, T.E., Convergence and reproducibility in molecular dynamics simulations of the DNA duplex d(GCACGAACGAACGAACGC) (2015) Biochim. Biophys. Acta, 1850, pp. 1041-1058","Orozco, M.; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Baldiri Reixac 10-12Spain; email: modesto.orozco@irbbarcelona.org",,,"Oxford University Press",,,,,03051048,,NARHA,"27084952","English","Nucleic Acids Res.",Article,"Final",Open Access,Scopus,2-s2.0-84971229282
"Sáez M.A., Fernández-Rodríguez J., Moutinho C., Sanchez-Mut J.V., Gomez A., Vidal E., Petazzi P., Szczesna K., Lopez-Serra P., Lucariello M., Lorden P., Delgado-Morales R., De La Caridad O.J., Huertas D., Gelpí J.L., Orozco M., López-Doriga A., Milà M., Perez-Jurado L.A., Pineda M., Armstrong J., Lázaro C., Esteller M.","56248310400;36870663600;7801367379;15123043200;55233887700;56312562600;26032785700;55243325900;8546561200;57188719163;57188724258;36150668100;56248314900;6701412280;35517522400;7102809158;36994788200;7006316022;7004218993;35473639700;35550350200;56902756200;14719291800;","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability",2016,"Genetics in Medicine","18","4",,"378","385",,13,"10.1038/gim.2015.100","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962553399&doi=10.1038%2fgim.2015.100&partnerID=40&md5=aa018a0e8f6cfa8e8b78a2777d39d6aa","Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Joint Biomedical Research Institute-Barcelona Supercomputing Center Computational Biology Program, Barcelona, Catalonia, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Catalonia, Spain; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Hereditary Cancer Program, Catalan Institute of Oncology-Bellvitge Institute for Biomedical Research (ICO-IDIBELL), Barcelona, Catalonia, Spain; Biochemistry and Molecular Genetics Department, Hospital Clínic, Barcelona, Catalonia, Spain; CIBERER (Biomedical Network Research Centre on Rare Diseases, Instituto de Salud Carlos III), Barcelona, Spain; Genetics Unit, University Pompeu Fabra, Barcelona, Catalonia, Spain; Department of Neurology, Hospital Sant Joan de Déu (HSJD), Barcelona, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain","Sáez, M.A., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Fernández-Rodríguez, J., Joint Biomedical Research Institute-Barcelona Supercomputing Center Computational Biology Program, Barcelona, Catalonia, Spain; Moutinho, C., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Sanchez-Mut, J.V., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Gomez, A., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Vidal, E., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Petazzi, P., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Szczesna, K., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Lopez-Serra, P., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Lucariello, M., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Lorden, P., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Delgado-Morales, R., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; De La Caridad, O.J., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Huertas, D., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain; Gelpí, J.L., Joint Biomedical Research Institute-Barcelona Supercomputing Center Computational Biology Program, Barcelona, Catalonia, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Catalonia, Spain; Orozco, M., Joint Biomedical Research Institute-Barcelona Supercomputing Center Computational Biology Program, Barcelona, Catalonia, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Catalonia, Spain, Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; López-Doriga, A., Hereditary Cancer Program, Catalan Institute of Oncology-Bellvitge Institute for Biomedical Research (ICO-IDIBELL), Barcelona, Catalonia, Spain; Milà, M., Biochemistry and Molecular Genetics Department, Hospital Clínic, Barcelona, Catalonia, Spain, CIBERER (Biomedical Network Research Centre on Rare Diseases, Instituto de Salud Carlos III), Barcelona, Spain; Perez-Jurado, L.A., CIBERER (Biomedical Network Research Centre on Rare Diseases, Instituto de Salud Carlos III), Barcelona, Spain, Genetics Unit, University Pompeu Fabra, Barcelona, Catalonia, Spain; Pineda, M., CIBERER (Biomedical Network Research Centre on Rare Diseases, Instituto de Salud Carlos III), Barcelona, Spain, Department of Neurology, Hospital Sant Joan de Déu (HSJD), Barcelona, Catalonia, Spain; Armstrong, J., CIBERER (Biomedical Network Research Centre on Rare Diseases, Instituto de Salud Carlos III), Barcelona, Spain, Department of Neurology, Hospital Sant Joan de Déu (HSJD), Barcelona, Catalonia, Spain; Lázaro, C., Hereditary Cancer Program, Catalan Institute of Oncology-Bellvitge Institute for Biomedical Research (ICO-IDIBELL), Barcelona, Catalonia, Spain; Esteller, M., Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain, Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain, Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain","Purpose:Autism spectrum disorders are associated with defects in social response and communication that often occur in the context of intellectual disability. Rett syndrome is one example in which epilepsy, motor impairment, and motor disturbance may co-occur. Mutations in histone demethylases are known to occur in several of these syndromes. Herein, we aimed to identify whether mutations in the candidate histone demethylase JMJD1C (jumonji domain containing 1C) are implicated in these disorders.Methods:We performed the mutational and functional analysis of JMJD1C in 215 cases of autism spectrum disorders, intellectual disability, and Rett syndrome without a known genetic defect.Results:We found seven JMJD1C variants that were not present in any control sample (∼ 6,000) and caused an amino acid change involving a different functional group. From these, two de novo JMJD1C germline mutations were identified in a case of Rett syndrome and in a patient with intellectual disability. The functional study of the JMJD1C mutant Rett syndrome patient demonstrated that the altered protein had abnormal subcellular localization, diminished activity to demethylate the DNA damage-response protein MDC1, and reduced binding to MECP2. We confirmed that JMJD1C protein is widely expressed in brain regions and that its depletion compromises dendritic activity.Conclusions:Our findings indicate that mutations in JMJD1C contribute to the development of Rett syndrome and intellectual disability.Genet Med 18 1, 378-385. © American College of Medical Genetics and Genomics.","autism; intellectual disability; mutational screening; Rett syndrome","histone demethylase; jumonji domain containing 1C protein; MDC1 protein; methyl CpG binding protein 2; protein; unclassified drug; histone demethylase; JMJD1C protein, human; n demethylase; adult; animal tissue; Article; brain region; case report; cellular distribution; controlled study; female; gene mutation; genetic variability; germline mutation; human; human tissue; intellectual impairment; male; mouse; mutational analysis; nonhuman; protein binding; protein expression; Rett syndrome; amino acid sequence; Autism Spectrum Disorder; brain; chemistry; conserved sequence; dna mutational analysis; gene expression; gene locus; gene order; genetic association study; genetics; Intellectual Disability; metabolism; middle aged; molecular model; mutation; nerve cell; pathology; position weight matrix; protein conformation; protein motif; protein transport; Rett syndrome; Adult; Amino Acid Motifs; Amino Acid Sequence; Autism Spectrum Disorder; Brain; Conserved Sequence; DNA Mutational Analysis; Female; Gene Expression; Gene Order; Genetic Association Studies; Genetic Loci; Humans; Intellectual Disability; Jumonji Domain-Containing Histone Demethylases; Male; Middle Aged; Models, Molecular; Mutation; Neurons; Oxidoreductases, N-Demethylating; Position-Specific Scoring Matrices; Protein Conformation; Protein Transport; Rett Syndrome",,"protein, 67254-75-5; JMJD1C protein, human; Jumonji Domain-Containing Histone Demethylases; Oxidoreductases, N-Demethylating",,,"Rett Syndrome Association of Australia: CA10/01474, RD06/0020/1050, PI10/01422, AKOPLOWITZ11-006, PI1002512, PI13/00285, RD12/0036/008, 2009-SGR293, FIS

PITN-GA-2012'316758, PITN-GA-2009'238242

Generalitat de Catalunya

Institució Catalana de Recerca i Estudis Avançats, ICREA

Fundación Cellex

Fondation Jérôme Lejeune

PI071327

Seventh Framework Programme

European Research Council: 268626

Ministerio de Economía y Competitividad: CSD2006-00049, SAF2011-22803","This study was supported by the European Community's Seventh Framework Program (FP7/2007'2013) under grant agreement PITN-GA-2012'316758 of the EPITRAIN project and PITN-GA-2009'238242 of DISCHROM; ERC grant agreement 268626 of the EPINORC project; the E-RARE EuroRETT network (Carlos III Health Institute project PI071327); the Fondation Lejeune (France); MINECO projects SAF2011-22803 and CSD2006-00049; the Cellex Foundation; the Bot?n Foundation; the Catalan Association for Rett Syndrome; Fundaci?n Alicia Koplowitz 2011 Grant AKOPLOWITZ11-006; the FIS project PI1002512; Grants PI10/01422, PI13/00285, CA10/01474, RD06/0020/1050, RD12/0036/008, and 2009-SGR293; and the Health and Science Departments of the Catalan government (Generalitat de Catalunya). K.S. and P.P. are EPITRAIN Research Fellows. M.E. is an ICREA Research Professor.",,,"(2013) Diagnostic and Statistical Manual of Mental Disorders, , American Psychiatric Association American Psychiatric Publishing: Arlington, VA; Anderson, D.K., Lord, C., Risi, S., Patterns of growth in verbal abilities among children with autism spectrum disorder (2007) J Consult Clin Psychol, 75, pp. 594-604; Bedogni, F., Rossi, R.L., Galli, F., Rett syndrome and the urge of novel approaches to study mecp2 functions and mechanisms of action (2014) Neurosci Biobehav Rev, 46, pp. 187-201; Bailey, A., Le Couteur, A., Gottesman, I., Autism as a strongly genetic disorder: Evidence from a british twin study (1995) Psychol Med, 25, pp. 63-77; Rosenberg, R.E., Law, J.K., Yenokyan, G., McGready, J., Kaufmann, W.E., Law, P.A., Characteristics and concordance of autism spectrum disorders among 277 twin pairs (2009) Arch Pediatr Adolesc Med, 163, pp. 907-914; Zafeiriou, D.I., Ververi, A., Dafoulis, V., Kalyva, E., Vargiami, E., Autism spectrum disorders: The quest for genetic syndromes (2013) Am J Med Genet B Neuropsychiatr Genet, 162 B, pp. 327-366; Jeste, S.S., Geschwind, D.H., Disentangling the heterogeneity of autism spectrum disorder through genetic findings (2014) Nat Rev Neurol, 10, pp. 74-81; Ronemus, M., Iossifov, I., Levy, D., Wigler, M., The role of de novo mutations in the genetics of autism spectrum disorders (2014) Nat Rev Genet, 15, pp. 133-141; Flore, L.A., Milunsky, J.M., Updates in the genetic evaluation of the child with global developmental delay or intellectual disability (2012) Semin Pediatr Neurol, 19, pp. 173-180; Castermans, D., Vermeesch, J.R., Fryns, J.P., Identification and characterization of the trip8 and reep3 genes on chromosome 10q21.3 as novel candidate genes for autism (2007) Eur J Hum Genet, 15, pp. 422-431; Wolf, S.S., Patchev, V.K., Obendorf, M., A novel variant of the putative demethylase gene, s-jmjd1c, is a coactivator of the ar (2007) Arch Biochem Biophys, 460, pp. 56-66; Kim, S.M., Kim, J.Y., Choe, N.W., Regulation of mouse steroidogenesis by whistle and jmjd1c through histone methylation balance (2010) Nucleic Acids Res, 38, pp. 6389-6403; Watanabe, S., Watanabe, K., Akimov, V., Jmjd1c demethylates mdc1 to regulate the rnf8 and brca1-mediated chromatin response to DNA breaks (2013) Nat Struct Mol Biol, 20, pp. 1425-1433; Neale, B.M., Kou, Y., Liu, L., Patterns and rates of exonic de novo mutations in autism spectrum disorders (2012) Nature, 485, pp. 242-245; Iossifov, I., O'Roak, B.J., Sanders, S.J., The contribution of de novo coding mutations to autism spectrum disorder (2014) Nature, 515, pp. 216-221; Guerrini, R., Parrini, E., Epilepsy in rett syndrome, and cdkl5-And foxg1-gene-related encephalopathies (2012) Epilepsia, 53, pp. 2067-2078; An integrated map of genetic variation from 1,092 human genomes (2012) Nature, 491, pp. 56-65. , Consortium T 1000 GP; Sherry, S.T., Ward, M.H., Kholodov, M., Dbsnp: The ncbi database of genetic variation (2001) Nucleic Acids Res, 29, pp. 308-311; Tennessen, J.A., Bigham, A.W., O'Connor, T.D., Evolution and functional impact of rare coding variation from deep sequencing of human exomes (2012) Science, 337, pp. 64-69. , Broad GO; Seattle GO; NHLBI Exome Sequencing Project; Vollmar, M., Johansson, C., Krojer, T., Crystal structure of the jumonji domain of human jumonji domain containing 1c protein (2012) Protein Data Base PDB Id: 2YPD; Samocha, K.E., Robinson, E.B., Sanders, S.J., A framework for the interpretation of de novo mutation in human disease (2014) Nat Genet, 46, pp. 944-950; Ferrer-Costa, C., Gelpí, J.L., Zamakola, L., Parraga, I., De La Cruz, X., Orozco, M., Pmut: A web-based tool for the annotation of pathological mutations on proteins (2005) Bioinformatics, 21, pp. 3176-3178; Lein, E.S., Hawrylycz, M.J., Ao, N., Genome-wide atlas of gene expression in the adult mouse brain (2007) Nature, 445, pp. 168-176; Percy, A.K., Rett syndrome current status and new vistas (2002) Neurol Clin, 20, pp. 1125-1141; Sanchez-Mut, J.V., Huertas, D., Esteller, M., Aberrant epigenetic landscape in intellectual disability (2012) Prog Brain Res, 197, pp. 53-71; Urdinguio, R.G., Sanchez-Mut, J.V., Esteller, M., Epigenetic mechanisms in neurological diseases: Genes, syndromes, and therapies (2009) Lancet Neurol, 8, pp. 1056-1072; Jensen, L.R., Amende, M., Gurok, U., Mutations in the jarid1c gene, which is involved in transcriptional regulation and chromatin remodeling, cause x-linked mental retardation (2005) Am J Hum Genet, 76, pp. 227-236; Laumonnier, F., Holbert, S., Ronce, N., Mutations in phf8 are associated with x linked mental retardation and cleft lip/cleft palate (2005) J Med Genet, 42, pp. 780-786; De Rubeis, S., He, X., Goldberg, A.P., Synaptic, transcriptional and chromatin genes disrupted in autism (2014) Nature, 515, pp. 209-215. , DDD Study; Homozygosity Mapping Collaborative for Autism; UK10K Consortium","Esteller, M.; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL)Spain; email: mesteller@idibell.cat",,,"Nature Publishing Group",,,,,10983600,,GEMEF,"26181491","English","Gen. Med.",Article,"Final",Open Access,Scopus,2-s2.0-84962553399
"Aterido A., Julià A., Ferrándiz C., Puig L., Fonseca E., Fernández-López E., Dauden E., Sánchez-Carazo J.L., López-Estebaranz J.L., Moreno-Ramírez D., Vanaclocha F., Herrera E., de la Cueva P., Dand N., Palau N., Alonso A., López-Lasanta M., Tortosa R., García-Montero A., Codó L., Gelpí J.L., Bertranpetit J., Absher D., Capon F., Myers R.M., Barker J.N., Marsal S.","56239671200;57210878792;7005892900;7101770587;34975078800;6701713335;7003438085;9233529000;6603673238;8850383200;6603052674;7103001516;15043904600;55627563000;54412813600;36150353900;23035265100;55933194400;6603714021;55882083800;35517522400;7005566413;57198406019;7003850552;7403700738;7401680615;6603356384;","Genome-Wide Pathway Analysis Identifies Genetic Pathways Associated with Psoriasis",2016,"Journal of Investigative Dermatology","136","3",,"593","602",,17,"10.1016/j.jid.2015.11.026","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84977766689&doi=10.1016%2fj.jid.2015.11.026&partnerID=40&md5=ced34f239d22d8e4398e3866bbf74533","Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Dermatology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain; Dermatology Department, Hospital Universitario de Salamanca, Salamanca, Spain; Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain; Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; Dermatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain; Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Dermatology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain; Division of Genetics and Molecular Medicine, King's College London School of Medicine, Guy's Hospital, London, United Kingdom; Spanish National DNA Bank, Universidad de Salamanca, Salamanca, Spain; Life Sciences, Barcelona Supercomputing Centre, Barcelona, Spain; Spanish National Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States; St John's Institute of Dermatology, King's College London, London, United Kingdom","Aterido, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Julià, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Ferrándiz, C., Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Puig, L., Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Fonseca, E., Dermatology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain; Fernández-López, E., Dermatology Department, Hospital Universitario de Salamanca, Salamanca, Spain; Dauden, E., Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain; Sánchez-Carazo, J.L., Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; López-Estebaranz, J.L., Dermatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Moreno-Ramírez, D., Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain; Vanaclocha, F., Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain; Herrera, E., Dermatology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; de la Cueva, P., Dermatology Department, Hospital Universitario Infanta Leonor, Madrid, Spain; Dand, N., Division of Genetics and Molecular Medicine, King's College London School of Medicine, Guy's Hospital, London, United Kingdom; Palau, N., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Alonso, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; García-Montero, A., Spanish National DNA Bank, Universidad de Salamanca, Salamanca, Spain; Codó, L., Life Sciences, Barcelona Supercomputing Centre, Barcelona, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Centre, Barcelona, Spain; Bertranpetit, J., Spanish National Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States; Capon, F., Division of Genetics and Molecular Medicine, King's College London School of Medicine, Guy's Hospital, London, United Kingdom; Myers, R.M., HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States; Barker, J.N., Division of Genetics and Molecular Medicine, King's College London School of Medicine, Guy's Hospital, London, United Kingdom, St John's Institute of Dermatology, King's College London, London, United Kingdom; Marsal, S., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain","Psoriasis is a chronic inflammatory disease with a complex genetic architecture. To date, the psoriasis heritability is only partially explained. However, there is increasing evidence that the missing heritability in psoriasis could be explained by multiple genetic variants of low effect size from common genetic pathways. The objective of this study was to identify new genetic variation associated with psoriasis risk at the pathway level. We genotyped 598,258 single nucleotide polymorphisms in a discovery cohort of 2,281 case-control individuals from Spain. We performed a genome-wide pathway analysis using 1,053 reference biological pathways. A total of 14 genetic pathways (PFDR ≤ 2.55 × 10–2) were found to be significantly associated with psoriasis risk. Using an independent validation cohort of 7,353 individuals from the UK, a total of 6 genetic pathways were significantly replicated (PFDR ≤ 3.46 × 10–2). We found genetic pathways that had not been previously associated with psoriasis risk such as retinol metabolism (Pcombined = 1.84 × 10–4), the transport of inorganic ions and amino acids (Pcombined = 1.57 × 10–7), and post-translational protein modification (Pcombined = 1.57 × 10–7). In the latter pathway, MGAT5 showed a strong network centrality, and its association with psoriasis risk was further validated in an additional case-control cohort of 3,429 individuals (P &lt; 0.05). These findings provide insights into the biological mechanisms associated with psoriasis susceptibility. © 2015 The Authors",,"amino acid; HLA C antigen; interleukin 12p40; ion; retinol; Article; controlled study; DNA repair; gene replication; genetic analysis; genetic association; genetic identification; genetic risk; genetic susceptibility; genetic variation; genome-wide association study; genotype; human; inflammation; major clinical study; multicenter study; natural killer T cell; population risk; priority journal; protein metabolism; protein modification; protein processing; protein transport; psoriasis; risk assessment; risk factor; single nucleotide polymorphism; adult; case control study; female; genetic predisposition; genetics; genome-wide association study; male; middle aged; pathophysiology; prevalence; procedures; psoriasis; reference value; Spain; Adult; Case-Control Studies; Female; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prevalence; Psoriasis; Reference Values; Risk Assessment; Spain",,"amino acid, 65072-01-7; retinol, 68-26-8, 82445-97-4",,,"IPT-010000-2010-36, PSE-010000-2006-6","This study was funded by of the Spanish Ministry of Economy and Competitiveness, grant numbers: PSE-010000-2006-6 and IPT-010000-2010-36.",,,"http://www.biocarta.com, BIOCARTA Pathways. []; Austenaa, L.M., Carlsen, H., Ertesvag, A., Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging (2004) Faseb J, 18, pp. 1255-1257; Balato, A., Schiattarella, M., Lembo, S., Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid (2013) Arch Dermatol Res, 305, pp. 255-262; Bernstein, B.E., Stamatoyannopoulos, J.A., Costello, J.F., The NIH Roadmap Epigenomics Mapping Consortium (2010) Nat Biotechnol, 28, pp. 1045-1048; Bowes, J., Budu-Aggrey, A., Huffmeier, U., Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis (2015) Nat Commun, 6, p. 6046; Cargill, M., Schrodi, S.J., Chang, M., A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes (2007) Am J Hum Genet, 80, pp. 273-290; Clapham, D.E., Calcium signaling (2007) Cell, 131, pp. 1047-1058; Colantonio, L., Recalde, H., Sinigaglia, F., Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells (2002) Eur J Immunol, 32, pp. 1264-1273; Croft, D., Mundo, A.F., Haw, R., The Reactome pathway knowledgebase (2014) Nucleic Acids Res, 42, pp. D472-D477; Chen, D., Enroth, S., Ivansson, E., Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection (2014) Hum Mol Genet, 23, pp. 6047-6060; Chen, H.L., Li, C.F., Grigorian, A., T cell receptor signaling co-regulates multiple Golgi genes to enhance N-glycan branching (2009) J Biol Chem, 284, pp. 32454-32461; Damasiewicz-Bodzek, A., Wielkoszynski, T., Advanced protein glycation in psoriasis (2012) J Eur Acad Dermatol Venereol, 26, pp. 172-179; Demetriou, M., Granovsky, M., Quaggin, S., Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation (2001) Nature, 409, pp. 733-739; Du, Y., Xie, J., Chang, W., Genome-wide association studies: inherent limitations and future challenges (2012) Front Med, 6, pp. 444-450; Ferenczi, K., Burack, L., Pope, M., CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry (2000) J Autoimmun, 14, pp. 63-78; Fuhlbrigge, R.C., Kieffer, J.D., Armerding, D., Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells (1997) Nature, 389, pp. 978-981; Gibson, G., Rare and common variants: twenty arguments (2012) Nat Rev Genet, 13, pp. 135-145; Gilad, Y., Rifkin, S.A., Pritchard, J.K., Revealing the architecture of gene regulation: the promise of eQTL studies (2008) Trends Genet, 24, pp. 408-415; Golan, D., Lander, E.S., Rosset, S., Measuring missing heritability: inferring the contribution of common variants (2014) Proc Natl Acad Sci USA, 111, pp. E5272-E5281; Goldminz, A.M., Au, S.C., Kim, N., NF-kappaB: an essential transcription factor in psoriasis (2013) J Dermatol Sci, 69, pp. 89-94; Green, R.S., Stone, E.L., Tenno, M., Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis (2007) Immunity, 27, pp. 308-320; Grigorian, A., Demetriou, M., Mgat5 deficiency in T cells and experimental autoimmune encephalomyelitis (2011) ISRN Neurol, p. 374314; Gudjonsson, J.E., Elder, J.T., Psoriasis: epidemiology (2007) Clin Dermatol, 25, pp. 535-546; Gui, H., Li, M., Sham, P.C., Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset (2011) BMC Res Notes, 4, p. 386; Hahn, M.W., Kern, A.D., Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks (2005) Mol Biol Evol, 22, pp. 803-806; Hayashi, K., Jutabha, P., Endou, H., LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells (2013) J Immunol, 191, pp. 4080-4085; Hochberg, Y., Benjamini, Y., More powerful procedures for multiple significance testing (1990) Stat Med, 9, pp. 811-818; Iversen, O.J., Lysvand, H., Hagen, L., The autoantigen Pso p27: a post-translational modification of SCCA molecules (2011) Autoimmunity, 44, pp. 229-234; Jaeger, K., Paulsen, F., Wohlrab, J., Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin (2008) Histochem Cell Biol, 129, pp. 321-329; Johnson, R.C., Nelson, G.W., Troyer, J.L., Accounting for multiple comparisons in a genome-wide association study (GWAS) (2010) BMC Genomics, 11, p. 724; Joy, M.P., Brock, A., Ingber, D.E., High-betweenness proteins in the yeast protein interaction network (2005) J Biomed Biotechnol, 2005, pp. 96-103; Kanehisa, M., Goto, S., KEGG: Kyoto Encyclopedia of Genes and Genomes (2000) Nucleic Acids Res, 28, pp. 27-30; Khananshvili, D., The SLC8 gene family of sodium-calcium exchangers (NCX)—structure, function, and regulation in health and disease (2013) Mol Aspects Med, 34, pp. 220-235; Koster, R., Mitra, N., D'Andrea, K., Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors (2014) Hum Mol Genet, 23, pp. 6061-6068; Kugler, K.G., Mueller, L.A., Graber, A., MADAM: an open source meta-analysis toolbox for R and Bioconductor (2010) Source Code Biol Med, 5, p. 3; Lang, F., Stournaras, C., Alesutan, I., Regulation of transport across cell membranes by the serum- and glucocorticoid-inducible kinase SGK1 (2014) Mol Membr Biol, 31, pp. 29-36; Lavin, M.F., Birrell, G., Chen, P., ATM signaling and genomic stability in response to DNA damage (2005) Mutat Res, 569, pp. 123-132; Lizzul, P.F., Aphale, A., Malaviya, R., Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept (2005) J Invest Dermatol, 124, pp. 1275-1283; Manolio, T.A., Genomewide association studies and assessment of the risk of disease (2010) N Engl J Med, 363, pp. 166-176; Martens, J.H., Stunnenberg, H.G., BLUEPRINT: mapping human blood cell epigenomes (2013) Haematologica, 98, pp. 1487-1489; Mkhikian, H., Grigorian, A., Li, C.F., Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis (2011) Nat Commun, 2, p. 334; Nair, R.P., Ruether, A., Stuart, P.E., Polymorphisms of the IL12B and IL23R genes are associated with psoriasis (2008) J Invest Dermatol, 128, pp. 1653-1661; Nair, R.P., Stuart, P.E., Nistor, I., Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene (2006) Am J Hum Genet, 78, pp. 827-851; Nestle, F.O., Kaplan, D.H., Barker, J., Psoriasis (2009) N Engl J Med, 361, pp. 496-509; Park, J.H., Wacholder, S., Gail, M.H., Estimation of effect size distribution from genome-wide association studies and implications for future discoveries (2010) Nat Genet, 42, pp. 570-575; Purcell, S., Neale, B., Todd-Brown, K., PLINK: a tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81, pp. 559-575; Ramanan, V.K., Shen, L., Moore, J.H., Pathway analysis of genomic data: concepts, methods, and prospects for future development (2012) Trends Genet, 28, pp. 323-332; Raney, B.J., Cline, M.S., Rosenbloom, K.R., ENCODE whole-genome data in the UCSC genome browser (2011 update) (2011) Nucleic Acids Res, 39, pp. D871-D875; Roos, W.P., Kaina, B., DNA damage-induced cell death by apoptosis (2006) Trends Mol Med, 12, pp. 440-450; Rudd, P.M., Elliott, T., Cresswell, P., Glycosylation and the immune system (2001) Science, 291, pp. 2370-2376; Ryan, S.O., Cobb, B.A., Roles for major histocompatibility complex glycosylation in immune function (2012) Semin Immunopathol, 34, pp. 425-441; Strange, A., Capon, F., Spencer, C.C., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) Nat Genet, 42, pp. 985-990; Takekoshi, T., Wu, X., Mitsui, H., CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis (2013) J Invest Dermatol, 133, pp. 2530-2537; Tsoi, L.C., Elder, J.T., Abecasis, G.R., Graphical algorithm for integration of genetic and biological data: proof of principle using psoriasis as a model (2015) Bioinformatics, 31, pp. 1243-1249; Tsoi, L.C., Spain, S.L., Ellinghaus, E., Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci (2015) Nat Commun, 6, p. 7001; Tsoi, L.C., Spain, S.L., Knight, J., Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity (2012) Nat Genet, 44, pp. 1341-1348; Tsuruta, D., NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis (2009) Recent Pat Inflamm Allergy Drug Discov, 3, pp. 40-48; Vallabhajosyula, R.R., Chakravarti, D., Lutfeali, S., Identifying hubs in protein interaction networks (2009) PLoS One, 4, p. e5344; Vig, M., Kinet, J.P., Calcium signaling in immune cells (2009) Nat Immunol, 10, pp. 21-27; Vyse, T.J., Todd, J.A., Genetic analysis of autoimmune disease (1996) Cell, 85, pp. 311-318; Wang, K., Li, M., Hakonarson, H., Analysing biological pathways in genome-wide association studies (2010) Nat Rev Genet, 11, pp. 843-854; Weatherhead, S.C., Farr, P.M., Jamieson, D., Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation (2011) J Invest Dermatol, 131, pp. 1916-1926; Wolf, R., Orion, E., Ruocco, E., Abnormal epidermal barrier in the pathogenesis of psoriasis (2012) Clin Dermatol, 30, pp. 323-328; Wu, M.C., Kraft, P., Epstein, M.P., Powerful SNP-set analysis for case-control genome-wide association studies (2010) Am J Hum Genet, 86, pp. 929-942; Yin, X., Low, H.Q., Wang, L., Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility (2015) Nat Commun, 6, p. 6916; Yin, X., Wineinger, N.E., Cheng, H., Common variants explain a large fraction of the variability in the liability to psoriasis in a Han Chinese population (2014) BMC Genomics, 15, p. 87; Zgraggen, S., Huggenberger, R., Kerl, K., An important role of the SDF-1/CXCR4 axis in chronic skin inflammation (2014) PLoS One, 9, p. e93665; Zhang, K., Cui, S., Chang, S., i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study (2010) Nucleic Acids Res, 38, pp. W90-W95; Zhong, H., Yang, X., Kaplan, L.M., Integrating pathway analysis and genetics of gene expression for genome-wide association studies (2010) Am J Hum Genet, 86, pp. 581-591; Zhu, K.J., Zhu, C.Y., Shi, G., Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis (2013) Rheumatol Int, 33, pp. 1785-1790; Zuo, X., Sun, L., Yin, X., Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis (2015) Nat Commun, 6, p. 6793","Julià, A.; Rheumatology Research Group, Vall d'Hebron Research InstituteSpain; email: toni.julia@vhir.org",,,"Elsevier B.V.",,,,,0022202X,,JIDEA,"26743605","English","J. Invest. Dermatol.",Article,"Final",Open Access,Scopus,2-s2.0-84977766689
"Ivani I., Dans P.D., Noy A., Pérez A., Faustino I., Hospital A., Walther J., Andrio P., Goñi R., Balaceanu A., Portella G., Battistini F., Gelpí J.L., González C., Vendruscolo M., Laughton C.A., Harris S.A., Case D.A., Orozco M.","36545032500;25931363700;7004339304;35764684500;35315628900;15831739300;56959973100;55203611300;56960248500;56960348600;24781011400;35193719000;35517522400;30267572700;7007094071;7005668861;7403484884;7102943261;7102809158;","Parmbsc1: A refined force field for DNA simulations",2015,"Nature Methods","13","1",,"55","58",,200,"10.1038/nmeth.3658","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955684595&doi=10.1038%2fnmeth.3658&partnerID=40&md5=7505f300b5ec2144689fc7c194277116","Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain; Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom; Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, United States; Barcelona Supercomputing Center, Barcelona, Spain; Department of Chemistry, University of Cambridge, Cambridge, United Kingdom; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Instituto de Quimica Fisica Rocasolano, Consejo Superior de Investigaciones Cientificas, Madrid, Spain; School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom; Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, United States","Ivani, I., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Dans, P.D., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Noy, A., School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom; Pérez, A., Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, United States; Faustino, I., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Hospital, A., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Walther, J., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Andrio, P., Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain, Barcelona Supercomputing Center, Barcelona, Spain; Goñi, R., Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain, Barcelona Supercomputing Center, Barcelona, Spain; Balaceanu, A., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Portella, G., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom; Battistini, F., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain; Gelpí, J.L., Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; González, C., Instituto de Quimica Fisica Rocasolano, Consejo Superior de Investigaciones Cientificas, Madrid, Spain; Vendruscolo, M., Department of Chemistry, University of Cambridge, Cambridge, United Kingdom; Laughton, C.A., School of Pharmacy, University of Nottingham, Nottingham, United Kingdom, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, United Kingdom; Harris, S.A., School of Physics and Astronomy, University of Leeds, Leeds, United Kingdom; Case, D.A., Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, United States; Orozco, M., Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and Technology, Barcelona, Spain, Joint BSC-IRB Research Program in Computational Biology, IRB Barcelona, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","We present parmbsc1, a force field for DNA atomistic simulation, which has been parameterized from high-level quantum mechanical data and tested for nearly 100 systems (representing a total simulation time of ∼140 1/4s) covering most of DNA structural space. Parmbsc1 provides high-quality results in diverse systems. Parameters and trajectories are available at http://mmb.irbbarcelona.org/ParmBSC1/.",,"DNA; chemistry; quantum theory; DNA; Quantum Theory",,"DNA, 9007-49-2; DNA",,,"Biotechnology and Biological Sciences Research Council: BB-I019294-1

European Research Council: ERC SimDNA

BIO2012-32868

Instituto Nacional de Perinatología","M.O. thanks the Spanish Ministry of Science (BIO2012-32868), the Catalan SGR, the Instituto Nacional de Bioinformática and the European Research Council (ERC SimDNA) for support. M.O. is an academia researcher in the Catalan Institution for Research and Advanced Studies (ICREA). M.O. thanks the Barcelona Supercomputing Center for CPU and GPU time on MareNostrum and MinoTauro. C.A.L., S.A.H. and A.N. thank the UK HECBioSim Consortium for time on the ARCHER high-performance computing system (grant EP-L000253-1). A.N. was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; grant BB-I019294-1) and thanks ARC Leeds for computational resources. P.D.D. is a PEDECIBA (Programa de Desarrollo de las Ciencias Básicas) and SNI (Sistema Nacional de Investigadores; ANII, Uruguay) researcher. D.A.C. thanks C. Liu for assistance with the crystal simulation analysis.",,,"Perez, A., Luque, F.J., Orozco, M., (2012) Acc. Chem. Res., 45, pp. 196-205; Perez, A., Luque, F.J., Orozco, M.J., (2007) Am. Chem. Soc., 129, pp. 14739-14745; Varnai, P., Zakrzewska, K., (2004) Nucleic Acids Res., 32, pp. 4269-4280; Perez, A., (2007) Biophys. J., 92, pp. 3817-3829; Zgarbova, M., (2013) J. Chem. Theory Comput., 9, pp. 2339-2354; Krepl, M., (2012) J. Chem. Theory Comput., 8, pp. 2506-2520; Wing, R., (1980) Nature, 287, pp. 755-758; Lavery, R., (2010) Nucleic Acids Res., 38, pp. 299-313; Dans, P.D., Perez, A., Faustino, I., Lavery, R., Orozco, M., (2012) Nucleic Acids Res., 40, pp. 10668-10678; Lankas, F., Spackova, N., Moakher, M., Enkhbayar, P., Sponer, J., (2010) Nucleic Acids Res., 38, pp. 3414-3422; Thamann, T.J., Lord, R.C., Wang, A.H.J., Rich, A., (1981) Nucleic Acids Res., 9, pp. 5443-5458; Abrescia, N.G.A., Gonzalez, C., Gouyette, C., Subirana, J.A., (2004) Biochemistry, 43, pp. 4092-4100; Cubero, E., Luque, F.J., Orozco, M., (2001) J. Am. Chem. Soc., 123, pp. 12018-12025; Soyfer, V.N., Potaman, V.N., (1996) Triple-helical Nucleic Acids, , 1st edn. Springer-Verlag; Fadrna, E., (2009) J. Chem. Theory Comput., 5, pp. 2514-2530; Martn-Pintado, N., (2013) J. Am. Chem. Soc., 135, pp. 5344-5347; Olson, W.K., Gorin, A.A., Lu, X.-J., Hock, L.M., Zhurkin, V.B., (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 11163-11168; Perez, A., Lankas, F., Luque, F.J., Orozco, M., (2008) Nucleic Acids Res., 36, pp. 2379-2394; Moroz, J.D., Nelson, P., (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 14418-14422; Du, Q., Kotlyar, A., Vologodskii, A., (2008) Nucleic Acids Res., 36, pp. 1120-1128; Sponer, J., Jurecka, P., Hobza, P., (2004) J. Am. Chem. Soc., 126, pp. 10142-10151; Hobza, P., Kabelac, M., Sponer, J., Mejzlk, P., Vondrasek, J., (1997) J. Comput. Chem., 18, pp. 1136-1150; Sponer, J., (2006) Chemistry, 12, pp. 2854-2865; Orozco, M., Luque, F., (1994) J. Chem. Phys., 182, pp. 237-248; Colominas, C., Luque, F.J., Orozco, M., (1996) J. Am. Chem. Soc., 118, pp. 6811-6821; Orozco, M., Cubero, E., Hernandez, B., Lpez, J.M., Luque, F.J., (1999) Computational Chemistry: Reviews of Current Trends, 4, pp. 191-225. , (ed. Leszczynski, J.) World Scientific Publishing; Perez, A., (2005) Chemistry, 11, pp. 5062-5066; Beveridge, D.L., (2004) Biophys. J., 87, pp. 3799-3813; Portella, G., Germann, M.W., Hud, N.V., Orozco, M., (2014) J. Am. Chem. Soc., 136, pp. 3075-3086; Krishnan, R., Binkley, J.S., Seeger, R., Pople, J.A., (1980) J. Chem. Phys., 72, pp. 650-654; Woon, D.E., Dunning, T.H., Jr., (1993) J. Chem. Phys., 98, pp. 1358-1371; Halkier, A., (1998) Chem. Phys. Lett., 286, pp. 243-252; Halkier, A., Helgaker, T., Jrgensen, P., Klopper, W., Olsen, J., (1999) Chem. Phys. Lett., 302, pp. 437-446; Miertus, S., Scrocco, E., Tomasi, J., (1981) Chem. Phys., 55, pp. 117-129; Miertus, S., Tomasi, J., (1982) Chem. Phys., 65, pp. 239-245; Cances, E., Mennucci, B., Tomasi, J., (1997) J. Chem. Phys., 107, pp. 3032-3041; Bachs, M., Luque, F.J., Orozco, M.J., (1994) Comput. Chem., 15, pp. 446-454; Soteras, I., Curutchet, C., Bidon-Chanal, A., Orozco, M., Luque, F.J., (2005) J. Mol. Struct. THEOCHEM, 727, pp. 29-40; Soteras, I., Forti, F., Orozco, M., Luque, F.J., (2009) J. Phys. Chem. B, 113, pp. 9330-9334; Soteras, I., Orozco, M., Luque, F.J., (2010) J. Comput. Aided Mol. Des., 24, pp. 281-291; Marenich, A.V., Cramer, C.J., Truhlar, D.G., (2009) J. Phys. Chem. B, 113, pp. 6378-6396; Torrie, G.M., Valleau, J.P., (1977) J. Comput. Phys., 23, pp. 187-199; Hart, K., (2012) J. Chem. Theory Comput., 8, pp. 348-362; Wu, Z., Delaglio, F., Tjandra, N., Zhurkin, V.B., Bax, A., (2003) J. Biomol. NMR, 26, pp. 297-315; Zgarbova, M., (2011) J. Chem. Theory Comput., 7, pp. 2886-2902; Hess, B., Kutzner, C., Van Der Spoel, D., Lindahl, E., (2008) J. Chem. Theory Comput., 4, pp. 435-447; Galindo-Murillo, R., Roe, D.R., Cheatham Iii., T.E., (2014) Nat. Commun., 5, p. 5152; Ryckaert, J.-P., Ciccotti, G., Berendsen, H.J.C., (1977) J. Comput. Phys., 23, pp. 327-341; Hess, B., Bekker, H., Berendsen, H.J.C., Fraaije, J.G.E.M., (1997) J. Comput. Chem., 18, pp. 1463-1472; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., (1983) J. Chem. Phys., 79, pp. 926-935; Berendsen, H.J.C., Grigera, J.R., Straatsma, T.P., (1987) J. Phys. Chem., 91, pp. 6269-6271; Smith, D.E., Dang, L.X., (1994) J. Chem. Phys., 100, pp. 3757-3766; Darden, T., York, D., Pedersen, L., (1993) J. Chem. Phys., 98, pp. 10089-10092; Liu, C., Janowski, P.A., Case, D.A., (2015) Biochim. Biophys. Acta, 1850, pp. 1059-1071; Arnott, S., Hukins, D.W.L., (1972) Biochem. Biophys. Res. Commun., 47, pp. 1504-1509; Orozco, M., Perez, A., Noy, A., Luque, F.J., (2003) Chem. Soc. Rev., 32, pp. 350-364; Perez, A., (2005) J. Chem. Theory Comput., 1, pp. 790-800; Amadei, A., Linssen, A., Berendsen, H.J.C., (1993) Proteins, 17, pp. 412-425; Lankas, F., Sponer, J., Hobza, P., Langowski, J., (2000) J. Mol. Biol., 299, pp. 695-709; Noy, A., Perez, A., Lankas, F., Luque, F.J., Orozco, M., (2004) J. Mol. Biol., 343, pp. 627-638; Andricioaei, I., Karplus, M., (2001) J. Chem. Phys., 115, pp. 6289-6292; Schlitter, J., (1993) Chem. Phys. Lett., 215, pp. 617-621; Hess, B., (2000) Phys. Rev. e Stat. Phys. Plasmas Fluids Relat. Interdiscip. Topics, 62, p. 8438; Noy, A., Golestanian, R., (2012) Phys. Rev. Lett., 109, p. 228101; Zheng, G., Czapla, L., Srinivasan, A.R., Olson, W.K., (2010) Phys. Chem. Chem. Phys., 12, pp. 1399-1406; Cuervo, A., (2014) Proc. Natl. Acad. Sci. USA, 111, pp. E3624-E3630; Yang, L., Weerasinghe, S., Smith, P.E., Pettitt, P.M., (1995) Biophys. J., 69, pp. 1519-1527; Hospital, A., (2012) Bioinformatics, 28, pp. 1278-1279; Hospital, A., (2013) Nucleic Acids Res., 41, pp. W47-W55; Lavery, R., Moakher, M., Maddocks, J.H., Petkeviciute, D., Zakrzewska, K., (2009) Nucleic Acids Res., 37, pp. 5917-5929; Zweckstetter, M., (2008) Nat. Protoc., 3, pp. 679-690; Bernstein, F.C., (1977) Eur. J. Biochem., 80, pp. 319-324; Borgias, B.A., James, T.L., (1990) J. Magn. Reson., 87, pp. 475-487; Mobley, D.L., Chodera, J.D., Dill, K.A., (2006) J. Chem. Phys., 125, p. 084902; Sousa Da Silva, A.W., Vranken, W.F., (2012) BMC Res. Notes, 5, p. 367","Orozco, M.; Institute for Research in Biomedicine (IRB) Barcelona, Barcelona Institute of Science and TechnologySpain; email: modesto.orozco@irbbarcelona.org",,,"Nature Publishing Group",,,,,15487091,,,"26569599","English","Nat. Methods",Article,"Final",,Scopus,2-s2.0-84955684595
"Emperador A., Sfriso P., Villarreal M.A., Gelpí J.L., Orozco M.","57208980207;55480428500;56011459000;35517522400;7102809158;","PACSAB: Coarse-Grained Force Field for the Study of Protein-Protein Interactions and Conformational Sampling in Multiprotein Systems",2015,"Journal of Chemical Theory and Computation","11","12",,"5929","5938",,6,"10.1021/acs.jctc.5b00660","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949644173&doi=10.1021%2facs.jctc.5b00660&partnerID=40&md5=ef67132783d2c966e3f6a41dab71a4da","Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona, 08028, Spain; Joint BSC-IRB, Research Program in Computational Biology, IRB Barcelona, Barcelona, 08028, Spain; Instituto de Investigaciones en Fisicoquímica de Córdoba, Departamento de Matemática y Física, CONICET, Universidad Nacional de Córdoba, University City, Córdoba, 5000, Argentina; Barcelona Supercomputing Center, Jordi Girona 29, Barcelona, 08034, Spain; Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona, 08028, Spain","Emperador, A., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona, 08028, Spain, Joint BSC-IRB, Research Program in Computational Biology, IRB Barcelona, Barcelona, 08028, Spain; Sfriso, P., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona, 08028, Spain, Joint BSC-IRB, Research Program in Computational Biology, IRB Barcelona, Barcelona, 08028, Spain; Villarreal, M.A., Instituto de Investigaciones en Fisicoquímica de Córdoba, Departamento de Matemática y Física, CONICET, Universidad Nacional de Córdoba, University City, Córdoba, 5000, Argentina; Gelpí, J.L., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona, 08028, Spain, Joint BSC-IRB, Research Program in Computational Biology, IRB Barcelona, Barcelona, 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 29, Barcelona, 08034, Spain, Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona, 08028, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona, 08028, Spain, Joint BSC-IRB, Research Program in Computational Biology, IRB Barcelona, Barcelona, 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 29, Barcelona, 08034, Spain, Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona, 08028, Spain","Molecular dynamics simulations of proteins are usually performed on a single molecule, and coarse-grained protein models are calibrated using single-molecule simulations, therefore ignoring intermolecular interactions. We present here a new coarse-grained force field for the study of many protein systems. The force field, which is implemented in the context of the discrete molecular dynamics algorithm, is able to reproduce the properties of folded and unfolded proteins, in both isolation, complexed forming well-defined quaternary structures, or aggregated, thanks to its proper evaluation of protein-protein interactions. The accuracy and computational efficiency of the method makes it a universal tool for the study of the structure, dynamics, and association/dissociation of proteins. © 2015 American Chemical Society.",,"amyloid beta protein; amyloid beta protein[1-40]; peptide fragment; protein; chemistry; hydrogen bond; metabolism; molecular dynamics; protein domain; protein quaternary structure; protein unfolding; Amyloid beta-Peptides; Hydrogen Bonding; Molecular Dynamics Simulation; Peptide Fragments; Protein Interaction Domains and Motifs; Protein Structure, Quaternary; Protein Unfolding; Proteins",,"amyloid beta protein, 109770-29-8; protein, 67254-75-5; Amyloid beta-Peptides; amyloid beta-protein (1-40); Peptide Fragments; Proteins",,,"European Research Council, ERC",,,,"Morriss-Andrews, A., Shea, J.E., Computational studies of protein aggregation: Methods and applications (2015) Annu. Rev. Phys. Chem., 66, pp. 643-666; Orozco, M., A theoretical view of protein dynamics (2014) Chem. Soc. Rev., 43, pp. 5051-5066; Kleinjung, J., Fraternali, F., Design and application of implicit solvent models in biomolecular simulations (2014) Curr. Opin. Struct. Biol., 25, pp. 126-134; Saunders, M.G., Voth, G.A., Coarse-graining methods for computational biology (2013) Annu. Rev. Biophys., 42, pp. 73-93; Pasi, M., Lavery, R., Ceres, N., PaLaCe: A coarse-grain protein model for studying mechanical properties (2013) J. Chem. Theory Comput., 9, pp. 785-793; Hills, R.D., Jr., Lu, L., Voth, G.A., Multiscale coarse-graining of the protein energy landscape (2010) PLoS Comput. Biol., 6; Kar, P., Gopal, S.M., Cheng, Y.M., Predeus, A., Feig, M., RIMO: A Transferable Coarse-grained Force Field for Proteins (2013) J. Chem. Theory Comput., 9, pp. 3769-3788; Kapoor, A., Travesset, A., Folding and stability of helical bundle proteins from coarse-grained models (2013) Proteins: Struct., Funct., Genet., 81, pp. 1200-1211; Bereau, T., Deserno, M., Generic doarse-grained model for protein folding and aggregation (2009) J. Chem. Phys., 130, p. 235106; Liwo, A., Khalili, M., Czaplewski, C., Kalinowski, S., Oldziej, S., Wachucik, K., Scheraga, H.A., Modification and optimization of the united-residue (UNRES) potential energy function for canonical simulations. I. Temperature dependence of the effective energy function and tests of the optimization method with single training proteins (2007) J. Phys. Chem. B, 111, pp. 260-285; Sterpone, F., Melchionna, S., Tuffery, P., Pasquali, S., Mousseau, N., Cragnolini, T., Chebaro, Y., Derreumaux, P., The OPEP protein model: From single molecules,amyloid formation, crowding and hydrodynamics to DNA/RNA systems (2014) Chem. Soc. Rev., 43, pp. 4871-4893; Chebaro, Y., Pasquali, S., Derreumaux, P., The coase-grained OPEP force field for non-amyloid and amyloid proteins (2012) J. Phys. Chem. B, 116, pp. 8741-8752; Auer, S., Phase diagram of polypeptide chains (2011) J. Chem. Phys., 135, p. 175103; Urbanc, B., Cruz, L., Yun, S., Buldyrev, S.V., Bitan, G., Teplow, D.B., Stanley, H.E., In silico study of amyloid beta-protein folding and oligomerization (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17345-17350; Orozco, M., Orellana, L., Hospital, A., Naganathan, A.N., Emperador, A., Carrillo, O., Gelpi, J.L., Coarse-grained representation of protein flexibility. Foundations, successes, and shortcomings (2011) Adv. Protein Chem. Struct. Biol., 85, pp. 183-215; Emperador, A., Meyer, T., Orozco, M., Protein flexibility from discrete molecular dynamics simulations using quasi-physical potentials (2010) Proteins: Struct., Funct., Genet., 78, pp. 83-94; Marrink, S.J., De Vries, A.H., Mark, A.E., Coarse grained model for semiquantitative lipid simulations (2004) J. Phys. Chem. B, 108, pp. 750-760; Marrink, S.J., Risselada, H.J., Yefimov, S., Tieleman, D.P., De Vries, A.H., The MARTINI force field: Coarse grained model for biomolecular simulations (2007) J. Phys. Chem. B, 111, pp. 7812-7824; Monticelli, L., Kandasamy, S.K., Periole, X., Larson, R.G., Tieleman, D.P., Marrink, S.J., The MARTINI coarse-grained force field: Extension to proteins (2008) J. Chem. Theory Comput., 4, pp. 819-834; Anandakrishnan, R., Drozdetski, A., Walker, R.C., Onufriev, A.V., Speed of conformational change: Comparing explicit and implicit solvent molecular dynamics simulations (2015) Biophys. J., 108, pp. 1153-1164; Emperador, A., Meyer, T., Orozco, M., United-Atom Discrete Molecular Dynamics of Proteins Using Physics-Based Potentials (2008) J. Chem. Theory Comput., 4, pp. 2001-2010; Ding, F., Tsao, D., Nie, H., Dokholyan, N.V., Ab initio folding of proteins with all-atom discrete molecular dynamics (2008) Structure, 16, pp. 1010-1018; Neria, E., Fischer, S., Karplus, M., Simulation of activation free energies in molecular systems (1996) J. Chem. Phys., 105, pp. 1902-1921; Lazaridis, T., Karplus, M., Effective energy function for proteins in solution (1999) Proteins: Struct., Funct., Genet., 35, pp. 133-152; Moore, T.C., Iacovella, C.R., McCabe, C., Derivation of coarse-grained potentials via multistate iterative Boltzmann inversion (2014) J. Chem. Phys., 140, p. 224104; Miyazawa, S., Jernigan, R.L., Residue-residue potentials with a favorable contact pair term and an unfavorable high packing density term, for simulation and threading (1996) J. Mol. Biol., 256, pp. 623-644; Zhang, C., Vasmatzis, G., Cornette, J.L., DeLisi, C., Determination of atomic desolvation energies from the structures of crystallized proteins (1997) J. Mol. Biol., 267, pp. 707-726; Bitan, G., Vollers, S.S., Teplow, D.B., Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization (2003) J. Biol. Chem., 278, pp. 34882-34889; Olubiyi, O.O., Strodel, B., Structures of the amyloid β-peptides Aβ1-40 and Aβ1-42 as influenced by pH and a D-peptide (2012) J. Phys. Chem. B, 116, pp. 3280-3291; Nasica-Labouze, J., Nguyen, H., Sterpone, F., Berthomieu, O., Buchete, N.-V., Cote, S., De Simone, A., Derreumaux, P., Amyloid β protein and Alzheimer's disease: When computer simulations complement experimental studies (2015) Chem. Rev., 115, pp. 3518-3563; Takeda, T., Klimov, K., Probing the effect of amino-terminal truncation for Aβ40 peptides (2009) J. Phys. Chem. B, 113, pp. 6692-6702; Kim, S., Takeda, T., Klimov, K., Mapping conformational ensembles of Aβ oligomers in molecyular dynamics simulations (2010) Biophys. J., 99, pp. 1949-1958; Lin, Y.-S., Bowman, G.R., Beauchamp, K.A., Pande, V.S., Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer (2012) Biophys. J., 102, pp. 315-324; Pujol-Pina, R., Vilaprinyo-Pascual, S., Mazzucato, R., Arcellla, A., Vilaseca, M., Orozco, M., Carulla, N., (2015) Sci. Rep., 5, p. 14809; Barz, B., Olubiyi, O.O., Strodel, B., Early amyloid β-protein aggregation precedes conformational change (2014) Chem. Commun., 50, pp. 5373-5375; Rueda, M., Ferrer-Costa, C., Meyer, T., Perez, A., Camps, J., Hospital, A., Gelpi, J.L., Orozco, M., A consensus view of protein dynamics (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 796-801; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Perez, A., Carrillo, O., Orozco, M., MoDEL (Molecular Dynamics Extended Library): A database of atomistic molecular dynamics trajectories (2010) Structure, 18, pp. 1399-1409; Candotti, M., Perez, A., Ferrer-Costa, C., Rueda, M., Meyer, T., Gelpi, J.L., Orozco, M., Exploring early stages of the chemical unfolding of proteins at the proteome scale (2013) PLoS Comput. Biol., 9; Demarest, S.J., Martinez-Yamout, M., Chung, J., Chen, H., Xu, W., Dyson, H.J., Evans, R.M., Wright, P.E., Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators (2002) Nature, 415, pp. 549-553; Kjaergaard, M., Norholm, A.B., Hendus-Altenburger, R., Pedersen, S.F., Poulsen, F.M., Kragelund, B.B., Temperature-dependent structural changes in intrinsically disordered proteins: Formation of alpha-helices or loss of polyproline II? (2010) Protein Sci., 19, pp. 1555-1564; Esteban-Martin, S., Silvestre-Ryan, J., Bertoncini, C.W., Salvatella, X., Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein (2013) Biophys. J., 105, pp. 1192-1198; Hwang, H., Vreven, T., Janin, J., Weng, Z., Protein-protein docking benchmark version 4.0 (2010) Proteins: Struct., Funct., Genet., 78, pp. 3111-3114; Kastritis, P.L., Moal, I.H., Hwang, H., Weng, Z., Bates, P.A., Bonvin, A.M., Janin, J., A structure-based benchmark for protein-protein binding affinity (2011) Protein Sci., 20, pp. 482-491; Emperador, A., Solernou, A., Sfriso, P., Pons, C., Gelpi, J.L., Fernandez-Recio, J., Orozco, M., Efficient relaxation of protein-protein interfaces by discrete molecular dynamics (2013) J. Chem. Theory Comput., 9, pp. 1222-1229; Cheng, T.M., Blundell, T.L., Fernandez-Recio, J., PyDock: Electrostatics and desolvation for effective scoring of rigid-body protein-protein docking (2007) Proteins: Struct., Funct., Genet., 68, pp. 503-515; Fernandez-Recio, J., Totrov, M., Abagyan, R., Soft protein-protein docking in internal coordinates (2002) Protein Sci., 11, pp. 280-291; Sacquin-Mora, S., Carbone, A., Lavery, R., Identification of protein interaction partners and protein-protein interaction sites (2008) J. Mol. Biol., 382, pp. 1276-1289","Emperador, A.; Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Spain",,,"American Chemical Society",,,,,15499618,,JCTCC,"26597989","English","J. Chem. Theory Comput.",Article,"Final",,Scopus,2-s2.0-84949644173
"Puente X.S., Beà S., Valdés-Mas R., Villamor N., Gutiérrez-Abril J., Martín-Subero J.I., Munar M., Rubio-Pérez C., Jares P., Aymerich M., Baumann T., Beekman R., Belver L., Carrio A., Castellano G., Clot G., Colado E., Colomer D., Costa D., Delgado J., Enjuanes A., Estivill X., Ferrando A.A., Gelpí J.L., González B., González S., González M., Gut M., Hernández-Rivas J.M., López-Guerra M., Martín-García D., Navarro A., Nicolás P., Orozco M., Payer Á.R., Pinyol M., Pisano D.G., Puente D.A., Queirós A.C., Quesada V., Romeo-Casabona C.M., Royo C., Royo R., Rozman M., Russiñol N., Salaverría I., Stamatopoulos K., Stunnenberg H.G., Tamborero D., Terol M.J., Valencia A., López-Bigas N., Torrents D., Gut I., López-Guillermo A., López-Otín C., Campo E.","6701552499;6701673488;55532311800;7003554658;56651019800;6603744154;56925001700;56355193100;6603875118;35502361700;37025527600;24398587300;25222829900;6701732738;56415981400;55332884600;23468869800;7006086946;7201884637;55568508770;7801316774;36047834200;7004532329;35517522400;57193139209;56720064800;9233235300;36130221700;6602177131;15832383900;55702968900;7202496222;22835466100;7102809158;14634221900;6602137898;24588110800;56964934600;55366742300;6602590815;57210606178;35332784800;24176373200;7004425089;55485389600;6505867168;7004539534;7006024572;9640255500;7004114075;16308427600;6603569620;6603452371;56524174800;7004492510;7102600806;7103168343;","Non-coding recurrent mutations in chronic lymphocytic leukaemia",2015,"Nature","526","7574",,"519","524",,317,"10.1038/nature14666","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945248976&doi=10.1038%2fnature14666&partnerID=40&md5=bfdf3a350f98d9b696187e227b3af58a","Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Departament D'Anatomía Patològica, Microbiología i Farmacología, Universitat de Barcelona, Barcelona, 08036, Spain; Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain; Unidad de Genómica, IDIBAPS, Barcelona, 08036, Spain; Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, 08036, Spain; Institute for Cancer Genetics, Columbia University, New York, 10032, United States; Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, 33011, Spain; Center for Genomic Regulation (CRG), Pompeu Fabra University (UPF), Hospital Del Mar Research Institute (IMIM), Barcelona, 08003, Spain; Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Centro de Investigación Del Cáncer, Universidad de Salamanca-CSIC, Salamanca, 37007, Spain; Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, 08028, Spain; Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del País Vasco, Bilbao, 48007, Spain; Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, 28029, Spain; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thermi, Thessaloniki, 57001, Greece; Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, HB Nijmegen, 6500, Netherlands; Servicio de Hematología, Hospital Clínico de Valencia, Valencia, 46010, Spain","Puente, X.S., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Beà, S., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Valdés-Mas, R., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Villamor, N., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Gutiérrez-Abril, J., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Martín-Subero, J.I., Departament D'Anatomía Patològica, Microbiología i Farmacología, Universitat de Barcelona, Barcelona, 08036, Spain; Munar, M., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; Rubio-Pérez, C., Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain; Jares, P., Unidad de Genómica, IDIBAPS, Barcelona, 08036, Spain; Aymerich, M., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Baumann, T., Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, 08036, Spain; Beekman, R., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Belver, L., Institute for Cancer Genetics, Columbia University, New York, 10032, United States; Carrio, A., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Castellano, G., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Clot, G., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Colado, E., Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, 33011, Spain; Colomer, D., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Costa, D., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Delgado, J., Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, 08036, Spain; Enjuanes, A., Unidad de Genómica, IDIBAPS, Barcelona, 08036, Spain; Estivill, X., Center for Genomic Regulation (CRG), Pompeu Fabra University (UPF), Hospital Del Mar Research Institute (IMIM), Barcelona, 08003, Spain; Ferrando, A.A., Institute for Cancer Genetics, Columbia University, New York, 10032, United States; Gelpí, J.L., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; González, B., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; González, S., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; González, M., Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Centro de Investigación Del Cáncer, Universidad de Salamanca-CSIC, Salamanca, 37007, Spain; Gut, M., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, 08028, Spain; Hernández-Rivas, J.M., Servicio de Hematología, IBSAL-Hospital Universitario de Salamanca, Centro de Investigación Del Cáncer, Universidad de Salamanca-CSIC, Salamanca, 37007, Spain; López-Guerra, M., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Martín-García, D., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Navarro, A., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Nicolás, P., Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del País Vasco, Bilbao, 48007, Spain; Orozco, M., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; Payer, Á.R., Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, 33011, Spain; Pinyol, M., Unidad de Genómica, IDIBAPS, Barcelona, 08036, Spain; Pisano, D.G., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, 28029, Spain; Puente, D.A., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Queirós, A.C., Departament D'Anatomía Patològica, Microbiología i Farmacología, Universitat de Barcelona, Barcelona, 08036, Spain; Quesada, V., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Romeo-Casabona, C.M., Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del País Vasco, Bilbao, 48007, Spain; Royo, C., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Royo, R., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; Rozman, M., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain; Russiñol, N., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Salaverría, I., Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Stamatopoulos, K., Institute of Applied Biosciences, Center for Research and Technology Hellas, Thermi, Thessaloniki, 57001, Greece; Stunnenberg, H.G., Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen, HB Nijmegen, 6500, Netherlands; Tamborero, D., Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain; Terol, M.J., Servicio de Hematología, Hospital Clínico de Valencia, Valencia, 46010, Spain; Valencia, A., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, 28029, Spain; López-Bigas, N., Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, 08003, Spain; Torrents, D., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), Spanish National Bioinformatics Institute, Universitat de Barcelona, Barcelona, 08028, Spain; Gut, I., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, 08028, Spain; López-Guillermo, A., Servicio de Hematología, Hospital Clínic, IDIBAPS, Barcelona, 08036, Spain; López-Otín, C., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, 33006, Spain; Campo, E., Unitat de Hematología, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, 08036, Spain","Chronic lymphocytic leukaemia (CLL) is a frequent disease in which the genetic alterations determining the clinicobiological behaviour are not fully understood. Here we describe a comprehensive evaluation of the genomic landscape of 452 CLL cases and 54 patients with monoclonal B-lymphocytosis, a precursor disorder. We extend the number of CLL driver alterations, including changes in ZNF292, ZMYM3, ARID1A and PTPN11. We also identify novel recurrent mutations in non-coding regions, including the 3′ region of NOTCH1, which cause aberrant splicing events, increase NOTCH1 activity and result in a more aggressive disease. In addition, mutations in an enhancer located on chromosome 9p13 result in reduced expression of the B-cell-specific transcription factor PAX5. The accumulative number of driver alterations (0 to ≥ 4) discriminated between patients with differences in clinical behaviour. This study provides an integrated portrait of the CLL genomic landscape, identifies new recurrent driver mutations of the disease, and suggests clinical interventions that may improve the management of this neoplasia. © 2015 Macmillan Publishers Limited. All rights reserved.",,"ARID1A protein; Notch1 receptor; protein; protein tyrosine phosphatase SHP 2; transcription factor PAX5; unclassified drug; ZMYM3 protein; ZNF292 protein; 3' untranslated region; ARID1A protein, human; carrier protein; DNA; nerve protein; NOTCH1 protein, human; Notch1 receptor; nuclear protein; PAX5 protein, human; protein tyrosine phosphatase SHP 2; PTPN11 protein, human; transcription factor; transcription factor PAX5; ZMYM3 protein, human; ZNF292 protein, human; antibody; blood; cancer; cells and cell components; gene expression; genetic variation; mutation; 3' untranslated region; Article; chromosome 9p; chronic lymphatic leukemia; controlled study; disease activity; enhancer region; gene mutation; human; leukemogenesis; major clinical study; monoclonal b cell lymphocytosis; priority journal; protein expression; somatic mutation; splicing defect; alternative RNA splicing; B lymphocyte; biosynthesis; chromosome 9; chronic lymphatic leukemia; genetics; genomics; metabolism; mutation; nucleotide sequence; pathology; 3' Untranslated Regions; Alternative Splicing; B-Cell-Specific Activator Protein; B-Lymphocytes; Carrier Proteins; Chromosomes, Human, Pair 9; DNA Mutational Analysis; DNA, Neoplasm; Enhancer Elements, Genetic; Genomics; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Receptor, Notch1; Transcription Factors",,"protein, 67254-75-5; carrier protein, 80700-39-6; DNA, 9007-49-2; 3' Untranslated Regions; ARID1A protein, human; B-Cell-Specific Activator Protein; Carrier Proteins; DNA, Neoplasm; Nerve Tissue Proteins; NOTCH1 protein, human; Nuclear Proteins; PAX5 protein, human; Protein Tyrosine Phosphatase, Non-Receptor Type 11; PTPN11 protein, human; Receptor, Notch1; Transcription Factors; ZMYM3 protein, human; ZNF292 protein, human",,,"Instituto de Salud Carlos III

Banco Santander","Acknowledgements This work was funded by Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigacióndel Cáncer (RTICC). We are grateful to E. Santos for his continuedsupport tothis project,andN.Villahoz and M.C.Murofor theirexcellent workinthe coordination of the CLL Spanish Consortium. C.L.-O. is an Investigator of the Botin Foundation supported by Banco Santander through its Santander Universities Global Division, and E.Ca. and D.T. are Institució Catalana de Recerca i Estudis Avançats-Academia investigators. We acknowledge Partnership for Advanced Computing in Europe (PRACE) for awarding us access to resource Marenostrum based in Spain at the BSC, the Pershing Square Sohn Cancer Research Alliance and European Union’s FP7 through the Blueprint Consortium. Weare also verygrateful to all patients with CLL who have participated in this study.",,,"Gaidano, G., Foa, R., Dalla-Favera, R., Molecular pathogenesis of chronic lymphocytic leukemia (2012) J. Clin. Invest., 122, pp. 3432-3438; Zenz, T., Mertens, D., Kuppers, R., Dohner, H., Stilgenbauer, S., Frompathogenesis to treatment of chronic lymphocytic leukaemia (2010) Nature Rev. Cancer, 10, pp. 37-50; Pekarsky, Y., Zanesi, N., Croce, C.M., Molecular basis of CLL (2010) Semin. Cancer Biol., 20, pp. 370-376; Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G., Stevenson, F.K., Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia (1999) Blood, 94, pp. 1848-1854; Damle, R.N., Ig v gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia (1999) Blood, 94, pp. 1840-1847; Crespo, M., ZAP-70 expression as a surrogate for immunoglobulin-variableregion mutations in chronic lymphocytic leukemia (2003) N. Engl. J. Med., 348, pp. 1764-1775; Malek, S.N., The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia (2013) Oncogene, 32, pp. 2805-2817; Döhner, H., Genomic aberrations and survival in chronic lymphocytic leukemia (2000) N. Engl. J. Med., 343, pp. 1910-1916; Quesada, V., Exome sequencing identifies recurrentmutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia (2011) Nature Genet., 44, pp. 47-52; Puente, X.S., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (2011) Nature, 475, pp. 101-105; Landau, D.A., Evolution and impact of subclonal mutations in chronic lymphocytic leukemia (2013) Cell, 152, pp. 714-726; Fabbri, G., Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation (2011) J. Exp. Med., 208, pp. 1389-1401; Ramsay, A.J., POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia (2013) Nature Genet., 45, pp. 526-530; Damm, F., Acquired initiating mutations in early hematopoietic cells of CLL patients (2014) Cancer Discov., 4, pp. 1088-1101; Rossi, D., Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia (2012) Blood, 119, pp. 2854-2862; Ferreira, P.G., Transcriptomecharacterization byRNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia (2014) Genome Res., 24, pp. 212-226; Kulis, M., Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia (2012) Nature Genet., 44, pp. 1236-1242; Oakes, C.C., Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia (2014) Cancer Discov., 4, pp. 348-361; Hudson, T.J., International network of cancer genome projects (2010) Nature, 464, pp. 993-998; Alexandrov, L.B., Signatures ofmutational processes in humancancer (2013) Nature, 500, pp. 415-421; Khodabakhshi, A.H., Recurrent targets of aberrant somatic hypermutation in lymphoma (2012) Oncotarget, 3, pp. 1308-1319; Pasqualucci, L., Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas (2001) Nature, 412, pp. 341-346; Byrd, J.C., Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia (2013) N. Engl. J. Med., 369, pp. 32-42; Moncunill, V., Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads (2014) Nature Biotechnol., 32, pp. 1106-1112; Stephens, P.J., Massive genomic rearrangement acquired in a single catastrophic event during cancer development (2011) Cell, 144, pp. 27-40; Baca, S.C., Punctuated evolution of prostate cancer genomes (2013) Cell, 153, pp. 666-677; Rausch, T., Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations (2012) Cell, 148, pp. 59-71; Balatti, V., NOTCH1 mutations in CLL associated with trisomy 12 (2012) Blood, 119, pp. 329-331; Huang, F.W., Highly recurrent TERT promoter mutations in human melanoma (2013) Science, 339, pp. 957-959; Yamane, A., Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes (2011) Nature Immunol., 12, pp. 62-69; Lawrence, M.S., Mutational heterogeneity in cancer and the search for new cancer-associated genes (2013) Nature, 499, pp. 214-218; Simonis, M., Kooren, J., De Laat, W., An evaluation of 3C-basedmethods to capture DNA interactions (2007) Nature Methods, 4, pp. 895-901; Revilla-I-Domingo, R., The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis (2012) EMBO J., 31, pp. 3130-3146; Queiró, S.A.C., A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact (2015) Leukemia, 29, pp. 598-605; Strefford, J.C., Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: The case of SF3B1 and subset #2 (2013) Leukemia, 27, pp. 2196-2199; Agathangelidis, A., Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: A molecular classification with implications for targeted therapies (2012) Blood, 119, pp. 4467-4475; Rubio-Perez, C., In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities (2015) Cancer Cell, 27, pp. 382-396; Lobry, C., Oh, P., Aifantis, I., Oncogenic and tumor suppressor functions of Notch in cancer: It's NOTCH what you think (2011) J. Exp. Med., 208, pp. 1931-1935; O'Brien, P., Morin, P., Jr., Ouellette, R.J., Robichaud, G.A., The Pax-5 gene: A pluripotent regulator of B-cell differentiation and cancer disease (2011) Cancer Res., 71, pp. 7345-7350; Villamor, N., NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patientswith high risk of transformation and poor outcome (2013) Leukemia, 27, pp. 1100-1106; Bentley, D.R., Accurate whole human genome sequencing using reversible terminator chemistry (2008) Nature, 456, pp. 53-59; Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760; Li, H., The Sequence Alignment/Map format and SAMtools (2009) Bioinformatics, 25, pp. 2078-2079; Puente, X.S., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (2011) Nature, 475, pp. 101-105; Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Campbell, P.J., Stratton, M.R., Deciphering signatures of mutational processes operative in human cancer (2013) Cell Rep., 3, pp. 246-259; Delgado, J., Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption (2014) Haematologica, 99, pp. e231-e234; Edelmann, J., High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations (2012) Blood, 120, pp. 4783-4794; Valdés-Mas, R., Bea, S., Puente, D.A., Lopez-Otin, C., Puente, X.S., Estimation of copy number alterations from exome sequencing data (2012) PLoS ONE, 7; Bibikova, M., High density DNA methylation array with single CpG site resolution (2011) Genomics, 98, pp. 288-295; Bibikova, M., Genome-wide DNA methylation profiling using InfiniumR assay (2009) Epigenomics, 1, pp. 177-200; Aryee, M.J., Minfi: A flexible and comprehensive Bioconductor package for the analysis of InfiniumDNAmethylationmicroarrays (2014) Bioinformatics, 30, pp. 1363-1369; Kluk, M.J., Gauging NOTCH1 activation in cancer using immunohistochemistry (2013) PLoS ONE, 8; Van Dewerken, H.J., Robust4C-seq data analysis to screen for regulatoryDNA interactions (2012) Nature Methods, 9, pp. 969-972; Van De Werken, H.J., 4C technology: Protocols and data analysis (2012) Methods Enzymol., 513, pp. 89-112; Heckl, D., Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing (2014) Nature Biotechnol., 32, pp. 941-946; Heigwer, F., Kerr, G., Boutros, M., E-CRISP: Fast CRISPR target site identification (2014) Nature Methods, 11, pp. 122-123; Peto, R., Pike, M.C., Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data (1973) Biometrics, 29, pp. 579-584","López-Otín, C.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de OviedoSpain; email: clo@uniovi.es",,,"Nature Publishing Group",,,,,00280836,,NATUA,"26200345","English","Nature",Article,"Final",,Scopus,2-s2.0-84945248976
"Julià A., Pinto J.A., Gratacós J., Queiró R., Ferrándiz C., Fonseca E., Montilla C., Torre-Alonso J.C., Puig L., Venegas J.J.P., Nebro A.F., Fernández E., Muñoz-Fernández S., Daudén E., González C., Roig D., Carazo J.L.S., Zarco P., Erra A., Estebaranz J.L.L., Rodríguez J., Ramírez D.M., De La Cueva P., Vanaclocha F., Herrera E., Castañeda S., Rubio E., Salvador G., Díaz-Torné C., Blanco R., Domínguez A.W., Mosquera J.A., Vela P., Tornero J., Sánchez-Fernández S., Corominas H., Ramírez J., López-Lasanta M., Tortosa R., Palau N., Alonso A., García-Montero A.C., Gelpí J.L., Codó L., Day K., Absher D., Myers R.M., Cañete J.D., Marsal S.","57210878792;56883759100;23469245300;6603878341;7005892900;34975078800;12782882100;6603460831;7101770587;55338747000;6508226669;55933326900;7004546711;7003438085;36064831900;6602407204;23049315100;7006771455;16678368700;15730891100;57209135380;56884019300;15043904600;6603052674;7103001516;6701750483;56529071700;7003510663;12779759300;7102430622;56446294700;8055295800;7004528221;36151354800;55986702400;6602373022;55794210400;23035265100;55933194400;54412813600;36150353900;6603714021;35517522400;55882083800;55848565200;57198406019;7403700738;7003746360;6603356384;","A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk",2015,"Annals of the Rheumatic Diseases","74","10",,"1875","1881",,8,"10.1136/annrheumdis-2014-207190","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942935212&doi=10.1136%2fannrheumdis-2014-207190&partnerID=40&md5=2e51931f508e59463cc328ce19e0a5fc","Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Rheumatology Department, Complejo Hospitalario Juan Canalejo, A Coruña, Spain; Rheumatology Department, Hospital Parc Taulí, Sabadell, Barcelona, Spain; Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Dermatology Department, Complejo Hospitalario, Universitario de A Coruña, A Coruña, Spain; Rheumatology Department, Hospital Virgen de la Vega, Salamanca, Spain; Rheumatology Department, Hospital Monte Naranco, Oviedo, Spain; Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Rheumatology Department, Hospital de Jerez de la Frontera, Cádiz, Spain; UGC Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Málaga, Spain; Department of Dermatology, Hospital Universitario de Salamanca, Salamanca, Spain; Rheumatology Department, Hospital Universitario Infanta Sofía, Madrid, Spain; Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain; Rheumatology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain; Rheumatology Service, Hospital Moisès Broggi, Barcelona, Spain; Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; Rheumatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Dermatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain; Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain; Dermatology Department, Hospital Universitario de Octubre, Madrid, Spain; Dermatology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain; Rheumatology Department, Centro de Salud Virgen de los Reyes, Sevilla, Spain; Rheumatology Department, Hospital Mútua de Terrassa, Terrassa, Spain; Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain; Rheumatology Department, Complexo Hospitalario de Ourense, Ourense, Spain; Rheumatology Department, Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain; Rheumatology Department, Hospital General, Universitario de Alicante, Alicante, Spain; Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain; Rheumatology Department, Hospital La Mancha Centro, Alcázar de San Juan, Spain; Rheumatology Department, Hospital Clínic i Provincial and IDIBAPS, c/Villarroel 170, Barcelona, 08036, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Alabama, United States","Julià, A., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Pinto, J.A., Rheumatology Department, Complejo Hospitalario Juan Canalejo, A Coruña, Spain; Gratacós, J., Rheumatology Department, Hospital Parc Taulí, Sabadell, Barcelona, Spain; Queiró, R., Rheumatology Department, Hospital Universitario Central de Asturias, Oviedo, Spain; Ferrándiz, C., Dermatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Fonseca, E., Dermatology Department, Complejo Hospitalario, Universitario de A Coruña, A Coruña, Spain; Montilla, C., Rheumatology Department, Hospital Virgen de la Vega, Salamanca, Spain; Torre-Alonso, J.C., Rheumatology Department, Hospital Monte Naranco, Oviedo, Spain; Puig, L., Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Venegas, J.J.P., Rheumatology Department, Hospital de Jerez de la Frontera, Cádiz, Spain; Nebro, A.F., UGC Reumatología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Málaga, Spain; Fernández, E., Department of Dermatology, Hospital Universitario de Salamanca, Salamanca, Spain; Muñoz-Fernández, S., Rheumatology Department, Hospital Universitario Infanta Sofía, Madrid, Spain; Daudén, E., Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain; González, C., Rheumatology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain; Roig, D., Rheumatology Service, Hospital Moisès Broggi, Barcelona, Spain; Carazo, J.L.S., Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain; Zarco, P., Rheumatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Erra, A., Rheumatology Department, Hospital Sant Rafael, Barcelona, Spain; Estebaranz, J.L.L., Dermatology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain; Rodríguez, J., Rheumatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain; Ramírez, D.M., Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain; De La Cueva, P., Department of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain; Vanaclocha, F., Dermatology Department, Hospital Universitario de Octubre, Madrid, Spain; Herrera, E., Dermatology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain; Castañeda, S., Rheumatology Department, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain; Rubio, E., Rheumatology Department, Centro de Salud Virgen de los Reyes, Sevilla, Spain; Salvador, G., Rheumatology Department, Hospital Mútua de Terrassa, Terrassa, Spain; Díaz-Torné, C., Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Blanco, R., Rheumatology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain; Domínguez, A.W., Rheumatology Department, Complexo Hospitalario de Ourense, Ourense, Spain; Mosquera, J.A., Rheumatology Department, Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain; Vela, P., Rheumatology Department, Hospital General, Universitario de Alicante, Alicante, Spain; Tornero, J., Rheumatology Department, Hospital Universitario Guadalajara, Guadalajara, Spain; Sánchez-Fernández, S., Rheumatology Department, Hospital La Mancha Centro, Alcázar de San Juan, Spain; Corominas, H., Rheumatology Service, Hospital Moisès Broggi, Barcelona, Spain; Ramírez, J., Rheumatology Department, Hospital Clínic i Provincial and IDIBAPS, c/Villarroel 170, Barcelona, 08036, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Palau, N., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; Alonso, A., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain; Codó, L., HudsonAlpha Institute for Biotechnology, Alabama, United States; Day, K., HudsonAlpha Institute for Biotechnology, Alabama, United States; Absher, D., HudsonAlpha Institute for Biotechnology, Alabama, United States; Myers, R.M., HudsonAlpha Institute for Biotechnology, Alabama, United States; Cañete, J.D., Rheumatology Department, Hospital Clínic i Provincial and IDIBAPS, c/Villarroel 170, Barcelona, 08036, Spain; Marsal, S., Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Barcelona, 08035, Spain","Objective Copy number variants (CNVs) have been associated with the risk to develop multiple autoimmune diseases. Our objective was to identify CNVs associated with the risk to develop psoriatic arthritis (PsA) using a genome-wide analysis approach. Methods A total of 835 patients with PsA and 1498 healthy controls were genotyped for CNVs using the Illumina HumanHap610 BeadChip genotyping platform. Genomic CNVs were characterised using CNstream analysis software and analysed for association using the χ2 test. The most significant genomic CNV associations with PsA risk were independently tested in a validation sample of 1133 patients with PsA and 1831 healthy controls. In order to test for the specificity of the variants with PsA aetiology, we also analysed the association to a cohort of 822 patients with purely cutaneous psoriasis (PsC). Results A total of 165 common CNVs were identified in the genome-wide analysis. We found a highly significant association of an intergenic deletion between ADAMTS9 and MAGI1 genes on chromosome 3p14.1 (p=0.00014). Using the independent patient and control cohort, we validated the association between ADAMTS9-MAGI1 deletion and PsA risk (p=0.032). Using nextgeneration sequencing, we characterised the 26 kb associated deletion. Finally, analysing the PsC cohort we found a lower frequency of the deletion compared with the PsA cohort (p=0.0088) and a similar frequency to that of healthy controls (p&gt;0.3). Conclusions The present genome-wide scan for CNVs associated with PsA risk has identified a new deletion associated with disease risk and which is also differential from PsC risk.",,"ADAMTS9 gene; adult; Article; chromosome 3p; cohort analysis; controlled study; copy number variation; female; gene; gene deletion; gene linkage disequilibrium; gene locus; genetic association; genetic risk; genome analysis; genotype; human; MAGI1 gene; major clinical study; male; middle aged; priority journal; psoriasis; psoriatic arthritis; aged; case control study; clinical trial; copy number variation; genetic association; genetic predisposition; genetics; multicenter study; psoriatic arthritis; risk factor; ADAM protein; ADAMTS9 protein, human; MAGI1 protein, human; nerve cell adhesion molecule; ADAM Proteins; Adult; Aged; Arthritis, Psoriatic; Case-Control Studies; Cell Adhesion Molecules, Neuronal; DNA Copy Number Variations; Female; Gene Deletion; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Psoriasis; Risk Factors",,"ADAM Proteins; ADAMTS9 protein, human; Cell Adhesion Molecules, Neuronal; MAGI1 protein, human",,,,,,,"Gladman, D.D., Antoni, C., Mease, P., Psoriatic arthritis: Epidemiology, clinical features, course, and outcome (2005) Ann Rheum Dis, 64, pp. ii14-ii17; Julia, A., Tortosa, R., Hernanz, J.M., Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes (2012) Hum Mol Genet, 21, pp. 4549-4557; Gladman, D.D., Farewell, V.T., Pellett, F., HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs (2003) Hum Immunol, 64, pp. 887-889; Myers, A., Kay, L.J., Lynch, S.A., Recurrence risk for psoriasis and psoriatic arthritis within sibships (2005) Rheumatology (Oxford), 44, pp. 773-776; Bhalerao, J., Bowcock, A.M., The genetics of psoriasis: A complex disorder of the skin and immune system (1998) Hum Mol Genet, 7, pp. 1537-1545; Liu, Y., Helms, C., Liao, W., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci (2008) PLoS Genet, 4, p. e1000041; Ellinghaus, E., Ellinghaus, D., Stuart, P.E., Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 (2010) Nat Genet, 42, pp. 991-995; Strange, A., Capon, F., Spencer, C.C., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) Nat Genet, 42, pp. 985-990; Chen, H., Poon, A., Yeung, C., A genetic risk score combining ten psoriasis risk loci improves disease prediction (2011) PLoS One, 6, p. e19454; Ellinghaus, E., Stuart, P.E., Ellinghaus, D., Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL (2012) J Invest Dermatol, 132, pp. 1133-1140; Sheng, Y., Jin, X., Xu, J., Sequencing-based approach identified three new susceptibility loci for psoriasis (2014) Nat Commun, 5, p. 4331; Cook, E.H., Jr., Scherer, S.W., Copy-number variations associated with neuropsychiatric conditions (2008) Nature, 455, pp. 919-923; Hollox, E.J., Huffmeier, U., Zeeuwen, P.L., Psoriasis is associated with increased beta-defensin genomic copy number (2008) Nat Genet, 40, pp. 23-25; De Cid, R., Riveira-Munoz, E., Zeeuwen, P.L., Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis (2009) Nat Genet, 41, pp. 211-215; Huffmeier, U., Estivill, X., Riveira-Munoz, E., Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to susceptibility to psoriatic arthritis in German patients (2010) Ann Rheum Dis, 69, pp. 876-878; Julia, A., Domenech, E., Ricart, E., A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300 (2012) Gut, 62, pp. 1440-1445; Taylor, W., Gladman, D., Helliwell, P., Classification criteria for psoriatic arthritis: Development of new criteria from a large international study (2006) Arthritis Rheum, 54, pp. 2665-2673; Morton, N.E., Collins, A., Tests and estimates of allelic association in complex inheritance (1998) Proc Natl Acad Sci U S A, 95, pp. 11389-11393; Price, A.L., Patterson, N.J., Plenge, R.M., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nat Genet, 38, pp. 904-909; Peiffer, D.A., Le, J.M., Steemers, F.J., High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping (2006) Genome Res, 16, pp. 1136-1148; Alonso, A., Julia, A., Tortosa, R., CNstream: A method for the identification and genotyping of copy number polymorphisms using Illumina microarrays (2010) BMC Bioinformatics, 11, p. 264; Steemers, F.J., Chang, W., Lee, G., Whole-genome genotyping with the single-base extension assay (2006) Nat Methods, 3, pp. 31-33; (2013) R: A Language and Environment for Statistical Computing, , R Foundation for Statistical Computing: Vienna; Day, K., Song, J., Absher, D., Targeted Sequencing of Large Genomic Regions with CATCH-Seq (2014) PLoS One, 9, p. e111756; Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760; Willer, C.J., Li, Y., Abecasis, G.R., METAL: Fast and efficient meta-analysis of genomewide association scans (2010) Bioinformatics, 26, pp. 2190-2191; Okada, Y., Han, B., Tsoi, L.C., Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes (2014) Am J Hum Genet, 95, pp. 162-172; Kevorkian, L., Young, D.A., Darrah, C., Expression profiling of metalloproteinases and their inhibitors in cartilage (2004) Arthritis Rheum, 50, pp. 131-141; Lohmander, L.S., Neame, P.J., Sandy, J.D., The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis (1993) Arthritis Rheum, 36, pp. 1214-1222; Arner, E.C., Pratta, M.A., Decicco, C.P., Aggrecanase. A target for the design of inhibitors of cartilage degradation (1999) Ann N Y Acad Sci, 878, pp. 92-107; Partsch, G., Steiner, G., Leeb, B.F., Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid (1997) J Rheumatol, 24, pp. 518-523; Demircan, K., Hirohata, S., Nishida, K., ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes (2005) Arthritis Rheum, 52, pp. 1451-1460; Uysal, S., Unal, Z.N., Erdogan, S., Augmentation of ADAMTS9 gene expression by IL-1beta is reversed by NFkappaB and MAPK inhibitors, but not PI3 kinase inhibitors (2013) Cell Biochem Funct, 31, pp. 539-544; Laura, R.P., Ross, S., Koeppen, H., MAGI-1: A widely expressed, alternatively spliced tight junction protein (2002) Exp Cell Res, 275, pp. 155-170; Zaric, J., Joseph, J.M., Tercier, S., Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells (2012) Oncogene, 31, pp. 48-59; Kolawole, A.O., Sharma, P., Yan, R., The PDZ1 and PDZ3 domains of MAGI-1 regulate the eight-exon isoform of the coxsackievirus and adenovirus receptor (2012) J Virol, 86, pp. 9244-9254; Walsh, P.T., Buckler, J.L., Zhang, J., PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs (2006) J Clin Invest, 116, pp. 2521-2531; Buckner, J.H., Mechanisms of impaired regulation by CD4 (+) CD25 (+) FOXP3 (+) regulatory T cells in human autoimmune diseases (2010) Nat Rev Immunol, 10, pp. 849-859; Nograles, K.E., Brasington, R.D., Bowcock, A.M., New insights into the pathogenesis and genetics of psoriatic arthritis (2009) Nat Clin Pract Rheumatol, 5, pp. 83-91; Ryder, L.R., Bartels, E.M., Woetmann, A., FoxP3 mRNA splice forms in synovial CD4+ T cells in rheumatoid arthritis and psoriatic arthritis (2012) APMIS, 120, pp. 387-396; ENCODE Project Consortium, An integrated encyclopedia of DNA elements in the human genome (2012) Nature, 489, pp. 57-74; Lappalainen, T., Sammeth, M., Friedlander, M.R., Transcriptome and genome sequencing uncovers functional variation in humans (2013) Nature, 501, pp. 506-511; Fairfax, B.P., Humburg, P., Makino, S., Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression (2014) Science, 343, p. 1246949; Roberson, E.D., Bowcock, A.M., Psoriasis genetics: Breaking the barrier (2010) Trends Genet, 26, pp. 415-423","Marsal, S.; Rheumatology Research Group, Vall d'Hebron University Hospital, Pg Vall d'Hebron, 119-129, Spain",,,"BMJ Publishing Group",,,,,00034967,,ARDIA,"25990289","English","Ann. Rheum. Dis.",Article,"Final",,Scopus,2-s2.0-84942935212
"Georgieva M.V., Yahya G., Codó L., Ortiz R., Teixidó L., Claros J., Jara R., Jara M., Iborra A., Gelpí J.L., Gallego C., Orozco M., Aldea M.","56810797000;55971917800;55882083800;56385102900;57194230371;55337324900;45661298500;56810901900;57198205805;35517522400;56810882500;7102809158;7006288901;","Inntags: Small self-structured epitopes for innocuous protein tagging",2015,"Nature Methods","12","10",,"955","958",,11,"10.1038/nmeth.3556","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959161962&doi=10.1038%2fnmeth.3556&partnerID=40&md5=14c58fdf7d391c3077e8e66f3c283ef8","Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Department of Microbiology and Immunology, School of Pharmacy, Zagazig University, Zagazig, Egypt; Barcelona Supercomputing Center (BSC), Barcelona, Spain; Joint BSC-CRG-IRB Programme in Computational Biology, Barcelona, Spain; AbBcn Ltd, Bellaterra, Spain; Immunostep Ltd, Salamanca, Spain; Departament de Bioquimica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain","Georgieva, M.V., Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Yahya, G., Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain, Department of Microbiology and Immunology, School of Pharmacy, Zagazig University, Zagazig, Egypt; Codó, L., Barcelona Supercomputing Center (BSC), Barcelona, Spain, Joint BSC-CRG-IRB Programme in Computational Biology, Barcelona, Spain; Ortiz, R., Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Teixidó, L., AbBcn Ltd, Bellaterra, Spain; Claros, J., Immunostep Ltd, Salamanca, Spain; Jara, R., Immunostep Ltd, Salamanca, Spain; Jara, M., AbBcn Ltd, Bellaterra, Spain; Iborra, A., AbBcn Ltd, Bellaterra, Spain; Gelpí, J.L., Barcelona Supercomputing Center (BSC), Barcelona, Spain, Joint BSC-CRG-IRB Programme in Computational Biology, Barcelona, Spain, Departament de Bioquimica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; Gallego, C., Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain; Orozco, M., Joint BSC-CRG-IRB Programme in Computational Biology, Barcelona, Spain, Departament de Bioquimica, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Aldea, M., Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain","Protein tagging is widely used in approaches ranging from affinity purification to fluorescence-based detection in live cells. However, an intrinsic limitation of tagging is that the native function of the protein may be compromised or even abolished by the presence of the tag. Here we describe and characterize a set of small, innocuous protein tags (inntags) that we anticipate will find application in a variety of biological techniques. © 2015 Nature America, Inc. All rights reserved.",,"bacterial protein; chaperone; cyclin dependent kinase; epitope; insect protein; protein tag; vegetable protein; virus envelope protein; epitope; green fluorescent protein; monoclonal antibody; protein; recombinant protein; animal cell; Article; brain nerve cell; cell size; Escherichia coli; fibroblast; immunofluorescence; immunoprecipitation; intracellular space; mouse; nonhuman; priority journal; protein analysis; protein domain; protein folding; protein localization; structure analysis; three dimensional imaging; 3T3 cell line; animal; Bagg albino mouse; chemistry; female; fluorescent antibody technique; genetics; HEK293 cell line; human; immunology; metabolism; procedures; protein conformation; protein tertiary structure; Animals; Antibodies, Monoclonal; Epitopes; Female; Fluorescent Antibody Technique; Green Fluorescent Proteins; HEK293 Cells; Humans; Immunoprecipitation; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Protein Conformation; Protein Structure, Tertiary; Proteins; Recombinant Proteins",,"cyclin dependent kinase, 150428-23-2; protein, 67254-75-5; Antibodies, Monoclonal; Epitopes; Green Fluorescent Proteins; Proteins; Recombinant Proteins",,,"Institució Catalana de Recerca i Estudis Avançats, ICREA

INNPACTO IPT-010000-2010-19, CSD2007-15

Instituto Nacional de Técnica Aeroespacial

European Commission

Federación Española de Enfermedades Raras, FEDER","We thank A. Cornadó, E. Rebollo and S. Dillon (Harvard University) for technical assistance, M. Azor (AntibodyBcn) for administrative support and C. Mann (Centre de Génétique Moléculaire) for the anti-Cdc28 antibody. This work was funded by the Ministry of Economy and Competitiveness of Spain (INNPACTO IPT-010000-2010-19), Consolider-Ingenio 2010 (CSD2007-15), the Instituto Nacional de Bioinformática (INB) and the European Union (FEDER) and received financial support from Antibody BCN and Immunostep. M.O. acknowledges support from Institució Catalana de Recerca i Estudis Avançats.",,,"Shine, J., Fettes, I., Lan, N.C.Y., Roberts, J.L., Baxter, J.D., (1980) Nature, 285, pp. 456-463; Waugh, D.S., (2005) Trends Biotechnol., 23, pp. 316-320; Stadler, C., (2013) Nat. Methods, 10, pp. 315-323; Hoffmann, C., (2005) Nat. Methods, 2, pp. 171-176; Tompa, P., (2012) Trends Biochem. Sci., 37, pp. 509-516; Woestenenk, E.A., Hammarstrom, M., Van Den Berg, S., Hard, T., Berglund, H., (2004) J. Struct. Funct. Genomics, 5, pp. 217-229; Schembri, L., (2007) Nat. Methods, 4, pp. 107-108; Chant, A., Kraemer-Pecore, C.M., Watkin, R., Kneale, G.G., (2005) Protein Expr. Purif., 39, pp. 152-159; Liu, X., (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 10669-10674; Song, J., Markley, J.L., (2007) Protein Pept. Lett., 14, pp. 265-268; Landgraf, D., Okumus, B., Chien, P., Baker, T.A., Paulsson, J., (2012) Nat. Methods, 9, pp. 480-482; Kopito, R.R., (2000) Trends Cell Biol., 10, pp. 524-530; Vavouri, T., Semple, J.I., Garcia-Verdugo, R., Lehner, B., (2009) Cell, 138, pp. 198-208; Sopko, R., (2006) Mol. Cell, 21, pp. 319-330; Cook, M., Tyers, M., (2007) Curr. Opin. Biotechnol., 18, pp. 341-350; Morgan, D.O., (2007) The Cell Cycle: Principles of Control., , New Science Press; Kim, Y.E., Hipp, M.S., Bracher, A., Hayer-Hartl, M., Hartl, F.U., (2013) Annu. Rev. Biochem., 82, pp. 323-355; Vergés, E., Colomina, N., Garí, E., Gallego, C., Aldea, M., (2007) Mol. Cell, 26, pp. 649-662; Ferrezuelo, F., (2012) Nat. Commun., 3, p. 1012; Fredriksson, S., (2007) Nat. Methods, 4, pp. 327-329; Zhang, X., (2008) Nat. Methods, 5, pp. 163-165; Hayes, C.N., (2008) Bioinformatics, 24, pp. 2564-2565; Vita, R., (2010) Nucleic Acids Res., 38, pp. D854-D862; Bernstein, F.C., (1977) J. Mol. Biol., 112, pp. 535-542; Punta, M., (2012) Nucleic Acids Res., 40, pp. D290-D301; Saha, S., Raghava, G.P.S., (2004) Artificial Immune Systems, pp. 197-204. , (eds. Nicosia, G. et al.) Springer; Humphrey, W., Dalke, A., Schulten, K., (1996) J. Mol. Graph., 14, pp. 33-38; (2013) Nucleic Acids Res., 41, pp. D530-D535; Xue, B., (2010) Biochim. Biophys. Acta, 1804, pp. 996-1010; Pedraza, N., (2014) J. Neurosci., 34, pp. 13988-13997; Gallego, C., Garí, E., Colomina, N., Herrero, E., Aldea, M., (1997) EMBO J., 16, pp. 7196-7206; Sambrook, J., Russell, D.W., (2001) Molecular Cloning: A Laboratory Manual, , CSHL Press, Cold Spring Harbor, NY; Yahya, G., Parisi, E., Flores, A., Gallego, C., Aldea, M., (2014) Mol. Cell, 53, pp. 115-126; Afkarian, M., (2010) Mol. Cell. Proteomics, 9, pp. 2195-2204; Wang, H., Garí, E., Vergés, E., Gallego, C., Aldea, M., (2004) EMBO J., 23, pp. 180-190; Llanes, D., Nogal, M., Prados, F., Viñuela, E., (1992) Hybridoma, 10, pp. 757-762; Slaughter, B.D., Schwartz, J.W., Li, R., (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 20320-20325","Aldea, M.; Molecular Biology Institute of Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC)Spain; email: marti.aldea@ibmb.csic.es",,,"Nature Publishing Group",,,,,15487091,,,"26322837","English","Nat. Methods",Article,"Final",,Scopus,2-s2.0-84959161962
"Alonso A., Domènech E., Julià A., Panés J., García-Sánchez V., Mateu P.N., Gutiérrez A., Gomollón F., Mendoza J.L., Garcia-Planella E., Barreiro-De Acosta M., Muñoz F., Vera M., Saro C., Esteve M., Andreu M., Chaparro M., Manyé J., Cabré E., López-Lasanta M., Tortosa R., Gelpí J.L., García-Montero A.C., Bertranpetit J., Absher D., Myers R.M., Marsal S., Gisbert J.P.","36150353900;55403162200;57210878792;55857704800;23467027100;6507991598;35073883500;36854127900;7102491741;6507483158;16240700200;7103206318;55347520400;6603201272;7006785161;7006142866;24436876600;56566612900;7005671873;23035265100;55933194400;35517522400;6603714021;7005566413;57198406019;7403700738;6603356384;56240616000;","Identification of risk loci for crohn's disease phenotypes using a genome-wide association study",2015,"Gastroenterology","148","4",,"794","805",,23,"10.1053/j.gastro.2014.12.030","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84925357305&doi=10.1053%2fj.gastro.2014.12.030&partnerID=40&md5=bfd93171a9c99f2285e65bae88b74107","Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Department of Enginyeria de Sistemes, Automática i Informàtica Industrial, Polytechnic University of Catalonia, Barcelona, Spain; Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Gastroenterology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; Digestive System Service, Universidad de Córdoba, Hospital Universitario Reina Sofía, Córdobe, Spain; Digestive Medicine Service, Hospital la Fe, Valencia, Spain; Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Digestive System Service, Hospital Clínico Universitario, Zaragoza, Spain; Gastroenterology Service, Hospital Clínico San Carlos, Madrid, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Service, Hospital Clínico Universitario, Spain; Gastroenterology Service, Complejo Hospitalario de León, León, Spain; Gastroenterology Service, Hospital Universitario Puerta de Hierro, Madrid, Spain; Internal Medicine Service, Hospital de Cabueñes, Gijón, Spain; Gastroenterology Service, Hospital Universitari Mutua de Terrassa, Barcelona, Spain; Department of Gastroenterology, Institut Hospital Del Mar d'Investigacions Mèdiques, Institute of Research Hospital Del Mar, Barcelona, Spain; Gastroenterology Service, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain; Life Sciences, Barcelona Supercomputing Center, National Institute of Bioinformatics, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain; Nacional Genotyping Centre, Universitat Pompeu Fabra, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, AB, United States","Alonso, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain, Department of Enginyeria de Sistemes, Automática i Informàtica Industrial, Polytechnic University of Catalonia, Barcelona, Spain; Domènech, E., Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Julià, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Panés, J., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Gastroenterology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain; García-Sánchez, V., Digestive System Service, Universidad de Córdoba, Hospital Universitario Reina Sofía, Córdobe, Spain; Mateu, P.N., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Digestive Medicine Service, Hospital la Fe, Valencia, Spain; Gutiérrez, A., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Gomollón, F., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Digestive System Service, Hospital Clínico Universitario, Zaragoza, Spain; Mendoza, J.L., Gastroenterology Service, Hospital Clínico San Carlos, Madrid, Spain; Garcia-Planella, E., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Barreiro-De Acosta, M., Gastroenterology Service, Hospital Clínico Universitario, Spain; Muñoz, F., Gastroenterology Service, Complejo Hospitalario de León, León, Spain; Vera, M., Gastroenterology Service, Hospital Universitario Puerta de Hierro, Madrid, Spain; Saro, C., Internal Medicine Service, Hospital de Cabueñes, Gijón, Spain; Esteve, M., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Gastroenterology Service, Hospital Universitari Mutua de Terrassa, Barcelona, Spain; Andreu, M., Department of Gastroenterology, Institut Hospital Del Mar d'Investigacions Mèdiques, Institute of Research Hospital Del Mar, Barcelona, Spain; Chaparro, M., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Gastroenterology Service, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain; Manyé, J., Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; Cabré, E., Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Center, National Institute of Bioinformatics, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; García-Montero, A.C., National DNA Bank Carlos III, University of Salamanca, Salamanca, Spain; Bertranpetit, J., Nacional Genotyping Centre, Universitat Pompeu Fabra, Barcelona, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, AB, United States; Myers, R.M., HudsonAlpha Institute for Biotechnology, Huntsville, AB, United States; Marsal, S., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Gisbert, J.P., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain, Gastroenterology Service, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain","Background Aims Crohn's disease is a highly heterogeneous inflammatory bowel disease comprising multiple clinical phenotypes. Genome-wide association studies (GWASs) have associated a large number of loci with disease risk but have not associated any specific genetic variants with clinical phenotypes. We performed a GWAS of clinical phenotypes in Crohn's disease. Methods We genotyped 576,818 single-nucleotide polymorphisms in a well-characterized cohort of 1090 Crohn's disease patients of European ancestry. We assessed their association with 17 phenotypes of Crohn's disease (based on disease location, disease behavior, disease course, age at onset, and extraintestinal manifestations). A total of 57 markers with strong associations to Crohn's disease phenotypes (P &lt; 2 × 10-4) were subsequently analyzed in an independent replication cohort of 1296 patients of European ancestry. Results We replicated the association of 4 loci with different Crohn's disease phenotypes. Variants in MAGI1, CLCA2, 2q24.1, and LY75 loci were associated with a complicated stricturing disease course (Pcombined = 2.01 × 10-8), disease location (Pcombined = 1.3 × 10-6), mild disease course (Pcombined = 5.94 × 10-7), and erythema nodosum (Pcombined = 2.27 × 10-6), respectively. Conclusions In a GWAS, we associated 4 loci with clinical phenotypes of Crohn's disease. These findings indicate a genetic basis for the clinical heterogeneity observed for this inflammatory bowel disease. © 2015 by the AGA Institute.","Genetic Risk; IBD; SNP Clinical Outcome","tumor necrosis factor alpha inhibitor; cell surface receptor; chloride channel; CLCA2 protein, human; DEC-205 receptor; lectin; leukocyte antigen; MAGI1 protein, human; nerve cell adhesion molecule; adult; Article; chromosome 2; clinical feature; cohort analysis; controlled study; Crohn disease; disease activity; disease course; disease severity; erythema nodosum; female; follow up; gene expression; gene frequency; gene identification; gene linkage disequilibrium; gene locus; genetic association; genetic risk; genetic variability; genotype; haplotype; human; intestine resection; major clinical study; male; onset age; phenotype; priority journal; quantitative trait; replication study; single nucleotide polymorphism; survival; case control study; Caucasian; Crohn disease; genetic association; genetic predisposition; genetics; middle aged; phenotype; Adult; Antigens, CD; Case-Control Studies; Cell Adhesion Molecules, Neuronal; Chloride Channels; Chromosomes, Human, Pair 2; Crohn Disease; European Continental Ancestry Group; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Lectins, C-Type; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Receptors, Cell Surface",,"Antigens, CD; Cell Adhesion Molecules, Neuronal; Chloride Channels; CLCA2 protein, human; DEC-205 receptor; Lectins, C-Type; MAGI1 protein, human; Receptors, Cell Surface",,,,,,,"Cosnes, J., Gower-Rousseau, C., Seksik, P., Epidemiology and natural history of inflammatory bowel diseases (2011) Gastroenterology, 140, pp. 1785-1794e4; Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease (2007) Nature, 448, pp. 427-434; Jostins, L., Ripke, S., Weersma, R.K., Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease (2012) Nature, 491, pp. 119-124; Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease (2011) Nature, 474, pp. 307-317; Satsangi, J., Silverberg, M.S., Vermeire, S., The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications (2006) Gut, 55, pp. 749-753; Bayless, T.M., Tokayer, A.Z., Polito, J.M., II, Crohn's disease: Concordance for site and clinical type in affected family members-potential hereditary influences (1996) Gastroenterology, 111, pp. 573-579; Colombel, J.F., Grandbastien, B., Gower-Rousseau, C., Clinical characteristics of Crohn's disease in 72 families (1996) Gastroenterology, 111, pp. 604-607; Durães, C., MacHado, J.C., Portela, F., Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II) (2012) Inflamm Bowel Dis, 19, pp. 230-239; Cummings, J.R.F., Cooney, R.M., Clarke, G., The genetics of NOD-like receptors in Crohn's disease (2010) Tissue Antigens, 76, pp. 48-56; Eglinton, T.W., Roberts, R., Pearson, J., Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort (2012) Am J Gastroenterol, 107, pp. 589-596; Jung, C., Colombel, J.-F., Lemann, M., Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms (2012) PLoS One, 7, p. e52223; Lee, J.C., Espéli, M., Anderson, C.A., Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway (2013) Cell, 155, pp. 57-69; Adler, J., Rangwalla, S.C., Dwamena, B.A., The prognostic power of the NOD2 genotype for complicated Crohn's disease: A meta-analysis (2011) Am J Gastroenterol, 106, pp. 699-712; Economou, M., Trikalinos, T.A., Loizou, K.T., Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis (2004) Am J Gastroenterol, 99, pp. 2393-2404; Julia, A., Domenech, E., Ricart, E., A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300 (2013) Gut, 62, pp. 1440-1445; Lennard-Jones, J.E., Classification of inflammatory bowel disease (1989) Scand J Gastroenterol Suppl, 170, pp. 2-6. , discussion 16-19; Chaparro, M., Panes, J., Garcia, V., Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose escalation in patients losing response (2011) J Clin Gastroenterol, 45, pp. 113-118; Price, A.L., Patterson, N.J., Plenge, R.M., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nat Genet, 38, pp. 904-909; Delaneau, O., Zagury, J.-F., Marchini, J., Improved whole-chromosome phasing for disease and population genetic studies (2013) Nat Methods, 10, pp. 5-6; Howie, B., Marchini, J., Stephens, M., Genotype imputation with thousands of genomes (2011) G3 (Bethesda), 1, pp. 457-470; An integrated map of genetic variation from 1,092 human genomes (2012) Nature, 491, pp. 56-65. , The 1000 Genomes Project Consortium; Purcell, S., Neale, B., Todd-Brown, K., PLINK: A tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81, pp. 559-575; McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Genome-wide association studies for complex traits: Consensus, uncertainty and challenges (2008) Nat Rev Genet, 9, pp. 356-369; Kellis, M., Wold, B., Snyder, M.P., Defining functional DNA elements in the human genome (2014) Proc Natl Acad Sci U S A, 111, pp. 6131-6138; Kabakchiev, B., Silverberg, M.S., Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine (2013) Gastroenterology, 144, pp. 1488-1496e3; Therneau, T.M., (2000) Modeling Survival Data: Extending the Cox Model, , Springer Rochester, MN; (2013) R: A Language and Environment for Statistical Computing, , R Core Team Vienna, Austria; Luna, A., Nicodemus, K.K., Snp.plotter: An R-based SNP/haplotype association and linkage disequilibrium plotting package (2007) Bioinformatics, 23, pp. 774-776; Koslowski, M.J., Kubler, I., Chamaillard, M., Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease (2009) PLoS One, 4, p. e4496; Dambacher, J., Staudinger, T., Seiderer, J., Macrophage migration inhibitory factor (MIF)-173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease (2007) Inflamm Bowel Dis, 13, pp. 71-82; Fowler, S.A., Ananthakrishnan, A.N., Gardet, A., SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease (2014) J Crohns Colitis, 8, pp. 845-851; Marcil, V., Sinnett, D., Seidman, E., Association between genetic variants in the HNF4A gene and childhood-onset Crohn's disease (2012) Genes Immun, 13, pp. 556-565; Zeller, T., Wild, P., Szymczak, S., Genetics and beyond-the transcriptome of human monocytes and disease susceptibility (2010) PLoS One, 5, p. e10693; Dobrosotskaya, I., Guy, R.K., James, G.L., MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains (1997) J Biol Chem, 272, pp. 31589-31597; Hirabayashi, S., Tajima, M., Yao, I., JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1 (2003) Mol Cell Biol, 23, pp. 4267-4282; Laura, R.P., Ross, S., Koeppen, H., MAGI-1: A widely expressed, alternatively spliced tight junction protein (2002) Exp Cell Res, 275, pp. 155-170; Shen, L., Weber, C.R., Raleigh, D.R., Tight junction pore and leak pathways: A dynamic duo (2011) Annu Rev Physiol, 73, pp. 283-309; Tajima, M., Hirabayashi, S., Yao, I., Roles of immunoglobulin-like loops of junctional cell adhesion molecule 4; Involvement in the subcellular localization and the cell adhesion (2003) Genes Cells, 8, pp. 759-768; Garrido-Urbani, S., Bradfield, P.F., Imhof, B.A., Tight junction dynamics: The role of junctional adhesion molecules (JAMs) (2014) Cell Tissue Res, 355, pp. 701-715; Henderson, P., Van Limbergen, J.E., Schwarze, J., Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease (2011) Inflamm Bowel Dis, 17, pp. 382-395; Marchiando, A.M., Graham, W.V., Turner, J.R., Epithelial barriers in homeostasis and disease (2010) Ann Rev Pathol, 5, pp. 119-144; Turner, J.R., Intestinal mucosal barrier function in health and disease (2009) Nat Rev Immunol, 9, pp. 799-809; Clayburgh, D.R., Shen, L., Turner, J.R., A porous defense: The leaky epithelial barrier in intestinal disease (2004) Lab Invest, 84, pp. 282-291; McGuckin, M.A., Eri, R., Simms, L.A., Intestinal barrier dysfunction in inflammatory bowel diseases (2009) Inflamm Bowel Dis, 15, pp. 100-113; Sawada, N., Tight junction-related human diseases (2013) Pathol Int, 63, pp. 1-12; Benjamin, J., Makharia, G.K., Ahuja, V., Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease (2008) World J Gastroenterol, 14, pp. 1399-1405; Gassler, N., Rohr, C., Schneider, A., Inflammatory bowel disease is associated with changes of enterocytic junctions (2001) Am J Physiol Gastrointest Liver Physiol, 281, pp. G216-G228; Peeters, M., Geypens, B., Claus, D., Clustering of increased small intestinal permeability in families with Crohn's disease (1997) Gastroenterology, 113, pp. 802-807; Luissint, A.-C., Nusrat, A., Parkos, C., JAM-related proteins in mucosal homeostasis and inflammation (2014) Semin Immunopathol, 36, pp. 211-226; Peterson, L.W., Artis, D., Intestinal epithelial cells: Regulators of barrier function and immune homeostasis (2014) Nat Rev Immunol, 14, pp. 141-153; Granlund, A., Flatberg, A., Ostvik, A.E., Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis (2013) PLoS One, 8, p. e56818; Haritunians, T., Taylor, K.D., Targan, S.R., Genetic predictors of medically refractory ulcerative colitis (2010) Inflamm Bowel Dis, 16, pp. 1830-1840; Jauregi-Miguel, A., Fernandez-Jimenez, N., Irastorza, I., Alteration of tight junction gene expression in Celiac disease (2014) J Pediatr Gastroenterol Nutr, 58, pp. 762-767; Norén, E., Almer, S., Söderman, J., Association between genetic markers related to tight junctions and inflammatory bowel disease (2014) 9th Congress of ECCO, p. P664. , European Crohn's and Colitis Organisation, Vienna, Austria; Kobayashi, A., Donaldson, D.S., Kanaya, T., Identification of novel genes selectively expressed in the follicle-associated epithelium from the meta-analysis of transcriptomics data from multiple mouse cell and tissue populations (2012) DNA Res, 19, pp. 407-422; Mabbott, N.A., Donaldson, D.S., Ohno, H., Microfold (M) cells: Important immunosurveillance posts in the intestinal epithelium (2013) Mucosal Immunol, 6, pp. 666-677; Bustin, S.A., Li, S.R., Dorudi, S., Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer (2001) DNA Cell Biol, 20, pp. 331-338; Suzuki, R., Miyamoto, S., Yasui, Y., Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate (2007) BMC Cancer, 7, p. 84; Schafer, P.H., Parton, A., Gandhi, A.K., Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis (2010) Br J Pharmacol, 159, pp. 842-855; Salari, P., Abdollahi, M., Phosphodiesterase inhibitors in inflammatory bowel disease (2012) Expert Opin Investig Drugs, 21, pp. 261-264; Shrimpton, R.E., Butler, M., Morel, A.S., CD205 (DEC-205): A recognition receptor for apoptotic and necrotic self (2009) Mol Immunol, 46, pp. 1229-1239; Inaba, K., Swiggard, W.J., Inaba, M., Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145: I. Expression on dendritic cells and other subsets of mouse leukocytes (1995) Cell Immunol, 163, pp. 148-156; Tel, J., Benitez-Ribas, D., Hoosemans, S., DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells (2011) Eur J Immunol, 41, pp. 1014-1023","Domènech, E.; Gastroenterology and Hepatology Department, Hospital Universitari Germans Trias i PujolSpain; email: edomenech.germanstrias@gencat.cat",,,"W.B. Saunders",,,,,00165085,,GASTA,"25557950","English","Gastroenterology",Article,"Final",,Scopus,2-s2.0-84925357305
"Hospital A., Goñi J.R., Orozco M., Gelpí J.L.","15831739300;7003678701;7102809158;35517522400;","Molecular dynamics simulations: Advances and applications",2015,"Advances and Applications in Bioinformatics and Chemistry","8","1",,"37","47",,104,"10.2147/AABC.S70333","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954211632&doi=10.2147%2fAABC.S70333&partnerID=40&md5=0fc5dc9da7fbfca2034d4ed5c1df48e6","Iinstitute for Research in Biomedicine, The Barcelona Institute of Science and Technology, University of Barcelona, Barcelona, Spain; Joint BSC-IiRB Research Program in Computational Biology, University of Barcelona, Barcelona, Spain; Barcelona Supercomputing Center, University of Barcelona, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Hospital, A., Iinstitute for Research in Biomedicine, The Barcelona Institute of Science and Technology, University of Barcelona, Barcelona, Spain; Goñi, J.R., Joint BSC-IiRB Research Program in Computational Biology, University of Barcelona, Barcelona, Spain, Barcelona Supercomputing Center, University of Barcelona, Barcelona, Spain; Orozco, M., Iinstitute for Research in Biomedicine, The Barcelona Institute of Science and Technology, University of Barcelona, Barcelona, Spain, Joint BSC-IiRB Research Program in Computational Biology, University of Barcelona, Barcelona, Spain, Barcelona Supercomputing Center, University of Barcelona, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Gelpí, J.L., Joint BSC-IiRB Research Program in Computational Biology, University of Barcelona, Barcelona, Spain, Barcelona Supercomputing Center, University of Barcelona, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Molecular dynamics simulations have evolved into a mature technique that can be used effectively to understand macromolecular structure-to-function relationships. Present simulation times are close to biologically relevant ones. Information gathered about the dynamic properties of macromolecules is rich enough to shift the usual paradigm of structural bioinformatics from studying single structures to analyze conformational ensembles. Here, we describe the foundations of molecular dynamics and the improvements made in the direction of getting such ensemble. Specific application of the technique to three main issues (allosteric regulation, docking, and structure refinement) is discussed. © 2015 Hospital et al.","Allostery; Conformational ensembles; Docking; Molecular dynamics; Refinement; Structure prediction",,,,,,,,,,"Berman, H.M., Battistuz, T., Bhat, T.N., The protein data bank (2002) Acta Crystallogr D Biol Cryst, 58, pp. 899-907; Flores, S., Echols, N., Milburn, D., The database of macromolecular motions: new features added at the decade mark (2006) Nucleic Acids Res, 34 (DATABASE ISSUE), pp. D296-D301; Bhabha, G., Biel, J.T., Fraser, J.S., Keep on moving: discovering and perturbing the conformational dynamics of enzymes (2015) Acc Chem Res, 48 (2), pp. 423-430; Cockrell, G.M., Kantrowitz, E.R., ViewMotions rainbow: a new method to illustrate molecular motions in proteins (2013) J Mol Graph Model, 40, pp. 48-53; Gerstein, M., Krebs, W., A database of macromolecular motions (1998) Nucleic Acids Res, 26 (18), pp. 4280-4290; Goh, C.S., Milburn, D., Gerstein, M., Conformational changes associated with protein-protein interactions (2004) Curr Opin Struct Biol, 14 (1), pp. 104-109; Kokkinidis, M., Glykos, N.M., Fadouloglou, V.E., Protein flexibility and enzymatic catalysis (2012) Adv Protein Chem Struct Biol, 87, pp. 181-218; Stevens, R.C., Lipscomb, W.N., Allosteric control of quaternary states in E. coli aspartate transcarbamylase (1990) Biochem Biophys Res Commun, 171 (3), pp. 1312-1318; Shinoda, T., Arai, K., Shigematsu-Iida, M., Distinct conformation-mediated functions of an active site loop in the catalytic reactions of NAD-dependent D-lactate dehydrogenase and formate dehydrogenase (2005) J Biol Chem, 280 (17), pp. 17068-17075; Karplus, M., Role of conformation transitions in adenylate kinase (2010) Proc Natl Acad Sci U S A, 107 (17), p. E71. , author reply E72; Kalko, S.G., Gelpi, J.L., Fita, I., Orozco, M., Theoretical study of the mechanisms of substrate recognition by catalase (2001) J Am Chem Soc, 123 (39), pp. 9665-9672; Jakopitsch, C., Droghetti, E., Schmuckenschlager, F., Furtmuller, P.G., Smulevich, G., Obinger, C., Role of the main access channel of catalase-peroxidase in catalysis (2005) J Biol Chem, 280 (51), pp. 42411-42422; Bidon-Chanal, A., Marti, M.A., Crespo, A., Ligand-induced dynamical regulation of NO conversion in Mycobacterium tuberculosis truncated hemoglobin-N (2006) Proteins, 64 (2), pp. 457-464; Hara, I., Ichise, N., Kojima, K., Relationship between the size of the bottleneck 15 A from iron in the main channel and the reactivity of catalase corresponding to the molecular size of substrates (2007) Biochemistry, 46 (1), pp. 11-22; Bidon-Chanal, A., Marti, M.A., Estrin, D.A., Luque, F.J., Dynamical regulation of ligand migration by a gate-opening molecular switch in truncated hemoglobin-N from Mycobacterium tuberculosis (2007) J Am Chem Soc, 129 (21), pp. 6782-6788; Guallar, V., Lu, C., Borrelli, K., Egawa, T., Yeh, S.R., Ligand migration in the truncated hemoglobin-II from Mycobacterium tuberculosis: the role of G8 tryptophan (2009) J Biol Chem, 284 (5), pp. 3106-3116; Daigle, R., Guertin, M., Lague, P., Structural characterization of the tunnels of Mycobacterium tuberculosis truncated hemoglobin N from molecular dynamics simulations (2009) Proteins, 75 (3), pp. 735-747; Ahalawat, N., Murarka, R.K., Conformational changes and allosteric communications in human serum albumin due to ligand binding (2015) J Biomol Struct Dyn, pp. 1-13; Barbany, M., Meyer, T., Hospital, A., Molecular dynamics study of naturally existing cavity couplings in proteins (2015) PLoS One, 10 (3); Bowman, G.R., Bolin, E.R., Hart, K.M., Maguire, B.C., Marqusee, S., Discovery of multiple hidden allosteric sites by combining Markov state models and experiments (2015) Proc Natl Acad Sci U S A, 112 (9), pp. 2734-2739; Bouvier, B., Zakrzewska, K., Lavery, R., Protein-DNA recognition triggered by a DNA conformational switch (2011) Angew Chem Int Ed Engl, 50 (29), pp. 6516-6518; Zakrzewska, K., Lavery, R., Towards a molecular view of transcriptional control (2012) Curr Opin Struct Biol, 22 (2), pp. 160-167; Perez, A., Noy, A., Lankas, F., Luque, F.J., Orozco, M., The relative flexibility of B-DNA and A-RNA duplexes: database analysis (2004) Nucleic Acids Res, 32 (20), pp. 6144-6151; Leo-Macias, A., Lopez-Romero, P., Lupyan, D., Zerbino, D., Ortiz, A.R., An analysis of core deformations in protein superfamilies (2005) Biophys J, 88 (2), pp. 1291-1299; Velazquez-Muriel, J.A., Rueda, M., Cuesta, I., Pascual-Montano, A., Orozco, M., Carazo, J.M., Comparison of molecular dynamics and superfamily spaces of protein domain deformation (2009) BMC Struct Biol, 9, p. 6; Micheletti, C., Comparing proteins by their internal dynamics: exploring structure-function relationships beyond static structural alignments (2013) Phys Life Rev, 10 (1), pp. 1-26; Baxa, M.C., Haddadian, E.J., Jumper, J.M., Freed, K.F., Sosnick, T.R., Loss of conformational entropy in protein folding calculated using realistic ensembles and its implications for NMR-based calculations (2014) Proc Natl Acad Sci U S A, 111 (43), pp. 15396-15401; Noe, F., Schuette, C., Vanden-Eijnden, E., Reich, L., Weikl, T.R., Constructing the equilibrium ensemble of folding pathways from short off-equilibrium simulations (2009) Proc Natl Acad Sci U S A, 106 (45), pp. 19011-19016; Naganathan, A.N., Orozco, M., The native ensemble and folding of a protein molten-globule: functional consequence of downhill folding (2011) J Am Chem Soc, 133 (31), pp. 12154-12161; Candotti, M., Esteban-Martin, S., Orozco, M., Atomistic insights on protein-urea structural organization from MD simulations of a chemically denatured protein ensemble determined by NMR (2012) FEBS J, 279, pp. 531-531; Bryn Fenwick, R., Esteban-Martin, S., Salvatella, X., Understanding biomolecular motion, recognition, and allostery by use of conformational ensembles (2011) Eur Biophys J, 40 (12), pp. 1339-1355; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of folded proteins (1977) Nature, 267 (5612), pp. 585-590; Warshel, A., Levitt, M., Theoretical studies of enzymic reactions-dielectric, electrostatic and steric stabilization of carbonium-ion in reaction of lysozyme (1976) J Mol Biol, 103 (2), pp. 227-249; Roccatano, D., Barthel, A., Zacharias, M., Structural flexibility of the nucleosome core particle at atomic resolution studied by molecular dynamics simulation (2007) Biopolymers, 85 (5-6), pp. 407-421; Sharma, S., Ding, F., Dokholyan, N.V., Multiscale modeling of nucleosome dynamics (2007) Biophys J, 92 (5), pp. 1457-1470; Tinoco, I., Jr., Wen, J.D., Simulation and analysis of single-ribosome translation (2009) Phys Biol, 6 (2); Brandman, R., Brandman, Y., Pande, V.S., A-site residues move independently from P-site residues in all-atom molecular dynamics simulations of the 70S bacterial ribosome (2012) PLoS One, 7 (1); Orozco, M., Orellana, L., Hospital, A., Coarse-grained representation of protein flexibility. Foundations, successes, and shortcomings (2011) Advances in Proteins Chemistry and Structural Biology, 85, pp. 183-215. , Christov C, editor Computational Chemistry Methods in Structural Biology. Waltham, MA: Academic Press; Lazaridis, T., Karplus, M., Effective energy function for proteins in solution (1999) Proteins, 35 (2), pp. 133-152; Roux, B., Simonson, T., Implicit solvent models (1999) Biophys Chem, 78 (1-2), pp. 1-20; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem Rev, 100 (11), pp. 4187-4226; Bashford, D., Case, D.A., Generalized born models of macromolecular solvation effects (2000) Ann Rev Phys Chem, 51, pp. 129-152; Haberthuer, U., Caflisch, A., FACTS: fast analytical continuum treatment of solvation (2008) J Comput Chem, 29 (5), pp. 701-715; Luchko, T., Gusarov, S., Roe, D.R., Three-dimensional molecular theory of solvation coupled with molecular dynamics in Amber (2010) J Chem Theory Comput, 6 (3), pp. 607-624; Vorobjev, Y.N., Advances in implicit models of water solvent to compute conformational free energy and molecular dynamics of proteins at constant pH (2011) Adv Protein Chem Struct Biol, 85, pp. 281-322; Kleinjung, J., Fraternali, F., Design and application of implicit solvent models in biomolecular simulations (2014) Curr Opin Struct Biol, 25, pp. 126-134; Anandakrishnan, R., Drozdetski, A., Walker, R.C., Onufriev, A.V., Speed of conformational change: comparing explicit and implicit solvent molecular dynamics simulations (2015) Biophys J, 108 (5), pp. 1153-1164; Hermans, J., Berendsen, H.J.C., Vangunsteren, W.F., Postma, J.P.M., A consistent empirical potential for water-protein interactions (1984) Biopolymers, 23 (8), pp. 1513-1518; Mackerell, A.D., Wiorkiewiczkuczera, J., Karplus, M., An all-atom empirical energy function for the simulation of nucleic-acids (1995) J Am Chem Soc, 117 (48), pp. 11946-11975; Ott, K.H., Meyer, B., Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations (1996) J Comput Chem, 17 (8), pp. 1068-1084; MacKerell, A.D., Bashford, D., Bellott, M., All-atom empirical potential for molecular modeling and dynamics studies of proteins (1998) J Phys Chem B, 102 (18), pp. 3586-3616; Cornell, W.D., Cieplak, P., Bayly, C.I., A 2nd generation force-field for the simulation of proteins, nucleic-acids, and organic-molecules (1995) J Am Chem Soc, 117 (19), pp. 5179-5197; Kaminski, G.A., Friesner, R.A., Tirado-Rives, J., Jorgensen, W.L., Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides (2001) J Phys Chem B, 105 (28), pp. 6474-6487; Rueda, M., Ferrer-Costa, C., Meyer, T., A consensus view of protein dynamics (2007) Proc Natl Acad Sci U S A, 104 (3), pp. 796-801; Perez, A., Lankas, F., Luque, F.J., Orozco, M., Towards a molecular dynamics consensus view of B-DNA flexibility (2008) Nucleic Acids Res, 36 (7), pp. 2379-2394; Case, D.A., Darden, T.A., Cheatham, T.E.I., (2012) AMBER 12, , San Francisco, CA: University of California; Brooks, B.R., Brooks, C.L., III, Mackerell, A.D., Jr., CHARMM: the biomolecular simulation program (2009) J Comput Chem, 30 (10), pp. 1545-1614; Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E., GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation (2008) J Chem Theory Comput, 4 (3), pp. 435-447; Nelson, M.T., Humphrey, W., Gursoy, A., NAMD: a parallel, object oriented molecular dynamics program (1996) Int J Supercomput Appl High Perform Comput, 10 (4), pp. 251-268; Larsson, P., Hess, B., Lindahl, E., Algorithm improvements for molecular dynamics simulations (2011) Wiley Interdiscip Rev Comput Mol Sci, 1 (1), pp. 93-108; Harvey, M.J., Giupponi, G., De Fabritiis, G., ACEMD: accelerating biomolecular dynamics in the microsecond time scale (2009) J Chem Theory Comput, 5 (6), pp. 1632-1639; Pan, A.C., Roux, B., Building Markov state models along pathways to determine free energies and rates of transitions (2008) J Chem Phys, 129 (6); Bowman, G.R., Huang, X., Pande, V.S., Using generalized ensemble simulations and Markov state models to identify conformational states (2009) Methods, 49 (2), pp. 197-201; Chodera, J.D., Noe, F., Markov state models of biomolecular conformational dynamics (2014) Curr Opin Struct Biol, 25, pp. 135-144; Da, L.T., Sheong, F.K., Silva, D.A., Huang, X., Application of Markov state models to simulate long timescale dynamics of biological macromolecules (2014) Adv Exp Med Biol, 805, pp. 29-66; Voelz, V.A., Bowman, G.R., Beauchamp, K., Pande, V.S., Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39) (2010) J Am Chem Soc, 132 (5), pp. 1526-1528; Buch, I., Giorgino, T., De Fabritiis, G., Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations (2011) Proc Natl Acad Sci U S A, 108 (25), pp. 10184-10189; Micheletti, C., Laio, A., Parrinello, M., Reconstructing the density of states by history-dependent metadynamics (2004) Phys Rev Lett, 92 (17); Laio, A., Rodriguez-Fortea, A., Gervasio, F.L., Ceccarelli, M., Parrinello, M., Assessing the accuracy of metadynamics (2005) J Phys Chem B, 109 (14), pp. 6714-6721; Raiteri, P., Laio, A., Gervasio, F.L., Micheletti, C., Parrinello, M., Efficient reconstruction of complex free energy landscapes by multiple walkers metadynamics (2006) J Phys Chem B, 110 (8), pp. 3533-3539; Barducci, A., Bonomi, M., Parrinello, M., Metadynamics (2011) Wiley Interdiscip Rev Comput Mol Sci, 1 (5), pp. 826-843; Dickson, A., Brooks, C.L., WExplore: hierarchical exploration of high-dimensional spaces using the weighted ensemble algorithm (2014) J Phys Chem B, 118 (13), pp. 3532-3542; Abdul-Wahid, B., Feng, H., Rajan, D., AWE-WQ: fast-forwarding molecular dynamics using the accelerated weighted ensemble (2014) J Chem Inf Model, 54 (10), pp. 3033-3043; Doshi, U., Hamelberg, D., Towards fast, rigorous and efficient conformational sampling of biomolecules: advances in accelerated molecular dynamics (2015) Biochim Biophys Acta, 1850 (5), pp. 878-888; Miao, Y., Feixas, F., Eun, C., McCammon, J.A., Accelerated molecular dynamics simulations of protein folding (2015) J Comput Chem, 36 (20), pp. 1536-1549; Nymeyer, H., Gnanakaran, S., Garcia, A.E., Atomic simulations of protein folding, using the replica exchange algorithm (2004) Methods Enzymol, 383, pp. 119-149; Kubitzki, M.B., de Groot, B.L., Molecular dynamics simulations using temperature-enhanced essential dynamics replica exchange (2007) Biophys J, 92 (12), pp. 4262-4270; Meng, Y., Dashti, D.S., Roitberg, A.E., Computing alchemical free energy differences with Hamiltonian replica exchange molecular dynamics (H-REMD) simulations (2011) J Chem Theory Comput, 7 (9), pp. 2721-2727; Burgi, R., Kollman, P.A., Van Gunsteren, W.F., Simulating proteins at constant pH: an approach combining molecular dynamics and Monte Carlo simulation (2002) Proteins, 47 (4), pp. 469-480; Stern, H.A., Molecular simulation with variable protonation states at constant pH (2007) J Chem Phys, 126 (16); Baptista, A.M., Martel, P.J., Petersen, S.B., Simulation of protein conformational freedom as a function of pH: constant-pH molecular dynamics using implicit titration (1997) Proteins, 27 (4), pp. 523-544; Goh, G.B., Hulbert, B.S., Zhou, H., Brooks, C.L., Constant pH molecular dynamics of proteins in explicit solvent with proton tautomerism (2014) Proteins, 82 (7), pp. 1319-1331; Itoh, S.G., Damjanovic, A., Brooks, B.R., pH replica-exchange method based on discrete protonation states (2011) Proteins, 79 (12), pp. 3420-3436; Meyer, T., D'Abramo, M., Hospital, A., MoDEL (molecular dynamics extended library): a database of atomistic molecular dynamics trajectories (2010) Structure, 18 (11), pp. 1399-1409; Jo, S., Kim, T., Iyer, V.G., Im, W., CHARMM-GUI: a web-based graphical user interface for CHARMM (2008) J Comput Chem, 29 (11), pp. 1859-1865; Miller, B.T., Singh, R.P., Klauda, J.B., Hodoscek, M., Brooks, B.R., Woodcock, H.L., III, CHARMMing: a new, flexible web portal for CHARMM (2008) J Chem Inf Model, 48 (9), pp. 1920-1929; Kota, P., GUIMACS-a Java based front end for GROMACS (2007) In Silico Biol, 7 (1), pp. 95-99; Sellis, D., Vlachakis, D., Vlassi, M., Gromita: a fully integrated graphical user interface to gromacs 4 (2009) Bioinform Biol Insights, 3, pp. 99-102; Roopra, S., Knapp, B., Omasits, U., Schreiner, W., jSimMacs for GROMACS: a Java application for advanced molecular dynamics simulations with remote access capability (2009) J Chem Inf Model, 49 (10), pp. 2412-2417; Humphrey, W., Dalke, A., Schulten, K., VMD: visual molecular dynamics (1996) J Mol Graph Model, 14 (1), pp. 33-38; Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., Gelpi, J.L., MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations (2012) Bioinformatics, 28 (9), pp. 1278-1279; Monod, J., Changeux, J.P., Jacob, F., Allosteric proteins and cellular control systems (1963) J Mol Biol, 6 (4), pp. 306-329; Monod, J., Wyman, J., Changeux, J.P., On nature of allosteric transitions-a plausible model (1965) J Mol Biol, 12 (1), pp. 88-118; Koshland, D.E., Nemethy, G., Filmer, D., Comparison of experimental binding data and theoretical models in proteins containing subunits (1966) Biochemistry, 5 (1), pp. 365-385; Henzler-Wildman, K.A., Thai, V., Lei, M., Intrinsic motions along an enzymatic reaction trajectory (2007) Nature, 450 (7171), pp. 838-844; Sfriso, P., Emperador, A., Orellana, L., Hospital, A., Lluis Gelpi, J., Orozco, M., Finding conformational transition pathways from discrete molecular dynamics simulations (2012) J Chem Theory Comput, 8 (11), pp. 4707-4718; Sfriso, P., Hospital, A., Emperador, A., Orozco, M., Exploration of conformational transition pathways from coarse-grained simulations (2013) Bioinformatics, 29 (16), pp. 1980-1986; Kim, M.K., Jernigan, R.L., Chirikjian, G.S., Efficient generation of feasible pathways for protein conformational transitions (2002) Biophys J, 83 (3), pp. 1620-1630; Bahar, I., Rader, A.J., Coarse-grained normal mode analysis in structural biology (2005) Curr Opin Struct Biol, 15 (5), pp. 586-592; Orellana, L., Rueda, M., Ferrer-Costa, C., Lopez-Blanco, J.R., Chacon, P., Orozco, M., Approaching elastic network models to molecular dynamics flexibility (2010) J Chem Theory Comput, 6 (9), pp. 2910-2923; Orellana, L., Orozco, M., Understanding protein dynamics with coarse-grained models: from structures to disease (2012) FEBS J, 279, pp. 528-528; Schlitter, J., Engels, M., Kruger, P., Jacoby, E., Wollmer, A., Targeted molecular-dynamics simulation of conformational change-application to the T-R transition in insulin (1993) Mol Simul, 10 (2-6), pp. 291-308; Kruger, P., Verheyden, S., Declerck, P.J., Engelborghs, Y., Extending the capabilities of targeted molecular dynamics: simulation of a large conformational transition in plasminogen activator inhibitor 1 (2001) Protein Sci, 10 (4), pp. 798-808; Perdih, A., Kotnik, M., Hodoscek, M., Solmajer, T., Targeted molecular dynamics simulation studies of binding and conformational changes in E. coli MurD (2007) Proteins, 68 (1), pp. 243-254; Deganutti, G., Cuzzolin, A., Ciancetta, A., Moro, S., Understanding allosteric interactions in G protein-coupled receptors using supervised molecular dynamics: a prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 (2015) Bioorg Med Chem, 23 (14), pp. 4065-4071; Arkhipov, A., Shan, Y., Das, R., Architecture and membrane interactions of the EGF receptor (2013) Cell, 152 (3), pp. 557-569; Klepeis, J.L., Lindorff-Larsen, K., Dror, R.O., Shaw, D.E., Long-timescale molecular dynamics simulations of protein structure and function (2009) Curr Opin Struct Biol, 19 (2), pp. 120-127; Anderson, J.S., Mustafi, S.M., Hernández, G., LeMaster, D.M., Statistical allosteric coupling to the active site indole ring flip equilibria in the FK506-binding domain (2014) Biophys Chem, 192, pp. 41-48; Boczek, E.E., Reefschläger, L.G., Dehling, M., Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90 (2015) Proc Natl Acad Sci U S A, 112 (25), pp. E3189-E3198; Wigley, D.B., Muirhead, H., Gamblin, S.J., Holbrook, J.J., Crystallization of a ternary complex of lactate-dehydrogenase from Bacillus stearothermophilus (1988) J Mol Biol, 204 (4), pp. 1041-1043; Wigley, D.B., Gamblin, S.J., Turkenburg, J.P., Structure of a ternary complex of an allosteric lactate-dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution (1992) J Mol Biol, 223 (1), pp. 317-335; Cameron, A.D., Roper, D.I., Moreton, K.M., Muirhead, H., Holbrook, J.J., Wigley, D.B., Allosteric activation in Bacillus stearothermophilus lactate-dehydrogenase investigated by an x-ray crystallographic analysis of a mutant designed to prevent tetramerization of the enzyme (1994) J Mol Biol, 238 (4), pp. 615-625; Jackson, R.M., Gelpi, J.L., Cortes, A., Construction of a stable dimer of Bacillus stearothermophilus lactate dehydrogenase (1992) Biochemistry, 31 (35), pp. 8307-8314; Esteban-Martin, S., Bryn Fenwick, R., Salvatella, X., Refinement of ensembles describing unstructured proteins using NMR residual dipolar couplings (2010) J Am Chem Soc, 132 (13), pp. 4626-4632; Koshland, D.E., Application of a theory of enzyme specificity to protein synthesis (1958) Proc Natl Acad Sci U S A, 44 (2), pp. 98-104; Hawkins, P.C.D., Nicholls, A., Conformer generation with OMEGA: learning from the data set and the analysis of failures (2012) J Chem Inf Model, 52 (11), pp. 2919-2936; Ishikawa, Y., A script for automated 3-dimentional structure generation and conformer search from 2-dimentional chemical drawing (2013) Bioinformation, 9 (19), pp. 988-992; Klett, J., Cortes-Cabrera, A., Gil-Redondo, R., Gago, F., Morreale, A., ALFA: Automatic ligand flexibility assignment (2014) J Chem Inf Model, 54 (1), pp. 314-323; Friesner, R.A., Banks, J.L., Murphy, R.B., Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy (2004) J Med Chem, 47 (7), pp. 1739-1749; Nabuurs, S.B., Wagener, M., De Vlieg, J., A flexible approach to induced fit docking (2007) J Med Chem, 50 (26), pp. 6507-6518; Borrelli, K.W., Vitalis, A., Alcantara, R., Guallar, V., PELE: protein energy landscape exploration. A novel Monte Carlo based technique (2005) J Chem Theory Comput, 1 (6), pp. 1304-1311; Emperador, A., Solernou, A., Sfriso, P., Efficient relaxation of protein-protein interfaces by discrete molecular dynamics simulations (2013) J Chem Theory Comput, 9 (2), pp. 1222-1229; Csermely, P., Palotai, R., Nussinov, R., Induced fit, conformational selection and independent dynamic segments: an extended view of binding events (2010) Trends Biochem Sci, 35 (10), pp. 539-546; Tobi, D., Bahar, I., Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state (2005) Proc Natl Acad Sci U S A, 102 (52), pp. 18908-18913; Fukunishi, Y., Structural ensemble in computational drug screening (2010) Exp Opin Drug Metab Toxicol, 6 (7), pp. 835-849; Ivetac, A., McCammon, J.A., A molecular dynamics ensemble-based approach for the mapping of druggable binding sites (2011) Methods Mol Biol, 819, pp. 3-12; Okamoto, Y., Kokubo, H., Tanaka, T., Ligand docking simulations by generalized-ensemble algorithms (2013) Dynamics of Proteins and Nucleic Acids, 92, pp. 63-91. , KarabenchevaChristova T, editor, Waltham, MA: Academic Press; Fenollosa, C., Oton, M., Andrio, P., Cortes, J., Orozco, M., Goni, J.R., SEABED: Small molEcule activity scanner weB servicE baseD (2015) Bioinformatics, 31 (5), pp. 773-775; Maria Novoa, E., Ribas de Pouplana, L., Barril, X., Orozco, M., Ensemble docking from homology models (2010) J Chem Theory Comput, 6 (8), pp. 2547-2557; Osguthorpe, D.J., Sherman, W., Hagler, A.T., Exploring protein flexibility: incorporating structural ensembles from crystal structures and simulation into virtual screening protocols (2012) J Phys Chem B, 116 (23), pp. 6952-6959; Chaudhuri, R., Carrillo, O., Laughton, C.A., Orozco, M., Application of drug-perturbed essential dynamics/molecular dynamics (ED/MD) to virtual screening and rational drug design (2012) J Chem Theory Comput, 8 (7), pp. 2204-2214; Dorn, M., Silva, M.B.E., Buriol, L.S., Lamb, L.C., Three-dimensional protein structure prediction: methods and computational strategies (2014) Comput Biol Chem, 53, pp. 251-276; Lindorff-Larsen, K., Piana, S., Dror, R.O., Shaw, D.E., How fast-folding proteins fold (2011) Science, 334 (6055), pp. 517-520; Piana, S., Lindorff-Larsen, K., Shaw, D.E., Protein folding kinetics and thermodynamics from atomistic simulation (2012) Proc Natl Acad Sci U S A, 109 (44), pp. 17845-17850; Piana, S., Lindorff-Larsen, K., Shaw, D.E., Atomic-level description of ubiquitin folding (2013) Proc Natl Acad Sci U S A, 110 (15), pp. 5915-5920; Bonneau, R., Baker, D., Ab initio protein structure prediction: progress and prospects (2001) Ann Rev Biophys Biomol Struct, 30, pp. 173-189; Lance, B.K., Deane, C.M., Wood, G.R., Exploring the potential of template-based modelling (2010) Bioinformatics, 26 (15), pp. 1849-1856; Joo, K., Lee, J., Lee, S., Seo, J.H., Lee, S.J., Lee, J., High accuracy template based modeling by global optimization (2007) Proteins, 69, pp. 83-89; Moult, J., A decade of CASP: progress, bottlenecks and prognosis in protein structure prediction (2005) Curr Opin Struct Biol, 15 (3), pp. 285-289; Roy, A., Kucukural, A., Zhang, Y., I-TASSER: a unified platform for automated protein structure and function prediction (2010) Nat Protoc, 5 (4), pp. 725-738; Zhang, Y., Protein structure prediction: when is it useful? (2009) Curr Opin Struct Biol, 19 (2), pp. 145-155; Ginalski, K., Elofsson, A., Fischer, D., Rychlewski, L., 3D-jury: a simple approach to improve protein structure predictions (2003) Bioinformatics, 19 (8), pp. 1015-1018; Misura, K.M.S., Baker, D., Progress and challenges in high-resolution refinement of protein structure models (2005) Proteins, 59 (1), pp. 15-29; Sali, A., Blundell, T.L., Comparative protein modeling by satisfaction of spatial restraints (1993) J Mol Biol, 234 (3), pp. 779-815; Raval, A., Piana, S., Eastwood, M.P., Dror, R.O., Shaw, D.E., Refinement of protein structure homology models via long, all-atom molecular dynamics simulations (2012) Proteins, 80 (8), pp. 2071-2079; Mirjalili, V., Feig, M., Protein structure refinement through structure selection and averaging from molecular dynamics ensembles (2013) J Chem Theory Comput, 9 (2), pp. 1294-1303; Chen, J., Brooks, C.L., III, Can molecular dynamics simulations provide high-resolution refinement of protein structure? (2007) Proteins, 67 (4), pp. 922-930; Pronk, S., Pall, S., Schulz, R., GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit (2013) Bioinformatics, 29 (7), pp. 845-854","Gelpí, J.L.; Department of Biochemistry and Molecular Biology, University of Barcelona, Faculty of Biology, Diagonal 643, Spain; email: gelpi@ub.edu",,,"Dove Medical Press Ltd",,,,,11786949,,,,"English","Adv. Appl. Bioinfo. Chem.",Review,"Final",Open Access,Scopus,2-s2.0-84954211632
"Julià A., Domènech E., Chaparro M., García-Sánchez V., Gomollón F., Panés J., Mañosa M., Barreiro-De Acosta M., Gutiérrez A., Garcia-Planella E., Aguas M., Muñoz F., Esteve M., Mendoza J.L., Vera M., Márquez L., Tortosa R., López-Lasanta M., Alonso A., Gelpí J.L., García-Montero A.C., Bertranpetit J., Absher D., Myers R.M., Gisbert J.P., Marsal S.","57210878792;55403162200;24436876600;23467027100;36854127900;55857704800;8615397500;16240700200;35073883500;6507483158;14422041700;7103206318;7006785161;7102491741;55347520400;9245682500;55933194400;23035265100;36150353900;35517522400;6603714021;7005566413;57198406019;7403700738;56240616000;6603356384;","A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis",2014,"Human molecular genetics","23","25",,"6927","6934",,21,"10.1093/hmg/ddu398","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919428213&doi=10.1093%2fhmg%2fddu398&partnerID=40&md5=015e5d962d94cc59ef05eda79d16fab8","Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain","Julià, A., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Domènech, E., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Chaparro, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; García-Sánchez, V., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gomollón, F., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Panés, J., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Mañosa, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Barreiro-De Acosta, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gutiérrez, A., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Garcia-Planella, E., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Aguas, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Muñoz, F., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Esteve, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Mendoza, J.L., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Vera, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Márquez, L., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Tortosa, R., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; López-Lasanta, M., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Alonso, A., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gelpí, J.L., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Bertranpetit, J., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Absher, D., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Myers, R.M., Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Gisbert, J.P., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Marsal, S., Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain","The genetic analysis of ulcerative colitis (UC) has provided new insights into the etiology of this prevalent inflammatory bowel disease. However, most of the heritability of UC (>70%) has still not been characterized. To identify new risk loci for UC we have performed the first genome-wide association study (GWAS) in a Southern European population and undertaken a meta-analysis study combining the newly genotyped 825 UC patients and 1525 healthy controls from Spain with the six previously published GWAS comprising 6687 cases and 19 718 controls from Northern-European ancestry. We identified a novel locus with genome-wide significance at 6q22.1 [rs2858829, P = 8.97 × 10(-9), odds ratio (OR) (95% confidence interval, CI] = 1.12 (1.08-1.16)] that was validated with genotype data from a replication cohort of the same Southern European ancestry consisting in 1073 cases and 1279 controls [combined P = 7.59 × 10(-10), OR (95% CI) = 1.12 (1.08-1.16)]. Furthermore, we confirmed the association of 33 reported associations with UC and we nominally validated the GWAS results of nine new risk loci (P < 0.05, same direction of effect). SNP rs2858829 lies in an intergenic region and is a strong cis-eQTL for FAM26F gene, a gene that is shown to be selectively upregulated in UC colonic mucosa with active inflammation. Our results provide new insight into the genetic risk background of UC, confirming that there is a genetic risk component that differentiates from Crohn's Disease, the other major form of inflammatory bowel disease. © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.",,"FAM26F protein, human; membrane protein; spacer DNA; adult; case control study; chromosome 6; female; gene locus; genetic association; genetic predisposition; genetics; genotype; human; male; meta analysis; middle aged; pathology; risk; single nucleotide polymorphism; ulcerative colitis; Adult; Case-Control Studies; Chromosomes, Human, Pair 6; Colitis, Ulcerative; DNA, Intergenic; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Male; Membrane Glycoproteins; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide",,"DNA, Intergenic; FAM26F protein, human; Membrane Glycoproteins",,,"Barcelona Supercomputing Center

Instituto Nacional de Perinatología

IPT-010000-2010-36, PSE-010000-2006-6","1Rheumatology Research Group, Vall d’Hebron Hospital Research Institute, Barcelona, Spain, 2Gastroenterology and Hepatology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 3Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 4Gastroenterology Service, Hospital Universitario de la Princesa and IP, Madrid, Spain, 5Digestive System Service, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain, 6Digestive System Service, Hospital Clínico Universitario, Zaragoza, Spain, 7Gastroenterology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain, 8Gastroenterology Service, Hospital Clínico Universitario, Santiago de Compostela, Spain, 9Gastroenterology Service, Hospital General de Alicante, Alicante, Spain, 10Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 11Digestive Medicine, University and Polytechnic La Fe Hospital, Valencia, Spain, 12Gastroenterology Service, Complejo Hospitalario de León, León, Spain, 13Gastroenterology Service, Hospital Universitari Mutua de Terrassa, Barcelona, Spain, 14Gastroenterology Service, Hospital Clínico San Carlos, Madrid, Spain, 15Gastroenterology Service, Hospital Universitario Puerta de Hierro, Madrid, Spain, 16Department of Gastroenterology, IMIM. (Hospital del Mar Medical Research Institute), Pompeu Fabra University, Barcelona, Spain, 17Life Sciences, Barcelona Supercomputing Centre, National Institute of Bioinformatics, Barcelona, Spain, 18Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain, 19Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain, 20Nacional Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain and 21HudsonAlpha Institute for Biotechnology, Alabama, USA","The authors would like to acknowledge the use of the published results from the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) meta-analysis (results available at: http://www.ibdgenetics.org/). We thank Genoma España Foundation, the Barcelona Supercomputing Centre (BSC), Instituto Nacional de Bioinformática (INB), the Centro Nacional de Gen-otipado (CeGEN), the Banco Nacional de ADN (USAL) and the Hudson Alpha Institute for Biotechnology for their support.","This study was supported by of the Ministry of Economy and Competitiveness, Spain (grant numbers PSE-010000-2006-6, IPT-010000-2010-36).",,,,,,,,,,14602083,,,"25082827","English","Hum. Mol. Genet.",Article,"Final",Open Access,Scopus,2-s2.0-84919428213
"Moncunill V., Gonzalez S., Beà S., Andrieux L.O., Salaverria I., Royo C., Martinez L., Puiggròs M., Segura-Wang M., Stütz A.M., Navarro A., Royo R., Gelpí J.L., Gut I.G., López-Otín C., Orozco M., Korbel J.O., Campo E., Puente X.S., Torrents D.","56602763700;56720064800;6701673488;8579829200;6505867168;35332784800;57197030926;14625731700;36239584100;7007031948;7202496222;24176373200;35517522400;56524174800;7102600806;7102809158;6602985468;7103168343;6701552499;6603452371;","Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads",2014,"Nature Biotechnology","32","11",,"1106","1112",,35,"10.1038/nbt.3027","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84936754552&doi=10.1038%2fnbt.3027&partnerID=40&md5=456d7279dd6c520e3891e204d50b27d7","Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; European Molecular Biology Laboratory, Genome Biology Research Unit, Heidelberg, Germany; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Centro Nacional de Analisis Genomico (CNAG), Barcelona, Spain; Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo-IUOPA, Oviedo, Spain; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain","Moncunill, V., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; Gonzalez, S., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; Beà, S., Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Andrieux, L.O., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; Salaverria, I., Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Royo, C., Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Martinez, L., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain; Puiggròs, M., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; Segura-Wang, M., European Molecular Biology Laboratory, Genome Biology Research Unit, Heidelberg, Germany; Stütz, A.M., European Molecular Biology Laboratory, Genome Biology Research Unit, Heidelberg, Germany; Navarro, A., Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Royo, R., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; Gelpí, J.L., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Gut, I.G., Centro Nacional de Analisis Genomico (CNAG), Barcelona, Spain; López-Otín, C., Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo-IUOPA, Oviedo, Spain; Orozco, M., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Korbel, J.O., European Molecular Biology Laboratory, Genome Biology Research Unit, Heidelberg, Germany; Campo, E., Department of Pathology, Hematopathology Unit, Hospital Clinic, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain; Puente, X.S., Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo-IUOPA, Oviedo, Spain; Torrents, D., Joint IRB-BSC Program in Computational Biology, Barcelona Supercomputing Center, Barcelona, Spain, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain","The development of high-throughput sequencing technologies has advanced our understanding of cancer. However, characterizing somatic structural variants in tumor genomes is still challenging because current strategies depend on the initial alignment of reads to a reference genome. Here, we describe SMUFIN (somatic mutation finder), a single program that directly compares sequence reads from normal and tumor genomes to accurately identify and characterize a range of somatic sequence variation, from single-nucleotide variants (SNV) to large structural variants at base pair resolution. Performance tests on modeled tumor genomes showed average sensitivity of 92% and 74% for SNVs and structural variants, with specificities of 95% and 91%, respectively. Analyses of aggressive forms of solid and hematological tumors revealed that SMUFIN identifies breakpoints associated with chromothripsis and chromoplexy with high specificity. SMUFIN provides an integrated solution for the accurate, fast and comprehensive characterization of somatic sequence variation in cancer. © 2014 Nature America, Inc. All rights reserved.",,"Diseases; Tumors; Average sensitivities; High-throughput sequencing; Initial alignment; Integrated solutions; Performance tests; Sequence variations; Single nucleotides; Structural variations; Genes; Article; cancer genetics; controlled study; gene sequence; gene structure; genetic algorithm; genetic variability; human; mantle cell lymphoma; medulloblastoma; priority journal; single nucleotide polymorphism; somatic mutation; somatic mutation finder; chromosomal mapping; genetic variation; genetics; high throughput sequencing; human genome; mutation; neoplasm; nucleotide; Chromosome Mapping; Genetic Variation; Genome, Human; High-Throughput Nucleotide Sequencing; Humans; Mutation; Neoplasms; Nucleotides; Polymorphism, Single Nucleotide",,"Nucleotides",,,"Secretaría de Estado de Investigacion, Desarrollo e Innovacion, I+D+i

Ministerio de Economía y Competitividad

Ministerio de Economía y Competitividad

Bioinformatics Institute

Instituto de Salud Carlos III: RD12/0036/0036

European Commission: Health-F2-2010-260791","The ICGC-CLL Genome Consortium is funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII), Red Temática de Investigación del Cáncer (RTICC) of the ISCIII (RD12/0036/0036) and National Institute of Bioinformatics (INB). This study was also supported by Ministerio de Economía y Competitividad, Secretaría De Estado De Investigación, Desarrollo e Innovación PLAN NACIONAL de I+D+i 2008-2011, Subprograma de Apoyo a Centros y Unidades de excelencia Severo","Ochoa; and Plan Nacional SAF12/38432; Generalitat de Catalunya AGAUR 2009-SGR-992; Fondo de Investigaciones Sanitarias (PI11/01177); Association for International Cancer Research (12-0142). J.O.K. and M.S.W. were supported by the European Commission (Health-F2-2010-260791). C.L.-O. is an investigator of the Botin Foundation. E.C. and M.O. are ICREA Academia Researchers. We also thank S. Guijarro and C. Gómez for their excellent technical assistance.",,"Kandoth, C., Mutational landscape and significance across 12 major cancer types (2013) Nature, 502, pp. 333-339; Frampton, G.M., Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing (2013) Nat. Biotechnol, 31, pp. 1023-1031; Cibulskis, K., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples (2013) Nat. Biotechnol, 31, pp. 213-219; Puente, X.S., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (2011) Nature, 475, pp. 101-105; Degner, J.F., Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data (2009) Bioinformatics, 25, pp. 3207-3212; Chen, K., BreakDancer: An algorithm for high-resolution mapping of genomic structural variation (2009) Nat. Methods, 6, pp. 677-681; Rausch, T., DELLY: Structural variant discovery by integrated paired-end and split-read analysis (2012) Bioinformatics, 28, pp. i333-i339; Alexandrov, L.B., Signatures of mutational processes in human cancer (2013) Nature, 500, pp. 415-421; 1000 Genomes Project Consortium, An integrated map of genetic variation from 1, 092 human genomes (2012) Nature, 491, pp. 56-65; Ye, K., Schulz, M.H., Long, Q., Apweiler, R., Ning, Z., Pindel: A pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads (2009) Bioinformatics, 25, pp. 2865-2871; Wang, J., CREST maps somatic structural variation in cancer genomes with base-pair resolution (2011) Nat. Methods, 8, pp. 652-654; Beá, S., Landscape of somatic mutations and clonal evolution in mantle cell lymphoma (2013) Proc. Natl. Acad. Sci. USA, 110, pp. 18250-18255; Rausch, T., Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations (2012) Cell, 148, pp. 59-71; Korbel, J.O., Campbell, P.J., Criteria for inference of chromothripsis in cancer genomes (2013) Cell, 152, pp. 1226-1236; Gonzalez-Perez, A., IntOGen-mutations identifies cancer drivers across tumor types (2013) Nat. Methods, 10, pp. 1081-1082; Baca, S.C., Punctuated evolution of prostate cancer genomes (2013) Cell, 153, pp. 666-677; Shen, M.M., Chromoplexy: A new category of complex rearrangements in the cancer genome (2013) Cancer Cell, 23, pp. 567-569; Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760; Richter, J., Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing (2012) Nat. Genet, 44, pp. 1316-1320; Teles Alves, I., Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer (2014) Oncogene, , 3 February; Huang, W., Li, L., Myers, J.R., Marth, G.T., ART: A next-generation sequencing read simulator (2012) Bioinformatics, 28, pp. 593-594; Young, M.A., Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells (2012) Cell Stem Cell, 10, pp. 570-582; Jones, D.T., Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma (2013) Nat. Genet, 45, pp. 927-932; Wang, K., Li, M., Hakonarson, H., ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data (2010) Nucleic Acids Res, 38, p. e164; Untergasser, A., Primer3-new capabilities and interfaces (2012) Nucleic Acids Res, 40, p. e115; Shaffer, L.G., McGowan-Jordan, J., Schmid, M., (2013) ISCN 2013: An International System for Human Cytogenetic Nomenclature, , Kargar, 2013; Krzywinski, M., Circos: An information aesthetic for comparative genomics (2009) Genome Res, 19, pp. 1639-1645","Torrents, D.email: david.torrents@bsc.es",,,"Nature Publishing Group",,,,,10870156,,NABIF,"25344728","English","Nat. Biotechnol.",Article,"Final",Open Access,Scopus,2-s2.0-84936754552
"Repchevsky D., Gelpi J.L.","37038218100;35517522400;","BioSWR - Semantic web services registry for bioinformatics",2014,"PLoS ONE","9","9", e107889,"","",,3,"10.1371/journal.pone.0107889","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907192029&doi=10.1371%2fjournal.pone.0107889&partnerID=40&md5=c2a6f3046f5740a6217addd07c3f6981","Barcelona Supercomputing Center, Life-Sciences Department, National Institute of Bioinformatics, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Repchevsky, D., Barcelona Supercomputing Center, Life-Sciences Department, National Institute of Bioinformatics, Barcelona, Spain; Gelpi, J.L., Barcelona Supercomputing Center, Life-Sciences Department, National Institute of Bioinformatics, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Despite of the variety of available Web services registries specially aimed at Life Sciences, their scope is usually restricted to a limited set of well-defined types of services. While dedicated registries are generally tied to a particular format, generalpurpose ones are more adherent to standards and usually rely on Web Service Definition Language (WSDL). Although WSDL is quite flexible to support common Web services types, its lack of semantic expressiveness led to various initiatives to describe Web services via ontology languages. Nevertheless, WSDL 2.0 descriptions gained a standard representation based on Web Ontology Language (OWL). BioSWR is a novel Web services registry that provides standard Resource Description Framework (RDF) based Web services descriptions along with the traditional WSDL based ones. The registry provides Webbased interface for Web services registration, querying and annotation, and is also accessible programmatically via Representational State Transfer (REST) API or using a SPARQL Protocol and RDF Query Language. BioSWR server is located at ><http://inb.bsc.es/BioSWR/and its code is available at ><https://sourceforge.net/projects/bioswr/under the LGPL license. © 2014 PLOS ONE.",,"Article; bioinformatics; computer aided design; computer analysis; computer interface; computer language; computer program; information service; Internet; registration; semantics; Web Service Definition Language; biology; data base; factual database; nomenclature; Computational Biology; Database Management Systems; Databases, Factual; Terminology as Topic; User-Computer Interface",,,"BioSWR",,,,,,"Pettifer, S., Ison, J., Kalas, M., Thorne, D., McDermott, P., The EMBRACE web service collection (2010) Nucleic Acids Res, 38, pp. W683-W688. , (Web Server issue); Bhagat, J., Tanoh, F., Nzuobontane, E., Laurent, T., Orlowski, J., BioCatalogue: A universal catalogue of web services for the life sciences (2010) Nucleic Acids Res, 38, pp. W689-W694. , (Web Server); Kopecký, J., Vitvar, T., Bournez, C., Farrell, J., SAWSDL: Semantic Annotations for WSDL and XML Schema (2007) IEEE Internet Comput, 11 (6), pp. 60-67; Wilkinson, M.D., Senger, M., Kawas, E., Bruskiewich, R., Interoperability with Moby 1.0-it's better than sharing your toothbrush! (2008) Brief Bioinform, 9 (3), pp. 220-231; Wilkinson, M., Schoof, H., Ernst, R., Haase, D., BioMOBY successfully integrates distributed heterogeneous bioinformatics Web Services. The PlaNet exemplar case (2005) Plant Physiol, 138 (1), pp. 5-17; Ison, J., Kalas, M., Jonassen, I., Bolser, D., Uludag, M., EDAM: An ontology of bioinformatics operations, types of data and identifiers, topics and formats (2013) Bioinformatics, 29 (10), pp. 1325-1332; Hull, D., Wolstencroft, K., Stevens, R., Goble, C., Pocock, M.R., Taverna: A tool for building and running workflows of services (2006) Nucleic Acids Res, 34, pp. 729-732. , (Web Server issue); Franks, J., Hallam-Baker, P., Hostetler, J., Lawrence, S., Leach, P., (1999) HTTP Authentication: Basic and Digest Access Authentication, , http://www.ietf.org/rfc/rfc2617.txt, (2617). IETF. Retrieved from; (2014) TinyMoby, , http://sourceforge.net/projects/tinymoby/, Accessed, July 25th; (2014) TinyWSDL, , http://sourceforge.net/projects/tinywsdl/, Accessed, July 25th; (2014) MobyCore, , http://sourceforge.net/projects/mobycore/, Accessed, July 25th; Peterson, W., Brown, D., (1961) Cyclic Codes for Error Detection Proc, 49, pp. 228-235. , IRE, Institute of Electrical & Electronics Engineers (IEEE); Broekstra, J., Kampman, A., Van Harmelen, F., Sesame: A generic architecture for storing and querying RDF and RDF schema (2002) International Semantic Web Conference, 2342, pp. 54-68. , Springer Berlin Heidelberg; Kopecký, J., WSDL RDF mapping: Developing ontologies from standardized XML languages (2006) Advances in Conceptual Modeling - Theory and Practice, 4231, pp. 312-322. , Springer Berlin Heidelberg, 2006; Horridge, M., Bechhofer, S., The OWL API: A Java API for OWL ontologies (2011) Semant Web, 2 (1), pp. 11-21; (2014) Web Services Description Language (WSDL) Version 2.0 Part 1: Core Language, , http://www.w3.org/TR/wsdl20/, Accessed, July 25th; (2014) Web Services Description Language (WSDL) Version 2.0 Part 2: Adjuncts, , http://www.w3.org/TR/wsdl20-adjuncts/, Accessed, July 25th; (2014) Apache XmlSchema, , http://ws.apache.org/xmlschema/, Accessed, July 25th","Repchevsky, D.; Barcelona Supercomputing Center, Life-Sciences Department, National Institute of BioinformaticsSpain",,,"Public Library of Science",,,,,19326203,,POLNC,"25233118","English","PLoS ONE",Article,"Final",Open Access,Scopus,2-s2.0-84907192029
"Ramírez-Bajo M.J., De Atauri P., Ortega F., Westerhoff H.V., Gelpí J.L., Centelles J.J., Cascante M.","8296410400;6603151649;56583570400;7101854663;35517522400;7004245930;7006946294;","Effects of cadmium and mercury on the upper part of skeletal muscle glycolysis in mice",2014,"PLoS ONE","9","1", e80018,"","",,10,"10.1371/journal.pone.0080018","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84900339525&doi=10.1371%2fjournal.pone.0080018&partnerID=40&md5=10b28d2e71a2fb7233918eb6825a1313","Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Department of Molecular Cell Physiology, Faculty of Biology, Vrije Universiteit, Amsterdam, Netherlands; Manchester Interdisciplinary Biocentre-3.018, School of Chemical Engineering and Analytical Science, University of Manchester, Manchester, United Kingdom; Synthetic Systems Biology, SILS and NISB, University of Amsterdam, Amsterdam, Netherlands; Laboratori Experimental de Nefrologia I Trasplantament, Hospital Clinic de Barcelona, Barcelona, Spain; Astrazeneca, RandD DS Computational Sciences, Mereside, Alderley Park, Macclesfield, Cheshire, United Kingdom","Ramírez-Bajo, M.J., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain, Laboratori Experimental de Nefrologia I Trasplantament, Hospital Clinic de Barcelona, Barcelona, Spain; De Atauri, P., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Ortega, F., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain, Astrazeneca, RandD DS Computational Sciences, Mereside, Alderley Park, Macclesfield, Cheshire, United Kingdom; Westerhoff, H.V., Department of Molecular Cell Physiology, Faculty of Biology, Vrije Universiteit, Amsterdam, Netherlands, Manchester Interdisciplinary Biocentre-3.018, School of Chemical Engineering and Analytical Science, University of Manchester, Manchester, United Kingdom, Synthetic Systems Biology, SILS and NISB, University of Amsterdam, Amsterdam, Netherlands; Gelpí, J.L., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain; Centelles, J.J., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Cascante, M., Department of Biochemistry and Molecular Biology and IBUB, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain","The effects of pre-incubation with mercury (Hg2+) and cadmium (Cd2+) on the activities of individual glycolytic enzymes, on the flux and on internal metabolite concentrations of the upper part of glycolysis were investigated in mouse muscle extracts. In the range of metal concentrations analysed we found that only hexokinase and phosphofructokinase, the enzymes that shared the control of the flux, were inhibited by Hg2+ and Cd2+. The concentrations of the internal metabolites glucose-6-phosphate and fructose-6-phosphate did not change significantly when Hg2+ and Cd2+ were added. A mathematical model was constructed to explore the mechanisms of inhibition of Hg2+ and Cd2+ on hexokinase and phosphofructokinase. Equations derived from detailed mechanistic models for each inhibition were fitted to the experimental data. In a concentration- dependent manner these equations describe the observed inhibition of enzyme activity. Under the conditions analysed, the integral model showed that the simultaneous inhibition of hexokinase and phosphofructokinase explains the observation that the concentrations of glucose-6-phosphate and fructose-6-phosphate did not change as the heavy metals decreased the glycolytic flux. © 2014 Ramírez-Bajo et al.",,"6 phosphofructokinase; cadmium; fructose 6 phosphate; glucose 6 phosphate; glucose 6 phosphate isomerase; hexokinase; mercury; 6 phosphofructokinase; cadmium; fructose phosphate; fructose-6-phosphate; glucose; glucose 6 phosphate; hexokinase; mercury; animal tissue; article; computer model; controlled study; enzyme activity; enzyme inhibition; glycolysis; leg muscle; mathematical model; metabolite; molecular model; mouse; muscle metabolism; nonhuman; animal; C57BL mouse; drug effects; glycolysis; in vitro study; metabolism; skeletal muscle; toxicity; Animals; Cadmium; Fructosephosphates; Glucose; Glucose-6-Phosphate; Glycolysis; Hexokinase; In Vitro Techniques; Mercury; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Phosphofructokinase-1; Phosphofructokinases",,"6 phosphofructokinase, 9001-80-3; cadmium, 22537-48-0, 7440-43-9; fructose 6 phosphate, 56-83-7, 643-13-0; glucose 6 phosphate, 56-73-5; glucose 6 phosphate isomerase, 106388-37-8, 9001-41-6; hexokinase, 9001-51-8; mercury, 14302-87-5, 7439-97-6; fructose phosphate, 36119-15-0; glucose, 50-99-7, 84778-64-3; Cadmium; fructose-6-phosphate; Fructosephosphates; Glucose; Glucose-6-Phosphate; Hexokinase; Mercury; Phosphofructokinase-1; Phosphofructokinases",,,"Engineering and Physical Sciences Research Council, EPSRC: BBC0082191

Biotechnology and Biological Sciences Research Council, BBSRC: BBD0190791",,,,"Mas, A., Azcue, J.M., (1993) Metales en Sistemas Biológicos, , Barcelona: Promociones y Publicaciones Universitarias, S.A; Pinto, E., Sigaud-Kutner, T.C.S., Leitao, M.A.S., Okamoto, O.K., Morse, D., Colepicolo, P., Heavy metal-induced oxidative stress in algae (2003) Journal of Phycology, 39 (6), pp. 1008-1018. , DOI 10.1111/j.0022-3646.2003.02-193.x; Nordberg, G.F., Fowler, B.A., Nordberg, M., Friberg, L., (2007) Handbook on the Toxicology of Metals, , Amsterdam: Elsevier; Diaz, S., Martin-Gonzalez, A., Carlos, G.J., Evaluation of heavy metal acute toxicity and bioaccumulation in soil ciliated protozoa (2006) Environment International, 32 (6), pp. 711-717. , DOI 10.1016/j.envint.2006.03.004, PII S0160412006000353; Förstner, U., Wittmann, G.T.W., (1979) Metal Pollution in the Aquatic Environment, , Berlin, Heidelberg, New York: Springer Verlag; Passow, H., Rothstein, A., Clarkson, T.W., The general pharmacology of the heavy metals (1961) Pharmacol Rev, 13, pp. 185-224; Vallee, B.L., Ulmer, D.D., Biochemical effects of mercury, cadmium, and lead (1972) Annu Rev Biochem, 41, pp. 91-128; Hilmy, A.M., Shabana, M.B., Daabees, A.Y., Bioaccumulation of cadmium: Toxicity in Mugil cephalus (1985) Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology, 81 (1), pp. 139-144. , DOI 10.1016/0742-8413(85)90105-7; Jin, Y.H., Clark, A.B., Slebos, R.J.C., Al-Refai, H., Taylor, J.A., Kunkel, T.A., Resnick, M.A., Gordenin, D.A., Cadmium is a mutagen that acts by inhibiting mismatch repair (2003) Nature Genetics, 34 (3), pp. 326-329. , DOI 10.1038/ng1172; Letelier, M.E., Lepe, A.M., Faundez, M., Salazar, J., Marin, R., Aracena, P., Speisky, H., Possible mechanisms underlying copper-induced damage in biological membranes leading to cellular toxicity (2005) Chemico-Biological Interactions, 151 (2), pp. 71-82. , DOI 10.1016/j.cbi.2004.12.004; Kesseler, A., Brand, M.D., Localisation of the sites of action of cadmium on oxidative phosphorylation in potato tuber mitochondria using top-down elasticity analysis (1994) European Journal of Biochemistry, 225 (3), pp. 897-906. , DOI 10.1111/j.1432-1033.1994.0897b.x; Ciapaite, J., Nauciene, Z., Baniene, R., Wagner, M.J., Krab, K., Modular kinetic analysis reveals differences in Cd2+ and Cu2+ ion-induced impairment of oxidative phosphorylation in liver (2009) Febs J, 276, pp. 3656-3668; Chassagnole, C., Quentin, E., Fell, D.A., De Atauri, P., Mazat, J.-P., Dynamic simulation of pollutant effects on the threonine pathway in Escherichia coli (2003) Comptes Rendus - Biologies, 326 (5), pp. 501-508. , DOI 10.1016/S1631-0691(03)00098-2; Strydom, C., Robinson, C., Pretorius, E., Whitcutt, J.M., Marx, J., Bornman, M.S., The effect of selected metals on the central metabolic pathways in biology: A review (2006) Water SA, 32 (4), pp. 543-554. , http://www.wrc.org.za/downloads/watersa/2006/Oct%2006/1939.pdf; Jannaschk, D., Burgos, M., Centerlles, J.J., Ovadi, J., Cascante, M., Application of metabolic control analysis to the study of toxic effects of copper in muscle glycolysis (1999) FEBS Letters, 445 (1), pp. 144-148. , DOI 10.1016/S0014-5793(99)00117-9, PII S0014579399001179; Liliom, K., Wagner, G., Kovacs, J., Comin, B., Cascante, M., Orosz, F., Ovadi, J., Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro: Decreased sensitivity to copper toxicity (1999) Biochemical and Biophysical Research Communications, 264 (2), pp. 605-610. , DOI 10.1006/bbrc.1999.1547; Liliom, K., Wagner, G., Pacz, A., Cascante, M., Kovacs, J., Ovadi, J., Organization-dependent effects of toxic bivalent ions: Microtubule assembly and glycolysis (2000) European Journal of Biochemistry, 267 (15), pp. 4731-4739. , DOI 10.1046/j.1432-1327.2000.01526.x; Jalilehvand, F., Leung, B.O., Mah, V., Cadmium(II) complex formation with cysteine and penicillamine (2009) Inorg Chem, 48, pp. 5758-5771; Quig, D., Cysteine metabolism and metal toxicity (1998) Altern Med Rev, 3, pp. 262-270; Kacser, H., Burns, J.A., The control of flux (1973) Symp Soc Exp Biol, 27, pp. 65-104; Kacser, H., Burns, J.A., Fell, D.A., The control of flux (1995) Biochem Soc Trans, 23, pp. 341-366; Heinrich, R., Rapoport, T.A., A linear steady-state treatment of enzymatic chains. General properties, control and effector strength (1974) Eur J Biochem, 42, pp. 89-95; Fell, D.A., (1997) Understanding the Control of Metabolism, , London: Portland Press; Groen, A.K., Wanders, R.J., Westerhoff, H.V., Van Der Meer, R., Tager, J.M., Quantification of the contribution of various steps to the control of mitochondrial respiration (1982) J Biol Chem, 257, pp. 2754-2757; Puigjaner, J., Rais, B., Burgos, M., Comin, B., Ovadi, J., Cascante, M., Comparison of control analysis data using different approaches: Modelling and experiments with muscle extract (1997) FEBS Letters, 418 (1-2), pp. 47-52. , DOI 10.1016/S0014-5793(97)01347-1, PII S0014579397013471; Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal Biochem, 72, pp. 248-254; Van Eunen, K., Bouwman, J., Daran-Lapujade, P., Postmus, J., Canelas, A.B., Measuring enzyme activities under standardized in vivo-like conditions for systems biology (2010) Febs J, 277, pp. 749-760; Bergmeyer, H.U., (1984) Methods of Enzymatic Analysis, 2-3. , Deerfield Beach, Florida: Weinheim; Small, J.R., Kacser, H., Responses of metabolic systems to large changes in enzyme activities and effectors. 1. The linear treatment of unbranched chains (1993) European Journal of Biochemistry, 213 (1), pp. 613-624; Brand, I.A., Söling, H.D., Rat liver phosphofructokinase. Purification and characterization of its reaction mechanism (1974) J Biol Chem, 249, pp. 7824-7831; Grossbard, L., Schimke, R.T., Multiple hexokinases of rat tissues. Purification and comparison of soluble forms (1966) J Biol Chem, 241, pp. 3546-3560; Kiefer, F., Arnold, K., Künzli, M., Bordoli, L., Schwede, T., The SWISSMODEL Repository and associated resources (2009) Nucleic Acids Research, 37, pp. D387-D392; Hubbard, S.J., Thornton, J.M., (1993) 'NACCESS', Computer Program, , Department of Biochemistry and Molecular Biology, University College London; Raïs, B., Puigjaner, J., Comín, B., Cascante, M., Potential errors related to control coefficients determination in mouse muscle glycolysis (1996) Biothermokinetics of the Living Cells, pp. 174-180. , Westerhoff HV, Snoep JL, Sluse FE, Wijker JE, Kholodenko BN, editors. Amsterdam: Biothermokinetics Press; Marín-Hernández, A., Rodríguez-Enríquez, S., Vital-González, P.A., Flores-Rodríguez, F.L., Macías-Silva, M., Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an overexpressed but strongly product-inhibited hexokinase (2006) Febs J, 273, pp. 1975-1988; Ovadi, J., Orosz, F., A new concept for control of glycolysis (1997) Channelling in Intermediary Metabolism London, pp. 237-268. , Agius L, Sherratt HSA, editors. Portland Press Ltd; Kacser, H., Acerenza, L., A universal method for achieving increases in metabolite production (1993) European Journal of Biochemistry, 216 (2), pp. 361-367; Fell, D.A., Thomas, S., Physiological control of metabolic flux: The requirement for multisite modulation (1995) Biochem J, 311 (PART 1), pp. 35-39; Rodriguez-Prados, J.C., De Atauri, P., Maury, J., Ortega, F., Portais, J.C., In silico strategy to rationally engineer metabolite production: A case study for threonine in Escherichia coli (2009) Biotechnol Bioeng, 103, pp. 609-620",,,,"Public Library of Science",,,,,19326203,,POLNC,"24489641","English","PLoS ONE",Article,"Final",Open Access,Scopus,2-s2.0-84900339525
"Sfriso P., Emperador A., Gelpí J.L., Orozco M.","55480428500;57208980207;35517522400;7102809158;","Discrete molecular dynamics: Foundations and biomolecular applications",2014,"Computational Approaches to Protein Dynamics: From Quantum to Coarse-Grained Methods",,,,"339","361",,4,"10.1201/b17979","https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008254258&doi=10.1201%2fb17979&partnerID=40&md5=4568efcf3989fb6804f06471b8d55aba","Institute for Research in Biomedicine, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Institute for Research in Biomedicine, Barcelona, Spain","Sfriso, P., Institute for Research in Biomedicine, Barcelona, Spain; Emperador, A., Institute for Research in Biomedicine, Barcelona, Spain; Gelpí, J.L., Department of Biochemistry and Molecular Biology, University of Barcelona, Institute for Research in Biomedicine, Barcelona, Spain; Orozco, M., Department of Biochemistry and Molecular Biology, University of Barcelona, Institute for Research in Biomedicine, Barcelona, Spain","In this chapter, we present modern computational approaches to use small-angle x-ray scattering (SAXS) in the analysis of flexible proteins. SAXS is a powerful method for analyzing the structure and structural changes of biological macromolecules in solution (Svergun et al. 2013). The method is most often used for purified solutions of globular proteins and complexes where all particles can be considered identical and the experimental scattering can be related to the structure of a single particle (although the scattering is typically isotropic due to the average over particle orientations). In this case, SAXS provides information about the overall shape and can construct three-dimensional (3-D) low-resolution models, either ab initio or using rigid body analysis in terms of known high resolution structures of domains or subunits. © 2015 by Taylor & Francis Group, LLC.",,"Proteins; X ray scattering; Biological macromolecule; Computational approach; Globular proteins; High-resolution structures; Low resolution; Particle orientation; Single particle; Threedimensional (3-d); Molecular dynamics",,,,,,,,,"Henzler-Wildman, K.A., Lei, M., Thai, V., Kerns, S.J., Karplus, M., Kern, D., A hierarchy of timescales in protein dynamics is linked to enzyme catalysis (2007) Nature, 450, pp. 913-916; Velazquez-Muriel, J.A., Rueda, M., Cuesta, I., Pascual-Montano, A., Orozco, M., Carazo, J.-M., Comparison of molecular dynamics and superfamily spaces of protein domain deformation (2009) BMC Struct. Biol. [Online], 9, p. 6; Bakan, A., Bahar, I., The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 14349-14354; Yang, L., Song, G., Jernigan, R.L., How well can we understand large-scale protein motions using normal modes of elastic network models? (2007) Biophys. J., 93, pp. 920-929; Bahar, I., Chennubhotla, C., Tobi, D., Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation (2007) Curr. Opin. Struct. Biol., 17, pp. 633-640; Tobi, D., Bahar, I., Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 18908-18913; Eyal, E., Dutta, A., Bahar, I., Cooperative dynamics of proteins unraveled by network models (2011) WIREs Comput. Mol. Sci., 1, pp. 426-439; Dobbins, S.E., Lesk, V.I., Sternberg, M.J.E., Insights into protein flexibility: The relationship between normal modes and conformational change upon protein-protein docking (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 10390-10395; Gerstein, M., Krebs, W., A database of macromolecular motions (1998) Nucleic Acids Res., 26, pp. 4280-4290; Falke, J.J., Enzymology. A moving story (2002) Science, 295, pp. 1480-1481; Leo-Macias, A., Lopez-Romero, P., Lupyan, D., Zerbino, D., Ortíz, A.R., An analysis of core deformations in protein superfamilies (2005) Biophys. J., 88, pp. 1291-1299; Micheleti, C., Comparing proteins by their internal dynamics: Exploring structure-function relationships beyond static structural alignments (2013) Phys. Life Rev., 10, pp. 1-26; Orozco, M., The dynamic view of proteins: Comment on “Comparing proteins to their internal dynamics: Exploring structure-function relationships beyond static structural alignments.” (2013) Phys. Life Rev., 10, pp. 29-30; Stein, A., Rueda, M., Panjkovich, A., Orozco, M., Aloy, P., A systematic study of the energetics involved in structural changes upon association and connectivity in protein interaction networks (2011) Structure, 19, pp. 881-889; Orellana, L., Rueda, M., Ferrer-Costa, C., Lopez-Blanco, J.R., Chacón, P., Orozco, M., Approaching elastic network models to molecular dynamics flexibility (2010) J. Chem. Theory Comput., 6, pp. 2910-2923; Sfriso, P., Emperador, A., Orellana, L., Hospital, A., Gelpí, J.L., Orozco, M., Finding conformational transition pathways from discrete molecular dynamics simulations (2012) J. Chem. Theory Comput., 8, pp. 4707-4718; Henzler-Wildman, K.A., Thai, V., Lei, M., Ott, M., Wolf-Watz, M., Fenn, T., Pozharski, E., Karplus, M., Intrinsic motions along an enzymatic reaction trajectory (2007) Nature, 450, pp. 838-844; Lindorff-Larsen, K., Best, R.B., Depristo, M.A., Dobson, C.M., Vendruscolo, M., Simultaneous determination of protein structure and dynamics (2005) Nature, 433, pp. 128-132; Ban, D., Funk, M., Gulich, R., Egger, D., Sabo, T.M., Walter, K.F.A., Fenwick, R.B., De Groot, B.L., Kinetics of conformational sampling in ubiquitin (2011) Angew. Chem. Int. Ed., 50, pp. 11437-11440; Fenwick, R.B., Esteban-Martin, S., Richter, B., Lee, D., Walter, K.F.A., Milovanovic, D., Becker, S., Salvatella, X., Weak long-range correlated motions in a surface patch of ubiquitin involved in molecular recognition (2011) J. Am. Chem. Soc., 133, pp. 10336-10339; Kubitzki, M.B., De Groot, B.L., The atomistic mechanism of conformational transition in adenylate kinase: A TEE-REX molecular dynamics study (2008) Structure, 16, pp. 1175-1182; Shimamura, T., Weyand, S., Beckstein, O., Rutherford, N.G., Hadden, J.M., Sharples, D., Sansom, M.S.P., Cameron, A.D., Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1 (2010) Science, 328, pp. 470-473; Paci, E., Lindorff-Larsen, K., Dobson, C.M., Karplus, M., Vendruscolo, M., Transition state contact orders correlate with protein folding rates (2005) J. Mol. Biol., 352, pp. 495-500; Orozco, M., Orellana, L., Hospital, A., Naganathan, A.N., Emperador, A., Carrillo, O., Gelpí, J.L., Coarse-grained representation of protein flexibility. Foundations, successes, and shortcomings (2011) Adv. Protein Chem. Struct. Biol., 85, pp. 183-215; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., Hospital, A., Gelpí, J.L., Orozco, M., A consensus view of protein dynamics (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 796-801; Karplus, M., Kuriyan, J., Molecular dynamics and protein function (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 6679-6685; Tozzini, V., Coarse-grained models for proteins (2005) Curr. Opin. Struct. Biol., 15, pp. 144-150; Bolhuis, P.G., Chandler, D., Dellago, C., Geissler, P.L., Transition path sampling: Throwing ropes over rough mountain passes, in the dark (2002) Annu. Rev. Phys. Chem., 53, pp. 291-318; Bolhuis, P.G., Transition-path sampling of beta-hairpin folding (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 12129-12134; Wales, D.J., Energy landscapes: Calculating pathways and rates (2006) Int. Rev. Phys. Chem., 25, pp. 237-282; Jamroz, M., Orozco, M., Kolinski, A., Kmiecik, S., Consistent view of protein fluctuations from all-atom molecular dynamics and coarse-grained dynamics with knowledge-based force-field (2013) J. Chem. Theory Comput., 9, pp. 119-125; Naganathan, A.N., Orozco, M., The native ensemble and folding of a protein molten-globule: Functional consequence of downhill folding (2011) J. Am. Chem. Soc., 133, pp. 12154-12161; García, A.E., Onuchic, J.N., Folding a protein in a computer: An atomic description of the folding/unfolding of protein A (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 13898-13903; Taketomi, H., Ueda, Y., Gō, N., Studies on protein folding, unfolding and fluctuations by computer simulation (1975) Int. J. Pept. Protein Res., 7, pp. 445-459; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., Cicin-Sain, D., Orozco, M., FlexServ: An integrated tool for the analysis of protein flexibility (2009) Bioinformatics, 25, pp. 1709-1710; Yang, Z., Májek, P., Bahar, I., Allosteric transitions of supramolecular systems explored by network models: Application to chaperonin GroEL (2009) PLoS Comput. Biol., 5, p. e1000360; Lezon, T.R., Sali, A., Bahar, I., Global motions of the nuclear pore complex: Insights from elastic network models (2009) PLoS Comput. Biol., 5, p. e1000496; Bahar, I., Lezon, T.R., Yang, L.-W., Eyal, E., Global dynamics of proteins: Bridging between structure and function (2010) Annu. Rev. Biophys., 39, pp. 23-42; Bahar, I., Lezon, T.R., Bakan, A., Shrivastava, I.H., Normal mode analysis of biomolecular structures: Functional mechanisms of membrane proteins (2010) Chem. Rev., 110, pp. 1463-1497; Lopez-Blanco, J.R., Garzón, J.I., Chacón, P., iMod: Multipurpose normal mode analysis in internal coordinates (2011) Bioinformatics, 27, pp. 2843-2850; Jorgensen, W.L., Tirado-Rives, J., Molecular modeling of organic and biomolecular systems using BOSS and MCPRO (2005) J. Comput. Chem., 26, pp. 1689-1700; McCammon, J.A., Harvey, S.C., (1988) Dynamics of Proteins and Nucleic Acids, , Cambridge University Press, Cambridge; Karplus, M., Petsko, G.A., Molecular dynamics simulations in biology (1990) Nature, 347, pp. 631-639; Emperador, A., Meyer, T., Orozco, M., Protein flexibility from discrete molecular dynamics simulations using quasi-physical potentials (2010) Proteins, 78, pp. 83-94; Meyer, T., D’Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Pérez, A., Carrillo, O., Repchevsky, D., MoDEL (Molecular Dynamics Extended Library): A database of atomistic molecular dynamics trajectories (2010) Structure, 18, pp. 1399-1409; Ding, F., Tsao, D., Nie, H., Dokholyan, N.V., Ab initio folding of proteins with all-atom discrete molecular dynamics (2008) Structure, 16, pp. 1010-1018; Lazaridis, T., Karplus, M., Effective energy function for proteins in solution (1999) Proteins, 35, pp. 133-152; Ding, F., Borreguero, J., Buldyrev, S.V., Stanley, H., Dokholyan, N., Mechanism for the α-helix to β-hairpin transition (2003) Proteins, 53, pp. 220-228; Shirvanyants, D., Ding, F., Tsao, D., Ramachandran, S., Dokholyan, N.V., Discrete molecular dynamics: An efficient and versatile simulation method for fine protein characterization (2012) J. Phys. Chem. B, 116, pp. 8375-8382; Ding, F., Buldyrev, S., Dokholyan, N., Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model (2005) Biophys. J., 88, pp. 147-155; Marchut, A.J., Hall, C.K., Side-chain interactions determine amyloid formation by model polyglutamine peptides in molecular dynamics simulations (2006) Biophys. J., 90, pp. 4574-4584; Urbanc, B., Cruz, L., Yun, S., Buldyrev, S.V., Bitan, G., Teplow, D.B., Stanley, H.E., In silico study of amyloid beta-protein folding and oligomerization (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17345-17350; Nguyen, H.D., Hall, C.K., Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 16180-16185; Kyte, J., Doolittle, R.F., A simple method for displaying the hydropathic character of a protein (1982) J. Mol. Biol., 157, pp. 105-132; Zhou, Y., Karplus, M., Interpreting the folding kinetics of helical proteins (1999) Nature, 401, pp. 400-403; Emperador, A., Carrillo, O., Rueda, M., Orozco, M., Exploring the suitability of coarse-grained techniques for the representation of protein dynamics (2008) Biophys. J., 95, pp. 2127-2138; Pérez, A., Luque, F.J., Orozco, M., Frontiers in molecular dynamics simulations of DNA (2012) Acc. Chem. Res., 45, pp. 196-205; Orozco, M., Noy, A., Pérez, A., Recent advances in the study of nucleic acid flexibility by molecular dynamics (2008) Curr. Opin. Struct. Biol., 18, pp. 185-193; Ding, F., Sharma, S., Chalasani, P., Demidov, V.V., Broude, N.E., Dokholyan, N.V., Ab initio RNA folding by discrete molecular dynamics: From structure prediction to folding mechanisms (2008) RNA, 14, pp. 1164-1173; Gherghe, C.M., Leonard, C.W., Ding, F., Dokholyan, N.V., Weeks, K.M., Native-like RNA tertiary structures using a sequence-encoded cleavage agent and refinement by discrete molecular dynamics (2009) J. Am. Chem. Soc., 131, pp. 2541-2546; Ding, F., Lavender, C.A., Weeks, K.M., Dokholyan, N.V., Three-dimensional RNA structure refinement by hydroxyl radical probing (2012) Nat. Methods, 9, pp. 603-608; Zhou, Y., Hall, C., Karplus, M., First-order disorder-to-order transition in an isolated homopolymer model (1996) Phys. Rev. Lett., 77, pp. 2822-2825; Zhou, Y., Karplus, M., Folding thermodynamics of a model three-helix-bundle protein (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 14429-14432; Dokholyan, N.V., Buldyrev, S.V., Stanley, H.E., Shakhnovich, E.I., Discrete molecular dynamics studies of the folding of a protein-like model (1998) Fold. Des., 3, pp. 577-587; Rapaport, D.C., (2004) The Art of Molecular Dynamics Simulation, , Cambridge University Press, New York; Apostolov, R., Axner, L., Agren, H., Ayugade, E., Duta, M., Gelpí, J.L., Gimenez, J., Trefethen, A., ScalaLife: Scalable software services for life science (2011) Proceedings of 9th HealthGrid Conference; Erpenbeck, J.J., Wood, W.W., Molecular dynamics techniques for hard-core systems (1977) Modern Theoretical Chemistry, 6B, p. 1. , Berne, B. J., ed., Plenum, New York; Lubachevsky, B.D., How to simulate billiards and similar systems (1991) J. Comput. Phys., 94, pp. 255-283; Larsson, P., Hess, B., Lindahl, E., Algorithm improvements for molecular dynamics simulations (2011) WIREs Comput. Mol. Sci., 1, pp. 93-108; Smith, S.W., Hall, C.K., Freeman, B.D., Molecular dynamics for polymeric fluids using discontinuous potentials (1997) J. Comput. Phys., 134, pp. 16-30; Khan, M.A., Herbordt, M.C., Parallel discrete molecular dynamics simulation with speculation and in-order commitment (2011) J. Comput. Phys., 230, pp. 6563-6582; Sharma, S., Ding, F., Nie, H., Watson, D., Unnithan, A., Lopp, J., Pozefsky, D., Dokholyan, N.V., iFold: A platform for interactive folding simulations of proteins (2006) Bioinformatics, 22, pp. 2693-2694; Sharma, S., Ding, F., Dokholyan, N.V., iFoldRNA: Three-dimensional RNA structure prediction and folding (2008) Bioinformatics, 24, pp. 1951-1952; Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., Gelpí, J.L., MDWeb and MDMoby: An integrated web-based platform for molecular dynamics simulations (2012) Bioinformatics, 28, pp. 1278-1279; Proctor, E.A., Ding, F., Dokholyan, N., Discrete molecular dynamics (2011) WIREs Comput. Mol. Sci., 1, pp. 80-92; Ramachandran, S., Kota, P., Ding, F., Dokholyan, N.V., Automated minimization of steric clashes in protein structures (2011) Proteins, 79, pp. 261-270; Fleishman, S.J., Whitehead, T.A., Ekiert, D.C., Dreyfus, C., Corn, J.E., Strauch, E.-M., Wilson, I.A., Baker, D., Computational design of proteins targeting the conserved stem region of influenza hemagglutinin (2011) Science, 332, pp. 816-821; Azoitei, M.L., Correia, B.E., Ban, Y.-E.A., Carrico, C., Kalyuzhniy, O., Chen, L., Schroeter, A., Kwong, P.D., Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold (2011) Science, 334, pp. 373-376; Ding, F., Dokholyan, N.V., Emergence of protein fold families through rational design (2006) PLoS Comput. Biol., 2, p. e85; Ueda, Y., Taketomi, H., Gō, N., Studies on protein folding, unfolding, and fluctuations by computer simulation. II. A three-dimensional lattice model of lysozyme (1978) Biopolymers, 17, pp. 1531-1548; Laing, C., Schlick, T., Computational approaches to RNA structure prediction, analysis, and design (2011) Curr. Opin. Struct. Biol., 21, pp. 306-318; Urbanc, B., Borreguero, J., Cruz, L., Stanley, H., Ab initio discrete molecular dynamics approach to protein folding and aggregation (2006) Methods Enzymol., 412, pp. 314-338; Urbanc, B., Cruz, L., Teplow, D.B., Stanley, H.E., Computer simulations of Alzheimers amyloid-protein folding and assembly (2006) Curr. Alzheimer Res., 3, pp. 493-504; Sharma, S., Ding, F., Dokholyan, N.V., Probing protein aggregation using discrete molecular dynamics (2008) Front. Biosci., 13, pp. 4795-4808; Walsh, D.M., Hartley, D.M., Kusumoto, Y., Fezoui, Y., Condron, M.M., Lomakin, A., Benedek, G.B., Teplow, D.B., Amyloid β-protein fibrillogenesis (1999) J. Biol. Chem., 274, pp. 25945-25952; Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Viola, K.L., Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins (1998) Proc. Natl. Acad. Sci. U. S. A., 95, pp. 6448-6453; Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J., Selkoe, D.J., Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo (2002) Nature, 416, pp. 535-539; Peng, S., Ding, F., Urbanc, B., Buldyrev, S.V., Cruz, L., Stanley, H.E., Dokholyan, N.V., Discrete molecular dynamics simulations of peptide aggregation (2004) Phys. Rev. E., 69, p. 041908; Urbanc, B., Cruz, L., Ding, F., Sammond, D., Khare, S., Buldyrev, S.V., Stanley, H.E., Dokholyan, N.V., Molecular dynamics simulation of amyloid β dimer formation (2004) Biophys. J., 87, pp. 2310-2321; Bitan, G., Kirkitadze, M.D., Lomakin, A., Vollers, S.S., Benedek, G.B., Teplow, D.B., Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 330-335; Bitan, G., Vollers, S.S., Teplow, D.B., Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization (2003) J. Biol. Chem., 278, pp. 34882-34889; Urbanc, B., Betnel, M., Cruz, L., Bitan, G., Teplow, D., Elucidation of amyloid β-protein oligomerization mechanisms: Discrete molecular dynamics study (2010) J. Am. Chem. Soc., 132, pp. 4266-4280; Borreguero, J., Urbanc, B., Lazo, N.D., Buldyrev, S.D., Teplow, D.B., Stanley, H.E., Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 6015-6020; Urbanc, B., Betnel, M., Cruz, L., Li, H., Structural basis for Aβ1-42 toxicity inhibition by Aβ C-Terminal fragments: Discrete molecular dynamics study (2011) J. Mol. Biol., 410, pp. 316-328; Emperador, A., Meyer, T., Orozco, M., United-atom discrete molecular dynamics of proteins using physics-based potentials (2008) J. Chem. Theory Comput., 4, pp. 2001-2010; Proctor, E.A., Yin, S., Tropsha, A., Dokholyan, N.V., Discrete molecular dynamics distinguishes nativelike binding poses from decoys in difficult targets (2012) Biophys. J., 102, pp. 144-151; Emperador, A., Solernou, A., Sfriso, P., Pons, C., Gelpí, J.L., Fernández-Recio, J., Orozco, M., Efficient relaxation of protein-protein interfaces by discrete molecular dynamics simulations (2013) J. Chem. Theory Comput., 9, pp. 1222-1229; Cheng, T.M.K., Blundell, T.L., Fernandez Recio, J., pyDock: Electrostatics and desolvation for effective scoring of rigid-body protein-protein docking (2007) Proteins, 68, pp. 503-515",,,,"CRC Press",,,,,,9781482297867; 9781466561571,,,"English","Computational Approaches to Protein Dynamics: From Quantum to Coarse-Grained Methods",Book Chapter,"Final",,Scopus,2-s2.0-85008254258
"Candotti M., Pérez A., Ferrer-Costa C., Rueda M., Meyer T., Gelpí J.L., Orozco M.","36058488900;35764684500;8866407700;35518639700;55913919700;35517522400;7102809158;","Exploring Early Stages of the Chemical Unfolding of Proteins at the Proteome Scale",2013,"PLoS Computational Biology","9","12", e1003393,"","",,8,"10.1371/journal.pcbi.1003393","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892707939&doi=10.1371%2fjournal.pcbi.1003393&partnerID=40&md5=9df7418483390ac435e326695b7d6942","Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Joint Research Program in Computational Biology, Institute for Research in Biomedicine and Barcelona Supercomputing Center, Barcelona, Spain; Laufer Center, Stony Brook University, Stony Brook, NY, United States; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, United States; Theoretische und Computergestützte Biophysik, Max-Planck-Institut für Biophysikalische Chemie, Göttingen, Germany; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Candotti, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Joint Research Program in Computational Biology, Institute for Research in Biomedicine and Barcelona Supercomputing Center, Barcelona, Spain; Pérez, A., Laufer Center, Stony Brook University, Stony Brook, NY, United States; Ferrer-Costa, C., Joint Research Program in Computational Biology, Institute for Research in Biomedicine and Barcelona Supercomputing Center, Barcelona, Spain; Rueda, M., Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, United States; Meyer, T., Theoretische und Computergestützte Biophysik, Max-Planck-Institut für Biophysikalische Chemie, Göttingen, Germany; Gelpí, J.L., Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain, Joint Research Program in Computational Biology, Institute for Research in Biomedicine and Barcelona Supercomputing Center, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","After decades of using urea as denaturant, the kinetic role of this molecule in the unfolding process is still undefined: does urea actively induce protein unfolding or passively stabilize the unfolded state? By analyzing a set of 30 proteins (representative of all native folds) through extensive molecular dynamics simulations in denaturant (using a range of force-fields), we derived robust rules for urea unfolding that are valid at the proteome level. Irrespective of the protein fold, presence or absence of disulphide bridges, and secondary structure composition, urea concentrates in the first solvation shell of quasi-native proteins, but with a density lower than that of the fully unfolded state. The presence of urea does not alter the spontaneous vibration pattern of proteins. In fact, it reduces the magnitude of such vibrations, leading to a counterintuitive slow down of the atomic-motions that opposes unfolding. Urea stickiness and slow diffusion is, however, crucial for unfolding. Long residence urea molecules placed around the hydrophobic core are crucial to stabilize partially open structures generated by thermal fluctuations. Our simulations indicate that although urea does not favor the formation of partially open microstates, it is not a mere spectator of unfolding that simply displaces to the right of the folded←→unfolded equilibrium. On the contrary, urea actively favors unfolding: it selects and stabilizes partially unfolded microstates, slowly driving the protein conformational ensemble far from the native one and also from the conformations sampled during thermal unfolding. © 2013 Candotti et al.",,"proteome; urea; article; controlled study; disulfide bond; hydrophobicity; protein conformation; protein content; protein folding; protein secondary structure; protein stability; protein unfolding; simulation; Protein Unfolding; Proteome",,"urea, 57-13-6",,,"European Research Council, ERC",,,,"Kauzmann, W., Some factors in the interpretation of protein denaturation (1959) Adv Protein Chem, 14, pp. 1-63; England, J.L., Haran, G., Role of solvation effects in protein denaturation: from thermodynamics to single molecules and back (2011) Annu Rev Phys Chem, 62, pp. 257-277; Soper, A.K., Castner, E.W., Luzar, A., Impact of urea on water structure: a clue to its properties as a denaturant? (2003) Biophys Chem, 105 (2-3), pp. 649-666; Tirado-Rives, J., Orozco, M., Jorgensen, W.L., Molecular dynamics simulations of the unfolding of barnase in water and 8 M aqueous urea (1997) Biochemistry, 36 (24), pp. 7313-7329; Bennion, B.J., Daggett, V., The molecular basis for the chemical denaturation of proteins by urea (2003) Proc Natl Acad Sci U S A, 100 (9), pp. 5142-5147; Auton, M., Holthauzen, L.M., Bolen, D.W., Anatomy of energetic changes accompanying urea-induced protein denaturation (2007) Proc Natl Acad Sci U S A, 104 (39), pp. 15317-15322; Klimov, D.K., Straub, J.E., Thirumalai, D., Aqueous urea solution destabilizes Abeta(16-22) oligomers (2004) Proc Natl Acad Sci U S A, 101 (41), pp. 14760-14765; Canchi, D.R., García, A.E., Backbone and side-chain contributions in protein denaturation by urea (2011) Biophys J, 100 (6), pp. 1526-1533; O'Brien, E.P., Dima, R.I., Brooks, B., Thirumalai, D., Interactions between hydrophobic and ionic solutes in aqueous guanidinium chloride and urea solutions: lessons for protein denaturation mechanism (2007) J Am Chem Soc, 129 (23), pp. 7346-7353; Stumpe, M.C., Grubmüller, H., Interaction of urea with amino acids: implications for urea-induced protein denaturation (2007) J Am Chem Soc, 129 (51), pp. 16126-16131; Stumpe, M.C., Grubmüller, H., Polar or apolar-the role of polarity for urea-induced protein denaturation (2008) PLoS Comput Biol, 4 (11), pp. e1000221; Stumpe, M.C., Grubmüller, H., Urea impedes the hydrophobic collapse of partially unfolded proteins (2009) Biophys J, 96 (9), pp. 3744-3752; Hua, L., Zhou, R., Thirumalai, D., Berne, B.J., Urea denaturation by stronger dispersion interactions with proteins than water implies a 2-stage unfolding (2008) Proc Natl Acad Sci U S A, 105 (44), pp. 16928-16933; Lindgren, M., Westlund, P.O., On the stability of chymotrypsin inhibitor 2 in a 10 M urea solution. The role of interaction energies for urea-induced protein denaturation (2010) Phys Chem Chem Phys, 12, pp. 9358-9366; Candotti, M., Esteban-Martin, S., Salvatella, X., Orozco, M., Towards an atomistic description of the urea-denatured state of proteins (2013) Proc Natl Acad Sci U S A, 110 (15), pp. 5933-5938; Lim, W.K., Rösgen, J., Englander, S.W., Urea, but not guanidinium, destabilizes proteins by forming hydrogen bonds to the peptide group (2009) Proc Natl Acad Sci U S A, 106 (8), pp. 2595-2600; Berteotti, A., Barducci, A., Parrinello, M., Effect of urea on the -hairpin conformational ensemble and protein denaturation mechanism (2011) J Am Chem Soc, 133 (43), pp. 17200-17206; Mayor, U., Johnson, C.M., Daggett, V., Fersht, A.R., Protein folding and unfolding in microseconds to nanoseconds by experiment and simulation (2000) Proc Natl Acad Sci U S A, 97 (25), pp. 13518-13522; Murzin, A.G., Brenner, S.E., Hubbard, T., Chothia, C., SCOP: a structural classification of proteins database for the investigation of sequences and structures (1995) J Mol Biol, 247, pp. 536-540; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., A consensus view of protein dynamics (2007) Proc Natl Acad Sci U S A, 104 (3), pp. 796-801; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories (2010) Structure, 18, pp. 1399-1409; Shaw, D.E., Maragakis, P., Lindorff-Larsen, K., Piana, S., Dror, R.O., Atomic-Level Characterization of the Structural Dynamics of Proteins (2010) Science, 330 (6002), pp. 341-346; Maiorov, V.N., Crippen, G.M., Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins (1994) J Mol Biol, 235 (2), pp. 625-634; Courtenay, E.S., Capp, M.W., Record Jr., M.T., Thermodynamics of interactions of urea and guanidinium salts with protein surface: relationship between solute effects on protein processes and changes in water-accessible surface area (2001) Protein Sci, 10 (12), pp. 2485-2497; Stumpe, M.C., Grubmüller, H., Aqueous Urea Solutions: Structure, Energetics, and Urea Aggregation (2007) J Phys Chem B, 111 (22), pp. 6220-6228; Lindgren, M., Westlund, P.O., The affect of urea on the kinetics of local unfolding processes in chymotrypsin inhibitor 2 (2010) Biophys Chem, 151 (1-2), pp. 46-53; Day, R., Beck, D., Armen, R., Daggett, V., A Consensus View of Fold Space: Combining SCOP, CATH, and the Dali Domain Dictionary (2003) Protein Sci, 12, pp. 2150-2160; Bernstein, F.C., Koetzle, T.F., Williams, G.J., Meyer Jr., E.E., Brice, M.D., The Protein Data Bank: A Computer-based Archival File For Macromolecular Structures (1977) J Mol Biol, 112, p. 535; Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations (2012) Bioinformatics, 28 (9), pp. 1278-1279; Jorgensen, W.L., Tirado-Rives, J., Molecular modeling of organic and biomolecular systems using BOSS and MCPRO (2005) J Comput Chem, 26, pp. 1689-1700; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79, pp. 926-935; Weerasinghe, S., Smith, P.E., Kirkwood-Buff derived force field for mixtures of urea and water (2003) J Phys Chem B, 107, pp. 3891-3898; Caballero-Herrera, A., Nilsson, L., Urea parametrization for molecular dynamics simulations (2006) Journal of Molecular Structure: THEOCHEM, 758, pp. 139-148; Jorgensen, W.L., Tirado-Rives, J., The OPLS Force Field for Proteins. Energy Minimizations for Crystals of Cyclic Peptides and Crambin (1988) J Am Chem Soc, 110 (6), pp. 1657-1666; MacKerell, A.D., Bashford, D., Dunbrack, M.R.L., Evanseck, J.D., Field, M.J., All-atom empirical potential for molecular modeling and dynamics studies of proteins (1998) J Phys Chem B, 102, pp. 3586-3616; Wang, J., Cieplak, P., Kollman, P.A., How well does a restrained electrostatic potential (resp) model perform in calculating conformational energies of organic and biological molecules (2000) J Comp Chem, 21, pp. 1049-1074; Piana, S., Lindorff-Larsen, K., Shaw, D.E., How robust are protein folding simulations with respect to force field parameterization? (2011) Biophys J, 100 (9), pp. L47-L49; Essmann, U., Perera, L., Berkowitz, M.L., Darden, T., Lee, H., A Smooth Particle Mesh Ewald Method (1995) J Chem Phys, 103, p. 8577; Phillips, J., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Scalable molecular dynamics with NAMD (2005) J Comput Chem, 26, pp. 1781-1802; Andersen, H.C., RATTLE: A ""Velocity"" Version of the SHAKE Algorithm for Molecular Dynamics Calculations (1983) Journal of Computational Physics, 52, pp. 24-34; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79 (2), pp. 926-935; Martyna, G.J., Tobias, D.J., Klein, M.L., Constant pressure molecular dynamics algorithms (1994) J Chem Phys, 101 (5), p. 4177; Feller, S.E., Zhang, Y., Pastor, R.W., Brooks, B.R., Constant pressure molecular dynamics simulation: The Langevin piston method (1995) J Chem Phys, 103 (11), p. 4613; Humphrey, Dalke, A., Schulten, K., VMD - Visual Molecular Dynamics (1996) J Molec Graphics, 14 (1), pp. 33-38","Orozco, M.; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; email: modesto.orozco@irbbarcelona.org",,,,,,,,1553734X,,,"24348236","English","PLoS Comput. Biol.",Article,"Final",Open Access,Scopus,2-s2.0-84892707939
"Julià A., Domènech E., Ricart E., Tortosa R., García-Sánchez V., Gisbert J.P., Mateu P.N., Gutiérrez A., Gomollón F., Mendoza J.L., Garcia-Planella E., Barreiro-De Acosta M., Muñoz F., Vera M., Saro C., Esteve M., Andreu M., Alonso A., López-Lasanta M., Codó L., Gelpí J.L., García-Montero A.C., Bertranpetit J., Absher D., Panés J., Marsal S.","57210878792;55403162200;6603606915;22235662000;23467027100;15738414000;6507991598;23070761700;36854127900;7102491741;6507483158;16240700200;7103206318;55347520400;6603201272;7006785161;7006142866;36150353900;23035265100;55882083800;35517522400;6603714021;7005566413;57198406019;55857704800;6603356384;","A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300",2013,"Gut","62","10",,"1440","1445",,25,"10.1136/gutjnl-2012-302865","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878550316&doi=10.1136%2fgutjnl-2012-302865&partnerID=40&md5=0cf0cd0925bca567a821534351b15054","Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Digestive System Service, Hospital Universitari Germans Trias i Pujol, Badalona, 08196, Spain; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain; Gastroenterology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain; Digestive System Service, Hospital Universitario Reina Sofía, Córdoba, Spain; Gastroenterology Service, Hospital Universitario de la Princesa and IP, Madrid, Spain; Digestive Medicine Service, Hospital la Fe, Valencia, Spain; Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Digestive System Service, Hospital Clínico Universitario, Zaragoza, Spain; Gastroenterology Service, Hospital Clínico San Carlos, Madrid, Spain; Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Gastroenterology Service, Hospital Clínico Universitario, Santiago de Compostela, Spain; Gastroenterology Service, Complejo Hospitalario de León, León, Spain; Gastroenterology Service, Hospital Universitario Puerta de Hierro, Madrid, Spain; Internal Medicine Service, Hospital de Cabueñes, Gijón, Spain; Gastroenterology Service, Hospital Universitari Mutua de Terrassa, Barcelona, Spain; Department of Gastroenterology, IMIM, Institute of Research Hospital del Mar, Parc de Salut Mar, Pompeu Fabra University, Barcelona, Spain; Barcelona Supercomputing Centre, Life Sciences, National Institute of Bioinformatics, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Nacional Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States","Julià, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Domènech, E., Digestive System Service, Hospital Universitari Germans Trias i Pujol, Badalona, 08196, Spain, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain; Ricart, E., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; García-Sánchez, V., Digestive System Service, Hospital Universitario Reina Sofía, Córdoba, Spain; Gisbert, J.P., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Service, Hospital Universitario de la Princesa and IP, Madrid, Spain; Mateu, P.N., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Digestive Medicine Service, Hospital la Fe, Valencia, Spain; Gutiérrez, A., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Service, Hospital General de Alicante, Alicante, Spain; Gomollón, F., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Digestive System Service, Hospital Clínico Universitario, Zaragoza, Spain; Mendoza, J.L., Gastroenterology Service, Hospital Clínico San Carlos, Madrid, Spain; Garcia-Planella, E., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Barreiro-De Acosta, M., Gastroenterology Service, Hospital Clínico Universitario, Santiago de Compostela, Spain; Muñoz, F., Gastroenterology Service, Complejo Hospitalario de León, León, Spain; Vera, M., Gastroenterology Service, Hospital Universitario Puerta de Hierro, Madrid, Spain; Saro, C., Internal Medicine Service, Hospital de Cabueñes, Gijón, Spain; Esteve, M., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Service, Hospital Universitari Mutua de Terrassa, Barcelona, Spain; Andreu, M., Department of Gastroenterology, IMIM, Institute of Research Hospital del Mar, Parc de Salut Mar, Pompeu Fabra University, Barcelona, Spain; Alonso, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; López-Lasanta, M., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain; Codó, L., Barcelona Supercomputing Centre, Life Sciences, National Institute of Bioinformatics, Barcelona, Spain; Gelpí, J.L., Barcelona Supercomputing Centre, Life Sciences, National Institute of Bioinformatics, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; García-Montero, A.C., Banco Nacional de ADN Carlos III, University of Salamanca, Salamanca, Spain; Bertranpetit, J., Nacional Genotyping Centre (CeGen), Universitat Pompeu Fabra, Barcelona, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, AL, United States; Panés, J., Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain, Gastroenterology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain; Marsal, S., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona, Spain","Objective: Genome-wide association studies (GWAS) have identified multiple risk loci for Crohn's disease (CD). However, the cumulative risk exerted by these loci is low, and the likelihood that additional, as-yet undiscovered loci contribute to the risk of CD is very high. We performed a GWAS on a southern European population to identify new CD risk loci. Design: We genotyped 620 901 genome markers on 1341 CD patients and 1518 controls from Spain. The top association signals representing new candidate risk loci were subsequently analysed in an independent replication cohort of 1365 CD patients and 1396 controls. Results: We identified a genome-wide significant association on chromosome 22q13.2 in the intergenic region between the RBX1 and EP300 genes (single nucleotide polymorphism rs4820425, OR 1.27, 95% CI 1.17 to 1.38, p=3.42E-8). We also found suggestive evidence for the association of the IFNGR2 (21q22.11), FOXP2 (7q31), MACROD2 (20p12.1) and AIF1 (6p21.3) loci with CD risk. Conclusions: In this GWAS performed on a southern European cohort, we have identified a new risk locus for CD between RBX1 and EP300. This study demonstrates that using populations of different ancestry is a useful strategy to identify new risk loci for CD.",,"allograft inflammatory factor 1; E1A associated p300 protein; transcription factor FOXP2; adult; AIF1 gene; article; chromosome 22q; cohort analysis; controlled study; Crohn disease; EP300 gene; Europe; female; FoxP2 gene; gene; gene locus; genetic association; genetic risk; genetic susceptibility; human; IFNGR2 gene; MACROD2 gene; major clinical study; male; priority journal; RBX1 gene; risk assessment; single nucleotide polymorphism; Crohn's Disease; Genetic Polymorphisms; Genetics; Adult; Carrier Proteins; Case-Control Studies; Chromosomes, Human, Pair 22; Crohn Disease; DNA, Intergenic; E1A-Associated p300 Protein; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Spain",,"allograft inflammatory factor 1, 200890-56-8; Carrier Proteins; DNA, Intergenic; E1A-Associated p300 Protein, 2.3.1.48; EP300 protein, human, 2.3.1.48; RBX1 protein, human",,,,,,,"Loftus Jr., E.V., Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences (2004) Gastroenterology, 126 (6), pp. 1504-1517. , DOI 10.1053/j.gastro.2004.01.063; Khor, B., Gardet, A., Xavier, R.J., Genetics and pathogenesis of inflammatory bowel disease (2011) Nature, 474, pp. 307-317; Duerr, R.H., Taylor, K.D., Brant, S.R., Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., Cho, J.H., A genome-wide association study identifies IL23R as an inflammatory bowel disease gene (2006) Science, 314 (5804), pp. 1461-1463. , DOI 10.1126/science.1135245; Franke, A., McGovern, D.P., Barrett, J.C., Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci (2011) Nat Genet, 42, pp. 1118-1125; Lees, C.W., Barrett, J.C., Parkes, M., New IBD genetics: Common pathways with other diseases (2011) Gut, 60, pp. 1739-1753; Barrett, J.C., Hansoul, S., Nicolae, D.L., Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008) Nat Genet, 40, pp. 955-962; Hirschhorn, J.N., Genomewide association studies - Illuminating biologic pathways (2009) N Engl J Med, 360, pp. 1699-1701; Lennard-Jones, J.E., Classification of inflammatory bowel disease (1989) Scandinavian Journal of Gastroenterology, Supplement, 24 (170), pp. 2-6; Julià, A., Ballina, J., Cañete, J., Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility (2008) Arthritis Rheum, 58, pp. 2275-2286; Nelis, M., Esko, T., Magi, R., Genetic structure of Europeans: A view from the north-east (2009) PLoS One, 4, pp. e5472; Chaparro, M., Panes, J., Garcia, V., Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose ""escalation"" in patients losing response (2011) J Clin Gastroenterol, 45, pp. 113-118; Alonso, A., Julia, A., Tortosa, R., CNstream: A method for the identification and genotyping of copy number polymorphisms using Illumina microarrays (2010) BMC Bioinformatics, 11, p. 264; Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A., Reich, D., Principal components analysis corrects for stratification in genome-wide association studies (2006) Nature Genetics, 38 (8), pp. 904-909. , DOI 10.1038/ng1847, PII NG1847; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R., Bender, D., Maller, J., Sham, P.C., PLINK: A tool set for whole-genome association and population-based linkage analyses (2007) American Journal of Human Genetics, 81 (3), pp. 559-575. , DOI 10.1086/519795; Feng, X., Wang, H., Takata, H., Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells (2011) Nat Immunol, 12, pp. 544-550; Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M., Regulatory T cells and immune tolerance (2008) Cell, 133 (5), pp. 775-787. , DOI 10.1016/j.cell.2008.05.009, PII S0092867408006247; Purcell, S., Cherny, S.S., Sham, P.C., Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits (2003) Bioinformatics, 19 (1), pp. 149-150. , DOI 10.1093/bioinformatics/19.1.149; Hung, R.J., McKay, J.D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Brennan, P., A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 (2008) Nature, 452 (7187), pp. 633-637. , DOI 10.1038/nature06885, PII NATURE06885; Li, Y., Willer, C.J., Ding, J., MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes (2010) Genet Epidemiol, 34, pp. 816-834; Zeller, T., Wild, P., Szymczak, S., Genetics and beyond - The transcriptome of human monocytes and disease susceptibility (2010) PLoS One, 5, pp. e10693; Anderson, C.A., Boucher, G., Lees, C.W., Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) Nat Genet, 43, pp. 246-252; Liu, L., Scolnick, D.M., Trievel, R.C., Zhang, H.B., Marmorstein, R., Halazonetis, T.D., Berger, S.L., P53 Sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage (1999) Molecular and Cellular Biology, 19 (2), pp. 1202-1209; Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D.H., Nabel, G.J., Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator (1997) Science, 275 (5299), pp. 523-527. , DOI 10.1126/science.275.5299.523; Gayther, S.A., Batley, S.J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Caldas, C., Mutations truncating the EP300 acetylase in human cancers (2000) Nature Genetics, 24 (3), pp. 300-303. , DOI 10.1038/73536; Chen, L.F., Greene, W.C., Shaping the nuclear action of NF-kappaB (2004) Nat Rev Mol Cell Biol, 5, pp. 392-401; Wang, K., Zhang, H., Kugathasan, S., Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease (2009) Am J Hum Genet, 84, pp. 399-405; Zhang, M., Zhang, J., Rui, J., P300-mediated acetylation stabilizes the Th-inducing POK factor (2010) J Immunol, 185, pp. 3960-3969; Van Loosdregt, J., Vercoulen, Y., Guichelaar, T., Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization (2010) Blood, 115, pp. 965-974; Fairfax, B.P., Makino, S., Radhakrishnan, J., Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles (2012) Nat Genet, 44, pp. 502-510; Davis, K.M., Nakamura, S., Weiser, J.N., Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. Pneumoniae colonization in mice (2011) J Clin Invest, 121, pp. 3666-3676; Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls (2007) Nature, 447, pp. 661-678. , WTCC; Libioulle, C., Louis, E., Hansoul, S., Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4 (2007) PLoS Genet, 3, pp. e58; Kenny, E.E., Pe'er, I., Karban, A., A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci (2012) PLoS Genet, 8, pp. e1002559; Gaya, D.R., Russell, R.K., Nimmo, E.R., New genes in inflammatory bowel disease: Lessons for complex diseases? (2006) Lancet, 367, pp. 1271-1284; Nakagome, S., Takeyama, Y., Mano, S., Population-specific susceptibility to Crohn's disease and ulcerative colitis; dominant and recessive relative risks in the Japanese population (2010) Ann Hum Genet, 74, pp. 126-136; Prescott, N.J., Dominy, K.M., Kubo, M., Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease (2010) Hum Mol Genet, 19, pp. 1828-1839; Gasche, C., Grundtner, P., Genotypes and phenotypes in Crohn's disease: Do they help in clinical management? (2005) Gut, 54 (1), pp. 162-167. , DOI 10.1136/gut.2003.035600; Elding, H., Lau, W., Swallow, D.M., Dissecting the genetics of complex inheritance: Linkage disequilibrium mapping provides insight into Crohn disease (2011) Am J Hum Genet, 89, pp. 798-805; Parkes, M., Barrett, J.C., Prescott, N.J., Tremelling, M., Anderson, C.A., Fisher, S.A., Roberts, R.G., Mathew, C.G., Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility (2007) Nature Genetics, 39 (7), pp. 830-832. , DOI 10.1038/ng2061, PII NG2061; Imielinski, M., Baldassano, R.N., Griffiths, A., Common variants at five new loci associated with early-onset inflammatory bowel disease (2009) Nat Genet, 41, pp. 1335-1340","Domènech, E.; Digestive System Service, Hospital Universitari Germans Trias i Pujol, Badalona, 08196, Spain; email: edomenech.germanstrias@gencat.cat",,,,,,,,00175749,,GUTTA,"22936669","English","Gut",Article,"Final",,Scopus,2-s2.0-84878550316
"Hospital A., Gelpi J.L.","15831739300;35517522400;","High-throughput molecular dynamics simulations: Toward a dynamic view of macromolecular structure",2013,"Wiley Interdisciplinary Reviews: Computational Molecular Science","3","4",,"364","377",,2,"10.1002/wcms.1142","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879101177&doi=10.1002%2fwcms.1142&partnerID=40&md5=75f909c11ae001641267b446dc337db2","Institute of Research in Biomedicine, Joint IRB-BSC Computational Biology Programme, Structural Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; Barcelona Supercomputing Center, Joint Program IRB-BSC for Computational Biology, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Hospital, A., Institute of Research in Biomedicine, Joint IRB-BSC Computational Biology Programme, Structural Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; Gelpi, J.L., Barcelona Supercomputing Center, Joint Program IRB-BSC for Computational Biology, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Molecular dynamics (MD) simulation is nowadays the eligible theoretical technique to account for macromolecular flexibility. Molecular simulations, from ab initio to coarse-grained representation levels, allow having a direct visualization of macromolecular dynamic behavior and its influence in molecular recognition. In the postgenomic era, where most bioinformatics studies should be performed genome-wide, molecular simulations should not be an exception. However, moving MD simulations to the high-throughput regime is not a trivial issue. High-performance computing systems (highly parallel supercomputers or graphical processing units-based systems) allow performing large and complex simulations at a significantly reduced time. Besides, data storage strategies have also been largely improved. However, system preparation and trajectory analysis are still performed almost manually and become highly limited by the need of human intervention. A number of projects, like Dynameomics, BioSimGrid, or MoDEL have addressed the issue of high-throughput MD. Such initiatives have released tools that have meant a significant progress in the field. The extension of structural studies, mainly molecular simulations, to the high-throughput regime, will allow matching genomic-wide studies now performed. © 2013 John Wiley & Sons, Ltd.",,"Direct visualization; High performance computing systems; Macromolecular dynamics; Macromolecular structures; Molecular dynamics simulations; Molecular simulations; Theoretical technique; Trajectory analysis; Bioinformatics; Genes; Molecular dynamics; Molecular recognition; Molecular structure; Supercomputers; Macromolecules",,,,,,,,,"Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The protein data bank (2000) Nucleic Acids Res, 28, pp. 235-242; The universal protein resource (UniProt) in 2010 (2010) Nucleic Acids Res, 38, pp. D142-D148. , UnitProt Consortium; Magrane, M., Consortium, U., UniProt knowledgebase: a hub of integrated protein data (2011) Database (Oxford), 2011. , bar009; Benson, D.A., Karsch-Mizrachi, I., Clark, K., Lipman, D.J., Ostell, J., Sayers, E.W., GenBank (2011) Nucleic Acids Res, 40, pp. D48-D53; Tramontano, A., Comparative modelling techniques: where are we? (2003) Comp Funct Genomics, 4, pp. 402-405; Bouvier, B., Zakrzewska, K., Lavery, R., Protein-DNA recognition triggered by a DNA conformational switch (2011) Angew Chem Int Ed Engl, 50, pp. 6516-6518; Zakrzewska, K., Lavery, R., Towards a molecular view of transcriptional control (2012) Curr Opin Struct Biol, 22, pp. 160-167; Kumar, S., Ma, B., Tsai, C.J., Wolfson, H., Nussinov, R., Folding funnels and conformational transitions via hinge-bending motions (1999) Cell Biochem Biophys, 31, pp. 141-164; Tsai, C.J., Kumar, S., Ma, B., Nussinov, R., Folding funnels, binding funnels, and protein function (1999) Protein Sci, 8, pp. 1181-1190; Bahar, I., Chennubhotla, C., Tobi, D., Intrinsic dynamics of enzymes in the unbound state and relation to allosteric regulation (2007) Curr Opin Struct Biol, 17, pp. 633-640; Stevens, R.C., Lipscomb, W.N., Allosteric control of quaternary states in E. coli aspartate transcarbamylase (1990) Biochem Biophys Res Commun, 171, pp. 1312-1318; Shinoda, T., Arai, K., Shigematsu-Iida, M., Ishikura, Y., Tanaka, S., Yamada, T., Kimber, M.S., Taguchi, H., Distinct conformation-mediated functions of an active site loop in the catalytic reactions of NAD-dependent d-lactate dehydrogenase and formate dehydrogenase (2005) J Biol Chem, 280, pp. 17068-17075; Karplus, M., Role of conformation transitions in adenylate kinase (2010) Proc Natl Acad Sci USA, 107, pp. E71. , author reply E72; Kalko, S.G., Gelpi, J.L., Fita, I., Orozco, M., Theoretical study of the mechanisms of substrate recognition by catalase (2001) J Am Chem Soc, 123, pp. 9665-9672; Jakopitsch, C., Droghetti, E., Schmuckenschlager, F., Furtmuller, P.G., Smulevich, G., Obinger, C., Role of the main access channel of catalase-peroxidase in catalysis (2005) J Biol Chem, 280, pp. 42411-42422; Hara, I., Ichise, N., Kojima, K., Kondo, H., Ohgiya, S., Matsuyama, H., Yumoto, I., Relationship between the size of the bottleneck 15 A from iron in the main channel and the reactivity of catalase corresponding to the molecular size of substrates (2007) Biochemistry, 46, pp. 11-22; Bidon-Chanal, A., Marti, M.A., Estrin, D.A., Luque, F.J., Dynamical regulation of ligand migration by a gate-opening molecular switch in truncated hemoglobin-N from Mycobacterium tuberculosis (2007) J Am Chem Soc, 129, pp. 6782-6788; Guallar, V., Lu, C., Borrelli, K., Egawa, T., Yeh, S.R., Ligand migration in the truncated hemoglobin-II from Mycobacterium tuberculosis: the role of G8 tryptophan (2009) J Biol Chem, 284, pp. 3106-3116; Daigle, R., Guertin, M., Lague, P., Structural characterization of the tunnels of Mycobacterium tuberculosis truncated hemoglobin N from molecular dynamics simulations (2009) Proteins, 75, pp. 735-747; Perez, A., Noy, A., Lankas, F., Luque, F.J., Orozco, M., The relative flexibility of B-DNA and A-RNA duplexes: database analysis (2004) Nucleic Acids Res, 32, pp. 6144-6151; Leo-Macias, A., Lopez-Romero, P., Lupyan, D., Zerbino, D., Ortiz, A.R., An analysis of core deformations in protein superfamilies (2005) Biophys J, 88, pp. 1291-1299; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; Roccatano, D., Barthel, A., Zacharias, M., Structural flexibility of the nucleosome core particle at atomic resolution studied by molecular dynamics simulation (2007) Biopolymers, 85, pp. 407-421; Tinoco, I.J., Wen, J.D., Simulation and analysis of single-ribosome translation (2009) Phys Biol, 6, p. 025006; Brandman, R., Brandman, Y., Pande, V.S., A-site residues move independently from P-site residues in all-atom molecular dynamics simulations of the 70S bacterial ribosome (2012) PLoS One, 7, pp. e29377; Orozco, M., Orellana, L., Hospital, A., Naganathan, A.N., Emperador, A., Carrillo, O., Gelpi, J.L., Coarse-grained representation of protein flexibility. Foundations, successes, and shortcomings (2011) Adv Protein Chem Struct Biol, 85, pp. 183-215; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem Rev, 100, pp. 4187-4226; Vorobjev, Y.N., Advances in implicit models of water solvent to compute conformational free energy and molecular dynamics of proteins at constant pH (2011) Adv Protein Chem Struct Biol, 85, pp. 281-322; Hermans, J., Berendsen, H.J.C., Vangunsteren, W.F., Postma, J.P.M., A consistent empirical potential for water-protein interactions (1984) Biopolymers, 23, pp. 1513-1518; Mackerell, A.D., Wiorkiewiczkuczera, J., Karplus, M., An all-atom empirical energy function for the simulation of nucleic-acids (1995) J Am Chem Soc, 117, pp. 11946-11975; Ott, K.H., Meyer, B., Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations (1996) J Comput Chem, 17, pp. 1068-1084; MacKerell, A.D., Bashford, D., Bellott, M., Dunbrack, R.L., Evanseck, J.D., Field, M.J., Fischer, S., Ha, S., All-atom empirical potential for molecular modeling and dynamics studies of proteins (1998) J Phys Chem B, 102, pp. 3586-3616; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A 2nd generation force-field for the simulation of proteins, nucleic-acids, and organic-molecules (1995) J Am Chem Soc, 117, pp. 5179-5197; Kaminski, G.A., Friesner, R.A., Tirado-Rives, J., Jorgensen, W.L., Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides (2001) J Phys Chem B, 105, pp. 6474-6487; Rueda, M., Ferrer-Costa, C., Meyer, T., Perez, A., Camps, J., Hospital, A., Gelpi, J.L., Orozco, M., A consensus view of protein dynamics (2007) Proc Natl Acad Sci USA, 104, pp. 796-801; Perez, A., Lankas, F., Luque, F.J., Orozco, M., Towards a molecular dynamics consensus view of B-DNA flexibility (2008) Nucleic Acids Res, 36, pp. 2379-2394; Case, D.A., Darden, T.A., Cheatham, I.T.E., Simmerling, C.L., Wang, J., Duke, R.E., Luo, R., Merz, K.M., (2012) AMBER 12, , San Francisco, California: University of California, San Francisco; Brooks, B.R., Brooks, C.3., Mackerell, A.J., Nilsson, L., Petrella, R.J., Roux, B., Won, Y., Boresch, S., CHARMM: the biomolecular simulation program (2009) J Comput Chem, 30, pp. 1545-1614; Hess, B., Kutzner, C., van der Spoel, D., Lindahl, E., GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation (2008) J Chem Theory Comput, 4, pp. 435-447; Nelson, M.T., Humphrey, W., Gursoy, A., Dalke, A., Kale, L.V., Skeel, R.D., Schulten, K., NAMD: a parallel, object oriented molecular dynamics program (1996) Int J Supercomput Appl High Perf Comput, 10, pp. 251-268; Larsson, P., Hess, B., Lindahl, E., Algorithm improvements for molecular dynamics simulations (2010) WIREs Comput Mol Sci, 1, pp. 93-108; Tanner, D.E., Chan, K.Y., Phillips, J.C., Schulten, K., Parallel generalized born implicit solvent calculations with NAMD (2011) J Chem Theory Comput, 7, pp. 3635-3642; Predescu, C., Lippert, R.A., Eastwood, M.P., Ierardi, D., Xu, H., Jensen, M.O., Bowers, K.J., Dror, R.O., Computationally efficient molecular dynamics integrators with improved sampling accuracy (2012) Mol Phys, 110, pp. 967-983; Bowers, K.J., Dror, R.O., Shaw, D.E., The midpoint method for parallelization of particle simulations (2006) J Chem Phys, 124, p. 184109; Shaw, D.E., A fast, scalable method for the parallel evaluation of distance-limited pairwise particle interactions (2005) J Comput Chem, 26, pp. 1318-1328; Harvey, M., Giupponi, G., De Fabritiis, G., ACEMD: accelerated molecular dynamics simulations in the microseconds timescale (2009) J Chem Theory Comput, 5, pp. 1632-1639; Kikugawa, G., Apostolov, R., Kamiya, N., Taiji, M., Himeno, R., Nakamura, H., Yonezawa, Y., Application of MDGRAPE-3, a special purpose board for molecular dynamics simulations, to periodic biomolecular systems (2009) J Comput Chem, 30, pp. 110-118; Shaw, D.E., Deneroff, M.M., Dror, R.O., Kuskin, J.S., Larson, R.H., Salmon, J.K., Young, C., Chao, J.C., Anton, a special-purpose machine for molecular dynamics simulation (2008) Commun ACM, 51, pp. 91-97; Shirts, M., Pande, V.S., Computing: screen savers of the world unite (2000) Science, 290, pp. 1903-1904; Buch, I., Harvey, M.J., Giorgino, T., Anderson, D.P., De Fabritiis, G., High-throughput all-atom molecular dynamics simulations using distributed computing (2010) J Chem Inf Model, 50, pp. 397-403; Bertini, I., Case, D.A., Ferella, L., Giachetti, A., Rosato, A., A Grid-enabled web portal for NMR structure refinement with AMBER (2011) Bioinformatics, 27, pp. 2384-2390; Micheletti, C., Laio, A., Parrinello, M., Reconstructing the density of states by history-dependent metadynamics (2004) Phys Rev Lett, 92, p. 170601; Laio, A., Rodriguez-Fortea, A., Gervasio, F.L., Ceccarelli, M., Parrinello, M., Assessing the accuracy of metadynamics (2005) J Phys Chem B, 109, pp. 6714-6721; Raiteri, P., Laio, A., Gervasio, F.L., Micheletti, C., Parrinello, M., Efficient reconstruction of complex free energy landscapes by multiple walkers metadynamics (2006) J Phys Chem B, 110, pp. 3533-3539; Nymeyer, H., Gnanakaran, S., Garcia, A.E., Atomic simulations of protein folding, using the replica exchange algorithm (2004) Methods Enzymol, 383, pp. 119-149; Kubitzki, M.B., de Groot, B.L., Molecular dynamics simulations using temperature-enhanced essential dynamics replica exchange (2007) Biophys J, 92, pp. 4262-4270; Meng, Y., Dashti, D.S., Roitberg, A.E., Computing alchemical free energy differences with Hamiltonian replica exchange molecular dynamics (H-REMD) simulations (2011) J Chem Theory Comput, 7, pp. 2721-2727; Burgi, R., Kollman, P.A., Van Gunsteren, W.F., Simulating proteins at constant pH: an approach combining molecular dynamics and Monte Carlo simulation (2002) Proteins, 47, pp. 469-480; Stern, H.A., Molecular simulation with variable protonation states at constant pH (2007) J Chem Phys, 126, p. 164112; Tai, K., Murdock, S., Wu, B., Ng, M.H., Johnston, S., Fangohr, H., Cox, S.J., Sansom, M.S., BioSimGrid: towards a worldwide repository for biomolecular simulations (2004) Org Biomol Chem, 2, pp. 3219-3221; Silva, C.G., Ostropytskyy, V., Loureiro-Ferreira, N., Berrar, D., Dubitzky, W., Brito, R.M.M., (2006) P-found: The protein Folding and Unfolding Simulation Repository, , New York: IEEE; Apostolov, R., Axner, L., Agren, H., Ayugade, E., Duta, M., Gelpi, J.L., Gimenez, J., Jamitzky, F., ScalaLife: scalable software services for Life Science (2011) Proceedings of the 9th HealthGrid Conference, , Bristol, UK; van der Kamp, M.W., Schaeffer, R.D., Jonsson, A.L., Scouras, A.D., Simms, A.M., Toofanny, R.D., Benson, N.C., Rysavy, S., Dynameomics: a comprehensive database of protein dynamics (2010) Structure, 18, pp. 423-435; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Perez, A., Carrillo, O., Repchevsky, D., MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories (2010) Structure, 18, pp. 1399-1409; Day, R., Beck, D.A., Armen, R.S., Daggett, V., A consensus view of fold space: combining SCOP, CATH, and the Dali Domain Dictionary (2003) Protein Sci, 12, pp. 2150-2160; Meyer, T., Ferrer-Costa, C., Perez, A., Rueda, M., Bidon-Chanal, A., Luque, F.J., Laughton, C.A., Orozco, M., Essential dynamics: a tool for efficient trajectory compression and management (2006) J Chem Theory Comput, 2, pp. 251-258; Beck, D.A., Alonso, D.O.V., Daggett, V., (2000) In Lucem molecular Mechanics, , Seattle, Washington: University of Washington; Simms, A.M., Toofanny, R.D., Kehl, C., Benson, N.C., Daggett, V., Dynameomics: design of a computational lab workflow and scientific data repository for protein simulations (2008) Protein Eng Des Sel, 21, pp. 369-377; Lavery, R., Zakrzewska, K., Beveridge, D., Bishop, T.C., Case, D.A., Cheatham, T.3., Dixit, S., Laughton, C., A systematic molecular dynamics study of nearest-neighbor effects on base pair and base pair step conformations and fluctuations in B-DNA (2009) Nucleic Acids Res, 38, pp. 299-313; Jo, S., Kim, T., Iyer, V.G., Im, W., CHARMM-GUI: a web-based graphical user interface for CHARMM (2008) J Comput Chem, 29, pp. 1859-1865; Miller, B.T., Singh, R.P., Klauda, J.B., Hodoscek, M., Brooks, B.R., Woodcock, H.3., CHARMMing: a new, flexible web portal for CHARMM (2008) J Chem Inf Model, 48, pp. 1920-1929; Kota, P., GUIMACS-a Java based front end for GROMACS (2007) In Silico Biol, 7, pp. 95-99; Sellis, D., Vlachakis, D., Vlassi, M., Gromita: a fully integrated graphical user interface to gromacs 4 (2009) Bioinform Biol Insights, 3, pp. 99-102; Roopra, S., Knapp, B., Omasits, U., Schreiner, W., jSimMacs for GROMACS: a Java application for advanced molecular dynamics simulations with remote access capability (2009) J Chem Inf Model, 49, pp. 2412-2417; Humphrey, W., Dalke, A., Schulten, K., VMD: visual molecular dynamics (1996) J Mol Graph, 14, pp. 33-38. , 27-38; Hospital, A., Andrio, P., Fenollosa, C., Cicin-Sain, D., Orozco, M., Gelpi, J.L., MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations (2012) Bioinformatics, 28, pp. 1278-1279; Wilkinson, M.D., Senger, M., Kawas, E., Bruskiewich, R., Gouzy, J., Noirot, C., Bardou, P., Saiz, E., Interoperability with Moby 1.0-it's better than sharing your toothbrush (2008) Brief Bioinfor, 9, pp. 220-231; Tsujishita, H., Hirono, S., CAMDAS: an automated conformational analysis system using molecular dynamics. Conformational analyzer with molecular dynamics and sampling (1997) J Comput Aided Mol Des, 11, pp. 305-315; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., Cicin-Sain, D., Orozco, M., FlexServ: an integrated tool for the analysis of protein flexibility (2009) Bioinformatics, 25, pp. 1709-1710; Potestio, R., Aleksiev, T., Pontiggia, F., Cozzini, S., Micheletti, C., ALADYN: a web server for aligning proteins by matching their large-scale motion (2010) Nucleic Acids Res, 38, pp. W41-W45; Zhang, Y., Skolnick, J., Scoring function for automated assessment of protein structure template quality (2004) Proteins, 57, pp. 702-710; Fenwick, R., Esteban-Martín, S., Salvatella, X., Understanding biomolecular motion, recognition, and allostery by use of conformational ensembles (2012) Eur Biophys J, 40, pp. 1339-1355; Amadei, A., Linssen, A.B.M., Berendsen, H.J.C., Essential dynamics of proteins (1993) Proteins, 17, pp. 412-425; Harvey, M.J., Giupponi, G., De Fabritiis, G., ACEMD: accelerating biomolecular dynamics in the microsecond time scale (2009) J Chem Theory Comput, 5, pp. 1632-1639; Perez, A., Luque, F.J., Orozco, M., Frontiers in molecular dynamics simulations of DNA (2011) Acc Chem Res, 45, pp. 196-205; Durrant, J.D., McCammon, J.A., Molecular dynamics simulations and drug discovery (2011) BMC Biol, 9, p. 71; Harvey, M.J., De Fabritiis, G., High-throughput molecular dynamics: the powerful new tool for drug discovery (2012) Drug Discov Today, 19-20, pp. 1059-1062; Borhani, D.W., Shaw, D.E., The future of molecular dynamics simulations in drug discovery (2012) J Comput Aided Mol Des, 26, pp. 15-26","Gelpi, J.L.; Barcelona Supercomputing Center, Joint Program IRB-BSC for Computational Biology, Computational Bioinformatics, National Institute of Bioinformatics, Barcelona, Spain; email: gelpi@ub.edu",,,,,,,,17590876,,,,"English","Wiley Interdiscip. Rev. Comput. Mol. Sci.",Article,"Final",,Scopus,2-s2.0-84879101177
"Emperador A., Solernou A., Sfriso P., Pons C., Gelpi J.L., Fernandez-Recio J., Orozco M.","57208980207;23028940200;55480428500;24071268100;35517522400;55909661300;7102809158;","Efficient relaxation of protein-protein interfaces by discrete molecular dynamics simulations",2013,"Journal of Chemical Theory and Computation","9","2",,"1222","1229",,10,"10.1021/ct301039e","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873694997&doi=10.1021%2fct301039e&partnerID=40&md5=2f771e38233e7e8f91dac953305ab593","Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona 08028, Spain; Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain; Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona 08028, Spain","Emperador, A., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona 08028, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Solernou, A., Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Sfriso, P., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona 08028, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Pons, C., Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Gelpi, J.L., Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain, Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona 08028, Spain; Fernandez-Recio, J., Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain; Orozco, M., Institute for Research in Biomedicine (IRB Barcelona), Baldiri i Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain, Joint BSC-IRB Research Program in Computational Biology, Barcelona, Spain, Departament de Bioquímica, Facultat de Biologia, Avgda Diagonal 645, Barcelona 08028, Spain","Protein-protein interactions are responsible for the transfer of information inside the cell and represent one of the most interesting research fields in structural biology. Unfortunately, after decades of intense research, experimental approaches still have difficulties in providing 3D structures for the hundreds of thousands of interactions formed between the different proteins in a living organism. The use of theoretical approaches like docking aims to complement experimental efforts to represent the structure of the protein interactome. However, we cannot ignore that current methods have limitations due to problems of sampling of the protein-protein conformational space and the lack of accuracy of available force fields. Cases that are especially difficult for prediction are those in which complex formation implies a non-negligible change in the conformation of the interacting proteins, i.e., those cases where protein flexibility plays a key role in protein-protein docking. In this work, we present a new approach to treat flexibility in docking by global structural relaxation based on ultrafast discrete molecular dynamics. On a standard benchmark of protein complexes, the method provides a general improvement over the results obtained by rigid docking. The method is especially efficient in cases with large conformational changes upon binding, in which structure relaxation with discrete molecular dynamics leads to a predictive success rate double that obtained with state-of-the-art rigid-body docking. © 2012 American Chemical Society.",,,,,,,,,,,"Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Tasumi, M., (1977) J. Mol. Biol., 112, pp. 535-542; Stein, A., Mosca, R., Aloy, P., (2011) Curr. Opin. Struct. Biol., 21, pp. 200-208; Venkatesan, K., Rual, J.-F., Vazquez, A., Stelzl, U., Lemmens, I., Hirozane-Kishikawa, T., Hao, T., Vidal, M., (2009) Nat. Methods, 6, pp. 83-90; Halperin, I., Ma, B., Wolfson, H., Nussinov, R., (2002) Proteins, 47, pp. 409-443; Ritchie, D., (2008) Curr. Protein Pept. Sci., 9, pp. 1-15; Pons, C., Grosdidier, S., Solernou, A., Pérez-Cano, L., Fernández-Recio, J., (2010) Proteins, 78, pp. 95-108; Fischer, H.E., (1894) Chem. Ber., 27, pp. 2985-2993; Stein, A., Rueda, M., Panjkovich, A., Orozco, M., Aloy, P., (2011) Structure, 19, pp. 881-889; Pons, C., D'Abramo, M., Svergun, D.I., Orozco, M., Bernadó, P., Fernández-Recio, J., (2010) J. Mol. Biol., 403, pp. 217-230; Zacharias, M., (2010) Curr. Opin. Struct. Biol., 20, pp. 180-186; Bonvin, A.M.J.J., (2006) Curr. Opin. Struct. Biol., 16, pp. 194-200; Fernández-Recio, J., Totrov, M., Abagyan, R., (2002) Protein Sci., 11, pp. 280-291; Fernández-Recio, J., Totrov, M., Abagyan, R., (2003) Proteins, 52, pp. 113-117; Fernández-Recio, J., Abagyan, R., Totrov, M., (2005) Proteins, 60, pp. 308-313; Dominguez, C., Boelens, R., Bonvin, A.M.J.J., (2003) J. Am. Chem. Soc., 125, pp. 1731-1737; Dobbins, S.E., Lesk, V.I., Sternberg, M.J.E., (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 10390-10395; Zacharias, M., (2004) Proteins, 54, pp. 759-767; Wang, C., Bradley, P., Baker, D., (2007) J. Mol. Biol., 373, pp. 503-519; Gray, J.J., Moughon, S., Wang, C., Schueler-Furman, O., Kuhlman, B., Rohl, C.A., Baker, D., (2003) J. Mol. Biol., 331, pp. 281-299; Chen, R., Mintseris, J., Janin, J., Weng, Z., (2003) Proteins, 52, pp. 88-91; Zhou, Y.Q., Karplus, M., (1999) Nature, 401, pp. 400-403; Emperador, A., Meyer, T., Orozco, M., (2010) Proteins, 78, pp. 83-94; Urbanc, B., Cruz, L., Yun, S., Buldyrev, S.V., Bitan, G., Teplow, D.B., Stanley, H.E., (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17345-17350; Ding, F., Buldyrev, S.V., Dokholyan, N.V., (2005) Biophys. J., 88, pp. 147-155; Ding, F., Sharma, S., Chalasani, P., Demidov, V.V., Broude, N.E., Dokholyan, N.V., (2008) RNA, 14, pp. 1164-1173; Ding, F., Laroque, J.J., Dokholyan, N.V., (2005) J. Biol. Chem., 280, pp. 40235-40240; Nguyen, H., Hall, C., (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 16180-16185; Ding, F., Borreguero, J.M., Buldyrev, S.V., Stanley, H.E., Dokholyan, N.V., (2003) Proteins, 53, pp. 220-228; Sfriso, P., Emperador, A., Orellana, L., Hospital, A., Gelpi, J.L., Orozco, M., (2012) J. Chem. Theory Comput., 8, pp. 4707-4718; Alder, B.J., Wainwright, T.E., (1959) J. Chem. Phys., 31, pp. 459-466; Smith, W.S., Hall, C.K., Freeman, B.D., (1997) J. Comput. Phys., 134, pp. 16-30; Hwang, H., Vreven, T., Janin, J., Weng, Z., (2010) Proteins, 78, pp. 3111-3114; Gabb, H.A., Jackson, R.M., Sternberg, M.J.E., (1997) J. Mol. Biol., 272, pp. 106-120; Cheng, T., Blundell, T.L., Fernández-Recio, J., (2007) Proteins, 68, pp. 503-515; Grosdidier, S., Pons, C., Solernou, A., Fernández-Recio, J., (2007) Proteins, 69, pp. 852-858; Pons, C., Solernou, A., Pérez-Cano, L., Grosdidier, S., Fernández-Recio, J., (2010) Proteins, 78, pp. 3182-3188; Fernández-Recio, J., Totrov, M., Abagyan, R., (2004) J. Mol. Biol., 335, pp. 843-865; Lazaridis, T., Karplus, M., (1999) Proteins, 35, pp. 133-152; Rueda, M., Chachon, P., Orozco, M., (2007) Structure, 15, pp. 565-575; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., Hospital, A., Gelpí, J.L., Orozco, M., (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 796-801","Fernandez-Recio, J.; Barcelona Supercomputing Center, Jordi Girona 29, Barcelona 08034, Spain; email: juanf@bsc.es",,,,,,,,15499618,,JCTCC,,"English","J. Chem. Theory Comput.",Article,"Final",,Scopus,2-s2.0-84873694997
"Hospital A., Faustino I., Collepardo-Guevara R., González C., Gelpí J.L., Orozco M.","15831739300;35315628900;6508367636;30267572700;35517522400;7102809158;","NAFlex: a web server for the study of nucleic acid flexibility.",2013,"Nucleic acids research","41","Web Server issue",,"W47","55",,15,"10.1093/nar/gkt378","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883591595&doi=10.1093%2fnar%2fgkt378&partnerID=40&md5=e9bc3c516fc413cd27bc1005ec1c3f0e","Institute for Research in Biomedicine, Molecular Modelling and Bioinformatics Department, Barcelona, 08028, Spain","Hospital, A., Institute for Research in Biomedicine, Molecular Modelling and Bioinformatics Department, Barcelona, 08028, Spain; Faustino, I.; Collepardo-Guevara, R.; González, C.; Gelpí, J.L.; Orozco, M.","We present NAFlex, a new web tool to study the flexibility of nucleic acids, either isolated or bound to other molecules. The server allows the user to incorporate structures from protein data banks, completing gaps and removing structural inconsistencies. It is also possible to define canonical (average or sequence-adapted) nucleic acid structures using a variety of predefined internal libraries, as well to create specific nucleic acid conformations from the sequence. The server offers a variety of methods to explore nucleic acid flexibility, such as a colorless wormlike-chain model, a base-pair resolution mesoscopic model and atomistic molecular dynamics simulations with a wide variety of protocols and force fields. The trajectories obtained by simulations, or imported externally, can be visualized and analyzed using a large number of tools, including standard Cartesian analysis, essential dynamics, helical analysis, local and global stiffness, energy decomposition, principal components and in silico NMR spectra. The server is accessible free of charge from the mmb.irbbarcelona.org/NAFlex webpage.",,"DNA; DNA binding protein; mitochondrial protein; mitochondrial transcription factor A; transcription factor; article; chemistry; computer program; conformation; DNA sequence; human; Internet; molecular dynamics; sequence analysis; DNA; DNA-Binding Proteins; Humans; Internet; Mitochondrial Proteins; Molecular Dynamics Simulation; Nucleic Acid Conformation; Sequence Analysis, DNA; Sequence Analysis, RNA; Software; Transcription Factors",,"DNA, 9007-49-2; DNA, 9007-49-2; DNA-Binding Proteins; Mitochondrial Proteins; mitochondrial transcription factor A; Transcription Factors",,,"Fundación Botín

275096

Seventh Framework Programme

European Research Council

Instituto Nacional de Perinatología

Ministerio de Economía y Competitividad: BIO2012-3286

European Research Council","Funding for open access charge: Spanish Ministerio de Economı´a y Competitividad [BIO2012-3286]; European Research Council Advanced Grant (ERC); Instituto Nacional de Bioinformática (INB); Consolider E-Science Project; EU-Scalalife project; Fundación Marcelino Botín; European Union’s Seventh Framework Programme (FP7/2007–2013) [275096 to R.C.-G. and M.O.].",,,,"Hospital, A.",,,,,,,,13624962,,,"23685436","English","Nucleic Acids Res.",Article,"Final",Open Access,Scopus,2-s2.0-84883591595
"Sfriso P., Emperador A., Orellana L., Hospital A., Gelpí J.L., Orozco M.","55480428500;57208980207;35311824100;15831739300;35517522400;7102809158;","Finding conformational transition pathways from discrete molecular dynamics simulations",2012,"Journal of Chemical Theory and Computation","8","11",,"4707","4718",,22,"10.1021/ct300494q","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84869073773&doi=10.1021%2fct300494q&partnerID=40&md5=147e77931b36e9df05f5899b0532bff8","Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Structural Bioinformatics Node, Instituto Nacional de Bioinformática, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Computational Bioinformatics Node, Instituto Nacional de Bioinformática, Barcelona Supercomputing Center, Jordi Girona 29, Barcelona, 08034, Spain; Departament de Bioquímica, Facultat de Biologia, Universtitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain","Sfriso, P., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Emperador, A., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Orellana, L., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Hospital, A., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain, Structural Bioinformatics Node, Instituto Nacional de Bioinformática, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; Gelpí, J.L., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain, Computational Bioinformatics Node, Instituto Nacional de Bioinformática, Barcelona Supercomputing Center, Jordi Girona 29, Barcelona, 08034, Spain, Departament de Bioquímica, Facultat de Biologia, Universtitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain; Orozco, M., Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain, Structural Bioinformatics Node, Instituto Nacional de Bioinformática, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain, Departament de Bioquímica, Facultat de Biologia, Universtitat de Barcelona, Avgda Diagonal 647, Barcelona, 08028, Spain","We present a new method for estimating pathways for conformational transitions in macromolecules from the use of discrete molecular dynamics and biasing techniques based on a combination of essential dynamics and Maxwell-Demon sampling techniques. The method can work with high efficiency at different levels of resolution, including the atomistic one, and can help to define initial pathways for further exploration by means of more accurate atomistic molecular dynamics simulations. The method is implemented in a freely available Web-based application accessible at http://mmb.irbbarcelona.org/MDdMD. © 2012 American Chemical Society.",,,,,,,,,,,"Henzler-Wildman, K.A., Thai, V., Lei, M., Ott, M., Wolf-Watz, M., Fenn, T., Pozharski, E., Kern, D., (2007) Nature, 450, pp. 838-844; Velazquez-Muriel, J.A., Rueda, M., Cuesta, I., Pascual-Montano, A., Orozco, M., Carazo, J.-M., (2009) BMC Struct. Biol., 9, p. 6; Bakan, A., Bahar, I., (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 14349-14354; Yang, L., Song, G., Jernigan, R.L., (2007) Biophys. J., 93, pp. 920-929; Bahar, I., Chennubhotla, C., Tobi, D., (2007) Curr. Opin. Struct. Biol., 17, pp. 633-640; Tobi, D., Bahar, I., (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 18908-18913; Eyal, E., Dutta, A., Bahar, I., (2011) WIREs Comput. Mol. Sci., 1, pp. 426-439; Dobbins, S.E., Lesk, V.I., Sternberg, M.J.E., (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 10390-10395; Gerstein, M., Krebs, W., (1998) Nucleic Acids Res., 26, pp. 4280-4290; Falke, J.J., (2002) Science, 295, pp. 1480-1481; Leo-Macias, A., Lopez-Romero, P., Lupyan, D., Zerbino, D., Ortíz, A.R., (2005) Biophys. J., 88, pp. 1291-1299; Stein, A., Rueda, M., Panjkovich, A., Orozco, M., Aloy, P., (2011) Structure, 19, pp. 881-889; Orellana, L., Rueda, M., Ferrer-Costa, C., Lopez-Blanco, J.R., Chacón, P., Orozco, M., (2010) J. Chem. Theory Comput., 6, pp. 2910-2923; Lindorff-Larsen, K., Best, R.B., Depristo, M.A., Dobson, C.M., Vendruscolo, M., (2005) Nature, 433, pp. 128-132; Ban, D., Funk, M., Gulich, R., Egger, D., Sabo, T.M., Walter, K.F.A., Fenwick, R.B., Griesinger, C., (2011) Angew. Chem., Int. Ed., 50, pp. 11437-11440; Fenwick, R.B., Esteban-Martin, S., Richter, B., Lee, D., Walter, K.F.A., Milovanovic, D., Becker, S., Salvatella, X., (2011) J. Am. Chem. Soc., 133, pp. 10336-10339; Kubitzki, M.B., De Groot, B.L., (2008) Structure, 16, pp. 1175-1182; Maragakis, P., Karplus, M., (2005) J. Mol. Biol., 352, pp. 807-822; Shimamura, T., Weyand, S., Beckstein, O., Rutherford, N.G., Hadden, J.M., Sharples, D., Sansom, M.S.P., Cameron, A.D., (2010) Science, 328, pp. 470-473; Paci, E., Lindorff-Larsen, K., Dobson, C.M., Karplus, M., Vendruscolo, M., (2005) J. Mol. Biol., 352, pp. 495-500; Orozco, M., Orellana, L., Hospital, A., Naganathan, A., Emperador, A., Carrillo, O., Gelpí, J., (2011) Advances in Protein Chemistry and Structural Biology, 85, pp. 183-215. , Christov, C. Burlington Academic Press: Burlington, MA; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., Hospital, A., Gelpí, J.L., Orozco, M., (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 796-801; Karplus, M., Kuriyan, J., (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 6679-6685; Amadei, A., Linssen, A., Berendsen, H.J.C., (1993) Proteins, 17, pp. 412-425; Tozzini, V., (2005) Curr. Opin. Struct. Biol., 15, pp. 144-150; Juraszek, J., Bolhuis, P.G., (2008) Biophys. J., 95, pp. 4246-4257; Dellago, C., Bolhuis, P.G., Geissler, P.L., (2002) Adv. Chem. Phys., pp. 1-78; Juraszek, J., Vreede, J., Bolhuis, P.G., (2012) Chem. Phys., 396, pp. 30-44; Bolhuis, P.G., Chandler, D., Dellago, C., Geissler, P.L., (2002) Annu. Rev. Phys. Chem., 53, pp. 291-318; Bolhuis, P.G., (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 12129-12134; Wales, D.J., (2006) Int. Rev. Phys. Chem., 25, pp. 237-282; Khalili, M., Wales, D.J., (2008) J. Phys. Chem. B, 112, pp. 2456-2465; Wales, D.J., Bogdan, T.V., (2006) J. Phys. Chem. B, 110, pp. 20765-20776; Evans, D.A., Wales, D.J., (2003) J. Chem. Phys., 119, pp. 9947-9955; McCammon, J.A., Gelin, B.R., Karplus, M., (1977) Nature, 267, pp. 585-590; Brooks, C., Karplus, M., Pettitt, M., (1988) Adv. Chem. Phys., 71, pp. 35-58; Leone, V., Marinelli, F., Carloni, P., Parrinello, M., (2010) Curr. Opin. Struct. Biol., 20, pp. 148-154; Beckstein, O., Denning, E.J., Perilla, J.R., Woolf, T.B., (2009) J. Mol. Biol., 394, pp. 160-176; Perilla, J.R., Beckstein, O., Denning, E.J., Woolf, T.B., (2010) J. Comput. Chem., 32, pp. 196-209; Laio, A., Parrinello, M., (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 12562-12566; Barducci, A., Bonomi, M., Parrinello, M., (2011) WIREs Comput. Mol. Sci., 1, pp. 826-843; Schlitter, J., (1995) J. Mol. Graph., 12, pp. 84-89; Krüger, P., Verheyden, S., Declerck, P.J., Engelborghs, Y., (2001) Protein Sci., 10, pp. 798-808; Jarzynski, C., (1997) Phys. Rev. Lett., 78, pp. 2690-2693; Liphardt, J., Dumont, S., Smith, S.B., Tinoco, I., Bustamante, C., (2002) Science, 296, pp. 1832-1835; Bahar, I., Rader, A., (2005) Curr. Opin. Struct. Biol., 15, pp. 586-592; Derreumaux, P., Mousseau, N., (2007) J. Chem. Phys., 126, p. 025101; Tirion, M., (1996) Phys. Rev. Lett., 77, pp. 1905-1908; Devane, R., Shinoda, W., Moore, P.B., Klein, M.L., (2009) J. Chem. Theory Comput., 5, pp. 2115-2124; Kim, M.K., Chirikjian, G.S., Jernigan, R.L., (2002) J. Mol. Graphics Modell., 21, pp. 151-160; Kim, M.K., Jernigan, R.L., Chirikjian, G.S., (2002) Biophys. J., 83, pp. 1620-1630; Mendez, R., Bastolla, U., (2010) Phys. Rev. Lett., 104, p. 228103; Lopez-Blanco, J.R., Garzón, J.I., Chacón, P., (2011) Bioinformatics, 27, pp. 2843-2850; Rueda, M., Chacón, P., Orozco, M., (2007) Structure, 15, pp. 565-575; Ding, F., Dokholyan, N.V., (2005) Trends Biotechnol., 23, pp. 450-455; Ding, F., Dokholyan, N.V., Buldyrev, S.V., Stanley, H.E., Shakhnovich, E.I., (2002) Biophys. J., 83, pp. 3525-3532; Shirvanyants, D., Ding, F., Tsao, D., Ramachandran, S., Dokholyan, N.V., (2012) J. Phys. Chem. B, 116, pp. 8375-8382; Emperador, A., Meyer, T., Orozco, M., (2008) J. Chem. Theory Comput., 4, pp. 2001-2010; Emperador, A., Meyer, T., Orozco, M., (2010) Proteins: Struct., Funct., Bionf., 78, pp. 83-94; Emperador, A., Carrillo, O., Rueda, M., Orozco, M., (2008) Biophys. J., 95, pp. 2127-2138; Ding, F., Buldyrev, S., Dokholyan, N., (2005) Biophys. J., 88, pp. 147-155; Zhou, Y., Karplus, M., (1997) Proc. Natl. Acad. Sci. U. S. A., 94, pp. 14429-14432; Ding, F., Sharma, S., Chalasani, P., Demidov, V.V., Broude, N.E., Dokholyan, N.V., (2008) RNA, 14, pp. 1164-1173; Krebs, W.G., Gerstein, M.B., (2000) Nucleic Acids Res., 28, pp. 1665-1675; Ye, Y., Godzik, A., (2004) Nucleic Acids Res., 32, pp. 582-W585; Flores, S., Echols, N., Milburn, D., Hespenheide, B., Keating, K., Lu, J., Wells, S., Gerstein, M., (2006) Nucleic Acids Res., 34, pp. 296-D301; Lindahl, E., Azuara, C., Koehl, P., Delarue, M., (2006) Nucleic Acids Res., 34, pp. 52-W56; Franklin, J., Koehl, P., Doniach, S., Delarue, M., (2007) Nucleic Acids Res., 35, pp. 477-W482; Weiss, D.R., Levitt, M., (2009) J. Mol. Biol., 385, pp. 665-674; Yang, Z., Májek, P., Bahar, I., (2009) PLoS Comput. Biol., 5, p. 1000360; Lezon, T.R., Sali, A., Bahar, I., (2009) PLoS Comput. Biol., 5, p. 1000496; Bahar, I., Lezon, T.R., Yang, L.-W., Eyal, E., (2010) Annu. Rev. Biophys., 39, pp. 23-42; Bahar, I., Lezon, T.R., Bakan, A., Shrivastava, I.H., (2010) Chem. Rev., 110, pp. 1463-1497; Bryngelson, J., Onuchic, J., Socci, N., Wolynes, P., (1995) Proteins: Struct., Funct., Bionf., 21, pp. 167-195; Proctor, E.A., Ding, F., Dokholyan, N., (2011) WIREs Comput. Mol. Sci., 1, pp. 80-92; Ding, F., Tsao, D., Nie, H., Dokholyan, N.V., (2008) Structure, 16, pp. 1010-1018; Urbanc, B., Borreguero, J., Cruz, L., Stanley, H., (2006) Methods Enzymol., 412, pp. 314-338; Smith, S., Hall, C., Freeman, B., (1997) J. Comput. Phys., 134, pp. 16-30; Taketomi, H., Ueda, Y., Go, N., (1975) Int. J. Pept. Protein Res., 7, pp. 445-459; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., Cicin-Sain, D., Orozco, M., (2009) Bioinformatics, 25, pp. 1709-1710; Nguyen, H.D., Hall, C.K., (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 16180-16185; Gherghe, C.M., Leonard, C.W., Ding, F., Dokholyan, N.V., Weeks, K.M., (2009) J. Am. Chem. Soc., 131, pp. 2541-2546; Hajdin, C.E., Ding, F., Dokholyan, N.V., Weeks, K.M., (2010) RNA, 16, pp. 1340-1349; Dokholyan, N.V., Buldyrev, S.V., Stanley, H.E., Shakhnovich, E.I., (1998) Folding Des., 3, pp. 577-587; Ding, F., Lavender, C.A., Weeks, K.M., Dokholyan, N.V., (2012) Nat. Methods, pp. 603-608; Peng, S., Ding, F., Urbanc, B., Buldyrev, S.V., Cruz, L., Stanley, H.E., Dokholyan, N.V., (2004) Phys. Rev. e, 69, p. 041908; Urbanc, B., Betnel, M., Cruz, L., Bitan, G., Teplow, D., (2010) J. Am. Chem. Soc., 132, pp. 4266-4280; Urbanc, B., Cruz, L., Yun, S., Buldyrev, S.V., Bitan, G., Teplow, D.B., Stanley, H.E., (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 17345-17350; Ding, F., Borreguero, J., Buldyrev, S.V., Stanley, H., Dokholyan, N., (2003) Proteins: Struct., Funct., Bionf., 53, pp. 220-228; Lazaridis, T., Karplus, M., (1999) Proteins: Struct., Funct., Bionf., 35, pp. 133-152; Meyer, T., Dabramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Pérez, A., Carrillo, O., Orozco, M., (2010) Structure, 18, pp. 1399-1409; Rueda, M., Cubero, E., Laughton, C.A., Orozco, M., (2004) Biophys. J., 87, pp. 800-811; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T., Weissig, H., Shindyalov, I.N., Bourne, P.E., (2000) Nucleic Acids Res., 28, pp. 235-242; Wiederstein, M., Sippl, M.J., (2007) Nucleic Acids Res., 35, pp. 407-W410","Orozco, M.; Joint IRB-BSC Program in Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona, 08028, Spain; email: modesto.orozco@irbbarcelona.org",,,,,,,,15499618,,JCTCC,,"English","J. Chem. Theory Comput.",Article,"Final",,Scopus,2-s2.0-84869073773
"Canela-Xandri O., Julià A., Gelpí J.L., Marsal S.","23569322400;57210878792;35517522400;6603356384;","Unveiling Case-Control Relationships in Designing a Simple and Powerful Method for Detecting Gene-Gene Interactions",2012,"Genetic Epidemiology","36","7",,"710","716",,3,"10.1002/gepi.21665","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867551398&doi=10.1002%2fgepi.21665&partnerID=40&md5=e4a9badc86762a0ee7ad021ec9a86dfb","Rheumatology Research Group Vall d'Hebron Research Insitute, Barcelona, Spain; Barcelona Supercomputing Centre, Barcelona, Spain","Canela-Xandri, O., Rheumatology Research Group Vall d'Hebron Research Insitute, Barcelona, Spain; Julià, A., Rheumatology Research Group Vall d'Hebron Research Insitute, Barcelona, Spain; Gelpí, J.L., Barcelona Supercomputing Centre, Barcelona, Spain; Marsal, S., Rheumatology Research Group Vall d'Hebron Research Insitute, Barcelona, Spain","The detection of gene-gene interactions (i.e., epistasis) in the human genome is becoming decisive for the complete characterization of the genetic factors associated with complex binary traits. Despite the fact that many methods have been developed to address this challenging issue, their performance still remains insufficient. We will show how case and control groups store complementary information regarding interactions, and the use of this fundamental property in the design of a new, rapid, and highly powerful epistasis analysis method. Unlike previous approaches where statistical methods are tested over a very limited range of situations, we have performed an exhaustive evaluation of the power of our new method. To this end, we also propose a more comprehensive interpretation of epistasis in which genotype interactions may be of risk, protective, or neutral. In this extended view of genetic interactions, we demonstrate that our method has superior performance than existing approaches, thus, providing a highly powerful tool for the identification of gene-gene interactions associated with binary traits. © 2012 Wiley Periodicals, Inc.","Binary trait; Epistasis; Genome-wide association study; Statistical method","article; case control study; epistasis; gene gene interaction; gene linkage disequilibrium; genetic association; genotype; human; methodology; probability; statistical analysis; Case-Control Studies; Data Interpretation, Statistical; Epistasis, Genetic; Genetic Loci; Genome-Wide Association Study; Humans; Models, Genetic; Multifactorial Inheritance; Software",,,,,,,,,"Agresti, A., (2002) Categorical Data Analysis, , 2nd ed.). Hoboken, NJ: Wiley-Interscience; Breiman, L., Random forests (2001) Mach Learn, 45, pp. 5-32; Cantor, R.M., Lange, K., Sinsheimer, J.S., Prioritizing GWAS results: a review of statistical methods and recommendations for their application (2010) Am J Hum Genet, 86, pp. 6-22; Chen, L., Yu, G., Langefeld, C.D., Miller, D.J., Guy, R.T., Raghuram, J., Yuan, X., Wang, Y., Comparative analysis of methods for detecting interacting loci (2011) BMC Genom, 12, p. 344; Cordell, H.J., Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans (2002) Hum Mol Genet, 11, pp. 2463-2468; Cordell, H.J., Detecting gene-gene interactions that underlie human diseases (2009) Nat Rev Genet, 10, pp. 392-404; Evans, D.M., Spencer, C.C.A., Pointon, J.J., Su, Z., Harvey, D., Kochan, G., Oppermann, U., Donnelly, P., Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility (2011) Nat Genet, 43, pp. 761-767; Frankel, W.N., Schork, N.J., Who's afraid of epistasis? (1996) Nat Genet, 14, pp. 371-373; Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S., Manolio, T.A., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits (2009) Proc Natl Acad Sci USA, 106, pp. 9362-9367; Hoh, J., Ott, J., Mathematical multi-locus approaches to localizing complex human trait genes (2003) Nat Rev Genet, 4, pp. 701-709; Li, W., Reich, J., A complete enumeration and classification of two-locus disease models (2000) Hum Hered, 50, pp. 334-349; Maher, B., Personal genomes: the case of the missing heritability (2008) Nature, 456, pp. 18-21; Manolio, T.A., Collins, F.S., Cox, N.J., Goldstein, D.B., Hindorff, L.A., Hunter, D.J., McCarthy, M.I., Visscher, P.M., Finding the missing heritability of complex diseases (2009) Nature, 461, pp. 747-753; Marchini, J., Donnelly, P., Cardon, L.R., Genome-wide strategies for detecting multiple loci that influence complex diseases (2005) Nat Genet, 37, pp. 413-417; Moore, J.H., Gilbert, J.C., Tsai, C.-T., Chiang, F.-T., Holden, T., Barney, N., White, B.C., A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility (2006) J Theor Biol, 241, pp. 252-261; Motsinger-Reif, A.A., Reif, D.M., Fanelli, T.J., Ritchie, M.D., A comparison of analytical methods for genetic association studies (2008) Genet Epidemiol, 32, pp. 767-778; Phillips, P.C., Epistasis-the essential role of gene interactions in the structure and evolution of genetic systems (2008) Nat Rev Genet, 9, pp. 855-867; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R., Bender, D., Maller, J., Sham, P.C., PLINK: a tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81, pp. 559-575; Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Parl, F.F., Moore, J.H., Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer (2001) Am J Hum Genet, 69, pp. 138-147; Strange, A., Capon, F., Spencer, C.C., Knight, J., Weale, M.E., Allen, M.H., Barton, A., Trembath, R.C., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) Nat Genet, 42, pp. 985-990; Wang, Y., Liu, G., Feng, M., Wong, L., An empirical comparison of several recent epistatic interaction detection methods (2011) Bioinformatics, 2, pp. 2936-2943; Yang, C., He, Z., Wan, X., Yang, Q., Xue, H., Yu, W., SNPHarvester: a filtering-based approach for detecting epistatic interactions in genome-wide association studies (2009) Bioinformatics, 25, pp. 504-511; Zhang, Y., Liu, J.S., Bayesian inference of epistatic interactions in case-control studies (2007) Nat Genet, 39, pp. 1167-1173; Zhao, J., Jin, L., Xiong, M., Test for interaction between two unlinked loci (2006) Am J Hum Genet, 79, pp. 831-845","Julià, A.; Rheumatology Research Group Vall d'Hebron Research Insitute, Barcelona, Spain; email: ajulia@ir.vhebron.net",,,,,,,,07410395,,GENYE,"22886951","English","Genet. Epidemiol.",Article,"Final",,Scopus,2-s2.0-84867551398
"Kulis M., Heath S., Bibikova M., Queirós A.C., Navarro A., Clot G., Martínez-Trillos A., Castellano G., Brun-Heath I., Pinyol M., Barberán-Soler S., Papasaikas P., Jares P., Beà S., Rico D., Ecker S., Rubio M., Royo R., Ho V., Klotzle B., Hernández L., Conde L., López-Guerra M., Colomer D., Villamor N., Aymerich M., Rozman M., Bayes M., Gut M., Gelpí J.L., Orozco M., Fan J.-B., Quesada V., Puente X.S., Pisano D.G., Valencia A., López-Guillermo A., Gut I., López-Otín C., Campo E., Martín-Subero J.I.","36523169300;57202147571;55730689600;55366742300;7202496222;55332884600;36127955000;56415981400;6506568658;6602137898;10739887200;55303949000;6603875118;6701673488;57205336150;55383063200;55383175400;24176373200;53866366900;26537672200;57195257875;15922449500;15832383900;7006086946;7003554658;35502361700;7004425089;36050558500;36130221700;35517522400;7102809158;34881634800;6602590815;6701552499;24588110800;16308427600;7004492510;56524174800;7102600806;7103168343;6603744154;","Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia",2012,"Nature Genetics","44","11",,"1236","1242",,298,"10.1038/ng.2443","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84868198427&doi=10.1038%2fng.2443&partnerID=40&md5=3f46e2825cbc6af10cd3d3dde67c372c","Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Illumina, Inc., San Diego, CA, United States; Departamento de Anatomía Patológica, Farmacología y Microbiología, Universitat de Barcelona, Barcelona, Spain; Servicio de Hematología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Unidad de Genómica, IDIBAPS, Barcelona, Spain; Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona, Spain; Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Joint Program on Computational Biology, Barcelona Supercomputing Center (BSC), Institute of Research in Biomedicine (IRB), Barcelona, Spain; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain","Kulis, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Heath, S., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Bibikova, M., Illumina, Inc., San Diego, CA, United States; Queirós, A.C., Departamento de Anatomía Patológica, Farmacología y Microbiología, Universitat de Barcelona, Barcelona, Spain; Navarro, A., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Clot, G., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Martínez-Trillos, A., Servicio de Hematología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Castellano, G., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Brun-Heath, I., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Pinyol, M., Unidad de Genómica, IDIBAPS, Barcelona, Spain; Barberán-Soler, S., Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona, Spain; Papasaikas, P., Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona, Spain; Jares, P., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Beà, S., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Rico, D., Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Ecker, S., Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Rubio, M., Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Royo, R., Joint Program on Computational Biology, Barcelona Supercomputing Center (BSC), Institute of Research in Biomedicine (IRB), Barcelona, Spain; Ho, V., Illumina, Inc., San Diego, CA, United States; Klotzle, B., Illumina, Inc., San Diego, CA, United States; Hernández, L., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Conde, L., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; López-Guerra, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Colomer, D., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Villamor, N., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Aymerich, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Rozman, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Bayes, M., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Gut, M., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Gelpí, J.L., Joint Program on Computational Biology, Barcelona Supercomputing Center (BSC), Institute of Research in Biomedicine (IRB), Barcelona, Spain; Orozco, M., Joint Program on Computational Biology, Barcelona Supercomputing Center (BSC), Institute of Research in Biomedicine (IRB), Barcelona, Spain; Fan, J.-B., Illumina, Inc., San Diego, CA, United States; Quesada, V., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain; Puente, X.S., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain; Pisano, D.G., Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Valencia, A., Structural Biology and Biocomputing Program, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; López-Guillermo, A., Servicio de Hematología, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Gut, I., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; López-Otín, C., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo, Oviedo, Spain; Campo, E., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Barcelona, Spain; Martín-Subero, J.I., Departamento de Anatomía Patológica, Farmacología y Microbiología, Universitat de Barcelona, Barcelona, Spain","We have extensively characterized the DNA methylomes of 139 patients with chronic lymphocytic leukemia (CLL) with mutated or unmutated IGHV and of several mature B-cell subpopulations through the use of whole-genome bisulfite sequencing and high-density microarrays. The two molecular subtypes of CLL have differing DNA methylomes that seem to represent epigenetic imprints from distinct normal B-cell subpopulations. DNA hypomethylation in the gene body, targeting mostly enhancer sites, was the most frequent difference between naive and memory B cells and between the two molecular subtypes of CLL and normal B cells. Although DNA methylation and gene expression were poorly correlated, we identified gene-body CpG dinucleotides whose methylation was positively or negatively associated with expression. We have also recognized a DNA methylation signature that distinguishes new clinico-biological subtypes of CLL. We propose an epigenomic scenario in which differential methylation in the gene body may have functional and clinical implications in leukemogenesis. © 2012 Nature America, Inc. All rights reserved.",,"bisulfite; DNA; article; B lymphocyte; chronic lymphatic leukemia; DNA methylation; enhancer region; epigenetics; gene expression; gene identification; genetic analysis; human; leukemogenesis; lymphocyte subpopulation; major clinical study; memory cell; microarray analysis; priority journal; Adult; Aged; Aged, 80 and over; Alternative Splicing; B-Lymphocytes; CpG Islands; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation; Genome, Human; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged",,"DNA, 9007-49-2; bisulfite, 15181-46-1, 7631-90-5, 7773-03-7",,,"Seventh Framework Programme

Fundação para a Ciência e a Tecnologia

Generalitat de Catalunya

282510

Agència de Gestió d’Ajuts Universitaris i de Recerca, AGAUR

MCyT-BIO2007-666855

Instituto de Salud Carlos III

Ministerio de Economía y Competitividad","We thank M. Seifert for advice about isolating normal mature B-cell subpopulations and C. Rozman, J. Valcárcel, R. Küppers and R. Siebert for their comments on the manuscript. We are grateful to S. Guijarro, S. Martín, C. Capdevila, M. Sánchez and L. Plà for excellent technical assistance; to M. Lozano for helping us obtain normal peripheral blood samples; and to N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are indebted to the Hospital Clínic de Barcelona–IDIBAPS Biobank-Tumor Bank and Hematopathology Collection for the sample procurement. We are also very grateful to the patients with CLL who have participated in this study. This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the Instituto de Salud Carlos III (ISCIII) (to E.C. and C.L.-O.) and the Red Temática de Investigación del Cáncer (RTICC) of the ISCIII (to E.C.), project SAF2009-08663 (to J.I.M.-S.) and project MCyT-BIO2007-666855 (to A.V.), as well as the European Union’s Seventh Framework Programme through the Blueprint Consortium (grant agreement 282510) (to E.C. and I.G.) and the Botín Foundation (to C.L.-O.). J.I.M.-S. is supported by a Ramon y Cajal contract of the MINECO, M.K. by the Agència de Gestió d’Ajuts Universitaris i de Recerca (Generalitat de Catalunya), A.C.Q. by the Portuguese Fundação para a Ciência e a Tecnologia, S.B.-S. by an EMBO Long-Term Fellowship and S.E. by La Caixa.",,,"Rozman, C., Montserrat, E., Chronic lymphocytic leukemia (1995) N. Engl. J. Med., 333, pp. 1052-1057; Zenz, T., Mertens, D., Kuppers, R., Dohner, H., Stilgenbauer, S., From pathogenesis to treatment of chronic lymphocytic leukaemia (2010) Nat. Rev. Cancer, 10, pp. 37-50; Chiorazzi, N., Ferrarini, M., Cellular origin(s) of chronic lymphocytic leukemia: Cautionary notes and additional considerations and possibilities (2011) Blood, 117, pp. 1781-1791; Baylin, S.B., Jones, P.A., A decade of exploring the cancer epigenome-biological and translational implications (2011) Nat. Rev. Cancer, 11, pp. 726-734; Cedar, H., Bergman, Y., Epigenetics of haematopoietic cell development (2011) Nat. Rev. Immunol., 11, pp. 478-488; Deaton, A.M., Cell type-specific DNA methylation at intragenic CpG islands in the immune system (2011) Genome Res., 21, pp. 1074-1086; Rodríguez-Paredes, M., Esteller, M., Cancer epigenetics reaches mainstream oncology (2011) Nat. Med., 17, pp. 330-339; Kanduri, M., Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia (2010) Blood, 115, pp. 296-305; Rahmatpanah, F.B., Large-scale analysis of DNA methylation in chronic lymphocytic leukemia (2009) Epigenomics, 1, pp. 39-61; Tong, W.G., Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact (2010) Epigenetics, 5, pp. 499-508; Lister, R., Human DNA methylomes at base resolution show widespread epigenomic differences (2009) Nature, 462, pp. 315-322; Lister, R., Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells (2011) Nature, 471, pp. 68-73; Berman, B.P., Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains (2012) Nat. Genet., 44, pp. 40-46; Shaknovich, R., DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation (2011) Blood, 118, pp. 3559-3569; Bibikova, M., High-density DNA methylation array with single CpG site resolution (2011) Genomics, 98, pp. 288-295; Klein, U., Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells (2001) J. Exp. Med., 194, pp. 1625-1638; Rosenwald, A., Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia (2001) J. Exp. Med., 194, pp. 1639-1648; Kanber, D., The human retinoblastoma gene is imprinted (2009) PLoS Genet., 5, pp. e1000790; Ernst, J., Mapping and analysis of chromatin state dynamics in nine human cell types (2011) Nature, 473, pp. 43-49; Maunakea, A.K., Conserved role of intragenic DNA methylation in regulating alternative promoters (2010) Nature, 466, pp. 253-257; Hansen, K.D., Increased methylation variation in epigenetic domains across cancer types (2011) Nat. Genet., 43, pp. 768-775; Ohm, J.E., A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing (2007) Nat. Genet., 39, pp. 237-242; Schlesinger, Y., Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer (2007) Nat. Genet., 39, pp. 232-236; Widschwendter, M., Epigenetic stem cell signature in cancer (2007) Nat. Genet., 39, pp. 157-158; Shukla, S., CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing (2011) Nature, 479, pp. 74-79; Papaemmanuil, E., Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts (2011) N. Engl. J. Med., 365, pp. 1384-1395; Quesada, V., Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia (2012) Nat. Genet., 44, pp. 47-52; Wang, L., SF3B1 and other novel cancer genes in chronic lymphocytic leukemia (2011) N. Engl. J. Med., 365, pp. 2497-2506; Yoshida, K., Frequent pathway mutations of splicing machinery in myelodysplasia (2011) Nature, 478, pp. 64-69; Chan, T.A., Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis (2008) PLoS Med., 5, pp. e114; Puente, X.S., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (2011) Nature, 475, pp. 101-105; Jones, P.A., Functions of DNA methylation: Islands, start sites, gene bodies and beyond (2012) Nat. Rev. Genet., 13, pp. 484-492; Adams, D., BLUEPRINT to decode the epigenetic signature written in blood (2012) Nat. Biotechnol., 30, pp. 224-226; International network of cancer genome projects (2010) Nature, 464, pp. 993-998. , The International Cancer Genome Consortium; Bibikova, M., Genome-wide DNA methylation profiling using Infinium assay (2009) Epigenomics, 1, pp. 177-200; Du, P., Kibbe, W.A., Lin, S.M., Lumi: A pipeline for processing Illumina microarray (2008) Bioinformatics, 24, pp. 1547-1548; Marco-Sola, S., Sammeth, M., Guigó, R., Ribeca, P., The GEM mapper: Fast, accurate and versatile alignment by filtration Nat. Methods, , in the press; Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A., Affy-analysis of Affymetrix GeneChip data at the probe level (2004) Bioinformatics, 20, pp. 307-315; Falcon, S., Gentleman, R., Using GOstats to test gene lists for GO term association (2007) Bioinformatics, 23, pp. 257-258; Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing (1995) J. R. Stat. Soc. B, 57, pp. 289-300; Karolchik, D., The UCSC Table Browser data retrieval tool (2004) Nucleic Acids Res., 32, pp. D493-D496; Simpson, T.I., Armstrong, J.D., Jarman, A.P., Merged consensus clustering to assess and improve class discovery with microarray data (2010) BMC Bioinformatics, 11, p. 590","Martín-Subero, J.I.; Departamento de Anatomía Patológica, Farmacología y Microbiología, Universitat de Barcelona, Barcelona, Spain; email: imartins@clinic.ub.es",,,,,,,,10614036,,NGENE,"23064414","English","Nat. Genet.",Article,"Final",,Scopus,2-s2.0-84868198427
"Juliá A., Tortosa R., Hernanz J.M., Cañete J.D., Fonseca E., Ferrándiz C., Unamuno P., Puig L., Fernández-Sueiro J.L., Sanmartí R., Rodríguez J., Gratacós J., Dauden E., Sánchez-Carazo J.L., López-Estebaranz J.L., Moreno-Ramírez D., Queiró R., Montilla C., Torre-Alonso J.C., Pérez-Venegas J.J., Vanaclocha F., Herrera E., Muñoz-Fernández S., González C., Roig D., Erra A., Acosta I., Fernández-Nebro A., Zarco P., Alonso A., López-Lasanta M., García-Montero A., Gelpí J.L., Absher D., Marsal S.","57210878792;22235662000;6701846509;7003746360;34975078800;7005892900;6602365341;7101770587;6602628983;7004460755;57209135380;23469245300;7003438085;9233529000;6603673238;8850383200;6603878341;12782882100;6603460831;55338747000;6603052674;7103001516;7004546711;30267572700;6602407204;16678368700;56082492800;57195363279;7006771455;36150353900;23035265100;6603714021;35517522400;57198406019;6603356384;","Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes",2012,"Human Molecular Genetics","21","20", dds295,"4549","4557",,46,"10.1093/hmg/dds295","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867135183&doi=10.1093%2fhmg%2fdds295&partnerID=40&md5=ee643f1404ae6f9fcb0cdaa28788ca27","Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; Dermatology Service, Hospital Universitario Gregorio Marañón, Madrid 28007, Spain; Rheumatology Service, Hospital Clínic de Barcelona, Barcelona 08036, Spain; Dermatology Service, Complejo Hospitalario Universitario de A Coruña, A Coruña 15001, Spain; Dermatology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona 08916, Spain; Dermatology Service, Hospital Universitario de Salamanca, Salamanca 37007, Spain; Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona 08040, Spain; Rheumatology Service, Complejo Hospitalario Juan Canalejo, A Coruña 15006, Spain; Rheumatology Service, Hospital Universitari de Bellvitge, Barcelona 08907, Spain; Rheumatology Service, Hospital Parc Taulí, Sabadell, Barcelona 08208, Spain; Dermatology Service, Hospital Universitario La Princesa, Madrid 28006, Spain; Dermatology Service, Hospital General Universitario de Valencia, Valencia 46014, Spain; Dermatology Service, Hospital Universitario Fundación Alcorcón, Madrid 29922, Spain; Dermatology Service, Hospital Universitario Virgen Macarena, Sevilla 41009, Spain; Rheumatology Service, Hospital Universitario Central de Asturias, Oviedo 33006, Spain; Rheumatology Service, Hospital Virgen de la Vega, Salamanca 37007, Spain; Rheumatology Service, Hospital Monte Naranco, Oviedo 33012, Spain; Rheumatology Service, Hospital de Jerez de la Frontera, Cádiz 11407, Spain; Dermatology Service, Hospital Universitario 12 de Octubre, Madrid 28041, Spain; Dermatology Service, Hospital Universitario Virgen de la Victoria, Málaga 29010, Spain; Rheumatology Service, Hospital Universitario Infanta Sofía, Madrid 28702, Spain; Rheumatology Service, Hospital Universitario Gregorio Marañón, Madrid 28009, Spain; Rheumatology Service, Centre d'Atenció Especialitzada de Cornellà, Cornellà, Barcelona 08940, Spain; Rheumatology Service, Hospital Sant Rafael, Barcelona 08035, Spain; Rheumatology Service, Hospital Regional Universitario Carlos Haya, Málaga 29009, Spain; Rheumatology Service, Hospital Universitario Fundación Alcorcón, Madrid 28922, Spain; Spanish National DNA Bank, Universidad de Salamanca, Salamanca 37007, Spain; Life Sciences, Barcelona Supercomputing Centre, Barcelona 08034, Spain; HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, United States","Juliá, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; Tortosa, R., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; Hernanz, J.M., Dermatology Service, Hospital Universitario Gregorio Marañón, Madrid 28007, Spain; Cañete, J.D., Rheumatology Service, Hospital Clínic de Barcelona, Barcelona 08036, Spain; Fonseca, E., Dermatology Service, Complejo Hospitalario Universitario de A Coruña, A Coruña 15001, Spain; Ferrándiz, C., Dermatology Service, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona 08916, Spain; Unamuno, P., Dermatology Service, Hospital Universitario de Salamanca, Salamanca 37007, Spain; Puig, L., Dermatology Service, Hospital de la Santa Creu i Sant Pau, Barcelona 08040, Spain; Fernández-Sueiro, J.L., Rheumatology Service, Complejo Hospitalario Juan Canalejo, A Coruña 15006, Spain; Sanmartí, R., Rheumatology Service, Hospital Clínic de Barcelona, Barcelona 08036, Spain; Rodríguez, J., Rheumatology Service, Hospital Universitari de Bellvitge, Barcelona 08907, Spain; Gratacós, J., Rheumatology Service, Hospital Parc Taulí, Sabadell, Barcelona 08208, Spain; Dauden, E., Dermatology Service, Hospital Universitario La Princesa, Madrid 28006, Spain; Sánchez-Carazo, J.L., Dermatology Service, Hospital General Universitario de Valencia, Valencia 46014, Spain; López-Estebaranz, J.L., Dermatology Service, Hospital Universitario Fundación Alcorcón, Madrid 29922, Spain; Moreno-Ramírez, D., Dermatology Service, Hospital Universitario Virgen Macarena, Sevilla 41009, Spain; Queiró, R., Rheumatology Service, Hospital Universitario Central de Asturias, Oviedo 33006, Spain; Montilla, C., Rheumatology Service, Hospital Virgen de la Vega, Salamanca 37007, Spain; Torre-Alonso, J.C., Rheumatology Service, Hospital Monte Naranco, Oviedo 33012, Spain; Pérez-Venegas, J.J., Rheumatology Service, Hospital de Jerez de la Frontera, Cádiz 11407, Spain; Vanaclocha, F., Dermatology Service, Hospital Universitario 12 de Octubre, Madrid 28041, Spain; Herrera, E., Dermatology Service, Hospital Universitario Virgen de la Victoria, Málaga 29010, Spain; Muñoz-Fernández, S., Rheumatology Service, Hospital Universitario Infanta Sofía, Madrid 28702, Spain; González, C., Rheumatology Service, Hospital Universitario Gregorio Marañón, Madrid 28009, Spain; Roig, D., Rheumatology Service, Centre d'Atenció Especialitzada de Cornellà, Cornellà, Barcelona 08940, Spain; Erra, A., Rheumatology Service, Hospital Sant Rafael, Barcelona 08035, Spain; Acosta, I., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; Fernández-Nebro, A., Rheumatology Service, Hospital Regional Universitario Carlos Haya, Málaga 29009, Spain; Zarco, P., Rheumatology Service, Hospital Universitario Fundación Alcorcón, Madrid 28922, Spain; Alonso, A., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; López-Lasanta, M., Rheumatology Service, Hospital Regional Universitario Carlos Haya, Málaga 29009, Spain; García-Montero, A., Spanish National DNA Bank, Universidad de Salamanca, Salamanca 37007, Spain; Gelpí, J.L., Life Sciences, Barcelona Supercomputing Centre, Barcelona 08034, Spain; Absher, D., HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806, United States; Marsal, S., Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain","Recent genome-wide association studies (GWASs) have identified >20 new loci associated with the susceptibility to psoriasis vulgaris (PsV) risk. We investigated the association of PsV and its main clinical subphenotypes with 32 loci having previous genome-wide evidence of association with PsV (P < 5e-8) or strong GWAS evidence (P < 5e-5 in discovery and P < 0.05 in replication sample) in a large cohort of PsV patients (n = 2005) and controls (n = 1497). We provide the first independent replication for COG6 (P = 0.00079) and SERPINB8 (P = 0.048) loci with PsV. In those patients having developed psoriatic arthritis (n = 955), we found, for the first time, a strong association with IFIH1 (P = 0.013). Analyses of clinically relevant PsV subtypes yielded a significant association of severity of cutaneous disease with variation at LCE3D locus (P = 0.0005) in PsV and nail involvement with IL1RN in purely cutaneous psoriasis (PsC, P = 0.007). In an exploratory analysis of epistasis, we replicated the previously described HLA-C-ERAP1 interaction with PsC. Our findings show that common genetic variants associated with a complex phenotype like PsV influence different subphenotypes of high clinical relevance. © The Author 2012. Published by Oxford University Press. All rights reserved.",,"adult; article; controlled study; disease severity; epistasis; female; gene locus; genetic analysis; genetic association; genetic risk; genetic variability; human; major clinical study; male; phenotype; priority journal; psoriasis vulgaris; skin disease; Adaptor Proteins, Vesicular Transport; Alleles; Aminopeptidases; Case-Control Studies; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Genotype; HLA-C Antigens; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Phenotype; Psoriasis; Skin",,"Adaptor Proteins, Vesicular Transport; Aminopeptidases, 3.4.11.-; COG6 protein, human; ERAP1 protein, human, 3.4.11.-; HLA-C Antigens; IL1RN protein, human; Interleukin 1 Receptor Antagonist Protein",,,"Ministerio de Ciencia e Innovación, MICINN: PSE-010000-2006-6","This work was supported by the Ministerio de Ciencia e Inno-vación Strategic Project (PSE-010000-2006-6).",,,"Nestle, F.O., Kaplan, D.H., Barker, J., Psoriasis (2009) N. Engl. J. Med., 361, pp. 496-509; Bhalerao, J., Bowcock, A.M., The genetics of psoriasis: a complex disorder of the skin and immune system (1998) Hum. Mol. Genet., 7, pp. 1537-1545; Nair, R.P., Stuart, P.E., Nistor, I., Hiremagalore, R., Chia, N.V., Jenisch, S., Weichenthal, M., Christophers, E., Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene (2006) Am. J. Hum. Genet., 78, pp. 827-851; Nair, R.P., Ruether, A., Stuart, P.E., Jenisch, S., Tejasvi, T., Hiremagalore, R., Schreiber, S., Voorhees, J.J., Polymorphisms of the IL12B and IL23R genes are associated with psoriasis (2008) J. Invest. Dermatol., 24, p. 24; Nair, R.P., Duffin, K.C., Helms, C., Ding, J., Stuart, P.E., Goldgar, D., Gudjonsson, J.E., Feng, B.J., Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways (2009) Nat. Genet., 41, pp. 199-204; Strange, A., Capon, F., Spencer, C.C., Knight, J., Weale, M.E., Allen, M.H., Barton, A., Bergboer, J.G., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 (2010) Nat. Genet., 42, pp. 985-990; Ellinghaus, E., Ellinghaus, D., Stuart, P.E., Nair, R.P., Debrus, S., Raelson, J.V., Belouchi, M., Ding, J., Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 (2010) Nat. Genet., 42, pp. 991-995; Stuart, P.E., Nair, R.P., Ellinghaus, E., Ding, J., Tejasvi, T., Gudjonsson, J.E., Li, Y., Gieger, C., Genome-wide association analysis identifies three psoriasis susceptibility loci (2010) Nat. Genet., 42, pp. 1000-1004; Sun, L.D., Cheng, H., Wang, Z.X., Zhang, A.P., Wang, P.G., Xu, J.H., Zhu, Q.X., Zhang, F.R., Association analyses identify six new psoriasis susceptibility loci in the Chinese population (2010) Nat. Genet., 42, pp. 1005-1009; Gladman, D.D., Natural history of psoriatic arthritis (1994) Baillieres Clin. Rheumatol., 8, pp. 379-394; Marsal, S., Armadans-Gil, L., Martinez, M., Gallardo, D., Ribera, A., Lience, E., Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis (1999) Rheumatology (Oxford), 38, pp. 332-337; Mease, P., Genovese, M.C., Gladstein, G., Kivitz, A.J., Ritchlin, C., Tak, P.P., Wollenhaupt, J., Kelly, S., Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial (2011) Arthritis Rheum, 63, pp. 939-948; Liu, Y., Helms, C., Liao, W., Zaba, L.C., Duan, S., Gardner, J., Wise, C., Pullinger, C.R., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci (2008) PLoS Genet, 4, pp. e1000041; Allen, M.H., Ameen, H., Veal, C., Evans, J., Ramrakha-Jones, V.S., Marsland, A.M., Burden, A.D., Barker, J.N., The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis (2005) J. Invest. Dermatol., 124, pp. 103-106; Zhang, X.J., Huang, W., Yang, S., Sun, L.D., Zhang, F.Y., Zhu, Q.X., Zhang, F.R., Pu, X.M., Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 (2009) Nat. Genet., 41, pp. 205-210; Winkler, C., Lauber, C., Adler, K., Grallert, H., Illig, T., Ziegler, A.G., Bonifacio, E., An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes (2011) Diabetes, 60, pp. 685-690; Bowes, J., Eyre, S., Flynn, E., Ho, P., Salah, S., Warren, R.B., Marzo-Ortega, H., Ryan, A.W., Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris (2011) Ann. Rheum. Dis., 70, pp. 1016-1019; Ibrahim, G., Waxman, R., Helliwell, P.S., The prevalence of psoriatic arthritis in people with psoriasis (2009) Arthritis Rheum, 61, pp. 1373-1378; Gelfand, J.M., Gladman, D.D., Mease, P.J., Smith, N., Margolis, D.J., Nijsten, T., Stern, R.S., Rolstad, T., Epidemiology of psoriatic arthritis in the population of the United States (2005) J. Am. Acad. Dermatol., 53, p. 573; Gudjonsson, J.E., Karason, A., Runarsdottir, E.H., Antonsdottir, A.A., Hauksson, V.B., Jonsson, H.H., Gulcher, J., Valdimarsson, H., Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients (2006) J. Invest. Dermatol., 126, pp. 740-745; Bergboer, J.G., Tjabringa, G.S., Kamsteeg, M., van Vlijmen-Willems, I.M., Rodijk-Olthuis, D., Jansen, P.A., Thuret, J.Y., Zeeuwen, P.L., Psoriasis risk genes of the late cornified envelope-3 group are distinctly expressed compared with genes of other LCE groups (2011) Am. J. Pathol., 178, pp. 1470-1477; Leonardi, C.L., Powers, J.L., Matheson, R.T., Goffe, B.S., Zitnik, R., Wang, A., Gottlieb, A.B., Etanercept as monotherapy in patients with psoriasis (2003) N. Engl. J. Med., 349, pp. 2014-2022; Henseler, T., Schmitt-Rau, K., A comparison between BSA, PASI (2008) PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis. Int. J. Dermatol., 47, pp. 1019-1023; Elder, J.T., Bruce, A.T., Gudjonsson, J.E., Johnston, A., Stuart, P.E., Tejasvi, T., Voorhees, J.J., Nair, R.P., Molecular dissection of psoriasis: integrating genetics and biology (2010) J. Invest. Dermatol., 130, pp. 1213-1226; Gabay, C., Palmer, G., Mutations in the IL1RN locus lead to autoinflammation (2009) Nat. Rev. Rheumatol., 5, pp. 480-482; Aksentijevich, I., Masters, S.L., Ferguson, P.J., Dancey, P., Frenkel, J., van Royen-Kerkhoff, A., Laxer, R., Pham, T.H., An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist (2009) N. Engl. J. Med., 360, pp. 2426-2437; Augustin, M., Reich, K., Blome, C., Schafer, I., Laass, A., Radtke, M.A., Nail psoriasis in Germany: epidemiology and burden of disease (2010) Br. J. Dermatol., 163, pp. 580-585; Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., Mielants, H., Classification criteria for psoriatic arthritis: development of new criteria from a large international study (2006) Arthritis Rheum, 54, pp. 2665-2673; Kosoy, R., Nassir, R., Tian, C., White, P.A., Butler, L.M., Silva, G., Kittles, R., Belmont, J.W., Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America (2009) Hum. Mutat., 30, pp. 69-78; Pritchard, J.K., Stephens, M., Donnelly, P., Inference of population structure using multilocus genotype data (2000) Genetics, 155, pp. 945-959; Purcell, S., Cherny, S.S., Sham, P.C., Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits (2003) Bioinformatics, 19, pp. 149-150; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Daly, M.J., PLINK: a tool set for whole-genome association and population-based linkage analyses (2007) Am. J. Hum. Genet., 81, pp. 559-575; Ihaka, R., Gentleman, R., R: a language for data analysis and graphics (1996) J Comput. Graph. Statist., pp. 299-314; Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Daly, M.J., PLINK: a tool set for whole-genome association and population-based linkage analyses (2007) Am. J. Hum. Genet., 81, pp. 559-575; Callen, J.P., Krueger, G.G., Lebwohl, M., McBurney, E.I., Mease, P., Menter, A., Paller, A.S., Zimmerman, G., AAD consensus statement on psoriasis therapies (2003) J. Am. Acad. Dermatol., 49, pp. 897-899; Puig, L., Bordas, X., Carrascosa, J.M., Dauden, E., Ferrandiz, C., Hernanz, J.M., Lopez-Estebaranz, J.L., Vanaclocha, F., Consensus document on the evaluation and treatment of moderate-to-severe psoriasis Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology (2009) Actas. Dermosifiliogr., 100, pp. 277-286; Pariser, D.M., Bagel, J., Gelfand, J.M., Korman, N.J., Ritchlin, C.T., Strober, B.E., Van Voorhees, A.S., Lebwohl, M.G., National Psoriasis Foundation clinical consensus on disease severity (2007) Arch. Dermatol., 143, pp. 239-242","Marsal, S.; Rheumatology Research Group, Vall d'Hebron Research Institute, Barcelona 08035, Spain; email: smarsal@ir.vhebron.net",,,,,,,,09646906,,HMGEE,"22814393","English","Hum. Mol. Genet.",Article,"Final",Open Access,Scopus,2-s2.0-84867135183
"Hospital A., Andrio P., Fenollosa C., Cicin-Sain D., Orozco M., Gelpí J.L.","15831739300;55203611300;57199554447;57172992900;7102809158;35517522400;","MDWeb and MDMoby: An integrated web-based platform for molecular dynamics simulations",2012,"Bioinformatics","28","9", bts139,"1278","1279",,62,"10.1093/bioinformatics/bts139","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860456767&doi=10.1093%2fbioinformatics%2fbts139&partnerID=40&md5=047280905e286d6116ff11ef86da468f","Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain; Barcelona Supercomputing Center, Jordi Girona 31, Barcelona 08034, Spain; Structural Bioinformatics Node, National Institute of Bioinformatics, Josep Samitier 1-5, Barcelona 08028, Spain; Computatinal Bioinformatics Node, National Institute of Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Av. Diagonal 643, Barcelona 08028, Spain","Hospital, A., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Barcelona 08034, Spain, Structural Bioinformatics Node, National Institute of Bioinformatics, Josep Samitier 1-5, Barcelona 08028, Spain; Andrio, P., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Computatinal Bioinformatics Node, National Institute of Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain; Fenollosa, C., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Computatinal Bioinformatics Node, National Institute of Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain; Cicin-Sain, D., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Barcelona 08034, Spain, Structural Bioinformatics Node, National Institute of Bioinformatics, Josep Samitier 1-5, Barcelona 08028, Spain; Orozco, M., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Barcelona 08034, Spain, Structural Bioinformatics Node, National Institute of Bioinformatics, Josep Samitier 1-5, Barcelona 08028, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Av. Diagonal 643, Barcelona 08028, Spain; Gelpí, J.L., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Barcelona 08034, Spain, Computatinal Bioinformatics Node, National Institute of Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Av. Diagonal 643, Barcelona 08028, Spain","MDWeb and MDMoby constitute a web-based platform to help access to molecular dynamics (MD) in the standard and high-throughput regime. The platform provides tools to prepare systems from PDB structures mimicking the procedures followed by human experts. It provides inputs and can send simulations for three of the most popular MD packages (Amber, NAMD and Gromacs). Tools for analysis of trajectories, either provided by the user or retrieved from our MoDEL database (http://mmb.pcb.ub.es/MoDEL) are also incorporated. The platform has two ways of access, a set of web-services based on the BioMoby framework (MDMoby), programmatically accessible and a web portal (MDWeb). © The Author 2012. Published by Oxford University Press. All rights reserved.",,"nucleic acid; protein; article; chemistry; computer program; human; Internet; molecular dynamics; Humans; Internet; Molecular Dynamics Simulation; Nucleic Acids; Proteins; Software",,"protein, 67254-75-5; Nucleic Acids; Proteins",,,"Fundación Botín

European Commission: INFSO-RI-261523

European Research Council

Ministry of Education and Science: CTQ2005-09365, BIO2006-01602

Instituto de Salud Carlos III

Bioinformatics Institute","Funding: Spanish Ministry of Education and Science [grant numbers: BIO2006-01602, CTQ2005-09365, CONSOLIDER E-Science Project in Supercomputation]; The EU Commission [contract INFSO-RI-261523, ScalaLife project]; the Instituto de Salud Carlos III [National Institute of Bioinformatics and the COMBIOMED network]; the ERC for an Advanced Grant to M.O., and the Fundación Marcelino Botín.",,,"Interoperability with Moby 1.0 - It's better than sharing your toothbrush (2008) Brief. Bioinform., 1, pp. 1-12. , BioMoby Consortium; Camps, J., FlexServ: an integrated tool for the analysis of protein flexibility (2009) Bioinformatics, 25, pp. 1709-1710; Case, D.A., (2010) AMBER 11, , University of California, San Francisco; Emperador, A., Exploring the suitability of coarse-grained techniques for the representation of protein dynamics (2008) Biophys. J., 95, pp. 2127-2138; Hess, B., GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation (2008) J. Chem. Theory Comput., 4, pp. 435-447; Hull, D., Taverna: a tool for building and running workflows of services (2006) Nucleic Acids Res., 34, pp. 729-732. , (Web Server Issue); Humphrey, W., VMD: visual molecular dynamics (1996) J. Mol. Graphics, 14, pp. 33-38; Martín-Requena, V., jORCA: easily integrating bioinformatics Web Services (2010) Bioinformatics, 26, pp. 553-559; McCammon, J.A., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; Meyer, T., MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories (2010) Structure, 18, pp. 1399-1409; Phillips, J.C., Scalable molecular dynamics with NAMD (2005) J. Comp. Chem., 26, pp. 1781-1802; Rueda, M., A consensous view to protein dynamics (2007) Proc. Natl Acad. Sci. USA, 104, pp. 796-801; van der Kamp, M.W., Dynameomics: a comprehensive database of protein dynamics (2010) Structure, 18, pp. 423-435","Gelpí, J.L.; Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Barcelona Science Park, Josep Samitier 1-5, Barcelona 08028, Spain; email: gelpi@ub.edu",,,,,,,,13674803,,BOINF,"22437851","English","Bioinformatics",Article,"Final",Open Access,Scopus,2-s2.0-84860456767
"Djebali S., Lagarde J., Kapranov P., Lacroix V., Borel C., Mudge J.M., Howald C., Foissac S., Ucla C., Chrast J., Ribeca P., Martin D., Murray R.R., Yang X., Ghamsari L., Lin C., Bell I., Dumais E., Drenkow J., Tress M.L., Gelpí J.L., Orozco M., Valencia A., van Berkum N.L., Lajoie B.R., Vidal M., Stamatoyannopoulos J., Batut P., Dobin A., Harrow J., Hubbard T., Dekker J., Frankish A., Salehi-Ashtiani K., Reymond A., Antonarakis S.E., Guigó R., Gingeras T.R.","57195520028;15073820500;6603162390;36606353800;7101710930;7004105304;6602252392;16506892700;6603602005;6507461045;12766653600;57196726225;24448457600;35742335900;14060041600;8949007900;57197007893;16480180200;6603366956;6603493350;35517522400;7102809158;16308427600;6507869757;35076233800;7202764997;6603232343;54882365400;56387265000;12774086800;19534744500;7202457423;9747325900;6602886663;7003341196;36049009800;7004339139;7003527869;","Evidence for transcript networks composed of chimeric rnas in human cells",2012,"PLoS ONE","7","1", e28213,"","",,41,"10.1371/journal.pone.0028213","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855396196&doi=10.1371%2fjournal.pone.0028213&partnerID=40&md5=10c94939e1046453612da56046298baf","Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Affymetrix Inc., Santa Clara, CA, United States; Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, Geneva, Switzerland; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; The Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland; Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States; Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain; Institute of Research in Biomedicine and Barcelona Supercomputer Center, Joint Program on Computational Biology. Parc Científic de Barcelona, Universitat de Barcelona, Facultat de Biologia, Barcelona, Catalonia, Spain; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, United States; University of Washington, Seattle, WA, United States; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates, and Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States; Departament de Ciènces Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Helicos BioSciences Corporation, Cambridge, MA, United States; Université Lyon 1, CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, INRIA BAMBOO, Villeurbanne, France; Integromics, S.L., Grisolía Tres Cantos, Madrid, Spain","Djebali, S., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Lagarde, J., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Kapranov, P., Affymetrix Inc., Santa Clara, CA, United States, Helicos BioSciences Corporation, Cambridge, MA, United States; Lacroix, V., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain, Université Lyon 1, CNRS, UMR5558, Laboratoire de Biométrie et Biologie Evolutive, INRIA BAMBOO, Villeurbanne, France; Borel, C., Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, Geneva, Switzerland; Mudge, J.M., Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Howald, C., The Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland; Foissac, S., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain, Affymetrix Inc., Santa Clara, CA, United States, Integromics, S.L., Grisolía Tres Cantos, Madrid, Spain; Ucla, C., Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, Geneva, Switzerland; Chrast, J., The Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland; Ribeca, P., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Martin, D., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Murray, R.R., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Yang, X., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Ghamsari, L., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Lin, C., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Bell, I., Affymetrix Inc., Santa Clara, CA, United States; Dumais, E., Affymetrix Inc., Santa Clara, CA, United States; Drenkow, J., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States; Tress, M.L., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain; Gelpí, J.L., Institute of Research in Biomedicine and Barcelona Supercomputer Center, Joint Program on Computational Biology. Parc Científic de Barcelona, Universitat de Barcelona, Facultat de Biologia, Barcelona, Catalonia, Spain; Orozco, M., Institute of Research in Biomedicine and Barcelona Supercomputer Center, Joint Program on Computational Biology. Parc Científic de Barcelona, Universitat de Barcelona, Facultat de Biologia, Barcelona, Catalonia, Spain; Valencia, A., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre, Madrid, Spain; van Berkum, N.L., Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, United States; Lajoie, B.R., Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, United States; Vidal, M., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States; Stamatoyannopoulos, J., University of Washington, Seattle, WA, United States; Batut, P., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States; Dobin, A., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States; Harrow, J., Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Hubbard, T., Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Dekker, J., Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA, United States; Frankish, A., Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Salehi-Ashtiani, K., Center for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA, United States, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates, and Center for Genomics and Systems Biology, Department of Biology, New York University, New York, NY, United States; Reymond, A., The Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland; Antonarakis, S.E., Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, Geneva, Switzerland; Guigó, R., Bioinformatics and Genomics, Centre for Genomic Regulation, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain, Departament de Ciènces Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Catalonia, Spain; Gingeras, T.R., Affymetrix Inc., Santa Clara, CA, United States, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States","The classic organization of a gene structure has followed the Jacob and Monod bacterial gene model proposed more than 50 years ago. Since then, empirical determinations of the complexity of the transcriptomes found in yeast to human has blurred the definition and physical boundaries of genes. Using multiple analysis approaches we have characterized individual gene boundaries mapping on human chromosomes 21 and 22. Analyses of the locations of the 5′ and 3′ transcriptional termini of 492 protein coding genes revealed that for 85% of these genes the boundaries extend beyond the current annotated termini, most often connecting with exons of transcripts from other well annotated genes. The biological and evolutionary importance of these chimeric transcripts is underscored by (1) the non-random interconnections of genes involved, (2) the greater phylogenetic depth of the genes involved in many chimeric interactions, (3) the coordination of the expression of connected genes and (4) the close in vivo and three dimensional proximity of the genomic regions being transcribed and contributing to parts of the chimeric RNAs. The non-random nature of the connection of the genes involved suggest that chimeric transcripts should not be studied in isolation, but together, as an RNA network. © 2012 Djebali et al.",,"chimeric RNA; RNA; unclassified drug; chimerin; RNA; RNA isoform; transcriptome; amino acid sequence; article; chromosome 21; chromosome 22; controlled study; exon; gene expression regulation; gene interaction; gene regulatory network; genetic analysis; genetic transcription; human; human cell; human tissue; molecular cloning; molecular genetics; molecular phylogeny; reverse transcription polymerase chain reaction; RNA analysis; transcriptomics; algorithm; biological model; cells; chemistry; chromosome 1; female; gene expression profiling; gene regulatory network; genetic transcription; genetics; male; metabolism; methodology; microarray analysis; nucleic acid amplification; physiology; validation study; Bacteria (microorganisms); Algorithms; Cells; Chimerin Proteins; Chromosomes, Human, Pair 1; Female; Gene Expression Profiling; Gene Regulatory Networks; Humans; Male; Microarray Analysis; Models, Biological; Nucleic Acid Amplification Techniques; RNA; RNA Isoforms; Transcription, Genetic; Transcriptome; Validation Studies as Topic",,"RNA, 63231-63-0; Chimerin Proteins; RNA, 63231-63-0; RNA Isoforms",,,,,,,"Kaessmann, H., Origins, evolution, and phenotypic impact of new genes (2010) Genome Res, 20, pp. 1313-1326; Wu, X., Xiao, H., Progress in the detection of human genome structural variations (2009) Sci China C Life Sci, 52, pp. 560-567; Li, H., Wang, J., Mor, G., Sklar, J., A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells (2008) Science, 321, pp. 1357-1361; Gingeras, T.R., Implications of chimaeric non-co-linear transcripts (2009) Nature, 461, pp. 206-211; Denoeud, F., Kapranov, P., Ucla, C., Frankish, A., Castelo, R., Prominent use of distal 5′ transcription start sites and discovery of a large number of additional exons in ENCODE regions (2007) Genome Res, 17, pp. 746-759; Djebali, S., Kapranov, P., Foissac, S., Lagarde, J., Reymond, A., Efficient targeted transcript discovery via array-based normalization of RACE libraries (2008) Nat Methods, 5, pp. 629-635; Kapranov, P., Drenkow, J., Cheng, J., Long, J., Helt, G., Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays (2005) Genome Res, 15, pp. 987-997; Li, X., Zhao, L., Jiang, H., Wang, W., Short homologous sequences are strongly associated with the generation of chimeric RNAs in eukaryotes (2009) J Mol Evol, 68, pp. 56-65; Maher, C.A., Palanisamy, N., Brenner, J.C., Cao, X., Kalyana-Sundaram, S., Chimeric transcript discovery by paired-end transcriptome sequencing (2009) Proc Natl Acad Sci U S A, 106, pp. 12353-12358; Parra, G., Reymond, A., Dabbouseh, N., Dermitzakis, E.T., Castelo, R., Tandem chimerism as a means to increase protein complexity in the human genome (2006) Genome Res, 16, pp. 37-44; Unneberg, P., Claverie, J.M., Tentative mapping of transcription-induced interchromosomal interaction using chimeric EST and mRNA data (2007) PLoS One, 2, pp. e254; Houseley, J., Tollervey, D., Apparent non-canonical trans-splicing is generated by reverse transcriptase in vitro (2010) PLoS One, 5, pp. e12271; Bowman, R.R., Hu, W.S., Pathak, V.K., Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis (1998) J Virol, 72, pp. 5198-5206; Gilboa, E., Mitra, S.W., Goff, S., Baltimore, D., A detailed model of reverse transcription and tests of crucial aspects (1979) Cell, 18, pp. 93-100; Temin, H.M., Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation (1993) Proc Natl Acad Sci U S A, 90, pp. 6900-6903; McManus, C.J., Duff, M.O., Eipper-Mains, J., Graveley, B.R., Global analysis of trans-splicing in Drosophila (2010) Proc Natl Acad Sci U S A, 107, pp. 12975-12979; Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project (2007) Nature, 447, pp. 799-816; Harrow, J., Denoeud, F., Frankish, A., Reymond, A., Chen, C.K., GENCODE: producing a reference annotation for ENCODE (2006) Genome Biol, 7 (SUPPL. 1), pp. 1-9. , S4; Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Circos: an information aesthetic for comparative genomics (2009) Genome Res, 19, pp. 1639-1645; Fullwood, M.J., Wei, C.L., Liu, E.T., Ruan, Y., Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses (2009) Genome Res, 19, pp. 521-532; Quail, M.A., Kozarewa, I., Smith, F., Scally, A., Stephens, P.J., A large genome center's improvements to the Illumina sequencing system (2008) Nat Methods, 5, pp. 1005-1010; Cocquet, J., Chong, A., Zhang, G., Veitia, R.A., Reverse transcriptase template switching and false alternative transcripts (2006) Genomics, 88, pp. 127-131; Qu, Y., Boutjdir, M., RNase protection assay for quantifying gene expression levels (2007) Methods Mol Biol, 366, pp. 145-158; Thorvaldsen, J.L., Bartolomei, M.S., Ribonuclease protection (2001) Methods Mol Biol, 181, pp. 133-144; Khanin, R., Wit, E., How scale-free are biological networks (2006) J Comput Biol, 13, pp. 810-818; Dostie, J., Richmond, T.A., Arnaout, R.A., Selzer, R.R., Lee, W.L., Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements (2006) Genome Res, 16, pp. 1299-1309; Ozsolak, F., Platt, A.R., Jones, D.R., Reifenberger, J.G., Sass, L.E., Direct RNA sequencing (2009) Nature, 461, pp. 814-818; Jackson, D.A., Hassan, A.B., Errington, R.J., Cook, P.R., Visualization of focal sites of transcription within human nuclei (1993) EMBO J, 12, pp. 1059-1065; Pombo, A., Cook, P.R., The localization of sites containing nascent RNA and splicing factors (1996) Exp Cell Res, 229, pp. 201-203; Akiva, P., Toporik, A., Edelheit, S., Peretz, Y., Diber, A., Transcription-mediated gene fusion in the human genome (2006) Genome Res, 16, pp. 30-36; Kannan, K., Wang, L., Wang, J., Ittmann, M.M., Li, W., Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing (2011) Proc Natl Acad Sci U S A, 108, pp. 9172-9177; Roy, S.W., Irimia, M., When good transcripts go bad: artifactual RT-PCR 'splicing' and genome analysis (2008) Bioessays, 30, pp. 601-605; Collins, J.E., Goward, M.E., Cole, C.G., Smink, L.J., Huckle, E.J., Reevaluating human gene annotation: a second-generation analysis of chromosome 22 (2003) Genome Res, 13, pp. 27-36; Kent, W.J., BLAT-the BLAST-like alignment tool (2002) Genome Res, 12, pp. 656-664; Rozen, S., Skaletsky, H., Primer3 on the WWW for general users and for biologist programmers (2000) Methods Mol Biol, 132, pp. 365-386; Salehi-Ashtiani, K., Yang, X., Derti, A., Tian, W., Hao, T., Isoform discovery by targeted cloning, 'deep-well' pooling and parallel sequencing (2008) Nat Methods, 5, pp. 597-600; Walhout, A.J., Temple, G.F., Brasch, M.A., Hartley, J.L., Lorson, M.A., GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes (2000) Methods Enzymol, 328, pp. 575-592; Gordon, D., Abajian, C., Green, P., Consed: a graphical tool for sequence finishing (1998) Genome Res, 8, pp. 195-202; Searle, S.M., Gilbert, J., Iyer, V., Clamp, M., The otter annotation system (2004) Genome Res, 14, pp. 963-970; Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., Basic local alignment search tool (1990) J Mol Biol, 215, pp. 403-410; Sonnhammer, E.L., Wootton, J.C., Integrated graphical analysis of protein sequence features predicted from sequence composition (2001) Proteins, 45, pp. 262-273; Durbin, R., Griffiths, E., Acedb genome database (2005) Online Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics, , In: Interscience W, editors; Wilming, L.G., Gilbert, J.G., Howe, K., Trevanion, S., Hubbard, T., The vertebrate genome annotation (Vega) database (2008) Nucleic Acids Res, 36, pp. D753-D760; Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., STAR: mapping non-contiguous RNA-seq data (2011) Submitted; Krzywinski, M.I., Schein, J.E., Birol, I., Connors, J., Gascoyne, R., Circos: An information aesthetic for comparative genomics (2009) Genome Res","Antonarakis, S. E.; Department of Genetic Medicine and Development, University of Geneva Medical School, University Hospitals of Geneva, Geneva, Switzerland; email: gingeras@cshl.edu",,,,,,,,19326203,,,"22238572","English","PLoS ONE",Article,"Final",Open Access,Scopus,2-s2.0-84855396196
"Quesada V., Conde L., Villamor N., Ordóñez G.R., Jares P., Bassaganyas L., Ramsay A.J., Beà S., Pinyol M., Martínez-Trillos A., López-Guerra M., Colomer D., Navarro A., Baumann T., Aymerich M., Rozman M., Delgado J., Giné E., Hernández J.M., González-Díaz M., Puente D.A., Velasco G., Freije J.M.P., Tubío J.M.C., Royo R., Gelpí J.L., Orozco M., Pisano D.G., Zamora J., Vázquez M., Valencia A., Himmelbauer H., Bayés M., Heath S., Gut M., Gut I., Estivill X., López-Guillermo A., Puente X.S., Campo E., López-Otín C.","6602590815;15922449500;7003554658;55405604900;6603875118;36917806900;23475504400;6701673488;6602137898;36127955000;15832383900;7006086946;7202496222;37025527600;35502361700;7004425089;55568508768;6701325681;56330799300;9233235300;56964934600;7006478980;7005118867;57193881114;24176373200;35517522400;7102809158;24588110800;56385214300;55628532056;16308427600;35242348600;36050558500;57202147571;36130221700;56524174800;36047834200;7004492510;6701552499;7103168343;7102600806;","Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia",2012,"Nature Genetics","44","1",,"47","52",,627,"10.1038/ng.1032","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84555171449&doi=10.1038%2fng.1032&partnerID=40&md5=eb5870cd1bef975b6cfb23d612c6df3c","Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), Barcelona, Spain; Unidad de Genómica, IDIBAPS, Barcelona, Spain; Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; Servicio de Hematología, Hospital Universitario, Universidad de Salamanca, Salamanca, Spain; Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Universitat de Barcelona, Barcelona, Spain; Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Ultrasequencing Unit, CRG-UPF, Barcelona, Spain; Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain","Quesada, V., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Conde, L., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Villamor, N., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Ordóñez, G.R., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Jares, P., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Bassaganyas, L., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), Barcelona, Spain; Ramsay, A.J., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Beà, S., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Pinyol, M., Unidad de Genómica, IDIBAPS, Barcelona, Spain; Martínez-Trillos, A., Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; López-Guerra, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Colomer, D., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Navarro, A., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Baumann, T., Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; Aymerich, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Rozman, M., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Delgado, J., Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; Giné, E., Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; Hernández, J.M., Servicio de Hematología, Hospital Universitario, Universidad de Salamanca, Salamanca, Spain; González-Díaz, M., Servicio de Hematología, Hospital Universitario, Universidad de Salamanca, Salamanca, Spain; Puente, D.A., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Velasco, G., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Freije, J.M.P., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Tubío, J.M.C., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), Barcelona, Spain; Royo, R., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Universitat de Barcelona, Barcelona, Spain; Gelpí, J.L., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Universitat de Barcelona, Barcelona, Spain; Orozco, M., Programa Conjunto de Biología Computacional, Barcelona Supercomputing Center (BSC), Universitat de Barcelona, Barcelona, Spain; Pisano, D.G., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Zamora, J., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Vázquez, M., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Valencia, A., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, Madrid, Spain; Himmelbauer, H., Ultrasequencing Unit, CRG-UPF, Barcelona, Spain; Bayés, M., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Heath, S., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Gut, M., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Gut, I., Centro Nacional de Análisis Genómico, Parc Científic de Barcelona, Barcelona, Spain; Estivill, X., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), Barcelona, Spain; López-Guillermo, A., Servicio de Hematología, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain; Puente, X.S., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; Campo, E., Unidad de Hematopatología, Servicio de Anatomía Patológica, Hospital Clínic, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; López-Otín, C., Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain","Here we perform whole-exome sequencing of samples from 105 individuals with chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults in Western countries. We found 1,246 somatic mutations potentially affecting gene function and identified 78 genes with predicted functional alterations in more than one tumor sample. Among these genes, SF3B1, encoding a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP), is somatically mutated in 9.7% of affected individuals. Further analysis in 279 individuals with CLL showed that SF3B1 mutations were associated with faster disease progression and poor overall survival. This work provides the first comprehensive catalog of somatic mutations in CLL with relevant clinical correlates and defines a large set of new genes that may drive the development of this common form of leukemia. The results reinforce the idea that targeting several well-known genetic pathways, including mRNA splicing, could be useful in the treatment of CLL and other malignancies.",,"small nuclear ribonucleoprotein; article; cancer growth; chronic lymphatic leukemia; controlled study; correlation analysis; exome; gene; gene function; gene identification; gene mutation; genome analysis; human; major clinical study; mutational analysis; overall survival; priority journal; protein subunit; RNA splicing; sequence analysis; SF3B1 gene; somatic mutation; Amino Acid Sequence; Disease Progression; Exome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Phosphoproteins; Ribonucleoprotein, U2 Small Nuclear; Sequence Alignment",,"Phosphoproteins; Ribonucleoprotein, U2 Small Nuclear; SF3B1 protein, human",,,"Ministerio de Ciencia e Innovación, MICINN

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación, MICINN","We are grateful to P. Klatt for continuous support, E. Montserrat, J. Valcárcel, P. Nicolás and C. Romeo­Casabona for helpful comments, S. Guijarro, S. Martín, C. Capdevila, M. Sánchez and L. Plá for excellent technical assistance, and N. Villahoz and C. Muro for excellent work in the coordination of the CLL Spanish Consortium. We are also very grateful to all the individuals with CLL who participated in this study. This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII. C.L­O. is an Investigator of the Botín Foundation.",,,"Rozman, C., Montserrat, E., Chronic lymphocytic leukemia (1995) N. Engl. J. Med., 333, pp. 1052-1057; Zenz, T., Mertens, D., Kuppers, R., Dohner, H., Stilgenbauer, S., From pathogenesis to treatment of chronic lymphocytic leukaemia (2010) Nat. Rev. Cancer, 10, pp. 37-50; Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Chiorazzi, N., Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia (1999) Blood, 94 (6), pp. 1840-1847; Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G., Stevenson, F.K., Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia (1999) Blood, 94 (6), pp. 1848-1854; Puente, X.S., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia (2011) Nature, 475, pp. 101-105; Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Stratton, M.R., Patterns of somatic mutation in human cancer genomes (2007) Nature, 446 (7132), pp. 153-158. , DOI 10.1038/nature05610, PII NATURE05610; Pleasance, E.D., A comprehensive catalogue of somatic mutations from a human cancer genome (2010) Nature, 463, pp. 191-196; Pleasance, E.D., A small-cell lung cancer genome with complex signatures of tobacco exposure (2010) Nature, 463, pp. 184-190; Greif, P.A., Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing (2011) Leukemia, 25, pp. 821-827; Chapman, M.A., Initial genome sequencing and analysis of multiple myeloma (2011) Nature, 471, pp. 467-472; Wahl, M.C., Will, C.L., Luhrmann, R., The spliceosome: Design principles of a dynamic RNP machine (2009) Cell, 136, pp. 701-718; Wang, H., Nora, G.J., Ghodke, H., Opresko, P.L., Single molecule studies of physiologically relevant telomeric tails reveal POT1 mechanism for promoting G-quadruplex unfolding (2011) J. Biol. Chem., 286, pp. 7479-7489; Marfella, C.G.A., Imbalzano, A.N., The Chd family of chromatin remodelers (2007) Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 618 (1-2), pp. 30-40. , DOI 10.1016/j.mrfmmm.2006.07.012, PII S0027510707000309, Chromatin: Repair, Remodeling and Regulation; Prazeres, H., Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells (2011) Oncogene, 30, pp. 1302-1317; Tiacci, E., BRAF mutations in hairy-cell leukemia (2011) N. Engl. J. Med., 364, pp. 2305-2315; Zhang, X., Sequence Analysis of 515 Kinase Genes in Chronic Lymphocytic Leukemia, , Leukemia published online (24 June 2011) doi:10.1038/leu.2011.163; Zainuddin, N., TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukemia (2011) Leuk. Res., 35, pp. 272-274; Fabbri, G., Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation (2011) J. Exp. Med., 208, pp. 1389-1401; Folco, E.G., Coil, K.E., Reed, R., The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region (2011) Genes Dev., 25, pp. 440-444; Corrionero, A., Minana, B., Valcarcel, J., Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A (2011) Genes Dev., 25, pp. 445-459; Golas, M.M., Sander, B., Will, C.L., Luhrmann, R., Stark, H., Molecular architecture of the multiprotein splicing factor SF3b (2003) Science, 300 (5621), pp. 980-984. , DOI 10.1126/science.1084155; David, C.J., Manley, J.L., Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged (2010) Genes Dev., 24, pp. 2343-2364; Karni, R., De Stanchina, E., Lowe, S.W., Sinha, R., Mu, D., Krainer, A.R., The gene encoding the splicing factor SF2/ASF is a proto-oncogene (2007) Nature Structural and Molecular Biology, 14 (3), pp. 185-193. , DOI 10.1038/nsmb1209, PII NSMB1209; Golan-Gerstl, R., Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma (2011) Cancer Res., 71, pp. 4464-4472; Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Yoshida, M., Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA (2007) Nature Chemical Biology, 3 (9), pp. 576-583. , DOI 10.1038/nchembio.2007.18, PII NCHEMBIO200718; Yoshida, K., Frequent pathway mutations of splicing machinery in myelodysplasia (2011) Nature, 478, pp. 64-69; Papaemmanuil, E., Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts (2011) N. Engl. J. Med., 365, pp. 1384-1395; Visconte, V., SF3B1, A Splicing Factor Is Frequently Mutated in Refractory Anemia with Ring Sideroblasts, , Leukemia published online (2 September 2011) doi:10.1038/leu.2011.232; Chen, A.A., Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer (2009) Carcinogenesis, 30, pp. 977-981; Bulwin, G.C., TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression (2006) J. Immunol., 177, pp. 6833-6841; Brown, P.J., Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL (2008) Blood, 111, pp. 2816-2824; Hudson, T.J., International network of cancer genome projects (2010) Nature, 464, pp. 993-998; Bentley, D.R., Accurate whole human genome sequencing using reversible terminator chemistry (2008) Nature, 456, pp. 53-59; Trapnell, C., Pachter, L., Salzberg, S.L., TopHat: Discovering splice junctions with RNA-Seq (2009) Bioinformatics, 25, pp. 1105-1111; Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760; Li, H., The Sequence Alignment/Map format and SAMtools (2009) Bioinformatics, 25, pp. 2078-2079; Baudot, A., De La Torre, V., Valencia, A., Mutated genes, pathways and processes in tumours (2010) EMBO Rep., 11, pp. 805-810; Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., Hirakawa, M., KEGG for representation and analysis of molecular networks involving diseases and drugs (2010) Nucleic Acids Res., 38, pp. D355-D360; Schaefer, C.F., PID: The pathway interaction database (2009) Nucleic Acids Res., 37, pp. D674-D679; Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Sherlock, G., Gene ontology: Tool for the unification of biology (2000) Nature Genetics, 25 (1), pp. 25-29. , DOI 10.1038/75556; Reva, B., Antipin, Y., Sander, C., Predicting the functional impact of protein mutations: Application to cancer genomics (2011) Nucleic Acids Res., 39, pp. E118; Wu, S., Zhang, Y., MUSTER: Improving protein sequence profile-profile alignments by using multiple sources of structure information (2008) Proteins: Structure, Function and Genetics, 72 (2), pp. 547-556. , DOI 10.1002/prot.21945; Peto, R., Pike, M.C., Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data (1973) Biometrics, 29, pp. 579-584","López-Otín, C.; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain; email: clo@uniovi.es",,,,,,,,10614036,,NGENE,"22158541","English","Nat. Genet.",Article,"Final",,Scopus,2-s2.0-84555171449
"Puente X.S., Pinyol M., Quesada V., Conde L., Ordóñez G.R., Villamor N., Escaramis G., Jares P., Beá S., González-Díaz M., Bassaganyas L., Baumann T., Juan M., López-Guerra M., Colomer D., Tubío J.M.C., López C., Navarro A., Tornador C., Aymerich M., Rozman M., Hernández J.M., Puente D.A., Freije J.M.P., Velasco G., Gutiérrez-Fernández A., Costa D., Carrio A., Guijarro S., Enjuanes A., Hernndez L., Yage J., Nicols P., Romeo-Casabona C.M., Himmelbauer H., Castillo E., Dohm J.C., De Sanjos S., Piris M.A., De Alava E., Miguel J.S., Royo R., Gelpi J.L., Torrents D., Orozco M., Pisano D.G., Valencia A., Guigi R., Bayes M., Heath S., Gut M., Klatt P., Marshall J., Raine K., Stebbings L.A., Futreal P.A., Stratton M.R., Campbell P.J., Gut I., Lopez-Guillermo A., Estivill X., Montserrat E., López-Otín C., Campo E.","6701552499;6602137898;6602590815;15922449500;55405604900;7003554658;6507111327;6603875118;6701673488;9233235300;36917806900;37025527600;7006971346;15832383900;7006086946;57193881114;57200852988;7202496222;36919357300;35502361700;7004425089;56330799300;56964934600;7005118867;7006478980;9234544800;7201884637;6701732738;49461218000;7801316774;57195257875;49462069500;57199531238;57210606178;35242348600;57209096997;22957290400;42461230700;7005482577;55845678400;57204649938;24176373200;35517522400;6603452371;7102809158;24588110800;16308427600;7004339139;36050558500;57202147571;36130221700;7005662549;57205132929;15122481800;6507650083;35377883800;7004406099;35397659000;56524174800;7004492510;36047834200;55431625100;7102600806;7103168343;","Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia",2011,"Nature","475","7354",,"101","105",,1001,"10.1038/nature10113","https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960036578&doi=10.1038%2fnature10113&partnerID=40&md5=f01a30f21a76524e142ad7710e21f062","Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Unidad de Genómica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Servicio de Hematologia, Hospital Universitario, Universidad de Salamanca, 37007 Salamanca, Spain; Servicio de Hematologia, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, Spain; Servicio de Inmunologia, Hospital Clinic, IDIBAPS, 08036 Barcelona, Spain; Hospital Clinico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain; Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del Pais Vasco, 48007 Bilbao, Spain; Ultrasequencing Unit, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Unidad de Infecciones y Cáncer, Institut Català de Oncologia-IDIBELL, 08907 Hospitalet de Llobregat, Spain; Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain; Programa Conjunto de Biologia Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), 08028 Barcelona, Spain; Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, 28029 Madrid, Spain; Genomic Bioinformatics Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Centro Nacional de Análisis Genómico, Parc Cientific de Barcelona, 08028 Barcelona, Spain; Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, 28049 Madrid, Spain; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom","Puente, X.S., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Pinyol, M., Unidad de Genómica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain; Quesada, V., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Conde, L., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Ordóñez, G.R., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Villamor, N., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Escaramis, G., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Jares, P., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Beá, S., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; González-Díaz, M., Servicio de Hematologia, Hospital Universitario, Universidad de Salamanca, 37007 Salamanca, Spain; Bassaganyas, L., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Baumann, T., Servicio de Hematologia, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, Spain; Juan, M., Servicio de Inmunologia, Hospital Clinic, IDIBAPS, 08036 Barcelona, Spain; López-Guerra, M., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Colomer, D., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Tubío, J.M.C., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain, Hospital Clinico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain; López, C., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Navarro, A., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Tornador, C., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Aymerich, M., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Rozman, M., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Hernández, J.M., Servicio de Hematologia, Hospital Universitario, Universidad de Salamanca, 37007 Salamanca, Spain; Puente, D.A., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Freije, J.M.P., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Velasco, G., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Gutiérrez-Fernández, A., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Costa, D., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Carrio, A., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Guijarro, S., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Enjuanes, A., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Hernndez, L., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain; Yage, J., Servicio de Inmunologia, Hospital Clinic, IDIBAPS, 08036 Barcelona, Spain; Nicols, P., Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del Pais Vasco, 48007 Bilbao, Spain; Romeo-Casabona, C.M., Cátedra Inter-Universitaria de Derecho y Genoma Humano, Universidad de Deusto, Universidad Del Pais Vasco, 48007 Bilbao, Spain; Himmelbauer, H., Ultrasequencing Unit, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Castillo, E., Ultrasequencing Unit, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Dohm, J.C., Ultrasequencing Unit, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; De Sanjos, S., Unidad de Infecciones y Cáncer, Institut Català de Oncologia-IDIBELL, 08907 Hospitalet de Llobregat, Spain; Piris, M.A., Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain; De Alava, E., Servicio de Hematologia, Hospital Universitario, Universidad de Salamanca, 37007 Salamanca, Spain; Miguel, J.S., Servicio de Hematologia, Hospital Universitario, Universidad de Salamanca, 37007 Salamanca, Spain; Royo, R., Programa Conjunto de Biologia Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), 08028 Barcelona, Spain; Gelpi, J.L., Programa Conjunto de Biologia Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), 08028 Barcelona, Spain; Torrents, D., Programa Conjunto de Biologia Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), 08028 Barcelona, Spain; Orozco, M., Programa Conjunto de Biologia Computacional, Barcelona Supercomputing Center (BSC), Institut de Recerca Biomèdica (IRB), 08028 Barcelona, Spain; Pisano, D.G., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, 28029 Madrid, Spain; Valencia, A., Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Spanish National Bioinformatics Institute, 28029 Madrid, Spain; Guigi, R., Genomic Bioinformatics Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Bayes, M., Centro Nacional de Análisis Genómico, Parc Cientific de Barcelona, 08028 Barcelona, Spain; Heath, S., Centro Nacional de Análisis Genómico, Parc Cientific de Barcelona, 08028 Barcelona, Spain; Gut, M., Centro Nacional de Análisis Genómico, Parc Cientific de Barcelona, 08028 Barcelona, Spain; Klatt, P., Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, 28049 Madrid, Spain; Marshall, J., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Raine, K., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Stebbings, L.A., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Futreal, P.A., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Stratton, M.R., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Campbell, P.J., Wellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom; Gut, I., Centro Nacional de Análisis Genómico, Parc Cientific de Barcelona, 08028 Barcelona, Spain; Lopez-Guillermo, A., Servicio de Hematologia, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, Spain; Estivill, X., Genes and Disease Programme, Center for Genomic Regulation, Pompeu Fabra University (CRG-UPF), 08003 Barcelona, Spain; Montserrat, E., Servicio de Hematologia, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, Spain; López-Otín, C., Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; Campo, E., Unidad de Hematopatologia, Hospital Clinic, Universitat de Barcelona, 08036 Barcelona, Spain","Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution. Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes. The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer. © 2011 Macmillan Publishers Limited. All rights reserved.",,"exportin 1; interleukin 1 receptor; interleukin 1 receptor blocking agent; interleukin 6; macrophage inflammatory protein 1alpha; macrophage inflammatory protein 1beta; monocyte chemotactic protein 1; myeloid differentiation factor 88; Notch1 receptor; RNA; toll like receptor; blood system disorder; cancer; gene expression; genetic analysis; genome; molecular analysis; mutation; pathogenicity; acute lymphoblastic leukemia; adult; article; chronic leukemia; chronic lymphatic leukemia; cytokine release; gene expression; gene mutation; gene sequence; human; human cell; human genome; immune system; leukemia cell line; leukemogenesis; major clinical study; mouse; nonhuman; overall survival; pathogenesis; priority journal; recurrent cancer",,"macrophage inflammatory protein 1alpha, 155075-84-6; macrophage inflammatory protein 1beta, 122071-81-2; RNA, 63231-63-0; toll like receptor, 409141-78-2",,,"Ministerio de Ciencia e Innovación, MICINN

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación, MICINN","Acknowledgements This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII. C.L.-O. is an Investigator of the Botin Foundation and D.T., of the ICREA program. We thank E. Santos for his support of this project, A. Carracedo and J. Benítez for genotyping studies, C. Fortuny for the supply of samples and N. Villahoz and M. C. Muro for their work in the coordination of the CLL-ICGC Consortium. We are also grateful to all patients with CLL who participated in this study.",,,"Rozman, C., Montserrat, E., Chronic lymphocytic leukemia (1995) N. Engl. J. Med., 333, pp. 1052-1057; Zenz, T., Mertens, D., Kuppers, R., Dohner, H., Stilgenbauer, S., Frompathogenesis to treatment of chronic lymphocytic leukaemia (2010) Nature Rev. Cancer, 10, pp. 37-50; Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Chiorazzi, N., Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia (1999) Blood, 94 (6), pp. 1840-1847; Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G., Stevenson, F.K., Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia (1999) Blood, 94 (6), pp. 1848-1854; Pleasance, E.D., A comprehensive catalogue of somatic mutations from a human cancer genome (2010) Nature, 463, pp. 191-196; Pleasance, E.D., A small-cell lung cancer genome with complex signatures of tobacco exposure (2010) Nature, 463, pp. 184-190; Greenman, C., Stephens, P., Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Stratton, M.R., Patterns of somatic mutation in human cancer genomes (2007) Nature, 446 (7132), pp. 153-158. , DOI 10.1038/nature05610, PII NATURE05610; Spencer, J., Dunn-Walters, D.K., Hypermutation at A-T base pairs: The A nucleotide replacement spectrum is affected by adjacent nucleotides and there is no reverse complementarity of sequences flanking mutated A and T nucleotides (2005) Journal of Immunology, 175 (8), pp. 5170-5177; Weng, A.P., Ferrando, A.A., Lee, W., Morris IV, J.P., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Aster, J.C., Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia (2004) Science, 306 (5694), pp. 269-271. , DOI 10.1126/science.1102160; Sportoletti, P., NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL (2010) Br. J. Haematol., 151, pp. 404-406; Rosati, E., Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells (2009) Blood, 113, pp. 856-865; Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., Hirakawa, M., KEGG for representation and analysis of molecular networks involving diseases and drugs (2010) Nucleic Acids Res., 38, pp. D355-D360; Palomero, T., Wei, K.L., Odom, D.T., Sulis, M.L., Real, P.J., Margolin, A., Barnes, K.C., Ferrando, A.A., NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (48), pp. 18261-18266. , DOI 10.1073/pnas.0606108103; Ngo, V.N., Oncogenically active MYD88 mutations in human lymphoma (2011) Nature, 470, pp. 115-119; O'Neill, L.A.J., Bowie, A.G., The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling (2007) Nature Reviews Immunology, 7 (5), pp. 353-364. , DOI 10.1038/nri2079, PII NRI2079; Coste, I., Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation (2010) J. Clin. Invest., 120, pp. 3663-3667; Burger, J.A., High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation (2009) Blood, 113, pp. 3050-3058; Muzio, M., Expressionand functionof toll like receptors in chronic lymphocytic leukaemia cells (2009) Br. J. Haematol., 144, pp. 507-516; Ferrigno, P., Posas, F., Koepp, D., Saito, H., Silver, P.A., Regulated nucleo/cytoplasmic exchange of HOG1 MAPK requires the importin β homologs NMD5 and XPO1 (1998) EMBO Journal, 17 (19), pp. 5606-5614. , DOI 10.1093/emboj/17.19.5606; Kroll, J., Shi, X., Caprioli, A., Liu, H.-H., Waskow, C., Lin, K.-M., Miyazaki, T., Sato, T.N., The BTB-kelch protein KLHL6 is involved in B-lymphocyte antigen receptor signaling and germinal center formation (2005) Molecular and Cellular Biology, 25 (19), pp. 8531-8540. , DOI 10.1128/MCB.25.19.8531-8540.2005; Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R.S.K., Kuppers, R., Dalla-Favera, R., Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas (2001) Nature, 412 (6844), pp. 341-346. , DOI 10.1038/35085588; Aqeilan, R.I., Calin, G.A., Croce, C.M., MiR-15a and miR-16-1in cancer: Discovery, function and future perspectives (2010) Cell Death Differ., 17, pp. 215-220; Moreno-Bueno, G., CyclinD1gene (CCND1)mutations in endometrial cancer (2003) Oncogene, 22, pp. 6115-6118; Hudson, T.J., International network of cancer genome projects (2010) Nature, 464, pp. 993-998; Bentley, D.R., Accurate whole human genome sequencing using reversible terminator chemistry (2008) Nature, 456, pp. 53-59; Li, H., Durbin, R., Fast and accurate short read alignment with Burrows-Wheeler transform (2009) Bioinformatics, 25, pp. 1754-1760","López-Otín, C.; Departamento de Bioquimica y Biologia Molecular, Instituto Universitario de Oncologia, Universidad de Oviedo, 33006 Oviedo, Spain; email: clo@uniovi.es",,,"Nature Publishing Group",,,,,00280836,,NATUA,,"English","Nature",Article,"Final",Open Access,Scopus,2-s2.0-79960036578
"Orozco M., Orellana L., Hospital A., Naganathan A.N., Emperador A., Carrillo O., Gelpí J.L.","7102809158;35311824100;15831739300;6504519433;57208980207;6603236640;35517522400;","Coarse-grained representation of protein flexibility. Foundations, Successes, and Shortcomings",2011,"Advances in Protein Chemistry and Structural Biology","85",,,"183","215",,24,"10.1016/B978-0-12-386485-7.00005-3","https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052787895&doi=10.1016%2fB978-0-12-386485-7.00005-3&partnerID=40&md5=acf5c03904537a64fb289b86a913c62c","Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain; National Institute of Bioinformatics, Structural Bioinformatics Node, Baldiri Reixac 10-12, Barcelona, Spain; Departament de Bioquímica i Biologia Molecular, Facultat de Biología, Barcelona, Spain","Orozco, M., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain, National Institute of Bioinformatics, Structural Bioinformatics Node, Baldiri Reixac 10-12, Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biología, Barcelona, Spain; Orellana, L., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain; Hospital, A., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain, National Institute of Bioinformatics, Structural Bioinformatics Node, Baldiri Reixac 10-12, Barcelona, Spain; Naganathan, A.N., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain; Emperador, A., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain; Carrillo, O., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain; Gelpí, J.L., Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain, National Institute of Bioinformatics, Structural Bioinformatics Node, Baldiri Reixac 10-12, Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biología, Barcelona, Spain","Flexibility is the key magnitude to understand the variety of functions of proteins. Unfortunately, its experimental study is quite difficult, and in fact, most experimental procedures are designed to reduce flexibility and allow a better definition of the structure. Theoretical approaches have become then the alternative but face serious timescale problems, since many biologically relevant deformation movements happen in a timescale that is far beyond the possibility of current atomistic models. In this complex scenario, coarse-grained simulation methods have emerged as a powerful and inexpensive alternative. Along this chapter, we will review these coarse-grained methods, and explain their physical foundations and their range of applicability. © 2011 Elsevier Inc.",,,,,,,,,,,"Abseher, R., Horstink, L., Hilbers, C.W., Nilges, M., Essential spaces defined by NMR structure ensembles and molecular dynamics simulation show significant overlap (1998) Proteins: Structure, Function and Genetics, 31 (4), pp. 370-382. , DOI 10.1002/(SICI)1097-0134(19980601)31:4<370::AID-PROT4>3.0.CO;2-M; Arkhipov, A., Freddolino, P.L., Imada, K., Namba, K., Schulten, K., Coarse-grained molecular dynamics simulations of a rotating bacterial flagellum (2006) Biophysical Journal, 91 (12), pp. 4589-4597. , http://www.biophysj.org/cgi/reprint/91/12/4589.pdf, DOI 10.1529/biophysj.106.093443; Arkhipov, A., Freddolino, P.L., Schulten, K., Stability and Dynamics of Virus Capsids Described by Coarse-Grained Modeling (2006) Structure, 14 (12), pp. 1767-1777. , DOI 10.1016/j.str.2006.10.003, PII S0969212606004023; Atilgan, A.R., Durell, S.R., Jernigan, R.L., Demirel, M.C., Keskin, O., Bahar, I., Anisotropy of fluctuation dynamics of proteins with an elastic network model (2001) Biophys. J., 80, pp. 505-515; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The Protein Data Bank (2000) Nucleic Acids Research, 28 (1), pp. 235-242; Brooks Iii, C.L., Karplus, M., Pettitt, B.M., Dynamical simulation methods (1988) Proteins: A Theoretical Perspective of Dynamics, Structure and Thermodynamics; Advances in Chemical Physics, Vol. LXXI, pp. 33-58. , John Willey & Sons New York; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., FlexServ: An integrated tool for the analysis of protein flexibility (2009) Bioinformatics, 25 (13), pp. 1709-1710; Clementi, C., Nymeyer, H., Onuchic, J.N., Topological and energetic factors: What determines the structural details of the transition state ensemble and ""en-route"" intermediates for protein folding? An investigation for small globular proteins (2000) J. Mol. Biol., 298, pp. 937-953; Clementi, C., Garcia, A.E., Onuchic, J.N., Interplay among tertiary contacts, secondary structure formation and side-chain packing in the protein folding mechanism: All-atom representation study of protein L (2003) Journal of Molecular Biology, 326 (3), pp. 933-954. , DOI 10.1016/S0022-2836(02)01379-7; Ding, F., Dokholyan, N.V., Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 19696-19701; Ding, F., Buldyrev, S.V., Dokholyan, N.V., Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model (2005) Biophysical Journal, 88 (1), pp. 147-155. , DOI 10.1529/biophysj.104.046375; Dobbins, S.E., Lesk, V.I., Sternberg, M.J.E., Expand + Insights into protein flexibility: The relationship between normal modes and conformational change upon protein-protein docking (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 10390-10395; Emperador, A., Carrillo, O., Rueda, M., Orozco, M., Exploring the suitability of coarse-grained techniques for the representation of protein dynamics (2008) Biophys. J., 95, pp. 2127-2138; Emperador, A., Meyer, T., Orozco, M., United-atom discrete molecular dynamics of proteins using physics-based potentials (2008) J. Chem. Theory Comput., 4, pp. 2001-2010; Emperador, A., Meyer, T., Orozco, M., Protein flexibility from discrete molecular dynamics simulations using quasi-physical potentials (2010) Proteins, 78, pp. 83-94; Gardiner, C.W., (1989) Handbook of Stochastic Methods for Physics, Chemistry and the Natural Science, , second ed. Springer Berlin; Go, N., Protein folding as a stochastic process (1983) J. Stat. Phys., 30, pp. 413-423; Harvey, M.J., Giupponi, G., De Fabritiis, G., ACEMD: Accelerating biomolecular dynamics in the microsecond time scale (2009) J. Chem. Theory Comput., 5 (6), pp. 1632-1639; Hess, B., Van Der Spoel, D., Lindahl, E., GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation (2008) J. Chem. Theory Comput., 4 (3), pp. 435-447; Hinsen, K., Petrescu, A., Dellerue, S., Bellissent-Funel, M., Kneller, G., Harmonicity in slow protein dynamics (2000) Chem. Phys., 261, pp. 25-37; Jeong, J.I., Jang, Y., Kim, M.K., A connection rule for α-carbon coarse-grained elastic network models using chemical bond information (2006) Journal of Molecular Graphics and Modelling, 24 (4), pp. 296-306. , DOI 10.1016/j.jmgm.2005.09.006, PII S1093326305001075; Jorgensen, W.L., Tirado-Rives, J., Molecular modeling of organic and biomolecular systems using BOSS and MCPRO (2005) Journal of Computational Chemistry, 26 (16), pp. 1689-1700. , DOI 10.1002/jcc.20297; Karplus, M., McCammon, J.A., Molecular dynamics simulations of proteins (2002) Nat. Struct. Biol., 9, pp. 646-652; Khalili, M., Liwo, A., Scheraga, H.A., Kinetic studies of folding of the B-domain of staphylococcal protein A with molecular dynamics and a united-residue (UNRES) model of polypeptide chains (2006) Journal of Molecular Biology, 355 (3), pp. 536-547. , DOI 10.1016/j.jmb.2005.10.056, PII S0022283605013033; Kondrashov, D.A., Cui, Q., Phillips Jr., G.N., Optimization and evaluation of a coarse-grained model of protein motion using x-ray crystal data (2006) Biophysical Journal, 91 (8), pp. 2760-2767. , http://www.biophysj.org/cgi/reprint/91/8/2760, DOI 10.1529/biophysj.106.085894; Kong, Y., Ma, J., Karplus, M., Lipscomb, W.N., The allosteric mechanism of yeast chorismate mutase: A dynamic analysis (2006) Journal of Molecular Biology, 356 (1), pp. 237-247. , DOI 10.1016/j.jmb.2005.10.064, PII S0022283605013240; Kovacs, J.A., Chacon, P., Abagyan, R., Predictions of protein flexibility: First-order measures (2004) Proteins: Structure, Function and Genetics, 56 (4), pp. 661-668. , DOI 10.1002/prot.20151; Krebs, W.G., Alexandrov, V., Wilson, C.A., Echols, N., Yu, H., Gerstein, M., Normal mode analysis of macromolecular motions in a database framework: Developing mode concentration as a useful classifying statistic (2002) Proteins: Structure, Function and Genetics, 48 (4), pp. 682-695. , DOI 10.1002/prot.10168; Kubo, R., Some Aspects of the Statistical Mechanical Theory of irreversible Processes (1959) Lectures in Theoretical Physics, Vol. 1, pp. 120-203. , W. British, Interscience New York; Kubo, R., Linear Response Theory of Irreversible Processes (1965) Statistical Mechanics of Equilibrium and Non-Equilibrium, Proc. Int. Symposium, Aachen, pp. 81-99. , J. Meixner, North-Holland Amsterdam; Lemons, D.S., Paul Langevin's 1908 paper ""on the Theory of Brownian Motion"" (1977) Am. J. Phys., 65 (11), pp. 1079-1081. , (Sur la théorie du mouvement brownien, C. R. Acad. Sci. (Paris) 146, 530-533 (1908)); Liwo, A., Khalili, M., Scheraga, H.A., Ab initio simulations of protein-folding pathways by molecular dynamics with the united-residue model of polypeptide chains (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (7), pp. 2362-2367. , DOI 10.1073/pnas.0408885102; Liwo, A., Khalili, M., Czaplewski, C., Kalinowski, S., Oldziej, S., Wachucik, K., Modification and optimization of the UNRES potential energy function for canonical simulations (2007) J. Phys. Chem. B, 111, pp. 260-285; Ma, J., Coarse-grained elastic normal mode analysis and its applications in X-ray crystallographic refinement at moderate resolutions (2009) Coarse-Graining of Condensed Phase and Biomolecular Systems, pp. 255-266. , G.A. Voth, CRC Press Boca Raton, FL; Marrink, S.J., Risselada, H.J., Yefimov, S., Tieleman, D.P., De Vries, A.H., The MARTINI force field: Coarse grained model for biomolecular simulations (2007) Journal of Physical Chemistry B, 111 (27), pp. 7812-7824. , DOI 10.1021/jp071097f; Marrink, S.J., Fuhrmans, M., Risselada, H.J., Periole, X., The MARTINI force-field (2009) Coarse Grained of Condensed Phase and Biomolecular Systems, pp. 5-20. , G.A. Voth, CRC Press Boca Raton, FL; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; MacKerell Jr., A.D., Wiorkiewicz-Kuczera, J., Karplus, M., An all-atom empirical energy function for the simulation of nucleic acids (1995) Journal of the American Chemical Society, 117 (48), pp. 11946-11975; Mendez, R., Bastolla, U., Torsional Network Model: Normal modes in torsion angle space better correlate with conformational changes in Proteins (2010) Phys. Rev. Lett., 104, pp. 228103-228107; Meyer, T., D'Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C., Pérez, A., Carrillo, O., Orozco, M., MoDEL (molecular dynamics extended library): A database of atomistic moleculardynamics trajectories (2010) Structure, , (In Press); Moritsugu, K., Smith, J.C., Coarse-grained biomolecular simulation with REACH: Realistic extension algorithm via covariance hessian (2007) Biophysical Journal, 93 (10), pp. 3460-3469. , http://www.biophysj.org/cgi/reprint/93/10/3460, DOI 10.1529/biophysj.107.111898; Orellana, L., Rueda, M., Ferrer-Costa, C., López-Blanco, J.R., Chacón, P., Orozco, M., Approaching elastic network models to molecular dynamics flexibility (2010) J. Chem. Theory Comput., 6, pp. 2910-2923; Phillips Jr., G.N., Normal mode analysis in studying protein motions with X-ray crystallography (2006) Normal Mode Analysis: Theory and Applications to Biological and Chemical Systems, pp. 155-170. , Q. Cui, I. Bahar, Chapman & Hall/CRC Boca Raton, FL; Phillips, J.C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Schulten, K., Scalable molecular dynamics with NAMD (2005) Journal of Computational Chemistry, 26 (16), pp. 1781-1802. , DOI 10.1002/jcc.20289; Rueda, M., Ferrer-Costa, C., Meyer, T., Perez, A., Camps, J., Hospital, A., Gelpi, J.L., Orozco, M., A consensus view of protein dynamics (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (3), pp. 796-801. , DOI 10.1073/pnas.0605534104; Rueda, M., Chacon, P., Orozco, M., Thorough Validation of Protein Normal Mode Analysis: A Comparative Study with Essential Dynamics (2007) Structure, 15 (5), pp. 565-575. , DOI 10.1016/j.str.2007.03.013, PII S0969212607001414; Rueda, M., Bottegoni, G., Abagyan, R., Consistent improvement of cross-docking results using binding site ensembles generated with elastic network normal modes (2009) J. Chem. Inf. Model., 49 (3), pp. 716-725; Sen, T.Z., Jernigan, R.L., Optimizing the parameters of the Gaussian network model for ATP-binding proteins (2006) Normal Mode Analysis: Theory and Applications to Biological and Chemical Systems, pp. 171-186. , Q. Cui, I. Bahar, CRC Press Boca Raton, CA; Shih, A.Y., Arkhipov, A., Freddolino, P.L., Schulten, K., Coarse grained protein-lipid model with application to protein particles (2006) J. Phys. Chem. B, 110, pp. 3674-3684; Sorenson, J.M., Head-Gordon, T., Toward minimalist models of larger proteins: A ubiquitin-like protein (2002) Proteins: Structure, Function and Genetics, 46 (4), pp. 368-379. , DOI 10.1002/prot.1174; Taketomi, H., Ueda, Y., Studies on protein folding, unfolding and fluctuations by computer simulations. 1. Effect of specific amino-acid sequence represented by specific inter-unit interactions (1975) Int. J. Pept. Prot. Res., 7, pp. 445-459; Tama, F., Gadea, F.X., Marques, O., Sanejouand, Y.-H., Building-block approach for determining low-frequency normal modes of macromolecules (2000) Proteins: Structure, Function and Genetics, 41 (1), pp. 1-7. , DOI 10.1002/1097-0134(20001001)41:1<1::AID-PROT10>3.0.CO;2-P; Tirion, M.M., Large amplitude elastic motions in proteins from a single-parameter, atomic analysis (1996) Physical Review Letters, 77 (9), pp. 1905-1908; Ulmscheneider, J.P., Jorgensen, W.L., Monte Carlo backbone sampling for polypeptides with variable bond angles and dihedral angles using concerted rotations and a Gaussian bias (2003) J. Chem. Phys., 118, p. 4261; Van Der Kamp, M.W., Schaeffer, R.D., Jonsson, A.L., Scouras, A.D., Simms, A.M., Toofanny, R.D., Dynameomics: A comprehensive database of protein dynamics (2010) Structure, 18, pp. 423-435; Van Kampen, N.G., (1981) Stochastic Processes in Physics and Chemistry, , North-Holland Amsterdam; Voelz, V.A., Bowman, G.R., Beauchamp, K., Pande, V.S., Molecular simulation of ab initio protein folding for a millisecond folder NTL9(1-39) (2010) J. Am. Chem. Soc., 132 (5), pp. 1526-1528; Yang, L.-W., Eyal, E., Chennubhotla, C., Jee, J., Gronenborn, A.M., Bahar, I., Insights into Equilibrium Dynamics of Proteins from Comparison of NMR and X-Ray Data with Computational Predictions (2007) Structure, 15 (6), pp. 741-749. , DOI 10.1016/j.str.2007.04.014, PII S0969212607001839; Zhou, Y., Karplus, M., Interpreting the folding kinetics of helical proteins (1999) Nature, 401 (6751), pp. 400-403. , DOI 10.1038/43940","Orozco, M.; Joint IRB-BSC Program on Computational Biology, Barcelona Supercomputing Center, Institute of Research in Biomedicine, Barcelona, Spain",,,"Academic Press Inc.",,,,,18761623,,,,"English","Adv. Protein Chem. Struct. Biol.",Book Chapter,"Final",,Scopus,2-s2.0-80052787895
"Meyer T., D'Abramo M., Hospital A., Rueda M., Ferrer-Costa C., Pérez A., Carrillo O., Camps J., Fenollosa C., Repchevsky D., Gelpí J.L., Orozco M.","55913919700;57196462897;15831739300;35518639700;8866407700;35764684500;6603236640;57198367291;57199554447;37038218100;35517522400;7102809158;","MoDEL (Molecular Dynamics Extended Library): A Database of Atomistic Molecular Dynamics Trajectories",2010,"Structure","18","11",,"1399","1409",,78,"10.1016/j.str.2010.07.013","https://www.scopus.com/inward/record.uri?eid=2-s2.0-78149459697&doi=10.1016%2fj.str.2010.07.013&partnerID=40&md5=73acd15cf04f30475c587ebb9e18ba01","Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain; National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Departament de Bioquímica i Biología Molecular, Facultat de Biología, Avgda Diagonal 645, Barcelona 08028, Spain","Meyer, T., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain; D'Abramo, M., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Hospital, A., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Rueda, M., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Ferrer-Costa, C., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Pérez, A., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain; Carrillo, O., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Camps, J., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Fenollosa, C., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Repchevsky, D., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; Gelpí, J.L., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Departament de Bioquímica i Biología Molecular, Facultat de Biología, Avgda Diagonal 645, Barcelona 08028, Spain; Orozco, M., Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Barcelona Supercomputing Center, Jordi Girona 31, Edifici Torre Girona, Barcelona 08034, Spain, National Institute of Bioinformatics, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain, Departament de Bioquímica i Biología Molecular, Facultat de Biología, Avgda Diagonal 645, Barcelona 08028, Spain","More than 1700 trajectories of proteins representative of monomeric soluble structures in the protein data bank (PDB) have been obtained by means of state-of-the-art atomistic molecular dynamics simulations in near-physiological conditions. The trajectories and analyses are stored in a large data warehouse, which can be queried for dynamic information on proteins, including interactions. Here, we describe the project and the structure and contents of our database, and provide examples of how it can be used to describe the global flexibility properties of proteins. Basic analyses and trajectories stripped of solvent molecules at a reduced resolution level are available from our web server. © 2010 Elsevier Ltd.",,"amino acid sequence; article; computer program; computer simulation; molecular dynamics; molecular dynamics extended library; priority journal; protein analysis; Protein Data Bank; protein database; protein structure",,,,,"BIO2009-10964, CTQ2005-09365-C02-02","MoDEL is a massive effort involving, directly or indirectly, a large part of the Molecular Modeling and Bioinformatics group at IRB Barcelona and the BSC. We are also indebted to Dr. Sergi Girona and the MareNostrum support team for making this project possible. Helpful comments from Prof. F. J. Luque and many colleagues at IRB Barcelona and the BSC are gratefully acknowledged. This work was supported by the Spanish Ministry of Science (CTQ2005-09365-C02-02, BIO2009-10964), INB-Genoma España, the Consolider E-science project, EU-ScalaLife project), the COMBIOMED RETICS project and the Fundación Marcelino Botin .",,,"Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., Basic local alignment search tool (1990) J. Mol. Biol., 215, pp. 403-410; Amadei, A., Linssen, A.B., Berendsen, H.J., Essential dynamics of proteins (1993) Proteins, 17, pp. 412-425; Andricioaei, I., Karplus, M., On the calculation of entropy from covariance matrices of the atomic fluctuations (2001) J. Chem. Phys., 115, pp. 6289-6292; Bahar, I., Rader, A.J., Coarse-grained normal mode analysis in structural biology (2005) Curr. Opin. Struct. Biol., 15, pp. 586-592; Beck, D.A., Jonsson, A.L., Schaefer, R.D., Scott, K.A., Day, R., Toofanny, R.D., Alonso, D.O.V., Daggett, V., Dynameomics: mass annotation of protein dynamics and unfolding in water by high-throughput atomistic molecular dynamics simulations (2008) Protein Eng. Des. Sel., 21, pp. 2038-2050; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The Protein Data Bank (2000) Nucleic Acids Res., 28, pp. 235-242; Berrar, D., Stahl, F., Silva, C., Rodrigues, J.R., Brito, R.M., Dubitzky, W., Towards data warehousing and mining of protein unfolding simulation data (2005) J. Clin. Monit. Comput., 19, pp. 307-317; Interoperability with Moby 1.0-it's better than sharing your toothbrush! (2008) Brief. Bioinform., 9, pp. 220-231. , BioMoby Consortium; Brooks, C.L., Karplus, M., Pettitt, B.M., (1987) Proteins: A Theoretical Perspective of Dynamics, Structure and Thermodynamics, , Cambridge University Press, Cambridge; Camps, J., Carrillo, O., Emperador, A., Orellana, L., Hospital, A., Rueda, M., Cicin-Sain, D., Orozco, M., FlexServ: an integrated tool for the analysis of protein flexibility (2009) Bioinformatics, 25, pp. 1709-1710; Carrillo, O., Orozco, M., GRID-MD-a tool for massive simulation of protein channels (2008) Proteins, 70, pp. 892-899; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham, T.E., Ross, W.S., Simmerling, C.L., Darden, T.L., Cheng, A.L., (2004) AMBER 8 Computer Program, , University of California, San Francisco; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J. Am. Chem. Soc., 117, pp. 5179-5197; Daniel, R.M., Dumm, R.V., Finney, J.L., Smith, J.C., The role of dynamics in enzyme activity (2003) Annu. Rev. Biophys. Biomol. Struct., 32, pp. 69-92; Day, R., Beck, D.A.C., Armen, R.S., Dagget, V., A consensus view of fold space: Combining SCOP, CATH and the Dali Domain Dictionary (2003) Protein Sci., 12, pp. 2150-2160; Emperador, A., Carrillo, O., Rueda, M., Orozco, M., Exploring the suitability of coarse-grained techniques for the representation of protein dynamics (2008) Biophys. J., 95, pp. 2127-2138; Emperador, A., Meyer, T., Orozco, M., United-atom discrete molecular dynamics of proteins using physics-based potentials (2008) J. Chem. Theory Comput., 4, pp. 2001-2010; Fernández-Recio, J., Totrov, M., Skorodumov, C., Abagyan, R., Optimal Docking Area: a new method for predicting protein-protein interaction sites (2005) Proteins, 58, pp. 134-143; Finn, R.D., Tate, J., Mistry, J., Coggill, P.C., Sammut, J.S., Hotz, H.R., Ceric, G., Bateman, A., (2008) The PFAM protein families databases. Nucleic Acids Research, 36, pp. D281-D288; Gelpí, J.L., Kalko, S.G., Barril, X., Cirera, J., de La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: improved setup procedure molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Goldstein, R.A., The structure of protein evolution and the evolution of protein structure (2008) Curr. Opin. Struct. Biol., 18, pp. 170-177; Harris, S.A., Gavathiotis, E., Searle, M.S., Orozco, M., Laughton, C.A., Cooperativity in drug-DNA recognition: a molecular dynamics study (2001) J. Am. Chem. Soc., 123, pp. 12658-12663; Henzler-Wildman, K.A., Lei, M., Thai, V., Kerns, S.J., Karplus, M., Kern, D., A hierarchy of timescales in protein dynamics is linked to enzyme catalysis (2007) Nature, 450, pp. 913-916; Hermans, J., Berendsen, H.J.C., Van Gunsteren, W.F., Postma, J.P.M., A consistent empirical potential for water-protein interactions (1984) Biopolymers, 23, pp. 1513-1518; Hess, B., van der Spoel, D., Lindahl, E., GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation (2008) J. Chem. Theory Comput., 4, pp. 435-447; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J. Chem. Phys., 79, pp. 926-935; Jorgensen, W.L., Maxwell, D.S., Tirado-Rives, J., Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids (1996) J. Am. Chem. Soc., 118, pp. 11225-11236; Karplus, M., Kuriyan, J., Molecular dynamics and protein function (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 6679-6685; Kehl, C., Simms, A.M., Toofanny, R.D., Daggett, V., Dynameomics: a multi-dimensional analysis-optimized database for dynamic protein data (2008) Protein Eng. Des. Sel., 21, pp. 379-386; Krissinel, E., Henrick, K., Inference of macromolecular assemblies from crystalline state (2007) J. Mol. Biol., 372, pp. 774-797; Kuhlman, B., Baker, D., Native protein sequences are close to optimal for their structures (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 10383-10388; Leo-Macias, A., Lopez-Romero, P., Lupyan, D., Zerbino, D., Ortiz, A.R., An analysis of core deformations in protein superfamilies (2005) Biophys. J., 88, pp. 1291-1299; Lindorff-Larsen, K., Best, R.B., Depristo, M.A., Dobson, C.M., Vendruscolo, M., Simultaneous determination of protein structure and dynamics (2005) Nature, 433, pp. 128-132; Ma, J., Karplus, M., The allosteric mechanism of the chaperonin GroEL: a dynamic analysis (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 8502-8507; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; MacKerell, A., Wiorkiewicz-Kuczera, J., Karplus, M., An all-atom empirical energy function for the simulation of nucleic acids (1995) J. Am. Chem. Soc., 117, pp. 11946-11975; MacKerell, A.D., Bashford, D., Bellott, M., Dunbrack, R.L., Evanseck, J.D., Field, M.J., Fischer, S., Ha, S., All-atom empirical potential for molecular modeling and dynamics studies of proteins (1998) J. Phys. Chem. B, 102, pp. 3586-3616; Meyer, T., Ferrer-Costa, C., Pérez, A., Rueda, A., Bidon-Chanal, A., Luque, F.J., Laughton, C.A., Orozco, M., Essential dynamics: a tool for efficient trajectory compression and management (2006) J. Chem. Theory Comput., 2, pp. 251-258; Murzin, A.G., Brenner, S.E., Hubbard, T., Chothia, C., SCOP: a structural classification of proteins database for the investigation of sequences and structures (1995) J. Mol. Biol., 247, pp. 536-540; Ng, M.H., Johnston, S., Wu, B., Murdock, S.E., Tai, K.H., Fangohr, H., Cox, S.J., Jeffreys, P., BioSimGrid: Grid-enabled biomolecular simulation data storage and analysis (2006) Future Gener. Comput. Syst., 22, pp. 657-664; Noy, A., Meyer, T., Rueda, M., Ferrer, C., Valencia, A., Perez, A., de la Cruz, X., Fernández-Recio, J., Data mining of molecular dynamics trajectories of nucleic acids (2006) J. Biomol. Struct. Dyn., 23, pp. 447-456; Orozco, M., Pérez, A., Noy, A., Luque, F.J., Theoretical methods for the simulation of nucleic acids (2003) Chem. Soc. Rev., 32, pp. 350-364; Ott, K.H., Meyer, B., Parametrization of GROMOS force field for oligosaccharides and assessment of efficiency of molecular dynamics simulations (1996) J. Comput. Chem., 17, pp. 1068-1084; Pearl, F., Todd, A., Sillitoe, I., Dibley, M., Redfern, O., Lewis, T., Bennett, C., Grant, A., The CATH Domain Structure Database and related resources Gene3D and DHS provide comprehensive domain family information for genome analysis (2005) Nucleic Acids Res., 33, pp. D247-D251; Phillips, J.C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Schulten, K., Scalable molecular dynamics with NAMD (2005) J. Comput. Chem., 26, pp. 1781-1802; Qian, B., Ortiz, A.R., Baker, D., Improvement of comparative model accuracy by free-energy optimization along principal components of natural structural variation (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 15346-15351; Rueda, M., Chacón, P., Orozco, M., Thorough validation of protein normal mode analysis: a comparative study with essential dynamics (2007) Structure, 15, pp. 565-575; Rueda, M., Ferrer-Costa, C., Meyer, T., Pérez, A., Camps, J., Hospital, A., Gelpí, J.L., Orozco, M., A consensus view of protein dynamics (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 796-801; Schlitter, J., Estimation of absolute and relative entropies of macromolecules using the covariance matrix (1993) Chem. Phys. Lett., 215, pp. 617-621; Simms, A.M., Toofanny, R.D., Kehl, C., Benson, N.C., Daggett, V., Dynameomics: design of a computational lab workflow and scientific data repository for protein simulations (2008) Protein Eng. Des. Sel., 21, pp. 369-377; Gene ontology: tool for the unification of biology (2000) Nat. Genet., 25, pp. 25-29. , The Gene Ontology Consortium; The Universal Protein Resource (UniProt) in 2010 (2010) Nucleic Acids Res., 40, pp. D142-D148. , The UniProt Consortium; Tirion, M.M., Large amplitude elastic motions in proteins from a single-parameter, atomic analysis (1996) Phys. Rev. Lett., 77, pp. 1905-1908; Tozzini, V., Coarse-grained models for proteins (2005) Curr. Opin. Struct. Biol., 15, pp. 144-150; Velazquez-Muriel, J.A., Rueda, M., Cuesta, I., Pascual-Montano, A., Orozco, M., Carazo, J.M., Comparison of molecular dynamics and superfamily spaces of protein domain deformation (2009) BMC Struct. Biol., 17, p. 6; Wishart, D.S., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., Woolsey, J., DrugBank: a comprehensive resource for in silico drug discovery and exploration (2006) Nucleic Acids Res., 34, pp. D668-D672; Yang, L., Song, G., Jernigan, R.L., Protein elastic network models and the ranges of cooperativity (2009) Proc. Natl. Acad. Sci. USA, 106, pp. 12347-12352; Zhang, Y., Skolnick, J., Scoring function for automated assessment of protein structure template quality (2004) Proteins, 57, pp. 702-710; Zhou, Y., Vitkup, D., Karplus, M., Native proteins are surface-molten solids: application of the lindemann criterion for the solid versus liquid state (1999) J. Mol. Biol., 285, pp. 1371-1375","Orozco, M.; Joint IRB-BSC Computational Biology Programme, Institute of Research in Biomedicine, Parc Científic de Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"Cell Press",,,,,09692126,,STRUE,,"English","Structure",Article,"Final",Open Access,Scopus,2-s2.0-78149459697
"Tejedor E., Badia R.M., Royo R., Gelpí J.L.","24823556000;6603994224;24176373200;35517522400;","Enabling HMMER for the grid with COMP superscalar",2010,"Procedia Computer Science","1","1",,"2639","2648",,1,"10.1016/j.procs.2010.04.297","https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650278101&doi=10.1016%2fj.procs.2010.04.297&partnerID=40&md5=e1b2224806e85ff7c6e1012e1779ace2","Universitat Politècnica de Catalunya, Jordi Girona, 34, 08034 Barcelona, Spain; Barcelona Supercomputing Center, Jordi Girona, 29, 08034 Barcelona, Spain; Consejo Superior de Investigaciones Científicas, Serrano, 117, Madrid E-28006, Spain; National Institute of Bioinformatics, Spain; Dept. of Biochemistry and Molecular Biology (Universitat de Barcelona), Institute of Research on Biomedicine, Spain","Tejedor, E., Universitat Politècnica de Catalunya, Jordi Girona, 34, 08034 Barcelona, Spain, Barcelona Supercomputing Center, Jordi Girona, 29, 08034 Barcelona, Spain; Badia, R.M., Barcelona Supercomputing Center, Jordi Girona, 29, 08034 Barcelona, Spain, Consejo Superior de Investigaciones Científicas, Serrano, 117, Madrid E-28006, Spain; Royo, R., Barcelona Supercomputing Center, Jordi Girona, 29, 08034 Barcelona, Spain, National Institute of Bioinformatics, Spain; Gelpí, J.L., Barcelona Supercomputing Center, Jordi Girona, 29, 08034 Barcelona, Spain, National Institute of Bioinformatics, Spain, Dept. of Biochemistry and Molecular Biology (Universitat de Barcelona), Institute of Research on Biomedicine, Spain","The continuously increasing size of biological sequence databases has motivated the development of analysis suites that, by means of parallelization, are capable of performing faster searches on such databases. However, many of these tools are not suitable for execution on mid-to-large scale parallel infrastructures such as computational Grids. This paper shows how COMP Superscalar can be used to effectively parallelize on the Grid a sequence analysis program. In particular, we present a sequential version of the HMMER hmmpfam tool that, when run with COMP Superscalar, is decomposed into tasks and run on a set of distributed resources, not burdening the programmer with parallelization efforts. Although performance is not a main objective of this work, we also present some test results where COMP Superscalar, using a new pre-scheduling technique, clearly outperforms a well-known parallelization of the hmmpfam algorithm.","Bionformatics applications; Parallel programming models","Computer science; Computers; Biological sequences; Computational grids; Distributed resources; Parallel programming model; Parallelizations; Pre-scheduling; Sequence analysis; Superscalar; Parallel programming",,,,,,,,,"http://www.ncbi.nlm.nih.gov, web site; HMMER: Biosequence Analysis Using Profile Hidden Markov Models, , http://hmmer.janelia.org; Asanovic, K., Bodik, R., Catanzaro, B.C., Gebis, J.J., Husbands, P., Keutzer, K., Patterson, D.A., Yelick, K.A., (2006) The Landscape of Parallel Computing Research: A View from Berkeley, , http://www.eecs.berkeley.edu/Pubs/TechRpts/2006/EECS-2006-183.html, Tech. Rep. UCB/EECS-2006-183, EECS Department, University of California, Berkeley Dec; Tejedor, E., Badia, R., COMP Superscalar: Bringing GRID superscalar and GCM Together 8th IEEE International Symposium on Cluster Computing and the Grid, 2008; Walters, J.P., Qudah, B., Chaudhary, V., Accelerating the HMMER Sequence Analysis Suite Using Conventional Processors (2006) AINA '06: Proceedings of the 20th International Conference on Advanced Information Networking and Applications, 1, pp. 289-294. , (AINA'06), IEEE Computer Society, Washington, DC, USA, doi:http://dx.doi.org/10.1109/AINA.2006.68; Horn, D.R., Houston, M., Hanrahan, P., ClawHMMER: A Streaming HMMer-Search Implementation (2005) SC '05: Proceedings of the 2005 ACM/IEEE Conference on Supercomputing, IEEE Computer Society, Washington, DC, USA, p. 11. , doi:http://dx.doi.org/10.1109/SC.2005.18; TimeLogic Biocomputing Solutions. DeCypherHMM, , http://www.timelogic.com; Parallel Virtual Machine, , http://www.csm.ornl.gov/pvm/; Walters, J.P., MPI-HMMER, , http://www.mpihmmer.org; Walters, J.P., Darole, R., Chaudhary, V., Improving mpi-hmmer's scalability with parallel i/o (2009) Parallel and Distributed Processing Symposium, International, pp. 1-11. , 0; Jiang, K., Thorsen, O., Peters, A., Smith, B., Sosa, C.P., An Efficient Parallel Implementation of the Hidden Markov Methods for Genomic Sequence-Search on a Massively Parallel System (2008) IEEE Transactions on Parallel and Distributed Systems, 19 (1), pp. 15-23; Chukkapalli, G., Guda, C., Subramaniam, S., SledgeHMMER: A web server for batch searching the Pfam database (2004) Nucleic Acids Research, 32. , 1 July W542-W544(1); Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., Basic Local Alignment Search Tool (1990) Journal of Molecular Biology, 215 (3), pp. 403-410; Darling, A.E., Carey, L., Feng, W.-C., The Design, Implementation, and Evaluation of mpiBLAST (2003) ClusterWorld Conference & Expo and the 4th International Conference on Linux Cluster: The HPC Revolution 2003, San Jose, California; Yang, C.-T., Han, T.-F., Kan, H.-C., G-blast: A grid-based solution for mpiblast on computational grids (2007) TENCON 2007 - 2007 IEEE Region 10 Conference, pp. 1-5. , doi:10.1109/TENCON.2007.4429009; Dialinos, V., Badia, R.M., Sirvent, R., Perez, J.M., Labarta, J., Implementing phylogenetic inference with grid superscalar (2005) CCGRID '05: Proceedings of the Fifth IEEE International Symposium on Cluster Computing and the Grid (CCGrid'05), 2, pp. 1093-1100. , IEEE Computer Society, Washington, DC, USA; Badia, R.M., Labarta, J., Sirvent, R., Pérez, J.M., Cela, J.M., Grima, R., Programming Grid Applications with GRID superscalar (2003) Journal of GRID Computing, 1 (2), pp. 151-170; Caromel, D., Klauser, W., Vayssiere, J., Towards Seamless Computing and Metacomputing in Java (1998) Concurrency Practice and Experience, 10 (11-13), pp. 1043-1061. , http://proactive.inria.fr; Allen, G., Davis, K., Goodale, T., Hutanu, A., Kaiser, H., Kielmann, T., Merzky, A., Ullmer, B., The Grid Application Toolkit: Towards Generic and Easy Application Programming Interfaces for the Grid (2005) Proceedings of the IEEE, 93, pp. 534-550; Java Annotations, , http://java.sun.com/j2se/1.5.0/docs/guide/language/annotations.html; Eddy, S.R., Profile hidden Markov models (1998) Bioinformatics, 14 (9), pp. 755-763; Quinn, A., Hunter, S., HMMer Benchmarking for ELIXIR, , http://www.ebi.ac.uk/seqdb/confluence/display/InterPro/ HMMer+benchmarking+for+ELIXIR; UniProt Archive, , http://www.ebi.ac.uk/uniparc/","Tejedor, E.; Universitat Politècnica de Catalunya, Jordi Girona, 34, 08034 Barcelona, Spain; email: etejedor@ac.upc.edu",,,"Elsevier B.V.",,,,,18770509,,,,"English","Procedia Comput. Sci.",Conference Paper,"Final",Open Access,Scopus,2-s2.0-78650278101
"Perez D.I., Conde S., Pérez C., Gil C., Simon D., Wandosell F., Moreno F.J., Gelpí J.L., Luque F.J., Martínez A.","25522211400;7004283200;56220726900;7005901759;16176746200;7004250810;7202722573;35517522400;23025357900;7404025454;","Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools",2009,"Bioorganic and Medicinal Chemistry","17","19",,"6914","6925",,33,"10.1016/j.bmc.2009.08.042","https://www.scopus.com/inward/record.uri?eid=2-s2.0-69949184443&doi=10.1016%2fj.bmc.2009.08.042&partnerID=40&md5=5b02ecbbbfbdecfeecfd456b9d1e54af","Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain; Centro de Biología Molecular 'Severo Ochoa', CSIC-UAM, Universidad Autonoma de Madrid, 28049 Madrid, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Biología, Universidad de Barcelona, Avda. Diagonal 645, 08028 Barcelona, Spain; Departamento de Fisicoquímica, Instituto de Biomedicina (IBUB), Facultad de Farmacia, Avda. Diagonal 643, 08028 Barcelona, Spain","Perez, D.I., Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; Conde, S., Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; Pérez, C., Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; Gil, C., Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; Simon, D., Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain, Centro de Biología Molecular 'Severo Ochoa', CSIC-UAM, Universidad Autonoma de Madrid, 28049 Madrid, Spain; Wandosell, F., Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain, Centro de Biología Molecular 'Severo Ochoa', CSIC-UAM, Universidad Autonoma de Madrid, 28049 Madrid, Spain; Moreno, F.J., Centro de Biología Molecular 'Severo Ochoa', CSIC-UAM, Universidad Autonoma de Madrid, 28049 Madrid, Spain; Gelpí, J.L., Departamento de Bioquímica y Biología Molecular, Facultad de Biología, Universidad de Barcelona, Avda. Diagonal 645, 08028 Barcelona, Spain; Luque, F.J., Departamento de Fisicoquímica, Instituto de Biomedicina (IBUB), Facultad de Farmacia, Avda. Diagonal 643, 08028 Barcelona, Spain; Martínez, A., Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain","Thienylhalomethylketones, whose chemical, biological, and pharmaceutical data are here reported, are the first irreversible inhibitors of GSK-3β described to date. Their inhibitory activity is likely related to the cysteine residue present in the ATP-binding site, which is proposed as a relevant residue for modulation of GSK-3 activity. The good cell permeability of the compounds allows them to be used in different cell models. Overall, the results presented here support the potential use of halomethylketones as pharmacological tools for the study of GSK-3β functions and suggest a new mechanism for GSK-3β inhibition that may be considered for further drug design. © 2009 Elsevier Ltd. All rights reserved.","Alzheimer's disease; GSK-3β inhibitors; Halomethylketones; Tau phosphorylation","adenosine triphosphate; antibody; cysteine; glycogen synthase kinase 3 inhibitor; glycogen synthase kinase 3beta; ketone derivative; neurotransmitter; neurotransmitter receptor; tau protein; thiol derivative; animal cell; article; binding site; cell membrane permeability; chemical reaction; drug design; drug mechanism; enzyme activity; enzyme inhibition; IC 50; molecular model; mouse; nerve cell culture; nonhuman; protein phosphorylation; receptor binding; structure activity relation; Western blotting; Animals; Binding Sites; Cell Membrane Permeability; Glycogen Synthase Kinase 3; Humans; Ketones; Protein Kinase Inhibitors; Structure-Activity Relationship",,"adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; cysteine, 4371-52-2, 52-89-1, 52-90-4; thiol derivative, 13940-21-1; Glycogen Synthase Kinase 3, 2.7.11.26; Ketones; Protein Kinase Inhibitors; glycogen synthase kinase 3 beta, 2.7.1.37",,,,,,,"Cohen, P., (2002) Nat. Rev. Drug Disc., 1, p. 309; Sawa, M., (2008) Mini-Rev. Med. Chem., 8, p. 1291; Hochhaus, A., (2008) J. Natl. Compr. Canc. Netw., 6 (SUPPL. 2), pp. S1; Danovi, S.A., Wong, H.H., Lemoine, N.R., (2008) Br. Med. Bull., 87, p. 97; Noble, M.E., Endicott, J.A., Johnson, L.N., (2004) Science, 303, p. 1800; Schmidt, R., Neff, F., Lampl, C., Benke, T., Anditsch, M., Bancher, C., Dal-Bianco, P., Dodel, R., (2008) Neuropsychiatr., 22, p. 153; Hooper, C., Killick, R., Lovestone, S., (2008) J. Neurochem., 104, p. 1433; (2006) In Glycogen Synthase Kinase 3 and its Inhibitors, , Martinez A., Castro A., and Medina M. (Eds), John Wiley & Sons, New Jersey; Huang, H.C., Klein, P.S., (2006) Curr. Drug Targets, 7, p. 1389; Cohen, P., Goedert, M., (2004) Nat. Rev. Drug Disc., 3, p. 479; Martinez, A., (2008) Med. Res. Rev., 28, p. 773; Martinez, A., Perez, D.I., (2008) J. Alzheimers Dis., 15, p. 181; Martinez, A., Alonso, M., Castro, A., Dorronsoro, I., (2008) Medicinal Chemistry of Alzheimer's disease, p. 225. , A.E. Martinez Ed, Transworld Research Network: Kerala; Castro, A., Conde, S., Rodriguez-Franco, M.I., Martinez, A., (2002) Mini-Rev. Med. Chem., 2, p. 37; Castro, A., Martinez, A., (2001) Mini-Rev. Med. Chem., 1, p. 267; Martinez, A., Alonso, M., Castro, A., Perez, C., Moreno, F.J., (2002) J. Med. Chem., 45, p. 1292; Conde, S., Perez, D.I., Martinez, A., Perez, C., Moreno, F.J., (2003) J. Med. Chem., 46, p. 4631; Woodgett, J.R., (1989) Anal. Biochem., 180, p. 237; Martinez, A., Alonso, M., Castro, A., Dorronsoro, I., Gelpi, J.L., Luque, F.J., Perez, C., Moreno, F.J., (2005) J. Med. Chem., 48, p. 7103; Rosenfeld, R., Vajda, S., DeLisi, C., (1995) Annu. Rev. Biophys. Biomol. Struct., 24, p. 677; Ahn, N.G., Resing, K.A., (2005) Science, 308, p. 1266; Gattis, J.L., Ruben, E., Fenley, M.O., Ellington, W.R., Chapman, M.S., (2004) Biochemistry, 43, p. 8680; Anselmo, A.N., Cobb, M.H., (2004) Biochem. J., 381, pp. e1; Vulpetti, A., Crivori, P., Cameron, A., Bertrand, J., Brasca, M.G., D'Alessio, R., Pevarello, P., (2005) J. Chem. Inf. Model., 45, p. 1282; Rauber, P., Angliker, H., Walker, B., Shaw, E., (1986) Biochem. J., 239, p. 633; Drenth, J., Kalk, K.H., Swen, H.M., (1976) Biochemistry, 15, p. 3731; Rahman, M.A., Senga, T., Oo, M.L., Hasegawa, H., Biswas, M.H., Mon, N.N., Huang, P., Hamaguchi, M., (2008) Oncol. Rep., 19, p. 975; Mazanetz, M.P., Fischer, P.M., (2007) Nat. Rev. Drug Disc., 6, p. 464; Dajani, R., Fraser, E., Roe, S.M., Young, N., Good, V., Dale, T.C., Pearl, L.H., (2001) Cell, 105, p. 721; Kockeritz, L., Doble, B., Patel, S., Woodgett, J.R., (2006) Curr. Drug Targets, 7, p. 1377; Orme, M.H., Giannini, A.L., Vivanco, M.D., Kypta, R.M., (2003) Mol. Cell Neurosci., 24, p. 673; Di, L., Kerns, E.H., (2003) Curr. Opin. Chem. Biol., 7, p. 402; Veber, D.F., Johnson, S.R., Cheng, H.-Y., Smith, B.R., Ward, K.W., Kopple, K.D., (2002) J. Med. Chem., 45, p. 2615; Dorronsoro, I., Chana, A., Abasolo, I., Castro, A., Gil, C., Stud, M., Martinez, A., (2004) QSAR Comb. Sci., 23, p. 89; Powers, J.C., Asgian, J.L., Ekici, O.D., James, K.E., (2002) Chem. Rev., 102, p. 4639; Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., Chuang, D.-M., (2009) Mol. Psychiatry, 14, p. 51; Lochhead, P.A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N., Cleghon, V., (2006) Mol. Cell, 24, p. 627; Li, Z., Tan, F., Thiele, C.J., (2007) Mol. Cancer Ther., 6, p. 3113; Uhlen, S., Wikberg, J.E., (1991) Pharmacol. Toxicol., 69, p. 341; Grandy, D.K., Marchionni, M.A., Makam, H., Stofko, R.E., Alfano, M., Frothingham, L., Fischer, J.B., Server, A.C., (1989) Proc. Natl. Acad. Sci. U.S.A., 86, p. 9762; MacKenzie, R.G., VanLeeuwen, D., Pugsley, T.A., Shih, Y.H., Demattos, S., Tang, L., Todd, R.D., O'Malley, K.L., (1994) Eur. J. Pharmacol., 266, p. 79; Murphy, D.E., Snowhill, E.W., Williams, M., (1987) Neurochem. Res., 12, p. 775; Sills, M.A., Fagg, G., Pozza, M., Angst, C., Brundish, D.E., Hurt, S.D., Wilusz, E.J., Williams, M., (1991) Eur. J. Pharmacol., 192, p. 19; Richards, M.H., (1990) Br. J. Pharmacol., 99, p. 753; Pabreza, L.A., Dhawan, S., Kellar, K.J., (1991) Mol. Pharmacol., 39, p. 9; Sharples, C.G., Kaiser, S., Soliakov, L., Marks, M.J., Collins, A.C., Washburn, M., Wright, E., Wonnacott, S., (2000) J. Neurosci., 20, p. 2783; Peroutka, S.J., Snyder, S.H., (1979) Mol. Pharmacol., 16, p. 687; Parker, G.J., Law, T.L., Lenoch, F.J., Bolger, R.E., (2000) J. Biomol. Screen., 5, p. 77; Lengyel, I., Nairn, A., McCluskey, A., Toth, G., Penke, B., Rostas, J., (2001) J. Neurochem., 76, p. 1066; Carpenter, G., King Jr., L., Cohen, S., (1979) J. Biol. Chem., 254, p. 4884; Al-Hasani, H., Passlack, W., Klein, H.W., (1994) FEBS Lett., 349, p. 17; Robbins, D.J., Zhen, E., Owaki, H., Vanderbilt, C.A., Ebert, D., Geppert, T.D., Cobb, M.H., (1993) J. Biol. Chem., 268, p. 5097; Williams, D.H., Wilkinson, S.E., Purton, T., Lamont, A., Flotow, H., Murray, E.J., (1998) Biochemistry, 37, p. 9579; Cheng, H.C., Nishio, H., Hatase, O., Ralph, S., Wang, J.H., (1992) J. Biol. Chem., 267, p. 9248; Sayas, C.L., Avila, J., Wandosell, F., (2002) J. Neurosci., 22, p. 6863; Klein, P.S., Melton, D.A., (1996) Proc. Natl. Acad. Sci. U.S.A., 93, p. 8455; Mehler, E.L., Solmajer, T., (1991) Protein Eng., 4, p. 903; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J. Am. Chem. Soc., 117, p. 5179; Morley, S.D., Afshar, M., (2004) J. Comput. Aided Mol. Des., 18, p. 189; Barril, X., Hubbard, R.E., Morley, S.D., (2004) Mini-Rev. Med. Chem., 4, p. 779","Martínez, A.; Instituto de Química Médica-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain; email: amartinez@iqm.csic.es",,,,,,,,09680896,,BMECE,"19747834","English","Bioorg. Med. Chem.",Article,"Final",,Scopus,2-s2.0-69949184443
"Camps J., Carrillo O., Emperador A., Orellana L., Hospital A., Rueda M., Cicin-Sain D., D'Abramo M., Gelpí J.L., Orozco M.","57198367291;6603236640;57208980207;35311824100;15831739300;35518639700;57172992900;57196462897;35517522400;7102809158;","FlexServ: An integrated tool for the analysis of protein flexibility",2009,"Bioinformatics","25","13",,"1709","1710",,57,"10.1093/bioinformatics/btp304","https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649236681&doi=10.1093%2fbioinformatics%2fbtp304&partnerID=40&md5=780abf25093c436c00e5fb05d5a4a8a4","Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain; Barcelona Supercomputing Centre, Barcelona, Spain; National Institute of Bioinformatics, Department of Computational Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain; National Institute of Bioinformatics, Department of Structural Bioinformatics, Josep Samitier 1-5, Barcelona, Spain; Department of Biochemistry and Molecular Biology, University of Barcelona, Av Diagonal 645, Barcelona 08028, Spain","Camps, J., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, National Institute of Bioinformatics, Department of Computational Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain; Carrillo, O., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain; Emperador, A., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain; Orellana, L., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain; Hospital, A., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, National Institute of Bioinformatics, Department of Structural Bioinformatics, Josep Samitier 1-5, Barcelona, Spain; Rueda, M., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain; Cicin-Sain, D., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, National Institute of Bioinformatics, Department of Structural Bioinformatics, Josep Samitier 1-5, Barcelona, Spain; D'Abramo, M., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Av Diagonal 645, Barcelona 08028, Spain; Gelpí, J.L., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, National Institute of Bioinformatics, Department of Computational Bioinformatics, Jordi Girona 31, Barcelona 08034, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Av Diagonal 645, Barcelona 08028, Spain; Orozco, M., Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain, Barcelona Supercomputing Centre, Barcelona, Spain, National Institute of Bioinformatics, Department of Structural Bioinformatics, Josep Samitier 1-5, Barcelona, Spain, Department of Biochemistry and Molecular Biology, University of Barcelona, Av Diagonal 645, Barcelona 08028, Spain","Summary: FlexServ is a web-based tool for the analysis of protein flexibility. The server incorporates powerful protocols for the coarse-grained determination of protein dynamics using different versions of Normal Mode Analysis (NMA), Brownian dynamics (BD) and Discrete Dynamics (DMD). It can also analyze user provided trajectories. The server allows a complete analysis of flexibility using a large variety of metrics, including basic geometrical analysis, B-factors, essential dynamics, stiffness analysis, collectivity measures, Lindemann's indexes, residue correlation, chain-correlations, dynamic domain determination, hinge point detections, etc. Data is presented through a web interface as plain text, 2D and 3D graphics. © The Author 2009. Published by Oxford University Press. All rights reserved.",,"protein; article; bioinformatics; computer interface; correlation analysis; dynamics; geometry; Internet; online system; priority journal; protein determination; residue analysis; Computational Biology; Databases, Protein; Internet; Protein Conformation; Proteins; Sequence Analysis, Protein; Software",,"protein, 67254-75-5; Proteins","FlexServ",,"Fundación Botín

Ministry of Education and Science: CTQ2005-09365, BIO2006-01602

Bioinformatics Institute","Funding: Spanish Ministry of Education and Science [grant numbers: BIO2006-01602, CTQ2005-09365, CONSOLIDER Project in Supercomputation]; the Spanish Ministry of Health [COMBIOMED network]; the Fundación Marcelino Botín; and the National Institute of Bioinformatics.",,,"Altschul, S.F., Basic local alignment search tool (1990) J. Mol. Biol, 215, pp. 403-410; Amadei, A., Essential dynamics of proteins (1993) Proteins, 17, pp. 412-425; Atilgan, A.R., Anisotropy of fluctuation dynamics of proteins with an elastic network model (2001) Biophys. J, 80, pp. 505-515; Berman, H.M., The protein data bank (2000) Nucleic Acid Res, 28, pp. 235-242; Damm, K.L., Carlson, H.A., Gaussian-weighted RMSD superposition of proteins: A structural comparison for flexible proteins and predicted protein structures (2006) Biophys. J, 90, pp. 45558-45573; Dokholyan, N.V., Discrete molecular dynamics studies of the folding of a protein-like model (1998) Folding Des, 3, pp. 577-587; Emperador, A., Exploring the suitability of coarse-grained techniques for the representation of protein dynamics (2008) Biophys. J, 95, pp. 2127-2138; Falke, J.J., Enzymology - a moving story (2002) Science, 295, pp. 1480-1481; Henzler-Wildman, K.A., A hierarchy of timescales in protein dynamics is linked to enzyme catalysis (2007) Nature, 450, pp. 913-916; Kovacs, J.A., Predictions of protein flexibility: First-order measures (2004) Proteins, 56, pp. 661-668; Ma, J., Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes (2005) Structure, 13, pp. 373-380; McCammon, J.A., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; Meyer, T., Essential dynamics: A tool for efficient trajectory compression and management (2006) J. Chem. Theory Comput, 2, pp. 251-258; Navizet, I., Probing protein mechanics: Residue-level properties and their use in defining domains (2004) Biophys. J, 87, pp. 1426-1435; Rueda, M., Thorough validation of protein normal mode analysis: A comparative study with essential dynamics (2007) Structure, 15, pp. 565-575; Rueda, M., A consensus view of protein dynamics (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 796-801; Sacquin-Mora, S., Lavery, R., Investigating the local flexibility of functional residues in hemoproteins (2006) Biophys. J, 90, pp. 2706-2717; (2008) Nucleic .Acid Res, 36, pp. D190-D195. , The Uniprot Consortium; Tirion, M.M., Large amplitude elastic motions in proteins from a single-parameter, atomic analysis (1996) Phys. Rev. Lett, 77, pp. 1905-1908","Orozco, M.; Joint IRB-BSC Program on Computational Biology, Institute of Research in Biomedicine, Josep Samitier 1-5, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,,,,,,13674803,,BOINF,"19429600","English","Bioinformatics",Article,"Final",Open Access,Scopus,2-s2.0-67649236681
"Lama A., Pawaria S., Bidon-Chanal A., Anand A., Gelpi J.L., Arya S., Marti M., Estrin D.A., Luque F.J., Dikshit K.L.","55374262500;14036156100;9741781000;57197558315;35517522400;15831255800;7103082873;7005821604;23025357900;7003423048;","Role of pre-A motif in nitric oxide scavenging by truncated hemoglobin, HbN, of Mycobacterium tuberculosis",2009,"Journal of Biological Chemistry","284","21",,"14457","14468",,46,"10.1074/jbc.M807436200","https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649831231&doi=10.1074%2fjbc.M807436200&partnerID=40&md5=4c75743c3793104926b77ad3a4833011","Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; Departamento de Química Inorgánica, Analítica y Química Física, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón II C1428EHA, Buenos Aires, Argentina; Department of Physical Chemistry and Institute of Biomedicine, IBUB, University of Barcelona, Avda Diagonal 643, 08028 Barcelona, Spain","Lama, A., Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; Pawaria, S., Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; Bidon-Chanal, A., Departamento de Química Inorgánica, Analítica y Química Física, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón II C1428EHA, Buenos Aires, Argentina; Anand, A., Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; Gelpi, J.L., Departamento de Química Inorgánica, Analítica y Química Física, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón II C1428EHA, Buenos Aires, Argentina; Arya, S., Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; Marti, M., Department of Physical Chemistry and Institute of Biomedicine, IBUB, University of Barcelona, Avda Diagonal 643, 08028 Barcelona, Spain; Estrin, D.A., Department of Physical Chemistry and Institute of Biomedicine, IBUB, University of Barcelona, Avda Diagonal 643, 08028 Barcelona, Spain; Luque, F.J., Departamento de Química Inorgánica, Analítica y Química Física, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón II C1428EHA, Buenos Aires, Argentina; Dikshit, K.L., Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India","Mycobacterium tuberculosis truncated hemoglobin, HbN, is endowed with a potent nitric-oxide dioxygenase activity and has been found to relieve nitrosative stress and enhance in vivo survival of a heterologous host, Salmonella enterica Typhimurium, within the macrophages. These findings implicate involvement of HbN in the defense of M. tuberculosis against nitrosative stress. The protein carries a tunnel system composed of a short and a long tunnel branch that has been proposed to facilitate diatomic ligand migration to the heme and an unusual Pre-A motif at the N terminus, which does not contribute significantly to the structural integrity of the protein, as it protrudes out of the compact globin fold. Strikingly, deletion of Pre-A region from the M. tuberculosis HbN drastically reduces its ability to scavenge nitric oxide (NO), whereas its insertion at the N terminus of Pre-A lacking HbN of Mycobacterium smegmatis improved its nitric-oxide dioxygenase activity. Titration of the oxygenated adduct of HbN and its mutants with NO indicated that the stoichiometric oxidation of protein is severalfold slower when the Pre-A region is deleted in HbN. Molecular dynamics simulations show that the excision of Pre-A motif results in distinct changes in the protein dynamics, which cause the gate of the tunnel long branch to be trapped into a closed conformation, thus impeding migration of diatomic ligands toward the heme active site. The present study, thus, unequivocally demonstrates vital function of Pre-A region in NO scavenging and unravels its unique role by which HbN might attain its efficient NO-detoxification ability. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.",,"Active site; Dioxygenase; In-vivo; M. tuberculosis; Molecular dynamics simulations; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nitrosative stress; Protein dynamics; Salmonella enterica; Truncated hemoglobins; Detoxification; Dynamics; Ligands; Molecular dynamics; Nitric oxide; Porphyrins; Hemoglobin; dioxygenase; heme; hemoglobin HbN; nitric oxide; truncated hemoglobin; unclassified drug; mutant protein; nitric oxide; scavenger; truncated hemoglobin; amino terminal sequence; article; controlled study; detoxification; enzyme active site; enzyme activity; ligand binding; molecular dynamics; Mycobacterium smegmatis; Mycobacterium tuberculosis; nitric oxide scavenging; nitrosative stress; nonhuman; Pre A motif; priority journal; protein analysis; protein folding; protein function; protein interaction; protein metabolism; protein motif; protein structure; protein transport; stoichiometry; amino acid sequence; chemical structure; chemistry; circular dichroism; computer simulation; drug effect; Escherichia coli; gene deletion; metabolism; molecular genetics; oxidation reduction reaction; pliability; protein motif; protein secondary structure; structure activity relation; thermodynamics; X ray crystallography; Mycobacterium smegmatis; Mycobacterium tuberculosis; Salmonella enterica; Amino Acid Motifs; Amino Acid Sequence; Circular Dichroism; Computer Simulation; Crystallography, X-Ray; Escherichia coli; Free Radical Scavengers; Models, Molecular; Molecular Sequence Data; Mutant Proteins; Mycobacterium smegmatis; Mycobacterium tuberculosis; Nitric Oxide; Oxidation-Reduction; Pliability; Protein Structure, Secondary; Sequence Deletion; Structure-Activity Relationship; Thermodynamics; Truncated Hemoglobins",,"dioxygenase, 37292-90-3; heme, 14875-96-8; nitric oxide, 10102-43-9; Free Radical Scavengers; Mutant Proteins; Nitric Oxide, 10102-43-9; Truncated Hemoglobins",,,,,,,"Fenton, M.J., Vermeulen, M.W., (1996) Infect. Immun, 64, pp. 683-690; Fenton, M.J., (1998) Curr. Opin. Hematol, 5, pp. 72-78; Chan, J., Xing, Y., Magliozzo, R.S., Bloom, B.R., (1992) J. Exp. Med, 175, pp. 1111-1122; MacMicking, J.D., North, R.J., LaCourse, R., Mudgett, J.S., Shah, S.K., Nathan, C.F., (1997) Proc. Natl. Acad. Sci. U. S. A, 94, pp. 5243-5248; Stevanin, T.M., Poole, R.K., Demoncheaux, E.A., Read, R.C., (2002) Infect. Immun, 70, pp. 4399-4405; Gardner, P.R., Constantino, G., Szabo, C., Salzman, A.L., (1997) J. Biol. Chem, 272, pp. 25071-25076; Gardner, P.R., Constantino, G., Salzman, A.L., (1998) J. Biol. Chem, 273, pp. 26528-26533; Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A., (1990) Proc. Natl. Acad. Sci. U. S. A, 87, pp. 1620-1624; Couture, M., Yeh, S.R., Wittenberg, B.A., Wittenberg, J.B., Ouellet, Y., Rousseau, L., Guertin, M.A., (1999) Proc. Natl. Acad. Sci. U. S. A, 96, pp. 11223-11228; Ouellet, H., Ouellet, Y., Richard, C., Labarre, M., Wittenberg, B.A., Wittenberg, J.B., Guertin, M., (2002) Proc. Natl. Acad. Sci. U. S. A, 99, pp. 5902-5907; Pathania, R., Navani, N.K., Gardner, A.M., Gardner, P.R., Dikshit, K.L., (2002) Mol. Microbiol, 45, pp. 1303-1314; Pawaria, S., Rajamohan, G., Gambhir, V., Lama, A., Varshney, G.C., Dikshit, K.L., (2007) Microb. Pathog, 42, pp. 119-128; Milani, M., Pesce, A., Ouellet, Y., Ascenzi, P., Guertin, M., Bolognesi, M., (2001) EMBO J, 20, pp. 3902-3909; Milani, M., Pesce, A., Ouellet, Y., Dewilde, S., Friedman, J., Ascenzi, P., Guertin, M., Bolognesi, M., (2004) J. Biol. Chem, 279, pp. 21520-21525; Crespo, A., Martí, M.A., Kalko, S.G., Morreale, A., Orozco, M., Gelpí, J.L., Luque, F.J., Estrin, D.A., (2005) J. Am. Chem. Soc, 127, pp. 4433-4444; Bidon-Chanal, A., Martí, M.A., Crespo, A., Milani, M., Orozco, M., Bolognesi, M., Luque, F.J., Estrin, D.A., (2006) Proteins, 64, pp. 457-464; Bidon-Chanal, A., Martí, M.A., Estrin, D.A., Luque, F.J., (2007) J. Am. Chem. Soc, 129, pp. 6782-6788; Arti, M.A., Bidon-Chanal, A., Crespo, A., Yeh, S.R., Guallar, V., Luque, F.J., Estrin, D.A., (2008) J. Am. Chem. Soc, 130, pp. 1688-1693; Couture, M., Chamberland, H., St-Pierre, B., Lafontaine, J., Guertin, M., (1994) Mol. Gen. Genet, 243, pp. 185-197; Das, T.K., Couture, M., Lee, H.C., Peisach, J., Rousseau, D.L., Wittenberg, B.A., Wittenberg, J.B., Guertin, M., (1999) Biochemistry, 38, pp. 15360-15368; Wittenberg, J.B., Bolognesi, M., Wittenberg, B.A., Guertin, M., (2002) J. Biol. Chem, 277, pp. 871-874; Hill, D.R., Belbin, T.J., Thorsteinsson, M.V., Bassam, D., Brass, S., Ernst, A., Boger, P., Potts, M., (1996) J. Bacteriol, 178, pp. 6587-6598; Lama, A., Pawaria, S., Dikshit, K.L., (2006) FEBS Lett, 580, pp. 403-4041; Kaur, R., Pathania, R., Sharma, V., Mande, S.C., Dikshit, K.L., (2002) Appl. Environ. Microbiol, 68, pp. 152-160; Gardner, P.R., Gardner, A.M., Martin, L.A., Salzman, A.L., (1998) Proc. Natl. Acad. Sci. U. S. A, 95, pp. 10378-10383; Gardner, P.R., (2008) Methods Enzymol, 436, pp. 213-233; Schwede, T., Kopp, J., Guex, N., Peitsch, M.C., (2003) Nucleic Acids Res, 31, pp. 3381-3385; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., (1983) J. Chem. Phys, 79, pp. 926-935; Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.R., Cheatham III, T.E., DeBolt, S., Ferguson, D., Kollman, P., (1995) Comput. Phys. Commun, 91, pp. 1-41; Amadei, A., Linssen, A.B.M., Berendsen, H.J.C., (2004) Proteins, 17, pp. 412-425; Cohen, J., Arkhipov, A., Braun, R., Schulten, K., (2006) Biophys. J, 91, pp. 1844-1857; Cohen, J., Schulten, K., (2007) Biophys. J, 93, pp. 3591-3600; Johnson, B.J., Cohen, J., Welford, R.W., Pearson, A.R., Schulten, K., Klinman, J.P., Wilmot, C.M., (2007) J. Biol. Chem, 282, pp. 17767-17776; Cohen, J., Olsen, K.W., Schulten, K., (2008) Methods Enzymol, 437, pp. 437-455; Scott, E.E., Gibson, Q.H., Olson, J.S., (2001) J. Biol. Chem, 276, pp. 5177-5188; Pawaria, S., Lama, A., Raje, M., Dikshit, K.L., (2008) Appl. Environ. Microbiol, 74, pp. 3512-3522; Vuletich, D.A., Lecomte, J.T., (2006) J. Mol. Evol, 62, pp. 196-210; Petřek, M., Otyepka, M., Banás, P., Košinová, P., Koča, J., Damborsky, J., (2006) BMC Bioinformatics, 7, pp. 316-324; Humphrey, W., Dalke, A., Schulten, K., (1996) J. Mol. Graph, 14, pp. 33-38","Dikshit, K.L.; Institute of Microbial Technology, Council of Scientific and Industrial Research India, Chandigarh 160036, India; email: kanak@imtech.res.in",,,,,,,,00219258,,JBCHA,"19329431","English","J. Biol. Chem.",Article,"Final",Open Access,Scopus,2-s2.0-67649831231
"Castaño T., Wang H., Campillo N.E., Ballester S., González-García C., Hernández J., Pérez C., Cuenca J., Pérez-Castillo A., Martínez A., Huertas O., Gelpí J.L., Luque F.J., Ke H., Gil C.","24334330500;8041566600;7003271773;6602501455;24468003900;57205866002;56220726900;21833841500;7005466124;7404025454;12041496500;35517522400;23025357900;7102102232;7005901759;","Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors",2009,"ChemMedChem","4","5",,"866","876",,46,"10.1002/cmdc.200900043","https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651115888&doi=10.1002%2fcmdc.200900043&partnerID=40&md5=dd2de6db7126278bae9949b60734680e","Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7260, United States; Unidad de Regulación Génica, CNM, Instituto de Salud Carlos III, Madrid, Spain; Instituto de Investigaciones Biomédicas (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain; Departamento de Fisicoquímica e Instituto de Biomedicina (IBUB), Facultad de Farmacia, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain; Departamento de Bioquímica Y Biología Molecular, Facultad de Bioquímica, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain","Castaño, T., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Wang, H., Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7260, United States; Campillo, N.E., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Ballester, S., Unidad de Regulación Génica, CNM, Instituto de Salud Carlos III, Madrid, Spain; González-García, C., Unidad de Regulación Génica, CNM, Instituto de Salud Carlos III, Madrid, Spain; Hernández, J., Unidad de Regulación Génica, CNM, Instituto de Salud Carlos III, Madrid, Spain; Pérez, C., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Cuenca, J., Instituto de Investigaciones Biomédicas (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain; Pérez-Castillo, A., Instituto de Investigaciones Biomédicas (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain; Martínez, A., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Huertas, O., Departamento de Fisicoquímica e Instituto de Biomedicina (IBUB), Facultad de Farmacia, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain; Gelpí, J.L., Departamento de Bioquímica Y Biología Molecular, Facultad de Bioquímica, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain; Luque, F.J., Departamento de Fisicoquímica e Instituto de Biomedicina (IBUB), Facultad de Farmacia, Universidad de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain; Ke, H., Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7260, United States; Gil, C., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain","PDE7 inhibitors regulate pro-inflammatory and immune T-cell functions, and are a potentially novel class of drugs especially useful in the treatment of a wide variety of immune and inflammatory disorders. Starting from our lead family of thioxoquinazolines, we designed, synthesized, and characterized a novel series of thioxoquinazoline derivatives. Many of these compounds showed inhibitory potencies at sub-micromolar levels against the catalytic domain of PDE7A1 and at the micromolar level against PDE4D2. Cell-based studies showed that these compounds not only increased intracellular cAMP levels, but also had interesting anti-inflammatory properties within a therapeutic window. The in silico data predict that these compounds are capable of the crossing the blood-brain barrier. The X-ray crystal structure of the PDE7A1 catalytic domain in complex with compound 15 at a resolution of 2.4 Å demonstrated that hydrophobic interactions at the active site pocket are a key feature. This structure, together with molecular modeling, provides insight into the selectivity of the PDE inhibitors and a template for the discovery of new PDE7 or PDE7/PDE4 dual inhibitors. © 2009 Wiley-VCH Verlag GmbH & Co. KGaA.","Drug design; Inflammation; PDE7; Thioxoquinazolines","2 methylthio 3 phenyl 4 thioxo 3,4 dihydroquinazoline; 2 methylthio 3 phenyl 4 thioxo 3,4 dihydrothieno[3,2 d]pyrimidine; 2 methylthio 4 oxo 3 phenyl 3,4 dihydroquinazoline; 2 methylthio 4 oxo 3 phenyl 3,4 dihydrothieno[3,2 d]pyrimidine; 3 (2,6 difluorophenyl) 2 methylthio 4 oxo 3,4 dihydrobenzo[4,5]thieno[3,2 d]pyrimidine; 3 (2,6 difluorophenyl) 2 methylthio 4 oxo 3,4 dihydrothieno[3,2 d]pyrimidine; 3 (2,6 difluorophenyl) 2 methylthio 4 thioxo 3,4 dihydrobenzo[4,5]thieno[3,2-d]pyrimidine; 3 phenyl 2,4 dithioxo 1,2,3,4 tetrahydroquinazoline; 6 bromo 4 oxo 3 phenyl 2 thioxo 1,2,3,4 tetrahydroquinazoline; cyclic AMP; isobutylmethylxanthine; phosphodiesterase VII; phosphodiesterase VII inhibitor; quinazoline derivative; rolipram; unclassified drug; antiinflammatory agent; phosphodiesterase inhibitor; phosphodiesterase IV; phosphodiesterase VII; quinazoline derivative; animal cell; antiinflammatory activity; article; biological activity; blood brain barrier; catalysis; computer model; controlled study; crystal structure; drug design; drug potency; drug structure; drug synthesis; enzyme inhibition; hydrophobicity; IC 50; molecular model; mouse; nonhuman; priority journal; protein domain; protein structure; structure analysis; X ray crystallography; animal; cell culture; chemistry; drug antagonism; enzyme active site; human; metabolism; structure activity relation; synthesis; Animals; Anti-Inflammatory Agents; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Drug Design; Humans; Mice; Phosphodiesterase Inhibitors; Quinazolines; Structure-Activity Relationship",,"cyclic AMP, 60-92-4; isobutylmethylxanthine, 28822-58-4; rolipram, 61413-54-5; Anti-Inflammatory Agents; Cyclic AMP, 60-92-4; Cyclic Nucleotide Phosphodiesterases, Type 4, 3.1.4.17; Cyclic Nucleotide Phosphodiesterases, Type 7, 3.1.4.17; Phosphodiesterase Inhibitors; Quinazolines",,,,,,,"Conti, M., Beavo, J., (2007) Annu. Rev. Biochem., 76, pp. 481-511; Essayan, D.M., (1999) Biochem. Pharmacol., 57, pp. 965-973; Allison, A.C., (2000) Immunopharmacology, 47, pp. 63-83; Lugnier, C., (2006) Pharmacol. Ther., 109, pp. 366-398; Dyke, H.J., Montana, J.G., (2002) Expert Opin. Invest. Drugs, 11, pp. 1-13; Spina, D., (2003) Drugs, 63, pp. 2575-2594; Menniti, F.S., Faraci, W.S., Schmidt, C.J., (2006) Nat. Rev. Drug Discovery, 5, pp. 660-670; Ekholm, D., Hemmer, B., Gao, G., Vergelli, M., Martin, R., Manganiello, V., (1997) J. Immunol., 159, pp. 1520-1529; Erdogan, S., Houslay, M.D., (1997) Biochem. J., 321, pp. 165-175; Giembycz, M.A., Corrigan, C.J., Seybold, J., Newton, R., Barnes, P.J., (1996) Br. J. Pharmacol., 118, pp. 1945-1958; Manning, C.D., Burman, M., Christensen, S.B., Cieslinski, L.B., Essayan, D.M., Grous, M., Torphy, T.J., Barnette, M.S., (1999) Br. J. Pharmacol., 128, pp. 1393-1398; Houslay, M.D., Schafer, P., Zhang, K.Y.J., (2005) Drug Discovery Today, 10, pp. 1503-1519; Chung, K., (2006) Eur. J. Pharmacol., 533, pp. 110-117; Giembycz, M.A., (2005) Curr. Opin. Pharmacol., 5, pp. 238-244; Li, L., Yee, C., Beavo, J.A., (1999) Science, 283, pp. 848-851; Nakata, A., Ogawa, K., Sasaki, T., Koyama, N., Wada, K., Kotera, J., Kikkawa, H., Kaminuma, O., (2002) Clin. Exp. Immunol., 128, pp. 460-466; Yang, G., McIntyre, K.W., Townsend, R.M., Shen, H.H., Pitts, W.J., Dodd, J.H., Nadler, S.G., Watson, A.J., (2003) J. Immunol., 171, pp. 6414-6420; Castro, A., Jerez, M.J., Gil, C., Martínez, A., (2005) Med. Res. Rev., 25, pp. 229-244; Martínez, A., Castro, A., Gil, C., Miralpeix, M., Segarra, V., Doménech, T., Beleta, J., Puigdoménech, P., (2000) J. Med. Chem., 43, pp. 683-689; Castro, A., Abasolo, M.I., Gil, C., Segarra, V., Martinez, A., (2001) Eur. J. Med. Chem., 36, pp. 333-338; Vergne, F., Bernardelli, P., Chevalier, E., (2005) Annu. Rep. Med. Chem., 40, pp. 227-241; Giembycz, M.A., Smith, S.J., (2006) Drugs Future, 31, pp. 207-229; Gil, C., Campillo, N.E., Perez, D.I., Martinez, A., (2008) Expert Opin. Ther. Pat., 18, pp. 1127-1139; Smith, S.J., Cieslinski, L.B., Newton, R., Donnelly, L.E., Fenwick, P.S., Nicholson, A.G., Barnes, P.J., Giembycz, M.A., (2004) Mol. Pharmacol., 66, pp. 1679-1689; Hatzelmann, A., Marx, D., Steinhilber, W., (2002), Altana Pharma AG, WO 02085906; Pitts, W.J., Watson, A.J., Dodd, J.H., (2002), Bristol-Meyers Squibb, WO 02088079; Vijayakrishnan, L., Rudra, S., Eapen, M.S., Dastidar, S., Ray, A., (2007) Expert Opin. Invest. Drugs, 16, pp. 1585-1599; Yamamoto, S., Sugahara, S., Naito, R., Ichikawa, A., Ikeda, K., Yamada, T., Shimizu, Y., (2006) Eur. J. Pharmacol., 541, pp. 106-114; Castro, A., Jerez, M.J., Gil, C., Calderon, F., Doménech, T., Nueda, A., Martínez, A., (2008) Eur. J. Med. Chem., 43, pp. 1349-1359; Satpanthi, P.S., Trivedi, J.P., (1971) J. Indian Chem. Soc., 48, pp. 1021-1026; Scheibye, S., El-Barbary, A.A., Lawesson, S.-O., (1982) Tetrahedron, 38, pp. 3753-3760; Jesberger, M., Davis, T.P., Barner, L., (2003) Synthesis, pp. 1929-1958; Wang, P., Wu, P., Egan, R.W., Billah, M.M., (2000) Biochem. Biophys. Res. Commun., 276, pp. 1271-1277; Bloom, T.J., Beavo, J.A., (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 14188-14192; Guerra, A., Paez, J.A., Campillo, N.E., (2008) QSAR Comb. Sci., 27, pp. 586-594; Wang, H.C., Liu, Y.D., Chen, Y.X., Robinson, H., Ke, H.M., (2005) J. Biol. Chem., 280, pp. 30949-30955; Ke, H., Wang, H., (2007) Curr. Top. Med. Chem., 7, pp. 391-403; Camps, P., El Achab, R., Gorbig, D.M., Morral, J., Munoz-Torrero, D., Badia, A., Banos, J.E., Luque, F.J., (1999) J. Med. Chem., 42, pp. 3227-3242; Foloppe, N., Fisher, L.M., Howes, R., Kierstan, P., Potter, A., Robertson, A.G.S., Surgenor, A.E., (2005) J. Med. Chem., 48, pp. 4332-4345; Lyne, P.D., Lamb, M.L., Saeh, J.C., (2006) J. Med. Chem., 49, pp. 4805-4808; Weis, A., Katebzadeh, K., Soderhjelm, P., Nilsson, I., Ryde, U., (2006) J. Med. Chem., 49, pp. 6596-6606; El-Sharief, A.M.S., Ammar, Y.A., Mohamed, Y.A., El-Gaby, M.S.A., (2002) Heteroat. Chem., 13, pp. 291-298; Alagarsamy, V., Giridhar, R., Yadav, M.R., (2005) Bioorg. Med. Chem. Lett., 15, pp. 1877-1880; Wagner, G., Rothe, L., (1971) Pharmazie, 26, pp. 459-461; Peck, A.B., Bach, F.H., (1973) J. Immunol. Methods, 3, pp. 147-163; Otwinowski, Z., Minor, W., (1997) Methods Enzymol., 276, pp. 307-326; Navaza, J., Saludjian, P., (1997) Methods Enzymol., 276, pp. 581-594; Jones, T.A., Zou, J.Y., Cowan, S.W., Kjeldgaard, M., (1991) Acta Crystallogr. Sect. A, 47, pp. 110-119; Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Warren, G.L., (1998) Acta Crystallogr. Sect. D, 54, pp. 905-921; Morley, S.D., Afshar, M., (2004) J. Comput. Aided Mol. Des., 18, pp. 189-208; Barril, X., Hubbard, R.E., Morley, S.D., (2004) Mini Rev. Med. Chem., 4, pp. 779-791; Gaussian 03: M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al- Laham, C. Y. Peng, A. Nanayakkara; AMBER 8: D. A. Case, T. A. Darden, T. E. Cheatham, C. L. Simmerling, J. Wang, R. E. Duke, R. Luo, K. M. Merz, B. Wang, D. A. Pearlman, M. Crowley, S. Brozell, V. Tsui, H. Gohlke, J. Mongan, V. Hornak, G. Cui, P. Beroza, C. Schafmeister, J. W. Caldwell, W. S. Ross, P. A. Kollman, University of California, San Francisco, CA (USA) 2000; Bayly, C.I., Cieplak, P., Cornell, W., Kollman, P.A., (1993) J. Phys. Chem., 97, pp. 10269-10280","Gil, C.; Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; email: cgil@iqm.csic.es",,,,,,,,18607179,,,"19350606","English","ChemMedChem",Article,"Final",,Scopus,2-s2.0-67651115888
"Wilkinson M.D., Senger M., Kawas E., Bruskiewich R., Gouzy J., Noirot C., Bardou P., Ng A., Haase D., Saiz E. de A., Wang D., Gibbons F., Gordon P.M.K., Sensen C.W., Carrasco J.M.R., Fernández J.M., Shen L., Links M., Ng M., pushneva N., Neerincx P.B.T., Leunissen J.A.M., Ernst R., Twigger S., Usadel B., Good B., Wong Y., Stein L., Crosby W., Karlsson J., Royo R., Párraga I., Ramírez S., Gelpi J.L., Trelles O., Pisano D.G., Jimenez N., Kerhornou A., Rosset R., Zamacola L., Tarraga J., Huerta-Cepas J., Carazo J.M., Dopazo J., Guigo R., Navarro A., Orozco M., Valencia A., Claros M.G., Pérez A.J., Aldana J., Rojano M.M., Fernandez-Santa Cruz R., Navas I., Schiltz G., Farmer A., Gessler D., Schoof H., Groscurth A.","55741082500;6602541805;15725375500;6603492167;7004423897;23501575300;6505947169;24176144500;57195245127;24176342500;57208250903;57207587567;34569739100;7003339025;24175919300;57190010914;56003134500;36150762800;36747600100;24176357900;8517620900;7006626503;11940382500;6602310364;6506402404;15834553900;24176407100;7202575097;57027258700;57194509147;24176373200;24176336500;57196958868;35517522400;6701552390;24588110800;36856560100;8634293600;24176435400;24176051200;14831958400;14219311300;35500936300;18133480200;7004339139;35477108400;7102809158;16308427600;7003612625;23022747400;6507036317;24176423100;24175594000;6508304108;35249196500;57198142753;6701508330;7004219155;24175621600;","Interoperability with Moby 1.0 - It's better than sharing your toothbrush!",2008,"Briefings in Bioinformatics","9","3",,"220","231",,71,"10.1093/bib/bbn003","https://www.scopus.com/inward/record.uri?eid=2-s2.0-43349101291&doi=10.1093%2fbib%2fbbn003&partnerID=40&md5=85a491a3fa7feec0b17866f2c491f3e4","The Heart and Lung Research Institute, St. Paul's Hospital, 1081 Burrard St., Vancouver, BC V6G 1Y3, Canada","Wilkinson, M.D., The Heart and Lung Research Institute, St. Paul's Hospital, 1081 Burrard St., Vancouver, BC V6G 1Y3, Canada; Senger, M.; Kawas, E.; Bruskiewich, R.; Gouzy, J.; Noirot, C.; Bardou, P.; Ng, A.; Haase, D.; Saiz, E. de A.; Wang, D.; Gibbons, F.; Gordon, P.M.K.; Sensen, C.W.; Carrasco, J.M.R.; Fernández, J.M.; Shen, L.; Links, M.; Ng, M.; pushneva, N.; Neerincx, P.B.T.; Leunissen, J.A.M.; Ernst, R.; Twigger, S.; Usadel, B.; Good, B.; Wong, Y.; Stein, L.; Crosby, W.; Karlsson, J.; Royo, R.; Párraga, I.; Ramírez, S.; Gelpi, J.L.; Trelles, O.; Pisano, D.G.; Jimenez, N.; Kerhornou, A.; Rosset, R.; Zamacola, L.; Tarraga, J.; Huerta-Cepas, J.; Carazo, J.M.; Dopazo, J.; Guigo, R.; Navarro, A.; Orozco, M.; Valencia, A.; Claros, M.G.; Pérez, A.J.; Aldana, J.; Rojano, M.M.; Fernandez-Santa Cruz, R.; Navas, I.; Schiltz, G.; Farmer, A.; Gessler, D.; Schoof, H.; Groscurth, A.","The BioMoby project was initiated in 2001 from within the model organism database community. It aimed to standardize methodologies to facilitate information exchange and access to analytical resources, using a consensus driven approach. Six years later, the BioMoby development community is pleased to announce the release of the 1.0 version of the interoperability framework, registry Application Programming Interface and supporting Perl and Java code-bases. Together, these provide interoperable access to over 1400 bioinformatics resources worldwide through the BioMoby platform, and this number continues to grow. Here we highlight and discuss the features of BioMoby that make it distinct from other Semantic Web Service and interoperability initiatives, and that have been instrumental to its deployment and use by a wide community of bioinformatics service providers. The standard, client software, and supporting code libraries are all freely available at http://www.biomoby.org/. © The Author 2008. Published by Oxford University Press.","Biomoby; Data integration; Interoperability; Schema; Semantic web; Web services","access to information; application service provider; Arabidopsis; article; bioinformatics; computer interface; computer language; computer model; data analysis software; Internet; online system; standardization; Computational Biology; Database Management Systems; Databases, Factual; Information Storage and Retrieval; Internet; Programming Languages; Systems Integration",,,"BioMoby",,,,,,"Stein, L., Creating a bionformatics nation (2002) Nature, 417, pp. 119-120; Pearson, H., Name Game, B., (2001) Nature, 411, pp. 631-632; Wilkinson, M.D., Links, M., BioMOBY: An open-source biological web services proposal (2002) Brief Bioinform, 3, pp. 331-341; Wilkinson, M.D., Gessler, D., Farmer, A., The BioMOBY project explores open-source, simple, extensible protocols for enabling biological database interoperability (2003) Proc Virt Conf Genom and Bioinf, 3, pp. 16-26; Wilkinson M. BioMOBY: The MOBY-S platform for interoperable data service provision. In: Richard P. Grant (ed.). Computational Genomics. Wymondham: Horizon Bioscience, 2004; (2007) Web Services Activity, , http://www.w3.org/2002/ws, 14 March, date last accesed; (2007) Web Services Description Language (WSDL), , http://www.w3.org/TR/wsdl, 1.1, 14 March, date last accessed; (2007) Semantic Annotations for Web Services Description Language Working Group, , http://www.w3.org/2002/ws/sawsdl, 14 March, date last accessed; Narayanan, S., McIlraith, S.A., Simulation, verification and automated composition of web services Proceedings of the 11th international conference on World Wide Web 2002, , doi/10.1145/511446.511457; Wu D, Sirin E, Hendler J, et al. Automatic Web Services Composition Using SHOP2. In: Proceedings of the World Wide Web Conference 2003. http://www2003.org/cdrom/papers/poster/p226/ p226-wu.html (14 March 2007, date last accessed); Korhonen, J., Pajunen, L., Puustjarvi, J., Automatic composition of Web service workflows using a semantic agent Proceedings IEEE/WIC International Conference on Web Intelligence 13-17 October 2003, pp. 566-569. , doi/10.1109/wi.2003.1241269; Gekas, J., Fasli, M., (2007) Automatic Web Service Composition Using Web Connectivity Analysis Techniques. W3C Workshop on Frameworks for Semantics in Web Services 2005 Position Paper, 2005, , http://www.w3.org/2005/04/FSWS/Submissions/39/web_service_composition.pd f, 14 March, date last accessed; Carman, M.J., Knoblock, C.A., (2007) Inducing Source Descriptions for Automated Web Service Composition. 2005, , http://www.isi.edu/integration/papers/carman05-wswkshp.pdf, 14 March, date last accessed; Thakkar, S., Ambite, L., Knoblock, A., Composing, optimizing, and executing plans for bioinformatics web services (2005) VLDB J, 14, pp. 330-353. , doi/10.1007/s00778-005-0158-4; (2007) Extensible Markup Language, , www.w3.org/XML, Available http:// 14 March, date last accessed; Seibel, P.N., Krüger, J., Hartmeier, S., XML schemas for common bioinformatic data types and their application in workflow systems (2006) BMC Bioinformatics, 7, p. 490. , doi/ 10.1186/1471-2105-7-490; Kawas, E., Senger, M., Wilkinson, M., BioMoby extensions to the Taverna workflow management and enactment software (2006) BMC Bioinformatics, 7, p. 523. , doi/10.1186/1471-2105-7-523; Lord, P., Bechhofer, S., Wilkinson, M.D., Applying semantic web services to bioinformatics: Experiences gained, lessons learnt (2004) Lect Notes Comput Sci, 3298, pp. 350-364; Good, B., Wilkinson, M.D., The life sciences semantic web is full of creeps! (2006) Brief Bioinform, 7, pp. 275-286; Wilkinson, M.D., Gbrowse Moby: A web-based browser for BioMOBY Services (2006) SCFBM, 1, p. 4. , doi/10.1186/1751-0473-1-4; Wilkinson, M.D., Schoof, H., Ernst, R., BioMOBY successfully integrates distributed heterogeneous bioinformatics Web Services. The PlaNet exemplar case (2002) Plant Physiol, 138, pp. 5-17. , doi/ 10.1104/pp.104.059170; (2007) GO Database Abbreviations, , http://geneontology.org/cgi-bin/xrefs.cgi, 14 March, date last accessed; Ashburner, M., Ball, C.A., Blake, J.A., Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium (2000) Nat Genet, 25, pp. 25-29. , doi/10.1038/75556; Senger M. The BioMoby Dashboard. Available at http://biomoby.open-bio.org/CVS_CONTENT/moby-live/Java/docs/ Dashboard.html (14 March 2007, date last accessed); Stevens RD, Robinson AJ, Goble CA. myGrid: Personalised bioinformatics on the information grid. Bioinformatics 2003;19(Suppl 1)i302-4; (2007) Life Sciences Analysis Engine Specification, , http://www.omg.org/technology/documents/formal/lsae.htm, 14 March, date List accessed; Gordon, P.M.K., Trinh, Q., Sensen, C.W., Semantic web service provision: A realistic framework for bioinformatics programmers (2007) Bioinformatics, 23, pp. 1178-1180; Senger, M., Kawas, E., (2007) MoSeS - Code Generators, , http://biomoby.open-bio.org/CVS_CONTENT/moby-live/Java/docs/Moses-genera tors.html, 14 March, date last accessed; Phillips, J., Chilukuri, R., Fragoso, G., The caCORE software development kit: Streamlining construction of interoperable biomedical information services (2006) BMC Med Inform Decis Mak, 6, p. 2. , doi/10.1186/1472-6947-6-2; (2007) SOAP 1.2 Specification, , http://www.w3.org/TR/soap, 14 March, date last accessed; Hull, D., Wolstencroft, K., Stevens, R., Taverna: A tool for building and running workflows of services (2006) Nucleic Acids Res, 34, pp. W729-W732. , doi/10.1093/nar/gk1320; Navas-Delgado, I., Rojano-Munoz Mdel, M., Ramirez, S., Intelligent client for integrating bioinformatics services (2006) Bioinformatics, 22, pp. 106-111. , doi/10.1093/bioinformatics/ bti740; Carrere, S., Gouzy, J., REMORA: A pilot in the ocean of BioMoby web-services (2006) Bioinformatics, 22, pp. 900-901. , doi/10.1093/ bioinformatics/bdl001; Turinsky, A.L., Ah-Seng, A.C., Gordon, P.M., Bioinformatics visualization and integration with open standards: The Bluejay genomic browser (2005) In Silico Biol, 5, pp. 187-198; Gordon, P.M.K., Sensen, C.W., Seahawk: Moving beyond HTML in web-based bioinformatics analysis (2007) BMC Bioinformatics, 8, p. 208; Open Biomedical Ontologies Consortium. http://obo.sourceforge.net (14 March 2007, date last accessed); Simple Semantic Web Architecture and Protocol. http://sswap.info. (14 March 2007, date last accessed); Wheeler, D.L., Barrett, T., Benson, D.A., Database resources of the national center for biotechnology information (2006) Nucleic Acids Res, 34, pp. D173-D180. , doi/10.1093/nar/gkj158; NCBI e-Utilities Function Call. http://eutils.ncbi.nlm. nih.gov/entrez/ eutils/efetch.fcgi?db=gene&mode=xml&id=640 (14 March 2007, date last accessed); Good, B.M., Tranfield, E.M., Tan, P.C., Fast, cheap and out of control: A zero curation model for ontology development (2006) Proceedings of the Pacific Symposium on Biocomputing, pp. 128-139; Wang, G., Liu, A., Extending XL Schema with nonmonotonic inheritence (2003) Lect Now Comput Science, 2814, pp. 402-407. , doi/10.1007/b13245; (2007) Web Ontology Language (OWL), , www.w3.org/2004/OWL, Available http:// 14 March, date last accessed; (2007) Resource Description Framework (RDF), , http://www.w3.org/RDF, 14 March, date last accessed; Tsarkov, D., Horrocks, I., FaCT++ Description Logic Reasoner: System Description (2006) Proceedings of the International Joint Conference on Automated Reasoning (IJCAR 2006); Haarslev, V., Moller, R., Racer: A core inference engine for the semantic web (2003) 2nd International Workshop on Evaluation of Ontology-based Tools (EON-2003), , Sanibel Island, FL; Sirin, E., Parsia, B., Grau, B.C., (2007) Pellet: A practical OWL-DL reasoner. 2006, , http://www.mindswap.org/papers/PelletJWS.pdf, 9 November, date last accessed","Wilkinson, M.D.; The Heart and Lung Research Institute, St. Paul's Hospital, 1081 Burrard St., Vancouver, BC V6G 1Y3, Canada; email: markw@illuminae.com",,,,,,,,14675463,,,"18238804","English","Brief. Bioinform.",Article,"Final",Open Access,Scopus,2-s2.0-43349101291
"Reig N., Del Rio C., Casagrande F., Ratera M., Gelpí J.L., Torrents D., Henderson P.J.F., Xie H., Baldwin S.A., Zorzano A., Fotiadis D., Palacín M.","6506101886;16506341300;17134173300;16507518400;35517522400;6603452371;35765334500;35241181800;7102790528;7005302863;7005670165;7006628474;","Functional and structural characterization of the first prokaryotic member of the L-amino acid transporter (LAT) family: A model for APC transporters",2007,"Journal of Biological Chemistry","282","18",,"13270","13281",,33,"10.1074/jbc.M610695200","https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250376457&doi=10.1074%2fjbc.M610695200&partnerID=40&md5=2166f6834683596335b6900851119ed3","Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain; M. E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland; Molecular Modeling and Bioinformatics, Institute for Research in Biomedicine, E-08028 Barcelona, Spain; Barcelona Supercomputing Center, Life Science Program, Institució Catalana de Recerca I Estudis Avançats, E-08034 Barcelona, Spain; Institute of Membrane and Systems Biology, University of Leeds, LS2 9JT Leeds, United Kingdom; Centre for Biomedical Research on Rare Diseases (CIBERER), E-08028 Barcelona, Spain; Ecole Polytechnique Fédérale de Lausanne, School of Life Sciences, Global Health Institute, CH-1015 Lausanne, Switzerland; Institute of Science, Wuhan University of Technology, 430070 Wuhan, Hubei, China; M.E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland; Institut de Recerca Biomedica, Park Científic de Barcelona, Josep Samitier 1-5, E-08028, Barcelona, Spain","Reig, N., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain, Ecole Polytechnique Fédérale de Lausanne, School of Life Sciences, Global Health Institute, CH-1015 Lausanne, Switzerland; Del Rio, C., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER), E-08028 Barcelona, Spain; Casagrande, F., M. E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland; Ratera, M., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER), E-08028 Barcelona, Spain; Gelpí, J.L., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain, Molecular Modeling and Bioinformatics, Institute for Research in Biomedicine, E-08028 Barcelona, Spain; Torrents, D., Barcelona Supercomputing Center, Life Science Program, Institució Catalana de Recerca I Estudis Avançats, E-08034 Barcelona, Spain; Henderson, P.J.F., Institute of Membrane and Systems Biology, University of Leeds, LS2 9JT Leeds, United Kingdom; Xie, H., Institute of Membrane and Systems Biology, University of Leeds, LS2 9JT Leeds, United Kingdom, Institute of Science, Wuhan University of Technology, 430070 Wuhan, Hubei, China; Baldwin, S.A., Institute of Membrane and Systems Biology, University of Leeds, LS2 9JT Leeds, United Kingdom; Zorzano, A., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain; Fotiadis, D., M. E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland, M.E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland; Palacín, M., Institute for Research in Biomedicine, Department of Biochemistry and Molecular Biology, University of Barcelona, E-08028 Barcelona, Spain, Centre for Biomedical Research on Rare Diseases (CIBERER), E-08028 Barcelona, Spain, Institut de Recerca Biomedica, Park Científic de Barcelona, Josep Samitier 1-5, E-08028, Barcelona, Spain","We have identified YkbA from Bacillus subtilis as a novel member of the L-amino acid transporter (LAT) family of amino acid transporters. The protein is ∼30% identical in amino acid sequence to the light subunits of human heteromeric amino acid transporters. Purified His-tagged YkbA from Escherichia coli membranes reconstituted in proteoliposomes exhibited sodium-independent, obligatory exchange activity for L-serine and L-threonine and also for aromatic amino acids, albeit with less activity. Thus, we propose that YkbA be renamed SteT (Ser/Thr exchanger transporter). Kinetic analysis supports a sequential mechanism of exchange for SteT. Freeze-fracture analysis of purified, functionally active SteT in proteoliposomes, together with blue native polyacrylamide gel electrophoresis and transmission electron microscopy of detergent-solubilized purified SteT, suggest that the transporter exists in a monomeric form. Freeze-fracture analysis showed spherical particles with a diameter of 7.4 nm. Transmission electron microscopy revealed elliptical particles (diameters 6 x 7 nm) with a distinct central depression. To our knowledge, this is the first functional characterization of a prokaryotic member of the LAT family and the first structural data on an APC (amino acids, polyamines, and choline for organocations) transporter. SteT represents an excellent model to study the molecular architecture of the light subunits of heteromeric amino acid transporters and other APC transporters. © 2007 by The American Society for Biochemistry and Molecular Biology, Inc.",,"Freeze-fracture analysis; Gel electrophoresis; Molecular architecture; Proteoliposomes; Biochemistry; Biological membranes; Escherichia coli; Molecular structure; Transmission electron microscopy; Amino acids; amino acid acetyltransferase; aromatic amino acid; choline; detergent; histone; polyamine derivative; protein subunit; protein YkbA; serine; sodium; threonine; unclassified drug; amino acid transporter; Escherichia coli protein; liposome; serine; threonine; amino acid sequence; article; Bacillus subtilis; bacterial membrane; controlled study; Escherichia coli; freeze fracture; kinetics; molecular model; nonhuman; particle size; polyacrylamide gel electrophoresis; priority journal; prokaryote; protein analysis; protein family; protein function; protein purification; protein structure; proteoliposome; transmission electron microscopy; Bacillus subtilis; chemical structure; chemistry; Escherichia coli; genetics; metabolism; phylogeny; physiology; protein tertiary structure; transport at the cellular level; Bacillus subtilis; Escherichia coli; Prokaryota; Amino Acid Transport Systems, Neutral; Bacillus subtilis; Biological Transport; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Proteins; Liposomes; Microscopy, Electron, Transmission; Models, Molecular; Phylogeny; Protein Structure, Tertiary; Serine; Threonine",,"amino acid acetyltransferase, 9029-88-3; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; histone, 9062-68-4; serine, 56-45-1, 6898-95-9; sodium, 7440-23-5; threonine, 36676-50-3, 72-19-5; Amino Acid Transport Systems, Neutral; Escherichia coli Proteins; Liposomes; Serine, 56-45-1; Threonine, 72-19-5",,,,,,,"Jack, D.L., Paulsen, I.T., Saier Jr., M.H., (2000) Microbiology, 146, pp. 1797-1814; Palacin, M., Kanai, Y., (2004) Pflugers Arch, 447, pp. 490-494; Verrey, F., Closs, E.I., Wagner, C.A., Palacin, M., Endou, H., Kanai, Y., (2004) Pflugers Arch, 447, pp. 532-542; Palacin, M., Nunes, V., Font-Llitjos, M., Jimenez-Vidal, M., Fort, J., Gasol, E., Pineda, M., Zorzano, A., (2005) Physiology (Bethesda), 20, pp. 112-124; Calonge, M.J., Gasparini, P., Chillaron, J., Chillon, M., Gallucci, M., Rousaud, F., Zelante, L., Palacin, M., (1994) Nat. Genet, 6, pp. 420-425; Feliubadalo, L., Font, M., Purroy, J., Rousaud, F., Estivill, X., Nunes, V., Golomb, E., Estevez, R., (1999) Nat. Genet, 23, pp. 52-57; Torrents, D., Mykkanen, J., Pineda, M., Feliubadalo, L., Estevez, R., de Cid, R., Sanjurjo, P., Palacin, M., (1999) Nat. Genet, 21, pp. 293-296; Borsani, G., Bassi, M.T., Sperandeo, M.P., De Grandi, A., Buoninconti, A., Riboni, M., Manzoni, M., Sebastio, G., (1999) Nat. Genet, 21, pp. 297-301; Sato, H., Tamba, M., Ishii, T., Bannai, S., (1999) J. Biol. Chem, 274, pp. 11455-11458; Bassi, M.T., Gasol, E., Manzoni, M., Pineda, M., Riboni, M., Martin, R., Zorzano, A., Palacin, M., (2001) Pflugers Arch, 442, pp. 286-296; Kaleeba, J.A., Berger, E.A., (2006) Science, 311, pp. 1921-1924; Baker, D.A., McFarland, K., Lake, R.W., Shen, H., Tang, X.C., Toda, S., Kalivas, P.W., (2003) Nat. Neurosci, 6, pp. 743-749; Sato, H., Shiiya, A., Kimata, M., Maebara, K., Tamba, M., Sakakura, Y., Makino, N., Bannai, S., (2005) J. Biol. Chem, 280, pp. 37423-37429; Chillaron, J., Roca, R., Valencia, A., Zorzano, A., Palacin, M., (2001) Am. J. Physiol, 281, pp. F995-F1018; Torras-Llort, M., Torrents, D., Soriano-Garcia, J.F., Gelpi, J.L., Estevez, R., Ferrer, R., Palacin, M., Moreto, M., (2001) J. Membr. Biol, 180, pp. 213-220; Reig, N., Chillaron, J., Bartoccioni, P., Fernandez, E., Bendahan, A., Zorzano, A., Kanner, B., Bertran, J., (2002) EMBO J, 21, pp. 4906-4914; Gasol, E., Jimenez-Vidal, M., Chillaron, J., Zorzano, A., Palacin, M., (2004) J. Biol. Chem, 279, pp. 31228-31236; Jimenez-Vidal, M., Gasol, E., Zorzano, A., Nunes, V., Palacin, M., Chillaron, J., (2004) J. Biol. Chem, 279, pp. 11214-11221; Kashiwagi, K., Kuraishi, A., Tomitori, H., Igarashi, A., Nishimura, K., Shirahata, A., Igarashi, K., (2000) J. Biol. Chem, 275, pp. 36007-36012; Hu, L.A., King, S.C., (1999) Biochem. J, 339, pp. 649-655; Habermeier, A., Wolf, S., Martine, U., Graf, P., Closs, E.I., (2003) J. Biol. Chem, 278, pp. 19492-19499; Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., (1990) J. Mol. Biol, 215, pp. 403-410; Chang, A.B., Lin, R., Keith Studley, W., Tran, C.V., Saier Jr., M.H., (2004) Mol. Membr. Biol, 21, pp. 171-181; Do, C.B., Mahabhashyam, M.S., Brudno, M., Batzoglou, S., (2005) Genome Res, 15, pp. 330-340; Castresana, J., (2000) Mol. Biol. Evol, 17, pp. 540-552; Chenna, R., Sugawara, H., Koike, T., Lopez, R., Gibson, T.J., Higgins, D.G., Thompson, J.D., (2003) Nucleic Acids Res, 31, pp. 3497-3500; Xie, H., Patching, S.G., Gallagher, M.P., Litherland, G.J., Brough, A.R., Venter, H., Yao, S.Y., Baldwin, S.A., (2004) Mol. Membr. Biol, 21, pp. 323-336; Chillaron, J., Estevez, R., Mora, C., Wagner, C.A., Suessbrich, H., Lang, F., Gelpi, J.L., Palacin, M., (1996) J. Biol. Chem, 271, pp. 17761-17770; Eleno, N., Deves, R., Boyd, C.A., (1994) J. Physiol. (Lond.), 479, pp. 291-300; Lopez, O., de la Maza, A., Coderch, L., Lopez-Iglesias, C., Wehrli, E., Parra, J.L., (1998) FEBS Lett, 426, pp. 314-318; Schagger, H., Aquila, H., von Jagow, G., (1988) Anal. Biochem, 173, pp. 201-205; Kunst, F., Ogasawara, N., Moszer, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., Bessieres, P., Bolotin, A., Borchert, S., Borriss, R., Boursier, L., Brans, A., Braun, M., Brignell, S. C., Bron, S., Brouillet, S., Bruschi, C. V., Caldwell, B., Capuano, V., Carter, N. M., Choi, S.-K., Codani, J.-J., Connerton, I. F., Cummings, N. J., Daniel, R. A., Denizot, F., Devine, K. M., Düsterhöft, A., Ehrlich, S. D., Emmerson, P. T., Entian, K. D., and Errington, J. (1997) Nature 390, 249-256; Riley, M., Abe, T., Arnaud, M.B., Berlyn, M.K., Blattner, F.R., Chaudhuri, R.R., Glasner, J.D., Wanner, B.L., (2006) Nucleic Acids Res, 34, pp. 1-9; Kashiwagi, K., Miyamoto, S., Suzuki, F., Kobayashi, H., Igarashi, K., (1992) Proc. Natl. Acad. Sci. U. S. A, 89, pp. 4529-4533; Torrents, D., Estevez, R., Pineda, M., Fernandez, E., Lloberas, J., Shi, Y.B., Zorzano, A., Palacin, M., (1998) J. Biol. Chem, 273, pp. 32437-32445; Fernandez, E., Carrascal, M., Rousaud, F., Abian, J., Zorzano, A., Palacin, M., Chillaron, J., (2002) Am. J. Physiol. Renal Physiol, 283, pp. F540-F548; Dierks, T., Riemer, E., Kramer, R., (1988) Biochim. Biophys. Acta, 943, pp. 231-244; Suda, K., Filipek, S., Palczewski, K., Engel, A., Fotiadis, D., (2004) Mol. Membr. Biol, 21, pp. 435-446; Abramson, J., Smirnova, I., Kasho, V., Verner, G., Kaback, H.R., Iwata, S., (2003) Science, 301, pp. 610-615; Ivanova, N., Sorokin, A., Anderson, I., Galleron, N., Candelon, B., Kapatral, V., Bhattacharyya, A., Kyrpides, N., (2003) Nature, 423, pp. 87-91; Meier, C., Ristic, Z., Klauser, S., Verrey, F., (2002) EMBO J, 21, pp. 580-589; Heuberger, E.H., Veenhoff, L.M., Duurkens, R.H., Friesen, R.H., Poolman, B., (2002) J. Mol. Biol, 317, pp. 591-600; Costello, M.J., Escaig, J., Matsushita, K., Viitanen, P.V., Menick, D.R., Kaback, H.R., (1987) J. Biol. Chem, 262, pp. 17072-17082; Turk, E., Kim, O., le Coutre, J., Whitelegge, J.P., Eskandari, S., Lam, J.T., Kreman, M., Wright, E.M., (2000) J. Biol. Chem, 275, pp. 25711-25716; Dekker, J.P., Boekema, E.J., Witt, H.T., Rögner, M., (1988) Biochim. Biophys. Acta, 936, pp. 307-318; Zhuang, J., Prive, G.G., Werner, G.E., Ringler, P., Kaback, H.R., Engel, A., (1999) J. Struct. Biol, 125, pp. 63-75","Fotiadis, D.; M.E. Müller Institute for Microscopy, Biozentrum, University of Basel, CH-4056 Basel, Switzerland; email: dimitrios.fotiadis@unibas.ch",,,,,,,,00219258,,JBCHA,"17344220","English","J. Biol. Chem.",Article,"Final",Open Access,Scopus,2-s2.0-34250376457
"Soliva R., Gelpí J.L., Almansa C., Virgili M., Orozco M.","6602492780;35517522400;6601923469;36830051200;7102809158;","Dissection of the recognition properties of p38 MAP kinase. Determination of the binding mode of a new pyridinyl-heterocycle inhibitor family",2007,"Journal of Medicinal Chemistry","50","2",,"283","293",,20,"10.1021/jm061073h","https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846404143&doi=10.1021%2fjm061073h&partnerID=40&md5=b154d2a57a436b15fb47dcd9f026910b","Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Drug Discovery, J. Uriach y Cia, Poligon Industrial Riera de Caldes, Camí Reial 51-57, Palau de Plegamans, Barcelona 08184, Spain; Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexos II, Jordi Girona 31, Barcelona 08028, Spain; Structural Bioinformatics Node, Instituto Nacional de Bioinformática, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","Soliva, R., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain, Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Drug Discovery, J. Uriach y Cia, Poligon Industrial Riera de Caldes, Camí Reial 51-57, Palau de Plegamans, Barcelona 08184, Spain; Gelpí, J.L., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain, Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexos II, Jordi Girona 31, Barcelona 08028, Spain; Almansa, C., Drug Discovery, J. Uriach y Cia, Poligon Industrial Riera de Caldes, Camí Reial 51-57, Palau de Plegamans, Barcelona 08184, Spain; Virgili, M., Drug Discovery, J. Uriach y Cia, Poligon Industrial Riera de Caldes, Camí Reial 51-57, Palau de Plegamans, Barcelona 08184, Spain; Orozco, M., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain, Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexos II, Jordi Girona 31, Barcelona 08028, Spain, Structural Bioinformatics Node, Instituto Nacional de Bioinformática, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","The main recognition characteristics of the ATP binding site of p38 mitogen activated protein kinase alpha (p38α MAPK) have been explored by a combination of modeling and bioinformatics techniques, making special emphasis in the characteristics of the site that justifies binding specificity with respect to other MAP kinases. Particularly, we have analyzed the binding mode of a new family of p38 MAPK inhibitors based on the pyridinyl-heterocycle core. This family of compounds has a marked pseudosymmetry and can exist in different tautomeric forms, which makes the determination of the binding mode especially challenging. A combination of homology modeling, quantum mechanics, classical docking, and molecular dynamics calculations allowed us to determine the main characteristics defining the binding mode of this new scaffold in the ATP binding site of p38α. A set of free energy calculations allowed us to verify the binding mode proposed, giving an overall excellent agreement with the experimental values. Finally, the binding mode of this new family of compounds was compared to that of other members of the pyridinyl and pyrimidinyl heterocycle class. © 2007 American Chemical Society.",,"adenosine triphosphate; heterocyclic compound; mitogen activated protein kinase 14; mitogen activated protein kinase p38; mitogen activated protein kinase p38 inhibitor; pyridine derivative; article; binding affinity; binding site; bioinformatics; enzyme active site; isomer; molecular dynamics; molecular model; molecular recognition; quantum mechanics",,"adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5",,,,,,,"Dinarello, C.A., Inflammatory cytokines: Interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases (1991) Curr. Opin. Immunol, 3, pp. 941-948; Feldmann, M.L., Brennan, F.M., Maini, R.N., Role of cytokines in rheumatoid arthritis (1996) Annu. Rev. Immunol, 14, pp. 397-440; Newton, R.C., Decicco, C.P., Therapeutic potential and strategies for inhibiting TNF alpha (1999) J. Med. Chem, 42, pp. 2295-2314; Pugsley, M. K. Etanercept: Immunex. Curr. Opin. Invest. Drugs 2001, 2, 1726; Bondeson, J., Maini, R.N., Tumor necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: The clinical experience with infliximab. Remicade (2001) Int. J. Clin. Pract, 55, p. 211; Lee, J. C.; Laydon, J. T.; McDonnell, P. C.; Gallagher, T. F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M. J.; Heys, J. R.; Landvatter, S. W.; Strickler, J. E.; McLaughlin, M. M.; Siemens, I. R.; Fisher, S. M.; Livi, G. P.; White, J. R.; Adams, J. L.; Young, P. R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372, 739-746; Kumar, S., Boehm, J., Lee, J.C., p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases (2003) Nat. Rev. Drug Discovery, 2, pp. 717-726; Salituro, F.G., Germann, U.A., Wilson, K.P., Bemis, G.W., Fox, T., Su, M.S.-S., Inhibitors of p38 MAP kinase: Therapeutic intervention in cytokine-mediated diseases (1999) Curr. Med. Chem, 6, pp. 807-823; Tong, L.; Pav, S.; White, D. M.; Rogers, S.; Crane, K. M.; Cywin, C. L.; Brown, M. L.; Pargellis, C. A. A highly specific inhibitor of human p38 MAP kinase binds in the ATP binding pocket. Nat. Struct. Biol. 1997, 4, 311-316; Boehm, J.C., Adams, J.L., New inhibitors of p38 MAP kinase (2000) Expert Opin. Ther. Patents, 10, pp. 25-37; Jackson, P.F., Bullington, J.L., Pyridinylimidazole based p38 MAP kinase inhibitors (2002) Curr. Topics Med. Chem, 2, pp. 1011-1020; de Dios, A.; Shih, C.; Lopez de Urald, e. B.; Sánchez, C.; del Prado, M.; Martin Cabrejas, L. M.; Pleite, S.; Blanco-Urgoiti, J.; Lorite, M. J.; Nevill, C. R., Jr.; Bonjouklian, R.; York, J.; Vieth, M.; Wang, Y.; Magnus, N.; Campbell, R. M.; Anderson, B. D.; McCann, D. J.; Giera, D. D.; Lee, P. A.; Schultz, R. M.; Li, L. C.; Johnson, L. M.; Wolos, J. A. Design of potent and selective 2-aminobenzimidazole-based p38alpha MAP kinase inhibitors with excellent in vivo efficacy. J Med. Chem. 2002, 48, 2270-2273; McClure, K.F., Abramov, Y.A., Laird, E.R., Barberia, J.T., Cai, W., Carty, T.J., Cortina, S.R., Tao, Y., Theoretical and experimental design of atypical kinase inhibitors: Application to p38 MAP kinase (2005) J. Med. Chem, 48, pp. 5728-5737; Cirillo, P.F., Pargellis, C., Regan, J., The non-heterocycle classes of p38 MAP kinase inhibitors (2002) Curr. Topics Med. Chem, 2, pp. 1021-1035; Leftheris, K.; Ahmed, G.; Chan, R.; Dyckman, A. J.; Hussain, Z.; Ho, K.; Hynes, J., Jr.; Letourneau, J.; Li, W.; Lin, S.; Metzger, A.; Moriarty, K. J.; Riviello, C.; Shimshock, Y.; Wen, J.; Wityak, J.; Wrobleski, S. T.; Wu, H.; Wu, J.; Desai, M.; Gillooly, K. M.; Lin, T. H.; Loo, D.; McIntyre, K. W.; Pitt, S.; Shen, D. R.; Shuster, D. J.; Zhang, R.; Diller, D.; Doweyko, A.; Sack, J.; Baldwin, J.; Banish, J.; Dodd, J.; Henderson, I.; Kanner, S.; Schieven, G. L.; Webb, M. The discovery of orally active triaminotriazine aniline amides as inhibitors of p38 MAP kinase. J. Med. Chem. 2004, 47, 6283-91; Regan, J., Breitfelder, S., Cirillo, P.F., Gilmore, T., Graham, A.G., Hickey, E., Klaus, B., Torcellini, C., Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate (2002) J. Med. Chem, 45, pp. 2994-3008; Pargellis, C., Tong, L., Churchill, L., Cirillo, P.F., Gilmore, T., Graham, A.G., Grob, P.M., Regan, J., Inhibition of p38 MAP kinase by utilizing a novel allosteric bindig site (2002) Nat. Struct. Biol, 9, pp. 268-272; Almansa, C., Virgili, M., Pyrazolopyridine Derivatives International Patent Application WO 2004076450; All IC50s referenced in the paper were determined by Upstate Ltd. (ATP concentration of 100 μM in an enzyme competitive inhibition assay); Kollman, P.A., Free energy calculations: Applications to chemical and biochemical phenomena (1993) Chem. Rev, 93, pp. 2395-2417; Jorgensen, W.L., The many roles of computation in drug discovery (2004) Science, 303, pp. 1813-1818; Pearlman, D.A., Charifson, P.S., Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase proteins system (2001) J. Med. Chem, 44, pp. 3417-3423; Gelpí, J.L., Kalko, S.G., Barril, X., Cirera, J., de la Cruz, X., Luque, F.J., Orozco, M., Classical Molecular Interaction Potentials: Improved Setup Procedure in Molecular Dynamics Simulations of Proteins (2001) Proteins, 45, p. 428; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., Second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J. Am. Chem. Soc, 117, pp. 5179-5197; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of sample potential functions for simulating liquid water (1983) J. Chem. Phys, 79, pp. 926-935; Bayly, C. I.; Cieplak, P.; Cornell, W. D.; Kollman, P. A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges. J. Chem. Phys. 1993, 97, 10269-10280; Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., Stewart, J.J., AMI, P., A new general purpose quantum mechanical molecular odel (1985) J. Am. Chem. Soc, 107, pp. 3902-3909; Aleman, C., Canela, E.I., Franco, R., Orozco, M., A new strategy for the evaluation of force parameters from quantum mechanical computations (1991) J. Comput. Chem, 12, pp. 664-674; The hydrated systems were subjected to 4000 cycles of energy minimization of water hydrogens; (ii) 4000 cycles of energy minimization of all water molecules; (iii) 2000 cycles of energy minimization of the entire system except the protein; (iv) 2000 cycles of energy minimization of waters, counterions, inhibitor, and all residues lining the ATP binding site (group 1), i.e., residues 27-89, 102-120, 129-190, 193-194, 200-202, 204-209, 211-213, 215-216, 221, 228, and 318-331. The optimized systems were thermalized by increasing the temperature from 150 to 300 K in four steps during 50 ps. They were then equilibrated for 100 ps at constant temperature (T = 300 K). Water, inhibitor, counterions, and all the residues in group 1 were allowed to move during the trajectories; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J. Comput. Phys, 23, pp. 327-341; Geometries were optimised at the HF/6-31.G* level, and energy was computed at the MP2/6-311++G(d) and MP4/6-31G(d) level for the unsubstituted bicycle (see Figure 2). In the case of compound 13, the ONIOM procedure was applied (ref 32), representing the central bicycle as the higher layer at the MP4/6-31G* level and the rest of the molecule at the HF/6-31G* level (see Figure 2); Dapprich, S., Komaromi, I., Byun, K.S., Morokuma, K., Frisch, M.J., A new ONIOM implementation in Gaussian 98. Part I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives (1999) THEOCHEM, 461, pp. 1-21; Orozco, M., Luque, J.L., Theoretical study of the tautomerism and protonation of 7-aminopyrazolopyrimidine in the gas phase and in aqueous solution (1995) J. Am. Chem. Soc, 117, pp. 1378-1386; Orozco, M., Canela, E.I., Mallol, J., Lluis, C., Franco, R., Ab initio study of the protonation and the tautomerism of the 7-aminopyrazolopyrimidine molecule (1990) J. Org. Chem, 55, pp. 753-756; Curutchet, C., Orozco, M., Luque, F.J., Solvation in octanol: Parametrization of the continuum MST model (2001) J. Comput. Chem, 22, pp. 1180-1193; Miertus, S., Tomasi, J., Aproximate evaluations of the electrostatic free energy and internal energy changes in solution processes (1982) Chem. Phys, 65, pp. 239-245; Frisch, M. J, Trucks, G. W, Schlegel, H. B, Scuseria, G. E, Robb, M. A, Cheeseman, J. R, Zakrzewski, V. G, Montgomery, J. A, Jr, Stratmann, R. E, Burant, J. C, Dapprich, S, Millam, J. M, Daniels, A. D, Kudin, K. N, Strain, M. C, Farkas, O, Tomasi, J, Barone, V, Cossi, M, Cammi, R, Mennucci, B, Pomelli, C, Adamo, C, Clifford, S, Ochterski, J, Petersson, G. A, Ayala, P. Y, Cui, Q, Morokuma, K, Malick, D. K, Rabuck, A. D, Raghavachari, K, Foresman, J. B, Cioslowski, J, Ortiz, J. V, Baboul, A. G, Stefanov, B. B, Liu, G, Liashenko, A, Piskorz, P, Komaromi, I, Gomperts, R, Martin, R. L, Fox, D. J, Keith, T, Al-Laham, M. A, Peng, C. Y, Nanayakkara, A, Gonzalez, C, Challacombe, M, Gill, P. M. W, Johnson, B, Chen, W, Wong, M. W, Andres, J. L, Gonzalez, C, Head-Gordon, M, Replogle, E. S, Pople, J. A. Gaussian 98, rev. A.7, Gaussian, Inc, Pittsburgh, PA, 1998; Peterson, M.; Poirier, R. MonsterGauss; Department of Biochemistry, University of Toronto: Toronto, Canada: version modified by Cammi, R. and Tomasi, J., 1987, and by Luque, F. J. and Orozco, M., 2004; Kalko, S.G., Luque, F.J., Orozco, M., (2002) UBEXTRACT Program, , University of Barcelona: Barcelona, Spain; Soliva, R., Almansa, C., Kalco, S.G., Luque, F.J., Orozco, M., Theoretical studies of the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? (2003) J. Med. Chem, 46, pp. 1372-1382; Mehler, E.L., Solmajer, T., Electrostatic effects in proteins: Comparison of dielectric and charge models (1991) Protein Eng, 4, pp. 903-910; The dehydration particle is a simple cubic particle (1 Å3 in this work) which is assumed to remove water in its environment. The desolvation penalty is then determined by integrating the solvation density as computed by the SEDO version of the Poisson-Boltzmann method see ref 43; Arora, N., Bashford, D., Solvation energy density occlusion approximation for evaluation of desolvation penalties in biomolecular interactions (2001) Proteins, 43, pp. 12-27; Protein Data Bank, , http://www.rcsb.org/pdb; Scapin, G., Patel, S.B., Lisnock, J., Becker, J.W., LoGrasso, P.V., The structure of JNK3 in complex with small molecule inhibitors: Structural basis for potency and selectivity (2003) Chem. Biol, 10, pp. 705-712; Colominas, C., Luque, F.J., Orozco, M., Tautomerism and protonation of guanine and cytosine. Implications in the formation of triplex DNA (1996) J. Am. Chem. Soc, 118, pp. 6811-6821; Trygubenko, S.A., Bogdan, T.V., Sponer, J., Rueda, M., Orozco, M., Luque, F.J., Slavíek, P., Hobza, P., Correlated ab initio study of nucleic acid bases and their tautomers in the gas phase and aqueous solition.1. Cytosine (2002) Phys. Chem Chem. Phys, 4, pp. 4192-4203; Ribas, J., Cubero, E., Luque, F.J., Orozco, M., Theoretical study of alkyl-PI and aryl-PI interactions. Reconciling theory and experiment (2002) J. Org. Chem, 67, pp. 7057-7065; Tsuzuki, S., Honda, K., Uchimaru, T., Mikami, M., Tanabe, K., Origin of the attraction and directionality of the NH/PI interaction: Comparison with the OH/PI and CH/PI interactions (2000) J. Am. Chem. Soc, 122, p. 11450; Gum, R.J., McLaughlin, M.M., Kumar, S., Wang, Z., Bower, M.J., Lee, J.C., Adams, J.L., Young, P.R., Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB203580, by alteration of one or more amino acids within the ATP binding pocket (1998) J. Biol. Chem, 273, pp. 15605-15610; Young, P.R., McLaughlin, M.M., Kumar, S., Kassis, S., Doyle, M.L., McNulty, D., Gallagher, T.F., Lee, J.C., Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site (1997) J. Biol. Chem, 272, pp. 12116-12121; The experimental relative free energies of binding were approximated based on the IC50s of compound 13 and its derivatives by ΔΔ GBinding A-B = RT ln(IC50 A/IC50 B); Dominguez, C., Tamayo, N., Zhang, D., P38 inhibitors: Beyond pyridinylimidazoles (2005) Expert Opin. Ther. Patents, 15, pp. 801-816","Orozco, M.; Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"American Chemical Society",,,,,00222623,,JMCMA,"17228870","English","J. Med. Chem.",Article,"Final",,Scopus,2-s2.0-33846404143
"Rueda M., Ferrer-Costa C., Meyer T., Pérez A., Camps J., Hospital A., Gelpi J.L., Orozco M.","35518639700;8866407700;55913919700;35764684500;57198367291;15831739300;35517522400;7102809158;","A consensus view of protein dynamics",2007,"Proceedings of the National Academy of Sciences of the United States of America","104","3",,"796","801",,138,"10.1073/pnas.0605534104","https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846512402&doi=10.1073%2fpnas.0605534104&partnerID=40&md5=667e70db5e30b3d47d24c919c5462e74","Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain; Structural Biology Node, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain; Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universität de Barcelona, Avgda Diagonal 645, 08028 Barcelona, Spain","Rueda, M., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Ferrer-Costa, C., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Meyer, T., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universität de Barcelona, Avgda Diagonal 645, 08028 Barcelona, Spain; Pérez, A., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Camps, J., Structural Biology Node, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Hospital, A., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Structural Biology Node, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain; Gelpi, J.L., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universität de Barcelona, Avgda Diagonal 645, 08028 Barcelona, Spain; Orozco, M., Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Structural Biology Node, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain, Computational Biology Program, Barcelona Supercomputing Center, Edifici Nexus II, Jordi Girona 31, 08028 Barcelona, Spain, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universität de Barcelona, Avgda Diagonal 645, 08028 Barcelona, Spain","The dynamics of proteins in aqueous solution has been investigated through a massive approach based on ""state of the art"" molecular dynamics simulations performed for all protein metafolds using the four most popular force fields (OPLS, CHARMM, AMBER, and GROMOS). A detailed analysis of the massive database of trajectories (>1.5 terabytes of data obtained using ≈50 years of CPU) allowed us to obtain a robust-consensus picture of protein dynamics in aqueous solution. © 2007 by The National Academy of Sciences of the USA.","Force field; Molecular dynamics; Molecular modeling; Protein structure","aqueous solution; article; consensus; molecular dynamics; priority journal; protein conformation; protein folding; protein protein interaction; protein structure; Computational Biology; Computer Simulation; Crystallography, X-Ray; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Protein Conformation; Protein Folding; Proteins",,"Proteins",,,,,,,"Waldron, T.T., Murphy, K.P., (2003) Biochemistry, 42, pp. 5058-5064; Lee-Wei, Y., Bahar, I., (2005) Structure (London), 13, pp. 893-904; Sacquin-Mora, S., Lavery, R., (2006) Biophys J, 90, pp. 2706-2717; Remy, I., Wilson, I.A., Michnick, S.W., (1999) Science, 283, pp. 990-993; McCammon, J.A., Gelin, B.R., Karplus, M., (1977) Nature, 267, pp. 585-590; Karplus, M., McCammon, J.A., (1986) Sci Am, 254, pp. 42-51; Allen, M.P., Tildesley, D.J., (1989) Computer Simulation of Liquids (Clarendon, Oxford); Brooks III, C.L., Karplus, M., Pettitt, B.M., (1987) Proteins: A theoretical Perspective of Dynamics, Structure and Thermodynamics, , Cambridge Univ Press, Cambridge, UK; Warshel, A., (1976) Nature, 260, pp. 679-683; Ponder, J.W., Case, D.A., (2003) Adv Protein Chem, 66, pp. 27-85; van Gunsteren, W.F., Berendsen, H.J., Hermans, J., Hol, W.G., Postma, J.P., (1983) Proc Natl Acad Sci USA, 80, pp. 4315-4319; Tirado-Rives, J., Jorgensen, W.L., (1991) Biochemistry, 30, pp. 3864-3871; Tirado-Rives, J., Jorgensen, W.L., (1990) J Am Chem Soc, 112, pp. 2773-2781; Karplus, M., McCammon, J.A., (2002) Nat Struct Biol, 9, pp. 646-652; Karplus, M., Kuriyan, J., (2005) Proc Natl Acad Sci USA, 102, pp. 6679-6685; Weiner, S.J., Kollman, P.A., Case, D.A., Singh, U.C., Ohio, C., Alagona, G., Profeta Jr, S., Weiner, P., (1984) J Am Chem Soc, 106, pp. 765-784; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz Jr, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J Am Chem Soc, 117, pp. 5179-5197; MacKerell Jr, A.D., Bashford, D., Bellott, M., Dunbrack, R.L., Evanseck, J.D., Field, M.J., Fischer, S., Ha, S., (1998) J Phys Chem B, 102, pp. 3586-3616; MacKerell Jr, A.D., Wiorkiewicz-Kuczera, J., Karplus, M., (1995) J Am Chem Soc, 117, pp. 11946-11975; Damm, W., Frontera, A., Tirado-Rives, J., Jorgensen, W.L., (1997) J Comput Chem, 18, pp. 1955-1970; Jorgensen, W.L., Maxwell, D.S., Tirado-Rives, J., (1996) J Am Chem Soc, 118, pp. 11225-11236; Kaminski, G., Duffy, E.M., Matsui, T., Jorgensen, W.L., (1994) J Phys Chem, 98, pp. 13077-13082; Kaminski, G.A., Friesner, R.A., Tirado-Rives, J., Jorgensen, W.L., (2001) J Phys Chem B, 105, pp. 6474-6487; Ott, K.-H., Meyer, B., (1996) J Comput Chem, 17, pp. 1068-1084; Hermans, J., Berendsen, H.J.C., Van Gunsteren, W.F., Postma, J.P.M., (1984) Biopolymers, 23, pp. 1513-1518; Zhou, Y., Vitkup, D., Karplus, M., (1999) J Mol Biol, 285, pp. 1371-1375; Lindorff-Larsen, K., Best, R.B., Depristo, M.A., Dobson, C.M., Vendruscolo, M., (2005) Nature, 433, pp. 128-132; Perez, A., Bias, J.R., Rueda, M., López-Bes, J.M., de La Cruz, X., Luque, F.J., Orozco, M., (2005) J Chem Theory Comput, 1, pp. 790-800; Strop, P., Mayo, S.L., (2000) Biochemistry, 39, pp. 1251-1255; Andreeva, A., Howorth, D., Brenner, S.E., Hubbard, T.J., Chothia, C., Murzin, A.G., (2004) Nucleic Acids Res, 32, pp. D226-D229; Murzin, A.G., Brenner, S.E., Hubbard, T., Chothia, C., (1995) J Mol Biol, 247, pp. 536-540; Pearl, F., Todd, A., Sillitoe, I., Dibley, M., Redfern, O., Lewis, T., Bennett, C., Lee, D., (2005) Nucleic Acids Res, 33, pp. D247-D251; Dietmann, S., Park, J., Notredame, C., Heger, A., Lappe, M., Holm, L., (2001) Nucleic Acids Res, 29, pp. 55-57; Holm, L., Sander, C., (1995) Trends Biochem Sci, 20, pp. 478-480; Day, R., Beck, D.A., Armen, R.S., Daggett, V., (2003) Protein Sci, 12, pp. 2150-2160; Darden, T.L., York, D., Pedersen, L., (1993) J Chem Phys, 98, pp. 10089-10092; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., (1977) J Comput Phys, 23, pp. 327-341; Andersen, H.C., (1983) J Comput Phys, 52, pp. 24-34; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., (1983) J Chem Phys, 79, pp. 926-935; Mahoney, M.W., Jorgensen, W.L., (2000) J Chem Phys, 112, pp. 8910-8922; Berendsen, H.J.C., Postma, J.P.M., van Gunsteren, W.F., Hermans, J., (1981) Intermolecular Forces, p. 331. , ed Pullman B Reidel, Dordrecht, The Netherlands, pp; Case DA, Pearlman DA, Caldwell JW, Cheatham TE, III, Ross WS, Simmerling CL, Darden TL, Marz KM, Stanton RV, Cheng AL, et al. (2004) AMBER 8 (University of California, San Francisco); Kale, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., Phillips, J., Schulten, K., (1999) J Comput Phys, 151, pp. 283-312; Phillips, J.C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Schulten, K., (2005) J Comput Chem, 26, pp. 1781-1802; Berendsen, H.J.C., van der Spoel, D., van Drunen, R., (1995) Comput Phys Commun, 91, pp. 43-56; Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A.E., Berendsen, H.J., (2005) J Comput Chem, 26, pp. 1701-1718; Tirado-Rives, J., Orozco, M., Jorgensen, W.L., (1997) Biochemistry, 36, pp. 7313-7329; Caballero-Herrera, A., Nilsson, A., (2006) J Mol Struct, 758, pp. 139-148; Zhang, Y., Skolnick, J., (2004) Proteins, 57, pp. 702-710; Hubbard SJ, Thornton JM (1993) NACCESS (Dept of Biochemistry and Molecular Biology, University College, London); Kabsch, W., Sander, C., (1983) Biopolymers, 22, pp. 2577-2637; Laskowski, R.A., MacArthur, M.W., Moss, D.S., Thornton, J.M., (1993) J Appl Crystallogr, 26, pp. 283-291; Morris, A.L., MacArthur, M.W., Hutchinson, E.G., Thornton, J.M., (1992) Proteins, 12, pp. 345-364; Amadei, A., Linssen, A.B., Berendsen, H.J., (1993) Proteins, 17, pp. 412-425; Harris, S.A., Gavathiotis, E., Searle, M.S., Orozco, M., Laughton, C.A., (2001) J Am Chem Soc, 123, pp. 12658-12663; Schlitter, J., (1993) Chem Phys Lett, 215, pp. 617-621; Andricioaei, I., Karplus, M., (2001) J Chem Phys, 115, pp. 6289-6292; Hess, B., (2000) Phys Rev E Stat Nonlin Soft Matter Phys, 62, pp. 8438-8448","Orozco, M.; Molecular Modelling and Bioinformatics Unit, Institut de Recerca Biomèdica, Parc Cientific de Barcelona, Josep Samitier 1-5, 08028 Barcelona, Spain; email: modesto@mmb.pcb.ub.es",,,,,,,,00278424,,PNASA,"17215349","English","Proc. Natl. Acad. Sci. U. S. A.",Article,"Final",Open Access,Scopus,2-s2.0-33846512402
"Talavera D., Morreale A., Meyer T., Hospital A., Ferrer-Costa C., Gelpi J.L., De La Cruz X., Soliva R., Luque F.J., Orozco M.","6603113545;7006977091;55913919700;15831739300;8866407700;35517522400;6603686486;6602492780;23025357900;7102809158;","A fast method for the determination of fractional contributions to solvation in proteins",2006,"Protein Science","15","11",,"2525","2533",,2,"10.1110/ps.062406706","https://www.scopus.com/inward/record.uri?eid=2-s2.0-33751083105&doi=10.1110%2fps.062406706&partnerID=40&md5=86bf14e4cf502134e5293ef88f2e1645","Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain; Unidad de Bioinformática, Centro Biología Molecular Severo Ochoa, Campus de Cantoblanco, Madrid 28049, Spain; Departament de Bioquímica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona 08028, Spain; Institució Catalana Per la Recerca I Estudis Avançats (ICREA), Barcelona 08018, Spain; Drug Discovery, J. Uriach Y Compañía, Barcelona 08184, Spain; Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Barcelona 08028, Spain; Nodo de Estructura Y Modelización, Instituto Nacional de Bioinformática, Fundación Genoma España, Madrid 28020, Spain; Computational Biology Program, Barcelona Supercomputing Center, Barcelona 08034, Spain; Molecular Modeling and Bioinformatics Unit, Institut de Rercerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","Talavera, D., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain; Morreale, A., Unidad de Bioinformática, Centro Biología Molecular Severo Ochoa, Campus de Cantoblanco, Madrid 28049, Spain; Meyer, T., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain; Hospital, A., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain; Ferrer-Costa, C., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain; Gelpi, J.L., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain, Departament de Bioquímica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona 08028, Spain, Computational Biology Program, Barcelona Supercomputing Center, Barcelona 08034, Spain; De La Cruz, X., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain, Institució Catalana Per la Recerca I Estudis Avançats (ICREA), Barcelona 08018, Spain; Soliva, R., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain, Drug Discovery, J. Uriach Y Compañía, Barcelona 08184, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Barcelona 08028, Spain; Orozco, M., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomèdica, Barcelona 08028, Spain, Departament de Bioquímica I Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona 08028, Spain, Nodo de Estructura Y Modelización, Instituto Nacional de Bioinformática, Fundación Genoma España, Madrid 28020, Spain, Computational Biology Program, Barcelona Supercomputing Center, Barcelona 08034, Spain, Molecular Modeling and Bioinformatics Unit, Institut de Rercerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","A fast method for the calculation of residue contributions to protein solvation is presented. The approach uses the exposed polar and apolar surface of protein residues and has been parametrized from the fractional contributions to solvation determined from linear response theory coupled to molecular dynamics simulations. Application of the method to a large subset of proteins taken from the Protein Data Bank allowed us to compute the expected fractional solvation of residues. This information is used to discuss when a residue or a group of residues presents an uncommon solvation profile. Published by Cold Spring Harbor Laboratory Press. Copyright © 2006 The Protein Society.","Molecular dynamics; Protein solvation; Protein stability; Protein structure","alanine; arginine; asparagine; aspartic acid; cysteine; glutamic acid; glutamine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; article; data base; molecular dynamics; priority journal; protein analysis; protein determination; protein stability; solvation",,"alanine, 56-41-7, 6898-94-8; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; asparagine, 70-47-3, 7006-34-0; aspartic acid, 56-84-8, 6899-03-2; cysteine, 4371-52-2, 52-89-1, 52-90-4; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glutamine, 56-85-9, 6899-04-3; glycine, 56-40-6, 6000-43-7, 6000-44-8; histidine, 645-35-2, 7006-35-1, 71-00-1; isoleucine, 7004-09-3, 73-32-5; leucine, 61-90-5, 7005-03-0; lysine, 56-87-1, 6899-06-5, 70-54-2; methionine, 59-51-8, 63-68-3, 7005-18-7; phenylalanine, 3617-44-5, 63-91-2; proline, 147-85-3, 7005-20-1; serine, 56-45-1, 6898-95-9; threonine, 36676-50-3, 72-19-5; tryptophan, 6912-86-3, 73-22-3; tyrosine, 16870-43-2, 55520-40-6, 60-18-4; valine, 7004-03-7, 72-18-4",,,,,,,"Aqvist, J., Ion water interaction potentials derived from free-energy perturbation simulations (1990) J. Phys. Chem., 94, pp. 8021-8024; Aqvist, J., Hansson, T., Validity of electrostatic linear response in polar solvents (1996) J. Phys. Chem., 100, pp. 9512-9521; Aqvist, J., Medina, C., Samuelsson, J.E., A new method for predicting binding affinity in computer-aided drug design (1994) Protein Eng., 7, pp. 385-391; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The Protein Data Bank (2000) Nucleic Acids Res., 28, pp. 235-242; Böttcher, C.J.F., (1952) Theory of Electrostatic Polarisation, , Elsevier, Amsterdam; Carlson, H.A., Jorgensen, W.L., An extended linear response method for determining free energies of hydration (1995) J. Phys. Chem., 99, pp. 10667-10673; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids and organic molecules (1995) J. Am. Chem. Soc., 117, pp. 5179-5197; Cramer, C.J., Truhlar, D.F., Implicit solvation models: Equilibria, structure, spectra and dynamics (1999) Chem. Rev., 99, pp. 2161-2200; Darden, T.A., York, D.M., Pedersen, L.G., Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems (1993) J. Chem. Phys., 98, pp. 10089-10092; Davis, M.E., McCammon, J.A., Electrostatics in biomolecular structure and dynamics (1990) Chem. Rev., 90, pp. 509-521; Gelpi, J.L., Kalko, S.G., Barril, X., Cirera, J., De La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Gilson, M.K., Honig, B., Calculation of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies and conformational analysis (1988) Proteins, 4, pp. 7-18; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J. Chem. Phys., 79, pp. 926-935; King, U., Warshel, A., Investigation of the free-energy functions for electron-transfer reactions (1990) J. Chem. Phys., 93, pp. 8682-8692; Kong, Y.S., Warshel, A., Linear free energy relationships with quantum mechanical corrections: Classical and quantum mechanical rate constants for hydride transfer between NAD+ analogs in solution (1995) J. Am. Chem. Soc., 117, pp. 6234-6242; Lee, F.S., Chu, Z.T., Bolger, M.B., Warshel, A., Calculations of antibody-antigen interactions: Microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603 (1992) Protein Eng., 5, pp. 215-228; Lee, F.S., Chu, Z.T., Warshel, A., Microscopic and semimicroscopic calculations of electrostatic energies in proteins by the POLARIS and ENZYMIX programs (1993) J. Comput. Chem., 14, pp. 161-185; Luque, F.J., Bofill, J.M., Orozco, M., New strategies to incorporate the solvent polarization in self-consistent reaction field and free-energy perturbation simulations (1995) J. Chem. Phys., 103, pp. 10183-10191; Luque, F.J., Curutchet, C., Muñoz-Muriedas, J., Bidon-Chanal, A., Soteras, I., Morreale, A., Gelpí, J.L., Orozco, M., Continuum solvation models: Dissecting the free energy of solvation (2003) Phys. Chem. Chem. Phys., 5, pp. 3827-3836; Morreale, A., Gelpí, J.L., Luque, F.J., Orozco, M., Continuum and discrete calculation of fractional contributions to solvation free energy (2003) J. Comput. Chem., 24, pp. 1610-1623; Morreale, A., De La Cruz, X., Meyer, T., Gelpí, J.L., Luque, F.J., Orozco, M., Linear response theory: An alternative to PB and GB methods for the analysis of molecular dynamics trajectories? (2004) Proteins, 57, pp. 458-467; Morreale, A., De La Cruz, X., Meyer, T., Gelpí, J.L., Luque, F.J., Orozco, M., Partition of protein solvation into group contributions from molecular dynamics simulations (2005) Proteins, 58, pp. 101-109; Muñoz, J., Barril, X., Hernández, B., Orozco, M., Luque, F.J., Hydrophobic similarity between molecules: A MST-based hydrophobic similarity index (2002) J. Comput. Chem., 23, pp. 554-563; Orozco, M., Luque, F.J., Generalized linear response approximation in discrete methods (1997) Chem. Phys. Lett., 265, pp. 473-480; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem. Rev., 100, pp. 4187-4225; Orozco, M., Luque, F.J., Habibolahzadeh, D., Gao, J., The polarization contribution to the free energy of hydration (1995) J. Chem. Phys., 102, pp. 6145-6152; Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham, T.E., DeBolt, S., Ferguson, D., Kollman, P.A., AMBER: A package of computer programs for applying molecular mechanics normal mode analysis molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules (1995) Comput. Phys. Commun., 91, pp. 1-41; Pierce, A.C., Jorgensen, W.L., Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations (2001) J. Med. Chem., 44, pp. 1043-1050; Rivail, J.L., Rinaldi, D., Liquid-state quantum chemistry. Computational applications of the polarizable continuum models (1995) Computational Chemistry Reviews of Current Trends, pp. 139-174. , (ed. J. Leszczynski), World Scientific, Singapore; Roux, B., Yu, H.A., Karplus, M., Molecular basis for the Born model of ion solvation (1990) J. Phys. Chem., 94, pp. 4683-4688; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J. Comput. Phys., 23, pp. 327-341; Shoichet, B.K., Baase, W.A., Kuroki, R., Matthews, B.W., A relationship between protein stability and protein function (1995) Proc. Natl. Acad. Sci., 92, pp. 452-456; Still, W.C., Tempczyk, A., Hawley, R.C., Hendrickson, T., Semi-analytical treatment of solvation for molecular mechanics and dynamics (1990) J. Am. Chem. Soc., 112, pp. 6127-6129; Tomasi, J., Persico, M., Molecular interactions in solution: An overview of methods based on continuous distributions of the solvent (1994) Chem. Rev., 94, pp. 2027-2094; Warshel, A., Russell, S.T., Calculations of electrostatic interactions in biological systems and in solutions (1984) Q. Rev. Biophys., 17, pp. 283-422; Wesolowski, S.S., Jorgensen, W.L., Estimation of binding affinities for celecoxib analogues with COX-2 via Monte Carlo-extended linear response (2002) Bioorg. Med. Chem. Lett., 12, pp. 267-270","Orozco, M.; Molecular Modeling and Bioinformatics Unit, Institut de Rercerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"Cold Spring Harbor Laboratory Press",,,,,09618368,,PRCIE,"17001031","English","Protein Sci.",Article,"Final",,Scopus,2-s2.0-33751083105
"Martinez A., Alonso M., Castro A., Dorronsoro I., Gelpí J.L., Luque F.J., Pérez C., Moreno F.J.","7404025454;57210540492;7402832250;7003794320;35517522400;23025357900;56220726900;7202722573;","SAR and 3D-QSAR studies on thiadiazolidinone derivatives: Exploration of structural requirements for glycogen synthase kinase 3 inhibitors",2005,"Journal of Medicinal Chemistry","48","23",,"7103","7112",,94,"10.1021/jm040895g","https://www.scopus.com/inward/record.uri?eid=2-s2.0-28544449332&doi=10.1021%2fjm040895g&partnerID=40&md5=77f712104e7b747b43fd2a61980927cd","Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Centro de Biología Molecular Severe Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Química, Universidad de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Departamento de Fisicoquímica, Facultad de Farmacia, Universidad de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain","Martinez, A., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain, NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain; Alonso, M., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain, NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain; Castro, A., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain, NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain; Dorronsoro, I., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain, NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain; Gelpí, J.L., Departamento de Bioquímica y Biología Molecular, Facultad de Química, Universidad de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Luque, F.J., Departamento de Fisicoquímica, Facultad de Farmacia, Universidad de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; Pérez, C., Instituto de Química Médica (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain; Moreno, F.J., Centro de Biología Molecular Severe Ochoa (CSIC-UAM), Universidad Autónoma de Madrid, 28049 Madrid, Spain","The 2,4-disubstituted thiadiazolidinones (TDZD) are described as the first ATP-noncompetitive GSK-3 inhibitors. Following an SAR study about TDZD, different structural modifications in the heterocyclic ring aimed to test the influence of each heteroatom on the biological study are here reported here. Various compounds such as hydantoins, dithiazolidindiones, rhodanines, maleimides, and triazoles were synthesized and screened as GSK-3 inhibitors. After an extensive SAR study among these different heterocyclic families, TDZDs have been revealed as a privileged scaffold for the selective inhibition of GSK-3. A CoMFA analysis was also performed highlighting the molecular electrostatic field interaction in the interaction of TDZDs with GSK-3. Moreover, first mapping studies indicate two binding modes which in turn might imply relevant differences in the mechanism that underly the inhibitory activity of TDZDs. © 2005 American Chemical Society.",,"adenosine triphosphate; carbonyl derivative; cyclic AMP dependent protein kinase; cyclin B; glycogen synthase kinase 3; glycogen synthase kinase 3 inhibitor; hydantoin derivative; hymenialdisine; indirubin; indole derivative; maleimide derivative; nitrogen; paullone derivative; protein kinase C; rhodanine; sulfur; thiadiazole derivative; thiazolidine derivative; triazole derivative; unclassified drug; Alzheimer disease; article; drug structure; enzyme inhibition; quantitative structure activity relation; structure activity relation; X ray crystallography; Binding Sites; Glycogen Synthase Kinase 3; Hydantoins; Maleimides; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Rhodanine; Structure-Activity Relationship; Thiadiazoles",,"adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; indirubin, 479-41-4; nitrogen, 7727-37-9; protein kinase C, 141436-78-4; rhodanine, 141-84-4; sulfur, 13981-57-2, 7704-34-9; Glycogen Synthase Kinase 3, EC 2.7.1.37; Hydantoins; Maleimides; Rhodanine, 141-84-4; Thiadiazoles",,,,,,,"Wauwe, J.V., Haefner, B., Glycogen synthase kinase-3 as drug target: From wallflower to center of attention (2003) Drug New Perspect., 16, pp. 557-565; Cohen, P., Goedert, M., GSK-3 inhibitors: Development and therapeutic potential (2004) Nat. Rev. Drug Discovery, 3, pp. 479-487; Kaidanovich, O., Eldar-Finkelman, H., The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes (2002) Expert Opin. Ther. Targets, 6, pp. 555-561; Grimes, C.A., Jope, R.S., The multifaceted roles of glycogen synthase kinase 3beta in cellular signalling (2001) Prog. Neurobiol., 65, pp. 391-426; Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., Woodgett, J., Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes (2000) Nature, 406, pp. 86-90; Martinez, A., Castro, A., Dorronsoro, I., Alonso, M., Glycogen synthase kinase 3 inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflamation (2002) Med. Res. Chem., 22, pp. 373-384; Dorronsoro, I., Castro, A., Martinez, A., Inhibitors of glycogen synthase kinase-3: Future therapy for unmet medical needs? (2002) Expert Opin. Ther. Pat., 12, pp. 1527-1536; Meijer, L., Thunnissen, A.M., White, A.W., Garnier, M., Nikolic, M., Tsai, L.H., Walter, J., Pettit, G.R., Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenaldisine, a marine sponge constituent (2000) Chem. Biol., 7. , 51-63.20; Leost, M., Schultz, C., Link, A., Wu, Y.Z., Biernat, J., Mandelkow, E.M., Bibb, J.A., Meijer, L., Paullones are potent inhibitors of glycogen synthase kinase-Sbeta and cyclin-dependent kinase 5/p25 (2000) Eur. J. Biochem., 267, pp. 5983-5994; Leclerc, S., Garnier, M., Hoessel, R., Marko, D., Bibb, J.A., Snyder, G.L., Greengard, P., Meijer, L., Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors (2001) J. Biol. Chem., 276, pp. 251-260; Smith, D.G., Buffet, M., Fenwick, A.E., Haigh, D., Ife, R.J., Saunders, M., Slingsby, B.P., Ward, R.W., 3-Anilino-4-arylmaleimides: Potent and selective inhibitors of Glycogen synthase kinase-3 (GSK-3) (2001) Bioorg. Med. Chem. Lett., 11, pp. 635-639; Martinez, A., Alonso, M., Castro, A., Perez, C., Moreno, F.J., First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease (2002) J. Med. Chem., 45, pp. 1292-1299; Ter Haar, E., Coll, J.T., Austen, D.A., Hsiao, H.M., Swenson, L., Jain, J., Structure of GSK-3beta reveals a primed phosphorylation mechanism (2001) Nat. Struct. Biol., 8, pp. 593-596; Dajani, R., Fraser, E., Roe, S.M., Young, N., Good, V., Dale, T.C., Pearl, L.H., Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition (2001) Cell, 705, pp. 721-732; Bertrand, J.A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H.M., Flocco, M., Structural characterization of the GSK-3 active site using selective and nonselective ATP-mimetic inhibitors (2003) J. Mol. Biol., 33, pp. 393-407; Bhat, R., Xue, Y., Berg, S., Hellberg, S., Ormo, M., Nilsson, Y., Radesater, A.C., Avila, J., Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 (2003) J. Biol. Chem., 278, pp. 45937-45945; Meijer, L., Skaltsounis, A.L., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X.P., Greengard, P., GSK-3 selective inhibitors derived from Tyrian purple indirubins (2003) Chem. Biol., 10, pp. 1255-1266; Polychronopoulos, P., Magiatis, P., Skaltsounis, A., Myrianthopoulos, V., Mikros, E., Tarricone, A., Musacchio, A., Meijer, L., Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases (2004) J. Med. Chem., 47, pp. 935-946; Alonso, M., Martínez, A., GSK-3 inhibitors: Discoveries and developments (2004) Curr. Med. Chem., 11, pp. 753-761; Cramer III, R.D., Patterson, D.E., Bunce, J.D., Comparative molecular field analysis (ComFA). 1. Effect of shape on binding of steroids to carrier proteins (1988) J. Am. Chem. Soc., 770, pp. 5959-5967; Walker, A.M., A high yielding synthesis of N-alkyl maleimides using a novel modification of the mitsunobu reaction (1995) J. Org. Chem., 60, pp. 5352-5355; Zumach, G., Weiss, W., Kühle, E., (1966) Belgian Pat. 682820, , Farbenfabriken Bayer A. G., June; MacLauchlin, C., May, I.H., Izydore, R.A., Synthesis and Cytotoxic action of 1-Oxoalkyl and l,2-Dioxoalkyl-l,2,4- triazolidine-3,5-diones in Murine and Human tissue cultured Cells (1999) Arch. Pharm. Pharm. Med. Chem., 332, pp. 225-232; Hoshitsugu, A., Matsui, M., Fujii, A., Kontani, T., Koshiyuki, O., Koizumi, T., Shiro, M., Asymmetric Diels-Alder Reaction of optically active a-(2-exo-Hydroxy-O- bornyl)-sulfinylmaleimides and its applicattion to optically active 5-functionalized Pyrrolines via Retro-Diels-Alder Reaction (1994) J. Chem. Soc., Perkin. Trans. 1, pp. 25-39; Corrie, J.E.T., Thiol-reactive fluorescent probes for protein labelling (1994) J. Chem. Soc., Perkin. Trans, 1, pp. 2975-2982; Janda, K.D., Ashley, J.A., Jones, T.M., McLeod, D.A., Schloeder, D.M., Weinhous, M.I., Inmobilized catalytic antibodies in aqueous and organic solvents (1990) J. Am. Chem. Soc., 772, pp. 8886-8888; Foye, W.O., Tovivich, P., N-glucopyranosyl-5-aralkylidenerhodanines: Synthesis and antibacterial and antiviral activities (1977) J. Pharm. Sci., 66, pp. 1607-1611; Sudo, K., Matsumoto, Y., Matsushima, M., Fujiwara, M., Konno, K., Shimotohno, K., Shigeta, S., Yokota, T., Novel hepatitis C virus protease inhibitors: Thiazolidine derivatives (1997) Biochem. Biophys. Res. Commun., 238, pp. 643-647; Mishra, S., Srivastava, S.K., Srivastava, S.D., Synthesis of 5-arylidene-2-aryl-3-(phenothiazino/benzo- triazoloacetamidyl)-1,3-thiazolidine-4-ones as antiinflamatory, anticonvulsant, analgesic and antimicrobial agents (1997) Indian. J. Chem. Sect. B., 36, pp. 826-830; Peet, N.P., Genomics Research: Where are the drugs? (2000) Idrugs, 3, pp. 131-132; Gelpi, J.L., Kalko, S.G., Barril, X., Cirera, J., De La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Bertrand, J.A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H.M., Flocco, M., Structural characterization of the GSK-3β active site using selective and nonselectve ATP-mimetic inhibitors (2003) J. Mol. Biol., 333, pp. 393-407; Paul, N., Rognan, D., ConsDock: A new program for the consensus analysis of protein-ligand interactions (2002) Proteins, 47, pp. 521-533; Cohen, M.S., Zhang, C., Shokat, K.M., Taunton, J., Structural bioinformatics-based design of selective, irreversible kinase inhibitors (2005) Science, 308, pp. 1318-1321; Martin-Aparicio, E., Fuertes, A., Perez-Puerto, M.J., Perez, D., Alonso, M., Martinez, A., Medina, M., TDZDs: GSK-3 inhibitors as therapeutic agents for Alzheimer's disease and others tauopathies (2004) Neurobiol. Aging, 25, pp. S596; Girard, M.L., Dreux, C., Possibilités Réactionnelles et Structurales de dérivés de la Thiazolidine. I.-Addition, Substitution, Hydrolyse (1968) Bull. Soc. Chim. Fr., 3, pp. 3461-3468; Zumach, G., Weiss, W., Kühle, E., British Patent 1,136,737 (June, 1966) (1969) Chem. Abstr., 70, p. 7795; MacLauchlin, C., May, I.H., Izydore, R.A., Synthesis and cytotoxic action of 1-oxoalkyl and 1,2-dioxoalkyl-1,2,4- triazolidine-3,5-diones in murine and human tissue cultured cells (1999) Arch. Pharm. Pharm. Med. Chem., 332, pp. 225-232; Woodget, J.R., Use of peptide substrates for affinity purification of protein-serine kinases (1989) Anal. Biochem., 180, pp. 237-241; Parker, G.J., Law, T.L., Lenoch, F.J., Bolger, R.E., Development of High Through-put screening assays using fluorescence polarization: Nuclear receptor-ligand-binding and kinase*/phosphatase assays (2000) J. Biomol. Screen., 5, pp. 77-88; Lengyel, I., Nairn, A.C., Mc Cluskey, A., Toth, B., Penke, B., Rostas, J.A.P., Auto-inhibition of Ca2+/calmodulin-dependent protein kinase II by its ATP-binding domain (2001) J. Neurochem., 76, pp. 1066-1072; Carpenter, G., King, L., Cohen, S., Rapid enhancement of protein phosphorylation in A-431 cell membrane preparation by epidermal growth factor (1979) J. Biol. Chem., 254, pp. 4884-4891; Al-Hasani, H., Pablack, W., Klein, H.W., Phosphoryl exchange is involved in the mechanism of the insulin receptor kinase (1994) FEBS Lett., 349, pp. 17-22; Robbins, D.J., Zhen, E., Owaki, H., Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro (1993) J. Biol. Chem., 26, pp. 5097-5106; Williams, D.H., Wilkinson, S.E., Purton, T., Lamont, A., Flotow, A., Murray, E.J., Ro 09-2210 exhibits potent anti-proliferative effects on activated T cells by selectively blocking MKK activity (1998) Biochemistry, 37, pp. 9579-9585; Cheng, H.C., Nishio, H., Hatase, O., Ralph, S., Wang, J.H., A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of Src-family tyrosine kinases (1992) J. Biol. Chem., 13, pp. 9248-9256; Gastaiger, J., Marsili, M., Iterative partial equalization of orbital electronegativity-rapid access to atomic charges (1980) Tetrahedron, 36, pp. 3219-3228; Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., Stewart, J.J., AM1: A new general purpose quantum mechanical molecular model (1985) J. Am. Chem. Soc., 707, pp. 3902-3909; Stewart, J.J., MOPAC: A semiempirical molecular orbital program (1990) J. Comput.-Aided Mol. Des., 4, pp. 1-105; Gaillard, P., Carrupt, P.A., Testa, B., Boudon, A., Molecular lipophilicity potential, a tool in 3D QSAR: Method and applications (1994) J. Comput.-Aided Mol. Des., 8, pp. 83-96; SYBYL Molecular Modelling Package, Version 6.6, , Tripos St. Louis, MO; Mehler, E.L., Solmajer, T., Electrostatic effects in proteins: Comparison of dielectric and charge models (1991) Protein Eng., 4, pp. 903-910; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Fergurson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins nucleic acids and organic molecules (1995) J. Am. Chem. Soc., 117, pp. 5179-5197; Bayly, C.I., Cieplak, P., Cornell, W.D., Kollman, P.A., A well-behaved electrostatic potential based method using charge restraints from deriving atomic charges: The RESP model (1993) J. Phys. Chem., 97, pp. 10268-10280","Martinez, A.; NeuroPharma, S.A., Avda. de la Industria 52, 28760 Tres Cantos, Madrid, Spain; email: amartinez@neuropharma.es",,,,,,,,00222623,,JMCMA,"16279768","English","J. Med. Chem.",Article,"Final",,Scopus,2-s2.0-28544449332
"Ferrer-Costa C., Gelpí J.L., Zamakola L., Parraga I., de la Cruz X., Orozco M.","8866407700;35517522400;8866406800;24176336500;6603686486;7102809158;","PMUT: A web-based tool for the annotation of pathological mutations on proteins",2005,"Bioinformatics","21","14",,"3176","3178",,366,"10.1093/bioinformatics/bti486","https://www.scopus.com/inward/record.uri?eid=2-s2.0-25144496606&doi=10.1093%2fbioinformatics%2fbti486&partnerID=40&md5=0b0e00b00c9a45c3c424b44682aad633","Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Departament de Bioquímica i Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Instituto Nacional de Bioinformàtica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Institució Catalana per la Recerca i Estudis Avançats, Passeig Lluís Companys 23, 08018 Barcelona, Spain","Ferrer-Costa, C., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Gelpí, J.L., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Departament de Bioquímica i Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Zamakola, L., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Instituto Nacional de Bioinformàtica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Parraga, I., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Instituto Nacional de Bioinformàtica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; de la Cruz, X., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Institució Catalana per la Recerca i Estudis Avançats, Passeig Lluís Companys 23, 08018 Barcelona, Spain; Orozco, M., Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Departament de Bioquímica i Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain, Instituto Nacional de Bioinformàtica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","Summary: PMUT allows the fast and accurate prediction (∼80% success rate in humans) of the pathological character of single point amino acidic mutations based on the use of neural networks. The program also allows the fast scanning of mutational hot spots, which are obtained by three procedures: (1) alanine scanning, (2) massive mutation and (3) genetically accessible mutations. A graphical interface for Protein Data Bank (PDB) structures, when available, and a database containing hot spot profiles for all non-redundant PDB structures are also accessible from the PMUT server. © The Author 2005. Published by Oxford University Press. All rights reserved.",,"alanine; amino acid; protein; access to information; accuracy; article; artificial neural network; computer graphics; computer interface; computer prediction; controlled study; genetic analysis; human; Internet; mutational analysis; priority journal; protein analysis; Protein Data Bank; protein database; protein structure; amino acid substitution; artificial neural network; chemical model; chemical structure; chemistry; computer interface; computer program; computer simulation; Internet; methodology; sequence alignment; sequence analysis; site directed mutagenesis; Amino Acid Substitution; Computer Simulation; Internet; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Neural Networks (Computer); Proteins; Sequence Alignment; Sequence Analysis, Protein; Software; User-Computer Interface",,"alanine, 56-41-7, 6898-94-8; amino acid, 65072-01-7; protein, 67254-75-5; Proteins",,,"Instituto Nacional de Técnica Aeroespacial","This work has been supported by the Instituto Nacional de Bioin-formática (INB-Genoma España), Fundación Ramón-Areces and the",,,"Altschul, S.F., Gapped BLAST and PSI-BLAST: A new generation of protein database search programs (1997) Nucleic Acids Res., 25, pp. 3389-3402; Bateman, A., The Pfam protein families database (2002) Nucleic Acids Res., 30, pp. 276-280; Berman, H.M., The Protein Data Bank (2000) Nucleic Acids Res., 28, pp. 235-242; Chasman, D., Adams, R.M., Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation (2001) J. Mol. Biol., 307, pp. 683-706; Ferrer-Costa, C., Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties (2002) J. Mol. Biol., 315, pp. 771-786; Ferrer-Costa, C., Sequence-based prediction of pathological mutations (2004) Proteins, 57, pp. 811-819; Ferrer-Costa, C., Use of bioinformatics tools for the annotation of disease-associated mutations in animal models (2005) Proteins, , in press; Ng, P.C., Henikoff, S., Accounting for human polymorphisms predicted to affect protein function (2002) Genome Res., 12, pp. 436-446; Rost, B., Sander, C., Prediction of protein secondary structure at better than 70% accuracy (1993) J. Mol. Biol., 232, pp. 584-599; Saunders, C.T., Baker, D., Evaluation of structural and evolutionary contributions to deleterious mutation prediction (2002) J. Mol. Biol., 322, pp. 891-901; Sayle, R.A., Milner-White, E.J., RASMOL: Biomolecular graphics for all (1995) Trends Biochem. Sci., 20, p. 374; Sunyaev, S., Prediction of deleterious human alleles (2001) Hum. Mol. Genet., 10, pp. 591-597; Wang, Z., Moult, J., SNPs, protein structure, and disease (2001) Hum. Mutat., 17, pp. 263-270","Orozco, M.; Molecular Modeling and Bioinformatics Unit, Institut de Recerca Biomédica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"Oxford University Press",,,,,13674803,,BOINF,"15879453","English","Bioinformatics",Article,"Final",Open Access,Scopus,2-s2.0-25144496606
"Crespo A., Martí M.A., Kalko S.G., Morreale A., Orozco M., Gelpi J.L., Luque F.J., Estrin D.A.","7102210879;7103082873;6602247257;7006977091;7102809158;35517522400;23025357900;7005821604;","Theoretical study of the truncated hemoglobin HbN: Exploring the molecular basis of the NO detoxification mechanism",2005,"Journal of the American Chemical Society","127","12",,"4433","4444",,94,"10.1021/ja0450004","https://www.scopus.com/inward/record.uri?eid=2-s2.0-16244367739&doi=10.1021%2fja0450004&partnerID=40&md5=5e0f372311b4d34c2e22eb68d539de7b","Departamento de Quimica Inorganica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires (C1428EHA), Argentina; Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Bioinformatics Unit, IDIBAPS, c/Villaroel 170, 08036 Barcelona, Spain","Crespo, A., Departamento de Quimica Inorganica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires (C1428EHA), Argentina; Martí, M.A., Departamento de Quimica Inorganica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires (C1428EHA), Argentina; Kalko, S.G., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain, Bioinformatics Unit, IDIBAPS, c/Villaroel 170, 08036 Barcelona, Spain; Morreale, A., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Orozco, M., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Gelpi, J.L., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; Estrin, D.A., Departamento de Quimica Inorganica, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires (C1428EHA), Argentina","Mycobacterium tuberculosis is the causative agent of human tuberculosis. The nitric oxide reaction with oxy-truncated hemoglobin N (IrHbN) has been proposed to be responsible for the resistance mechanism by which this microorganism can evade the toxic effects of NO. In this work, we explore the molecular basis of the NO detoxification mechanism using a combination of classical and hybrid quantum-classical (QM-MM) simulation techniques. We have investigated the structural flexibility of the protein, the ligand affinity properties, and the nitric oxide reaction with coordinated O2. The analysis of the classical MD trajectory allowed us to identify Phe62 as the gate of the main channel for ligand diffusion to the active site. Moreover, the opening of the channel stems from the interplay between collective backbone motions and local rearrangements in the side chains of the residues that form the bottleneck of the tunnel. Even though the protein environment is not found to make a significant contribution to the heme moiety catalyzed reaction, the binding site influences the physiological function of the enzyme at three different levels. First, by isolating the intermediates formed in the reaction, it prevents nondesired reactions from proceeding. Second, it modulates the ligand (O2, NO) affinity of the protein, which can be ascribed to both distal and proximal effects. Finally, the stabilization of the Tyr33-Gln58 pair upon O2 binding might alter the essential dynamics of the protein, leading in turn to a mechanism for ligand-induced regulation. © 2005 American Chemical Society.",,"Bacteria; Computer simulation; Diffusion; Diseases; Microorganisms; Proteins; Quantum theory; Reaction kinetics; Toxicity; Detoxifications; Mycobacterium tuberculosis; Nitric oxides; Toxic effects; Nitrogen compounds; glycine; hemoglobin; ligand; nitric oxide; tyrosine; article; bacterial infection; binding site; cell survival; detoxification; enzyme active site; gene rearrangement; molecular dynamics; Mycobacterium tuberculosis; quantum theory; simulation; tuberculosis; Heme; Hemoglobins; Metabolic Detoxication, Drug; Models, Molecular; Mycobacterium tuberculosis; Nitric Oxide; Oxidation-Reduction; Oxygen; Protein Conformation; Quantum Theory; Thermodynamics",,"glycine, 56-40-6, 6000-43-7, 6000-44-8; hemoglobin, 9008-02-0; nitric oxide, 10102-43-9; tyrosine, 16870-43-2, 55520-40-6, 60-18-4; Heme, 14875-96-8; Hemoglobins; Nitric Oxide, 10102-43-9; Oxygen, 7782-44-7",,,,,,,"Bloom, B.R., (1994) Tuberculosis: Pathogenesis, Protection and Control, , ASM Press: Washington D.C; MacMicking, J.D., North, R.J., LaCourse, R., Mudgett, J.S., Shah, S.K., Nathan, C.F., (1997) Proc. Natl. Acad. Sci. U.S.A., 94, pp. 5243-5248; Clark, I.A., Rocket, K.A., (1996) Adv. Parasitol., 37, pp. 1-56; Colasanti, M., Gradoni, L., Mattu, M., Persichini, T., Salvati, L., Venturini, G., Ascenzi, P., (2002) Int. J. Mol. Med., 9, pp. 131-134; Gardner, P.R., Gardner, A.M., Martin, A.M., Dou, Y., Li, T., Olson, J.S., Zhu, H., Riggs, A.F., (2000) J. Biol. Chem., 275, pp. 12581-12589; Liu, L., Zeng, M., Hausladen, A., Heitman, J., Stamler, J.S., (2000) Proc. Natl. Acad. Sci. U.S.A., 97, pp. 4672-4676; Eich, R.F., Li, T., Lemon, D.D., Doherty, D.H., Curry, S.R., Aitken, J.F., Mathews, A.J., Olson, J.S., (1996) Biochemistry, 35, pp. 6976-6983; Ascenzi, P., Slavati, L., Brunori, M., (2001) FEBS Lett., 501, pp. 103-105; Pesce, A., Bolognesi, M., Bocedi, A., Ascenzi, P., Dewilde, S., Moens, L., Hankeln, T., Burmester, T., (2002) EMBO Rep., 3, pp. 1146-1151; Pesce, A., Dewilde, S., Nardini, M., Moens, L., Ascenzi, P., Hankeln, T., Burmester, T., Bolognesi, M., (2003) Structure, 11, pp. 1087-1095; Couture, M., Yeh, S., Wittenberg, B.A., Wittenberg, J.B., Ouellet, Y., Rousseau, D.L., Guertin, M., (1999) Proc. Natl. Acad. Sci. U.S.A., 96, pp. 11223-11228; Moens, L., Vanfleteren, J., Van Der Peer, Y., Peeters, K., Kapp, O., Czeluzniak, J., Goodman, M., Vinogradov, S., (1996) Mol. Biol. Evol., 13, pp. 324-333; Couture, M., Chamberland, H., St-Pierre, B., Lafontaine, J., Guertin, M., (1994) Mol. Gen. Genet., 243, pp. 185-197; Pesce, A., Couture, M., Dewilde, S., Guertin, M., Yamauchi, K., Ascenzi, P., Moens, L., Bolognesi, M., (2000) EMBO J., 19, pp. 2424-2434; Milani, M., Pesce, A., Ouellet, Y., Ascenzi, P., Guertin, M., Bolognesi, M., (2001) EMBO J., 20, pp. 3902-3909; Milani, M., Pesce, A., Ouellet, Y., Dewilde, S., Friedman, J., Ascenzi, P., Guertin, M., Bolognesi, M., (2004) J. Biol. Chem., 279, pp. 21520-21525; Yeh, S.R., Couture, M., Ouellet, Y., Guertin, M., Rousseau, D.L., (2000) J. Biol. Chem., 275, pp. 1679-1684; Ouellet, H., Ouellet, Y., Richard, C., Labarre, M., Wittenberg, B., Wittenberg, J., Guertin, M., (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 5902-5907; Mukai, M., Ouellet, Y., Ouellet, H., Guertin, M., Yeh, S., (2004) Biochemistry, 43, pp. 2764-2770; Jorgensen, W.L., Chandrasekar, J., Madura, J., Impey, R.W., Klein, M.L., (1983) J. Chem. Phys., 79, pp. 926-935; Luty, B.A., Tironi, I.G., Van Gunsteren, W.F., (1995) J. Chem. Phys., 103, pp. 3014-3021; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., (1977) J. Comput. Phys., 23, pp. 327-341; Wang, J., Cieplak, P., Kollman, P.A., (2000) J. Comput. Chem., 21, p. 1049; Bayly, C.I., Cieplak, P., Cornell, W.D., Kollman, P.A., (1993) J. Phys. Chem., 97, pp. 10269-10280; Banci, L., (2003) Curr. Opin. Chem. Biol., 7, pp. 143-149; Laskowski, R.A., (1995) J. Mol. Graphics, 13, pp. 323-330; Gelpí, J.L., Kalko, S., De La Cruz, X., Barril, X., Cirera, J., Luque, F.J., Orozco, M., (2001) Proteins, 45, pp. 428-437; García, A.E., (1992) Phys. Rev. Lett., 68, pp. 2696-2699; Rueda, M., Kalko, S.G., Luque, F.J., Orozco, M., (2003) J. Am. Chem. Soc., 125, pp. 8007-8014; Fradera, X., Marquez, M., Smith, B., Orozco, M., Luque, F.J., (2003) J. Org. Chem., 68, pp. 4663-4673; Wlodek, S.T., Clark, T.W., Scott, L.R., McCammon, J.A., (1997) J. Am. Chem. Soc., 119, pp. 9513-9522; Warshel, A., Levitt, M., (1976) J. Mol. Biol., 103, pp. 227-249; Zhang, X., Harrison, D.H.T., Cui, Q., (2002) J. Am. Chem. Soc., 124, pp. 14871-14878; Ryde, U., (2003) Curr. Opin. Chem. Biol., 7, pp. 136-142; Ridder, L., Harvey, J.N., Rietjens, I.M.C.M., Vervoort, J., Mulholland, A.J., (2003) J. Phys. Chem. B, 107, pp. 2118-2126; Schöneboom, J.C., Cohen, S., Lin, H., Shaik, S., Thiel, W., (2004) J. Am. Chem. Soc., 126, pp. 4017-4034; Devi-Kesavan, L.S., Gao, J., (2003) J. Am. Chem. Soc., 125, pp. 1532-1540; Soler, J.M., Artacho, E., Gale, J., García, A., Junquera, J., Ordejón, P., Sánchez-Portal, D., (2002) J. Phys.: Condens. Matter, 14, pp. 2745-2779; Martí, M.A., Scherlis, D.A., Doctorovich, F.A., Ordejón, P., Estrin, D.A., (2003) J. Biol. Inorg. Chem., 6, pp. 595-600; Troullier, N., Martins, J.L., (1991) Phys. Rev. B, 43, pp. 1993-2006; Louie, S.G., Froyen, S., Cohen, M.L., (1982) Phys. Rev. B, 26, pp. 1738-1742; Perdew, J.P., Burke, K., Ernzerhof, M., (1996) Phys. Rev. Lett., 77, pp. 3865-3868; Eichinger, M., Tavan, P., Hutter, J., Parrnello, M., (1999) J. Chem. Phys., 110, pp. 10452-10467; Rovira, C., Schultze, B., Eichinger, M., Evanseck, J.D., Parrinello, M., (2001) Biophys. J., 81, pp. 435-445; Scherlis, D.A., Martí, M.A., Ordejón, P., Estrin, D.A., (2002) Int. J. Quantum Chem., 90, pp. 1505-1514; Rovira, C., Kunc, K., Hutter, J., Ballone, P., Parrinello, M., (1997) J. Phys. Chem. A, 101, pp. 8914-8925; Crespo, A., Scherlis, D.A., Martí, M.A., Ordejón, P., Roitberg, A.E., Estrin, D.A., (2003) J. Phys. Chem. B, 107, pp. 13728-13736; Kachalova, G.S., Popov, A.N., Bartunik, H.D., (1999) Science, 284, pp. 473-476; Englander, S.W., Kallenbach, N.R.Q., (1983) Rev. Biophys., 16, pp. 521-655; Wuthrich, K.Q., (1987) Rev. Biophys., 19, pp. 3-5; Amadei, A., Linssen, A.B., Berendsen, H.J., (1993) Proteins, 17, pp. 412-425; McCammon, J.A., Harvey, S.C., (1987) Dynamics of Proteins and Nucleic Acids, , Cambridge University Press: New York; Gogonea, V., Osawa, E., (1995) J. Comput. Chem., 16, pp. 817-842; Shen, T., Tai, K., Henchman, R.H., McCammon, J.A., (2002) Acc. Chem. Res., 35, pp. 332-340; Scherlis, D.A., Estrin, D.A., (2001) J. Am. Chem. Soc., 123, pp. 8436-8437; Bolognesi, M., personal communication; Kundu, S., Snyder, B., Das, K., Chowdhury, P., Park, J., Petrich, J.W., Hargrove, M.S., (2002) Struct. Funct. Genet., 46, pp. 268-277; Jain, R., Chan, M.K., (2003) J. Biol. Inorg. Chem., 8, pp. 1-11; Jensen, M.P., Riley, D.P., (2002) Inorg. Chem., 41, pp. 4788-4797; Shimanovich, R., Groves, J.T., (2001) Arch. Biochem. Biophys., 387, pp. 307-317; Herald, S., Shivashankar, K., (2003) Biochemistry, 42, pp. 14036-14046; Guallar, V., Friesner, R.A., (2004) J. Am. Chem. Soc., 126, pp. 8501-8508; Schöneboom, J.C., Lin, H., Reuter, N., Thiel, W., Cohen, S., Ogliaro, F., Shaik, S., (2002) J. Am. Chem. Soc., 124, pp. 8142-8151; Poole, R.K., Hughes, M.N., (2000) Mol. Microbiol., 36, pp. 775-783; Flögel, U., Merx, M.W., Gödecke, A., Decking, U.K., Schrader, J., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 735-740; Frauenfelder, H., McMahan, B.H., Austin, R.H., Chu, K., Groves, J.T., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 2370-2374; Couture, M., Das, T.K., Lee, H.C., Peisach, J., Rousseau, D.L., Wittenberg, B.A., Wittenberg, J.B., Guertin, M., (1999) J. Biol. Chem., 274, pp. 6898-6910; Das, T.K., Weber, R.E., Dewilde, S., Wittenberg, J.B., Wittenberg, B.A., Yamauchi, K., Van Hauwaert, M.L., Rousseau, D.L., (2000) Biochemistry, 39, p. 14330; Das, T.K., Couture, M., Ouellet, Y., Guertin, M., Rousseau, D.L., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 479-484","Luque, F.J.; Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal 643, 08028 Barcelona, Spain; email: fjluque@ub.edu",,,,,,,,00027863,,JACSA,"15783226","English","J. Am. Chem. Soc.",Article,"Final",,Scopus,2-s2.0-16244367739
"Morreale A., De La Cruz X., Meyer T., Gelpí J.L., Luque F.J., Orozco M.","7006977091;6603686486;55913919700;35517522400;23025357900;7102809158;","Partition of protein solvation into group contributions from molecular dynamics simulations",2005,"Proteins: Structure, Function and Genetics","58","1",,"101","109",,11,"10.1002/prot.20292","https://www.scopus.com/inward/record.uri?eid=2-s2.0-10844268827&doi=10.1002%2fprot.20292&partnerID=40&md5=f6af1d4578630a63a8f4e67eaecacf66","Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Inst. Catalana Recerca i Estudis A., Lluís Companys, 23, Barcelona 08028, Spain; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Avgda Diagonal 643, Barcelona 08028, Spain","Morreale, A., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; De La Cruz, X., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Inst. Catalana Recerca i Estudis A., Lluís Companys, 23, Barcelona 08028, Spain; Meyer, T., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Gelpí, J.L., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Avgda Diagonal 643, Barcelona 08028, Spain; Orozco, M., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain","Linear response theory coupled to molecular dynamics simulations with an explicit solvent representation is used to derive fractional contributions of amino acid residues to the solvation of proteins. The new fractional methods developed here are compared with standard approaches based on empirical 1D and 3D statistical potentials, as well as with estimates obtained from the analysis of classical molecular interaction potentials. The new fractional methods, which have a clear physical basis and explicitly account for the effects due to protein structure and flexibility, provide an accurate picture of the contribution to solvation of different regions of the protein. © 2004 Wiley-Liss, Inc.","Fractional solvation; Free energy of hydration; Linear response theory; Molecular dynamics; Protein-solvent interations","amino acid; protein; article; energy; molecular dynamics; molecular interaction; molecular model; priority journal; protein interaction; protein structure; simulation; solvation; statistical analysis; theory; three dimensional imaging",,"amino acid, 65072-01-7; protein, 67254-75-5",,,,,,,"Böttcher, C.J.F., (1952) Theory of Electrostatic Polarisation, , Amsterdam: Elsevier; Tomasi, J., Persico, M., Molecular interactions in solution: An overview of methods based on continuous distributions of the solvent (1994) Chem Rev, 94, pp. 2027-2094; Cramer, C.J., Truhlar, D.F., Implicit solvation models: Equilibria structure spectra and dynamics (1999) Chem Rev, 99, pp. 2161-2200; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem Rev, 100, pp. 4187-4225; Rivail, J.L., Rinaldi, D., Liquid-state quantum chemistry: Computational applications of the polarizable continuum models (1995) Computational Chemistry Reviews of Current Trends, p. 139. , Leszczynski J, editor. Singapore: World Scientific; Martin, Y.C., (1978) Quantitative Drug Design. A Critical Introduction, , New York: Marcel Dekker; Horvath, A.L., (1992) Molecular Design, , Amsterdam: Elsevier; Hansch, C., Leo, A., (1995) Exploring QSAR: Fundaments and Applications in Chemistry and Biology, , Washington, DC: American Chemical Society; Leo, A., Hansch, C., Elkins, D., Partition coefficients and their uses (1971) Chem Rev, 71, pp. 525-616; Rekker, R.F., (1977) The Hydrophobic Fragmental Constant, , New York: Elsevier; Jones, S., Thornton, J.M., Principles of protein-protein interactions (1996) Proc Natl Acad Sci USA, 93, pp. 13-20; Jones, S., Thornton, J.M., Analysis of protein-protein interaction sites using surface patches (1997) J Mol Biol, 272, pp. 121-132; Von Heijne, G., Membrane proteins: From sequence to structure (1994) Ann Rev Biophys Biomol Struct, 23, pp. 167-192; Bartlett, G.J., Porter, C.T., Borkakoti, N., Thornton, J.M., Analysis of catalytic residues in enzyme active sites (2002) J Mol Biol, 324, pp. 105-121; Jones, S., Shanahan, H.P., Berman, H.M., Thornton, J.M., Using electrostatic potentials to predict DNA-binding sites on DNA-binding proteins (2003) Nucleic Acids Res, 31, pp. 7189-7198; Eisenberg, D., Schwarz, E., Komaromy, M., Wall, R., Analysis of membrane and surface protein sequences with the hydrophobic moment plot (1984) J Mol Biol, 179, pp. 125-142; Fauchere, J.L., Plisca, V., Hydrophobic parameters π of amino acid side chains from the partitioning of N-acetyl-amino acid amides (1983) Eur J Med Chem, 18, pp. 369-375; Wolfenden, R., Andersson, L., Cullis, P.M., Sothgate, C.C.B., Affinities of amino acid chains for solvent water (1981) Biochemistry, 20, pp. 849-855; Kyte, J., Doolittle, R.F., A simple method for displaying the hydropathic character of a protein (1982) J Mol Biol, 157, pp. 105-132; Rose, G.D., Geselowitz, A.R., Lesser, G.J., Lee, R.H., Zehfus, H., Hydrophobicity of amino acid residues in globular proteins (1985) Science, 229, pp. 834-838; Sippl, M.J., Boltzmann's principle, knowledge-bases mean fields and protein folding. An approach to the computational determination of protein structures (1993) J Comput-Aided Mol Des, 7, pp. 473-501; Eiseberg, D., McLachan, A.D., Solvation energy in protein folding and binding (1986) Nature, 319, pp. 199-203; Lazaridis, T., Karplus, M., Discrimination of the native from misfolded protein models with an energy function including implicit solvation (1999) J Mol Biol, 288, pp. 477-487; Sipple, M.A., ProSa 2003. PROtein Structure Analysis. Version 4.0, 17, pp. 355-362; Morreale, A., Gelpi, J.L., Luque, F.J., Orozco, M., Continuum and discrete calculation of fractional contributions to solvation free energy (2003) J Comput Chem, 24, pp. 1610-1623; Muñoz, J., Barril, X., Hernández, B., Orozco, M., Luque, F.J., Hydrophobic similarity between molecules: A MST-based hydrophobic similarity index (2002) J Comput Chem, 23, pp. 554-563; Luque, F.J., Bofill, J.M., Orozco, M., New strategies to incorporate the solvent polarization in self-consistent reaction field and free-energy perturbation simulations (1995) J Chem Phys, 103, pp. 10183-10191; Luque, F.J., Curutchet, C., Muñoz-Muriedas, J., Bidon-Chanal, A., Soteras, I., Morreale, A., Gelpí, J.L., Orozco, M., Continuum solvation models: Dissecting the free energy of solvation (2003) Phys Chem Chem Phys, 5, pp. 3827-3836; Lee, F.S., Chu, Z.T., Warshel, A., Microscopic and semimicroscopic calculations of electrostatic energies in proteins by the POLARIS and ENZYMIX programs (1993) J Comput Chem, 14, pp. 161-185; Lee, F.S., Chu, Z.T., Bolger, M.B., Warshel, A., Calculations of antibody-antigen interactions: Microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603 (1992) Prot Eng, 5, pp. 215-228; Warshel, A., Rusell, S.T., Calculations of electrostatic interactions in biological systems and in solutions (1984) Quart Rev Biophys, 17, pp. 283-422; Roux, B., Yu, H.A., Karplus, M., Molecular basis for the Born model of ion solvation (1990) J Phys Chem, 94, pp. 4683-4688; King, U., Warshel, A., Investigation of the free-energy functions for electron-transfer reactions (1990) J Chem Phys, 93, pp. 8682-8692; Kong, Y.S., Warshel, A., Linear free energy relationships with quantum mechanical corrections: Classical and quantum mechanical rate constants for hydride transfer between NAD+ analogs in solutions (1995) J Am Chem Soc, 117, pp. 6234-6242; Aqvist, J., Ion water interaction potentials derived from free-energy perturbation simulations (1990) J Phys Chem, 94, pp. 8021-8024; Aqvist, J., Medina, C., Samuelsson, J.E., A new method for predicting binding affinity in computer-aided drug design (1994) Prot Eng, 7, pp. 385-391; Aqvist, J., Hansson, T., Validity of electrostatic linear response in polar solvents (1996) J Phys Chem, 100, pp. 9512-9521; Orozco, M., Luque, F.J., Habibolahzadeh, D., Gao, J., The polarization contribution to the free energy of hydration (1995) J Chem Phys, 102, pp. 6145-6152; Carlson, H.A., Jorgensen, W.L., An extended linear response method for determining free energies of hydration (1995) J Phys Chem, 99, pp. 10667-10673; Pierce, A.C., Jorgensen, W.L., Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations (2001) J Med Chem, 44, pp. 1043-1050; Wesolowski, S.S., Jorgensen, W.L., Estimation of binding affinities for celecoxib analogues with COX-2 via Monte Carlo-extended linear response (2002) Bioorg Med Chem Lett, 12, pp. 267-270; Orozco, M., Luque, F.J., Generalized linear response approximation in discrete methods (1997) Chem Phys Lett, 265, pp. 473-480; Morreale, A., De La Cruz, X., Meyer, T., Gelpi, J.L., Luque, F.J., Orozco, M., Linear Response Theory: An alternative to PB and GB methods for the analysis of molecular dynamics trajectories? (2004) Proteins, , Forthcoming; Meyer, T., De La Cruz, X., Luque, F.J., Orozco, M., To be published; Gelpi, J.L., Kalko, S.G., Barril, X., Cirera, J., De La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J Comput Phys, 23, pp. 327-341; Darden, T.A., York, D.M., Pedersen, L.G., Particle mesh Ewald: An NXlog(N) method for Ewald sums in large systems (1993) J Chem Phys, 98, pp. 10089-10092; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Fergurson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins nucleic acids and organic molecules (1995) J Am Chem Soc, 117, pp. 5179-5197; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79, pp. 926-935; Mehler, E.L., Solmajer, T., Electrostatic effects in proteins: Comparison of dielectric and charge models (1991) Protein Eng, 4, pp. 903-910","Luque, F.J.; Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Avgda Diagonal 643, Barcelona 08028, Spain; email: javier@far1.far.ub.es",,,"Wiley-Liss Inc.",,,,,08873585,,PSFGE,"15517587","English","Proteins Struct. Funct. Genet.",Article,"Final",,Scopus,2-s2.0-10844268827
"Morreale A., De La Cruz X., Meyer T., Gelpí J.L., Luque F.J., Orozco M.","7006977091;6603686486;55913919700;35517522400;23025357900;7102809158;","Linear response theory: An alternative to PB and GB methods for the analysis of molecular dynamics trajectories?",2004,"Proteins: Structure, Function and Genetics","57","3",,"458","467",,9,"10.1002/prot.20169","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962438833&doi=10.1002%2fprot.20169&partnerID=40&md5=1527209341e2809fdeeec928a28daac4","Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain; Institucio Catalana Per Recerca I E., Barcelona, Spain; Dept. de Bioquim. I Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain; Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","Morreale, A., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain; De La Cruz, X., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain, Institucio Catalana Per Recerca I E., Barcelona, Spain; Meyer, T., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain; Gelpí, J.L., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain, Dept. de Bioquim. I Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain; Orozco, M., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Barcelona, Spain, Dept. de Bioquim. I Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain, Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain","We explore the use of classical Linear Response Theory (LRT) as an alternative strategy to the use of Molecular Mechanics/Poisson-Boltzmann strategies to compute the solvation free energy of macromolecules from molecular dynamics simulations using an explicit representation of solvent. The method reproduces well the free energy of solvation of standard amino acid side chains, small peptides, and proteins. The use of a fully discrete representation of solvent avoids the possible problems of continuum models to represent the solvation of systems containing tightly bound water molecules. © 2004 Wiley-Liss, Inc.",,"amino acid; water; analysis; article; binding affinity; calculation; energy; molecular dynamics; molecular mechanics; molecule; priority journal; reproducibility; simulation; solvation; technique; theory",,"amino acid, 65072-01-7; water, 7732-18-5",,,,,,,"Warshel, A., Bicycle-pedal model for the first step in the vision process (1976) Nature, 260, pp. 679-683; McCammon, J.A., Molecular Dynamics Study of the Bovine Pancreatic Trypsin Inhibitor (1976) Report of the 1976 Workshop, Models for Protein Dynamics, p. 137. , Berendsen HJC, editor. Models for protein dynamics. CECAM, Université de Paris IX Orsay, France;; McCammon, J.A., Gelin, B.R., Karplus, M., Dynamics of folded proteins (1977) Nature, 267, pp. 585-590; Orozco, M., Rueda, M., Blas, J.R., Cubero, E., Luque, F.J., Laughton, C.A., Molecular dynamic simulations of nucleic acids Encyclopedia of Computational Chemistry, , New York: Wiley (in press); Orozco, M., Pérez, A., Noy, A., Luque, F.J., Theoretical Methods for the Simulation of Nucleic Acids (2003) Chem Soc Rev, 32, pp. 350-364; McCammon, J.A., Harvey, S.C., (1987) Dynamics of Proteins and Nucleic Acids, , New York: Cambridge University Press; Wang, W., Donini, O., Reyes, C.M., Kollman, P.A., Biomolecular simulations: Recent developments in force-fields simulations of enzyme catalysis protein-ligand protein-protein and protein-nucleic acid noncovalent interactions (2001) Annu Rev Biophys Biomol Struct, 30, pp. 211-243; Kollman, P.A., Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules (1996) Acc Chem Res, 29, pp. 461-469; Cheatham, T.E., Kollman, P.A., Molecular dynamics simulation of nucleic acids (2000) Ann Rev Phys Chem, 51, pp. 435-471; Van Gunsteren, W.F., Mark, A.E., On the interpretation of biochemical data by molecular dynamics computer simulation (1992) Eur J Biochem, 204, pp. 947-961; Van Gunsteren, W.F., Berendsen, H.J., Computer simulation of molecular dynamics: Methodology applications and perspectives in chemistry (1990) Angew Che Int Ed Engl, 29, pp. 992-1023; Karplus, M., Petsko, G.A., Molecular dynamics simulations in biology (1990) Nature, 347, pp. 631-639; Karplus, M., McCammon, J.A., Molecular dynamics simulations of biomolecules (2002) Nature Struct Biol, 9, pp. 646-652; Warshel, A., (1991) Computer Modeling of Chemical Reactions in Enzymes and Solutions, , New York: Wiley; Orozco, M., Luque, P.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem Rev, 100, pp. 4187-4225; Andricioaei, I., Karplus, M., On the calculation of entropy from covariance matrices of the atomic fluctuations (2001) J Chem Phys, 115, pp. 6289-6292; Schlitter, J., Estimation of absolute and relative entropies of macromolecules using the covariance matrix (1993) Chem Phys Let, 215, pp. 617-621; Harris, S.A., Gavathiotis, E., Searle, M.S., Orozco, M., Laughton, C.A., Cooperativity in drug-DNA recognition: A molecular dynamics study (2001) J Am Chem Soc, 123, pp. 12658-12663; Schafer, H., Mark, A.E., Van Gunsteren, W.F., Absolute entropies from molecular dynamics simulation trajectories (2000) J Chem Phys, 113, pp. 7809-7817; Weiser, J., Shenkin, P.S., Still, W.C., Approximate atomic surfaces from linear combination of pairwise overlaps (LCPO) (1999) J Comp Chem, 20, pp. 217-230; Gilson, M.K., Honig, B., Calculation of the total electrostatic energy of a macromolecular system: Solvation energies binding energies and conformational analysis (1988) Proteins, 4, pp. 7-18; Davis, M.E., McCammon, J.A., Electrostatics in biomolecular structure and dynamics (1990) Chem Rev, 90, pp. 509-521; Still, W.C., Tempczyk, A., Hawley, R.C., Hendrickson, T., Semianalytical treatment of solvation for molecular mechanics and dynamics (1990) J Am Chem Soc, 112, pp. 6127-6129; Srinivasan, J., Cheatham, T.E., Kollman, P.A., Case, D.A., Continuum solvent studies of the stability of DNA RNA and phosphoramidate-DNA helices (1998) J Am Chem Soc, 120, pp. 9401-9409; Lee, M.R., Duan, Y., Kollman, P.A., Use of MM/PB/SA in estimating the free energies of proteins: Application to native intermediates and unfolded vilin headpiece (2000) Proteins, 39, pp. 309-316; Kollman, P.A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Cheatham, T.E., Calculating the structure and free energies of complex molecules: Combining molecular mechanics and continuum models (2000) Acc Chem Res, 33, pp. 889-897; Cubero, E., Luque, F.J., Orozco, M., Theoretical studies of d(A:T)-based parallel-stranded DNA duplexes (2001) JAm Chem Soc, 123, pp. 12018-12025; Cubero, E., Abrescia, N.G.A., Subirana, J.A., Luque, F.J., Orozco, M., Theoretical study of a new DNA structure: The antiparallel Hoogsteen duplex (2003) J Am Chem Soc, 125, pp. 14603-14612; Böttcher, C.J.F., (1952) Theory of Electrostatic Polarisation, , Amsterdam: Elsevier; Tomasi, J., Persico, M., Molecular interactions in solution: An overview of methods based on continuous distributions of the solvent (1994) Chem Rev, 94, pp. 2027-2094; Cramer, C.J., Truhlar, D.F., Implicit solvation models: Equilibria structure spectra and dynamics (1999) Chem Rev, 99, pp. 2161-2200; Luque, F.J., Curutchet, C., Muñoz-Muriedas, J., Bidon-Chanal, A., Soteras, I., Morreale, A., Gelpí, J.L., Orozco, M., Continuum solvation models: Dissecting the free energy of solvation (2003) Phys Chem Chem Phys, 5, pp. 3827-3836; Rivail, J.L., Rinaldi, D., (1995) Liquid-State Quantum Chemistry: Computational Applications of the Polarizable Continuum Models, p. 139. , Leszczynski J, editor. Computational chemistry reviews of current trends. Singapore; World Scientific; Curutchet, C., Cramer, C.J., Truhlar, D.G., Ruiz-López, M.F., Rinaldi, D., Orozco, M., Luque, F.J., Electrostatic component of solvation comparison of SCRF continuum models (2003) J Comp Chem, 24, pp. 284-297; Curutchet, C., Orozco, M., Luque, F.J., Solvation in octanol: Parametrization of the continuum MST model (2001) J Comp Chem, 22, pp. 1180-1193; Warshel, J., Aqvist, J., Electrostatic energy and macromolecular function (1991) Annu Rev Biophys Biophys Chem, 20, pp. 267-298; Schutz, C.N., Warshel, A., What are the dielectric ""constants"" of proteins and how to validate electrostatic models? (2001) Proteins, 44, pp. 400-417; Warshel, A., Russell, S.T., Churg, A.K., Macroscopic models for studies of electrostatic interactions in proteins: Limitations and applicability (1984) Proc Natl Acad Sci USA, 81, pp. 4785-4789; Lee, F.S., Chu, Z.T., Warshel, A., Microscopic and semimicroscopic calculations of electrostatic energies in proteins by the POLARIS and ENZYMIX programs (1993) J Comp Chem, 14, pp. 161-185; Lee, F.S., Chu, Z.T., Bolger, M.B., Warshel, A., Calculations of antibody-antigen interactions: Microscopic and semi-microscopic evaluation of the free energies of binding of phosphorylcholine analogs to McPC603 (1992) Prot Eng, 5, pp. 215-228; Warshel, A., Rusell, S.T., Calculations of electrostatic interactions in biological systems and in solutions (1984) Q Rev Biophys, 17, pp. 283-422; Roux, B., Yu, H.A., Karplus, M., Molecular basis for the Born model of ion solvation (1990) J Phys Chem, 94, pp. 4683-4688; King, U., Warshel, A., Investigation of the free-energy functions for electron-transfer reactions (1990) J Chem Phys, 93, pp. 8682-8692; Kong, Y.S., Warshel, A., Linear free energy relationships with quantum mechanical corrections: Classical and quantum mechanical rate constants for hydride transfer between NAD+ analogs in solutions (1995) J Am Chem Soc, 117, pp. 6234-6242; Aqvist, J., Ion water interaction potentials derived from free-energy perturbation simulations (1990) J Phys Chem, 94, pp. 8021-8024; Aqvist, J., Medina, C., Samuelsson, J.E., A new method for predicting binding affinity in computer-aided drug design (1994) Prot Eng, 7, pp. 385-391; Aqvist, J., Hansson, T., Validity of electrostatic linear response in polar solvents (1996) J Phys Chem, 100, pp. 9512-9521; Orozco, M., Luque, F.J., Habibolahzadeh, D., Gao, J., The polarization contribution to the free energy of hydration (1995) J Chem Phys, 102, pp. 6145-6152; Carlson, H.A., Jorgensen, W.L., An extended linear response method for determining free energies of hydration (1995) J Phys Chem, 99, pp. 10667-10673; Pierce, A.C., Jorgensen, W.L., Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations (2001) J Med Chem, 44, pp. 1043-1050; Wesolowski, S.S., Jorgensen, W.L., Estimation of binding affinities for celecoxib analogues with COX-2 via Monte Carlo-extended linear response (2002) Bioorg Med Chem Lett, 12, pp. 267-270; Levy, R.M., Belhadj, M., Kitchen, D.E., Gaussian fluctuation formula for electrostatic free-energy changes in solution (1991) J Chem Phys, pp. 3627-3633; Kuharsi, R.A., Bader, J.S., Chandler, D., Sprik, M., Klein, M., Impey, R.W., Molecular model for aqueous ferrous-ferric electron transfer (1991) J Chem Phys, pp. 3627-3633; Ulstruo, J., (1979) Charge Transfer Processes in Condensed Media, , New York: Springer; Orozco, M., Luque, F.J., Generalized Linear Response Approximation in Discrete Methods (1997) Chem Phys Lett, 265, pp. 473-480; Miertus, S., Tomasi, J., Approximate evaluations of the electrostatic free energy and internal energy changes in solution processes (1982) Chem Phys, 65, pp. 239-245; Miertus, S., Scrocco, E., Tomasi, J., Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects (1981) Chem Phys, 55, pp. 117-129; Bachs, M., Luque, F.J., Orozco, M., Optimization of solute cavities and van der Waals parameters in ab initio MST-SCRF calculations of neutral molecules (1994) J Comput Chem, 15, pp. 446-454; Orozco, M., Bachs, M., Luque, F.J., Development of optimized MST/ SCRF methods for semiempirical calculations: The MNDO and PM3 Hamiltonians (1995) J Comput Chem, 16, pp. 563-575; Luque, F.J., Zhang, Y., Aleman, C., Bachs, M., Gao, J., Orozco, M., Solvent Effects in Chloroform Solution: Parametrization of the MST/SCRF Continuum Model (1996) J Phys Chem, 100, pp. 4269-4276; Luque, F.J., Alemán, C., Bachs, M., Orozco, M., Extension of MST/SCRF method to organic solvents: Ab initio and semiempirical parametrization for neutral solutes in CC14 (1996) J Comput Chem, 17, pp. 806-820; Insight II Computer Program Accelrys Co., San Diego, CA. 2003; Gelpi, J.L., Kalko, S.G., Barril, X., Cirera, J., De La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J Comput Phys, 23, pp. 327-341; Darden, T.A., York, D.M., Pedersen, L.G., Particle mesh Ewald: An NXlog(N) method for Ewald sums in large systems (1993) J Chem Phys, 98, pp. 10089-10092; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Fergurson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins nucleic acids and organic molecules (1995) J Am Chem Soc, 117, pp. 5179-5197; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79, pp. 926-935; Bayly, C.E., Cieplak, P., Cornell, W.D., Kollman, P.A., A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model (1993) J Phys Chem, 97, pp. 10269-10280; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham III, T.E., Ross, W.S., Simmerling, C.L., Darden, T.L., Kollman, P.A., (1999) AMBER6, , University of California, San Francisco; Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham, T.E., Debolt, S., Fergurson, D., Kollman, P.A., AMBER a package of computer programs for applying molecular mechanics normal mode analysis molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules (1995) Computer Physics Communications, 91, pp. 1-41; Weise, J., Shenkin, P.S., Still, W.C., Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO) (1999) J Comp Chem, 20, pp. 217-230; Bashford, D., Gerwert, K., Electrostatic calculations of the pKa values of ionizable groups in bacteriorhodopsin (1992) J Mol Biol, 224, pp. 473-496; Tsui, V., Case, D., Molecular dynamics simulations of nucleic acids with a generalized born solvation model (2000) J Am Chem Soc, 122, pp. 2489-2498; Feig, M., Onufriev, A., Lee, M.S., Im, W., Case, D.A., Brooks III, C.L., Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures (2004) J Comput Chem, 25, pp. 265-284","Orozco, M.; Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científic de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"Wiley-Liss Inc.",,,,,08873585,,PSFGE,"15382247","English","Proteins Struct. Funct. Genet.",Article,"Final",,Scopus,2-s2.0-84962438833
"Stollar E.J., Gelpí J.L., Velankar S., Golovin A., Orozco M., Luisi B.F.","6507298042;35517522400;12789098300;7102867948;7102809158;7004221679;","Unconventional interactions between water and heterocyclic nitrogens in protein structures",2004,"Proteins: Structure, Function and Genetics","57","1",,"1","8",,36,"10.1002/prot.20216","https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444228189&doi=10.1002%2fprot.20216&partnerID=40&md5=313f27cc97d9115adc49ec32c63ee91e","Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científica de Barcelona, Barcelona, Spain; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; EMBL Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom","Stollar, E.J., Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; Gelpí, J.L., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científica de Barcelona, Barcelona, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Velankar, S., EMBL Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Golovin, A., EMBL Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Orozco, M., Molec. Modeling and Bioinfo. Unit, Institut de Recerca Biomèdica, Parc Científica de Barcelona, Barcelona, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Luisi, B.F., Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom, Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom","We report an unusual interaction in which a water molecule approaches the heterocyclic nitrogen of tryptophan and histidine along an axis that is roughly perpendicular to the aromatic plane of the side chain. The interaction is distinct from the well-known conventional aromatic hydrogen-bond, and it occurs at roughly the same frequency in protein structures. Calculations indicate that the water-indole interaction is favorable energetically, and we find several cases in which such contacts are conserved among structural orthologs. The indole-water interaction links side chains and peptide backbone in turn regions, connects the side chains in β-sheets, and bridges secondary elements from different domains. We suggest that the water-indole interaction can be indirectly responsible for the quenching of tryptophan fluorescence that is observed in the folding of homeodomains and, possibly, many other proteins. We also observe a similar interaction between water and the imidazole nitrogens of the histidine side chain. Taken together, these observations suggest that the unconventional water-indole and water-imidazole interactions provide a small but favorable contribution to protein structures. © 2004 Wiley-Liss, Inc.","Aromatic hydrogen bonds; Molecular simulations; Protein structure; Tryptophan fluorescence; Water-protein interactions","aromatic hydrocarbon; heterocyclic nitro compound; histidine; imidazole derivative; indole; nitrogen; tryptophan; water; article; beta sheet; calculation; complex formation; crystal structure; hydrogen bond; hydrophobicity; priority journal; protein domain; protein folding; protein function; protein protein interaction; protein structure; water protein interaction; Amino Acids; Animals; Conserved Sequence; Databases, Protein; Drosophila Proteins; Electrostatics; Homeodomain Proteins; Hydrogen Bonding; Imidazoles; Indoles; Nitrogen; Protein Conformation; Protein Folding; Proteins; Spectrometry, Fluorescence; Thermodynamics; Transcription Factors; Tryptophan; Water",,"histidine, 645-35-2, 7006-35-1, 71-00-1; indole, 120-72-9; nitrogen, 7727-37-9; tryptophan, 6912-86-3, 73-22-3; water, 7732-18-5; Amino Acids; Drosophila Proteins; Homeodomain Proteins; Imidazoles; Indoles; Nitrogen, 7727-37-9; Proteins; Transcription Factors; Tryptophan, 73-22-3; Water, 7732-18-5; engrail protein, Drosophila; imidazole, 288-32-4; indole, 120-72-9",,,,,,,"Levitt, M., Perutz, M.F., Aromatic rings act as hydrogen bond acceptors (1988) J Mol Biol, 201, pp. 751-754; Burley, S.K., Petsko, G.A., Amino-aromatic interactions in proteins (1986) FEBS Lett, 203, pp. 139-143; Van Mourik, T., Price, S.L., Clary, D.C., Ab initio calculations on indole-water, 1-methylindole-water and indole-(water)2 (2000) Chem Phys Lett, 311, p. 253; Sarkhel, S., Rich, A., Egli, M., Water-nucleobase ""stacking"": H-pi and lone pair-pi interactions in the atomic resolution crystal structure of an RNA pseudoknot (2003) J Am Chem Soc, 125, pp. 8998-8999; Stollar, E.J., Mayor, U., Lovell, S.C., Federici, L., Freund, S.M., Fersht, A.R., Luisi, B.F., Crystal structures of engrailed homeodomain mutants: Implications for stability and dynamics (2003) J Biol Chem, 278, pp. 43699-43708; Gelpi, J.L., Kalko, S.G., Barril, X., Cirera, J., De La Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham, T.E., Ross, W.S., Simmerling, C.L., Darden, T.L., Kollman, P.A., (1999) AMBER. 6.0; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J Am Chem Soc, 117, p. 5179; Lee, C., Yang, W., Parr, R.G., Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density (1998) Phys Rev B, 37, p. 785; Boys, S.F., Bernardi, F., Calculation of small molecular interactions by differences of separate total energies. Some procedures with reduced errors (1970) Mol Phys, 19, p. 553; Orozco, M., Luque, F.J., Molecular Interaction Potential (MIP). A new tool for the study of chemical reactivity (1993) J Comp Chem, 14, pp. 587-603; Boutselakis, H., Dimitropoulos, D., Fillon, J., Golovin, A., Henrick, K., Hussain, A., Ionides, J., Vranken, W., E-MSD: The European Bioinformatics Institute Macromolecular Structure Database (2003) Nucleic Acids Res, 31, pp. 458-462; Adams, P.D., Chen, Y., Ma, K., Zagorski, M.G., Sonnichsen, F.D., McLaughlin, M.L., Barkley, M.D., Intramolecular quenching of tryptophan fluorescence by the peptide bond in cyclic hexapeptides (2002) J Am Chem Soc, 124, pp. 9278-9286; Nanda, V., Brand, L., Aromatic interactions in homeodomains contribute to the low quantum yield of a conserved, buried tryptophan (2000) Proteins, 40, pp. 112-125; Subramaniam, V., Jovin, T.M., Rivera-Pomar, R.V., Aromatic amino acids are critical for stability of the bicoid homeodomain (2001) J Biol Chem, 276, pp. 21506-21511; Thanki, N., Thornton, J.M., Goodfellow, J.M., Distributions of water around amino acid residues in proteins (1988) J Mol Biol, 202, pp. 637-657; Bateman, A., Coin, L., Durbin, R., Finn, R.D., Hollich, V., Griffiths-Jones, S., Khanna, A., Eddy, S.R., The Pfam protein families database (2004) Nucleic Acid Res, 32, pp. D138-D141","Luisi, B.F.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom; email: ben@cryst.bioc.cam.ac.uk",,,,,,,,08873585,,PSFGE,"15326588","English","Proteins Struct. Funct. Genet.",Article,"Final",,Scopus,2-s2.0-4444228189
"Pineda M., Wagner C.A., Bröer A., Stehberger P.A., Kaltenbach S., Gelpí J.Ll., Martín Del Río R., Zorzano A., Palacín M., Lang F., Bröer S.","36599039300;7402148810;6603662455;6507992251;57192938068;35517522400;6701443352;7005302863;57206445737;56363077100;7004987668;","Cystinuria-specific rBAT(R365W) mutation reveals two translocation pathways in the amino acid transporter rBAT-b0,+AT",2004,"Biochemical Journal","377","3",,"665","674",,32,"10.1042/bj20030956","https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744224231&doi=10.1042%2fbj20030956&partnerID=40&md5=561b9b6cedbcc15fd219028eb20cd2da","Dept. of Biochem. and Molec. Biology, Faculty of Biology, University of Barcelona, Barcelona 08028, Spain; Institute of Physiology, University of Zürich, 8057 Zürich, Switzerland; Sch. of Biochem. and Molec. Biology, Australian National University, Canberra, ACT 0200, Australia; Institute of Physiology, University of Tübingen, 72076 Tübingen, Germany; Servicio de Neurobiología, Hospital Ramón y Cajal, Crta de Colmenar Km 7, 28034 Madrid, Spain","Pineda, M., Dept. of Biochem. and Molec. Biology, Faculty of Biology, University of Barcelona, Barcelona 08028, Spain; Wagner, C.A., Institute of Physiology, University of Zürich, 8057 Zürich, Switzerland; Bröer, A., Sch. of Biochem. and Molec. Biology, Australian National University, Canberra, ACT 0200, Australia; Stehberger, P.A., Institute of Physiology, University of Tübingen, 72076 Tübingen, Germany; Kaltenbach, S., Institute of Physiology, University of Tübingen, 72076 Tübingen, Germany; Gelpí, J.Ll., Dept. of Biochem. and Molec. Biology, Faculty of Biology, University of Barcelona, Barcelona 08028, Spain; Martín Del Río, R., Servicio de Neurobiología, Hospital Ramón y Cajal, Crta de Colmenar Km 7, 28034 Madrid, Spain; Zorzano, A., Dept. of Biochem. and Molec. Biology, Faculty of Biology, University of Barcelona, Barcelona 08028, Spain; Palacín, M., Dept. of Biochem. and Molec. Biology, Faculty of Biology, University of Barcelona, Barcelona 08028, Spain; Lang, F., Institute of Physiology, University of Tübingen, 72076 Tübingen, Germany; Bröer, S., Sch. of Biochem. and Molec. Biology, Australian National University, Canberra, ACT 0200, Australia, Institute of Physiology, University of Tübingen, 72076 Tübingen, Germany","Apical reabsorption of dibasic amino acids and cystine in kidney is mediated by the heteromeric amino acid antiporter rBAT/b0,+AT (system b0,+). Mutations in rBAT cause cystinuria type A, whereas mutations in b0,+AT cause cystinuria type B. b0,+AT is the catalytic subunit, whereas it is believed that rBAT helps the routing of the rBAT/b0,+AT heterodimeric complex to the plasma membrane. In the present study, we have functionally characterized the cystinuria-specific R365W (Arg365 → Trp) mutation of human rBAT, which in addition to a trafficking defect, alters functional properties of the b0,+ transporter. In oocytes, where human rBAT interacts with the endogenous b 0,+AT subunit to form an active transporter, the rBAT(R365W) mutation caused a defect of arginine efflux without altering arginine influx or apparent affinities for intracellular or extracellular arginine. Transport of lysine or leucine remained unaffected. In HeLa cells, functional expression of rBAT(R365W)/b0,+AT was observed only at the permissive temperature of 33°C. Under these conditions, the mutated transporter showed 50% reduction of arginine influx and a similar decreased accumulation of dibasic amino acids. Efflux of arginine through the rBAT(R365W)/b0,+AT holotransporter was completely abolished. This supports a two-translocation- pathway model for antiporter b0,+, in which the efflux pathway in the rBAT(R365W)/b0,+AT holotran sporter is defective for arginine translocation or dissociation. This is the first direct evidence that mutations in rBAT may modify transport properties of system b0,+.","Antiporter; Cystinuria; Epithelial transport; Heteromeric amino acid transporter; Membrane transport; Structure-function relationship","Amino acids; Catalysis; Cell membranes; Dissociation; Mutagens; Plasma membrane; Biochemistry; amino acid; amino acid transporter; antiporter; arginine; leucine; lysine; mutant protein; protein rBAT; protein subunit; trypsin; unclassified drug; amino acid substitution; amino acid transport; animal cell; article; bioaccumulation; controlled study; cystinuria; dissociation; gene mutation; HeLa cell; human; human cell; mutational analysis; nonhuman; oocyte; priority journal; protein defect; protein expression; protein function; temperature dependence; Animalia",,"amino acid, 65072-01-7; arginine, 1119-34-2, 15595-35-4, 7004-12-8, 74-79-3; leucine, 61-90-5, 7005-03-0; lysine, 56-87-1, 6899-06-5, 70-54-2; trypsin, 9002-07-7",,,,,,,"Wagner, C.A., Lang, F., Broer, S., Function and structure of heterodimeric amino acid transporters (2001) Am. J. Physiol. Cell Physiol., 281, pp. C1077-C1093; Chillaron, J., Roca, R., Valencia, A., Zorzano, A., Palacin, M., Heteromeric amino acid transporters: Biochemistry, genetics, and physiology (2001) Am. J. Physiol. Renal Physiol., 281, pp. F995-F1018; Verrey, F., Jack, D.L., Paulsen, I.T., Saier Jr., M.H., Pfeiffer, R., New glycoprotein-associated amino acid transporters (1999) J. Membr. Biol., 172, pp. 181-192; Deves, R., Boyd, C.A., Surface antigen CD98(4R2): Not a single membrane protein, but a family of proteins with multiple functions (2000) J. Membr. Biol., 173, pp. 165-177; Broer, S., Wagner, C.A., Structure-function relationships of heterodimeric amino acid transporters (2002) Cell Biochem. Biophys., 36, pp. 155-168; Verrey, F., Meier, C., Rossier, G., Kuhn, L.C., Glycoprotein-associated amino acid exchangers: Broadening the range of transport specificity (2000) Pflugers Arch., 440, pp. 503-512; Reig, N., Chillaron, J., Bartoccioni, P., Fernandez, E., Bendahan, A., Zorzano, A., Kanner, B., Bertran, J., The light subunit of system b(0,+) is fully functional in the absence of the heavy subunit (2002) EMBO J., 21, pp. 4906-4914; Peter, G.J., Panova, T.B., Christie, G.R., Taylor, P.M., Cysteine residues in the C-terminus of the neutral- and basic-amino-acid transporter heavy-chain subunit contribute to functional properties of the system b0,+-type amino acid transporter (2000) Biochem. J., 351, pp. 677-682; Rajan, D.P., Huang, W., Kekuda, R., George, R.L., Wang, J., Conway, S.J., Devoe, L.D., Ganapathy, V., Differential influence of the 4F2 heavy chain and the protein related to b(0,+) amino acid transport on substrate affinity of the heteromeric b(0,+) amino acid transporter (2000) J. Biol. Chem., 275, pp. 14331-14335; Feliubadalo, L., Font, M., Purroy, J., Rousaud, F., Estivill, X., Nunes, V., Golomb, E., Kreiss, Y., Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (b0,+AT) of rBAT. International Cystinuria Consortium (1999) Nat. Genet., 23, pp. 52-57; Pfeiffer, R., Loffing, J., Rossier, G., Bauch, C., Meier, C., Eggermann, T., Loffing-Cueni, D., Verrey, F., Luminal heterodimeric amino acid transporter defective in cystinuria (1999) Mol. Biol. Cell, 10, pp. 4135-4147; Bauch, C., Verrey, F., Apical heterodimeric cystine and cationic amino acid transporter expressed in MDCK cells (2002) Am. J. Physiol. Renal Physiol., 283, pp. F181-F189; Fernandez, E., Carrascal, M., Rousaud, F., Abian, J., Zorzano, A., Palacin, M., Chillaron, J., rBAT-b(0,+)AT heterodimer is the main apical reabsorption system for cystine in the kidney (2002) Am. J. Physiol. Renal Physiol., 283, pp. F540-F548; Font, M.A., Feliubadalo, L., Estivill, X., Nunes, V., Golomb, E., Kreiss, Y., Pras, E., Zelante, L., Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-Type I cystinuria (2001) Hum. Mol. Genet., 10, pp. 305-316; Calonge, M.J., Gasparini, P., Chillaron, J., Chillon, M., Gallucci, M., Rousaud, F., Zelante, L., Di Silverio, F., Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine (1994) Nat. Genet., 6, pp. 420-425; Dello Strologo, L., Pras, E., Pontesilli, C., Beccia, E., Ricci-Barbini, V., De Sanctis, L., Ponzone, A., Zelante, L., Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: A need for a new classification (2002) J. Am. Soc. Nephrol., 13, pp. 2547-2553; Chillaron, J., Estevez, R., Samarzija, I., Waldegger, S., Testar, X., Lang, F., Zorzano, A., Palacin, M., An intracellular trafficking defect in type I cystinuria rBAT mutants M467T and M467K (1997) J. Biol. Chem., 272, pp. 9543-9549; Palacin, M., Borsani, G., Sebastio, G., The molecular bases of cystinuria and lysinuric protein intolerance (2001) Curr. Opin. Genet. Dev., 11, pp. 328-335; Bertran, J., Werner, A., Moore, M.L., Stange, G., Markovich, D., Biber, J., Testar, X., Murer, H., Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids (1992) Proc. Natl. Acad. Sci. U.S.A., 89, pp. 5601-5605; Wells, R.G., Hediger, M.A., Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases (1992) Proc. Natl. Acad. Sci. U.S.A., 89, pp. 5596-5600; Busch, A.E., Herzer, T., Waldegger, S., Schmidt, F., Palacin, M., Biber, J., Markovich, D., Lang, F., Opposite directed currents induced by the transport of dibasic and neutral amino acids in Xenopus oocytes expressing the protein rBAT (1994) J. Biol. Chem., 269, pp. 25581-25586; Chillaron, J., Estevez, R., Mora, C., Wagner, C.A., Suessbrich, H., Lang, F., Gelpi, J.L., Zorzano, A., Obligatory amino acid exchange via systems b0,+-like and y+L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids (1996) J. Biol. Chem., 271, pp. 17761-17770; Coady, M.J., Jalal, F., Chen, X., Lemay, G., Berteloot, A., Lapointe, J.Y., Electrogenic amino acid exchange via the rBAT transporter (1994) FEBS Lett., 356, pp. 174-178; Wagner, C.A., Friedrich, B., Setiawan, I., Lang, F., Broer, S., The use of Xenopus laevis oocytes for the functional characterization of heterologously expressed membrane proteins (2000) Cell. Physiol. Biochem., 10, pp. 1-12; Bertran, J., Werner, A., Chillaron, J., Nunes, V., Biber, J., Testar, X., Zorzano, A., Palacin, M., Expression cloning of a human renal cDNA that induces high affinity transport of L-cystine shared with dibasic amino acids in Xenopus oocytes (1993) J. Biol. Chem., 268, pp. 14842-14849; Broer, S., Broer, A., Hamprecht, B., Expression of Na+-independent isoleucine transport activity from rat brain in Xenopus laevis oocytes (1994) Biochim. Biophys. Acta, 1192, pp. 95-100; Mosckovitz, R., Udenfriend, S., Felix, A., Heimer, E., Tate, S.S., Membrane topology of the rat kidney neutral and basic amino acid transporter (1994) FASEB J., 8, pp. 1069-1074; Wang, Y., Tate, S.S., Oligomeric structure of a renal cystine transporter: Implications in cystinuria (1995) FEBS Lett., 368, pp. 389-392; Gasparini, P., Calonge, M.J., Bisceglia, L., Purroy, J., Dianzani, I., Notarangelo, A., Rousaud, F., Ponzone, A., Molecular genetics of cystinuria: Identification of four new mutations and seven polymorphisms, and evidence for genetic heterogeneity (1995) Am. J. Hum. Genet., 57, pp. 781-788; Meier, C., Ristic, Z., Klauser, S., Verrey, F., Activation of system L heterodimeric amino acid exchangers by intracellular substrates (2002) Embo J., 21, pp. 580-589; Stegen, C., Matskevich, I., Wagner, C.A., Paulmichl, M., Lang, F., Broer, S., Swelling-induced taurine release without chloride channel activity in Xenopus laevis oocytes expressing anion channels and transporters (2000) Biochim. Biophys. Acta, 1467, pp. 91-100; Torras-Llort, M., Torrents, D., Soriano-Garcia, J.F., Gelpi, J.L., Estevez, R., Ferrer, R., Palacin, M., Moreto, M., Sequential amino acid exchange across b(0,+)-like system in chicken brush border jejunum (2001) J. Membr. Biol., 180, pp. 213-220; Palacin, M., Goodyer, P., Nunes, V., Gasparini, P., Cystinuria (2001) Metabolic and Molecular Basis of Inherited Diseases, pp. 4909-4932. , Scriver, C. R., Beaudet, A. L., Sly, S. W. and Valle, D., eds., McGraw-Hill, New York; Albers, A., Lahme, S., Wagner, C., Kaiser, P., Zerres, K., Capasso, G., Pica, A., Bichler, K.H., Mutations in the SLC3A1 gene in cystinuric patients: Frequencies and identification of a novel mutation (1999) Genet. Test., 3, pp. 227-231; Ward, C.L., Kopito, R.R., Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins (1994) J. Biol. Chem., 269, pp. 25710-25718; Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E., Welsh, M.J., Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive (1992) Nature (London), 358, pp. 761-764; Saadi, I., Chen, X.Z., Hediger, M., Ong, P., Pereira, P., Goodyer, P., Rozen, R., Molecular genetics of cystinuria: Mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype (1998) Kidney Int., 54, pp. 48-55; Coady, M.J., Chen, X.Z., Lapointe, J.Y., rBAT is an amino acid exchanger with variable stoichiometry (1996) J. Membr. Biol., 149, pp. 1-8; Palmieri, F., Indiveri, C., Bisaccia, F., Kramer, R., Functional properties of purified and reconstituted mitochondrial metabolite carriers (1993) J. Bioenerg. Biomembr., 25, pp. 525-535; Restrepo, D., Cronise, B.L., Snyder, R.B., Knauf, P.A., A novel method to differentiate between ping-pong and simultaneous exchange kinetics and its application to the anion exchanger of the HL60 cell (1992) J. Gen. Physiol., 100, pp. 825-846","Bröer, S.; Sch. of Biochem. and Molec. Biology, Australian National University, Canberra, ACT 0200, Australia; email: stefan.broeer@anu.edu.au",,,"Portland Press Ltd",,,,,02646021,,BIJOA,"14561219","English","Biochem. J.",Article,"Final",,Scopus,2-s2.0-10744224231
"Luque F.J., Curutchet C., Muñoz-Muriedas J., Bidon-Chanal A., Soteras I., Morreale A., Gelpí J.L., Orozco M.","23025357900;9737651900;9250530400;9741781000;6505871837;7006977091;35517522400;7102809158;","Continuum solvation models: Dissecting the free energy of solvation",2003,"Physical Chemistry Chemical Physics","5","18",,"3827","3836",,81,"10.1039/b306954k","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962415061&doi=10.1039%2fb306954k&partnerID=40&md5=48582d5ccb326060c85d227206b66025","Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Dept. de Bioquim. i Biol. Molec., Facultat de Química, Universitat de Barcelona, c/. Martí i Franqués 1, 08028 Barcelona, Spain; Unitat Modelitzacio Molec. B., Institut de Recerca Biomèdica, Parc Científic de Barcelona, c/. Josep Samitier 1, 08028 Barcelona, Spain","Luque, F.J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Curutchet, C., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Muñoz-Muriedas, J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Bidon-Chanal, A., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Soteras, I., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Morreale, A., Dept. de Bioquim. i Biol. Molec., Facultat de Química, Universitat de Barcelona, c/. Martí i Franqués 1, 08028 Barcelona, Spain, Unitat Modelitzacio Molec. B., Institut de Recerca Biomèdica, Parc Científic de Barcelona, c/. Josep Samitier 1, 08028 Barcelona, Spain; Gelpí, J.L., Dept. de Bioquim. i Biol. Molec., Facultat de Química, Universitat de Barcelona, c/. Martí i Franqués 1, 08028 Barcelona, Spain, Unitat Modelitzacio Molec. B., Institut de Recerca Biomèdica, Parc Científic de Barcelona, c/. Josep Samitier 1, 08028 Barcelona, Spain; Orozco, M., Dept. de Bioquim. i Biol. Molec., Facultat de Química, Universitat de Barcelona, c/. Martí i Franqués 1, 08028 Barcelona, Spain, Unitat Modelitzacio Molec. B., Institut de Recerca Biomèdica, Parc Científic de Barcelona, c/. Josep Samitier 1, 08028 Barcelona, Spain","The most usual self-consistent reaction field (SCRF) continuum models for the description of solvation within the quantum mechanical (QM) framework are reviewed, trying to emphasize their common roots as well as the inherent approximations assumed in the calculation of the free energy of solvation. Particular attention is also paid to the specific features involved in the development of current state-of-the-art QM SCRF continuum models. This is used to discuss the need to maintain a close correspondence between each SCRF formalism and the specific details entailing its parametrization, as well as the need to be cautious in analyzing the balance between electrostatic and non-electrostatic contributions to the solvation free energy between different SCRF models. Finally, special emphasis is given to the post-processing of the free energy of solvation to derive parameters providing a compact picture of the ability of a molecule to interact with different solvents, which can be of particular interest in biopharmaceutical studies.",,"solvent; calculation; electricity; energy; experimental model; parametric test; quantum mechanics; review; solvation",,,,,,,,,"Curtiss, L.A., Redfern, P.C., Frurip, D.J., (2000) Reviews in Computational Chemistry, 15, p. 147. , ed. K. B. Lipkowitz and D. B. Boyd, Wiley, New York; Curtiss, L.A., Raghavachari, K., (1998) Computational Thermochemistry, p. 176. , ed. K. K. Irikura and D. J. Frurip, ACS Symposium Series 677, American Chemical Society, Washington; Chalasinski, G., Szczesniak, M.M., (2000) Chem. Rev., 100, p. 4227; Langhoff, S.R., (1995) Quantum Mechanical Electronic Structure Calculations with Chemical Accuracy, , Kluwer, Dordrecht; Parr, R.G., Yang, W., (1989) Density Functional Theory of Atoms and Molecules Oxford, , New York; Orozco, M., Luque, F.J., (2000) Chem. Rev., 100, p. 4187; Jorgensen, W.L., (1989) Acc. Chem. Res., 22, p. 184; Warshel, A., (1991) Computer Modeling of Chemical Reactions in Enzymes and Solutions, , Wiley, New York; Van Gunsteren, W.F., Luque, F.J., Timms, D., Torda, A.E., (1994) Annu. Rev. Biophys. Biomol. Struct., 23, p. 847; Cramer, C.J., Truhlar, D.G., (1994) Structure and Reactivity in Aqueous Solution, p. 24. , ACS Symposium Series 568, American Chemical Society, Washington D.C; Kollman, P.A., (1996) Acc. Chem. Res., 29, p. 461; Gao, J., (1996) Acc. Chem. Res., 29, p. 298; Tapia, O., Bertrán, J., (1996) Solvent Effects and Chemical Reactivity, , Kluwer, Dordrecht; Ruiz-López, M.F., Rivail, J.L., (1998) Encyclopedia of Computational Chemistry, 1, p. 437. , ed. P. v. R.Schleyer, Wiley, New York; Monard, G., Merz, K.M., (1999) Acc. Chem. Res., 32, p. 904; Tenno, S., Hirata, F., Kato, S., (1993) Chem. Phys. Lett., 214, p. 391; Shao, L., Yu, H., Gao, J.J., (1998) Phys. Chem. A, 102, p. 10366; Tomasi, J., Persico, M., (1994) Chem. Rev., 94, p. 2027; Rivail, J.L., Rinaldi, D., (1995) Computational Chemistry and Reviews of Current Trends, p. 139. , ed. J. Leszczynski, World Scientific, Singapore; Cramer, C.J., Truhlar, D.G., (1995) Reviews in Computational Chemistry, 6, p. 1. , ed. K. B. Lipkowitz and D. B. Boyd, VCH, New York; Orozco, M., Alhambra, C., Barril, X., López, J.M., Busquests, M.A., Luque, F.J.J., (1996) Mol. Model., 2, p. 1; Tomasi, J., Menucci, B., Cammi, R., Cossi, M., (1997) Theoretical Aspects of Biochemical Reactivity, , eds. G. Náray-Szabó, A. Warshel, Kluwer, Dordrecht; Cramer, C.J., Truhlar, D.G., (1999) Chem. Rev., 99, p. 2161; Ben-Naim, A., (1987) Solvation Thermodynamics, , Plenum, New York; Tomasi, J., Mennucci, B., (1998) Encyclopedia of Computational Chemistry, p. 53. , ed. P. v. R. Schleyer, N. L. Allinger, T. Clark, J. Gasteiger, P. A. Kollman, H. F. Schaefer, III and P. R. Schreiner, Wiley, Chichester; Huron, M.J., Claverie, P.J., (1972) J. Phys. Chem., 76, p. 2123; Huron, M.J., Claverie, P., (1974) J. Phys. Chem., 78, p. 1853; Huron, M.J., Claverie, P., (1974) J. Phys. Chem., 78, p. 1862; Bonaccorsi, R., Ghio, C., Tomasi, J., (1981) Current Aspects of Quantum Chemistry, p. 407. , ed. R. Carbó, Elsevier, Amsterdam; Amovilli, C., Mennucci, B., (1997) J. Phys. Chem. B, 101, p. 1051; Serrano-Andrés, L., Fülscher, M.P., Karlström, G., (1997) Int. J. Quantum Chem., 65, p. 167; Tomasi, J., Cammi, R., Mennucci, B., (1999) Int. J. Quantum Chem., 75, p. 783; Costa Cabral, B.J., Rinaldi, D., Rivail, J.L., (1984) C.R. Acad. Sci. Paris, 675, pp. 298II; Rinaldi, D., Costa Cabral, B.J., Rivail, J.L., (1986) Chem. Phys. Lett., 125, p. 495; Tuñón, I., Silla, E., Pascual-Ahuir, J.L., (1993) Chem. Phys. Lett., 203, p. 289; Simonson, T., Brünger, A.T., (1994) J. Phys. Chem., 98, p. 4683; Sinanoglu, O.J., (1981) Chem. Phys., 75, p. 463; Gogonea, V., Osawa, E.J., (1994) Mol. Struct. (THEOCHEM), 311, p. 305; Pierotti, R.A., (1976) Chem. Rev., 76, p. 717; Pollack, G.L., Kenna, R.P., Himm, J.F., Carr, P.W., (1989) J. Chem. Phys., 90, p. 6569; Wilcock, R.J., Battino, R., Danforth, W.F., Wilhelm, E., (1978) J. Chem. Thermodyn, 10, p. 817; Claverie, P., (1978) Intermolecular Interactions: From Diatomics to Biomolecules, , ed. B. Pullman, Wiley, Chichester; Huron, M.J., Claverie, P.J., (1972) Phys. Chem., 76, p. 2123; Floris, F.M., Tomasi, J.J., (1989) Comput. Chem., 10, p. 616; Floris, F.M., Tomasi, J., Pascual Ahuir, J.L.J., (1991) J. Comput. Chem., 12, p. 784; Floris, F.M., Tomasi, J., Pascual-Ahuir, J.L.J., (1991) Comput. Chem., 12, p. 784; Sitkoff, D., Sharp, K.A., Honig, B., (1994) J. Phys. Chem., 98, p. 1978; Pitera, J.W., Van Gunsteren, W.F.J., (2001) J. Am. Chem. Soc., 123, p. 3163; Sanhueza, J.E., Tapia, O., Laidlaw, W.G., Trsic, M., (1979) J. Chem. Phys., 70, p. 3096; Tapia, O., (1992) J. Math. Chem., 10, p. 139; Angyan, J.G., (1992) J. Math. Chem., 10, p. 93; Born, M.Z., (1920) Phys., 1, p. 45; Tanford, G., Kirkwood, J.G., (1957) J. Am. Chem. Soc., 79, p. 533; Bell, R.P., (1931) Trans. Farady Soc., 27, p. 797; Onsager, L., (1936) J. Am. Chem. Soc., 58, p. 1486; Hylton, J., Christoffersen, R.E., Hall, G.G., (1974) Chem. Phys. Lett., 26, p. 501; Tapia, O., Goscinski, O., (1975) Mol. Phys., 29, p. 1653; Rinaldi, D., Rivail, J.L., (1973) Theor. Chim. Acta, 32, p. 57; Rivail, J.L., Rinaldi, D., (1976) Chem. Phys., 18, p. 233; Yomosa, S., (1973) J. Phys. Soc. Japan, 35, p. 1738; Yomosa, S., (1974) J. Phys. Soc. Japan, 36, p. 1655; Katritzky, A.R., Zerner, M.C., Karelson, M.M., (1986) J. Am. Chem. Soc., 108, p. 7213; Agren, H., Medina-Llanos, C., Mikkelsen, K.V., (1987) Chem. Phys., 115, p. 43; Wong, M.W., Frisch, M.J., Wiberg, K.B., (1991) J. Am. Chem. Soc., 113, p. 4776; Curutchet, C., Cramer, C.J., Truhlar, D.G., Ruiz-López, M.F., Rinaldi, D., Orozco, M., Luque, F.J., (2003) J. Comput. Chem., 24, p. 284; Rinaldi, D., Ruiz-López, M.F., Rivail, J.L., (1983) J. Chem. Phys., 78, p. 834; Dillet, V., Rinaldi, D., Angyan, J.G., Rivail, J.L., (1993) Chem. Phys. Lett., 202, p. 18; Rivail, J.L.C.R., (1990) Acad Sci. Paris, 307, p. 311; Angyan, J.G., (1995) Chem. Phys. Lett., 241, p. 51; Ruiz-López, M.F., Bohr, F., Martins Costa, M.T.C., Rinaldi, D., (1994) Chem. Phys. Lett., 221, p. 109; Dillet, V., Rinaldi, D., Rivail, J.L., (1994) J. Phys. Chem., 98, p. 5034; Dillet, V., Rinaldi, D., Bertrán, J., Rivail, J.L., (1996) J. Chem. Phys., 104, p. 9437; Jano, I.C.R., (1965) Acad. Sci. Paris, 261, p. 103; Klopman, G., (1967) Chem. Phys. Lett., 1, p. 200; Constanciel, R., Tapia, O., (1978) Theor. Chim. Acta, 48, p. 75; Constanciel, R., Contreras, R., (1984) Theor. Chim. Acta, 65, p. 1; Chamber, C.C., Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1996) J. Phys. Chem., 100, p. 16385; Mulliken, R.S., (1955) J. Chem. Phys., 23, p. 1933; Storer, J.W., Giesen, D.J., Cramer, C.J., Truhlar, D.G., (1995) Comput-Aided Mol. J. Des., 9, p. 87; Li, J., Zhu, T., Cramer, C.J., Truhlar, D.G., (1998) J. Phys. Chem. A, 102, p. 1820; Li, J., Xing, J., Cramer, C.J., Truhlar, D.G., (1999) J. Chem. Phys., 111, p. 885; Li, J., Williams, B., Cramer, C.J., Truhlar, D.G., (1999) J. Chem. Phys., 110, p. 724; Li, J., Zhu, T., Cramer, C.J., Truhlar, D.G., (2000) J. Phys. Chem. B, 104, p. 2178; Löwdin, P.O., (1950) J. Chem. Phys., 18, p. 365; Cramer, C.J., Truhlar, D.G., (1991) J. Am. Chem. Soc., 113, p. 8305; Cramer, C.J., Truhlar, D.G., (1991) J. Am. Chem. Soc., 113, p. 9901; Cramer, C.J., Truhlar, D.G., (1992) Science, 256, p. 213; Truhlar, C.J., Cramer, D.G., (1992) J. Comput-Aided Mol Des, 6, p. 629; Giesen, D.J., Storer, J.W., Cramer, C.J., Truhlar, D.G., (1995) J. Am. Chem. Soc., 117, p. 1057; Liotard, D.A., Hawkins, G.D., Lynch, G.C., Cramer, C.J., Truhlar, D.G., (1995) J. Comput. Chem., 16, p. 442; Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1995) Chem. Phys. Lett., 246, p. 122; Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1996) J. Phys. Chem., 100, p. 19824; Miertus, S., Tomasi, J., (1982) Chem. Phys., 65, p. 239; Miertus, S., Scrocco, E., Tomasi, J., (1981) Chem. Phys., 55, p. 117; Coitiño, E.L., Tomasi, J., Cammi, R., (1995) J. Comput. Chem., 16, p. 20; Cammi, R., Tomasi, J., (1995) J. Comput. Chem., 16, p. 1449; Zauhar, R.J., (1991) J. Comput. Chem., 12, p. 575; Cammi, R., Cossi, M., Tomasi, J.J., (1996) Chem. Phys., 104, p. 4611; Cammi, R., Cossi, M., Mennucci, B., Pomelli, C.S., Tomasi, J., (1996) Int. J. Quantum Chem., 60, p. 1165; Cossi, M., Tomasi, J., Cammi, R., (1995) Int. J. Quantum Chem., 29, p. 695; Mennucci, B., Tomasi, J., (1997) J. Chem. Phys., 106, p. 5151; Tomasi, M., Cossi, B., Mennucci, J., Pitarch, J., (1998) J. Comput. Chem., 8, p. 833; Pomelli, C.S., Tomasi, J., (1998) Theor. Chem. Acc., 99, p. 34; Pomelli, C.S., Tomasi, J., (1999) J. Comput. Chem.; Cancés, E., Mennucci, B., Tomasi, J., (1997) J. Chem. Phys., 107, p. 3032; Mennucci, B., Cancés, E., Tomasi, J.J., (1997) Phys. Chem., 101 B, p. 10506; Mennucci, B., Cossi, M., Tomasi, J., (1995) J. Chem. Phys., 102, p. 6837; Mennucci, B., Cossi, M., Tomasi, J.J., (1996) J. Phys. Chem., 100, p. 1807; Olivares Del Valle, F.J., Tomasi, J., (1991) Chem. Phys., 150, p. 139; Olivares Del Valle, F.J., Aguilar, M.A., (1992) J. Comput. Chem., 13, p. 115; Olivares Del Valle, F.J., Aguilar, M.A., Tolosa, S., (1993) J. Mol. Struct. (THEOCHEM), 279, p. 223; Aguilar, M.A., Olivares Del Valle, F.J., Tomasi, J., (1993) J. Chem. Phys., 98, p. 7375; Fortunelli, A., (1995) J. Mol. Struct. (Theochem), 357, pp. 117-124; Contador, J.C., Aguilar, M.A., Olivares Del Valle, F.J., (1997) Chem. Phys., 214, p. 113; Cammi, R., Mennucci, B., Tomasi, J., (1999) J. Phys. Chem. A, 103, p. 9100; Klamt, A., Schüürmann, G.J., (1993) J. Chem. Soc., Perkin Trans, 2, p. 799; Klamt, A., Jonas, V., (1996) J. Chem. Phys., 92, p. 9972; Truong, T.N., Stefanovich, E.V., (1995) Chem. Phys. Lett., 240, p. 253; Truong, T.N., Nguyen, U.N., Stefanovich, E.V., (1996) Int. J. Quantum Chem., 30, p. 403; Barone, V., Cossi, M., (1998) J. Phys. Chem. A, 102, p. 1995; Pye, C.C., Ziegler, T., (1999) Theor. Chem. Acc., 101, p. 396; Cossi, M., Rega, N., Scalmani, G., Barone, V., (2003) J. Comput. Chem., 24, p. 669; Dolney, D.M., Hawkins, G.D., Winger, P., Liotard, D.A., Cramer, C.J., Truhlar, D.G., (2000) J. Comput. Chem., 21, p. 340; Klamt, A., (1995) J. Phys. Chem., 99, p. 2224; Rashin, A.A., Namboodiri, K., (1987) J. Phys. Chem., 91, p. 6003; Chudinov, G.E., Napolov, D.V., Basilevsky, M.V., (1992) Chem. Phys., 160, p. 41; Rashin, A.A., Bukatin, M.A., Andzelm, J., Hagler, A.T., (1994) Biophys. Chem., 51, p. 375; Stefanovich, E.V., Truong, T.N., (1995) Chem. Phys. Lett., 244, p. 65; Pliego J.R., Jr., Riveros, J.M., (2002) Chem. Phys. Lett., 355, p. 543; Aguilar, M.A., Martin, M.A., Tolosa, S., Olivares Del Valle, F.J., (1988) J. Mol. Struct. (THEOCHEM), 166, p. 313; Aguilar, M.A., Olivares Del Valle, F.J., (1989), p. 129; Gonçalves, P.F.B., Livotto, P.R., (1999) Chem. Phys. Lett., 304, p. 438; Orozco, M., Luque, F.J., Habibollahzadeh, D., Gao, J., (1995) J. Chem. Phys., 102, p. 6145; Gonçalves, P.F.B., Stassen, H., (2002) J. Comput. Chem., 23, p. 706; Foresman, J.B., Keith, T.A., Wiberg, K.B., Frisch, M.J., (1996) J. Phys. Chem., 100, p. 16098; Kölle, C., Jug, K., (1997) Comput. Chem., 18, p. 1; Jug, K., Kölle, C., Neumann, F., (1999) J. Comput. Chem., 20, p. 301; Orozco, M., Bachs, M., Luque, F.J., (1995) J. Comput. Chem., 16, p. 563; Tuñón, I., Ruiz-López, M.F., Rinaldi, D., Bertrán, J.J., (1996) Comput. Chem., 17, p. 148; note; Giesen, D.J., Gu, M.Z., Cramer, C.J., Truhlar, D.G., (1996) J. Org. Chem., 61, p. 8720; Giesen, D.J., Gu, M.Z., Cramer, C.J., Truhlar, D.G., (1997) J. Phys. Chem. B, 101, p. 2061; Li, J., Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1998) Chem. Phys. Lett., 288, p. 293; Zhu, T., Li, J., Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1998) J. Chem. Phys., 109, p. 9117; Li, J., Zhu, T., Hawkins, G.D., Winget, P., Liotard, D.A., Cramer, C.J., Truhlar, D.G., (1999) Theor. Chem. Acc., 103, p. 9; Barone, V., Cossi, M., Tomasi, J., (1997) J. Chem. Phys., 107, p. 3210; Bachs, M., Luque, F.J., Orozco, M.J., (1994) Comput. Chem., 15, p. 446; Luque, F.J., Alemán, C., Bachs, M., Orozco, M.J., (1996) Comput. Chem., 17, p. 806; Luque, F.J., Zhang, Y., Alemán, C., Bachs, M., Gao, J., Orozco, M.J., (1996) Phys. Chem., 100, p. 4269; Curutchet, C., Orozco, M., Luque, F.J., (2001) J. Comput. Chem., 22, p. 1180; Curutchet, C., Orozco, M., Luque, F.J., in preparation; Pascual-Ahuir, J.L., Silla, E., Tomasi, J., Bonaccorsi, R., (1987) J. Comput. Chem., 8, p. 778; Pascual-Ahuir, J.L., Silla, E., (1990) J. Comput. Chem., 11, p. 1047; Silla, E., Tuñón, I., Pascual-Ahuir, J.L., (1991) J. Comput. Chem., 9, p. 1077; Colominas, C., Luque, F.J., Teixidó, J., Orozco, M., (1999) Chem. Phys., 240, p. 253; Orozco, M., Luque, F.J., (1994) Chem. Phys., 182, p. 237; Curutchet, C., Orozco, M., Luque, F.J., in preparation; Klamt, A., Jonas, V., Bürger, T., Lohrenz, J.C.W., (1998) J. Phys. Chem. A, 102, p. 5074; Tomasi, J., Cammi, R., Mennucci, B., (1999) Int. J. Quantum Chem., 75, p. 783; Tomasi, J., Cammi, R., Mennucci, B., Cappelli, C., Corni, S., (2002) Phys. Chem. Chem. Phys., 4, p. 5967; Tanford, C., (1980) The Hydrophobic Effect, , Wiley, New York; Straatsma, T.P., Berendsen, H.J.C., Postma, J.P.M., (1986) J. Chem. Phys., 85, p. 6720; Southall, N.T., Dill, K.A., Haymet, A.D.J., (2002) J. Phys. Chem. B, 106, p. 521; Martin, Y.C., (1978) Quantitative Drug Design. A Critical Introduction, , Marcel Dekker, New York; Horvath, A.L., (1992) Molecular Design, , Elsevier, Amsterdam; Hansch, C., Leo, A., (1995) Exploring QSAR: Fundaments and Applications in Chemistry and Biology, , American Chemical Society, Washington DC; Palm, K., Luthman, K., Ungell, A.L., Strandlund, G., Begi, F., Lundahl, P., Artursson, P.J., (1998) Med. Chem., 41, p. 5382; Clark, D.J., (1999) Pharm. Sci., 88, p. 807; Leo, A., Hansch, C., Elkins, D., (1971) Chem. Rev., 71, p. 525; Hansch, C., Leo, A., (1979) Substituents Constants for Correlation Analysis in Chemistry and Biology, , John Wiley and Sons, New York; Rekker, R.F., (1977) The Hydrophobic Fragmental Constant, , Elsevier, New York; Manhold, R., Dross, K., (1996) Quant. Struct. Act. Relat., 15, p. 403; Manhold, R., Cruciani, G., Dross, K., Rekker, R.J., (1998) Comput.-Aided Mol. Des., 12, p. 573; Manhold, R., Van De Waterbeemd, H.J., (2001) Comput.-Aided Mol. Des., 15, p. 337; Cramer, C.J., Truhlar, D.G., (1992) Chem. Phys. Lett., 198, p. 74; Giesen, D.J., Chamber, C.C., Cramer, C.J., Truhlar, D.G., (1997) J. Phys. Chem. B., 101, p. 5084; Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1998) J. Phys. Chem. B., 102, p. 3257; Luque, F.J., Barril, X., Orozco, M.J., (1999) Comput.-Aided Mol. Des., 13, p. 139; Barril, X., Muñoz, J., Luque, F.J., Orozco, M., (2000) Phys. Chem. Chem. Phys., 2, p. 4897; Muñoz, J., Barril, X., Luque, F.J., Gelpi, J.L., Orozco, M., (2001) Fundamentals of Molecular Similarity, p. 143. , R.Carbó-Dorca, X.Girones, P.G.Mezey, Kluwer Academic/Plenum, New York; Muñoz, J., Barril, X., Hernández, B., Orozco, M., Luque, F.J., (2002) J. Comput. Chem., 23, p. 554; Muñoz-Muriedas, J., Perspicace, S., Bech, N., Guccione, S., Orozco, M., Luque, F.J., submitted; Luque, F.J., Bofill, J.M., Orozco, M., (1995) J. Chem. Phys., 103, p. 10183; Angyán, J.G., (1997) J Chem. Phys., 107, p. 1291; Luque, F.J., Bofill, J.M., Orozco, M., (1997) J. Chem. Phys., 107, p. 1293; Luque, F.J., Orozco, M., (1997) J. Phys. Chem., 101, p. 5573; Curutchet, C., Salichs, A., Barril, X., Orozco, M., Luque, F.J., (2003) J. Comput. Chem., 24, p. 32; Morreale, A., Gelpi, J.L., Luque, F.J., Orozco, M., (2003) J. Comput. Chem., 24, p. 1610; Eisenberg, D., McLachlan, A.D., (1986) Nature, 319, p. 199; Eisenberg, D., Schware, E., Komaromy, M., Wall, R.J., (1984) Mol. Biol., 179, p. 125; Carbó, R., Leyda, L., Arnau, M., (1980) Int. J. Quantum Chem., 17, p. 1185","Luque, F.J.; Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; email: javier@far1.far.ub.es",,,"Royal Society of Chemistry",,,,,14639076,,PPCPF,,"English","Phys. Chem. Chem. Phys.",Review,"Final",,Scopus,2-s2.0-84962415061
"Morreale A., Gelpí J.L., Luque F.J., Orozco M.","7006977091;35517522400;23025357900;7102809158;","Continuum and discrete calculation of fractional contributions to solvation free energy",2003,"Journal of Computational Chemistry","24","13",,"1610","1623",,8,"10.1002/jcc.10323","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042282852&doi=10.1002%2fjcc.10323&partnerID=40&md5=8dbe16dde6137e0b8caf4dfa5f89ff9d","Molec. Modelling Bioinformatic Unit, Institut de Recerca Biomedica, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Dept. de Bioquimica Biologia Molec., Facultat de Química, Universitat de Barcelona, Marti i Franques 1, Barcelona 08028, Spain; Departament de Fisicoquimica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal 643, Barcelona 08028, Spain","Morreale, A., Molec. Modelling Bioinformatic Unit, Institut de Recerca Biomedica, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; Gelpí, J.L., Molec. Modelling Bioinformatic Unit, Institut de Recerca Biomedica, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Dept. de Bioquimica Biologia Molec., Facultat de Química, Universitat de Barcelona, Marti i Franques 1, Barcelona 08028, Spain; Luque, F.J., Departament de Fisicoquimica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal 643, Barcelona 08028, Spain; Orozco, M., Molec. Modelling Bioinformatic Unit, Institut de Recerca Biomedica, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain, Dept. de Bioquimica Biologia Molec., Facultat de Química, Universitat de Barcelona, Marti i Franques 1, Barcelona 08028, Spain","Approaches to compute fractional contributions to the solvation free energy are developed in the context of continuum self consistent reaction field calculations (both classical and quantum mechanical), as well as in the framework of discrete molecular dynamics simulations. It is found that for a series of typical pharmacological drugs there is a good agreement between the different fractional descriptions. Algorithms reported here can be easily applied as molecular descriptors in the context of quantitative structure-activity relationships.","Continuum models; Discrete models; Fractional solvation; Solvation","Algorithms; Computer simulation; Continuum mechanics; Drug products; Free energy; Mathematical models; Numerical analysis; Quantum theory; Fractional contributions; Pharmacological drugs; Solvation free energy; Molecular dynamics; drug; algorithm; article; biology; chemical model; chemical structure; chemistry; computer simulation; energy transfer; methodology; structure activity relation; thermodynamics; Algorithms; Computational Biology; Computer Simulation; Energy Transfer; Models, Chemical; Molecular Structure; Pharmaceutical Preparations; Structure-Activity Relationship; Thermodynamics",,"Pharmaceutical Preparations",,,,,,,"Haggin, J., (1899) Viertelgahreshr Naturforsch Zuerich, 44, p. 88; Moore, W., (1919) Science, 49, p. 472; Martin, Y.C., (1978) Quantitative Drug Design. A Critical Introduction, , Marcel Dekker: New York; Horvath, A.L., (1992) Molecular Design, , Elsevier: Amsterdam; Hansch, C., Leo, A., (1995) Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, , American Chemical Society: Washington, DC; Hansch, C., Maloney, P.P., Fujita, T., Mui, R., (1963) Nature, 194, p. 178; Hansch, C., (1969) Acc Chem Res, 2, p. 232; Leo, A., Hansch, C., Elkins, D., (1971) Chem Rev, 71, p. 525; Hansch, C., Leo, A., (1979) Substituents Constants for Correlation Analysis in Chemistry and Biology, , John Wley and Sons: New York; Rekker, R.F., (1977) The Hydrophobic Fragmental Constant; Nys, G.G., Rekker, R.F., (1973) Chim Therap, 8, p. 521; Klopman, G., Wang, S., (1991) J Comput Chem, 12, p. 1025; Mannhold, R., Dross, K., (1996) Quant Struct Act Relat, 15, p. 403; Viswanadhan, V.N., Ghose, A.K., Chandra-Singh, U., Wendoloski, J., (1999) J Chem Inf Comput Sci, 39, p. 405; Kamlet, M.J., Doherty, R.M., Abraham, M.H., Marcus, Y., Taft, R.W., (1988) J Phys Chem, 92, p. 5244; Abraham, M.H., Chandha, H.S., Whiting, G.S., Mitchell, R.C., (1994) J Pharm Sci, 83, p. 1085; Haeberlein, M., Brick, T., (1997) J Chem Soc Perkin Trans, 2, p. 289; Cramer, C.J., (2002) Essentials of Computational Chemistry, , Wiley: Chichester; Orozco, M., Luque, F.J., (2000) Chem Rev, 100, p. 4187; Cramer, C.J., Truhlar, D.G., (1999) Chem Rev, 99, p. 2161; Tomasi, J., Persico, M., (1994) Chem Rev, 84, p. 2027; Rivail, J.L., Rinaldi, D., (1996) Computational Chemistry, Review of Current Trends, p. 139. , Leszcynski, J., Ed.; World Scientific Publishing: Singapore; Jorgensen, W.L., (1989) Acc Chem Res, 22, p. 184; Kollman, P.A., (1993) Chem Rev, 93, p. 2395; (1997) Computer Simulations in Biomolecular Systems. Theoretical and Experimental Applications, 3. , Van Gunsteren, W. F.; Weiner, P. K.; Wilkinson, A. J. (Eds.); Kluwer: Dordrecht; Essex, J.W., Reynolds, C.H., Richards, W.G., (1992) J Am Chem, 114, p. 3634; Ekslerowiez, J.E., Miller, J.L., Kollman, P.A., (1997) J Phys Chem B, 101, p. 10971; Best, S.A., Merz, K.M., Reynolds, C.H., (1999) J Phys Chem B, 103, p. 714; Duffy, E.M., Jorgensen, W.L., (2000) J Am Chem Soc, 122, p. 2878; Jorgensen, W.L., Duffy, E.M., (2000) Biorg Med Chem Lett, 10, p. 1155; Bonaccorsi, R., Floris, F., Tomasi, J., (1990) J Mol Liq, 47, p. 25; Giesen, D.J., Hawkins, G.D., Liotard, D.A., Cramer, C.J., Truhlar, D.G., (1997) Theor. Chem Acc, 98, p. 85; Giesen, D.J., Chambers, C.C., Cramer, C.J., Truhlar, D.G., (1997) J Phys Chem B, 101, p. 2061; Giesen, D.J., Chambers, C.C., Cramer, C.J., Truhlar, D.G., (1997) J Phys Chem B, 101, p. 5084; Li, J., Zhu, T., Hawkins, G.D., Winget, P., Liotard, D.A., Cramer, C.J., Truhlar, D.G., (1999) Theor Chem Acc, 103, p. 9; Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1997) J Phys Chem B, 101, p. 7147; Klamtz, A., Jonas, V., Buerger, T., Lohrenz, J.C.W., (1998) J Phys Chem A, 102, p. 5074; Klamtz, A., (1995) J Phys Chem, 99, p. 2224; Klamtz, A., Schüürmann, G., (1993) J Chem Soc Perkin Trans, 2, p. 799; Curutchet, C., Orozco, M., Luque, F.J., (2001) J Comput Chem, 22, p. 1180; Best, S.A., Merz, K.M., Reynolds, C.H., (1997) J Phys Chem B, 101, p. 10479; Barril, X., Muñoz, J., Luque, F.J., Orozco, M., (2000) Phys Chem Chem Phys, 2, p. 4897; Muñoz, J., Barril, X., Hernández, B., Orozco, M., Luque, F.J., (2002) J Comput Chem, 23, p. 554; Palm, K., Luthman, K., Ungell, A.L., Strandlund, G., Begi, F., Lundahl, P., Artursson, P., (1998) J Med Chem, 41, p. 5382; Clark, D., (1999) J Pharm Sci, 88, p. 807; Hawkins, G.D., Cramer, C.J., Truhlar, D.G., (1998) J Phys Chem B, 102, p. 3257; Luque, F.J., Barrill, X., Orozco, M., (1999) J Comput-Aided Mol des, 13, p. 139; Muñoz, J., Barril, X., Luque, F.J., Gelpi, J.L., Orozco, M., (2001) Fundamentals of Molecular Similarity, p. 143. , Carbo-Dorca, R., Girones, X., Mezey, P. G., Eds.; Kluwer Academic/Plenum Publishers: New York; Pierotti, R.A., (1976) Chem Rev, 76, p. 717; Clarevie, P., (1978) Intermolecular Interactions: From Diatomics to Biomolecules, , Pullman, B., Ed.; Wiley: Chichester; Bachs, M., Luque, F.J., Orozco, M., (1994) J Comput Chem, 15, p. 446; Orozco, M., Bachs, M., Luque, F.J., (1995) J Comput Chem, 16, p. 563; Luque, F.J., Zhang, Y., Aleman, C., Bachs, M., Gao, J., Orozco, M., (1996) J Phys Chem, 100, p. 4269; Luque, F.J., Alemán, C., Bachs, M., Orozco, M., (1996) J Comput Chem, 17, p. 806; Miertus, S., Tomasi, J., (1982) Chem Phys, 65, p. 239; Miertus, S., Scrocco, E., Tomasi, J., (1981) Chem Phys, 55, p. 117; Böttcher, C.J.F., (1952) Theory of Electrostatic Polarisation, , Elsevier: Amsterdam; Luque, F.J., Bofill, J.M., Orozco, M., (1995) J Chem Phys, 103, p. 10183; Angyán, J.G., (1997) J Chem Phys, 107, p. 1291; Luque, F.J., Boffill, J.M., Orozco, M., (1997) J Chem Phys, 107, p. 1293; Luque, F.J., Orozco, M., (1997) J Phys Chem, 101, p. 5573; Orozco, M., Roca, R., Alemán, C., Busquets, M.A., López, J.M., Luque, F.J., (1999) THEOCHEM, 371, p. 269; Colominas, C., Luque, F.J., Orozco, M., (1999) J Comput Chem, 20, p. 665; Colominas, C., Luque, F.J., Orozco, M., (1999) J Phys Chem A, 103, p. 6200; Carlson, H.A., Jorgensen, W.L., (1995) J Phys Chem, 99, p. 10667; Aqvist, J., Medina, C., Sammuelsson, J.E., (1994) Protein Eng, 7, p. 385; Orozco, M., Luque, F.J., (1997) Chem Phys Lett, 265, p. 473; Curutchet, C., Salich, A., Barril, X., Orozco, M., Luque, F.J.J., (2003) Comput Chem, 24, p. 32; Eisenberg, D., McLachlan, A.D., (1986) Nature, 319, p. 199; Eisenberg, D., Schware, E., Komaromy, M., Wall, R., (1984) J Mol Biol, 179, p. 125; Carbó, R., Leyda, L., Arnau, M., (1980) Int J Quantum Chem, 17, p. 1185; Bowe-Jenkins, P.E., Richard, W.G., (1986) J Chem Soc Chem Commun, p. 133; Bayly, C.E., Cieplak, P., Cornell, W.D., Kollman, P.A., (1993) J Phys Chem, 97, p. 10269; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., (1983) J Chem Phys, 79, p. 926; Ryackaert, J.P., Ciccotti, G., Berendsen, H.J.C., (1977) J Comput Phys, 23, p. 327; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Fergurson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J Am Chem Soc, 117, p. 5179; MOPAC 6.0, , Version locally modified by F. J. Luque and M. Orozco; University of Barcelona: Barcelona, Spain, 2001; Peterson, M., Poirier, R., Monstergauss, , Version modified by Cammi, R.l; Tomasi, J. (1987), and by Luque, F. J.; Orozco, M. (2002); Department of Biochemistry, University of Toronto: Canada; Muñoz, J., Oroxco, M., Colominas, C., Luque, F.J., (2003) MC-MST Program, , University of Barcelona: Barcelona, Spain; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham T.E. III, Ross, W.S., Simmerlingz, C.L., Darden, T.L., Kollman, P.A., (1999) AMBER6, , University of California: San Francisco","Orozco, M.; Molec. Modelling Bioinformatic Unit, Institut de Recerca Biomedica, Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona 08028, Spain; email: modesto@mmb.pcb.ub.es",,,"John Wiley and Sons Inc.",,,,,01928651,,JCCHD,"12926005","English","J. Comput. Chem.",Article,"Final",,Scopus,2-s2.0-0042282852
"Escaja N., Gelpí J.L., Orozco M., Rico M., Pedroso E., González C.","6603260646;35517522400;7102809158;7103144570;7005216545;30267572700;","Four-stranded DNA structure stabilized by a novel G:C:A:T tetrad",2003,"Journal of the American Chemical Society","125","19",,"5654","5662",,23,"10.1021/ja0344157","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037958711&doi=10.1021%2fja0344157&partnerID=40&md5=cf8144f4c14983cba1d7025b1df1faea","Inst. de Quimica Fisica Rocasolano, CSIC, C/, Serrano 119, 28006 Madrid, Spain; Departament de Quimica Organica, Universitat de Barcelona, C/, Marti i Franques 1-11, 08028 Barcelona, Spain; Departament de Bioquimica, Universitat de Barcelona, C/, Marti Franques 1-11, 08028 Barcelona, Spain","Escaja, N., Departament de Quimica Organica, Universitat de Barcelona, C/, Marti i Franques 1-11, 08028 Barcelona, Spain; Gelpí, J.L., Departament de Bioquimica, Universitat de Barcelona, C/, Marti Franques 1-11, 08028 Barcelona, Spain; Orozco, M., Departament de Bioquimica, Universitat de Barcelona, C/, Marti Franques 1-11, 08028 Barcelona, Spain; Rico, M., Inst. de Quimica Fisica Rocasolano, CSIC, C/, Serrano 119, 28006 Madrid, Spain; Pedroso, E., Departament de Quimica Organica, Universitat de Barcelona, C/, Marti i Franques 1-11, 08028 Barcelona, Spain; González, C., Inst. de Quimica Fisica Rocasolano, CSIC, C/, Serrano 119, 28006 Madrid, Spain","The solution structure of a cyclic oligonucleotide d〈pCGCTCATT〉 has been determined by two-dimensional NMR spectroscopy and restrained molecular dynamics. Under the appropriate experimental conditions, this molecule self-associates, forming a symmetric dimer stabilized by four intermolecular Watson-Crick base pairs. The resulting four-stranded structure consists of two G:C:A:T tetrads, formed by facing the minor groove side of the Watson-Crick base-pairs. Most probably, the association of the base-pairs is stabilized by coordinating a Na+ cation. This is the first time that this novel G:C:A:T tetrad has been found in an oligonucleotide structure. This observation increases considerably the number of sequences that may adopt a four-stranded architecture. Overall, the three-dimensional structure is similar to those observed previously in other quadruplexes formed by minor groove alignment of Watson-Crick base pairs. This resemblance strongly suggests that we may be observing a general motif for DNA-DNA recognition.",,"Dimers; Molecular dynamics; Molecular structure; Nuclear magnetic resonance spectroscopy; Positive ions; Sodium; Molecular stabilization; DNA; dimer; oligonucleotide; article; base pairing; DNA determination; DNA strand; DNA structure; molecular dynamics; molecular stability; molecule; nuclear magnetic resonance spectroscopy; Base Pairing; DNA; Kinetics; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Oligonucleotides; Solutions; Thermodynamics",,"DNA, 9007-49-2; Oligonucleotides; quadruplex DNA; Solutions",,,,,,,"Arthanari, H., Bolton, P.H., (2001) Chem. Biol., 8, pp. 221-230; Suhnel, J., (2001) Biopolymers, 61, pp. 32-51; Keniry, M.A., (2000) Biopolymers, 56, pp. 123-146; Feigon, J., Koshlap, K.M., Smith, F.W., (1995) Methods Enzymol., 261, pp. 225-255; Patel, D.J., Bouaziz, S., Kettani, A., Wang, Y., (1999) Oxford Handbook of Nucleic Acid Sructures, pp. 389-453. , Neidle, S., Ed.; Oxford University Press: New York; Williamson, J.R., (1994) Annu. Rev. Biophys. Biomol. Struct., 23, pp. 703-730; Schaffitzel, C., Berger, I., Postberg, J., Hanes, J., Lipps, H.J., Pluckthun, A., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 8572-8577; Leonard, G.A., Zhang, S., Peterson, M.R., Harrop, S.J., Helliwell, J.R., Cruse, W.B., D'Estaintot, B.L., Hunter, W.N., (1995) Structure, 3, pp. 335-340; Kettani, A., Kumar, R.A., Patel, D.J., (1995) J. Mol. Biol., 254, pp. 638-656; Salisbury, S.A., Wilson, S.E., Powell, H.R., Kennard, O., Lubini, P., Sheldrick, G.M., Escaja, N., Pedroso, E., (1997) Proc. Natl. Acad. Sci. U.S.A., 94, pp. 5515-5518; Kettani, A., Bouaziz, S., Gorin, A., Zhao, H., Jones, R.A., Patel, D.J., (1998) J. Mol. Biol., 282, pp. 619-636; Patel, P.K., Hosur, R.V., (1999) Nucleic Acids Res., 27, pp. 2457-2464; Patel, P.K., Koti, A.S., Hosur, R.V., (1999) Nucleic Acids Res., 27, pp. 3836-3843; Patel, P.K., Bhavesh, N.S., Hosur, R.V., (2000) Biochem. Biophys. Res. Commun., 270, pp. 967-971; Escaja, N., Pedroso, E., Rico, M., González, C., (2000) J. Am. Chem. Soc., 122, pp. 12732-12742; Zhang, N., Gorin, A., Majumdar, A., Kettani, A., Chernichenko, N., Skripkin, E., Patel, D.J., (2001) J. Mol. Biol., 312, pp. 1073-1088; McGavin, S., (1971) J. Mol. Biol., 55, pp. 293-298; Gaillard, C., Strauss, F., (1994) Science, 264, pp. 433-436; Bouaziz, S., Kettani, A., Patel, D.J., (1998) J. Mol. Biol., 282, pp. 637-652; Thorpe, J.H., Teixeira, S.C., Gale, B.C., Cardin, C.J., (2003) Nucleic Acids Res., 31, pp. 844-849; Parkinson, G.N., Lee, M.P., Neidle, S., (2002) Nature, 417, pp. 876-880; González, C., Escaja, N., Rico, M., Pedroso, E., (1998) J. Am. Chem. Soc., 120, pp. 2176-2177; Kettani, A., Bouaziz, S., Skripkin, E., Majumdar, A., Wang, W., Jones, R.A., Patel, D.J., (1999) Structure Fold Des., 7, pp. 803-815; Kuryavyi, V., Kettani, A., Wang, W., Jones, R., Patel, D.J., (2000) J. Mol. Biol., 295, pp. 455-469; Zhang, N., Gorin, A., Majumdar, A., Kettani, A., Chernichenko, N., Skripkin, E., Patel, D.J., (2001) J. Mol. Biol., 311, pp. 1063-1079; Alazzouzi, E., Escaja, N., Grandas, A., Pedroso, E., (1997) Angew. Chem. Int. Ed. Engl., 36, pp. 1506-1508; Plateau, P., Güeron, M., (1982) J. Am. Chem. Soc., 104, pp. 7310-7311; Kumar, A., Ernst, R.R., Wüthrich, K., (1980) Biochem. Biophys. Res. Commun., 95, pp. 1-6; Bax, A., Davies, D.J., (1985) J. Magn. Reson., 65, pp. 355-360; Piotto, M., Saudek, V., Sklenar, V., (1992) J. Biomol. NMR, 2, pp. 661-665; Sklenar, V., Miyashiro, H., Zon, G., Miles, H.T., Bax, A., (1986) FEBS Lett., 208, pp. 94-98; Bartels, C., Xia, T., Billeter, M., Güntert, P., Wüthrich, K., (1995) J. Biomol. NMR, 6, pp. 1-10; Borgias, B.A., James, T.L., (1990) J. Magn. Reson., 87, pp. 475-487; Guntert, P., Mumenthaler, C., Wüthrich, K., (1997) J. Mol. Biol., 273, pp. 282-298; Case, D. A.; Pearlman, D. A.; Caldwell, J. W.; III, T. E. C.; Ross, W. S.; Simmerling, C. L.; Darden, T. A.; Merz, K. M.; Stanton, R. V.; Cheng, A. L.; Vincent, J. J.; Crowley, M.; Ferguson, D. M.; Radmer, R. J.; Seibel, G. L.; Singh, U. C.; Weiner, P. K.; Kollman, P. A.; 5 ed.; University of California: San Francisco, 1997; Soliva, R., Monaco, V., Gomez-Pinto, I., Meeuwenoord, N.J., Marel, G.A., Boom, J.H., Gonzalez, C., Orozco, M., (2001) Nücleic Acids Res., 29, pp. 2973-2985; Lavery, R.; Sklenar, H.; 3.0 ed.; Laboratory of Theoretical Biochemistry CNRS: Paris, 1990; Koradi, R., Billeter, M., Wuthrich, K., (1996) J. Mol. Graphics, 14, pp. 29-32; Gelpí, J.L., Kalko, S., De la Cruz, X., Barril, X., Cirera, J., Luque, F.J., Orozco, M., (2001) Proteins, 45, pp. 428-437; Cheatham T.E. III, Cieplak, P., Kollman, P.A., (1999) J. Biomol. Struct. Dyn., 16, pp. 845-862; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J. Am. Chem. Soc., 117, pp. 5179-5197; Orozco, M., Luque, F.J., (2000) Chem. Rev., 100, pp. 4187-4225; Escaja, N., Gómez-Pinto, I., Rico, M., Pedroso, E., González, C., (2003) ChemBioChem, , in press; Rinkel, L.J., Altona, C., (1987) J. Biomol. Struct. Dyn., 4, pp. 621-649; Wijmenga, S.S., Mooren, W., Hilbers, C.W., (1993) NMR in Macromolecules, pp. 217-288. , Roberts, G. C., Ed.; IRL Press: Oxford; Phillips, K., Dauter, Z., Murchie, A.I., Lilley, D.M., Luisi, B., (1997) J. Mol. Biol., 273, pp. 171-182; Wilson, J.H., (1979) Proc. Natl. Acad. Sci. U.S.A., 76, pp. 3641-3645; Ramakrishnan, B., Sundaralingam, M., (1993) Biochemistry, 32, pp. 11458-11468; Subirana, J.A., Abrescia, N.G., (2000) Biophys. Chem., 86, pp. 179-189; Ban, C., Ramakrishnan, B., Sundaralingam, M., (1994) J. Mol. Biol., 236, pp. 275-285; Doherty, E.A., Batey, R.T., Masquida, B., Doudna, J.A., (2001) Nat. Struct. Biol., 8, pp. 339-343; Nissen, P., Ippolito, J.A., Ban, N., Moore, P.B., Steitz, T.A., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, pp. 4899-4903; Fry, M., Loeb, L.A., (1994) Proc. Natl. Acad. Sci. U.S.A., 91, pp. 4950-4954; Usdin, K., (1998) Nucleic Acids Res., 26, pp. 4078-4085","Pedroso, E.; Departament de Quimica Organica, Universitat de Barcelona, C/, Marti i Franques 1-11, 08028 Barcelona, Spain; email: pedroso@qo.ub.es",,,,,,,,00027863,,JACSA,"12733903","English","J. Am. Chem. Soc.",Article,"Final",,Scopus,2-s2.0-0037958711
"Muñoz J., Gelpí J.L., Soler-López M., Subirana J.A., Orozco M., Luque F.J.","7402874030;35517522400;6602220080;35597146000;7102809158;23025357900;","Can divalent metal cations stabilize the triplex motif? Theoretical study of the interaction of the hydrated Mg2+ cation with the G-G·C triplet",2002,"Journal of Physical Chemistry B","106","34",,"8849","8857",,16,"10.1021/jp026096w","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037194938&doi=10.1021%2fjp026096w&partnerID=40&md5=5ae60970e9b9fac99965ad0e7fc0160b","Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelon, Av. Diagonal s/n, 08028 Barcelona, Spain; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Departament d'Enginyeria Quimica, Univ. Politecnica de Catalunya, Av. Diagonal 647, 08028 Barcelona, Spain; Molec. Modeling and Bioinfo. Unit, Parc Científic de Barcelona, Baldiri i Reixach 1-5, 08028 Barcelona, Spain","Muñoz, J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelon, Av. Diagonal s/n, 08028 Barcelona, Spain; Gelpí, J.L., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Soler-López, M., Departament d'Enginyeria Quimica, Univ. Politecnica de Catalunya, Av. Diagonal 647, 08028 Barcelona, Spain; Subirana, J.A., Departament d'Enginyeria Quimica, Univ. Politecnica de Catalunya, Av. Diagonal 647, 08028 Barcelona, Spain; Orozco, M., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain, Molec. Modeling and Bioinfo. Unit, Parc Científic de Barcelona, Baldiri i Reixach 1-5, 08028 Barcelona, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelon, Av. Diagonal s/n, 08028 Barcelona, Spain","A theoretical investigation of the influence of pentahydrated Mg2+ cation binding on the Hoogsteen G-G·C triplet motif is presented. Theoretical calculations have been performed by using the structural data of the G-G·C triplet found in the crystallographic structure of the B-DNA duplex d(GCGAATTCG) [J. Biol. Chem. 1999, 274, 23683-23686]. The investigation involves a variety of theoretical analysis, which includes analysis of geometrical, energetic, electron topology, and electrostatic potential properties. Calculations show the large stabilizing effect of the Mg2+ cation on the G-G·C triplet. Such a stabilization mainly arises from the balance of electrostatic interactions between the cation with the three bases in the triplet. However, the cation-induced polarization, which is largely concentrated in the Hoogsteen guanine, also plays a significant contribution to the stabilization of the triplet. The results can be valuable to gain further insight into the cation-induced enhancement of the stability of triple helical structures.",,"Crystallography; Electrostatics; Hydration; Positive ions; Metal cations; Magnesium printing plates",,,,,,,,,"Sigel, A., Sigel, H., (1996) Interactions of metal ions with nucleotides, nucleic acids and their constituents, 32. , Metal Ions in Biological Systems; Marcel Dekker: New York; Jerkovic, B., Bolton, P.H., (2001) Biochemistry, 40, p. 9406; Nakano, S.I., Fujimoto, M., Hara, H., Sugimoto, N., (1999) Nucl. Acids Res., 27, p. 2957; Martin, R.B., Mariam, Y.H., (1979) Metal Ions in Biological Systems, 8, p. 57. , Sigel, H., Ed.; Marcel Dekker: New York; Howerton, S.B., Sines, C.C., Vanderveer, D., Williams, L.D., (2001) Biochemistry, 40, p. 10023; Jia, X., Zon, G., Marzilli, L.G., (1991) Inorg. Chem., 30, p. 228; Froystein, N.A., Davis, J.T., Reid, B.R., Sletten, E., (1993) Acta Chem. Scand., 47, p. 649; Marzilli, L.G., Ano, S.O., Intini, F.P., Natile, G., (1999) J. Am. Chem. Soc., 123, p. 9133; Duguid, J., Bloomfield, V.A., Benevides, J., Thomas, G.J., (1993) Biophys. J., 65, p. 1916; Egli, M., Williams, L.D., Fredericks, C.A., Rich, A., (1991) Biochemistry, 30, p. 1364; Takahara, P.M., Frederick, C.A., Lippard, S.J., (1996) J. Am. Chem. Soc., 118, p. 12309; Harper, A., Brannigan, J.A., Buck, M., Hewitt, L., Lewis, R.J., Moore, M.H., Schneider, B., (1998) Acta Crystallogr. D, 54, p. 1273; Abrescia, N.G.A., Malinina, L., Fernandez, L.G., Huynh-Dinh, T., Neidle, S., Subirana, J.A., (1999) Nucl. Acids Res., 27, p. 1593; Kankia, B.I., (2000) Nucl. Acid. Res., 28, p. 911; Minasov, G., Tereshko, V., Egli, M., (1999) J. Mol. Biol., 291, p. 83; Robinson, H., Gao, Y.G., Sanishvili, R., Joachimiak, A., Wang, A.H., (2000) J. Nucl. Acid. Res., 28, p. 1760; Kankia, B.I., Marky, L.A., (1999) J. Phys. Chem. B, 103, p. 8759; Subirana, J.A., Abrescia, N.G.A., (2000) Biophys. Chem., 86, p. 179; Soler-López, M., Malinina, L., Subirana, J.A., (2000) J. Biol. Chem., 275, p. 23034; Feig, A.L., Uhlenbeck, O.C., (1999) The RNA World, 2nd ed., p. 287. , Gesteland, R.F., Cech, T.R., Atkins, J.F., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY; Bukhman, Y.V., Draper, D.E., (1997) J. Mol. Biol., 273, p. 1020; Cate, J.H., Hanna, R.L., Doudna, J.A., (1997) Nature Struct. Biol., 4, p. 553; Misra, V.K., Draper, D.E., (1999) Biopolymers, 48, p. 113; Tinoco, I., Kieft, J.S., (1997) Nature Struct. Biol., 4, p. 509; Burkhardt, C., Zacharias, M., (2001) Nucl. Acids Res., 29, p. 3910; Laughlan, G., Murchie, A.I.H., Norman, D.G., Moore, M.H., Moody, P.C.E., Lilley, D.M.J., Luisi, B., (1994) Science, 265, p. 520; Hud, N.V., Smith, F.W., Anet, F.A.L., Feigon, J., (1996) Biochemistry, 35, p. 15383; Phillips, K., Dauter, Z., Murchie, A.I.H., Lilley, D.M., Luisi, B., (1997) J. Mol. Biol., 273, p. 171; Hud, N.V., Schultze, P., Feigon, J., (1998) J. Am. Chem. Soc., 120, p. 6403; Špačková, N., Berger, I., Šponer, J., (2001) J. Am. Chem. Soc., 123, p. 3295; Basu, S., Szewczak, A.A., Cocco, M., Strobel, S.A., (2000) J. Am. Chem. Soc., 122, p. 3240; Deng, J., Xiong, Y., Sundaralingam, M., (2001) Proc. Natl. Acad. Sci. U.S.A., 98, p. 13665; Hampel, K.J., Crosson, P., Lee, J.S., (1991) Biochemistry, 30, p. 4455; Lyamichev, V.I., Voloshin, O.N., Frank-Kamenetskii, M.D., Soyfer, V.N., (1991) Nucl. Acids Res., 19, p. 1633; Xodo, L.E., Manzini, G., Quadrifoglio, F., Van der Marel, G.A., Van Boom, J.H., (1991) Nucl. Acids Res., 19, p. 1633; Bernues, J., Azorin, F., (1995) Nucleic Acids and Molecular Biology, 9, p. 1. , Eckstein, F., Lilley, D.M.J., Eds.; Springer-Verlag: Berlin; Soyfer, V.N., Potaman, V.N., (1996) Triple-Helical Nucleic Acids, p. 100. , Springer: New York; Sugimoto, N., Wu, P., Hara, H., Kawamoto, Y., (2001) Biochemistry, 40, p. 9396; Sun, J.S., Helene, C., (1993) Curr. Opin. Struct. Biol., 3, p. 345; Bernues, J., Beltran, R., Casanovas, J.M., Azorín, F., (1990) Nucl. Acids Res., 17, p. 4067; Collier, D.A., Wells, R.D., (1990) J. Biol. Chem., 265, p. 10652; Malkov, V.A., Voloshin, O.N., Soyfer, V.N., Frank-Kamenetskii, M.D., (1993) Nucl. Acids Res., 21, p. 585; Potaman, V.N., Soyfer, V.N., (1994) J. Biomol. Struct. Dyn., 11, p. 1035; Šponer, J., Sabat, M., Burba, J.V., Doody, A.M., Leszczynski, J., Hobza, P., (1998) J. Biomol. Struct. Dyn., 16, p. 139; Vlieghe, D., Van Meervelt, L., Dautant, A., Gallois, B., Précigoux, G., Kennard, O., (1996) Acta Crystallogr., Sect. D, 52, p. 766; Soler-Lopez, M., Malinina, L., Liu, J., Huynh-Dinh, T., Subirana, J.A., (1999) J. Biol. Chem., 274, p. 23683; Soler-López, M., Malinina, L., Subirana, J.A., (2000) J. Biol. Chem., 275, p. 23034; Burda, J.V., Šponer, J., Hobza, P., (1996) J. Phys. Chem., 100, p. 7250; Šponer, J., Burda, J.V., Mejzlík, P., Leszczynski, J., Hobza, P., (1997) J. Biomol. Struct. Dyn., 14, p. 613; Gadre, S.R., Pundlik, S.S., Limaye, C., Rendell, A.P., (1998) Chem. Commun., p. 573; Šponer, J., Sabat, M., Burda, J.V., Leszczynski, J., Hobza, P., Lippert, B., (1999) J. Biol. Inorg. Chem., 4, p. 537; Šponer, J., Šponer, J.E., Gorb, L., Leszczynski, J., Lippert, B., (1999) J. Phys. Chem A, 103, p. 11406; Pelmenchikov, A., Zilberger, I., Leszczynski, J., Famulari, A., Sironi, M., Raimondi, M., (1999) Chem. Phys. Lett., 314, p. 496; Šponer, J., Šponer, J.E., Leszczynski, J., (2000) J. Biomol. Struct. Dyn., 17, p. 1087; Guerra, C.F., Bickelhaupt, M., Snijders, J.G., Baerends, E.J., (2000) J. Am. Chem. Soc., 122, p. 4117; Famulari, A., Moroni, F., Sironi, M., Raimondi, M., (2000) Comput. Chem., 24, p. 341; Petrov, A.S., Lamm, G., Pack, G.R., (2002) J. Phys. Chem. B, 106, p. 3294; Hobza, P., Šponer, J., (1999) Chem. Rev., 99, p. 3247; Burda, J.V., Šponer, J., Leszczynski, J., Hobza, P., (1997) J. Phys. Chem. B, 101, p. 9670; Šponer, J., Burda, J.V., Sabat, M., Leszczynski, J., Hobza, P., (1998) J. Phys. Chem. A, 102, p. 5951; Šponer, J., Sabat, M., Burda, J.V., Leszczynski, J., Hobza, P., (1998) J. Biomol. Struct. Dyn., 16, p. 139; Šponer, J., Burda, J.V., Sabat, M., Leszczynski, J., Hobza, P., (1999) J. Phys. Chem. B, 103, p. 2528; Šponer, J., Burda, J.V., Leszczynski, J., Hobza, P., (1999) J. Biomol. Struct. Dyn., 17, p. 61; Gresh, N., Šponer, J., (1999) J. Phys. Chem. B, 103, p. 11415; Šponer, J., Sabat, M., Gorb, L., Leszczynski, J., Lippert, B., Hobza, P., (2000) J. Phys. Chem. B, 104, p. 7535; Muñoz, J., Šponer, J., Hobza, P., Orozco, M., Luque, F.J., (2001) J. Phys. Chem. B, 105, p. 6051; Hariharan, P.C., Pople, J.A., (1978) Theor. Chim. Acta, 28, p. 213; Møller, C., Plesset, M.S., (1934) Phys. Rev., 46, p. 618; Boys, S.F., Bernardi, F., (1970) Mol. Phys., 19, p. 553; Bader, R.F.W., (1990) Atoms in Molecules. A Quantum Theory, , Oxford University Press: Oxford, U.K; Bader, R.F.W., (1991) Chem. Rev., 91, p. 893; Becke, A.D., Edgecombe, K.E., (1990) J. Chem. Phys., 92, p. 5397; Silvi, B., Savin, A., (1994) Nature., 31, p. 683; Savin, A., Nesper, R., Wengert, S., Fässler, T.F., (1992) Angew. Chem., Int. Ed. Engl., 36, p. 1809; Boyd, R.J., Choi, S.C., (1985) Chem. Phys. Lett., 120, p. 80; Boyd, R.J., Choi, S.C., (1985) Chem. Phys. Lett., 120, p. 80; Bader, R.F.W., Tang, T.H., Tal, Y., Biegler-König, F.W., (1982) J. Am. Chem. Soc., 104, p. 4178; Alkorta, I., Elguero, J., (1996) J. Phys. Chem., 100, p. 19367; Mallinson, P.R., Wozniak, K., Smith, G.T., McCormack, K.L., (1997) J. Am. Chem. Soc., 119, p. 11502; Roversi, P., Barzaghi, M., Merati, F., Destro, R., (1996) Can. J. Chem., 74, p. 4; Mo, O., Yáñez, M., Elguero, J., (1992) J. Chem. Phys., 97, p. 6628; Alkorta, I., Rozas, I., Elguero, J., (1998) Struct. Chem., 9, p. 243; Cubero, E., Orozco, M., Hobza, P., Luque, F.J., (1999) J. Phys. Chem. A, 103, p. 639; Cubero, E., Orozco, M., Luque, F., (1999) J. Chem. Phys. Lett., 310, p. 445; Alkorta, I., Rozas, I., Elguero, J., (1998) Chem. Soc. Rev., 27, p. 163; Fuster, F., Silvi, B., (2000) Theor. Chem. Acc., 104, p. 13; Scrocco, E., Tomasi, J., (1973) Top. Curr. Chem., 42, p. 95; Bonaccorsi, R., Petrongolo, C., Scrocco, E., Tomasi, J., (1971) Theor. Chim. Acta, 20, p. 331; Momany, F.A., (1978) J. Phys. Chem., 82, p. 592; Cox, S.R., Williams, D.E., (1981) J. Comput. Chem., 2, p. 304; Singh, U.C., Kollman, P.A., (1984) J. Comput. Chem., 5, p. 129; Chirlian, L.E., Fracl, M.E., (1987) J. Comput. Chem., 8, p. 894; Besler, B.H., Merz, K.M., Kollman, P.A., (1990) J. Comput. Chem., 11, p. 431; Ferenczy, G.G., Reynolds, C.A., Richards, W.G., (1990) J. Comput. Chem., 11, p. 159; Breneman, C.M., Wiberg, K.B., (1990) J. Comput. Chem., 11, p. 361; Orozco, M., Luque, F.J., (1990) J. Comput. Chem., 11, p. 909; Gelpí, J.L., Kalko, S.G., Barril, X., Cirera, J., De la Cruz, X., Luque, F.J., Orozco, M., (2001) Proteins, 45, p. 428; Case, D.A., Pearlman, D.A., Caldwell, J.C., Cheatham, T.E., Ross, W.S., Simmerling, C., Darden, T., Kollman, P.A., (1997) AMBER5, , University of California, San Francisco; Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Zakrzewski, V.G., Pople, J.A., (1998) Gaussian 98, revision A.7, , Gaussian, Inc.: Pittsburgh, PA; Biegler-König, F., Bader, R.F.W., Tang, T.H., (1982) J. Comput. Chem., 3, p. 317; Noury, S., Krokidis, X., Fuster, F., Silvi, B., (1997) TopMod package, , University Pierre et Marie Curie; Luque, F.J., Alhambra, C., Orozco, M., (1998) MOPETE program, , University of Barcelona; Gelpí, J.L., Luque, F.J., Orozco, M., (2000) CMIP program, , University of Barcelona; note; Koch, U., Popelier, P.L.A., (1995) J. Phys. Chem., 99, p. 9747; Popelier, P.L.A., (1998) J. Phys. Chem. A, 102, p. 1873; Hobza, P., Sponer, J., Cubero, E., Orozco, M., Luque, F.J., (2000) J. Phys. Chem. B, 104, p. 6286; Jorgensen, W.L., Severance, D.L., (1991) J. Am. Chem. Soc., 113, p. 209; Pranata, J., Wierschke, S.G., Jorgensen, W.L., (1991) J. Am. Chem. Soc., 113, p. 2810; Šponer, J., Leszczynski, J., Hobza, P., (1996) J. Phys. Chem., 100, p. 1965; Uchimaru, T., Korchowiec, J., Tsuzuki, S., Matsumara, K., Kawahara, S., (2000) Chem. Phys. Lett., 318, p. 203; note; Chiu, T.K., Dickerson, R.E., (2000) J. Mol. Biol., 301, p. 915; Khomyakova, E.B., Gousset, H., Liquier, J., Huynh-Dinh, T., Gouyette, C., Takahashi, M., Ftorentiev, V.L., Taillandier, E., (2000) Nucl. Acids Res., 18, p. 3511","Orozco, M.; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; email: modesto@luz.bq.ub.es",,,"American Chemical Society",,,,,15206106,,JPCBF,,"English","J Phys Chem B",Article,"Final",,Scopus,2-s2.0-0037194938
"Aviñó A., Frieden M., Morales J.C., De La Torre B.G., García R.G., Azorín F., Gelpí J.L., Orozco M., González C., Eritja R.","6701820899;6701393209;35577840400;7004676510;7403264174;57194271780;35517522400;7102809158;30267572700;56370367200;","Properties of triple helices formed by parallel-stranded hairpins containing 8-aminopurines",2002,"Nucleic Acids Research","30","12",,"2609","2619",,33,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-18444384215&partnerID=40&md5=57b488165ea1210a1c18e570500fb46c","Cygene Spain S.L., Parc Científic de Barcelona, Baldiri i Reixac 10-12, E-08028 Barcelona, Spain; Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franques, E-08028 Barcelona, Spain; Instituto de Estructura de la Materia, C.S.I.C., Serrano 119, E-28006 Madrid, Spain","Aviñó, A., Cygene Spain S.L., Parc Científic de Barcelona, Baldiri i Reixac 10-12, E-08028 Barcelona, Spain; Frieden, M., Cygene Spain S.L., Parc Científic de Barcelona, Baldiri i Reixac 10-12, E-08028 Barcelona, Spain; Morales, J.C., Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; De La Torre, B.G., Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; García, R.G., Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; Azorín, F., Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; Gelpí, J.L., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franques, E-08028 Barcelona, Spain; Orozco, M., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franques, E-08028 Barcelona, Spain; González, C., Instituto de Estructura de la Materia, C.S.I.C., Serrano 119, E-28006 Madrid, Spain; Eritja, R., Institut de Biologia Molecular de Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain","Parallel-stranded hairpins with a polypyrimidine sequence linked to a complementary purine carrying 8-aminopurines such as 8-aminoadenine, 8-aminoguanine and 8-aminohypoxanthine bind polypyrimidine sequences complementary (in an antiparallel sense) to the purine part by a triple helix. The relative stabilities of triplexes were assessed by UV-absorption melting experiments as a function of pH and salt concentration. Hairpins carrying 8-aminopurines give very stable triple helical structures even at neutral pH, as confirmed by gel-shift experiments, circular dichroism and nuclear magnetic resonance spectroscopy. The modified hairpins may be redesigned to cope with small interruptions in the polypyrimidine target sequence.",,"2,6 diaminopurine; adenine; complementary DNA; double stranded DNA; guanine; hypoxanthine; purine derivative; pyridine derivative; single stranded DNA; sodium chloride; circular dichroism; controlled study; DNA binding; DNA conformation; DNA sequence; gel mobility shift assay; gene targeting; melting point; molecular stability; nuclear magnetic resonance spectroscopy; nucleotide sequence; pH; priority journal; review; triple helix; ultraviolet spectroscopy",,"2,6 diaminopurine, 1904-98-9; adenine, 22177-51-1, 2922-28-3, 73-24-5; guanine, 69257-39-2, 73-40-5; hypoxanthine, 68-94-0; sodium chloride, 7647-14-5",,,"Dirección General de Investigación Científica y Técnica: PM99-0046, PB98-1222, CAL01-058-C2-2, BQU2000-0649

Generalitat de Catalunya: 2000-SGR-0018, 2001-SGR-0049","We thank the Dirección General de Investigación Científica y Técnica (grants PB98-1222, PM99-0046, BQU2000-0649 and CAL01-058-C2-2), the Generalitat de Catalunya (2000-SGR-0018 and 2001-SGR-0049) and Cygene Inc. for financial support.",,,"Thuong, N.T., Hélène, C., Sequence-specific recognition and modification of double-helical DNA by oligonucleotides (1993) Angew. Chem. Int. Ed. Engl, 32, pp. 666-690; Chan, P.P., Glazer, P.M., Triplex DNA: Fundamentals, advances and potential applications for gene therapy (1997) J. Mol. Med, 75, pp. 267-282; Vazquez, K., Wilson, J.H., Triplex-directed modification of genes and gene activity (1998) Trends Biochem. Sci, 23, pp. 4-9; Soyfer, V.N., Potaman, V.N., Triple Helical Nucleic Acids (1996), Springer-Verlag, New York; Malvy, C., Harel-Bellan, A., Pritchard, L.L., Triple Helix Forming Oligonucleotides (1999), Kluwer Academic Publishers, Dordrecht, The Netherlands; Robles, J., Grandas, A., Pedroso, E., Luque, F.J., Eritja, R., Orozco, M., Nucleic acid triple helices: Stability effects of nucleobase modifications (2002) Curr. Org. Chem, , in press; Luyten, I., Herdewijn, P., Hybridization properties of base-modified oligonucleotides within the double and triple helix motif (1998) Eur. J. Med. Chem, 33, pp. 515-576; Xodo, L.E., Manzini, G., Quadrifolio, F., van der Marel, G.A., van Boom, J.H., Effect of 5-methylcytosine on the stability of triple-stranded DNA - A thermodynamic study (1991) Nucleic Acids Res, 19, pp. 5625-5631; Povsic, T.J., Dervan, P., Triple helix formation by oligonucleotides on DNA extended to the physiological pH range (1989) J. Am. Chem. Soc, 111, pp. 3059-3061; Xiang, G., Bogacki, R., McLaughlin, L.W., Use of a pyrimidine nucleoside that functions as a bidentate hydrogen bond donor for the recognition of isolated or contiguous G-C base pairs by oligonucleotide-directed triplex formation (1996) Nucleic Acids Res, 24, pp. 1963-1970; Ono, A., Ts'o, P.O.P., Kan, L., Triplex formation of an oligonucleotide containing 2′-O-methylpseudoisocytidine with a DNA duplex at neutral pH (1992) J. Org. Chem, 57, pp. 3225-3230; Kandimalla, E.R., Agrawal, S., Hoogsteen DNA duplexes of 3′-3′ and 5′-5′-linked oligonucleotides and triplex formation with RNA and DNA pyrimidine single strands: Experimental and molecular modeling studies (1996) Biochemistry, 35, pp. 15332-15339; van de Sande, J.H., Ramsing, N.B., Germann, M.W., Elhorst, W., Kalisch, B.W., von Kitzing, E., Pon, R.T., Jovin, T.M., Parallel stranded DNA (1988) Science, 241, pp. 551-557; Rippe, K., Jovin, T.M., Parallel-stranded duplex DNA (1992) Methods Enzymol, 211, pp. 199-220; Giovannangeli, C., Montenay-Garestier, T., Rougée, M., Chassignol, M., Thuong, N.T., Hélène, C., Single-stranded DNA as a target for triple-helix formation (1991) J. Am. Chem. Soc, 113, pp. 7775-7777; Rumney, S., Kool, E.T., Structural optimisation of non-nucleotide loop replacements for duplex and triplex DNAs (1995) J. Am. Chem. Soc, 117, pp. 5635-5646; Güimil García, R., Ferrer, E., Macías, M.J., Eritja, R., Orozco, M., Theoretical calculations, synthesis and base pairing properties of oligonucleotides containing 8-amino-2′-deoxyadenosine (1999) Nucleic Acids Res, 27, pp. 1991-1998; Kawai, K., Saito, I., Sugiyama, H., Stabilization of Hoogsteen base pairing by introduction of NH2 group at the C8 position of adenine (1998) Tetrahedron Lett, 39, pp. 5221-5224; Rao, T.S., Durland, R.H., Revankar, G.R., Synthesis of oligonucleotides containing 7-(2-deoxy-β-D-erythro-pentofuranosyl)guanine and 8-amino-2′-deoxyguanosine (1994) J. Heterocyclic Chem, 31, pp. 935-940; Rieger, R.A., Iden, C.R., Gonikberg, E., Johnson, F., 8-Amino-2′-deoxyguanosine incorporation into oligomeric DNA (1999) Nucl. Nucl, 18, pp. 73-88; Soliva, R., Güimil García, R., Blas, J.R., Eritja, R., Asensio, J.L., González, C., Luque, F.J., Orozco, M., DNA-triplex stabilizing properties of 8-aminoguanine (2000) Nucleic Acids Res, 28, pp. 4531-4539; Cubero, E., Güimil García, R., Luque, F.J., Eritja, R., Orozco, M., The effect of amino groups on the stability of DNA duplexes and triplexes based on purines derived from inosine (2001) Nucleic Acids Res, 29, pp. 2522-2534; Cubero, E., Aviñó, A., de la Torre, B.G., Frieden, M., Eritja, R., Luque, F.J., González, C., Orozco, M., Hoogsteen-based parallel-stranded duplexes of DNA. The effect of 8-amino derivatives (2002) J. Am. Chem. Soc, 124, pp. 3133-3142; Aviñó, A., Morales, J.C., Frieden, M., de la Torre, B.G., Güimil García, R., Cubero, E., Luque, F.J., Eritja, R., Parallel-stranded hairpins containing 8-aminopurines. Novel efficient probes for triple-helix formation (2001) Bioorg. Med. Chem. Lett, 11, pp. 1761-1763; Plateau, P., Güéron, M., Exchangeable proton NMR without base-line distortion, using new strong-pulse sequences (1982) J. Am. Chem. Soc, 104, pp. 7310-7311; Lee, C., Yang, W., Parr, R.G., Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density (1998) Phys. Rev. B, 37, pp. 785-789; Boys, S.F., Bernardi, F., The calculation of small molecules interactions by the differences of separate total energies. Some procedures with reduced errors (1970) Mol. Phys, 19, pp. 553-559; Shields, G., Laughton, C.A., Orozco, M., Molecular dynamics simulations of the d(T·A·T) triple helix (1997) J. Am. Chem. Soc, 119, pp. 7463-7469; Cubero, E., Luque, F.J., Orozco, M., Theoretical studies of d(A:T)-based parallel-stranded DNA duplexes (2001) J. Am. Chem. Soc, 123, pp. 12018-12025; Shields, G., Laughton, C.A., Orozco, M., Molecular dynamics simulation of a PNA·DNA·PNA triple helix in aqueous solution (1998) J. Am. Chem. Soc, 120, pp. 5895-5904; Darden, T.A., York, D., Pedersen, L., Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems (1993) J. Chem. Phys, 98, pp. 10089-10092; Ryckaert, J.P., Ciccote, G., Berendsen, J.C., Numerical integration of the Cartesian equations of motion of a system with constrains: Molecular dynamics of n-alkanes (1977) J. Comput. Phys, 23, pp. 327-341; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R., Klein, M.L., Comparison of single potential functions for simulating liquid water (1983) J. Chem. Phys, 79, pp. 926-935; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J. Am. Chem. Soc, 117, pp. 5179-5197; Cheatham, T.E., Cieplak, P., Kollman, P.A., A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat (1999) J. Biomol. Struct. Dyn, 16, pp. 845-862; Soliva, R., Laughton, C.A., Luque, F.J., Orozco, M., Molecular dynamics simulations in aqueous solution of triple helices containing d(G·C·C) trios (1998) J. Am. Chem. Soc, 120, pp. 11226-11233; Manzini, G., Xodo, L.E., Gasparotto, D., Triple helix formation by oligopurine-oligopyrimidine DNA fragments-electrophoretic, and thermodynamic behaviour (1990) J. Mol. Biol, 213, pp. 833-843; Wang, S., Booher, M.A., Kool, E.T., Stabilities of nucleotide loops bridging the pyrimidine strands in DNA pyrimidine.purine.pyrimidine triplexes: Special stability of the CTTTG loop (1994) Biochemistry, 33, pp. 4639-4644; Gowers, D.M., Fox, K.R., Towards mixed sequence recognition by triple helix formation (1999) Nucleic Acids Res, 27, pp. 1569-1577; Venkatarangan, L., Sivaprasad, A., Jonson, F., Basu, A.K., Site-specifically located 8-amino-2′-deoxyguanosine: Thermodynamic stability and mutagenic properties in Escherichia coli (2001) Nucleic Acids Res, 29, pp. 1458-1463; Sugimoto, N., Wu, P., Hara, H., Kawamoto, Y., pH and cation effects on the properties of parallel pyrimidine motif DNA triplexes (2001) Biochemistry, 40, pp. 9396-9405; Liu, K., Miles, H.T., Frazier, J., Sasisekharan, V., A novel DNA duplex. A parallel-stranded DNA helix with Hoogsteen base pairing (1993) Biochemistry, 32, pp. 11802-11809","Eritja, R.; Inst. Biologia Molecular Barcelona, C.S.I.C., Jordi Girona 18-26, E-08034 Barcelona, Spain; email: recgma@cid.csic.es",,,"Oxford University Press",,,,,03051048,,NARHA,"12060677","English","Nucleic Acids Res.",Review,"Final",,Scopus,2-s2.0-18444384215
"Beuning P.J., Nagan M.C., Cramer C.J., Musier-Forsyth K., Gelpí J.-L., Bashford D.","6603528572;6507774246;7202488076;7005467107;35517522400;57204983978;","Efficient aminoacylation of the tRNAAla acceptor stem: Dependence on the 2:71 base pair",2002,"RNA","8","5",,"659","670",,15,"10.1017/S1355838202020277","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036247311&doi=10.1017%2fS1355838202020277&partnerID=40&md5=626bba1746eba3ec91dfcf51693c8527","Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States","Beuning, P.J., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; Nagan, M.C., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; Cramer, C.J., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; Musier-Forsyth, K., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; Gelpí, J.-L., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; Bashford, D., Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States","Specific aminoacylation by aminoacyl-tRNA synthetases requires accurate recognition of cognate tRNA substrates. In the case of alanyl-tRNA synthetase (AlaRS), RNA duplexes that mimic the acceptor stem of the tRNA are efficient substrates for aminoacylation in vitro. It was previously shown that recognition by AlaRS is severely affected by a simple base pair transversion of the G2:C71 pair at the second position in the RNA helix. In this study, we determined the aminoacylation efficiencies of 50 variants of the tRNAAla acceptor stem containing substitutions at the 2:71 position. We find that there is not a single functional group of the wild-type G2:C71 base pair that is critical for positive recognition. Rather, we observed that base-pair orientation plays an important role in recognition. In particular, pyrimidine2:purine71 combinations generally resulted in decreased aminoacylation efficiency compared to the corresponding purine:pyrimidine pair. Moreover, the activity of a pyrimidine:purine variant could be partially restored by the presence of a major groove amino group at position 71. In an attempt to understand this result further, dielectric continuum electrostatic calculations were carried out, in some cases with additional inclusion of van der Waals interaction energies, to determine interaction potentials of the wild-type duplexAla and seven 2:71 variants. This analysis revealed a positive correlation between major groove negative electrostatic potential in the vicinity of the 3:70 base pair and measured aminoacylation efficiency.","Atomic group mutagenesis; Electrostatic potential; Molecular dynamics; Molecular interaction potential; RNA recognition; TRNA acceptor stem","alanine; amino acid transfer RNA ligase; purine; pyrimidine; transfer RNA; aminoacylation; article; base pairing; calculation; dielectric constant; hydrogen bond; molecular dynamics; molecular interaction; molecular recognition; mutagenesis; nucleic acid base substitution; priority journal; Acylation; Alanine-tRNA Ligase; Base Pairing; Base Sequence; Electrostatics; Escherichia coli; Hydrogen Bonding; Mutagenesis, Site-Directed; Nucleic Acid Conformation; RNA, Bacterial; RNA, Transfer, Ala; Thermodynamics",,"Alanine-tRNA Ligase, EC 6.1.1.7; RNA, Bacterial; RNA, Transfer, Ala",,,,,,,"Auffinger, P., Westhof, E., Water and ion binding around RNA and DNA (C,G) oligomers (2000) J Mol Biol, 300, pp. 1113-1131; Bashford, D., An object-oriented programming suite for electrostatic effects in biological molecules (1997) Scientific computing in object-oriented parallel environments (iscope97), lecture notes in computer science, 1343, pp. 233-240. , Ishikawa Y, Oldehoeft RR, Reynders JVW, Tholburn M, eds. Berlin: Springer; Bashford, D., Gerwert, K., Electrostatic calculations of the pKa values of ionizable groups in bacteriorhodopsin (1992) J Mol Biol, 224, pp. 473-486; Berendsen, H.J.C., Postma, J.P.M., Van Gunsteren, W.F., DiNola, A., Haak, J.R., Molecular dynamics with coupling to an external bath (1984) J Comput Phys, 81, pp. 3684-3690; Beuning, P.J., Gulotta, M., Musier-Forsyth, K., Atomic group ""mutagensis"" reveals major groove fine interactions of a tRNA synthetase with an RNA helix (1997) J Am Chem Soc, 119, pp. 8397-8402; Beuning, P.J., Musier-Forsyth, K., Transfer RNA recognition by aminoacyl-tRNA synthetases (1999) Biopolymers (Nucleic Acid Sci), 52, pp. 1-28; Beuning, P.J., Yang, F., Schimmel, P., Musier-Forsyth, K., Specific atomic groups and RNA helix geometry in acceptor stem recognition by a tRNA synthetase (1997) Proc Natl Acad Sci USA, 94, pp. 10150-10154; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham T.E. III, Ross, W.S., Simmerling, C.L., Darden, T.A., Kollman, P.A., (1997) AMBER 5.0, , San Francisco, CA: University of California; Cate, J.H., Doudna, J.A., Metal-binding sites in the major groove of a large ribozyme domain (1996) Structure, 4, pp. 1221-1229; Cheatham T.E. III, Kollman, P.A., Molecular dynamics simulations highlight the structural differences among DNA:DNA, RNA:RNA, and DNA:RNA hybrid duplexes (1997) J Am Chem Soc, 119, pp. 4805-4825; Chin, K., Sharp, K.A., Honig, B., Pyle, A.M., Calculating the electrostatic properties of RNA provides new insights into molecular interactions and functions (2000) Nat Struct Biol, 6, pp. 1055-1061; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz K.M., Jr., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J Am Chem Soc, 117, pp. 5179-5197; Correll, C.C., Freeborn, B., Moore, P.B., Steitz, T.A., Metals, motifs, and recognition in the crystal structure of a 5S rRNA domain (1997) Cell, 91, pp. 705-712; Cusack, S., Yaremchuk, A., Tukalo, M., The crystal structure of the ternary complex of T. thermophilus seryl-tRNA synthetase with tRNASer and a seryl-adenylate analogue reveals a conformational switch in the active site (1996) EMBO J, 15, pp. 2834-2842; Ditchfield, R., Hehre, W.J., Pople, J.A., Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules (1971) J Chem Phys, 54, pp. 724-728; Fersht, A.R., Ashford, J.S., Bruton, C.J., Jakes, R., Koch, G.L.E., Hartley, B.S., Active site titration and aminoacyl adenylate binding stolchiometry of aminoacyl-tRNA synthetases (1975) Biochemistry, 14, pp. 1-4; Fischer, A.E., Beuning, P.J., Musier-Forsyth, K., Identification of discriminator base atomic groups that modulate the alanine aminoacylation reaction (1999) J Biol Chem, 274, pp. 37093-37096; Francklyn, C., Schimmel, P., Aminoacylation of RNA minihelices with alanine (1989) Nature, 337, pp. 478-481; Francklyn, C., Shi, J.-P., Schimmel, P., Overlapping nucleotide determinants for specific aminoacylation of RNA microhelices (1992) Science, 255, pp. 1121-1125; Freier, S.M., Kierzek, R., Jaeger, J.A., Sugimoto, N., Caruthers, M.H., Nielson, T., Turner, D.H., Improved free-energy parameters for predictions of RNA duplex stability (1986) Proc Natl Acad Sci USA, 83, pp. 9373-9377; Frisch, M., Trucks, G., Schlegel, H., Gill, P., Johnson, B., Robb, M., Cheeseman, J., Pople, J., (1998) Gaussian A.6, , Pittsburgh, PA: Gaussian, Inc; Gelpí, J.L., Kalko, S.G., Barril, X., Cirera, J., De la Cruz, X., Luque, F.J., Orozco, M., Classical molecular interaction potentials. Improved setup procedure in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Giegé, R., Sissler, M., Florentz, C., Universal rules and idiosyncratic features in tRNA identity (1998) Nucleic Acids Res, 26, pp. 5017-5035; Gilson, M.K., Honig, B., Calculation of total electrostatic energy of a macromolecular system: Solvation energies, binding energies, and conformational analysis (1988) Proteins, 4, pp. 7-18; Hariharan, P.C., Pople, J.A., The effects of d-functions on molecular orbital energies for hydrocarbons (1972) Chem Phys Lett, 66, pp. 217-219; Hehre, W.J., Ditchfield, R., Pople, J.A., Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules (1972) J Chem Phys, 56, pp. 2257-2261; Hehre, W.J., Radom, L., Schleyer, P.V.R., Pople, J.A., (1986) Ab initio molecular orbital theory, , New York: Wiley; Hou, Y.-M., Schimmel, P., A simple structural feature is a major determinant of the identity of a transfer RNA (1988) Nature, 333, pp. 140-145; Humphrey, W., Dalke, A., Schulten, K., VMD: Visual molecular dynamics (1996) J Mol Graph, 14, pp. 33-38; Ibba, M., Söll, D., Aminoacyl-tRNA synthesis (2000) Annu Rev Biochem, 69, pp. 617-650; Jorgensen, W.L., Chandreskhar, J., Madura, J.D., Impey, R.W., Klein, J., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79, pp. 926-935; Kieft, J.S., Tinoco, I., Solution structure of a metal-binding site in the major groove of RNA complexed with cobalt(III) hexamine (1997) Structure, 5, pp. 713-721; Lavery, R., Pullman, B., The electrostatic field of DNA: The role of nucleic acid conformation (1982) Nucleic Acids Res, 10, pp. 4383-4395; Lavery, R., Sklenar, H., The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids (1988) J Biomol Struct Dynamics, 6, pp. 63-91; Lavery, R., Sklenar, H., Defining the structure of irregular nucleic acids: Conventions and principles (1989) J Biomol Struct Dynamics, 6, pp. 655-667; Lavery, R., Sklenar, H., (1998) Curves 5.3, , Paris, France: Institut de Biologie Physico-Chimique; Le, S.Y., Chen, J.H., Pattabiraman, N., Maizel J.V., Jr., Ion-RNA interactions in the RNA pseudoknot of a ribosomal frameshifting site: Molecular modeling studies (1998) J Biomol Struct Dynamics, 16, pp. 1-11; Liu, H., Yap, L.-P., Musier-Forsyth, K., Single atomic group in RNA helix needed for positive and negative tRNA synthetase discrimination (1996) J Am Chem Soc, 118, pp. 2523-2524; Maniatis, T., Fritsch, E.F., Sambrook, J., (1982) Molecular cloning: A laboratory manual, , Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; McClain, W.H., Foss, K., Changing the identity of a tRNA by introducing a G-U wobble pair near the 3′ acceptor end (1988) Science, 240, pp. 793-796; McClain, W.H., Foss, K., Jenkins, R.A., Schneider, J., Four sites in the acceptor helix and one site in the variable pocket of tRNAAla determine the molecule's acceptor identity (1991) Proc Natl Acad Sci USA, 88, pp. 9272-9276; Misra, V.K., Hecht, J.L., Sharp, K.A., Friedman, R.A., Honig, B., Salt effects on protein-DNA interactions. The lambda cI repressor and EcoRI endonuclease (1994) J Mol Biol, 238, pp. 264-280; Montgomery, D.C., Peck, E.A., Vining, G.G., (2001) Introduction to linear regression analysis, 3rd ed., , New York: Wiley; Mueller, U., Schübel, H., Sprinzl, M., Heinemann, U., Crystal structure of acceptor stem of tRNA(Ala) from Escherichia coli shows unique G.U wobble base pair at 1.16 Å resolution (1999) RNA, 5, pp. 670-677; Musier-Forsyth, K., Transfer RNA acceptor stem determinants for specific aminoacylation by class II aminoacyl-tRNA synthetases (1998) J Biochem Mol Biol, 31, pp. 525-535; Musier-Forsyth, K., Schimmel, P., Functional contacts of a transfer RNA synthetase with 2′-hydroxyl groups in the RNA minor groove (1992) Nature, 357, pp. 513-515; Musier-Forsyth, K., Schimmel, P., Atomic determinants for aminoacylation of RNA minihelices and relationship to genetic code (1999) Acc Chem Res, 32, pp. 368-375; Musier-Forsyth, K., Shi, J.-P., Henderson, B., Bald, R., Fürste, J.P., Erdmann, V.A., Schimmel, P., Base analog-induced aminoacylation of an RNA helix by a tRNA synthetase (1995) J Am Chem Soc, 117, pp. 7253-7254; Musier-Forsyth, K., Usman, N., Scaringe, S., Doudna, J., Green, R., Schimmel, P., Specificity for aminoacylation of an RNA helix: An unpaired, exocyclic amino group in the minor groove (1991) Science, 253, pp. 784-786; Nagan, M.C., Beuning, P.J., Musier-Forsyth, K., Cramer, C.J., Importance of discriminator-base stacking interactions: Molecular dynamics analysis of A73 microhelixAIa variants (2000) Nucleic Acids Res, 28, pp. 2527-2534; Nagan, M.C., Kerimo, S.S., Musier-Forsyth, K., Cramer, C.J., Wild-type RNA microhelixAIa and 3:70 variants: Molecular dynamics analysis of local helical structure and tightly bound water (1999) J Am Chem Soc, 121, pp. 7310-7317; Orozco, M., Luque, F.J., Molecular interaction potential: A new tool for the theoretical study of molecular reactivity (1993) J Comput Chem, 14, pp. 587-602; Ott, G., Arnold, L., Limmer, S., Proton NMR studies of manganese ion binding to tRNA-derived acceptor stem duplexes (1993) Nucleic Acids Res, 21, pp. 5859-5864; Park, S.J., Schimmel, P., Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA (1988) J Biol Chem, 263, pp. 16527-16530; Press, W.H., Flannery, B.P., Teukolsky, S.A., Vetterling, W.T., (1986) Numerical recipes: The art of scientific computing, , Cambridge: Cambridge University Press; Ramos, A., Varani, G., Structure of the acceptor stem of Escherichia coli tRNAAla: Role of the G3:U70 base pair in synthetase recognition (1997) Nucleic Acids Res, 25, pp. 2083-2090; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J Comput Phys, 23, pp. 327-341; Saks, M.E., Sampson, J.R., Variant minihelix RNAs reveal sequence-specific recognition of the helical tRNASer acceptor stem by E. coli seryl-tRNA synthetase (1996) EMBO J, 15, pp. 2843-2849; Sankaranarayanan, R., Dock-Bregeon, A.-C., Romby, P., Caillet, J., Springer, M., Rees, B., Ehresmann, C., Moras, D., The structure of threonyl-tRNA synthetase-tRNAThr complex enlightens its repressor activity and reveals an essential zinc ion in the active site (1999) Cell, 97, pp. 371-381; Sanner, M.F., Olson, A.J., Spehner, J.-C., Reduced surface: An efficient way to compute molecular surfaces (1996) Biopolymers, 38, pp. 305-320; Scaringe, S.A., Francklyn, C., Usman, N., Chemical synthesis of biologically active oligoribonucleotides using β-cyanoethyl protected ribonucleoside phosphoramidites (1990) Nucleic Acids Res, 18, pp. 5433-5441; Sowers, L.C., Boulard, Y., Fazakerley, G.V., Multiple structures for the 2-aminopurine-cytosine mispair (2000) Biochemistry, 39, pp. 7613-7620; Sproat, B., Colonna, F., Mullah, B., Tsou, D., Andrus, A., Hampel, A., Vinayak, R., An efficient method for the isolation and purification of oligoribonucleotides (1995) Nucleosides Nucleotides, 14, pp. 255-273; Suga, H., Cowan, J.A., Szostak, J.W., Unusual metal ion catalysis in an acyl-transferase ribozyme (1998) Biochemistry, 37, pp. 10118-10125; Turner, D.H., Sugimoto, N., Freier, S.M., RNA structure prediction (1988) Annu Rev Biophys Biophys Chem, 17, pp. 167-192; Ullmann, G.M., Hauswald, M., Jensen, A., Knapp, E.W., Structural alignment of ferredoxin and flavodoxin based on electrostatic potentials: Implications for their interactions with photosystem I and ferredoxin-NADP reductase (2000) Proteins, 38, pp. 301-309; Vogtherr, M., Schübel, H., Limmer, S., Structural and dynamic helix geometry alterations induced by mismatch base pairs in double-helical RNA (1998) FEBS Lett, 429, pp. 21-26; Weeks, K.M., Crothers, D.M., Major groove accessibility of RNA (1993) Science, 261, pp. 1574-1577; Wu, X., Pitsch, S., Synthesis and pairing properties of oligoribo-nucleotide analogues containing a metal-binding site attached to β-D-allofuranosyl cytosine (1998) Nucleic Acids Res, 26, pp. 4315-4323; York, D.M., Darden, T.A., Pedersen, L.G., The effects of long-range electrostatic interactions in simulations of macromolecular crystals: Comparison of the Ewald and truncated list methods (1993) J Chem Phys, 99, pp. 8345-8348; Young, M.A., Jayaram, B., Beveridge, D.L., Intrusion of counterions into the spine of hydration in the minor groove of B-DNA: Fractional occupancy of electronegative pockets (1997) J Am Chem Soc, 119, pp. 59-69","Musier-Forsyth, K.; Department of Chemistry, 139 Smith Hall, 207 Pleasant Street SE, Minneapolis, MN 55455-0431, United States; email: musier@chem.umn.edu",,,,,,,,13558382,,RNARF,"12022232","English","RNA",Article,"Final",,Scopus,2-s2.0-0036247311
"Queralt R., Ezquerra M., Lieó A., Castellví M., Gelpí J., Ferrer I., Acarín N., Pasarín L., Blesa R., Oliva R.","6701730399;6603683564;38061577400;6602244361;35517522400;36042305900;6603128633;38062072200;56186408100;17635957400;","A novel mutation (V89l)in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances",2002,"Journal of Neurology Neurosurgery and Psychiatry","72","2",,"266","269",,39,"10.1136/jnnp.72.2.266","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036155190&doi=10.1136%2fjnnp.72.2.266&partnerID=40&md5=8819d82ca105748855f913c616ed0557","Genetics Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Neurology Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Bank of Neurological Tissues, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Neurology Service, Hospital Vall d'Hebron, Barcelona, Spain; Institut Psiquiatric, IMAS, Barcelona, Spain","Queralt, R., Genetics Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Ezquerra, M., Genetics Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Lieó, A., Neurology Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Castellví, M., Neurology Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Gelpí, J.; Ferrer, I., Bank of Neurological Tissues, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Acarín, N., Neurology Service, Hospital Vall d'Hebron, Barcelona, Spain; Pasarín, L., Institut Psiquiatric, IMAS, Barcelona, Spain; Blesa, R., Neurology Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Oliva, R., Genetics Service, Hospital Clinic, Universitat de Barcelona, Villarroel 170, 08036 Barcelona, Spain","A novel mutation (V89L) in the presenilin 1 (PSEN1) gene is described in a family with pathologically confirmed Alzheimer's disease. The mutation was identified in two affected members with early onset Alzheimer's disease characterised by early and marked behavioural disturbances. The mutation is located on the same side of the helix as other described mutations in the first transmembrane domain and its relation to other mutations in this helix suggests that they share a common pathogenic mechanism.",,"presenilin 1; adult; Alzheimer disease; article; behavior disorder; case report; DNA helix; familial disease; female; gene mutation; genetic analysis; human; male; pathogenesis; priority journal; Alzheimer Disease; Brain; Chromosomes, Human, Pair 14; DNA Mutational Analysis; Exons; Follow-Up Studies; Humans; Male; Membrane Proteins; Mental Disorders; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Presenilin-1",,"presenilin 1, 186986-30-1; Membrane Proteins; PSEN1 protein, human; Presenilin-1",,,,,,,"Goate, A., Chartier-Harlin, M.C., Mullan, M., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) Nature, 349, pp. 704-709; Sherrington, R., Rogaev, E.I., Liang, Y., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease (1995) Nature, 375, pp. 754-760; Levy-Lahad, E., Wasco, W., Poorkak, P., Candidate gene for the chromosome 1 familial Alzheimmer's disease locus (1995) Science, 269, pp. 973-977; Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Familial Alzheimer's disease in kindreds with missence mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene (1995) Nature, 376, pp. 775-778; Rosenberg, R.N., The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture (2000) Neurology, 54, pp. 2045-2054; McKhann, G., Drachman, D., Folstein, M.F., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA-work group under the auspices of Department of Health and Human Services, Task Force (1984) Neurology, 34, pp. 939-944; Cruts, M., Van Duijn, C.M., Backhovens, H., Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer's disease (1998) Hum Mol Genet, 7, pp. 43-51; Blesa, R., Adroer, R., Santacruz, P., High apolipoprotein E epsilon 4 allele frequency in age-related memory decline (1996) Ann Neurol, 39, pp. 515-518; Bersntein, F.C., Koetzle, T.F., Williams, G.J., The proteins data bank: A computer-based archival file for macromolecular structures (1977) J Mol Biol, 112, pp. 535-542; Ezquerra, M., Carnero, C., Blesa, R., A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures (1999) Neurology, 52, pp. 566-570; Finckh, U., Muller-Thomsen, T., Mann, U., High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes (2000) Am J Hum Genet, 66, pp. 110-117; Kamino, K., Sato, S., Sakaki, Y., Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families (1996) Neurosci Lett, 208, pp. 195-198; Steiner, H., Revesz, T., Neumann, M., A pathogenic presenilin-1 deletion causes abberrant A-beta-42 production in the absence of congophilic amyloid plaques (2000) J Biol Chem, 276, pp. 7233-7239; Jacquier, M., Arango, D., Torres, O., Presenilin mutations in a Colombian familial and sporadic AD sample (2000) Neurobiol Aging, (SUPPL. 1), pp. S176; Crook, R., Ellis, R., Shanks, M., Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation (1997) Ann Neurol, 42, pp. 124-128; Hardy, J., Crook, R., Presenilin mutations line up along transmembrane α-helices (2001) Neurosci Lett, 306, pp. 203-205","Oliva, R.; Genetics Service, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain; email: roliva@clinic.ub.es",,,,,,,,00223050,,JNNPA,"11796781","English","J. Neurol. Neurosurg. Psychiatry",Article,"Final",Open Access,Scopus,2-s2.0-0036155190
"Fradera X., De La Cruz X., Silva C.H.T.P., Gelpí J.L., Luque F.J., Orozco M.","7003772045;6603686486;35500040300;35517522400;23025357900;7102809158;","Ligand-induced changes in the binding sites of proteins",2002,"Bioinformatics","18","7",,"939","948",,37,"10.1093/bioinformatics/18.7.939","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036323965&doi=10.1093%2fbioinformatics%2f18.7.939&partnerID=40&md5=22a19df2aeaa936a3068fc08f20757d6","Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal s/n, Barcelona 08028, Spain; Departament de Bioquímica I Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Institut Catala de Recerca I Estudis Avançats (ICREA), Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain","Fradera, X., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal s/n, Barcelona 08028, Spain; De La Cruz, X., Departament de Bioquímica I Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain, Institut Catala de Recerca I Estudis Avançats (ICREA), Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Silva, C.H.T.P., Departament de Bioquímica I Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Gelpí, J.L., Departament de Bioquímica I Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal s/n, Barcelona 08028, Spain; Orozco, M., Departament de Bioquímica I Biología Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain","Classical molecular interaction potentials, in conjunction with other theoretical techniques, are used to analyze the dependence of the binding sites of representative proteins on the bound ligand. It is found that the ligand bound introduces in general small structural perturbations at the binding site of the protein. However, such small structural changes can lead to important alterations in the recognition pattern of the protein. The impact of these findings in docking procedures is discussed.",,"chymotrypsin; cytochrome P450; ligand; lysozyme; papain; protein; thymidine kinase; trypsin; xylose isomerase; analytic method; article; binding site; controlled study; molecular interaction; molecular recognition; priority journal; protein binding; protein structure; structure analysis",,"chymotrypsin, 9004-07-3, 9014-64-6; cytochrome P450, 9035-51-2; lysozyme, 9001-63-2; papain, 9001-73-4; protein, 67254-75-5; thymidine kinase, 9002-06-6, 9086-73-1; trypsin, 9002-07-7; xylose isomerase, 9023-82-9",,,,,,,"Alexeev, D., Baxter, R.L., Sawyer, L., Mechanistic implications and family from the structure of dethiobiotin synthetase (1994) Structure (London), 2, pp. 1061-1072; Apostolakis, J., Plückthum, A., Caflisch, A., Docking small ligands in flexible binding sites (1998) J. Comput. Chem, 19, pp. 21-37; Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E., The protein data bank (2000) Nucleic Acids Res, 28, pp. 235-242; Blaney, J.M., Dizo, J.S., A good ligand is hard to find: Automatic docking methods (1993) Perspect Drug. Discov. Des, 1, pp. 301-319; Brady, K., Wei, A.Z., Ringe, D., Abeles, R.H., Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: Comparison of slowly and rapidly equilibrating inhibitors (1990) Biochemistry, 29, pp. 7600-7607; Burley, S.K., An overview of structural genomics (2000) Nature Struct. Biol, 7, pp. 932-934; Burley, S.K., Almo, S.C., Bonanno, J.B., Capel, M., Chance, M.R., Gaasterland, T., Lin, D., Swaminathan, S., Strutural genomics: Beyond the human genome project (1999) Nat. Genet, 23, pp. 151-157; Carlson, H., Masukawa, K.M., McCammon, J.A., Method for including the dynamic fluctuations of a protein in computer-aided drug design (1999) J. Phys. Chem. A, 103, pp. 10 213-10 219; Carrell, H.L., Glusker, J.P., Burger, V., Manfre, F., Tritsch, D., Biellmann, J.F., X-ray analysis of D-xylose isomerase at 1.9 angstroms: Native enzyme in complex with substrate and with a mechanism-designed inactivator (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 4440-4444; Carrell, H.L., Hoier, H., Glusker, J.P., Modes of binding substrates and their analogues to the enzyme D-xylose isomerase (1994) Acta Crystallogr. D Biol. Crystallogr, 50, pp. 113-123; Cohen, G.H., Silverton, E.W., Davies, D.R., Refined crystal structure of gamma-chymotrypsin at 1.9 A resolution. Comparison with other pancreatic serine proteases (1981) J. Mol. Biol, 148, pp. 449-479; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K.M., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., A second generation force field for the simulation of proteins, nucleic acids, and organic molecules (1995) J. Am. Chem. Soc, 117, pp. 5179-5197; Ewing, T., Kuntz, I.D., Critical evaluation of search algorithm for flexible docking (1997) J. Comput. Chem, 18, pp. 1175-1189; Farber, G.K., New approaches to rational drug design (1999) Pharmacol. Ther, 84, pp. 327-332; Fradera, X., Knegttel, R.M.A., Mestres, J., Similarity-driven flexible ligand docking (2000) Proteins, 40, pp. 623-636; Gelpí, J.L., Kalko, S., de la Cruz, X., Barril, X., Cirera, J., Luque, F.J., Orozco, M., Use of classical molecular interaction potentials in molecular dynamics simulations of proteins (2001) Proteins, 45, pp. 428-437; Gilson, M., Honig, B., Calculation of the total electrostatic energy of a macromolecular system. Solvation energies, binding energies and conformational analysis (1988) Proteins, 4, pp. 7-18; Gilson, M., Sharp, K., Honig, B., Calculating the electrostatic potential of molecules in solution (1988) J. Comput. Chem, 9, pp. 327-335; Goodsell, D.S., Olson, A.J., Automated docking of substrates to proteins by simulated annealing (1990) Proteins, 8, pp. 195-202; Gohlke, H., Hendlich, M., Klebe, G., Knowledge-based scoring functions to predict protein-ligand interactions (2000) J. Mol. Biol, 295, pp. 337-356; Gschwend, D.A., Good, A.C., Kuntz, I.D., Molecular docking towards drug discovery (1996) J. Mol. Recognit, 8, pp. 175-186; Ha, S., Andreani, R., Robbins, A., Muegge, I., Evaluation of docking/scoring approaches: A comparatice study based on MMP3 inhibitors (2000) J. Comput. Aided Mol. Des, 14, pp. 435-448; Headley, A.G., Roe, S.M., Pearl, L.H., Protein data bank 1bb5 (1998), unpublished; Huang, W., Jia, J., Gibson, K.J., Taylor, W.S., Rendina, A.R., Schneider, G., Lindqvist, Y., Mechanism of an ATP-dependent carboxylase, dethiobiotin synthetase, based on studies of complexes with substrates and a intermediate (1995) Biochemistry, 34, pp. 10985-10995; Kaeck, H., Sandmark, J., Gibson, K.J., Schneider, G., Lindqvist, Y., Crystal structure of two quaternary complexes of dethiobiotin synthetase, enzyme-MgADP-ALF3-diaminopelargonic acid and enzyme-MgADP-dethiobiotin-phosphate; implications for catalysis (1998) Protein Sci, 7, pp. 2560-2566; Katz, B.A., Finer-Moore, J., Mortezaei, R., Rich, S.H., Stroud, R.M., Episelection: Novel Ki ∼nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface (1995) Biochemistry, 34, pp. 8264-8280; Kim, M.J., Yamamoto, D., Matsumoto, K., Inoue, M., Ishida, T., Mizuno, H., Sumiya, S., Kitamura, K., Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites (1992) Biochem. J, 287, pp. 797-803; Knegtel, R.M.A., Grootenhuis, P.D.J., Binding affinities and non-bonded interaction energies (1998) Perpect. Drug Discov. Des, 9, pp. 99-114; Knegtel, R.M.A., Kuntz, I.D., Oshiro, C.M., Molecular docking to ensembles of protein structures (1997) J. Mol. Biol, 266, pp. 424-440; Kreutter, K., Steinmetz, A.C., Liang, T.C., Prorok, M., Abeles, R.H., Ringe, D., Three-dimensional structure of chymotrypsin inactivated with (2S)-N-acetyl-L-alanyl-L-phenylalanyl alpha-chloroethane: Implications for the mechanism of inactivation of serine proteases by chloroketones (1994) Biochemistry, 33, pp. 13 792-13 800; Kuntz, I.D., Structure-based strategies for drug design and discovery (1992) Science, 257, pp. 1078-1082; Kuntz, I.D., Meng, E.C., Shoichet, B.K., Structure-based molecular design (1994) Acc. Chem. Res, 27, pp. 117-123; Laskowski, R.A., SURFNET: A program for visualizing molecular surfaces, cavities and intermolecular interactions (1995) J. Mol. Graph, 13, pp. 323-330; Liu, M., Wang, S., MCDOCK: A Monte Carlo simulation approach to the molecular docking problem (1999) J. Comput. Aided Mol. Des, 13, pp. 435-451; Lengauer, T., Rarey, M., Computational methods for biomolecular docking (1996) Curr. Opin. Struct. Biol, 6, pp. 402-406; Meng, E.C., Shoichet, B.K., Kuntz, I.D., Orientational sampling and rigid-body minimization in molecular docking (1993) Proteins, 17, pp. 266-278; Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., Olson, A.J., Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function (1998) J. Comput. Chem, 19, pp. 1639-1662; Muraki, M., Harata, K., Sugita, N., Sato, K., Origin of carbohydrate recognition specificity human lysozyme revealed by affinity labeling (1996) Biochemistry, 35, pp. 13562-13567; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem. Rev, 100, pp. 4187-4225; Poulos, T.L., Finzel, B.C., Howard, A.J., Crystal structure of substrate-free Pseudomonas putida cytochrome P450 (1986) Biochemistry, 25, pp. 5314-5322; Poulos, T.L., Howard, A.J., Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P450cam (1987) Biochemistry, 26, pp. 8165-8174; Poulos, T.L., Finzel, B.C., Howard, A.J., High-resolution crystal structure of cytochrome P450cam (1987) J. Mol. Biol, 195, pp. 687-700; Raag, R., Poulos, T.L., Crystal structure of the carbon monoxy-substrate-cytochrome P450/cam ternary complex (1989) Biochemistry, 28, pp. 7586-7592; Raag, R., Poulos, T.L., The structural basis for substrate-induced changes in redox potential and spin equilibrium in cytochrome P-450(cam) (1989) Biochemistry, 28, pp. 917-922; Raag, R., Poulos, T.L., Crystal structures of cytochrome P-450/cam complexed with camphane, thiocamphor, and adamantane: Factors controlling P-450 substrate hydroxylation (1991) Biochemistry, 30, pp. 2674-2684; Raag, R., Swanson, B.A., Poulos, T.L., Ortiz De Montellano, P.R., Formation, crystal structure, and rearrangement of a cytochrome P450cam-iron-phenyl complex (1990) Biochemistry, 29, pp. 8119-8126; Raag, R., Li, H., Jones, B.C., Poulos, T.L., Inhibitor-induced conformational change in cytochrome P450cam (1993) Biochemistry, 32, pp. 4571-4578; Rarey, M., Kramer, B., Lengauer, T., Klebe, G., A fast flexible docking method using an incremental construction algorithm (1996) J. Mol. Biol, 261, pp. 470-489; Sandalova, T., Schneider, G., Kack, H., Lindqvist, Y., Structure of dethiobiotin synthetase at 0.97 A resolution (1999) Acta Crystallogr. Sect. D, 55, pp. 610-624; Schroeder, E., Phillips, C., Garman, E., Harlos, K., Crawford, C., X-ray crystallographic structure of a papainleupeptin complex (1993) FEBS Lett, 315, pp. 38-42; Skolnick, J., Fetrow, J.S., Kolinski, A., Structural genomics and its importance for gene function analysis (2000) Nat. Biotechnol, 18, pp. 283-287; Song, H., Inaka, K., Maenaka, K., Matsushima, M., Structural changes of the active site cleft and different saccharide binding modes in lysozyme co-crystallized with hexa-n-acetylchitohexaose at pH 4.0 (1994) J. Mol. Biol, 244, pp. 522-540; Stoddard, B.L., Bruhnke, J., Porter, N., Ringe, D., Petsko, G.A., Structure and activity of two photoreversible cinnamates bound to chymotrypsin (1990) Biochemistry, 29, pp. 4871-4879; Tsuge, H., Nishimura, T., Tada, Y., Asao, T., Turk, D., Turk, V., Katunuma, N., Inhibition mechanism of cathepsin 1-specific inhibitors based on the crystal structure of papain-CLIK148 complex (1999) Biochem. Biophys. Res. Commun, 266, pp. 411-416; Vidakovic, M., Sligar, S.G., Li, H., Poulos, T.L., Understanding the role of the essential Asp251 in cytochrome P450cam using site-directed mutagenesis, crystallography, and kinetic solvent isotope effect (1998) Biochemistry, 37, pp. 9211-9219; Walters, W.P., Stahl, M.T., Murcko, M.A., Virtual screening an overview (1998) Drug Discov. Today, 3, pp. 160-178; Yamamoto, D., Matsumoto, K., Ohishi, H., Ishida, T., Inoue, M., Kitamura, K., Mizuno, H., Refined x-ray structure of papain(dot)E-64-c complex at 2.1-Angstroms resolution (1991) J. Biol. Chem, 266, pp. 14771-14777; Yamamoto, A., Tomoo, K., Doi, M., Ohishi, H., Inoue, M., Ishida, T., Yamamoto, D., Okada, Y., Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7 Angstroms resolution: Noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors (1992) Biochemistry, 31, pp. 11305-11309","Luque, F.J.; Department of Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Avgda Diagonal s/n, Barcelona 08028, Spain; email: modesto@luz.bq.ub.es",,,"Oxford University Press",,,,,13674803,,BOINF,"12117791","English","Bioinformatics",Article,"Final",Open Access,Scopus,2-s2.0-0036323965
"Trejo F., Gelpí J.Ll., Ferrer A., Boronat A., Busquets M., Cortés A.","16752093100;35517522400;56227050000;26643516900;7003927984;7102092256;","Contribution of engineered electrostatic interactions to the stability of cytosolic malate dehydrogenase",2001,"Protein Engineering","14","11",,"911","917",,10,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035666516&partnerID=40&md5=76a1da58341bb54f0032f36ab5e4e292","Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain; Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Avda. Diagonal 643, E-08028 Barcelona, Spain","Trejo, F., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain; Gelpí, J.Ll., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain; Ferrer, A., Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia, Universitat de Barcelona, Avda. Diagonal 643, E-08028 Barcelona, Spain; Boronat, A., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain; Busquets, M., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain; Cortés, A., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain","Protein engineering is a promising tool to obtain stable proteins. Comparison between homologous thermophilic and mesophilic enzymes from a given structural family can reveal structural features responsible for the enhanced stability of thermophilic proteins. Structures from pig heart cytosolic and Thermusflavus malate dehydrogenases (cMDH, Tf MDH), two proteins showing a 55% sequence homology, were compared with the aim of increasing cMDH stability using features from the Thermus flavus enzyme. Three potential salt bridges from Tf MDH were selected on the basis of their location in the protein (surface R176-D200, inter-subunit E57-K168 and intrasubunit R149-E275) and implemented on cMDH using site-directed mutagenesis. Mutants containing E275 were not produced in any detectable amount, which shows that the energy penalty of introducing a charge imbalance in a region that was not exposed to solvent was too unfavourable to allow proper folding of the protein. The salt bridge R149-E275, if formed, would not enhance stability enough to overcome this effect. The remaining mutants were expressed and active and no differences from wild-type other than stability were found. Of the mutants assayed, Q57E/L168K led to a stability increase of 0.4 kcal/mol, as determined by either guanidinium chloride denaturalization or thermal inactivation experiments. This results in a 15°C shift in the optimal temperature, thus confirming that the inter-subunit salt bridge initially present in the T.flavus enzyme was formed in the cMDH structure and that the extra energy obtained is transformed into an increase in protein stability. These results indicate that the use of structural features of thermophilic enzymes, revealed by a detailed comparison of three-dimensional structures, is a valid strategy to improve the stability of mesophilic malate dehydrogenases.","Electrostatic interactions; Folding; Mesophilic enzymes; Protein stability; Site-directed mutagenesis; Thermophilic enzymes","guanidine; malate dehydrogenase; protein; solvent; article; dissociation constant; electricity; energy; enzyme activity; enzyme inactivation; enzyme stability; genetic engineering; nonhuman; polyacrylamide gel electrophoresis; priority journal; protein folding; sequence homology; site directed mutagenesis; swine; Thermus; Catalysis; Cytosol; Guanidine; Kinetics; Malate Dehydrogenase; Models, Molecular; Mutagenesis, Site-Directed; Mutation; NAD; Protein Conformation; Protein Engineering; Protein Folding; Recombinant Proteins; Salts; Temperature; Thermodynamics; Thermus; Sus scrofa; Thermus; Thermus thermophilus",,"Guanidine, 113-00-8; Malate Dehydrogenase, EC 1.1.1.37; NAD, 53-84-9; Recombinant Proteins; Salts",,,,,,,"Anderson, E., Becktel, W., Dahlquist, F., (1990) Biochemistry, 29, pp. 2403-2408; Berstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer E.F., Jr., Brice, M.D., Rodgers, J.R., Kennard, O., Tasumi, M., (1977) J. Mol. Biol., 112, pp. 535-542; Birktoft, J.J., Rhodes, G., Banaszak, L.J., (1989) Biochemistry, 28, pp. 6065-6081; Canela, E.I., (1984) Int. J. Biomed. Comp., 15, pp. 121-130; Chapman, A.D.M., Cortés, A., Dafforn, T.R., Clarke, A.R., Brady, R.L., (1999) J. Mol. Biol., 285, pp. 703-712; Dao-Pin, S., Sauer, U., Nicholson, H., Matthews, B., (1991) Biochemistry, 30, pp. 7142-7153; Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, M.G., Genest, G., Hagler, A.T., (1988) Proteins, 4, pp. 37-47; Erwin, C.R., Barnett, B.L., Oliver, J.D., Sullivan, J.F., (1990) Protein Eng., 4, pp. 87-97; Fersht, A.R., (1987) Trends Biochem. Sci., 12, pp. 301-304; Goward, C., Miller, J.P., Nicholls, D., Irons, L., Scawen, M., O'brien, R., Chowdhry, B., (1994) Eur. J. Biochem., 224, pp. 249-255; Heukeshoven, J., Dernick, R., (1985) Electrophoresis, 6, pp. 103-112; Horton, R.M., Pease, L.R., (1991) Directed Mutagenesis: A Practical Approach, pp. 217-247. , McPherson,M.J. (ed.), Oxford University Press, Oxford; Kelly, C.A., Nishiyama, M., Ohnishi, Y., Beppu, T., Birktoft, J.J., (1993) Biochemistry, 32, pp. 3913-3922; Kimura, S., Oda, Y., Nakai, T., Katayanagi, K., Kitakuni, E., Nakai, C., Nakamura, H., Kanaya, S., (1992) Eur. J. Biochem., 206, pp. 337-343; Kono, H., Nishiyama, M., Tanokura, M., Doi, J., (1998) Protein Eng., 11, pp. 47-52; Matthews, B.W., Nicholson, H., Becktel, W.J., (1987) Proc. Natl Acad. Sci. USA, 84, pp. 6663-6667; Nicholson, H., Becktel, W.J., Mattheus, B.W., (1988) Nature, 336, pp. 651-656; Nishiyama, M., Kinoshita, M., Kudo, H., Horinouchi, S., Tanokura, M., (1996) Biochem. Biophys. Res. Commun., 225, pp. 844-848; Nobbs, T.J., Cortés, A., Gelpí, J.Ll., Holbrook, J.J., Atkinson, T., Scawen, M.D., Nicholls, D.J., (1994) Biochem. J., 300 (PART 2), pp. 491-499; Perutz, M.F., Raidt, H., (1975) Nature, 255, pp. 256-259; Richardson, J.S., Richardson, D.C., (1989) Prediction of Protein Structure and the Principles of Protein Conformation, pp. 1-98. , Fasman, G.D. (ed.), Plenum Press, New York; Ruggia, A., Gelpí, J.Ll., Busquets, M., Cascante, M., Cortés, A., (2001) J. Mol. Catal., B: Enzymatic, 11, pp. 743-755; Sanger, F., Nicklen, S., Coulson, A.R., (1977) Proc. Natl Acad. Sci. USA, 74, pp. 5463-5467; Serrano, L., Horovitz, A., Avron, B., Bycroft, M., Fersht, A., (1990) Biochemistry, 29, pp. 9343-9352; Staniforth, R.A., Cortés, A., Burston, S.G., Atkinson, T., Holbrook, J.J., Clarke, A.R., (1994) FEBS Lett., 344, pp. 129-136; Tanner, J.J., Hecht, R.M., Krause, K.L., (1996) Biochemistry, 35, pp. 2597-2609; Trejo, F., Costa, M., Gelpí, J.Ll., Busquets, M., Clarke, A.R., Holbrook, J.J., Cortés, A., (1996) Gene, 172, pp. 303-308; Trejo, F., Gelpí, J.Ll., Busquets, M., Cortés, A., (1999) Curr. Top. Pept. Protein Res., 3, pp. 173-180; Vihinen, M., (1987) Protein Eng., 1, pp. 477-480; Walker, J.E., Wonacott, A.J., Harris, J.I., (1980) Eur. J. Biochem., 108, pp. 581-586; Warburg, O., Christian, W., (1942) Biochem. Z, 310, pp. 384-421; Wigley, D.B., Clarke, A.R., Dunn, C.R., Barstow, D.A., Atkinson, T., Chia, W.N., Muirhead, H., Holbrook, J.J., (1987) Biochim. Biophys. Acta, 916, pp. 145-148; Yutani, K., Ogasahara, K., Tsujita, T., Sugino, Y., (1987) Proc. Natl Acad. Sci. USA, 84, pp. 4441-4444; Zhang, X., Baase, W., Shoichet, B., Wilson, K., Matthews, B., (1995) Protein Eng., 8, pp. 1017-1022","Cortés, A.; Dept. de Bioquimica i Biol. Molec., Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, Spain; email: cortes@sun.bq.ub.es",,,,,,,,02692139,,PRENE,"11742111","English","Protein Eng.",Article,"Final",,Scopus,2-s2.0-0035666516
"Gelpí J.L., Kalko S.G., Barril X., Cirera J., De La Cruz X., Luque F.J., Orozco M.","35517522400;6602247257;6602104920;9278582700;6603686486;23025357900;7102809158;","Classical molecular interaction potentials: Improved setup procedure in molecular dynamics simulations of proteins",2001,"Proteins: Structure, Function and Genetics","45","4",,"428","437",,75,"10.1002/prot.1159","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035576327&doi=10.1002%2fprot.1159&partnerID=40&md5=3bac2370f8c13f38265618d7e76163aa","Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Instituto de Biología Molecular de Barcelona, CSIC, Barcelona, Spain; Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain","Gelpí, J.L., Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Kalko, S.G., Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain, Instituto de Biología Molecular de Barcelona, CSIC, Barcelona, Spain; Barril, X., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain; Cirera, J., Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; De La Cruz, X., Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain; Luque, F.J., Departament de Fisicoquímica, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain, Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Orozco, M., Departament de Bioquímica I Biologia Molecular, Facultat de Química, Universitat de Barcelona, Barcelona, Spain","The latest version of the classical molecular interaction potential (CMIP) has the ability to predict the position of crystallographic waters in several proteins with great accuracy. This article analyzes the ability of the CMIP functional to improve the setup procedure of the molecular system in molecular dynamics (MD) simulations of proteins. To this end, the CMIP strategy is used to include both water molecules and counterions in different protein systems. The structural details of the configurations sampled from trajectories obtained using the CMIP setup procedure are compared with those obtained from trajectories derived from a standard equilibration process. The results show that standard MD simulations can lead to artifactual results, which are avoided using the CMIP setup procedure. Because the CMIP is easy to implement at a low computational cost, it can be very useful in obtaining reliable MD trajectories. © 2001 Wiley-Liss, Inc.","CMIP; Counterions; MD simulations; Water molecules","ion; protein; water; accuracy; article; calculation; cost control; crystallography; molecular dynamics; molecular interaction; priority journal; simulation; standardization; water flow; Acetylcholinesterase; Animals; Binding Sites; Catalase; Computer Simulation; Electrostatics; Humans; Ions; Models, Chemical; Motion; Protein Conformation; Proteins; Thymidine Kinase; Water",,"Acetylcholinesterase, EC 3.1.1.7; Catalase, EC 1.11.1.6; Ions; Proteins; Thymidine Kinase, EC 2.7.1.21; Water, 7732-18-5",,,,,,,"Brooks, C.L., Karplus, M., Pettitt, B.M., (1988) Proteins. A theoretical perspective of dynamics, structure and thermodynamics, , New York: John Wiley & Sons; Kollman, P., Free energy calculations: Applications to chemical and biochemical phenomena (1993) Chem Rev, 93, pp. 2395-2417; Kollman, P., Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules (1996) Acc Chem Res, 29, pp. 461-469; Kollman, P., Merz, K., Computer modeling of the interactions of complex molecules (1990) Acc Chem Res, 23, pp. 246-252; Karplus, M., Petsko, G.A., Molecular dynamics simulations in biology (1990) Nature, 347, pp. 631-639; Van Gunsteren, W.F., Mark, A.E., On the interpretation of biochemical data by molecular dynamics computer simulation (1992) Eur J Biochem, 204, pp. 947-961; Van Gunsteren, W.F., Berendsen, H.J.C., Computer simulation of molecular dynamics: Methodology, applications, and perspectives in chemistry (1990) Angew Chem Int Ed Engl, 29, pp. 992-1023; Scott, W.R., Hünenberger, P.H., Tironi, I.G., Mark, A.E., Billeter, S.R., Fennen, J., Torda, A.E., Van Gunsteren, W.F., The GROMOS Biomolecular simulation package (1999) J Phys Chem A, 103, pp. 3596-3607; Darden, T.E., York, D., Pedersen, L., Particle mesh Ewald: An n-log(N) method for Ewald sums in large systems (1993) J Chem Phys, 98, pp. 10089-10009; Van Gunsteren, W.F., Luque, F.J., Timms, D., Torda, A.E., Molecular mechanics in biology: From structure to function, taking account of solvation (1994) Annu Rev Biophys Biomol Struct, 23, pp. 847-863; Tirado-Rives, J., Orozco, M., Jorgensen, W.L., Molecular dynamics simulations of the unfolding of barnase in water and 8M aqueous urea (1997) Biochemistry, 36, p. 7313; Shields, G., Laughton, C.A., Orozco, M., Molecular dynamics simulation of the d(A - T-T) triple helix (1997) J Am Chem Soc, 119, pp. 7463-7469; Orozco, M., Luque, F.J., Theoretical methods for the description of the solvent effect in biomolecular systems (2000) Chem Rev, 100, pp. 4187-4225; Blaney, J.M., Weiner, P.K., Dearing, A., Kollman, P., Jorgensen, E.C., Oatley, S.J., Burridge, J.M., Blake, C.C.F., Molecular mechanics simulation of protein-ligand interactions: Binding of thyroid hormone analogues to prealbumin (1982) J Am Chem Soc, 104, pp. 6424-6434; Mehler, E.L., Solmajer, T., Electrostatic effects in proteins: Comparison of dielectric and charge models (1991) Protein Eng, 4, pp. 903-910; Gilson, M.K., Honig, B., Calculations of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies and conformational analysis (1988) Proteins, 4, pp. 7-18; Champness, J.N., Bennett, M.S., Wien, F., Visse, R., Summers, W.C., Herdewijn, P., Declercq, E., Sanderson, M.R., Exploration of the active site of herpes simplex virus thymidine kinase by x-ray crystallography of the enzyme in complex with its substrate, antiviral drugs and other nucleoside analogues (1998) Proteins, 32, pp. 350-361; Harel, M., Schalk, I., Ehret-Sabatier, L., Bouet, F., Goeldner, M., Hirth, C., Axelsen, P., Sussman, J.L., Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase (1993) Proc Natl Acad Sci USA, 90, pp. 9031-9035; Raves, M.L., Harel, M., Pang, Y.P., Silman, I., Kozikowski, A.P., Sussman, J.L., Structure of acetylcholinesterase complexes with the nootropic alkaloid (-)-huperzine A (1997) Nature Struct Biol, 4, pp. 57-63; Mate, M.J., Zamocky, M., Nykyri, L.M., Hertzog, C., Alzari, P.M., Betzel, C., Kolle, F., Fita, I., Structure of catalase-A from Saccharamoyces cerevisiae (1999) J Mol Biol, 268, pp. 135-149; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes (1977) J Comput Phys, 23, pp. 327-341; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., An all-atom empirical energy function for the simulation of nucleic acids (1995) J Am Chem Soc, 117, pp. 11946-11975; Jorgensen, W.L., Chandrasekhar, J., Madura, J., Impey, R.W., Klein, M.L., Comparison of simple potential functions for simulating liquid water (1983) J Chem Phys, 79, pp. 926-935; Alemán, C., Canela, E.I., Franco, R., Orozco, M., PAPQMD-a new strategy of the evaluation of force parameters from quantum mechanical calculations (1991) J Comp Chem, 12, pp. 664-674; Bayly, C.I., Cieplak, P., Cornell, W.D., Kollman, P.A., A well-behaved electrostatic potential based method using charge restrains from deriving atomic charges: The RESP model (1993) J Phys Chem, 97, pp. 10269-10280; Case, D.A., Pearlman, D.A., Caldwell, J.W., Cheatham, T.E., Ross, W.S., Simmerling, C.L., Darden, T.A., Kollman, P.A., (2000) AMBER 6, , San Francisco: University of California; Gelpi, J.L., Luque, F.J., Orozco, M., (2000) CMIP computer program, , University of Barcelona. Program is available upon request to the authors; Goodford, P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules (1985) J Med Chem, 28, pp. 849-857; Feig, M., Pettitt, B.M., Crystallographic water sites from a theoretical perspective (1998) Structure, 6, pp. 1351-1354; Izawa, S., Inoue, Y., Kimura, A., Importance of catalase in the adaptative response to hydrogen peroxide: Analysis of acatala saemic Saccharomyces cerevisiae (1996) Biochem J, 320, pp. 61-67; Schonbaum, G.R., Chance, B., Catalase (1976) The enzymes, 13, pp. 363-408. , Boyer PD, editor. New York: Academic Press; Klotz, M.G., Klassen, G.R., Loewen, P.C., Phylogenetic relationships among prokaryotic and eukaryotic catalases (1997) Mol Biol Evol, 14, pp. 951-958; Chance, B., Herbert, D., The enzyme-substrate compounds of bacterial catalase and peroxides (1950) Biochem J, 46, pp. 402-414; Chance, B., Effect of pH upon the reaction kinetics of the enzyme substrate compounds of catalase (1952) J Biol Chem, 194, pp. 471-481; Fita, I., Rossmann, M.G., The active center of catalase (1985) J Mol Biol, 185, pp. 21-37; Chen, M.S., Wlaker, J., Prusoff, W.H., Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme (1979) J Biol Chem, 254, pp. 10747-10753; Waldman, S.S., Haeusslein, E., Milman, G., Purification and characterization of herpes simplex virus (type 1) thymidine kinase produced in Escherichia coli by a high efficiency expression plasmid utilizing a lambda PL promoter and cI857 temperature-sensitive repressor (1983) J Biol Chem, 258, pp. 11571-11575; Cheng, Y.C., Huang, E.S., Lin, J.C., Mar, E.C., Pagano, J.S., Dutschman, G.E., Grill, S.P., Unique spectrum of activity of 9-[(1,3-dihydroxy-2 propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1 (1983) Proc Natl Acad Sci USA, 80, pp. 2767-2770; Benzi, G., Moretti, A., Is there a rational for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease (1998) Eur J Pharmacol, 346, pp. 1-13; Brufani, M., Filocamo, L., Lappa, S., Maggi, A., New acetylcholinesterase inhibitors (1997) Drugs Future, 22, p. 397; Camps, P., El Achab, R., Görbig, D.M., Morral, J., Muñoz-Torrero, D., Badia, A., Baños, J.E., Luque, F.J., Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease (1999) J Med Chem, 42, p. 3227; Barril, X., Orozco, M., Luque, F.J., Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase (1999) J Med Chem, 42, pp. 5110-5119; Camps, P., Cusack, B., Mallender, W.D., El Achab, R., Morral, J., Muñoz-Torrero, D., Rosenberry, T.L., Huprine X is a novel highaffinity inhibitor of acetylcholinesterase that is of interest for the treatment of Alzheimer's disease (2000) Mol Pharmacol, 57, p. 409; Camps, P., El Achab, R., Morral, J., Muñoz-Torrero, D., Badia, A., Bafios, J.E., Vivas, N.M., Luque, F.J., New tacrinehuperzine A hybrids (huprines): Highly potent tight-binding acetyl cholinesterase inhibitors of interest for the treatment of Alzheimer's disease (2000) J Med Chem, 43, pp. 4657-4666","Orozco, M.; Dept. de Bioquimica i Biol. Mole., Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, Barcelona 08028, Spain; email: modesto@luz.bq.ub.es",,,,,,,,08873585,,PSFGE,"11746690","English","Proteins Struct. Funct. Genet.",Article,"Final",,Scopus,2-s2.0-0035576327
"Calbó J., Marotta M., Cascalló M., Roig J.M., Gelpí J.L., Fueyo J., Mazo A.","7003548069;7004162740;6505853074;15751777500;35517522400;7004067662;7007042077;","Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer",2001,"Cancer Gene Therapy","8","10",,"740","750",,34,"10.1038/sj.cgt.7700374","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034774666&doi=10.1038%2fsj.cgt.7700374&partnerID=40&md5=59ae928b87b919cdabb2ff501a73840b","Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, United States","Calbó, J., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Marotta, M., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Cascalló, M., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Roig, J.M., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Gelpí, J.L., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain; Fueyo, J., Department of Neuro-Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, United States; Mazo, A., Department of Biochemistry and Molecular Biology, University of Barcelona, Barcelona, Spain","Pancreatic cancer has long carried poor prognosis. The development of new therapeutic approaches is particularly urgent. Inactivation of the tumor-suppressor gene p16INK4a/CDKN2, a specific inhibitor of the cyclin-dependent kinases CDK4 and CDK6, is the most common genetic alteration in human pancreatic cancer, making it an ideal target for gene replacement. Here we transfected tumor cells using a recombinant adenovirus containing the wt-p16 cDNA (Ad5RSV-p76). The overexpression of p16 decreased cell proliferation in all four human pancreatic tumor cell lines ((NP-9, NP-18, NP-29, and NP-31). However, G1 arrest and senescence were observed in only three. In contrast, the fourth (NP-18) showed a significant increase in apoptosis. This differential behavior may be related to the differences found in the expression level of E2F-1. Experiments on subcutaneous pancreatic xenografts demonstrated the effectiveness of p16 in the inhibition of pancreatic tumor growth in vivo. Taken together, our results indicate that approaches involving p16 replacement are promising in pancreatic cancer treatment.","Adenovirus; Apoptosis; p16; Pancreatic cancer; Senescence","antineoplastic agent; cyclin dependent kinase; cyclin dependent kinase 4; cyclin dependent kinase 6; gene product; protein p16; transcription factor E2F; transcription factor E2F1; unclassified drug; Adenovirus; animal experiment; animal model; animal tissue; apoptosis; article; cancer cell culture; controlled study; gene inactivation; gene overexpression; gene therapy; genetic transfection; human; human cell; mitosis inhibition; nonhuman; pancreas cancer; priority journal; senescence; tumor suppressor gene; virus recombinant; Adenocarcinoma; Adenoviridae; Animals; Apoptosis; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Cell Aging; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Gene Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Transfection; Tumor Cells, Cultured; Adenoviridae; Animalia",,"beta-Galactosidase, EC 3.2.1.23; Bromodeoxyuridine, 59-14-3; Cyclin-Dependent Kinase Inhibitor p16",,,"Comisión Interministerial de Ciencia y Tecnología: SAF98/042

Ministerio de Educación, Cultura y Deporte","This research was supported by Comisión Interministerial de Ciencia y Tecnología, Grant SAF98/042. J. C. is a recipient of predoctoral fellowship from Ministerio de Educación y Cultura. We acknowledge the help received from Jaume Comas, who is in charge of flow cytometry section in the Serveis Científico-Tècnics de la Uni-versitat de Barcelona. We thank Agnès Figueras and Meritxell Carrió for their technical assistance, Ignasi Catalán for the statistical analysis and Robin Rycroft for his editorial help.",,,"Landis, S.H., Murray, T., Bolden, S., Wingo, P.A., Cancer statistics, 1998 (1998) CA Cancer J Clin, 48, pp. 6-29; Evans, D.B., Abbruzzese, J.L., Rich, T.A., Cancer of the pancreas (1997) Cancer: Principles and Practice of Oncology. 5th ed., pp. 1054-1081. , De Vita VT, Hellman S, Rosenberg SA, eds. Philadelphia: Lippincott-Raven; Guzburg, W.H., Salmons, B., Novel clinical strategies for the treatment of pancreatic carcinoma (2001) Trends Mol Med, 7, pp. 30-37; Roth, J.A., Cristiano, R.J., Gene therapy for cancer: What have we done and where are we going? (1997) J Natl Cancer Inst, 89, pp. 21-39; Gómez-Navarro, J., Curiel, D.T., Douglas, J.T., Gene therapy for cancer (1999) Eur J Cancer, 35 (14), pp. 2039-2057; Vile, R.G., Russell, S.J., Lemoine, N.R., Cancer gene therapy: Hard lessons and new courses (2000) Gene Ther, 7, pp. 2-8; King, K.L., Cidlowski, J.A., Cell cycle and apoptosis: Common pathways to life and death (1995) J Cell Biochem, 8, pp. 175-185; Culver, K.W., Blaese, R.M., Gene therapy for cancer (1994) Trends Genet, 10, pp. 174-178; Favrot, M., Coll, J.L., Louis, N., Negoescu, A., Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy (1998) Gene Ther, 5, pp. 728-739; Sherr, C.J., The Pezcoller lecture: Cancer cell cycles revisited (2000) Cancer Res, 60, pp. 3689-3695; Chin, L., Pomerantz, J., DePinho, R.A., The INK4a/ARF tumor suppressor: One gene-two products-two pathways (1998) Trends Biochem Sci, 23, pp. 291-296; Yap, D.B.S., Hsieb, J.K., Chan, F.S.G., Lu, X., Mdm-2: A bridge over the two tumour suppressors, p53 and pRb (1999) Oncogene, 18, pp. 7681-7689; Weinberg, R.A., The retinoblastoma protein and cell cycle control (1995) Cell, 81, pp. 323-330; Lundberg, A.S., Weinberg, R.A., Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes (1998) Mol Cell Biol, 18 (2), pp. 753-761; Graña, X., Reddy, E.P., Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs) (1995) Oncogene, 11, pp. 211-219; Sherr, C.J., Roberts, M., CDK inhibitors: Positive and negative regulators of G1-phase progression (1999) Genes & Dev, 13, pp. 1501-1512; Graña, X., Garriga, J., Mayol, X., Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth (1998) Oncogene, 17, pp. 3365-3383; Müller, H., Bracken, A.P., Vernell, R., E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis (2001) Genes Dev, 15, pp. 267-285; Saphiro, G.I., Rollins, B.J., p16INK4A as a human tumor suppressor (1996) Biochim Biophys Acta, 1242, pp. 165-169; Caldas, C., Hahn, S.A., Da Costa, L.T., Frequent somatic mutations and homozygous deletions of the MTS1 gene in pancreatic adenocarcinoma (1994) Nat Genet, 8, pp. 27-32; Serrano, M., Hannon, G.J., Beach, D., A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4 (1993) Nature, 366, pp. 704-707; Lukas, J., Parry, D., Aagaard, L., Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16 (1995) Nature, 375, pp. 503-506; Alcorta, D.A., Xiong, Y., Phelps, D., Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts (1996) Proc Natl Acad Sci USA, 93, pp. 13742-13747; Robles, S.J., Adami, G.R., Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts (1998) Oncogene, 16, pp. 1113-1123; Serrano, M., Gómez-Lahoz, R.A., DePinho, R.A., Inhibition of ras-induced proliferation and cellular transformation by p16INK4A (1996) Science, 267, pp. 249-252; Serrano, M., Lin, A.W., McCurrach, M.E., Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16Ink4a (1997) Cell, 88, pp. 593-602; Rocco, J.W., Li, D., Liggett, W.H., p16INK4A adenovirusmediated gene therapy for human head and neck squamous cell cancer (1998) Clin Cancer Res, 4, pp. 1697-1704; Craig, C., Kim, M., Ohri, E., Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells (1998) Oncogene, 16, pp. 265-272; Uhrbom, D., Nister, M., Westermark, B., Induction of senescence in human malignant glioma cells by p16INK4A (1997) Oncogene, 15, pp. 505-514; Steiner, M.S., Zhang, Y., Farooq, F., Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence (2000) Cancer Gene Ther, 7 (3), pp. 360-372; Fueyo, J., Gómez-Manzano, C., Yung, W.K.A., Adenovirusmediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells (1996) Oncogene, 12, pp. 103-110; Harada, H., Nakagawa, K., Iwata, S., Restoration of wildtype p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas (1999) Cancer Res, 59, pp. 3783-3789; Chintala, S.K., Fueyo, J., Gómez-Manzano, C., Adenovirusmediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro (1997) Oncogene, 15, pp. 2049-2057; Wieser, R.J., Faust, D., Dietrich, C., Oesch, F., p16INK4 mediates contact inhibition of growth (1999) Oncogene, 18, pp. 277-281; Fahraeus, R., Lane, D.P., The p16INK4a tumour suppressor protein inhibits alpha-v-beta-3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alpha-v-beta-3 to focal contacts (1999) EMBO J, 18, pp. 2106-2118; Schreiber, M., Muller, W.J., Singh, G., Graham, F.L., Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21WAFI/CIPI, and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity (1999) Oncogene, 18, pp. 1663-1676; Frizelle, S.P., Grim, J., Zhou, J., Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression (1998) Oncogene, 16, pp. 3087-3095; Naruse, I., Heikese, I., Heike, Y., Hama, S., Mori, M., Saijo, N., High concentrations of recombinant adenovirus expressing p 16 gene induces apoptosis in lung cancer lines (1998) Anticancer Res, 18, pp. 4275-4282; Ghaaneh, P., Grenhalf, W., Humphreys, M., Adenovirusmediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo (2001) Gene Ther, 8, pp. 199-208; Villanueva, A., García, C., Paules, A.B., Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cells (1998) Oncogene, 17, pp. 1969-1978; Cascalló, M., Mercadé, E., Lluís, F., Genetic background determines the response to adenovirus-mediated wt-p53 expression in human pancreatic tumor cells (1999) Cancer Gene Ther, 6, pp. 428-436; Darzynkiewicz, Z., Li, X., Gong, J., Hara, S., Traganos, F., Analysis of cell death by flow cytometry (1995) Cell Growth and Apoptosis: A Practical Approach, 1st ed., pp. 143-167. , Studzinski GP, ed. NY: Oxford Univ. Press; Dimri, G.P., Lee, X., Basile, G., A biomarker that identifies senescent human cells in culture and aging skin in vivo (1995) Proc Natl Acad Sci USA, 92, pp. 9363-9367; Cascalló, M., Calbó, J., Gelpí, J.L.I., Mazo, A., Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer (2000) Cancer Gene Ther, 7, pp. 545-556; Becker, T.C., Noel, R.J., Coats, W.S., Use of recombinant adenovirus for metabolic engineering of mammalian cells (1994) Methods Cell Biol, 5, pp. 161-189; Bramson, J.L., Hitt, M., Gauldie, J., Graham, F.L., Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector (1997) Gene Ther, 4, pp. 1069-1076; Humphreys, M., Greenhalf, W., Neoptolemos, J.P., Ghaneh, P., The potential for gene therapy in pancreatic cancer (1999) Int J Pancreatol, 26, pp. 5-21; Peng, K.W., Strategies for targeting therapeutic gene delivery (1999) Mol Med Today, 5, pp. 448-453; Arap, W., Nishikawa, R., Furnari, F.B., Cavenee, W.K., Replacement of the p16/CDKN2 gene suppresses human glioma cell growth (1995) Cancer Res, 55, pp. 1351-1354; Bartek, J., Bartkova, J., Lukas, J., The retinoblastoma protein pathway in cell cycle control and cancer (1997) Exp Cell Res, 237, pp. 1-6; Sandig, K., Brandt, K., Herwig, S., Adenovirally transferred p16 and p53 genes cooperate to induce apoptotic tumor cell death (1997) Nat Med, 3, pp. 313-319; Kataoka, M., Wiehle, S., Spitz, F., Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells (2000) Oncogene, 19, pp. 1589-1595; Fang, X., Jin, X., Xu, H.J., Expression of p16 induces transcriptional downregulation of the RB gene (1998) Oncogene, 16, pp. 1-8; Holmberg, C., Helin, K., Sehested, M., Karlström, O., E2F-1-induced p53-independent apoptosis in transgenic mice (1998) Oncogene, 17, pp. 143-155; Steiner, M., Wang, Y., Zhang, Y., p16/MTS1/INK4A suppresses prostate cancer by both pRb-dependent and -independent pathways (2000) Oncogene, 19, pp. 1297-1306; Plath, T., Detjen, K., Welzel, M., A novel function for the tumor suppressor p16INK4a: Induction of anoikis via upregulation of the α5β1 fibronectin receptor (2000) J Cell Biol, 150, pp. 1467-1477; Rizk, N.P., Chang, M.Y., El-Kouri, C., The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer (1999) Cancer Gene Ther, 6 (4), pp. 1-301","Mazo, A.; Department of Biochemistry, C/ Martí i Franqués 1, 08028 Barcelona, Spain; email: adela@bq.ub.es",,,,,,,,09291903,,CGTHE,"11687897","English","Cancer Gene Ther.",Article,"Final",Open Access,Scopus,2-s2.0-0034774666
"Kalko S.G., Lluis Gelpí J., Fita I., Orozco M.","6602247257;35517522400;7006004728;7102809158;","Theoretical study of the mechanisms of substrate recognition by catalase",2001,"Journal of the American Chemical Society","123","39",,"9665","9672",,43,"10.1021/ja010512t","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035802360&doi=10.1021%2fja010512t&partnerID=40&md5=fc503cc89c7df26ced1e494485c7fd5b","Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Instituto de Biología Molecular de Barcelona, C.S.I.C, Jordi Girona 18-26, Barcelona 08034, Spain","Kalko, S.G., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Lluis Gelpí, J., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; Fita, I., Instituto de Biología Molecular de Barcelona, C.S.I.C, Jordi Girona 18-26, Barcelona 08034, Spain; Orozco, M., Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain","A variety of theoretical methods including classical molecular interaction potentials, classical molecular dynamics, and activated molecular dynamics have been used to analyze the substrate recognition mechanisms of peroxisomal catalase from Saccharomyces cerevisiae. Special attention is paid to the existence of channels connecting the heme group with the exterior of the protein. On the basis of these calculations a rationale is given for the unique catalytic properties of this enzyme, as well as for the change in enzyme efficiency related to key mutations. According to our calculations the water is expected to be a competitive inhibitor of the enzyme, blocking the access of hydrogen peroxide to the active site. The main channel is the preferred route for substrate access to the enzyme and shows a cooperative binding to hydrogen peroxide. However, the overall affinity of the main channel for H 2O 2 is only slightly larger than that for H 2O. Alternative channels connecting the heme group with the monomer interface and the NADP(H) binding site are detected. These secondary channels might be important for product release.",,"Molecular interaction; Catalysts; Enzymes; Hydrogen peroxide; Monomers; Molecular dynamics; catalase; hydrogen peroxide; reduced nicotinamide adenine dinucleotide phosphate; article; catalysis; enzyme active site; enzyme activity; enzyme mechanism; enzyme substrate; molecular dynamics; molecular interaction; nonhuman; Saccharomyces cerevisiae; Catalase; Fungal Proteins; Hydrogen Peroxide; Models, Chemical; Saccharomyces cerevisiae; Solutions; Substrate Specificity; Thermodynamics",,"catalase, 9001-05-2; hydrogen peroxide, 7722-84-1; reduced nicotinamide adenine dinucleotide phosphate, 53-57-6; Catalase, 1.11.1.6; Fungal Proteins; Hydrogen Peroxide, 7722-84-1; Solutions",,,,,,,"Leff, J.A., (1993) Inflammation, 17, p. 199; Halliwell, B., Aruoma, O.I., (1991) FEBS Lett., 281, p. 9; Halliwell, B., Gutteridge, J.M.C., (1990) Methods Enzymol., 186, p. 1; Taub, J., Lau, J.F., Ma, C., Hahn, J.H., Hoque, R., Rothblatt, J., Chalfie, M., (1999) Nature, 399, p. 162; Barynin, V.V., Vagin, A.A., Melik-Adamyan, V.R., Grebenko, A.I., Khangulov, S.V., Popov, A.N., Andrianova, M.E., Vainshtein, B.K., (1986) Sov. Phys. Crystallogr., 31, p. 457; Fraaije, M.W., Roubroeks, H.P., Hagen, W.R., Van Berkel, W.J.H., (1996) Eur. J. Biochem., 235, p. 192; Schonbaum, G.R., Chance, B., (1976) The Enzymes, 13, p. 363. , Academic Press: New York; Klotz, M.G., Klassen, G.R., Loewen, P.C., (1997) Mol. Biol. Evol., 14, p. 951; Chance, B., Herbert, D., (1950) Biochem. J., 46, p. 402; Nicholls, P., Schonbaum, G.R., (1963) The Enzymes, 8, p. 147. , Academic Press: New York; Deisseroth, A., Dounce, A., (1970) Physiol. Rev., 50, p. 319; Maté, M.J., Murshudov, G., Bravo, J., Melik-Adamyan, W., Loewen, P.C., Fita, I., (2001) Handbook of Metalloproteins, , Messerschmidt, A., Huber, R., Eds.; John Wiley: New York; Dolphin, D., Forman, A., Borg, D.C., Fajer, J., Felton, R.H., (1971) Proc. Natl. Acad. Sci. U.S.A., 68, p. 614; Ivancich, A., Jouve, H.M., Sartor, B., Galliard, J., (1997) Biochemistry, 36, p. 9356; Zimatkin, S.M., Liopo, A.V., Deitrice, R.A., (1998) Alcohol Clin. Exp. Res., 22, p. 1623; Hamby-Mason, R., Schenker, S., Chen, J.J., Perez, A., Henderson, G.I., (1997) Alcohol Clin. Exp. Res., 21, p. 1063; Hunt, W.A., (1996) Alcohol, 13, p. 147; Aragon, C.M., Amit, Z., (1992) Neuropharmacology, 31, p. 709; Lardinois, O.M., Rouxhet, P.G., (1994) Free Radical Res., 20, p. 29; Obinger, C., Maj, M., Nicholls, P., Loewen, P.C., (1997) Arch. Biochem. Biophys., 342, p. 58; Ivanchich, A., Jouve, H.M., Sartor, B., Gaillard, J., (1997) Biochemistry, 36, p. 9356; Murshudov, G.N., Melik-Adamyan, W.R., Grebenko, A.I., Barynin, V.V., Vagin, A.A., Vainshtein, B.K., Dauter, Z., Wilson, K.S., (1992) FEBS Lett., 312, p. 127; Gouet, P., Jouve, H.M., Dideberg, O., (1995) J. Mol. Biol., 249, p. 933; Bravo, J., Verdaguer, N., Tormo, J., Betzel, C., Switala, J., Loewen, P.C., Fita, I., (1995) Structure, 3, p. 491; Vainshtein, B.K., Melik-Adamyan, W.R., Barynin, V.V., Vagin, A.A., Grebenko, A.I., (1981) Nature, 293, p. 411; Melik-Adamyan, W.R., Barynin, V.V., Vagin, A.A., Borisov, V.V., Vainshtein, B.K., Fita, I., Murthy, M.R.N., Rossmann, M.G., (1986) J. Mol. Biol., 188, p. 63; Murthy, M.R.N., Reid, T.J., Sicignano, A., Tanaka, T., Rossmann, M.G., (1981) J. Mol. Biol., 152, p. 465; Fita, I., Silva, A.M., Murthy, M.R.N., Rossmann, M.G., (1986) Acta Crystallogr., Sect. B, 42, p. 497; Mate, M.J., Zamocky, M., Nykyri, L.M., Herzog, C., Alzari, P.M., Betzel, C., Koller, F., Fita, I., (1999) J. Mol. Biol., 286, p. 135; Putnam, C.D., Arvai, A.S., Bourne, Y., Tainer, J.A., (2000) J. Mol. Biol., 296, p. 295; Gouet, P., Jouve, H.M., Williams, P.A., Anderson, I., Andreoletti, P., Nussaume, L., Hadju, J., (1996) Nat. Struct. Biol., 3, p. 951; Chiu, J.T., Loewen, P.C., Switala, J., Gennis, R.B., Timkovich, R., (1989) J. Am. Chem. Soc., 111, p. 7046; Murshudov, G.N., Grebenko, A.I., Barynin, V., Dauter, Z., Wilson, K.S., Vainshtein, B.K., Melik-Adamyan, W., Fita, I., (1996) J. Biol. Chem., 271, p. 8863; Gelpi, J.Ll., Kalko, S.G., Barril, X., Cirera, J., De la Cruz, X., Luque, F.J., Orozco, M., (2001) Proteins, , In Press; Jorgensen, W.L., Chandrasekhar, J., Madura, J., Impey, R.W., Klein, M.L., (1983) J. Chem. Phys., 79, p. 926; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., (1977) J. Comput. Phys., 23, p. 327; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J. Am. Chem. Soc., 117, p. 11946; Alemán, C., Canela, E.I., Franco, R., Orozco, M., (1991) J. Comput. Chem., 12, p. 664; Bayly, C.I., Cieplak, P., Cornell, W.D., Kollman, P.A., (1993) J. Phys. Chem., 97, p. 10269; Berendsen, H.J.C., Postma, J.P.M., Van Gunsteren, W.F., DiNola, A., Haak, J.R., (1984) J. Chem. Phys., 81, p. 3684; Shields, G., Laughton, C.A., Orozco, M., (1997) J. Am. Chem. Soc., 119, p. 7463; Sevinc, M.S., Maté, M.J., Switala, J., Fita, I., Loewen, P.C., (1999) Protein Sci., 8, p. 490; Jones, P., (2001) J. Biol. Chem., 276, p. 13791","Orozco, M.; Dept. de Bioquimica i Biol. Molec., Facultat de Química, Universitat de Barcelona, Martí i Franquès 1, Barcelona 08028, Spain; email: modesto@luz.bq.ub.es",,,,,,,,00027863,,JACSA,"11572688","English","J. Am. Chem. Soc.",Article,"Final",,Scopus,2-s2.0-0035802360
"Barril X., Gelpí J.L., López J.M., Orozco M., Luque F.J.","6602104920;35517522400;7004419906;7102809158;23025357900;","How accurate can molecular dynamics/linear response and Poisson-Boltzmann/solvent accessible surface calculations be for predicting relative binding affinities? Acetylcholinesterase huprine inhibitors as a test case",2001,"Theoretical Chemistry Accounts","106","1-2",,"2","9",,27,"10.1007/s002140000216","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035593989&doi=10.1007%2fs002140000216&partnerID=40&md5=d0e0b3dfc044db08ada431f0c4ff8eaa","Dept. de Físico-Quim., Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Departament de Bioquímica, Facultat de Química, Universitat de Barcelona, Av. Martí i Franqués 1, 08028 Barcelona, Spain","Barril, X., Dept. de Físico-Quim., Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Gelpí, J.L., Departament de Bioquímica, Facultat de Química, Universitat de Barcelona, Av. Martí i Franqués 1, 08028 Barcelona, Spain; López, J.M., Dept. de Físico-Quim., Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; Orozco, M., Departament de Bioquímica, Facultat de Química, Universitat de Barcelona, Av. Martí i Franqués 1, 08028 Barcelona, Spain; Luque, F.J., Dept. de Físico-Quim., Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain","This study examines the accuracy of molecular dynamics-linear response (MD/LR) and Poisson-Boltzmann/solvent accessible surface (PB/SAS) calculations to predict relative binding affinities. A series of acetylcholinesterase (AChE) huprine inhibitors has been chosen as a test system owing to the availability of free-energy (thermodynamic integration) calculations. The results obtained with the MD/LR approach point out a clear relationship between the experimental affinity and the electrostatic interaction energy alone for a subset of huprines, but the suitability of the MD/LR approach to predict the binding affinity of the whole series of compounds is limited. On the other hand, PB/SAS calculations show a marked dependence on both the computational protocol and the nature of the inhibitor-enzyme complex.","Acetylcholinesterase inhibitors; Free-energy calculations; Linear response approximation; Poisson-Boltzmann/solvent accessible surface calculations; Prediction of binding affinities",,,,,,,,,,"Benzi, G., Moretti, A., (1998) Eur J Pharmacol, 346, pp. 1-13; Brufani, M., Filocamo, L., Lappa, S., Maggi, A., (1997) Drugs Future, 22, p. 397; (1987) Drugs Future, 12, p. 1032; Kozikowski, A.P., Xia, Y., Reddy, E.R., Tückmantel, W., Hanin, I., Tang, X.C., (1991) J Org Chem, 56, p. 4636; Kozikowski, A.P., Campini, G., Sun, L.Q., Wang, S., Saxena, A., Doctor, B.P., (1996) J Am Chem Soc, 118, p. 11357; Kozikowski, A.P., Ding, Q., Saxena, A., Doctor, B.P., (1996) Bioorg Med Chem Lett, 6, p. 259; Kaneko, S., Nakajima, N., Shikano, M., Katoh, T., Terashima, S., (1998) Tetrahedron, 54, p. 5485; Pang, Y.P., Quiram, P., Jelacic, T., Hong, F., Brimijoin, S.J., (1996) Biol Chem, 271, p. 23646; Jaen, J.C., Gregor, V.E., Lee, C., Davis, R., Emmerling, M., (1996) Bioorg Med Chem Lett, 6, p. 737; Chen, Y.L., Nielsen, J., Medberg, K., Dunaiskis, A., Jones, S., Russo, L., Johnson, J., Liston, D.J., (1992) Med Chem, 35, p. 1429; Atack, J.R., Yu, Q.S., Soncrant, T.T., Brossi, A., Rapoport, S.J., (1998) Pharmacol Exp Ther, 249, p. 194; Villalobos, A., Butler, T.W., Chapin, D.S., Chen, Y.L., DeMattos, S.B., Ives, J.L., Jones, S.B., White, W.F., (1995) J Med Chem, 38, p. 2802; Rampa, A., Bisi, A., Valenti, P., Recanatini, M., Cavalli, A., Andrisano, V., Cavrini, V., Giusti, P.J., (1998) Med Chem, 41, p. 3976; Sugimoto, H., Iimura, Y., Yamanishi, Y., Yamatsu, K.J., (1995) Med Chem, 38, p. 4821; Prous, J., Rabasseda, X., Castañer, J., (1996) Drugs Future, 10, p. 656; Aguado, F., Badia, A., Baños, J.E., Bosch, F., Bozzo, C., Camps, P., Contreras, J., Vivas, N.M., (1994) Eur J Med Chem, 29, p. 205; Badia, A., Baños, J.E., Camps, P., Contreras, J., Görbig, D.M., Muñoz-Torrero, D., Simon, M., Vivas, N.M., (1998) Bioorg Med Chem, 6, p. 427; Camps, P., El Achab, R., Görbig, D.M., Morral, J., Muñoz-Torrero, D., Badia, A., Baños, J.E., Luque, F.J., (1999) J Med Chem, 42, p. 3227; Camps, P., Cusack, B., Mallender, W.D., El Achab, R., Morral, J., Muñoz-Torrero, D., Rosenberry, T.L., (2000) Mol Pharmacol, 57, p. 409; Camps, P., El Achab, R., Morral, J., Muñoz-Torrero, D., Badia, A., Banos, J.E., Vivas, N.M., Luque, F.J., (2000) J Med Chem, , in press; Barril, X., Orozco, M., Luque, F.J., (1999) J Med Chem, 42, p. 5110; Harel, M., Schalk, I., Ehret-Sabatier, L., Bouet, F., Goeldner, M., Hirth, C., Axelsen, P., Sussman, J.L., (1993) Proc Natl Acad Sci USA, 90, p. 9031; Raves, M.L., Harel, M., Pang, Y.P., Silman, I., Kozikowski, A.P., Sussman, J.L., (1997) Nature Struct Biol, 4, p. 57; Kollamn, P., (1993) Chem Rev, 93, p. 2395; Åqvist, J., Medina, C., Samuelsson, J.E., (1994) Protein Eng, 7, p. 385; Hansson, T., Åqvist, J., (1995) Protein Eng, 8, p. 1137; Åqvist, J., (1996) J Comput Chem, 17, p. 1587; McDonald, N.A., Carlson, H.A., Jorgensen, W.L., (1997) J Phys Org Chem, 10, p. 563; Smith R.H., Jr., Jorgensen, W.L., Tirado-Rives, J., Lamb, M.L., Janssen, P.A.J., Michejda, C.J., Smith, M.B.K., (1998) J Med Chem, 41, p. 5272; Hansson, T., Marelius, J., Aqvist, J., (1998) J Comput-Aided Mol Des, 12, p. 27; Jones-Hertzog, D.K., Jorgensen, W.L., (1997) J Med Chem, 40, p. 1539; Gilson, M.K., Honig, B., (1988) Proteins Struct Funct Genet, 4, p. 7; Gilson, M.K., Sharp, K.A., Honig, B.H., (1988) J Comput Chem, 9, p. 327; Sharp, K.A., Honig, B., (1990) Annu Rev Biophys Biophys Chem, 19, p. 301; Pitera, J., Kollman, P., (1998) J Am Chem Soc, 120, p. 7557; Radmer, R.J., Kollman, P.A., (1998) J Comput-Aided Mol Des, 12, p. 215; Jorgensen, W.L., Chandrasekhar, J., Madura, J.D., Impey, R.W., Klein, M.L., (1983) J Chem Phys, 79, p. 926; Wlodek, S.T., Antosiewicz, J., McCammon, J.A., Straatsma, T.P., Gilson, M.K., Briggs, J.M., Humblet, C., Sussman, J.L., (1996) Biopolymers, 38, p. 109; Hariharan, P.C., Pople, J.A., (1973) Theor Chim Acta, 28, p. 213; Frisch, M.J., Trucks, G.W., Schlegel, H.B., Gill, P.M.W., Johnson, B.G., Robb, M.A., Cheeseman, J.R., Pople, J.A., (1995) Gaussian, 94. , revision A1. Gaussian, Pittsburgh, Pa; Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz, K., Ferguson, D.M., Spellmeyer, D.C., Kollman, P.A., (1995) J Am Chem Soc, 117, p. 5179; Bayly, C.I., Cieplak, P., Cornell, W.D., Kollman, P.A., (1993) J Chem Phys, 97, p. 10269; Ryckaert, J.P., Ciccotti, G., Berendsen, H.J.C., (1977) J Comput Phys, 23, p. 327; Case, D.A., Pearlman, D.A., Caldwell, J.C., Cheatham, T.E., Ross, W.S., Simmerling, C., Darden, T., Kollman, P.A., (1997) AMBER5, , University of California: San Francisco; Gelpí, J.L., Luque, F.J., Orozco, M., (2000) CMIP Program, , University of Barcelona; Sitkoff, D., Sharp, K.A., Honig, B., (1994) J Phys Chem, 98, p. 1978; Eriksson, M.A.L., Pitera, J., Kollman, P.A., (1999) J Med Chem, 42, p. 868","Luque, F.J.; Dept. de Físico-Quim., Facultat de Farmàcia, Universitat de Barcelona, Av. Diagonal s/n, 08028 Barcelona, Spain; email: javier@far1.far.ub.es",,,,,,,,1432881X,,,,"English","Theor. Chem. Acc.",Article,"Final",,Scopus,2-s2.0-0035593989
"Torras-Llort M., Torrents D., Soriano-García J.F., Gelpí J.L., Estévez R., Ferrer R., Palacín M., Moretó M.","6508375164;6603452371;6507405644;35517522400;7005268745;7005952255;57206445737;7006100184;","Sequential amino acid exchange across b0,+-like system in chicken brush border jejunum",2001,"Journal of Membrane Biology","180","3",,"213","220",,32,"10.1007/s002320010072","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035311014&doi=10.1007%2fs002320010072&partnerID=40&md5=31492692534bffa1d1d717e4526a047a","Departament de Fisiologia-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain","Torras-Llort, M., Departament de Fisiologia-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Torrents, D., Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain; Soriano-García, J.F., Departament de Fisiologia-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Gelpí, J.L., Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain; Estévez, R., Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain; Ferrer, R., Departament de Fisiologia-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain; Palacín, M., Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028 Barcelona, Spain; Moretó, M., Departament de Fisiologia-Divisió IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain","In the small intestine, cationic amino acids are transported by y+-like and b0,+-like systems present in the luminal side of the epithelium. Here, we report the characterization of a b0,+-like system in the apical membrane of the chicken jejunum, and its properties as an amino acid exchanger. Analysis of the brush border membrane by Western blot points out the presence of rBAT (protein related to b0,+ amino acid transport system) in these membranes. A functional mechanism for amino acid exchange across this system was established by kinetic analysis measuring fluxes at varying substrate concentrations both in internal (in) and external (out) vesicle compartments. This intestinal b0,+-like system functions for L-arginine as an obligatory exchanger since its transport capacity increases 100-200 fold in exchange conditions, thus suggesting an important role in the intestinal absorption of cationic amino acids. The kinetic analysis of Argin efflux velocities is compatible with the formation of a ternary complex and excludes a model involving a ping-pong mechanism. The binding affinity of Argout is higher than that of Argin, suggesting a possible order of binding (Argout first) for the formation of the ternary complex during the exchange cycle. A model of double translocation pathways with alternating access is discussed.","Heteroexchange; Homoexchange; Kinetic mechanism; L-arginine; rBAT; Vesicles","amino acid; arginine; amino acid transport; animal tissue; article; binding affinity; brush border; intestine absorption; jejunum; kinetics; membrane transport; nonhuman; Amino Acid Transport Systems; Animals; Antigens, CD; Antigens, CD98; Carrier Proteins; Chickens; Jejunum; Kinetics; Microvilli; Animalia; Gallus gallus",,"Amino Acid Transport Systems; Antigens, CD; Antigens, CD98; Carrier Proteins",,,,,,,"Ahmed, A., Peter, G.J., Taylor, P.M., Harper, A.A., Rennie, M.J., Sodium-independent currents of opposite polarity evoked by neutral and cationic amino acids in neutral and basic amino acids transporter cRNA-injected oocytes (1995) J. Biol. Chem., 270, pp. 8482-8486; Bush, A.E., Herzer, T., Waldegger, S., Schmidt, F., Palacín, M., Biber, J., Markovich, D., Lang, F., Opposite directed currents induced by the transport of dibasic and neutral amino acids in Xenopus oocytes expressing the protein rBAT (1994) J. Biol. Chem., 269, pp. 25581-25586; Cleland, W.W., (1970) The Enzymes, 2, pp. 1-65. , P.P. Boyer, editor. Academic Press, New York; Coady, M.J., Jalal, F., Chert, X.-Z., Lemay, G., Berteloot, A., Lapointe, J.-Y., Electrogenic amino acid exchange via the rBAT transporter (1994) FEBS Lett., 356, pp. 174-178; Coady, M.J., Chert, X.-Z., Lapointe, J.-Y., rBAT is an amino acid exchanger with a variable stoichiometry (1996) J. Membrane Biol., 150, pp. 1-8; Chairoungdua, A., Segawa, H., Kim, J.Y., Miyamoto, K., Haga, H., Fukui, Y., Mizoguchi, K., Kanai, Y., Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein (1999) J. Biol. Chem., 274, pp. 28845-28848; Chillarón, J., Estévez, R., Mora, C., Wagner, C.A., Suessbrich, H., Lang, F., Gelpí, J.L., Palacín, M., Obligatory amino acid exchange via systems b0,+ and y+L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids (1996) J. Biol. Chem., 271, pp. 17761-17770; Dierks, T., Riemer, E., Kramer, R., Reaction of the reconstituted aspartate/glutamate carrier from bovine heart mitochondria (1988) Biochim. Biophys. Acta, 943, pp. 231-244; Eleno, N., Devés, R., Boyd, C.A.R., Membrane potential dependence of the kinetics of amino acid transport systems in human placenta (1994) J. Physiol. (London), 479, pp. 291-300; Nontype I cystinuria caused by mutations in SLC7A9 encoding a subunit (b0,+AT) of rBAT (1998) Nature Genet., 23, pp. 52-57; Furriols, M., Chillarón, J., Mora, C., Castelló, A., Bertrán, J., Camps, M., Testar, X., Palacín, M., rBAT, related to L-cystine transport is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development (1993) J. Biol. Chem., 268, pp. 27060-27068; Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., Endou, H., Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98) (1998) J. Biol. Chem., 273, pp. 23629-23632; Kessler, M., Acuto, O., Storelli, C., Murer, H., Müller, M., Semenza, G., A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport system (1978) Biochim. Biophys. Acta, 506, pp. 136-154; Malathi, P., Preiser, H., Fairclough, P., Malett, P., Crane, R.K., A rapid method for the isolation of kidney brush border membranes (1979) Biochim. Biophys. Acta, 554, pp. 259-263; Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P.J., Loffing, J., Shoemaker, C.B., Verrey, F., Amino acid transport by heterodimers of 4F2hc/CD98 and members of a permease family (1998) Nature, 395, pp. 288-291; Mora, C., Chillarón, J., Calonge, M.J., Forgo, J., Testar, X., Nunes, V., Murer, H., Palacín, M., The rBAT gene is responsible for L-cystine uptake via the b0,+-like amino acid transporter system in a ""renal proximal tubular"" cell line (OK cells) (1996) J. Biol. Chem., 271, pp. 10569-10576; Mosckovitz, R., Undenfriend, S., Felix, A., Helmet, E., Tate, S.S., Membrane topology of the rat kidney neutral and basic amino acid transporter (1994) FASEB J., 8, pp. 1069-1074; Palacín, M., Bertran, J., Zorzano, A., Heteromeric amino acid transporters explain inherited aminoacidurias (2000) Curr. Opin. Nephrol. Hypertens., 9, pp. 547-553; Palacín, M., Chillarón, J., Mora, C., Role of the b0,+-like amino acid transport system in the renal reabsorption of cystine and dibasic amino acids (1996) Biochem. Soc. Trans., 24, pp. 856-863; Palacín, M., Estévez, R., Bertrán, J., Zorzano, A., Molecular biology of mammalian plasma membrane amino acid transporters (1998) Physiol. Rev., 78, pp. 969-1054; Pineda, M., Fernández, E., Torrents, D., Estévez, R., López, C., Camps, M., Lloberas, J., Palacín, M., Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids (1999) J. Biol. Chem., 274, pp. 19738-19744; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Soriano-García, J.F., Torras-Llort, M., Ferrer, R., Moretó, M., Multiple pathways for L-methionine transport in brush-border membrane vesicles from chicken jejunum (1998) J. Physiol. (London), 509, pp. 527-539; Torras-Llort, M., Ferrer, R., Soriano-García, J.F., Moretó, M., L-Lysine transport in chicken jejunal brush border membrane vesicles (1996) J. Membrane Biol., 152, pp. 183-193; Torras-Llort, M., Soriano-García, J.F., Ferrer, R., Moretó, M., Effect of a lysine-enriched diet on L-lysine transport by the brush-border membrane of the chicken jejunum (1998) Am. J. Physiol., 274, pp. R69-R75; Torrents, D., Estévez, R., Pineda, M., Fernández, E., Lloberas, J., Shi, Y.-B., Zorzano, A., Palacín, M., Identification and characterization of a membrane protein (y+L Amino Acid Transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance (1998) J. Biol. Chem., 273, pp. 32437-32445; Verrey, F., Jack, D.L., Paulsen, L.T., Saier M.H., Jr., Pfeifter, R., New glycoprotein-associated amino acid transporters (1999) J. Membrane Biol., 172, pp. 181-192; Wang, Y., Tate, S.S., Oligomeric structure of a renal cystine transporter: Implications in cystinuria (1995) FEBS Lett., 368, pp. 389-392","Ferrer, R.; Departament de Fisiologia-Divisio IV, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, 08028 Barcelona, Spain",,,,,,,,00222631,,JMBBB,"11337893","English","J. Membr. Biol.",Article,"Final",,Scopus,2-s2.0-0035311014
"Ruggia A., Gelpí J.L., Busquets M., Cascante M., Cortés A.","15721336900;35517522400;7003927984;7006946294;7102092256;","Effect of several anions on the activity of mitochondrial malate dehydrogenase from pig heart",2001,"Journal of Molecular Catalysis - B Enzymatic","11","4-6",,"743","755",,6,"10.1016/S1381-1177(00)00167-3","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035931361&doi=10.1016%2fS1381-1177%2800%2900167-3&partnerID=40&md5=44d3e93727db71506394a8fb7a7dcaa6","Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain","Ruggia, A., Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain; Gelpí, J.L., Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain; Busquets, M., Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain; Cascante, M., Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain; Cortés, A., Departament De Bioquímica I Biologia Molecular, Facultat De Química, Universitat De Barcelona, Martí i Franqués 1, Barcelona E-08028, Spain","Mitochondrial malate dehydrogenase (mMDH) shows a complex dependence upon ionic environment that includes kinetic and structural effects. We measured mMDH activity in several buffers (phosphate, MOPS, and MES) at pH 6.5 and 7.5, and in the presence of a number of anions, at highly diluted enzyme concentrations where mMDH showed significant loss of activity. Under these conditions, mMDH activity shows a non-linear dependence on enzyme concentration, in agreement with the existence of a dimer-monomer equilibrium, where only the dimeric form is active. According to this hypothesis, the dissociation constant of mMDH dimer has been determined to be 5.4 nM in the MES buffer at pH 6.5. Either the presence of a small anion like phosphate, or an increase of the pH from 6.5 to 7.5 shifts the equilibrium in favor of the dimeric form with the two effects appearing to be additive. To extend the study, we analysed the effect of a number of anions on the mMDH activity in 50 mM MOPS buffer at pH 7.5. All the anions had a dual effect: At low concentrations, they increased the activity of mMDH, while at high concentrations, they inhibited it. A more accurate analysis of the data revealed that the activation capacity of all the anions tested was similar, although they differed in their inhibitory influence. To show these differences more clearly, the experiment was repeated in 50 mM phosphate buffer at pH 7.5, under conditions where almost all activations were due to the buffer. The analysis of the results obtained under these conditions revealed the following sequence of inhibition potency: Phosphate<acetate<sulfate<chloride<bromide<nitrate<perchlorate<thiocyanate, that was in good agreement with their chaotropicity. The behaviour of mMDH in the presence of different ions and/or ionic strength indicates that at low ionic concentrations, increased activity is likely due to a stabilization of the dimeric form of the enzyme. Further increases in the ionic concentration, especially if chaotropic ions are used, lead to a loss of enzyme activity that appears to be a consequence of structural changes in the enzyme rather than kinetic effects. © 2001 Elsevier Science B.V.","Anions; Enzyme inhibition and activation; Kinetic mechanism; Mitochondrial malate dehydrogenase (mMDH); Monomer-dimer equilibrium","acetic acid; anion; bromide; buffer; chloride ion; malate dehydrogenase; nitrate; perchlorate; phosphate; sulfate; thiocyanate; conference paper; enzyme activity; enzyme kinetics; enzyme structure; heart; in vitro study; mitochondrion; pH; swine; theory",,,,"Boehringer, Germany; Sigma, United States","Dirección General de Enseñanza Superior e Investigación Científica","This work was supported by a grant (PB96-0990) from the Dirección General de Enseñanza Superior e Investigación Cientı́fica (DGESIC), Spain.",,,"Birktoft, J.J., Fernley, R.T., Bradshaw, R.A., Banaszak, L.J., (1982) Proc. Natl. Acad. Sci. U. S. A., 79, p. 6166; Birktoft, J.J., Carnahan, G.E., Rhodes, G., Roderick, S.L., Banaszak, L.J., (1989) Biochem. Soc. Trans., 17, p. 301; Harada, K., Wolfe, R.G., (1968) J. Biol. Chem., 243, p. 4131; Bleile, D.M., Shulz, R.A., Harrison, J.H., (1977) J. Biol. Chem., 252, p. 755; Wood, D.C., Hodges, C.D., Harrison, J.H., (1978) Biochem. Biophys. Res. Commun., 82, p. 943; Wood, D.C., Jurgensen, R.J., Geesin, C., Harrison, J.H., (1981) J. Biol. Chem., 256, p. 2377; Jurgensen, S.R., Harrison, J.H., (1982) J. Biol. Chem., 257, p. 569; Jurgensen, S.R., Wood, D.C., Mahler, J.C., Harrison, J.H., (1981) J. Biol. Chem., 256, p. 2383; Jaenicke, R., Rudolph, R., Heider, Y., (1979) Biochemistry, 18, p. 1217; Shore, J.D., Chakrabarti, S.K., (1976) Biochemistry, 15, p. 875; McKay, R.H., Jameson, D.M., (1991) Biophys. J., 59, p. 204; Sánchez, S.A., Hazlett, T.L., Brunet, J.E., Jameson, D.M., (1998) Protein Sci., 7, p. 2184; Frieden, C., Honnegger, J., Gilbert, H.R., (1978) J. Biol. Chem., 253, p. 816; Jensen, W.A., Armstrong, J.M.D., De Giorgio, J., Hearn, M.T.W., (1996) Biochim. Biophys. Acta, 1296, p. 23; Hodges, C.T., Wiggins, J.C., Harrison, J.H., (1977) J. Biol. Chem., 252, p. 6038; Blonde, D.J., Kresack, E.J., Kosicki, G.W., (1967) Can. J. Biochem., 45, p. 641; Kun, E., Eanes, R.Z., Volfin, P., (1967) Nature, 214, p. 1328; Siegel, L., (1967) Biochemistry, 6, p. 2261; Bracht, A., Campello, A.P., (1979) Experientia, 35, p. 1559; Place, G.A., Beynon, R.J., (1982) Int. J. Biochem., 14, p. 305; Gelpí, J.L., Imperial, S., Avilés, J.J., Busquets, M., Mazo, A., Cortés, A., (1993) Trends Comp. Biochem. Physiol., 1, p. 1099; López Cabrera, A., Cabré, F., Franco, R., Canela, E.I., (1988) Int. J. Bio-Med. Comp., 23, p. 9; Breiter, D.R., Resnik, E., Banaszak, L.J., (1994) Protein Sci., 3, p. 2023; Burguillo, J., Wright, A.J., Bardsley, W.G., (1983) Biochem. J., 211, p. 23; Hofmeister, F., (1888) Arch. Exp. Pathol. Pharmakol., 24, p. 247; Domènech, C., Bozal, X., Mazo, A., Cortés, A., Bozal, J., (1987) Comp. Biochem. Physiol., 88 B, p. 461; Domènech, C., Bozal, X., Mazo, A., Cortés, A., Bozal, J., (1987) Cryo Lett., 8, p. 74; Domènech, C., Bozal, X., Mazo, A., Cortés, A., Bozal, J., (1987) Cryo Lett., 8, p. 346; Birktoft, J.J., Rhodes, G., Banaszak, L.J., (1989) Biochemistry, 28, p. 6065; Abad-Zapatero, C., Griffith, J.P., Sussman, J.L., Rossman, M.G., (1987) J. Mol. Biol., 198, p. 445; Dunn, C.R., Wilks, H.M., Halsall, D.J., Atkinson, T., Clarke, A.R., Muirhead, H., Holbrook, J.J., (1991) Philos. Trans. R. Soc. London, 332, p. 177; Hall, M.D., Levitt, D.G., Banaszak, L.J., (1992) J. Mol. Biol., 226, p. 867; Hall, M.D., Banaszak, L.J., (1993) J. Mol. Biol., 232, p. 213; Gleason, W.B., Fu, Z., Birktoft, J., Banaszak, L.J., (1994) Biochemistry, 33, p. 2078; Chapman, A.D.M., Cortés, A., Dafforn, T.R., Clarke, A.R., Brady, R.L., (1999) J. Mol. Biol., 285, p. 703",,,,,,,,,13811177,,,,"English","J. Mol. Catal. B Enzym.",Article,"Final",,Scopus,2-s2.0-0035931361
"Cascalló M., Calbó J., Gelpí J.L., Mazo A.","6505853074;7003548069;35517522400;7007042077;","Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (ad5CMV-p53) in human pancreatic cancer",2000,"Cancer Gene Therapy","7","4",,"545","556",,38,"10.1038/sj.cgt.7700150","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034039072&doi=10.1038%2fsj.cgt.7700150&partnerID=40&md5=7c3bab9d6f73d4405d5c0697df64dc04","Dept. de Bioquim. i Biol. Molecular, C/Martí i Franqués, 1, 08028 Barcelona, Spain; Dept. of Biochem. and Molec. Biology, University of Barcelona, Barcelona, Spain","Cascalló, M., Dept. of Biochem. and Molec. Biology, University of Barcelona, Barcelona, Spain; Calbó, J., Dept. of Biochem. and Molec. Biology, University of Barcelona, Barcelona, Spain; Gelpí, J.L., Dept. of Biochem. and Molec. Biology, University of Barcelona, Barcelona, Spain; Mazo, A., Dept. de Bioquim. i Biol. Molecular, C/Martí i Franqués, 1, 08028 Barcelona, Spain, Dept. of Biochem. and Molec. Biology, University of Barcelona, Barcelona, Spain","Chemotherapy does not significantly improve prognosis in pancreatic cancer. New therapeutical approaches involving p53 gene replacement appear to be very encouraging due to the key role of p53 in the cell response to DNA damage. Here, we have evaluated the effectiveness of combining wild-type p53 (wt-p53) gene reintroduction (Ad5CMV-p53) and exposure to two genotoxic drugs, gemcitabine and cisplatin, in several human pancreatic cell lines. The efficiency of the combinations was clearly dependent upon timing, as assessed by cell survival determinations. Although wt-p53 transduction before drug treatment induced chemoresistance, p53 transduction in cells treated previously with gemcitabine increased cytotoxicity. Cell cycle profiles showed significant decreases in the percentage of cells in the S phase as a consequence arrests provoked by the expression of exogenous p53, reducing the number of cells susceptible to the drug. The sensitivity of cells to cisplatin, which has a lower degree of S-phase specificity, was not modified as much by p53 gene replacement. In contrast, the recognition of the previous drug-induced DNA damage by the newly expressed wt-p53 elicited increases in sub-G1 populations, consistent with the annexin determinations and bax/bcl-2 ratios observed. Experiments on subcutaneous pancreatic xenografts corroborated the effectiveness of this approach in vivo. Thus, the combination of p53 transduction and chemotherapy, under a correct schedule of administration, appears to be a very promising therapy for human pancreatic cancer.","Adenovirus; Apoptosis; Chemotherapy; p53; Pancreatic cancer","cisplatin; gemcitabine; protein p53; animal experiment; animal model; article; cancer chemotherapy; cell cycle S phase; controlled study; DNA damage; drug cytotoxicity; drug sensitivity; gene expression; gene therapy; genetic transduction; human; human cell; mouse; nonhuman; pancreas cancer; priority journal; prognosis; Adenoviridae; Animalia",,"cisplatin, 15663-27-1, 26035-31-4, 96081-74-2; gemcitabine, 103882-84-4",,"Lilly, Spain; Sigma, United States","Comisión Interministerial de Ciencia y Tecnología: SAF98/042","We thank Drs G. Capellà and F. Llúıs for giving us the pancreatic cell lines and xenograft models, and Drs. J. Fueyo and C. Gómez-Manzano for providing the p16 adenoviral construct and for useful criticism. We are grateful to Lilly S.A. (Madrid, Spain) for the gift of GE. We also acknowledge the help received from Dr. Jaume Comas, who is in charge of the flow cytometry section in the Serveis Cientifico Tècnics de la Universitat de Barcelona (Barcelona, Spain), the technical assistance of J. ter Huurne, and the editorial help provided by Robin Rycroft. This research was supported by Marató del Càncer-TV3 Grant 46/95 and by Comisíon Interministerial de Ciencia y Tecnología Grant SAF98/042. M.C. and J.C. are recipients of predoctoral fellowships from Generalitat de Catalunya and Ministerio de Educación, respectively.",,,"Wingo, P.A., Tong, T., Bolden, S., Cancer statistics (1995) CA Cancer J Clin., 45, pp. 8-30; Lionetto, R., Pugliese, V., Bruzzi, P., Rosso, R., No standard treatment is available for advanced pancreatic cancer (1995) Eur J Cancer., 31 A, pp. 882-887; Roth, J.A., Cristiano, R.J., Gene therapy for cancer: What have we done and where are we going? (1997) J Natl Cancer Inst., 89, pp. 21-39; Culver, K.W., Blaese, R.M., Gene therapy for cancer (1994) Trends Genet., 10, pp. 174-178; King, K.L., Cidlowski, J.A., Cell cycle and apoptosis: Common pathways to life and death (1995) J Cell Biochem., 8, pp. 175-185; Favrot, M., Coll, J.L., Louis, N., Negoescu, A., Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy (1998) Gene Ther., 5, pp. 728-739; Lowe, S.C., Ruley, H.E., Jacks, T., Housman, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer drugs (1993) Cell, 74, pp. 957-967; Hollstein, M., Sidranski, D., Vogelstein, B., Harris, C.C., p53 mutations in human cancers (1991) Science, 253, pp. 49-53; Ko, L.J., Prives, C., p53: Puzzle and paradigm (1996) Genes Dev., 10, pp. 1054-1072; Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., Craig, R.W., Participation of the p53 protein in the response to DNA damage (1991) Cancer Res., 51, pp. 6304-6311; Lane, D.P., p53, guardian of the genome (1992) Nature, 358, pp. 15-16; El-Deiry, W.S., Tokino, K., Velculescu, V.E., WAF1, a potential mediator of p53 tumor suppression (1993) Cell, 75, pp. 817-825; Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., Beach, D., p21 is a universal inhibitor of cyclin kinases (1993) Nature, 366, pp. 701-704; Steward, N., Hicks, G.G., Paraskevas, E., Mowat, M., Evidence for a second cell cycle block at G2/M by p53 (1995) Oncogene, 10, pp. 109-115; Agarwal, M.L., Agarwal, A., Taylor, W.R., Stark, G.R., P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts (1995) Proc Natl Acad Sci USA, 92, pp. 8493-8497; Guillouf, C., Rosselli, F., Krisnaraju, K., Moustacci, E., Hoffman, B., Liebermann, D.A., p53 involvement in control of G2 exit of the cell cycle: Role in DNA damage-induced apoptosis (1995) Oncogene, 10, pp. 2263-2270; Skladanowski, A., Larsen, A.K., Expression of a wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: Implications for gene therapy (1997) Cancer Res., 57, pp. 818-823; Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W., Vogelstein, B., A model for p53-induced apoptosis (1997) Nature, 389, pp. 300-305; Wu, S., El-Deiry, W.S., p53 and chemosensitivity (1996) Nat Med., 2, pp. 255-256; Lowe, S.W., Bodis, S., McClatchey, A., P53 status and the efficacy of cancer therapy in vivo (1994) Science, 266, pp. 807-810; Hawkins, D.S., Demers, G.W., Galloway, D.A., Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents (1996) Cancer Res., 56, pp. 892-898; Ceraline, J., Deplanque, G., Duclos, B., Inactivation of p53 in normal cells increases G2/M arrest and sensitivity to DNA-damaging agents (1998) Int J Cancer, 75, pp. 432-438; Wang, J., Bucana, C.D., Roth, J.A., Zhang, W.W., Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53 (1995) Cancer Gene Ther., 2, pp. 9-17; Gómez-Manzano, C., Fueyo, J., Kyritsis, P., Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis (1996) Cancer Res., 56, pp. 694-699; Kagawa, S., Fujiwara, T., Hizuta, A., p53 overexpression overcomes p21wa1/cip1-mediated G1 arrest and induces apoptosis in human cancer cells (1997) Oncogene, 5, pp. 1903-1909; Hamada, K., Alemany, R., Zhang, W.W., Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer (1996) Cancer Res., 56, pp. 3047-3054; Liu, T.J., El-Naggar, K., McDonnell, T.J., Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck (1995) Cancer Res., 55, pp. 3117-3122; Yang, C., Stambrook, P.J., Markowitz, S.D., Wild-type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest (1996) Clin Cancer Res., 2, pp. 1639-1647; Spitz, F.R., Nguyen, D., Skibber, J.M., Cusack, J., Roth, J.A., Cristiano, R.J., In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer (1996) Anticancer Res., 16, pp. 3415-3422; Xu, G.W., Sun, Z.T., Forrester, K., Wang, X.W., Coursen, J., Harris, C.C., Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene (1996) Hepatology, 24, pp. 1264-1268; Gjerset, R.A., Turla, S.T., Sobol, R.E., Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53 (1995) Mol Carcinog., 14, pp. 275-285; Goldsmith, M.E., Gudas, J.M., Schneider, E., Cowan, K.H., Wild-type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line (1995) J Biol Chem., 270, pp. 1894-1898; Kimura, M., Tagawa, M., Takenaga, K., Inability to induce the alteration of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene (1997) Anticancer Res., 17, pp. 879-884; Lang, D., Miknyoczki, S.J., Huang, L., Ruggeri, B.A., Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells (1998) Oncogene, 16, pp. 1593-1602; Cascalló, M., Mercadé, E., Lluís, F., Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells (1999) Cancer Gene Ther., 6, pp. 428-436; Villanueva, A., García, C., Paules, A.B., Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cells (1998) Oncogene, 17, pp. 1969-1978; Sagawe, Y., Yamagishi, H., Yamaguchi, N., Yamamura, Y., Oka, T., In vitro chemosensitivity of human pancreatic cancer cell lines (1996) Int J Pancreatol., 20, pp. 185-190; Lee, J.U., Hosotani, R., Wada, M., Mechanism of apoptosis induced by cisplatin and VP-16 in PANC-1 cells (1997) Anticancer Res., 17, pp. 3445-3450; Harris, C.C., Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies (1996) J Natl Cancer Inst., 88, pp. 1442-1455; Stucky-Marshall, L., New agents in gastrointestinal malignancies: Part 2: GEMCITABINE in clinical practice (1999) Cancer Nurs., 22, pp. 290-296; Serrano, M., Hannon, G.J., Beach, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 (1993) Nature, 366, pp. 704-707; Miyashita, T., Reed, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene (1995) Cell, 80, pp. 293-299; Yin, C., Knudson, C.M., Korsmeyer, S.J., Van Dyke, T., Bax suppresses tumorigenesis and stimulates apoptosis in vivo (1997) Nature, 385, pp. 637-640; Fujiwara, T., Grimm, E.A., Mukhoadhyay, T., Zhang, W.W., Owe-Schaub, B., Roth, J.A., Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene (1994) Cancer Res., 54, pp. 2287-2291; Nguyen, D.M., Spitz, F.R., Yen, N., Cristiano, R.J., Roth, J.A., Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer (1996) J Thorac Cardiovasc Surg., 112, pp. 1372-1376","Mazo, A.; Departament Bioquim. Biologia Molec., C/Marti i Franques, 1, 08028 Barcelona, Spain; email: adela@sgenz.bq.ub.es",,,"Nature Publishing Group",,,,,09291903,,CGTHE,"10811472","English","Cancer Gene Ther.",Article,"Final",,Scopus,2-s2.0-0034039072
"Busquets C., Merinero B., Christensen E., Gelpí J.L., Campistol J., Pineda M., Fernández-Alvarez E., Prats J.M., Sans A., Arteaga R., Martí M., Campos J., Martínez-Pardo M., Martínez-Bermejo A., Vaquerizo J., Orozco M., Ugarte M., Coll M.J., Ribes A.","6603645040;6602854012;7202966582;35517522400;7103042466;35473639700;7003284115;7005207803;7005589454;57198368912;9436010100;57202591404;7003570900;7005206080;6603648237;7102809158;7005900322;7102780743;15036696200;","Glutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically, and biochemically distinct",2000,"Pediatric Research","48","3",,"315","322",,96,"10.1203/00006450-200009000-00009","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033875134&doi=10.1203%2f00006450-200009000-00009&partnerID=40&md5=9b097a4fe95e68b7401e6c8a39a88c1f","Institut de Bioquímica Clínica, Barcelona 08280, Spain; Centro de Diagnóstico de Enfermedades Moleculares, Universidad Autónoma, Madrid 28049, Spain; Department of Clinical Genetics, Rigshospitalet, Copenhagen 2100, Denmark; Departament de Bioquímica, Universitat de Barcelona, Barcelona 08028, Spain; Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat 08950, Spain; Hospital de Cruces, Baracaldo 48903, Spain; Hospital Marqués de Valdecilla, Santander 39008, Spain; Hospital Materno-Infantil de Las Palmas, Las Palmas 35016, Spain; Hospital Clínico, Madrid 28040, Spain; Hospital Ramón y Cajal, Madrid 28034, Spain; Hospital Infantil La Paz, Madrid 28046, Spain; Hospital Universitario Infanta Cristina, Badajoz 06010, Spain; Institut de Bioquímica Clínica, Edifici Helios III, C/Mejía Lequerica s/n, Barcelona E-08028, Spain","Busquets, C., Institut de Bioquímica Clínica, Barcelona 08280, Spain; Merinero, B., Centro de Diagnóstico de Enfermedades Moleculares, Universidad Autónoma, Madrid 28049, Spain; Christensen, E., Department of Clinical Genetics, Rigshospitalet, Copenhagen 2100, Denmark; Gelpí, J.L., Departament de Bioquímica, Universitat de Barcelona, Barcelona 08028, Spain; Campistol, J., Hospital Clínico, Madrid 28040, Spain; Pineda, M., Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat 08950, Spain; Fernández-Alvarez, E., Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat 08950, Spain; Prats, J.M., Hospital de Cruces, Baracaldo 48903, Spain; Sans, A., Hospital Universitari Sant Joan de Déu, Esplugues de Llobregat 08950, Spain; Arteaga, R., Hospital Marqués de Valdecilla, Santander 39008, Spain; Martí, M., Hospital Materno-Infantil de Las Palmas, Las Palmas 35016, Spain; Campos, J., Hospital Clínico, Madrid 28040, Spain; Martínez-Pardo, M., Hospital Ramón y Cajal, Madrid 28034, Spain; Martínez-Bermejo, A., Hospital Infantil La Paz, Madrid 28046, Spain; Vaquerizo, J., Hospital Universitario Infanta Cristina, Badajoz 06010, Spain; Orozco, M., Departament de Bioquímica, Universitat de Barcelona, Barcelona 08028, Spain; Ugarte, M., Centro de Diagnóstico de Enfermedades Moleculares, Universidad Autónoma, Madrid 28049, Spain; Coll, M.J., Institut de Bioquímica Clínica, Barcelona 08280, Spain; Ribes, A., Institut de Bioquímica Clínica, Barcelona 08280, Spain, Institut de Bioquímica Clínica, Edifici Helios III, C/Mejía Lequerica s/n, Barcelona E-08028, Spain","Glutaryl-CoA dehydrogenase (GCDH) deficiency causes glutaric aciduria type I (GA I), an inborn error of metabolism that is characterized clinically by dystonia and dyskinesia and pathologically by neural degeneration of the caudate and putamen. Studies of metabolite excretion allowed us to categorize 43 GA I Spanish patients into two groups: group 1 (26 patients), those presenting with high excretion of both glutarate and 3-hydroxyglutarate, and group 2 (17 patients), those who might not be detected by routine urine organic acid analysis because glutarate might be normal and 3-hydroxyglutarate only slightly higher than controls. Single-strand conformation polymorphism (SSCP) screening and sequence analysis of the 11 exons and the corresponding intron boundaries of the GCDH gene allowed us to identify 13 novel and 10 previously described mutations. The most frequent mutations in group I were A293T and R402W with an allele frequency of 30% and 28%, respectively. These two mutations were also found in group 2, but always in heterozygosity, in particular in combination with mutations V400M or R227P. Interestingly, mutations V400M and R227P were only found in group 2, and at least one of these mutations was found in 11 of 15 unrelated alleles, accounting together for 53% of the mutant alleles in group 2. Therefore, it seems clear that two genetically and biochemically distinct groups of patients exist. The severity of the clinical phenotype seems to be closely linked to the development of encephalopathic crises rather than to residual enzyme activity or genotype. Comparison of GCDH protein with other acyl-CoA dehydrogenases (whose x-ray crystal structure has been determined) reveals that most of the mutations identified in GCDH protein seem to affect folding and tetramerization, as has been described for a number of mutations affecting mitochondrial β-oxidation acyl-CoA dehydrogenases.",,"glutaric acid; glutaric acid derivative; glutaryl coenzyme A dehydrogenase; article; brain disease; clinical article; disease association; disease severity; enzyme deficiency; gene mutation; gene sequence; glutaric aciduria type i; human; metabolic disorder; priority journal; protein folding; sequence analysis; single strand conformation polymorphism; Spain",,"glutaric acid, 110-94-1; glutaryl coenzyme A dehydrogenase, 37255-38-2",,,,,,,"Goodman, S.I., Frerman, F.E., Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia (1995), pp. 1451-1460. , Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th Ed. McGraw-Hill, New York; Superti-Furga, A., Hoffman, G., Glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency): Advances and unanswered questions (1997) Eur J Pediatr, 156, pp. 821-828; Baric, I., Zschocke, J., Christensen, E., Duran, M., Goodman, S.I., Leonard, J.V., Muller, E., Hoffmann, G.F., Diagnosis and management of glutaric aciduria type I (1998) J Inherit Metab Dis, 21, pp. 326-340; Hoffmann, G.F., Zschocke, J., Glutaric aciduria type I: From clinical, biochemical and molecular diversity to successful therapy (1999) J Inherit Metab Dis, 22, pp. 381-391; Goodman, S.I., Kratz, L.E., Di Giulio, K.A., Biery, B.J., Goodman, K.E., Isaya, G., Frerman, F.E., Cloning of glutaryl-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes in Escherichia coli (1995) Hum Mol Genet, 4, pp. 1493-1498; Greenberg, C.R., Duncan, A.M.V., Gregory, C.A., Singal, R., Goodman, S.I., Assignment of human glutaryl-CoA dehydrogenase gene (GCDH) to the short arm of chromosome 19 (19p13.2) by in situ hybridisation and somatic cell hybrid analysis (1994) Genomics, 21, pp. 289-290; Biery, B.J., Stein, D.E., Morton, D.H., Goodman, S.I., Gene structure and mutations of glutaryl-CoA dehydrogenase: Impaired association of enzyme subunits that is due to an A421V substitution causes glutaric acidemia type I in the Amish (1996) Am J Hum Genet, 59, pp. 1006-1011; Schwartz, M., Christensen, E., Superti-Furga, A., Brandt, N.J., The human glutaryl-CoA dehydrogenase gene: Report of intronic sequence and of 13 novel mutations causing glutaric aciduria type I (1998) Hum Genet, 102, pp. 452-458; Koeller, D.M., DiGiulio, K.A., Angeloni, S.V., Dowler, L.L., Frerman, F.E., White, R.A., Goodman, S.I., Cloning, structure, and chromosome localization of the mouse glutaryl-CoA dehydrogenase gene (1995) Genomics, 28, pp. 508-512; Greenberg, C.R., Reimer, D., Singal, R., Triggs-Raine, B., Chudley, A.E., Dilling, L.A., Philipps, S., Goodman, S.I., A G-to-T transversion at the +5 position of intron 1 in the glutaryl-CoA dehydrogenase gene is associated with the Island Lake variant of glutaric acidemia type I (1995) Hum Mol Genet, 4, pp. 493-495; Haworth, J.C., Singal, R., Goodman, S.I., Greenberg, C.R., TaqI polymorphism in intron 2 of the GCDH gene (1994) Hum Mol Genet, 3, p. 678; Anikster, Y., Shaag, A., Joseph, A., Mandel, H., Ben-Zeev, B., Christensen, E., Elpeleg, O.N., Glutaric aciduria type I in the Arab and Jewish communities in Israel (1996) Am J Hum Genet, 59, pp. 1012-1018; Christensen, E., Ribes, A., Busquets, C., Pineda, M., Duran, M., Poll-The, B.T., Greenberg, C.R., Schwartz, M., Compound heterozygosity in the glutaryl-CoA dehydrogenase gene with R227P mutation in one allele is associated with no or very low free glutarate excretion (1997) J Inherit Metab Dis, 20, pp. 383-386; Busquets, C., Coll, M.J., Christensen, E., Campistol, J., Clusellas, N., Vilaseca, M.A., Ribes, A., Feasibility of molecular prenatal diagnosis of gIutaric aciduria type I in chorionic villi (1998) J Inherit Metab Dis, 21, pp. 243-246; Goodman, S.I., Stein, D.E., Schlesinger, S., Christensen, E., Schwartz, M., Greenberg, C.R., Elpeleg, O.N., Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type 1): Review and report of thirty novel mutations (1998) Hum Mutat, 12, pp. 141-144; Ikeda, H., Kimura, T., Ikegami, T., Kato, M., Matsunaga, A., Yokoyama, S., Yamaguchi, S., Hayasaka, K., Novel mutations of the glutaryl-CoA dehydrogenase gene in two Japanese patients with glutaric aciduria type I (1998) Am J Med Genet, 80, pp. 327-329; Christensen, E., Improved assay of glutaryl-CoA dehydrogenase in cultured cells and liver: Application to glutaric aciduria type I (1983) Clin Chim Acta, 129, pp. 91-97; Campistol, J., Ribes, A., Alvarez, L., Christensen, E., Millington, D.S., Glutaric aciduria type I: Unusual biochemical presentation (1992) J Pediatr, 121, pp. 83-86; Prats, J.M., Ribes, A., Briones, M.P., Garaizar, C., Sanjurjo, P., Aciduria glutarica tipo 1 (1993) An Esp Pediatr, 38, pp. 343-347; Martinez-Lage, J.F., Casas, C., Fernandez, M.A., Puche, A., Rodriguez-Costa, T., Poza, M., Macrocephaly, dystonia, and bilateral temporal arachnoid cysts: Glutaric aciduria type I (1994) Childs Nerv Syst, 10, pp. 198-203; Artigas, J., Ribes, A., Rovira, A., Lorente, I., Briones, M.P., Aciduria glutarica tipo I con quistes aracnoideos (1995) Rev Neurol, 23, pp. 153-156; Merinero, B., Perez-Cerda, C., Font, L.M., Garcia, M.J., Aparicio, M., Lorenzo, G., Martinez Pardo, M., Ugarte, M., Variable clinical and biochemical presentation of seven Spanish cases with glutaryl-CoA dehydrogenase deficiency (1995) Neuropediatrics, 26, pp. 238-242; Pineda, M., Ribes, A., Busquets, C., Vilaseca, M.A., Aracil, A., Christensen, E., Glutaric aciduria type I with high residual glutaryl-CoA dehydrogenase activity (1998) Dev Med Child Neurol, 40, pp. 840-842; Verhaeghe, B.J., Lefevere, M.F., De Leenheer, A.P., Solid-phase extraction with strong anion-exchange columns for selective isolation and concentration of urinary organic acids (1988) Clin Chem, 3416, pp. 1077-1083; Antonorakis, S.E., Recommendations for a nomenclature system for human gene mutations (1998) Hum Murat, 11, pp. 1-3; Busquets, C., Coll, M.J., Ribes, A., Evidence of a single origin for the most frequent mutation R402W causing glutaryl-CoA dehydrogenase deficiency. Identification of 3 novel polymorphisms and haplotype definition (1999) Hum Murat, , Mutation in Brief 291 on-line; Nyhan, W.L., Zschocke, I., Hoffmann, G., Stein, D.E., Bao, L., Goodman, S.I., Glutaryl-CoA dehydrogenase deficiency presenting as 3-hydroxyglutaric aciduria (1999) Mol Genet Metab, 66, pp. 199-204; Liesert, M., Zschocke, I., Hoffmann, G.F., Muhlhauser, N., Buckel, W., Biochemistry of glutaric aciduria type I: Activities of in vitro expressed wild-type and mutant cDNA encoding human glutaryl-CoA dehydrogenase (1999) J Inherit Metab Dis, 22, pp. 256-258; Kim, J.-J.P., Wang, M., Paschke, R., Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate (1993) Proc Natl Acad Sci U S A, 90, pp. 7523-7527; Tiffany, K.A., Roberts, D.L., Wang, M., Paschke, Mohsen, A.-W.A., Kim, J.-J.P., Structure of human isovaleryl-CoA dehydrogenase at 2.6 (A) resolution: Structural basis for substrate specificity (1997) Biochemistry, 36, pp. 8455-8464; Djordjevic, S., Pace, C.P., Stankovich, M.T., Kim, J.-J.P., Three-dimensional structure of butyryl-CoA dehydrogenase from Megasphaera elsdenii (1995) Biochemistry, 34, pp. 2163-2171; Bross, P., Jespersen, C., Jensen, T.G., Andresen, B.S., Kristensen, M.J., Winter, V., Nandy, A., Gregersen, N., Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly, and stability of MCAD enzyme (1995) J Biol Chem, 17, pp. 10284-10290; Naito, E., Indo, Y., Tanaka, K., Identification of two variant short chain acyl-CoA dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-CoA dehydrogenase deficiency (1990) J Clin Invest, 85, pp. 1575-1582; Saijo, T., Kim, J.-J.P., Kuroda, Y., Tanaka, K., The roles of threonine-136 and glutamate-137 of human medium chain acyl-CoA dehydrogenase in FAD binding and peptide folding using site-directed mutagenesis: Creation of an FAD-dependent mutant, T136 (1998) Arch Biochem Biophys, 358, pp. 49-57; Andresen, B.S., Olpin, S., Poorthuis, B.J.H.M., Scholte, J.R., Vianey-Saban, C., Wanders, R., Ijlst, L., Gregersen, N., Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency (1999) Am J Hum Genet, 64, pp. 479-494; Roberts, D.L., Frerman, F.E., Kim, J.-J.P., Three-dimensional structure of human electron transfer flavoprotein to 2.1-(A) resolution (1996) Proc Natl Acad Sci U S A, 93, pp. 14355-14260; Waters, P.J., Parniak, M.A., Nowacki, P.N., Scriver, C.R., In vitro expression analysis of mutations in phenylalanine hydroxylase: Linking genotype to phenotype and structure to function (1998) Hum Mutat, 11, pp. 4-7; Andresen, B.S., Bross, P., Udvari, S., Kirk, J., Gray, G., Kmoch, S., Chamoles, N., Gregersen, The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: Is there correlation between genotype and phenotype (1997) Hum Mol Genet, 6, pp. 695-707; Gregersen, N., Winter, V.S., Corydon, M.J., Corydon, T.J., Rinaldo, P., Ribes, A., Martinez, G., Kolvraa, S., (1998) Hum Mol Genet, 7, pp. 619-627. , Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511CΠ T, is present at an unexpectedly high frequency in the general population, as was the case for 625GΠ A, together conferring susceptibility to ethylmalonic aciduria; Flott-Rahmel, B., Falter, C., Schluff, P., Fingerhut, R., Christensen, E., Jakobs, C., Musshoff, U., Ullrich, K., Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia type I (1997) J Inherit Metab Dis, 20, pp. 387-390; Ullrich, K., Flott-Rahmel, B., Schluff, P., Musshoff, Das, A., Lucke, T., Steinfeld, R., Roper, R., Glutaric aciduria type I: Pathomechanisms of neurodegeneration (1999) J Inherit Metab Dis, 22, pp. 392-403; Andresen, B.S., Bross, P., Vianey-Saban, C., Divry, P., Zabot, M., Roe, C.R., Nada, M.A., Gregersen, N., Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene (1996) Hum Mol Genet, 5, pp. 461-472; Shukla, A., Dikshit, M., Srimal, R.C., Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium (1995) Neurureport, 6, pp. 1629-1632; Shinawi, M., Gruener, N., Lerner, A., CSF levels of camitine in children with meningitis, neurulogic disorders, acute gastroenteritis, and seizure (1998) Neurology, 50, pp. 1869-1871; Hathaway, C.A., Appleyard, C.B., Percy, W.H., Williams, J.L., Collitis increases blood-brain barrier permeability in rabbits (1998) FASEB J, 12, pp. A391; Land, J.M., Goulder, P., Johnson, A., Hockaday, J., Glutaric aciduria type I: An atypical presentation together with some observations upon treatment and the possible cause of cerebral damage (1992) Neuropediatrics, 23, pp. 322-326; Ribes, A., Riudor, E., Briones, P., Christensen, E., Campistol, J., Millington, D.S., Significance of bound glutarate in the diagnosis of glutaric aciduria type I (1992) J Inherit Metab Dis, 15, pp. 367-370","Ribes, A.; Institut de Bioquimica Clinica, C/Mejia Lequerica s/n, E-08028 Barcelona, Spain",,,"Lippincott Williams and Wilkins",,,,,00313998,,PEREB,"10960496","English","Pediatr. Res.",Article,"Final",,Scopus,2-s2.0-0033875134
"Ezquerra M., Carnero C., Blesa R., Gelpí J.L., Ballesta F., Oliva R.","6603683564;6701646321;56186408100;35517522400;7003412011;17635957400;","A presenilin 1 mutation (ser169pro) associated with early-onset AD and myoclonic seizures",1999,"Neurology","52","3",,"566","570",,41,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033010135&partnerID=40&md5=40d4309e7c6881253248dad8b13afb3f","Neurology Service, Hosp. Univ. Virgen de las Nieves, Granada, Spain; Neurology Service, Hospital Clínic, Barcelona, Spain; Genetics Service, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain","Ezquerra, M.; Carnero, C., Neurology Service, Hosp. Univ. Virgen de las Nieves, Granada, Spain; Blesa, R., Neurology Service, Hospital Clínic, Barcelona, Spain; Gelpí, J.L.; Ballesta, F.; Oliva, R., Genetics Service, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain","Objective: To characterize the mutation responsible for early-onset AD in a large Spanish kindred. Background: Mutations in the presenilin 1 (PS1) gene have been identified and are known to be responsible for 18 to 50% of familial early-onset AD cases. Methods: Patients were characterized clinically. The proband was further studied with EEG, CSF analysis, CT, brain biopsy, and histology. Other members were studied using EEG, CT, MRI, and SPFCT. Genetic analysis of PS1 was performed using PCR amplification of PS1 exons and direct sequencing followed by PS1 modeling of the normal and mutant PS1 proteins. Results: A novel mutation (Ser169Pro) in exon 6 of the PS1 gene was identified in different affected members. The Ser169Pro mutation is located at a site of the PSI protein that is not a cluster of mutations. The mutation was not present in 100 general population controls and in 50 unrelated sporadic AD cases. The Ser169Pro mutation is associated with generalized myoclonic seizures several years after the initial symptoms ofAD, a very early AD onset (≤35 years), and a rapidly progressive cognitive decline. Conclusions: The absence of the PS1 Ser169Pro mutation in the general population and in sporadic AD cases together with its detection in the affected members of this kindred suggests that it is a pathogenic mutation. The serine to proline change predicts a kink in the α-helix of the transmembrane domain of the PS1 protein that could radically disrupt its normal structure. Further characterization of the effect of this mutation could help identify the function of the PS1 protein and the pathogenic mechanisms of AD.",,"presenilin 1; adult; Alzheimer disease; article; brain biopsy; brain scintiscanning; case report; computer assisted tomography; electroencephalogram; female; gene mutation; genetic analysis; genetic linkage; histopathology; human; myoclonus; nuclear magnetic resonance imaging; onset age; pathogenesis; polymerase chain reaction; priority journal; seizure; single photon emission computer tomography; Alzheimer Disease; Amino Acid Sequence; Epilepsies, Myoclonic; Exons; Membrane Proteins; Molecular Sequence Data; Mutation; Pedigree; Phenotype; Presenilin-1; Spain; Time Factors",,"Membrane Proteins; Presenilin-1",,,,,,,"Sherrington, R., Rogaev, E., Liang, Y., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease (1995) Nature, 375, pp. 754-760; Cruts, M., Hendriks, L., Van Broeckhoven, C., The presenilin genes: A new gene family involved in Alzheimer disease pathology (1996) Hum Mol Genet, 5, pp. 1449-1455; Levy-Lahad, E., Wasco, W., Yu, C., Candidate gene for the chromosome 1 familial Alzheimer's disease locus (1995) Science, 269, pp. 678-680; Goate, A., Chartier-Harlin, M.C., Giufra, L., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer disease (1991) Nature, 349, pp. 704-709; Cruts, M., Van Broeckhoven, C., Presenilin mutations in Alzheimer's disease (1998) Hum Mutat, 11, pp. 183-190; Hutton, M., Busfield, F., Wragg, M., Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease (1996) Neuroreport, 7, pp. 801-805; Gómez-Isla, T., Wasco, W., Pettingell, W., A novel presenilin mutation: Increased β-amyloid and neurofibrillary changes (1997) Ann Neurol, 41, pp. 809-813; Aldudo, J., Bullido, M.J., Arbizu, T., Oliva, R., Valdivieso, F., Identification of a novel mutation (Leu282Arg) of the presenilin 1 gene (1998) Neurosci Lett, 240, pp. 174-176; Levitan, D., Greenwald, I., Facilitation of lin-12 mediated signaling by sel-12, a Caenorhabditis elegans s182 Alzheimer's disease gene (1995) Nature, 377, pp. 351-354; Wragg, M., Hutton, M., Talbot, C., Genetic association between intron polymorphism in presenilin-1 gene and late-onset Alzheimer's disease (1996) Lancet, 347, pp. 509-512; Ezquerra, M., Blesa, R., Tolosa, E., The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease (1997) Neurosci Lett, 227, pp. 201-204; Montero, J., Arbizu, R., Ferrer, I., Aguilar, M., Peres-Serra, J., Clinical and pathologic study of an early case of Alzheimer's disease (1977) Med Clin (Barc), 69, pp. 515-518; Blesa, R., Adroer, R., Santacruz, P., Ascaso, C., Tolosa, E., Oliva, R., High apolipoprotein E epsilon 4 allele frequency in age-related memory decline (1996) Ann Neurol, 39, pp. 548-551; Bernstein, F.C., Koetzle, T.F., Williams, G.J., The Proteins Data Bank: A computer-based archival file for macromolecular structures (1977) J Mol Biol, 112, pp. 535-542; Murgolo, N.J., Brown, J.E., Bayne, M.L., Strader, C.D., Presenilins mutations in Alzheimer's disease: Molecular models suggest a potential functional locus (1996) Trends in Protein Science, 17, pp. 389-393; Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M.G., Hagler, A.T., Structure and energetics of ligand binding to proteins: E. coli dihydrofolate-reductase-trimethoprim, a drug-receptor system (1988) Proteins, 4, pp. 31-47; Von Heijne, G., Proline kinks in transmembrane α-helices (1991) J Mol Biol, 218, pp. 499-503; Eisenberg, D., Weiss, R., Terwillinger, T.C., The helical hydrophobic moment: A measure of the amphiphilicity of a helix (1982) Nature, 199, pp. 371-374; Li, X., Greenwald, I., Membrane topology of the C. elegans SEL-12 presenilin (1996) Neuron, 17, pp. 1015-1021; Woolfson, D.N., Mortishire-Smith, R.J., Williams, D.H., Conserved positioning of proline residues in membrane-spanning helices of ion-channel proteins (1991) Biochem Biophys Res Commun, 175, pp. 733-736; St. George-Hyslop, P., Genetics of Alzheimer disease (1997) Neuropathology of Dementing Disease, , Markesbery W, ed. London: Edward Arnold Publishers; Campion, D., Brice, A., Dumanchin, C., A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years (1996) Neuroreport, 7, pp. 1582-1584; Lopera, F., Ardilla, A., Martínez, A., Clinical features of early-onset Alzheimer disease in a large kindred with and E280A presenilin-1 mutation (1997) JAMA, 277, pp. 793-799; Axelman, K., Basun, H., Lannfelt, L., Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene (1998) Arch Neurol, 55, pp. 698-702; Harvey, R.J., Ellison, D., Hardy, H., Chromosome 14 familial Alzheimer's disease: The clinical and neuropathological characteristics of a family with a leucine to serine (L250S) substitution at codon 250 of the presenilin 1 gene (1998) J Neurol Neurosurg Psychiatry, 64, pp. 44-49; Crook, R., Ellis, R., Shanks, M., Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation (1997) Ann Neurol, 42, pp. 124-128; Fox, N.C., Kennedy, A.M., Harvey, R.J., Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene (1997) Brain, 120, pp. 491-501; Melanson, M., Nalbantoglu, J., Berkovic, S., Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease (1997) Neurology, 49, pp. 1732-1733; Guo, Q., Furukawa, K., Sopher, B.L., Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide (1996) Neuroreport, 8, pp. 379-383; Keller, J.N., Guo, Q., Holtsberg, F.W., Bruce-Keller, A.J., Mattson, M.P., Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production (1998) J Neurosci, 18, pp. 4439-4450; Trump, B.J., Berezesky, I.K., Calcium-mediated cell injury and cell death (1995) FASEB J, 9, pp. 219-228; Verkhratsky, A., Toescu, E.C., Calcium and neuronal ageing (1998) Trends Neurosci, 21, pp. 2-7; Guo, Q., Christakos, S., Robinson, N., Mattson, M.P., Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function (1998) Proc Natl Acad Sci USA, 95, pp. 3227-3232; Guo, Q., Robinson, N., Mattson, M.P., Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kB and stabilization of calcium homeostasis (1998) J Biol Chem, 273, pp. 12341-12351; Saito, K., Elce, J.S., Nixon, R.A., Widespread activation of calcium activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration (1993) Proc Natl Acad Sci USA, 90, pp. 2628-2632; Siman, R., Card, J.P., Davis, L.G., Proteolitic processing of beta-amyloid precursor by calpain I (1990) J Neurosci, 10, pp. 2400-2411; Wong, P.C., Zheng, H., Chen, H., Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm (1997) Nature, 387, pp. 288-292; Joutel, A., Corpechot, C., Ducros, A., Notch3 mutations in a CASADIL: A hereditary adult-onset condition causing stroke and dementia (1996) Nature, 383, pp. 707-710; Li, J., Xu, M., Zhou, H., Ma, J., Potter, H., Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation (1997) Cell, 90, pp. 917-927","Oliva, R.; Genetics Service, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain",,,,,,,,00283878,,NEURA,"10025789","English","Neurology",Article,"Final",,Scopus,2-s2.0-0033010135
"Romero-Isart N., Cols N., Termansen M.K., Gelpi J.L., Gonzalez-Duarte R., Atrian S., Capdevila M., Gonzalez-Duarte P.","6602293104;6603096443;6507799513;35517522400;7006670820;7003272506;6701334026;7003985264;","Erratum: Replacement of terminal cysteine with histidine in the metallothionein α and β domains maintains its binding capacity (European Journal of Biochemistry (1999) 259 (519-527))",1999,"European Journal of Biochemistry","259","3",,"961","",,,"10.1046/j.1432-1327.1999.00961.x","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033083854&doi=10.1046%2fj.1432-1327.1999.00961.x&partnerID=40&md5=c76407c6a560c81d3bc34f6f5871778f",,"Romero-Isart, N.; Cols, N.; Termansen, M.K.; Gelpi, J.L.; Gonzalez-Duarte, R.; Atrian, S.; Capdevila, M.; Gonzalez-Duarte, P.",[No abstract available],,"erratum; error; priority journal",,,,,,,,,,,,,,,,,,00142956,,EJBCA,,"English","Eur. J. Biochem.",Erratum,"Final",,Scopus,2-s2.0-0033083854
"Romero-Isart N., Cols N., Termansen M.K., Gelpí J.L., González-Duarte R., Atrian S., Capdevila M., Gonzàlez-Duarte P.","6602293104;6603096443;6507799513;35517522400;7006670820;7003272506;6701334026;7003985264;","Replacement of terminal cysteine with histidine in the metallothionein and β domains maintains its binding capacity",1999,"European Journal of Biochemistry","259","1-2",,"519","527",,30,"10.1046/j.1432-1327.1999.00074.x","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000680389&doi=10.1046%2fj.1432-1327.1999.00074.x&partnerID=40&md5=291ef15fe73cdc13ba9e1758c44b9dba","Departament de Química, Facultat de Ciències, Univ. Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain","Romero-Isart, N.; Cols, N.; Termansen, M.K.; Gelpí, J.L.; González-Duarte, R.; Atrian, S.; Capdevila, M.; Gonzàlez-Duarte, P., Departament de Química, Facultat de Ciències, Univ. Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain","To generate novel forms of metal-binding proteins, six mutant mouse metallothionein (MT) 1 fragments, in which a terminal cysteine residue was replaced by histidine, were expressed in Escherichia coli. The spectroscopic and analytical results showed that the αMT (C33H, C36H, C41H, C57H) and βMT (C5H, C13H) mutant forms bound 4 and 3 Zn(II) atoms per molecule of protein to the nearest integer, even though in C41H and C5H, species of lower stoichiometry were also detected. In Cd(II) titrations, all the Zn(II) ions bound to the mutant proteins were displaced from the binding sites, giving rise to Cd-mutated MT forms with 4 and 3 Cd(II), respectively. However, although Cys-to-His substitutions maintained the binding capacity of the MT fragments, they caused structural changes with respect to the wild-type proteins. While C13H, C36H and C57H seem to contain Zn(II)-aggregates that are closely related to those of the wild-type proteins, only C41H and C57H gave rise to Cd(II)-aggregates similar to those of Cd4-αMT, where the His residue plays the role of the substituted Cys. Despite the structural implications of the Cysto-His replacement, the dissociation constants showed no major decrease in the Cd-binding affinity in any of the mutants assayed compared with the wild-type.","Cadmium binding; Cysteine-to-histidine substitutions; Metallothionein fragments; Site-directed mutants; Zinc binding","cadmium; cysteine; histidine; metallothionein; mutant protein; zinc; amino acid sequence; amino acid substitution; article; binding affinity; binding site; DNA sequence; escherichia coli; gene expression; molecular cloning; nonhuman; polymerase chain reaction; priority journal; site directed mutagenesis; Amino Acid Sequence; Animals; Binding Sites; Cadmium; Circular Dichroism; Cysteine; Escherichia coli; Histidine; Mass Spectrometry; Metallothionein; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptide Fragments; Protein Conformation; Recombinant Proteins; Spectrophotometry, Ultraviolet; Zinc; Escherichia coli",,"Cadmium, 7440-43-9; Cysteine, 52-90-4; Histidine, 71-00-1; Metallothionein, 9038-94-2; Peptide Fragments; Recombinant Proteins; Zinc, 7440-66-6",,,,,,,"Huang, P.C., Metallothionein structure/function interface (1993) Metallothionein III, pp. 407-426. , (Suzuki, K.T., Imura, N. & Kimura, M., eds.), Birkhäuser-Verlag, Basel, Boston, Berlin; Kurasaki, M., Yamaguchi, R., Linde Arias, A.R., Okabe, M., Kojima, Y., Significance of α-fragment of metallothionein in cadmium binding (1997) Prot. Engng., 10, pp. 413-416; Cismowski, M.J., Narula, S.S., Armitage, I.M., Chernaik, M.L., Huang, P.C., Mutation of invariant cysteines of mammalian metallothionein alters metal binding capacity, cadmium resistance and Cd-113 NMR spectrum (1991) J. Biol. Chem., 26, pp. 24390-24397; Cismowski, M.J., Huang, P.C., Effect of cysteine replacements at positions 13 and 50 on metallothionein structure (1991) Biochemistry, 30, pp. 6626-6632; Romeyer, F.M., Jacobs, F.A., Brousseau, R., Expression of Neurospora crassa metallothionein and its variants in Escherichia coli (1990) Appl. and Envir. Microb., 56, pp. 2748-2754; Chernaik, M.L., Huang, P.C., Differential effect of cysteine to serine substitutions in metallothionein on cadmium resistance (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 3024-3028; Capdevila, M., Cols, N., Romero-Isart, N., González-Duarte, R., Atrian, S., González-Duarte, P., Recombinant synthesis of mouse Zn3-β and Zn4-α metallothionein 1 domains and characterization of their cadmium (II) binding capacity (1997) CMLS, Cell Mol. Life Sci., 53, pp. 681-688; Cols, N., Romero-Isart, N., Capdevila, M., Oliva, B., González-Duarte, P., González-Duarte, R., Atrian, S., Binding of excess cadmium (II) to Cd7-metallothionein from recombinant mouse Zn7-metallothionein 1. UV-VIS absorption and circular dichroism studies and theoretical location approach by surface accessibility analysis (1997) J. Inorg. Biochem., 68, pp. 157-166; Romero-Isart, N., Duran, N., Capdevila, M., González-Duarte, P., Maspocb, S., Torres, J., Metal binding properties of three Cys2X2 (X= His, Asp) metallothionein-related peptides (1998) Inorg. Chim. Acta, 278, pp. 10-14; Romero, N., Capdevila, M., González-Duarte, P., Otiva, B., Computational analysis of cysteine substitutions modelled on the α- and β-domains of Cd5,Zn2-metallothionein 2 (1996) J. Mol. Mod., 27, pp. 417-426; Robbins, A.H., McRee, D.E., Williamson, M., Collett, S.A., Xoung, N.H., Furey, W.F., Wang, B.C., Stout, C.D., Refined crystal structure of Cd,Zn metallothionein at 2.0 Å, resolution (1991) J. Mol. Biol., 221, pp. 1269-1293; Picard, V., Ersdal-Badju, E., Lu, A., Bock, S.C., A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase (1994) Nucleic Acids Res., 22, pp. 2587-2591; Landt, O., Grunert, H.-P., Hahn, U., A general method for rapid site-directed mutagenesis using the polymerase chain reaction (1990) Gene, 96, pp. 125-128; Sanger, F., Nicklen, S., Coulson, A.R., DNA sequencing with chain-terminating inhibitors (1977) Proc. Natl. Acad. Sci. USA, 74, pp. 5463-5467; Segel, I.H., (1975) Enzyme Kinetics Behaviour and Analysis of Rapid Equilibrium and Steady State Enzyme Systems, , Wiley, New York; Canela, E.I., A free-derivative program for non-linear regression analysis of enzyme kinetics to be used on small computers (1984) Int. J. Biomed. Comp., 15, pp. 121-130; Yu, X., Wojciechowski, M., Fenselau, C., Assessment of metals in reconstituted metallothioneins by electrospray mass spectrometry (1993) Anal Chem., 65, pp. 1355-1359; Fabris, D., Zaia, J., Hathout, Y., Fenselau, C., Retention of thiol protons in two classes of protein zinc ion coordination centers (1996) J. Am. Chem. Soc., 118, pp. 12242-12243; Willner, H.M., Kägi, J.H.R., Cadmium-thiotate clusters in metallothionein: Spectrophotometric and spectropolarimetric features (1987) Biochemistry, 26, pp. 6287-6292; Maret, W., Vallee, B.L., Cobalt as a probe and label of proteins (1993) Methods in Enzymology, pp. 52-71. , (Riordan, J.F. & Vallee, B.L., eds.), Academic Press, Inc., San Diego; Lever, A.B.P., (1986) Inorganic Electronic Spectroscopy, 2nd Edn., , Elsevier Science Publishers B, V., Amsterdam; Vašák, M., Kägi, J.H.R., Spectroscopic properties of metallothionein (1983) Met. Ions Biol. Syst., 15, pp. 213-273; Krizek, B.A., Merkle, D.L., Berg, J.M., Ligand variation and metal ion binding specificity in zinc finger peptides (1993) Inorg. Chem., 32, pp. 937-940; Messerte, B.A., Schäffer, A., Vašák, M., Kägi, J.H.R., Wüthrich, K., Comparison of the solution conformations of human [Zn7]metallothionein-2 and [Cd7]metallothionein-2 using nuclear magnetic resonance spectroscopy (1992) J. Mol. Biol., 225, pp. 433-443; Chang, C.-C., Huang, P.C., Semi-empirical simulation of Zn/Cd binding site preference in the metal binding domains of mammalian metallothionein (1996) Prot. Engng., 9, pp. 1165-1172","Gonzalez-Duarte, P.; Departament de Quimica, Facultat de Ciencies, Universitat Autonoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain; email: iqipilar@cc.uab.es",,,,,,,,00142956,,EJBCA,"9914535","English","Eur. J. Biochem.",Article,"Final",Open Access,Scopus,2-s2.0-0000680389
"Buscà R., Martínez M., Vilella E., Peinado J., Gelpi J.L., Deeb S., Auwerx J., Reina M., Vilaró S.","6602739402;55322238000;7003315915;6701608069;35517522400;7005367976;7101942868;7005694004;7005286074;","The carboxy-terminal region of human lipoprotein lipase is necessary for its exit from the endoplasmic reticulum",1998,"Journal of Lipid Research","39","4",,"821","833",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031969118&partnerID=40&md5=00ffaba2130220e9c0036d8790f50e19","Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain; Biomedical Research Center, Hospital St. Joan, 43201 Reus, Tarragona, Spain; Dept. of Biochem. and Molec. Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain; Departments of Genetics and Medicine, University of Washington, Seattle, WA 98195, United States; Laboratorie Biol. Reg. chez les E., Department d'Athérosclerose, Institut Pasteur, Rue Calmette, 59019 Lille, France; INSERM U385, Faculte de Medecine, 06107 Cedex 02, France","Buscà, R., Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain, INSERM U385, Faculte de Medecine, 06107 Cedex 02, France; Martínez, M., Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain; Vilella, E., Biomedical Research Center, Hospital St. Joan, 43201 Reus, Tarragona, Spain; Peinado, J., Dept. of Biochem. and Molec. Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain; Gelpi, J.L., Dept. of Biochem. and Molec. Biology, University of Barcelona, Diagonal 645, 08028, Barcelona, Spain; Deeb, S., Departments of Genetics and Medicine, University of Washington, Seattle, WA 98195, United States; Auwerx, J., Laboratorie Biol. Reg. chez les E., Department d'Athérosclerose, Institut Pasteur, Rue Calmette, 59019 Lille, France; Reina, M., Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain; Vilaró, S., Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain","Certain missense substitutions on the human lipase (hLPL) gene produce mutated proteins that are retained in different compartments along the secretory pathway. The purpose of the present study was to elucidate whether the C-terminal domain of the hLPL molecule could be important for secretion. We constructed by site-directed mutagenesis three carboxy-terminal mutated (F388→Stop, K428→Stop and K441→Stop) hLPL cDNAs that were expressed in COS1 cells. Immunoblotting of cell extracts showed that all three constructs led to similar levels of protein. Both wild type (WT) hLPL and the truncated K441→Stop hLPL were secreted to the extracellular medium, and presented a similar intracellular distribution pattern as shown by immunofluorescence. Neither F388→Stop nor K428→Stop hLPL protein was detected in cell medium. Immunofluorescence experiments showed that both truncated hLPL were retained within an intracellular compartment, which became larger. Double immunofluorescence analysis using antibodies against LPL and antiprotein disulfide isomerase as a marker showed that the truncated K428→Stop hLPL was retained within the rough endoplasmic reticulum. This truncated protein was not found in other compartments in the secretory pathway, such as Golgi complex and lysosomes, indicating that it did not exit the endoplasmic reticulum. Further analysis of the C-terminal region of the LPL molecular model showed both that F388→Stop and K428→Stop hLPL truncated proteins are highly hydrophobic. As retention of secretory proteins in the rough endoplasmic reticulum is a quality control mechanism of the secretory pathway, we conclude that the G-terminal domain of hLPL is critical for correct intracellular processing of the newly synthesized protein.","Carboxy-terminal domain; Endoplasmic reticulum; Immunofluorescence; Intracellular processing; Lipoprotein lipase; Secretion; Structure","complementary dna; disulfide; isomerase; lipoprotein lipase; mutant protein; secretory protein; animal cell; article; carboxy terminal sequence; cell strain cos1; cellular distribution; controlled study; human; human cell; immunofluorescence; intracellular transport; missense mutation; molecular model; nonhuman; priority journal; protein processing; protein synthesis; rough endoplasmic reticulum; site directed mutagenesis; DNA Mutational Analysis; Endoplasmic Reticulum, Rough; Humans; Lipoprotein Lipase; Mutagenesis, Site-Directed; Protein Processing, Post-Translational; Recombinant Proteins; Structure-Activity Relationship",,"Lipoprotein Lipase, EC 3.1.1.34; Recombinant Proteins",,,,,,,"Goldberg, I.J., Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis (1996) J. Lipid. Res., 37, pp. 693-707; Olivecrona, G., Olivecrona, T., Triglyceride lipases and atherosclerosis (1995) Curr. Opin. Lipidol., 6, pp. 291-305; Beisiegel, U., Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism (1995) Curr. Opin. Lipidol., 6, pp. 117-122; Braun, J.E.A., Severson, D.L., Regulation of the synthesis, processing and translocation of lipoprotein lipase (1992) Biochem. J., 287, pp. 337-347; Hide, W.A., Chan, L., Li, W.H., Structure and evolution of the lipase superfamily (1992) J. Lipid. Res., 33, pp. 167-178; Semenkovich, D.F., Luo, C.C., Nakanishi, M.K., Chen, S.-H., Smith, L.C., Chan, L., In vitro expression and site-specific mutagenesis of the cloned human lipoprotein lipase gene (1990) J. Biol. Chem., 265, pp. 5429-5433; Ben-Zeev, O., Doolittle, M.H., Davis, R.C., Elovson, J., Schotz, M.C., Maturation of lipoprotein lipase (1992) J. Biol. Chem., 267, pp. 6219-6227; Ben-Zeev, O., Stahnke, G., Liu, G., Davis, R.C., Doolittle, M.H., Lipoprotein lipase and hepatic lipase: The role of asparagine-linked glycosylation in the expression of a functional enzyme (1994) J. Lipid. Res., 35, pp. 1511-1523; Buscà, R., Pujama, M., Pognonec, P., Auwerx, J., Deeb, S.S., Reina, M., Vilaró, S., Absence of N-glycosylation at asparagine 43 in human lipoprotein lipase induces its accumulation in the rough endoplasmic reticulum and alters this cellular compartment (1995) J. Lipid. Res., 36, pp. 939-951; Van Tilbeurgh, H., Roussel, A., Lalouel, J.-M., Cambillau, C., Lipoprotein lipase. Molecular model based on the pancreatic lipase X-ray structure: Consequences for heparin binding and catalysis (1994) J. Biol. Chem., 269, pp. 4626-4633; Bengtsson-Olivecrona, G., Olivecrona, T., Jörnvall, H., Lipoprotein lipases from cow, guinea-pig and man (1986) Eur. J. Biochem., 161, pp. 291-1288; Lookene, A., Bengtsson-Olivecrona, G., Chymotryptic cleavage of lipoprotein lipase (1993) Eur. J. Biochem., 213, pp. 185-194; Emmerich, J., Beg, O.U., Peterson, J., Previato, L., Brunzell, J.D., Brewer, H.B., Santamarina-Fojo, S., Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156 and His241 (1992) J. Biol. Chen., 267, pp. 4161-4165; Faustinella, F., Chang, A., Van Biervlet, J.P., Catalytic triad residue mutation (Asp156→Gly), causing familial lipoprotein lipase deficiency: Co-inheritance with a nonsense mutation (Ser447→Ter in a Turkish family) (1991) J. Biol. Chem., 266, pp. 14418-14424; Dugi, K.A., Dichek, H.L., Santamarina-Fojo, S., Human hepatic and lipoprotein lipase. The loop covering the catalytic site mediates lipase substrate specificity (1995) J. Biol. Chem., 270, pp. 25396-25401; Ma, Y., Henderson, H.E., Liu, M.-S., Zhang, H., Forsythe, I.J., Clarke-Lewis, L., Harden, M.R., Brunzell, J.D., Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase (1994) J. Lipid. Res., 35, pp. 2049-2059; Hata, A., Ridinger, D.N., Sutherland, S., Emi, M., Shuhua, Z., Myers, R.L., Ren, K., Lalouel, J.-M., Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain (1993) J. Biol. Chem., 268, pp. 8447-8457; Yang, C.-Y., Wu, Z.-W., Yang, H.-X., Rohde, M.F., Gotto, A.M., Pownall, H.J., Structure of bovine milk lipoprotein lipase (1989) J. Biol. Chem., 264, pp. 16822-16827; Williams, S.E., Inoue, I., Tran, H., Fry, G.L., Pladet, M.W., Iverius, P.-H., Lalouel, J.-M., Strickland, D.K., The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/α2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoprotein to LRP (1994) J. Biol. Chem., 269, pp. 8653-8658; Nykjaer, A., Nielsen, M., Lookene, A., Meyer, N., Roigaard, H., Etzerodt, M., Beisiegel, U., Gliemann, J., A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells (1994) J. Biol. Chem., 269, pp. 31747-31755; Nielsen, M.S., Brejning, J., García, R., Zhang, H., Hayden, M.R., Vilaró, S., Gliemann, J., Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans (1997) J. Biol. Chem., 272, pp. 5821-5827; Lookene, A., Groot, N.B., Kastelein, J.J.P., Olivecrona, G., Bruin, T., Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity, and catalytic properties (1997) J. Biol. Chem., 272, pp. 766-772; Wong, H., Davis, R.C., Nikazy, J., Seebart, K.E., Schotz, M.C., Domain exchanger: Characterization of a chimeric lipase of hepatic lipase and lipoprotein lipase (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 11290-11294; Davis, R.C., Wong, H., Nikazy, J., Wang, K., Han, Q., Schotz, M.C., Chimeras of hepatic lipase and lipoprotein lipase: Domain localization of enzyme-specific properties (1992) J. Biol. Chem., 267, pp. 21499-21504; Wong, H., Davis, R.C., Thuren, T., Goers, J.W., Nikazy, J., Waite, M., Schotz, M.C., Lipoprotein lipase domain function (1994) J. Biol. Chem., 269, pp. 10319-10323; Auwerx, J., Leroy, P., Schoonjans, K., Lipoprotein lipase: Recent contributions from molecular biology (1992) Crit. Rev. Clin. Lab. Sci., 29, pp. 243-268; Santamarina-Fojo, S., Genetic dyslipoproteinemias: Role of lipoprotein lipase and apolipoprotein C-II (1992) Curr. Opin. Lipidol., 3, pp. 186-195; Santamarina-Fojo, S., Dugi, K.A., Structure, function and role of lipoprotein lipase in lipoprotein metabolism (1994) Curr. Opin. Lipidol., 5, pp. 117-125; Brunzell, J.D., Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome (1989) The Metabolic Basis of Inherited Disease. 6th Ed., pp. 1165-1180. , C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle, editors. McGraw Hill, New York; Gotoda, T., Yamada, N., Kawamura, M., Kozaki, K., Mori, N., Ishibashi, S., Shimano, H., Murase, T., Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency (1991) J. Clin. Invest., 88, pp. 1856-1864; Kobayashi, J., Nishida, T., Ameis, D., Stahnke, G., Schotz, M.C., Hashimoto, H., Fukamachi, I., Yoshida, S., A heterozygous mutation (the codon for Ser447→ a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia (1992) Biochem. Biophys. Res. Commun., 182, pp. 70-77; Kobayashi, Sasaki, N., Tashiro, J., Inadera, H., Saito, Y., Yoshida, S., A missense mutation (Ala334→Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia (1993) Biochem. Biophys. Res. Commun., 191, pp. 1046-1054; Previato, L., Guardamagna, O., Dugi, K.A., Ronan, R., Talley, G.D., Santamarina-Fojo, S., Brewer, H.B., A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410→Val) leads to enzyme inactivation and familial chylomicronemia (1994) J. Lipid. Res., 35, pp. 1552-1560; Henderson, H.E., Hassan, F., Marais, D., Hayden, M.R., A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase (1996) Biochem. Biophys. Res. Commun., 227, pp. 189-194; Wiebusch, H., Funke, H., Bruin, T., Bucher, H., Von Eckardstein, A., Kastelein, J.J., Assmann, G., Compound heterozygosity for a known (D250N) and a novel (E410K.) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia (1996) Hum. Mutat., 8, pp. 381-383; Buscà, R., Martínez, M., Vilella, E., Pognonec, P., Deeb, S., Auwerx, J., Reina, M., Vilaró, S., The mutation Gly142→Glu in human lipoprotein produces a missorted protein that is diverted to lysosomes (1996) J. Biol. Chem., 271, pp. 2139-2147; Auwerx, J.H., Deeb, S., Brunzell, J.D., Wolfbauer, G., Chait, A., Lipoprotein lipase gene expression in THP-1 cells (1989) Biochemistry, 28, pp. 4563-4567; Kundel, T.A., Roberts, J.D., Zakour, R.A., Rapid and efficient site-specific mutagenesis without phenotypic selection (1987) Methods Enzymol., 154, pp. 367-382; Miyazaki, J.I., Takaki, K., Tashiro, F., Tominega, A., Takatsu, K., Yamamura, K., Expression vector system based on the chicken-actin promoter directs efficient production of interleukin-5 (1989) Gene, 79, pp. 269-277; Niwa, H., Yamamura, K., Miyazaki, J., Efficient selection for high-expression transfects with a novel eukaryotic vector (1991) Gene, 108, pp. 193-200; Kriegler, M., (1990) Gene Transfer and Expression: A Laboratory Manual, pp. 99-100. , M. Stockton Press, New York; Buscà, R., Peinado, J., Vilella, E., Auwerx, J., Deeb, S.S., Vilaró, S., Reina, M., The Mutant Asn291→Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin (1995) FEBS Lett., 367, pp. 257-262; Liu, M.S., Ma, Y., Hayden, M.R., Brunzell, J.D., Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity (1992) Biochim. Biophys. Acta, 1128, pp. 113-115; Vilella, E., Joven, J., Fernández, M., Vilaró, S., Brunzell, J.D., Olivecrona, T., Bengtsson-Olivecrona, G., Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins (1993) J. Lipid. Res., 34, pp. 1555-1564; Ramírez, I., Kryski, A.J., Ben-Zeev, O., Schotz, M.C., Severson, S.L., Characterization of triacylglyceride hydrolase activities in isolated myocardial cells (1985) Biochem. J., 232, pp. 229-236; Nilsson, T., Lucocq, J.M., Mackay, D., Warren, G., The membrane spanning domain of β-1,4-galactosyltransferase specifies trans Golgi localization (1991) EMBO J., 10, pp. 3567-3575; Eisenberg, D., McLachlan, A.D., Solvation energy in protein folding and binding (1987) Nature, 319, pp. 199-203; Krapp, A., Zhang, H., Ginzinger, D., Liu, M.-S., Lindberg, A., Olivecrona, G., Hayden, M.R., Beisiegel, U., Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells (1995) J. Lipid. Res., 36, pp. 2362-2373; Helenius, A., Marquardt, T., Braakman, I., The endoplasmic reticulum as a protein-folding compartment (1992) Trends Cell Biol., 2, pp. 227-231; Kozaki, K., Gotoda, T., Kawamura, M., Shimano, H., Yazaki, Y., Ouchi, Y., Orimo, H., Yamada, N., Mutational analysis of human lipoprotein lipase by carboxyl-terminal truncation (1993) J. Lipid. Res., 34, pp. 1765-1772; Richardson, J.S., Richardson, D.C., Principles and patterns of protein conformation (1989) Prediction of Protein Structure and the Principles of Protein Conformation, pp. 1-98. , G. Fasman, editor. Plenum Press, New York; Lo, J.Y., Smith, L.C., Chan, L., Lipoprotein lipase: Role of intramolecular disulfide bonds in enzyme catalysis (1995) Biochem. Biophys. Res. Commun., 206, pp. 266-271; Flynn, G.C., Pohl, J., Flocco, M.T., Rothman, J.E., Peptide-binding specificity of the molecular chaperone BiP (1991) Nature, 353, pp. 726-730; Gaut, J.R., Hendershot, L.M., The modification and assembly of proteins in the endoplasmic reticulum (1993) Curr. Opin. Cell Biol., 5, pp. 589-595; Brewer, J.W., Corley, R.B., Quality control in protein biogenesis: Thiol-mediated retention monitors the redox state of proteins in the endoplasmic reticulum (1996) J. Cell Sci., 109, pp. 2383-2392; Fra, A.M., Fagioli, C., Finazzi, D., Sitia, R., Alberini, C.M., Quality control of ER synthesized proteins: An exposed thiol group as a three-way switch mediating assembly, retention and degradation (1993) EMBO J., 12, pp. 4755-4761; Isidoro, C., Maggioni, C., Demoz, M., Pizzagalli, A., Fra, A.M., Sitia, R., Exposed thiols confer localization in the endoplasmic reticulum by retention rather than retrieval (1996) J. Biol. Chem., 271, pp. 26138-26142; Marquardat, T., Helenius, A., Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum (1992) J. Biol. Chem., 117, pp. 505-513; Ma, Y., Ooi, T.C., Liu, M.-S., Zhang, H., McPherson, R., Edwards, A.L., Forsythe, I.J., Hayden, M.R., High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: Possible association with apolipoprotein E2 isoform (1994) J. Lipid. Res., 35, pp. 1066-1075; Coleman, T., Seip, R.L., Gimble, J.M., Lee, D., Maeda, N., Semenkovich, C.F., COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity (1995) J. Biol. Chem., 270, pp. 12518-12525","Vilaro, S.; Department of Cell Biology, University of Barcelona, Diagonal 645, 08028 Barcelona, Spain",,,,,,,,00222275,,JLPRA,"9555946","English","J. Lipid Res.",Article,"Final",,Scopus,2-s2.0-0031969118
"Ayala S., Colomer D., Gelpí J.L., Corrons J.L.","7004163671;7006086946;35517522400;35407434100;","alpha-Thalassaemia due to a single codon deletion in the alpha1-globin gene. Computational structural analysis of the new alpha-chain variant. Mutations in brief no. 132. Online.",1998,"Human mutation","11","5",,"412","",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032241309&partnerID=40&md5=cfed3d893c97c2314c05ccc94c5cdf20","Hematology Laboratory Department, Hospital Clínic i Provincial, Faculty of Medicine, University of Barcelona, Spain","Ayala, S., Hematology Laboratory Department, Hospital Clínic i Provincial, Faculty of Medicine, University of Barcelona, Spain; Colomer, D., Hematology Laboratory Department, Hospital Clínic i Provincial, Faculty of Medicine, University of Barcelona, Spain; Gelpí, J.L., Hematology Laboratory Department, Hospital Clínic i Provincial, Faculty of Medicine, University of Barcelona, Spain; Corrons, J.L., Hematology Laboratory Department, Hospital Clínic i Provincial, Faculty of Medicine, University of Barcelona, Spain","A new unstable alpha-globin chain associated with alpha-thalassemia phenotype has been found in a Spanish patient. Molecular analysis of the alpha-globin gene complex using PCR and non-radioactive single-strand conformation analysis, allowed to identify a new mutation in the second exon of the alpha-globin gene. Direct sequencing of the abnormal fragment revealed a 3 bp deletion, which led to the loss of a single codon corresponding to a Lys (K) residue at position 60 or 61 DK60 or DK61. Theoretical structural analysis, performed by computational methods, indicated that the loss of an amino acid residue at this position disturbed the contact region between the B and E-helices, affecting the overall stability of the molecule. Therefore, the DK60 and DK61 results in a structurally abnormal alpha-globin chain, not previously described, named Hb Clinic, which leads to the alpha-thalassemia phenotype in the heterozygote patient. No abnormal hemoglobin was detected by standard electrophoretic procedures, suggesting that this alpha-globin chain variant is so unstable that it may be catabolized immediately after its synthesis. This mutation was confirmed by PCR using an allele specific primer.",,"globin; alpha thalassemia; article; biology; case report; codon; gene deletion; genetics; human; Spain; alpha-Thalassemia; Codon; Computational Biology; Globins; Humans; Sequence Deletion; Spain",,"Codon; Globins, 9004-22-2",,,,,,,,"Ayala, S.",,,,,,,,10597794,,,"10206681","English","Hum. Mutat.",Article,"Final",,Scopus,2-s2.0-0032241309
"Alvarez J.A., Gelpí J.Ll., Johnsen K., Bernard N., Delcour J., Clarke A.R., Holbrook J.J., Cortés A.","57199919067;35517522400;16166449600;7102385373;7006178668;7403682319;7102156355;7102092256;","D-2-Hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus. I. Kinetic mechanism and pH dependence of kinetic parameters, coenzyme binding and substrate inhibition",1997,"European Journal of Biochemistry","244","1",,"203","212",,11,"10.1111/j.1432-1033.1997.00203.x","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031042367&doi=10.1111%2fj.1432-1033.1997.00203.x&partnerID=40&md5=c241cc5613ee54204acfd37c65ffcd9f","Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Unité de Génetique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain","Alvarez, J.A., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Gelpí, J.Ll., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Johnsen, K., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Bernard, N., Unité de Génetique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Delcour, J., Unité de Génetique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Clarke, A.R., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Holbrook, J.J., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Cortés, A., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués 1, E-08028 Barcelona, Spain","The steady-state kinetics of D-2-hydroxy-4-methylvalerate dehydrogenase have been studied at pH 8.0 by initial velocity, product Inhibition, and dead-end inhibition techniques. The mechanism is rapid-equilibrium ordered in the NAD+ plus D-2-hydroxy-4-methylvalerate direction, and steady-state ordered in the other direction. In both cases coenzyme is the first substrate added and both the E-NADH-D-2-hydroxy-4-methylvalerate and E-NAD+-2-oxo-4-methylvalerate give rise to abortive complexes which cause excess substrate inhibition. Steady-state measurements show that the rate-limiting step in both directions at pH 8.0 is between formation of the enzyme-coenzyme-substrate ternary complex and the release of the first product of the reaction. Transient kinetics combined with primary kinetic deuterium isotope effects show that in the NADH → NAD+ direction there is a slow, rate-limiting rearrangement of the E-NADH-oxoacid complex while hydride transfer is very fast. The release of NAD+ at pH 8.0 is 200-times faster than k(cat) (NADH → NAD+) whereas the release of NADH is only 5-times faster than k(cat) (NAD+ → NADH). The pH dependence of NADH binding depends upon the presence of two ionizable residues with a pK(a) of about 5.9. The pH dependence of kinetic parameters is explained by a third ionizable residue with pK(a) values 7.2 (in the E-NADH complex) and ≤6.4 (in the E-NAD+ complex) which may be the proton donor and acceptor for the chemical reaction. At pH 6.5 the mechanism changes in the NADH → NAD+ direction to be partly limited by the chemical step with a measured primary kinetic isotope effect of 5.7 and partly by an only slightly faster dissociation of NAD+. In addition the inhibition by excess oxo-4-methylvalerate is more pronounced. The mechanism implies that removing the positive charges created by the the two groups which control coenzyme affinity could both enhance the catalytic rate at pH 6.5 and diminish excess substrate inhibition to provide an enzyme better suited to the bulk synthesis of D-2-hydroxyacids.","D-2-Hydroxy-4-methylvalerate dehydrogenase; Lactobacillus delbrueckii bulgaricus; Mechanism; Steady-state kinetics; Transient kinetics","oxidoreductase; article; enzyme activity; enzyme binding; enzyme kinetics; enzyme mechanism; in vitro study; Lactobacillus delbrueckii; pH; priority journal",,"oxidoreductase, 9035-73-8, 9035-82-9, 9037-80-3, 9055-15-6",,,,,,,"Hummel, W., Kula, M.R., Dehydrogenases for synthesis of chiral compounds (1989) Eur. J. Biochem., 184, pp. 1-13; Hummel, W., Schütte, H., Kula, M.R., D-Hydroxyisocaproate dehydrogenase from Lactobacillus casei. A new enzyme suitable for stereospecific reduction of 2-ketocarhoxylic acids (1985) Appl. Microbiol. Biotechnol., 21, pp. 7-15; Schütte, H., Hummel, W., Tsai, H., Kulu, M.R., L-Leucine dehydrogenase from Bacillus cereus: Production, large scale purification and protein characterization (1985) Appl. Microbiol. Biotechnol., 22, pp. 306-317; Bernard, N., Johnsen, K., Ferain, T., Garmyn, D., Hols, P., Holbrook, J.J., Delcour, J., NAD+-dependent D-2-hydroxyisocaproate dehydrogenase of Lactobacillus delbrueckii subsp. bulgaricus. Gene cloning and enzyme characterization (1994) Eur: J. Biochem., 224, pp. 439-446; Yamazaki, Y., Maeda, H., Enzymatic synthesis of optically pure (R)-(-)-mandelic acid and other 2-hydroxycarboxylic acids: Screening for enzyme and its purification, characterization and use (1986) Agric. Biol. Chem., 50, pp. 2621-2631; Hummel, W., Schütte, H., Kula, M.R., d(-)-Mandelic acid dehydrogenase from Lactobacillus curvatus (1988) Appl. Microbiol. Biotechnol., 28, pp. 433-439; Kallwass, H.K.W., Potential of R-2-hydroxyisocaproate dehydrogenase from Lactobacillus casei for stereospecific reductions (1992) Enzyme Microbiol. Technol., 14, pp. 28-35; Lerch, H.P., Blöcker, H., Kallwass, H., Hoppe, J., Tsai, H., Collins, J., Cloning, sequencing and expression in Escherichia coli of the D-2-hydroxyisocaproate dehydrogenase gene of Lactobacillus casei (1989) Gene (Amst), 78, pp. 47-57; Grant, G.A., A new family of 2-hydroxyacid dehydrogenases (1989) Biochem. Biophys. Res. Commun., 165, pp. 1371-1374; Birktoft, J.J., Fernley, R.T., Bradshaw, R.A., Banaszak, L.J., Amino acid sequence homology among the 2-hydroxy acid dehydrogenase: Mitochondrial and eytoplasmic inalate dehydrogenase form a homologous system with lactate dehydrogenase (1982) Proc. Natl Acad. Sci. USA, 79, pp. 6166-6170; Bernard, N., Johnsen, K., Gelpí, J.L.I., Alvarez, J.A., Ferain, T., Garmyn, D., Hols, P., Delcour, J., D-2-Hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus, 11. Mutagenic analysis of catalytically important residues (1997) Eur. J. Biochem., 244, pp. 213-219; Vermeulen, N.M.J., Lourens, G.J., Potgieter, D.J.J., N-substituted oxamates as inhibitors of lactate dehydrogenase (1981) S. Afr. J. Sci., 77, pp. 566-569; Cleland, W.W., Steady state kinetics (1970) The Enzymes, 3rd Edn, 11, pp. 1-65. , Boyer, P. D., ed., Academic Press, New York; López-Cabrera, A., Cabré, F., Franco, R., Canela, E.I., Identification and rejection of outliers in enzyme kinetics (1988) Int. J. Bio-Med. Comp., 23, pp. 9-20; Stinson, R.A., Holbrook, J.J., Equilibrium binding of nicotinamide nucleotides to lactate dehydrogenases (1973) Biochem. J., 131, pp. 719-728; Segel, I.H., Steady state kinetics of multireactant enzymes (1975) Enzyme Kinetics, pp. 505-845. , Wiley-Interscience, New York; Holbrook, J.J., Liljas, A., Steindel, S.J., Rossmann, M.G., Lactate dehydrogenase (1975) The Enzymes, 3rd Edn, 11, pp. 191-292. , Boyer, P. D., ed., Academic Press, New York; Gelpí, J.Ll., Dordal, A., Montserrat, J., Mazo, A., Cortés, A., Kinetic studies of the regulation of mitochondrial malate dehydrogenase by citrate (1992) Biochem. J., 283, pp. 289-297; Clarke, A.R., Atkinson, T., Holbrook, J.J., From analysis to synthesis: New ligand binding sites on the lactate dehydrogenase framework. Part II (1989) Trends Biochem. Sci., 14, pp. 145-148; Lodola, A., Shore, J.D., Parker, D.M., Holbrook, J.J., Malate dehydrogenase of the cytosol. A kinetic investigation of the reaction mechanism and a comparison with lactate dehydrogenase (1978) Biochem. J., 175, pp. 987-998; Haro, I., Gelpí, J.L.I., Mazo, A., Cortés, A., Kinetic formulations for the reduction of ketomalonate by lactate dehydrogenase (1990) J. Enzyme Inhibition, 3, pp. 189-193; Wilks, H.M., Hart, K.W., Feeney, R., Dunn, C.R., Muirhead, H., Chia, W.N., Barstow, D.A., Holbrook, J.J., A specific and highly active malate dehydrogenase by redesign of a laclate dehydrogenase framework (1988) Science, 242, pp. 1541-1544; Cortés, A., Emery, D.C., Halsall, D.J., Jackson, R.M., Clarke, A.R., Holbrook, J.J., Charge balance in the α-hydroxyacid dehydrogenase vacuole: An acid test (1992) Protein Sci., 1, pp. 892-901; Taguchi, H., Ohta, T., D-Lactate dehydrogenase is a member of the D-isomer-specific 2-hydroxyacid dehydrogenase family (1991) J. Biol. Chem., 266, pp. 12588-12594; Kochhar, S., Hottinger, H., Chuard, N., Taylor, P.G., Atkinson, T., Scawen, M.D., Nicholls, D.J., Cloning and overexpression of Lactobacillns helveticus D-lactate dehydrogenase gene in Escherichia coli (1992) Eur. J. Biochem., 208, pp. 799-805; Gelpí, J.Ll., Jackson, R.M., Holbrook, J.J., Electrostaticinteractions energies in laclate dehydrogenase catalysis (1993) J. Chem. Soc. Farad. Trans., 89, pp. 2707-2716; Holbrook, J.J., Stinson, R.A., The use of ternary complexes to study ionizations and isomerizations during catalysis by lactate dehydrogenase (1973) Biochem. J., 131, pp. 739-748; Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer Jr., E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Tasumi, M., The Protein Data Bank: A computer-based archival file for macromolecular struktures (1977) J. Mol. Biol., 112, pp. 535-542; Cleland, W.W., The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations (1963) Biochim. Biophys. Acta, 67, pp. 104-137","Cortes, A.; Dept. Bioquimica/Biologia Molecular, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, E-08028 Barcelona, Spain",,,"Blackwell Publishing Ltd",,,,,00142956,,EJBCA,"9063465","English","EUR. J. BIOCHEM.",Article,"Final",,Scopus,2-s2.0-0031042367
"Bernard N., Johnsen K., Gelpi J.L., Alvarez J.A., Ferain T., Garmyn D., Hols P., Cortes A., Clarke A.R., Holbrook J.J., Delcour J.","7102385373;16166449600;35517522400;57199919067;6603565265;6701919612;7003321850;7102092256;7403682319;7102156355;7006178668;","D-2-Hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus. II. Mutagenic analysis of catalytically important residues",1997,"European Journal of Biochemistry","244","1",,"213","219",,19,"10.1111/j.1432-1033.1997.00213.x","https://www.scopus.com/inward/record.uri?eid=2-s2.0-8044229435&doi=10.1111%2fj.1432-1033.1997.00213.x&partnerID=40&md5=48b346532f29dc41336dbdaf89e70311","U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Département de Biologie, U. de Génétique, Univ. Catholique de Louvain, Place Croix du Sud 5 (6), B-1348 Louvain-Ia-Neuve, Belgium","Bernard, N., U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Johnsen, K., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Gelpi, J.L., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Alvarez, J.A., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Ferain, T., U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Garmyn, D., U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Hols, P., U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium; Cortes, A., Dept. de Bioquim. i Biol. Molecular, Universitat de Barcelona, Spain; Clarke, A.R., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Holbrook, J.J., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, United Kingdom; Delcour, J., U. de Génétique, Univ. Catholique de Louvain, Louvain-la-Neuve, Belgium, Département de Biologie, U. de Génétique, Univ. Catholique de Louvain, Place Croix du Sud 5 (6), B-1348 Louvain-Ia-Neuve, Belgium","Five residues involved in catalysis and coenzyme binding have been identified in D-2-hydroxy-4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus by using biochemical and genetical methods. Enzyme inactivation with diethylpyrocarbonate indicated that a single histidine residue was involved in catalysis. Since H296 is the only conserved histidine in the whole family of NAD-dependent D-2-hydroxyacid dehydrogenases, we constructed the B296Q and H296S mutants and showed that their catalytic efficiencies were reduced 105-fold compared with the wild-type enzyme. This low residual activity was shown to be insensitive to diethylpyrocarbonate. Taken together these data demonstrate that H296 is responsible for proton exchange in the redox reaction. Two acidic residues (D259 and E264) were candidates for maintaining H296 in the protonated state and their roles were examined by mutagenesis. The D259N and E264Q mutant enzymes both showed similar and large reductions in their k(cat)/K(m) ratios (200-800-fold, depending on pH), indicating that either D259 or E264 (or both) could partner H296. The conserved R235 residue was a candidate for binding the α-carboxyl group of the substrate and it was changed to lysine. The R235K mutant showed a 104-fold reduced k(cat)/K(m) due to both an increased K(m) and a reduced k(cat) for 2-oxo-4-methylvalerate. Thus R235 plays a role in binding the substrate carboxylate similar to R171 in the L-lactate dehydrogenases. Finally, we constructed the H205Q mutant to test the role of this partially conserved histidine residue (in 10/13 enzymes of the family). This mutant enzyme displayed a 7.7-fold increased k(cat) and a doubled catalytic efficiency at pH 5, was as sensitive to diethylpyrocarbonate as the wild-type but showed a sevenfold increased K(m) for NADH and a 100-fold increase in K(d) for NADH together with 10-30-fold lower substrate inhibition. The transient kinetic behaviour of the H205Q mutant is as predicted from our previous study on the enzymatic mechanism of D-2-hydroxy-4-methylvalerate dehydrogenase which showed that coenzyme binding is highly pH dependent and indicated that release of the oxidised coenzyme is a significant component of the rate-limiting processes in catalysis at pH 6.5.","D-2-hydroxy-4-methylvalerate dehydrogenase; D-lactate dehydrogenase; Lactobacillus delbrueckii bulgaricus; Substrate inhibition","oxidoreductase; article; enzyme active site; enzyme activity; enzyme analysis; enzyme inactivation; Lactobacillus delbrueckii; mutant; priority journal; site directed mutagenesis",,"oxidoreductase, 9035-73-8, 9035-82-9, 9037-80-3, 9055-15-6",,,,,,,"Bernard, N., Johnsen, K., Ferain, T., Garmyn, D., Hols, P., Holbrook, J.J., Delcour, J., NAD+-dependent D-2-hydroxyisocaproate dehydrogenase of Lactobacillus delbrueckii subsp. bulgaricus. Gene cloning and enzyme characterization (1994) Eur. J. Biochem., 224, pp. 439-446; Hummel, W., Schütte, H., Kula, M.-R., D-2-Hydroxyisocaproate dehydrogenase from Lactobacillus casei. A new enzyme suitable tor stereospecific reduction of 2-ketocarboxylic acids (1985) Appl. Microbiol. Biotechnol., 21, pp. 7-15; Grant, G.A., A new family of 2-hydroxyacid dehydrogenases (1989) Biochem. Biophys. Res. Commun., 165, pp. 1371-1374; Taguchi, H., Ohta, T., D-Lactate dehydrogenase is a member of the D-isomer-specific 2-hydroxyacid dehydrogenase family (1991) J. Biol. Chem., 266, pp. 12588-12594; Vinals, C., Depiereux, E., Feytmans, E., Prediction of structurally conserved regions of D-specific hydroxyacid dehydrogenases by multiple alignment with formate dehydrogenase (1993) Biochem. Biophys. Res. Commun., 192, pp. 182-188; Garmyn, D., Ferain, T., Bernard, N., Hols, P., Delplace, B., Delcour, J., Pediococcus acidilactici ldhD gene: Cloning, nucleotide sequence, and transcriptional analysis (1995) J. Bacteriol., 177, pp. 3427-3437; Clarke, A.R., Atkinson, T., Holbrook, J.J., From analysis to synthesis: New ligand binding sites on the lactate dehydrogenase framework. Part I (1989) Trends Biochem. Sci., 14, pp. 101-105; Clarke, A.R., Atkinson, T., Holbrook, J.J., From analysis to synthesis: New ligand binding sites on the lactate dehydrogenase framework. Part II (1989) Trends Biochem. Sci., 14, pp. 145-148; Alvarez, J.A., Johnsen, K., Gelpi, J.L.I., Bernard, N., Delcour, J., Clarke, A.R., Holbrook, J.J., Cortes, A., D-2-Hydroxy4-methylvalerate dehydrogenase from Lactobacillus delbrueckii subsp. bulgaricus. I. Kinetic mechanism and pH dependence of kinetic parameters, coenzyme binding and substrate inhibition (1997) Eur: J. Biochem., 244, pp. 203-212; Taguchi, H., Ohta, T., Histidine 296 is essential for the catalysis in Lactobacillus plantarum D-lactate dehydrogenase (1993) J. Biol. Chem., 268, pp. 18030-18034; Goldberg, J.D., Yoshida, A.E., Brick, P., Crystal structure of a NAD-dependent D-glycerate dehydrogenase at 2.4 Å resolution (1994) J. Mol. Biol., 236, pp. 1123-1140; Kochhar, S., Hunziker, P.E., Leong-Morgenthaler, P., Hottinger, H., Primary structure, physico-chemical properties, and chemical modification of NAD+-dependent D-lactate dehydrogenase. Evidence for the presence of Arg-235, His-303, Tyr-101, and Tip-19 at or near the active site (1992) J. Biol. Chem., 267, pp. 8499-8513; Taguchi, H., Ohta, T., Essential role of arginine 235 in the substrate binding site of Lactobacillus plantarum D-lactate dehydrogenase (1994) J. Biochem. (Tokyo), 115, pp. 930-936; Lamzin, V.S., Aleshin, A.E., Strokopytov, B.V., Yukhnevich, M.G., Popov, V.O., Harutyunyan, E.H., Wilson, K.S., Crystal structure of NAD-dependent formate dehydrogenase (1992) Eur. J. Biochem., 205, pp. 441-454; Lamzin, V.S., Dauter, Z., Popov, V.O., Harutyunyan, E.H., Wilson, K.S., High resolution structures of holo and apo formate dehydrogenase (1994) J. Mol. Biol., 236, pp. 759-785; Sambrook, J., Fritsch, E.F., Maniatis, T., (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn, , Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY; Sanger, F., Nicklen, S., Coulson, A.R., DNA sequencing with chain-terminating inhibitors (1977) Proc. Natl Acad. Sci. USA, 74, pp. 5463-5467; Dower, W.J., Miller, J.F., Ragsdale, C.W., High efficiency transformation of E. coli by high voltage electroporation (1988) Nucleic Acids Res., 16, p. 6127; Schägger, H., Von Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa (1987) Anal. Biochem., 166, pp. 368-379; Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer Jr., E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Tasumi, M., The protein databank: A computerbased archival pile for macromolecular structures (1977) J. Mol. Biol., 122, pp. 535-542; Jakubowski, H., Goldman, E., Editing of errors in selection of amino acids for protein synthesis (1992) Microbiol. Rev., 56, pp. 412-429; Kochhar, S., Chuard, N., Hottinger, H., Glutamate 264 modulates the pH dependence of the NAD+-dependent D-lactate dehydrogenase (1992) J. Biol. Chem., 267, pp. 20298-20301; Hart, K.W., Clarke, A.R., Wigley, D.B., Waldman, A.D.B., Chia, W.N., Barstow, D.A., Atkinson, T., Holbrook, J.J., A strong carboxylate-arginine interaction is important in substrate orientation and recognition in lactate dehydrogenase (1987) Biochim. Biophys. Acta, 914, pp. 294-298","Delcour, J.; Departement de Biologie, Unite de Genetique, Universite Catholique de Louvain, Place Croix du Sud 5, B-1348 Louvain-la-Neuve, Belgium; email: delcour@gene.ucl.ac.be",,,"Blackwell Publishing Ltd",,,,,00142956,,EJBCA,"9063466","English","EUR. J. BIOCHEM.",Article,"Final",,Scopus,2-s2.0-8044229435
"Chillarón J., Estévez R., Mora C., Wagner C.A., Suessbrich H., Lang F., Gelpí J.L., Testar X., Busch A.E., Zorzano A., Palacín M.","6603010780;7005268745;7102104620;7402148810;16684668900;56363077100;35517522400;7004574699;7101774552;7005302863;57206445737;","Obligatory amino acid exchange via systems b(o,+)-like and y+L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids",1996,"Journal of Biological Chemistry","271","30",,"17761","17770",,143,"10.1074/jbc.271.30.17761","https://www.scopus.com/inward/record.uri?eid=2-s2.0-8944233871&doi=10.1074%2fjbc.271.30.17761&partnerID=40&md5=a005f408e51a765ceefa86cefaa4ee36","Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Physiologisches Institut I, Eberhard-Karls-Univ. Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany; Dept. of Biochemistry, Faculty of Biology, University of Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain","Chillarón, J., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Estévez, R., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Mora, C., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Wagner, C.A., Physiologisches Institut I, Eberhard-Karls-Univ. Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany; Suessbrich, H., Physiologisches Institut I, Eberhard-Karls-Univ. Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany; Lang, F., Physiologisches Institut I, Eberhard-Karls-Univ. Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany; Gelpí, J.L., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Testar, X., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Busch, A.E., Physiologisches Institut I, Eberhard-Karls-Univ. Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany; Zorzano, A., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain; Palacín, M., Departament de Bioquímica, Facultat de Biologia, Universitat de Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain, Dept. of Biochemistry, Faculty of Biology, University of Barcelona, Avda, Diagonal 645, Barcelona 08028, Spain","Mutations in the rBAT gene cause type I cystinuria, a common inherited aminoaciduria of cystine and dibasic amino acids due to their defective renal and intestinal reabsorption (Calonge, M. J., Gasparini, P., Chillaron, J., Chillon, M., Gallucci, M., Rousaud, F., Zelante, L., Testar, X., Dallapiccola, B., Di Silverio, F., Barcelo, P., Estivill, X. Zorzano, A. Nunes, V., and Palacin, M. (1994) Nat. Genet. 6, 420-426; Calonge, M. J., Volipini, V., Bisceglia, L., Rousaud, F., De Sanctis, L., Beccia, E., Zelante, L., Testat, X., Zorzano, A., Estivill, X., Gasparini, P., Nunes, V., and Palacin, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9667-9671). One important question that remains to be clarified is how the apparently non- concentrative system b(o,+)-like, associated with rBAT expression, participates in the active renal reabsorption of these amino acids. Several studies have demonstrated exchange of amino acids induced by rBAT in Xenopus oocytes. Here we offer evidence that system b(o,+)-like is an obligatory amino acid exchanger in oocytes and in the 'renal proximal tubular' cell line OK. System b(o,+)-like showed a 1:1 stoichiometry of exchange, and the hetero-exchange dibasic (inward) with neutral (outward) amino acids were favored in oocytes. Obligatory exchange of amino acids via system b(o,+)- like fully explained the amino acid-induced current in rBAT-injected oocytes. Exchange via system b(o,+)-like is coupled enough to ensure a specific accumulation of substrates until the complete replacement of the internal oocyte substrates. Due to structural and functional analogies of the cell surface antigen 4F2hc to rBAT, we tested for amino acid exchange via system y+L-like. 4F2hc-injected oocytes accumulated substrates to a level higher than CAT1-injected oocytes (i.e. oocytes expressing system y+) and showed exchange of amino acids with the substrate specificity of system y+L and L- leucine-induced outward currents in the absence of extracellular sodium. In contrast to L-arginine, system y+L-like did not mediate measurable L- leucine efflux from the oocyte. We propose a role of systems b(o,+)-like and y+L-like in the renal reabsorption of cystine and dibasic amino acids that is based on their active tertiary transport mechanism and on the apical and basolateral localization of rBAT and 4F2hc, respectively, in the epithelial cells of the proximal tubule of the nephron.",,"amino acid; carrier protein; amino acid analysis; amino acid transport; animal cell; article; kidney tubule absorption; nonhuman; oocyte; priority journal; stoichiometry; xenopus laevis; Amino Acid Transport Systems, Basic; Amino Acids, Diamino; Animals; Biological Transport, Active; Carrier Proteins; Cell Line; Cystine; Kidney Tubules, Proximal; Kinetics; Membrane Glycoproteins; Models, Biological; Oocytes; Rats; Recombinant Proteins",,"Amino Acid Transport Systems, Basic; Amino Acids, Diamino; Carrier Proteins; Cystine, 56-89-3; Membrane Glycoproteins; Recombinant Proteins",,,,,,,"Calonge, M.J., Gasparini, P., Chillarón, J., Chillón, M., Gallucci, M., Rousaud, F., Zelante, L., Palacín, M., (1994) Nat. Genet., 6, pp. 420-426; Calonge, M.J., Nadal, M., Calvano, S., Testar, X., Zelante, L., Zorzano, A., Estivill, X., Nunes, V., (1994) Hum. Genet., 95, pp. 633-636; Pras, E., Arber, N., Aksentijevich, I., Katz, G., Shapiro, J.M., Prosen, L., Gruberg, L., Kastner, D.L., (1994) Nat. Genet., 6, pp. 415-419; Segal, S., Thier, S.O., (1995) The Metabolic and Molecular Bases of Inherited Diseases, 3, pp. 3581-3601. , Scriver, C. H., Beaudet, A. L., Sly, W. S., and Valle, D., eds 7th Ed., McGraw-Hill Inc., New York; Rosenberg, L.E., Durant, J.L., Holland, I.M., (1965) N. Engl. J. Med., 273, pp. 1239-1345; Rosenberg, L.E., Downing, S., Durant, J.L., Segal, S., (1966) J. Clin. Invest., 45, pp. 365-371; Calonge, M.J., Volipini, V., Bisceglia, L., Rousaud, F., De Sanctis, L., Beccia, E., Zelante, L., Palacín, M., (1995) Proc. Natl. Acad. Sci. U. S. A., 92, pp. 9667-9671; Gasparini, P., Calonge, M.J., Bisceglia, L., Purroy, J., Dianzani, I., Notarangelo, A., Rousaud, F., Zelante, L., (1995) Am. J. Hum. Genet., 57, pp. 781-788; Furriols, M., Chillarón, J., Mora, C., Castelló, A., Bertran, J., Camps, M., Testar, X., Palacin, M., (1993) J. Biol. Chem., 268, pp. 27060-126068; Pickel, V.M., Nirenberg, M.J., Chan, J., Mosckovitz, R., Udenfriend, S., Tate, S.S., (1993) Proc. Natl. Acad. Sci. U. S. A., 90, pp. 7779-7783; Bertran, J., Werner, A., Chillarón, J., Nunes, V., Biber, J., Testar, X., Zorzano, A., Palacín, M., (1993) J. Biol. Chem., 268, pp. 14842-14849; Lee, W.-S., Wells, R.G., Sabbag, R.V., Mohandas, T.K., Hediger, M.A., (1993) J. Clin. Invest., 91, pp. 1959-1963; Mora, C., Chillarón, J., Calonge, M.J., Forgo, J., Testar, X., Nunes, V., Murer, H., Palacín, M., (1996) J. Biol. Chem., 271, pp. 10569-10576; Van Winkle, L.J., Campione, A.L., Gorman, M.J., (1988) J. Biol. Chem., 263, pp. 3150-3163; Busch, A., Herzer, T., Waldegger, S., Schmidt, F., Palacín, M., Biber, J., Markovich, D., Lang, F., (1994) J. Biol. Chem., 269, pp. 25581-25586; Coady, M.J., Jalal, F., Chen, X., Lemay, G., Berteloot, A., Lapointe, J.-Y., (1994) FEBS Lett., 356, pp. 174-178; Ahmed, A., Peter, G.J., Taylor, P.M., Harper, A.A., Rennie, M.J., (1995) J. Biol. Chem., 270, pp. 8482-8486; Miyamoto, K.-I., Katai, K., Tatsumi, S., Sone, K., Segawa, H., Yamamoto, H., Taketani, Y., Takeda, E., (1995) Biochem. J., 310, pp. 951-956; Bertran, J., Magagnin, S., Werner, A., Markovich, D., Biber, J., Testar, X., Zorzano, A., Murer, H., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 5606-5610; Wells, R.G., Lee, W., Kanai, Y., Leiden, J.M., Hediger, M.A., (1992) J. Biol. Chem., 267, pp. 15285-15288; Teixeira, S., Di Grandi, S., Kühn, L.C., (1987) J. Biol. Chem., 262, pp. 9574-9580; Kim, J.V., Closs, E.I., Albritton, L.M., Cunningham, J.M., (1991) Nature, 352, pp. 725-728; Bertran, J., Werner, A., Moore, M.L., Stange, G., Markovich, D., Biber, J., Testar, X., Murer, H., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 5601-5605; Closs, E.I., Lyons, C.R., Kelly, C., Cunningham, J.M., (1993) J. Biol. Chem., 268, pp. 20796-20800; Schafer, J.A., Watkins, M.L., (1984) Pfluegers Arch., 401, pp. 143-151; Bertran, J., Werner, A., Stange, G., Markovich, D., Biber, J., Testar, X., Zorzano, A., Murer, H., (1992) Biochem. J., 281, pp. 717-723; Busch, A.E., Kavanaugh, M.P., Varnum, M.D., Adelman, J.P., North, R.A., (1992) J. Physiol. (Lond.), 450, pp. 455-468; Helmle-Kölb, C., Montrose, M.H., Stange, G., Murer, H., (1990) Pflügers Arch., 415, pp. 461-470; Koyama, H., Goodpasture, C., Miller, M.M., Teplitz, R.L., Riggs, A.D., (1978) In Vitro, 14, pp. 239-246; Biber, J., Murer, H., (1985) Am. J. Physiol, 249, pp. C430-C434; Taylor, M.A., Smith, L.D., (1987) Dev. Biol., 124, pp. 287-290; Cha, S., (1968) J. Biol. Chem., 243, pp. 820-825; Wells, R.G., Hediger, M.A., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 5596-5600; Tate, S.S., Yan, N., Udenfriend, S., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 1-5; Yan, N., Mosckovitz, R., Udenfriend, S., Tate, S.S., (1992) Proc. Natl. Acad. Sci. U. S. A., 89, pp. 9982-9985; Devés, R., Chavez, P., Boyd, C.A.R., (1992) J. Physiol. (Lond.), 454, pp. 491-501; Angelo, S., Devés, R., (1994) J. Membr. Biol., 141, pp. 183-192; Eleno, N., Revés, R., Boyd, C.A.R., (1994) J. Physiol. (Lond.), 479, pp. 291-300; Kavanaugh, M.C., (1993) Biochemistry, 32, pp. 5781-5785; White, M.F., (1985) Biochim. Biophys. Acta, 822, pp. 355-374; Fei, Y.-J., Prasad, P.D., Leibach, F.H., Ganapathy, V., (1995) Biochemistry, 34, pp. 8744-8751; Devés, R., Angelo, S., Chávez, P., (1993) J. Physiol. (Lond.), 468, pp. 753-766; Dierks, T., Salentin, A., Heberger, C., Krämer, R., (1990) Biochim. Biophys. Acta, 1028, pp. 268-280; Hemler, M.E., Strominger, J.L., (1982) J. Immunol., 129, pp. 623-628; Wang, Y., Tate, S.S., (1995) FEBS Lett., 368, pp. 389-392; Palacín, M., (1994) J. Exp. Biol., 196, pp. 123-137; Deleted in proof; Munck, B.G., Schultz, S.G., (1969) Biochim. Biophys. Acta, 183, pp. 182-193; Cheeseman, C.I., (1983) J. Physiol. (Lond.), 338, pp. 87-97; Cheeseman, C.I., (1992) Am. J. Physiol., 263, pp. R482-R488; Quackenbush, E.J., Goigos, A., Baumal, R., Letarte, M., (1986) J. Immunol., 136, pp. 118-124","Palacin, M.; Dept. of Biochemistry/Molec. Biol., Faculty of Biology, University of Barcelona, Avda. Diagonal 645, Barcelona 08028, Spain",,,,,,,,00219258,,JBCHA,"8663357","English","J. BIOL. CHEM.",Article,"Final",Open Access,Scopus,2-s2.0-8944233871
"Trejo F., Costa M., Gelpí J.L., Busquets M., Clarke A.R., Holbrook J.J., Cortés A.","16752093100;56317155800;35517522400;7003927984;7403682319;7102156355;7102092256;","Cloning, sequencing and functional expression of a DNA encoding pig cytosolic malate dehydrogenase: Purification and characterization of the recombinant enzyme",1996,"Gene","172","2",,"303","308",,8,"10.1016/0378-1119(96)00178-3","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030014711&doi=10.1016%2f0378-1119%2896%2900178-3&partnerID=40&md5=c3aa67a084e672eab4a3753ecdce40e0","Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain; Molecular Recognition Centre, Department of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom; Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain","Trejo, F., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain; Costa, M., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain; Gelpí, J.L., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain; Busquets, M., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain; Clarke, A.R., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom; Holbrook, J.J., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, Bristol BS8 1TD, United Kingdom; Cortés, A., Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, 08028-Barcelona, Spain, Dept. de Bioquim. i Biol. Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain","Using the polymerase chain reaction, DNA encoding cytosolic malate dehydrogenase (cMDH) has been cloned from a pig heart cDNA library. Large amounts of the enzyme (30 mg per litre of original culture) have been produced in Escherichia coli using an inducible expression vector (pKK223-3) in which the 5'-non-coding region of the gene was replaced with the tac promoter. The complete nucleotide sequence of the DNA is reported for the first time. The recombinant cMDH purified was shown to be identical to the native enzyme according to: chromatographic behaviour, isoelectric point, N-terminal amino acid sequence, and physicochemical and catalytic properties.",,"malate dehydrogenase; recombinant protein; amino acid sequence; amino terminal sequence; article; DNA sequence; enzyme activity; enzyme denaturation; enzyme purification; enzyme structure; enzyme synthesis; Escherichia coli; expression vector; gene expression; molecular cloning; nonhuman; nucleotide sequence; polymerase chain reaction; priority journal","GENBANK: U44846","malate dehydrogenase, 9001-64-3",,,"Comisión Interministerial de Ciencia y Tecnología

Comisión Interministerial de Ciencia y Tecnología

British Council: 194A, 193A","Autonomous University of Barcelona, for DNA sequencing, and the Department of Protein Chemistry in the CIB of Madrid, for protein N-terminal sequencing. This work was supported by a grant PB90-0472 of the Comision Interministerial de Ciencia y Tecnologia (CICYT) and the British Council (Acciones Integradas 193A and 194A).",,,"Banaszak, L.J., Bradshaw, R.A., Malate dehydrogenases (1975) The Enzymes, pp. 369-396. , Boyer, P.D. (Ed.), Academic Press, New York; Ben-Bassat, A., Bauer, K., Chang, S.Y., Myambo, K., Boosman, A., Chang, S., Processing of the initiation methionine from proteins: Properties of the Escherichia coli methionine aminopeptidase and its gene structure (1987) J. Bacteriol., 169, pp. 751-757; Bernstein, L.H., Grisham, M.B., Cole, K.D., Everse, J., Substrate inhibition of the mitochondrial and cytoplasmatic malate dehydrogenases (1978) J. Biol. Chem., 253, pp. 8697-8701; Birktoft, J.J., Bradshaw, R.A., Banaszak, L.J., Structure of porcine heart cytosolic malate dehydrogenase: Combining X-ray diffraction and chemical sequence data in structural studies (1987) Biochemistry, 26, pp. 2722-2734; Birktoft, J.J., Rhodes, G., Banaszak, L.J., Refined crystal structure of cytoplasmic malate dehydrogenase at 2.5-Å resolution (1989) Biochemistry, 28, pp. 6065-6081; Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding (1976) Anal. Biochem., 72, pp. 248-254; Canela, E.I., A free derivative program for non-linear regression analysis of enzyme kinetics to be used on small computers (1984) Int. J. Biomed. Comp., 15, pp. 121-130; D'Souza, S.F., Srere, P.A., Binding of citrate synthase to mitochondrial inner membranes (1983) J. Biol. Chem., 258, pp. 4706-4709; Domènech, C., Mazo, A., Artigas, R., Cortés, A., Bozal, J., Malate dehydrogenase species in the cytosolic fraction of chicken liver (1986) Biol. Chem. Hoppe-seyler, 367, pp. 1069-1076; Domènech, C., Abante, J.J., Bozal, F.X., Mazo, A., Cortés, A., Bozal, J., An improved purification method for cytosolic malate dehydrogenase from several sources (1988) Prepar. Biochem., 18, pp. 17-35; Dunn, C.R., Wilks, H.M., Halsall, D.J., Atkinson, T., Clarke, A.R., Muirhead, H., Holbrook, J.J., Design and synthesis of new enzymes based on the lactate dehydrogenase framework (1991) Phil. Trans. R. Soc. London B, 332, pp. 177-184; Fahien, L.A., Kmiotek, E.H., McDonald, M.J., Fibich, B., Mandic, M., Regulation of malate dehydrogenase activity by glutamate, citrate, α-ketoglutarate and multienzyme interaction (1988) J. Biol. Chem., 263, pp. 10687-10697; Friedman, K.D., Rosen, N.L., Newman, P.J., Montgomery, R.R., Screening of λgt11 libraries (1990) PCR Protocols: A Guide to Methods and Applications, pp. 253-258. , Innis, M.A., Gelfand, D.H., Sninsky, J.J., White, T.J. (Eds.), Academic Press, San Diego, CA; Gelpi, J.Ll., Dordal, A., Montserrat, J., Mazo, A., Cortés, A., Kinetic studies of the regulation of mitochondrial malate dehydrogenase by citrate (1992) Biochem. J., 283, pp. 289-297; Gelpí, J.Ll., Imperial, S., Avilés, J.J., Busquets, M., Mazo, A., Cortés, A., Comparison of several properties of cytosolic and mitochondrial malate dehydrogenases (1993) Trends Comparat. Biochem. Physiol, 1, pp. 1099-1118; Joh, T., Takeshima, H., Tsuzuki, T., Setoyama, C., Shimada, K., Tanase, S., Kuramitsu, S., Morino, Y., Cloning and sequence analysis of cDNAs encoding mammalian cytosolic malate dehydrogenase (1987) J. Biol. Chem., 262, pp. 15127-15131; Mullinax, T.R., Mock, J.N., McEvily, A.J., Harrison, J.H., Regulation of mitochondrial malate dehydrogenase. Evidence of an allosteric citrate binding site (1982) J. Biol. Chem., 257, pp. 13233-13239; Nagakawa, S., Yamada, T., Kato, K., Nishimura, O., Enzymatic cleavage of N-terminal methionine from recombinant human interleukin 2 and growth hormone by aminopeptidase N (1987) Biotechnology, 5, pp. 824-827; Sanger, F., Nicklen, S., Coulson, A.R., DNA sequencing with chain-terminating inhibitors (1977) Proc. Natl. Acad. Sci. USA, 74, pp. 5463-5467; Staniforth, R.A., Cortés, A., Burston, S.G., Atkinson, T., Holbrook, J.J., Clarke, A.R., The stability and hydrophobicity of cytosolic and mitochondrial malate dehydrogenases and their relation to chaperonin-assisted folding (1994) FEBS Lett., 344, pp. 129-136; Thorne, C.J.R., Grossman, L., Kaplan, N.O., Starch gel electrophoresis of malate dehydrogenase (1963) Biochim. Biophys. Acta, 73, pp. 193-203; Warburg, O., Christian, W., Isolation and crystalization of enolase (1942) Biochem. Z., 310, pp. 384-421; Weber, K., Osborn, M., The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis (1969) J. Biol. Chem., 244, pp. 4406-4412; Wilks, H.M., Halsall, D.J., Atkinson, T., Chia, W.N., Clarke, A.R., Holbrook, J.J., Designs for a broad substrate specifity keto acid dehydrogenase (1990) Biochemistry, 29 (37), pp. 8587-8591; Wilks, H.M., Moreton, K.M., Hart, K.W., Gelpí, J.Ll., Casy, G.M., Sessions, R.B., Willis, C.L., Holbrook, J.J., Opportunities for chiral synthesis with redesigned lactate dehydrogenases (1992) Harnessing Biotechnology for the 21st Century. ACS Conference Series, pp. 150-154. , Ladisch, M.R. and Bose, A. (Eds.)","Cortes, A.; Dept Bioquimica Biologia Molecular, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028-Barcelona, Spain",,,"Elsevier B.V.",,,,,03781119,,GENED,"8682322","English","GENE",Article,"Final",,Scopus,2-s2.0-0030014711
"Nobbs T.J., Cortes A., Gelpi J.L., Holbrook J.J., Atkinson T., Scawen M.D., Nicholls D.J.","57192362094;7102092256;35517522400;7102156355;7102823760;7003372380;7202973314;","Contribution of a buried aspartate residue towards the catalytic efficiency and structural stability of Bacillus stearothermophilus lactate dehydrogenase",1994,"Biochemical Journal","300","2",,"491","499",,10,"10.1042/bj3000491","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028226205&doi=10.1042%2fbj3000491&partnerID=40&md5=3a386ef8b6e160c53a2d11191791b1ba","Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom","Nobbs, T.J., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Cortes, A., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Gelpi, J.L., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Holbrook, J.J., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Atkinson, T., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Scawen, M.D., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom; Nicholls, D.J., Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom","The X-ray structure of lactate dehydrogenase (LDH) shows the side-chain carboxylate group of Asp-143 to be buried in the hydrophobic interior of the enzyme, where it makes hydrogenbonding interactions with both the side-chain hydroxyl group of Ser-273 and the main-chain amide group of His-195. This is an unusual environment for a carboxylate side-chain as hydrogen bonding normally occurs with water molecules at the surface of the protein. A charged hydrogen-bonding interaction in the interior of a protein would be expected to be much stronger than a similar interaction on the solvent-exposed exterior. In this respect the side-chain carboxylate group of Asp-143 appears to be important for maintaining tertiary structure by providing a common linkage point between three discontinuous elements of the secondary structure, α1F, βK and the β-turn joining βG and βH. The contribution of the Asp-143 side-chain to the structure and function of Bacillus stearothermophilus LDH was assessed by creating a mutant enzyme containing Asn-143. The decreased thermal stability of both unactivated and fructose-1,6-diphosphate (Fru-1,6-P2)-activated forms of the mutant enzyme support a structural role for Asp-143. Furthermore, the difference in stability of the wild-type and mutant enzymes in guanidinium chloride suggested that the carboxylate group of Asp-143 contributes at least 22 kJ/mol to the conformational stability of the wild-type enzyme. However, there was no alteration in the amount of accessible tryptophan fluorescence in the mutant enzyme, indicating that the mutation caused a structural weakness rather than a gross conformational change. Comparison of the wild-type and mutant enzyme steady-state parameters for various 2-keto acid substrates showed the mutation to have a general effect on catalysis, with an average difference in binding energy of 11 kJ/mol for the transition-state complexes. The different effects of pH and Fru-1,6-P2 on the wild-type and mutant enzymes also confirmed a perturbation of the catalytic centre in the mutant enzyme. As the side-chain of Asp-143 is not sufficiently close to the active site to be directly involved in catalysis or substrate binding it is proposed that the effects on catalysis shown by the mutant enzyme are induced either by a structural change or by charge imbalance at the active site. As Asp-143, His-195 and Ser-273 are absolutely conserved in all known LDH sequences this charged interaction is an important and general feature of the structure/function relationship in LDH.",,"2 oxoacid; aspartic acid; fructose 1,6 bisphosphate; lactate dehydrogenase; mutant protein; tryptophan; amino acid analysis; article; conformational transition; controlled study; enzyme activity; enzyme mechanism; enzyme structure; fluorescence; Geobacillus stearothermophilus; nonhuman; priority journal; protein secondary structure; structure activity relation; structure analysis; thermostability; X ray analysis",,"aspartic acid, 56-84-8, 6899-03-2; fructose 1,6 bisphosphate, 488-69-7; lactate dehydrogenase, 9001-60-9; tryptophan, 6912-86-3, 73-22-3",,,,,,,,"Scawen, M.D.; Division of Biotechnology, Ctr for Applied Microbiology and Res, Porton, Salisbury, United Kingdom",,,"Portland Press Ltd",,,,,02646021,,BIJOA,"8002955","English","BIOCHEM. J.",Article,"Final",,Scopus,2-s2.0-0028226205
"Gelpi J.Ll., Jackson R.M., Holbrook J.J.","35517522400;7404310264;7102156355;","Electrostatic interaction energies in lactate dehydrogenase catalysis",1993,"Journal of the Chemical Society, Faraday Transactions","89","15",,"2707","2716",,11,"10.1039/FT9938902707","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0008226765&doi=10.1039%2fFT9938902707&partnerID=40&md5=58c9eb9c02c03a9b06d1b8b8d6071eaf","Molecular Recognition Centre, Department of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom; Department of Biochemistry and Physiology, Faculty of Chemistry, University of Barcelona, Martí i Franqués 1, 08028-Barcelona, Spain; Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom","Gelpi, J.Ll., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom, Department of Biochemistry and Physiology, Faculty of Chemistry, University of Barcelona, Martí i Franqués 1, 08028-Barcelona, Spain; Jackson, R.M., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom; Holbrook, J.J., Molecular Recognition Centre, Department of Biochemistry, University of Bristol, University Walk, Bristol, BS8 1TD, United Kingdom","A macroscopic approach has been used to calculate electrostatic energies in complexes of L-lactate dehydrogenase with substrates. The different steps of the catalytic mechanism that have been analysed separately are binding of coenzymes and substrates, protonation of the enzyme, the substrate-induced conformational rearrangement of the protein and the chemical transformation of substrate to product. The contributions of the different amino acid residues to each step have been determined from their electrostatic interaction energies. The overall topology of lactate dehydrogenase protein subunit creates, through helix dipoles, two regions of positive potential. One, in the coenzyme-binding domain, stabilises the negatively charged coenzyme pyrophosphate group. The other stabilises both the anionic substrate binding and the developing negative charge excess on the substrate carbonyl in the transition state. The calculated electrostatic fields are those expected from the roles of amino acid side chains which had been previously suggested from site-directed mutagenesis experiments: that is Asp-53 is important in NADH binding, Arg-171 for pyruvate binding and Arg-109 for transition-state stabilisation. His-195, the proton donor/acceptor in catalysis, is stabilised in the protonated state by both Asp-168 and pyruvate. The closure of the active-site loop sequesters the substrate and the nicotinamide ring of the coenzyme in an internal active-site vacuole. The closure process is calculated to be electrostatically unfavourable due to the buried ionic species. Calculation suggests that favourable hydrophobic effects balance unfavourable electrostatic effects and give the precise balance of energies to drive loop (residues 99-112) movement which generates the catalytically competent species.",,,,,,,,,,,"Holbrook, J.J., Liljas, A., Steindel, S.J., Rossman, M.G., (1975) The Enzymes, 11, p. 191. , P. D. Boyer, Academic Press, New York, 2nd edn; Dunn, C.R., Wilks, H.M., Halsall, D.J., Atkinson, T., Clarke, A.R., Muirhead, H., Holbrook, J.J., (1989) Philos. Trans. R. Soc. London B, 332, p. 177; Holbrook, J.J., Ingram, V.A., (1973) Biochem. J., 131, p. 729; Clarke, A.R., Wigley, D.B., Chia, W.N., Barstow, D., Atkinson, T., Holbrook, J.J., (1986) Nature (London), 324, p. 699; Hart, K.W., Clarke, A.R., Wigley, D.B., Widman, A.D.B., Chia, W.N., Barstow, D.A., Atkinson, T., Holbrook, J.J., (1987) Biochim. Biophys. Acta, 914, p. 294; Cortes, A., Emery, D., Halsall, D.J., Jackson, R.M., Clarke, A.R., Holbrook, J.J., (1992) Protein Sci., 1, p. 892; Scawen, M.D., Barstow, D.A., Nichols, D.J., Atkinson, A., Clarke, A.R., Wigley, D.B., Hart, K., Holbrook, J.J., (1989) Gesellshaft fuer Biologisches Forschung GmbH Monograph, Advances in Protein Design, 12, p. 103. , H. Bloecker, J. Collins, R. D. Schmidt and D. Schonburg, VCH, Mannheim; Wilks, H.M., Hart, K.W., Feeney, R., Dunn, C.R., Muirhead, H., Chia, W.N., Barstow, D.A., Holbrook, J.J., (1988) Science, 242, p. 1541; Parker, D.M., Lodola, A., Holbrook, J.J., (1982) Biochem. J., 173, p. 959; Clarke, A.R., Wilks, H.M., Barstow, D.A., Atkinson, T., Chia, W.N., Holbrook, J.J., (1988) Biochemistry, 27, p. 1617; Clarke, A.R., Atkinson, T., Holbrook, J.J., (1989) Trends Biochem. Sci., 14, p. 145; Wilks, H.M., Moreton, K.M., Halsall, D.J., Hart, K.W., Sessions, R.D., Clarke, A.R., Holbrook, J.J., (1992) Biochemistry, 31, p. 7802; Warshel, A., Russel, S.T., (1984) Q. Rev. Biophys., 17, p. 283; Honig, B., Hubbell, W., Flewelling, R., (1986) Annu. Rev. Biophys. Biophys. Chem., 15, p. 163; Rogers, N.K., (1986) Prog. Biophys. Mol. Biol., 48, p. 37; Matthew, J.B., (1985) Annu. Rev. Biophys. Biophys. Chem., 14, p. 387; Harvey, S.C., (1989) Proteins, 5, p. 78; Sharp, K.A., Honig, B., (1990) Annu. Rev. Biophys. Biophys. Chem., 19, p. 301; Warshel, A., Naray-Szabo, G., Sussman, F., Hwang, J.K., (1989) Biochemistry, 28, p. 3629; Tanford, C., Kirkwood, J.G., (1957) J. Am. Chem. Soc., 79, p. 5333; Orttung, W.H., (1977) Ann. N. Y. Acad. Sci., 303, p. 22; Warwicker, J., Watson, H.C., (1982) J. Mol. Biol., 157, p. 671; Klapper, I., Hagstrom, R., Fine, R., Honig, B.H., (1986) Proteins, 1, p. 47; Gilson, M.K., Sharp, K.A., Honig, B.H., (1987) J. Comput. Chem., 9, p. 327; Gilson, M.K., Honig, B.H., (1988) Proteins, 3, p. 32; Wigley, D.B., Gamblin, S.J., Turkenburg, S.P., Dodson, E.J., Piontek, K., Muirhead, H., Holbrook, J.J., (1992) J. Mol. Biol., 223, p. 317; Abad-Zapatero, C., Griffith, J.P., Sussmann, J.L., Rossmann, M.G., (1987) J. Mol. Biol., 198, p. 445; Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M.G., Hagler, A.T., (1988) Proteins, 4, p. 37; Besler, B.H., Merz, K.M., Jr., Kollman, P.A., (1990) J. Comput. Chem., 11, p. 431; Stewart, J.J.P., (1990) QCPE Bull., 10, p. 86; Dewar, M.J.S., Thiel, W.J., (1979) J. Am. Chem. Soc., 99, p. 4899; Yadav, A., Jackson, R.M., Holbrook, J.J., Warshel, A., (1991) J. Am. Chem. Soc., 113, p. 4800; Wilks, H.M., Cortes, A., Emery, D.C., Halsall, D.J., Clarke, A.R., Holbrook, J.J., (1992) Ann. N. Y. Acad. Sci. 672, pp. 80-93. , Enzyme Engineering XI, D. S. Clark and D. Estell, New York; Feeney, R., Clarke, A.R., Holbrook, J.J., (1990) Biochem. Biophys. Res. Commun., 166, p. 667; Holbrook, J.J., (1973) Biochem. J., 133, p. 847; Eisenberg, D., McLachlan, A.D., (1986) Nature (London), 319, p. 199; Kraulis, P.J., (1991) J. Appl. Crystallogr., 24, p. 945","Gelpi, J.Ll.; Department of Biochemistry and Physiology, Faculty of Chemistry, University of Barcelona, Martí i Franqués 1, 08028-Barcelona, Spain",,,,,,,,09565000,,,,"English",,Article,"Final",,Scopus,2-s2.0-0008226765
"Gelpi J.L., Avilés J.J., Busquets M., Imperial S., Mazo A., Cortés A., Halsall D.J., John Holbrook J.","35517522400;15074725200;7003927984;6701683262;7007042077;7102092256;57196538166;8926490100;","Concepts in biochemistry: A theoretical approach to the discrimination and characterization of the different classes of reversible inhibitors",1993,"Journal of Chemical Education","70","10",,"805","816",,9,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0009909349&partnerID=40&md5=236714b2edc397e2b6a7c0b17f5fae28","Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Department of Biochemistry, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom","Gelpi, J.L., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Avilés, J.J., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Busquets, M., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Imperial, S., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Mazo, A., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Cortés, A., Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain; Halsall, D.J., Department of Biochemistry, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom; John Holbrook, J., Department of Biochemistry, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1TD, United Kingdom",[No abstract available],,,,,,,,,,,,"Cortés, A.; Departament de Bioquimica i Fisiologia, Facultat de Química, Universitat de Barcelona, Martí i Franqués, 1, 08028-Barcelona, Spain",,,,,,,,00219584,,,,"English",,Article,"Final",,Scopus,2-s2.0-0009909349
"Jackson R.M., Emery D.C., Wilks H.M., Moreton K.M., Halsall D.J., Sleigh R.N., Clarke A.R., Gelpi J.L., Cortes A., Behan-Martin M., Jones G.R.","7404310264;7101761526;6603712361;6603944110;57196538166;57205368561;7403682319;35517522400;7102092256;6507212679;7406141268;","Construction of a Stable Dimer of Bacillus stearothermophilus Lactate Dehydrogenase",1992,"Biochemistry","31","35",,"8307","8314",,28,"10.1021/bi00150a026","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026669091&doi=10.1021%2fbi00150a026&partnerID=40&md5=0ef2c0de0b1376cda445535aae93a5d5","Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Department of Biochemistry and Physiology, University of Barcelona, Marti y Franqués, Barcelona 08028, Spain; SERC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom","Jackson, R.M., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Emery, D.C., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Wilks, H.M., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Moreton, K.M., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Halsall, D.J., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Sleigh, R.N., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Clarke, A.R., Molecular Recognition Centre and Department of Biochemistry, University of Bristol School of Medical Sciences, Bristol BS8 1TD, United Kingdom; Gelpi, J.L., Department of Biochemistry and Physiology, University of Barcelona, Marti y Franqués, Barcelona 08028, Spain; Cortes, A., Department of Biochemistry and Physiology, University of Barcelona, Marti y Franqués, Barcelona 08028, Spain; Behan-Martin, M., SERC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom; Jones, G.R., SERC Daresbury Laboratory, Daresbury, Warrington WA4 4AD, United Kingdom","A molecular graphics analysis of the features which prevent cytosolic malate dehydrogenase dimers from forming tetramers was evaluated by its success in predicting the synthesis of a version of the LDH framework which is a stable dimer. Surface residues responsible for malate dehydrogenases being dimers were revealed by superimposing the structures of two dimers of pig cytosolic malate dehydrogenase on one homologous tetramer of L-lactate dehydrogenase from Bacillus stearothermophilus. Four regions were identified as composing the P-axis dimer-dimer interface. Two regions of the dimer were surface loops that collided when built as a tetramer: a large loop (residues 203-207, KNOBI) and a small loop (residues 264-269, KNOBII), and these were candidates to explain the dimeric character of malate dehydrogenase. The analysis was tested by constructing a synthetic B. stearothermophilus lactate dehydrogenase (KNOBI) containing the large malate dehydrogenase loop (residues 203-207 being AYIKLQAKE, and extra four amino acids). The new construct was thermotolerant (90 °C) and enzymically active with Kcat and KM (pyruvate) values similar to those of the wildtype enzyme. However, whereas the allosteric activator fructose 1, 6-bisphosphate decreased KM 100 times for wild type, it had no influence on KNOBI. The molecular volumes of 1-120 µM concentrations of the construct were measured by time-resolved decay of tryptophan fluorescence anisotropy and by gel filtration. Both methods showed the molecular weight of wild type increased from dimer to tetramer with Kd about 20 nM dimer. KNOBI remained a dimer under these conditions. In the presence of 1 mM fructose 1, 6-bisphosphate wild type was stabilized as tetramer with Kd decreased to about 100 nM. KNOBI did not form a tetramer with Kd &lt; 130 µM dimer either with or without the effector. It is concluded that presence of a large surface loop is a determinant for cytosolic malate dehydrogenase being a dimer. © 1992, American Chemical Society. All rights reserved.",,"dimer; fructose 1,6 bisphosphate; lactate dehydrogenase; malate dehydrogenase; tryptophan; allosterism; anisotropy; article; enzyme activity; enzyme analysis; enzyme kinetics; enzyme stability; enzyme structure; fluorescence; gel filtration; Geobacillus stearothermophilus; heat tolerance; nonhuman; priority journal; swine; Amino Acid Sequence; Animal; Bacillus stearothermophilus; Base Sequence; Chromatography, Gel; Comparative Study; Enzyme Stability; Escherichia coli; Lactate Dehydrogenase; Macromolecular Systems; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Protein Conformation; Recombinant Proteins; Sequence Homology, Nucleic Acid; Spectrometry, Fluorescence; Support, Non-U.S. Gov't; Swine; Felis catus; Geobacillus stearothermophilus; Sus scrofa",,"Lactate Dehydrogenase, EC 1.1.1.27; Macromolecular Systems; Oligodeoxyribonucleotides; Recombinant Proteins",,,,,,,"Banaszak, L.J., Bradshaw, R.A., (1975) Enzymes (3rd Ed.), 11A, pp. 369-396; Barstow, D., Clarke, A.R., Chia, W.N., Wigley, D., Sharman, A.F., Atkinson, T., Minton, N.P., Holbrook, J.J., (1986) Gene, 46, pp. 47-55; Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Tasumi, M., (1977) J. Mol. Biol., 112, pp. 535-542; Birktoft, J.J., Rhodes, G., Banaszak, L.J., (1989) Biochemistry, 28, pp. 6065-6081; Brosius, J., Holy, A., (1984) Proc. Natl. Acad. Sci. US.A., 81, pp. 6929-6933; Carter, P., Bedouelle, H., Winter, G., (1985) Nucleic Acids Res., 13, pp. 4431-4443; Clarke, A.R., Waldman, A.D.B., Munro, I., Holbrook, J.J., (1985) Biochim. Biophys. Acta, 828, pp. 375-379; Clarke, A.R., Evington, J.R.N., Dunn, C.R., Atkinson, T., Holbrook, J.J., (1986) Biochim. Biophys. Acta, 870, pp. 112-126; Clarke, A.R., Wigley, D.B., Chia, W.N., Barstow, D., Atkinson, T., Holbrook, J.J., (1986) Nature, 324, pp. 699-702; Clarke, A.R., Atkinson, T., Holbrook, J.J., (1989) Trends Biochem. Sci., 14, pp. 145-148; Cretin, C., Luchetta, P., Joly, C., Decottignies, P., Lepiniec, L., Gadal, P., Sallantin, M., Perrnollet, J.C., (1990) Eur. J. Biochem., 192, pp. 299-303; Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M.G., Hagler, A.T., (1988) Protein Struct., Funct. Genet., 4, pp. 37-47; Dunn, C.R., Wilks, H.M., Halsall, D.J., Atkinson, T., Clarke, A.R., Muirhead, H., Holbrook, J.J., (1991) Philos. Trans. R. Soc. (London) B, 332, pp. 177-185; Holbrook, J.J., Liljas, A., Steindel, S.J., Rossmann, M.G., (1975) Enzymes, 11 A, pp. 191-292.. , (3rd Ed.); Jeckel, D., Anders, R., Pfleiderer, G., (1973) Hoppe Seyler's Z. Physiol. Chem., 354, pp. 737-782; Leatherbarrow, R.J., (1990), Grafit v. 2.0, Erithracus Software Ltd., Staines, U.K; Metzler, M.C., Beverley, A., Rothermel, A., Nelson, T., (1989) Plant Mol. Biol., 12, pp. 713-722; Messing, J., Vieira, J., (1982) Gene, 19, pp. 269-276; Opitz, U., Rudolf, R., Jaenicke, R., Ericson, L., Neurath, H., (1981) Biochemistry, 26, pp. 1399-1406; Pfleiderer, G., Nagel, G., Buehler, H., (1991) Experientia, 47, pp. 470-475; Rossmann, M.G., Liljas, A., Brandan, C.-I., Banaszak, L.J., (1975) Enzymes, 11A, pp. 61-102. , (3rd Ed.); Sambrook, J., Fritsch, E.F., Maniatis, T., (1989) Molecular Cloning—a laboratory manual, , 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; Sanger, F., Coulson, A.R., Barrell, B.G., Smith, A.J.H., Roe, B.A., (1980) J. Mol. Biol., 143, pp. 161-178; Scheibe, R., Kampfenkel, K., Wessels, R., Tripier, D., (1991) Biochim. Biophys. Acta, 1076, pp. 1-8; Steffan, J.S., McAlister-Henn, L., (1991) Arch. Biochem. Biophys., 287, pp. 276-282; Struthers, R.S., Rivier, J., Hagler, A.T., (1984) Conformationally directed drug design: Peptides and Nucleic Acids as Templates or Targets, pp. 239-261. , (Vida, J.A., & Gordon, M., Eds.) American Chemical Society, Washington, DC; Waldman, A.D.B., Clarke, A.R., Wigley, D.B., Hart, K.W., Chia, W.N., Barstow, D.A., Atkinson, T., Holbrook, J.J., (1987) Biochim. Biophys. Acta, 913, pp. 66-71; Wigley, D.B., Gamblin, S.J., Turkenburg, J.P., Dodson, E.J., Piontek, K., Muirhead, H., Holbrook, J.J., (1992) J. Mol. Biol., 223, pp. 317-335",,,,,,,,,00062960,,,"1525168","English","Biochemistry",Article,"Final",,Scopus,2-s2.0-0026669091
"Imperial S., Gelpi J.L., Busquets M., Mazo A., Cortes A.","6701683262;35517522400;7003927984;7007042077;7102092256;","Effect of the buffer concentration on the separation of lactate dehydrogenase isoenzymes from different sources by electrophoresis",1991,"Analytical Letters","24","9",,"1553","1558",,1,"10.1080/00032719108052993","https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954627979&doi=10.1080%2f00032719108052993&partnerID=40&md5=0ca0c4721b3213fd480d58cb9f73eb72","Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain","Imperial, S., Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain; Gelpi, J.L., Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain; Busquets, M., Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain; Mazo, A., Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain; Cortes, A., Departament de Bioquimica. i Fisiologia, Facultat de Quimica, Universitat de Barcelona. Marti i Franques, 1. 08028 Barcelona, Spain","The separation of lactate dehydrogenase isoenzymes by zone electrophoresis using cellulose acetate strips as support was dependent on the concentration of the buffer used (5 mM and 50 mM, pH 7.4) and on the source of the material (chicken liver or guinea-pig liver). In three different 5 mM buffer systems, pH 7.4 (phosphate, veronal and Tris-HCl) the four lactate dehydrogenase isoenzymes present in chicken liver cytosol: M3H, M2H2, MH3 and H4 were resolved into four separated bands. M3H and M2H2 isoenzymes migrated towards the cathode whereas the other two isoenzymes showed anodic mobilities. In 50 mM buffers, pH 7.4 all enzyme activity appeared as a single band with anodic mobility similar to that of H4. Guinea-pig liver isoenzymes were well resolved in both buffer conditions and appeared as five bands with anodic mobilities. The different behaviour of the lactate dehydrogenase isoenzymes in 5 mM and 50 mM buffers can not be assigned to ionic strength effects but it may explained by assuming the binding of buffer anions to the different isoenzymes. © 1991, Taylor &amp; Francis Group, LLC. All rights reserved.","buffer concentration; isoenzymes; lactate dehydrogenase; zone electrophoresis",,,,,,,,,,"Andrews, A.T., (1981) Electrophoresis: Theory, techniques, and biochemical and clinical applications, pp. 247-253. , Clarendon Press, Oxford; Moss, D.W., (1979) Isoenzyme Analysis, The Chemical Society, pp. 1-74. , London; Cahn, R.D., Kaplan, N.O., Levine, L., Zwilling, E., (1962) Science, 136, pp. 962-969; Kaplan, N.O., Goodfriend, T.L., (1967) Advances in Enzyme Regulation, 2, pp. 203-212; Fine, I.H., Costello, L.A., (1963) Methods Enzymol, 6, pp. 958-972; Fine, I.H., Kaplan, N.O., Kuftinec, O., (1963) Biochemistry, 2, pp. 116-121; Adams, M.J., Liljas, A., Rossmann, M.G., (1973) J. Mol. Biol., 76, pp. 519-531",,,,,,,,,00032719,,,,"English","Anal. Lett.",Article,"Final",,Scopus,2-s2.0-84954627979
"Langa F., Gracia V., Gelpi J.L., Mazo A., Cortes A.","7003596090;15825274600;35517522400;7007042077;7102092256;","Comparative analysis of the binding of multiple forms of mitochondrial malate dehydrogenase to the inner membrane of the mitochondria",1991,"Biochemical Society Transactions","19","1",,"","",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-17044440788&partnerID=40&md5=7eed1226ebf89f8ef4f7d9803bdd29ae","Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain","Langa, F., Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Gracia, V., Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Gelpi, J.L., Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Mazo, A., Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Cortes, A., Departamento de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain",[No abstract available],,"malate dehydrogenase; animal tissue; chicken; conference paper; liver mitochondrion; mitochondrial membrane; nonhuman; priority journal; Animal; Chickens; Chromatography, Affinity; Intracellular Membranes; Isoenzymes; Malate Dehydrogenase; Mitochondria, Liver; Protein Binding; Submitochondrial Particles; Animalia; Gallus gallus",,"Isoenzymes; Malate Dehydrogenase, EC 1.1.1.37",,,,,,,,,,,,,,,,03005127,,BCSTB,"2037202","English","BIOCHEM. SOC. TRANS.",Conference Paper,"Final",,Scopus,2-s2.0-17044440788
"Gelpi J.L., Gracia V., Imperial S., Mazo A., Cortes A.","35517522400;15825274600;6701683262;7007042077;7102092256;","A rapid procedure for eliminating chromatofocusing buffer and concentrating minor active subforms of mitochondrial malate dehydrogenase",1990,"BioTechniques","9","5",,"616","618",,,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025065124&partnerID=40&md5=7b8b385614cfbbfe0329c40efe5409ff","Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain","Gelpi, J.L., Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Gracia, V., Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Imperial, S., Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Mazo, A., Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain; Cortes, A., Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain","Mitochondrial malate dehydrogenase from several sources contains different molecular forms whose origin is still under discussion. Separation of these subforms has been achieved by chromatofusing. A simple and rapid method, based on 5' AMP Sepharose chromatography, has been developed to concentrate mitochondrial malate dehydrogenase subforms and simultaneously remove chromatofocusing buffer.",,"buffer; malate dehydrogenase; article; chromatofocusing; methodology; mitochondrion; priority journal; Animal; Buffers; Chickens; Chromatography, Affinity; Isoelectric Focusing; Malate Dehydrogenase; Mitochondria, Liver",,"Buffers; Malate Dehydrogenase, EC 1.1.1.37",,,,,,,,"Mazo, A.; Department de Bioquimica, Facultat de Quimica, Universitat de Barcelona, Marti i Franques 1, 08028 Barcelona, Spain",,,,,,,,07366205,,BTNQD,"2268429","English","BIOTECHNIQUES",Article,"Final",,Scopus,2-s2.0-0025065124
"Dordal A., Mazo A., Gelpi J.L.I., Cortes A.","6603267288;7007042077;35517522400;7102092256;","Factors affecting L-malate activation of mitochondrial malate dehydrogenase from chicken liver",1990,"Biochemistry International","20","1",,"177","182",,2,,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025136723&partnerID=40&md5=580c1b93b41f7921ab8caae15d8ff3f4","Departament de Bioquimica i Fisiologia, Fac. Quimica, Universitat de Barcelona, Barcelona, Spain","Dordal, A., Departament de Bioquimica i Fisiologia, Fac. Quimica, Universitat de Barcelona, Barcelona, Spain; Mazo, A., Departament de Bioquimica i Fisiologia, Fac. Quimica, Universitat de Barcelona, Barcelona, Spain; Gelpi, J.L.I., Departament de Bioquimica i Fisiologia, Fac. Quimica, Universitat de Barcelona, Barcelona, Spain; Cortes, A., Departament de Bioquimica i Fisiologia, Fac. Quimica, Universitat de Barcelona, Barcelona, Spain","Mitochondrial malate dehydrogenase is activated by high concentrations of L-malate. In this paper, several factors affecting this activation on chicken liver enzyme have been investigated. The results obtained show clearly that this phenomenon is an intrinsic property of this enzyme since it does not depend on pH or ionic strength of the reaction medium. However, L-malate activation decreases when NAD+ concentration diminishes (5 mM → 0.2 mM) in such a way that when NAD+ concentration is 0.2 mM, L-malate does not activate mitochondrial malate dehydrogenase. On the other hand, several activators of this enzymatic system, such as citrate or phosphate, also produce the elimination of this activation by L-malate; in this case, the phenomenon seems be due to a competitive binding to a regulatory site of the different metabolites implied.",,"liver enzyme; malate dehydrogenase; malic acid; animal cell; article; chicken; nonhuman; priority journal; Animal; Chickens; Citrates; Enzyme Activation; Ligands; Malate Dehydrogenase; Malates; Mitochondria, Liver; Phosphates; Animalia; Gallus gallus",,"Citrates; Ligands; Malate Dehydrogenase, EC 1.1.1.37; Malates; Phosphates",,,,,,,,,,,,,,,,01585231,,BIIND,"2328021","English","BIOCHEM. INT.",Article,"Final",,Scopus,2-s2.0-0025136723
"Mazo A., Gelpí J.Ll., Cartés A.","7007042077;35517522400;24368528800;","Comparison of the kinetic behaviour of lactate dehydrogenase and cytosolic and mitochondrial malate dehydrogenase from guinea pig skeletal muscle",1990,"Journal of Molecular Catalysis","58","2",,"269","275",,1,"10.1016/0304-5102(90)85046-K","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025388014&doi=10.1016%2f0304-5102%2890%2985046-K&partnerID=40&md5=17cf4f49c9c4e4fc0c9e37b6540cb288","Departement de Bioquímica i Fisiologia. Facultat de Química, Universitá de BarcelonaSpain, Spain","Mazo, A., Departement de Bioquímica i Fisiologia. Facultat de Química, Universitá de BarcelonaSpain, Spain; Gelpí, J.Ll., Departement de Bioquímica i Fisiologia. Facultat de Química, Universitá de BarcelonaSpain, Spain; Cartés, A., Departement de Bioquímica i Fisiologia. Facultat de Química, Universitá de BarcelonaSpain, Spain","Comparative kinetic studies performed with several structural analogues of pvruvate and oxaloacetate have demonstrated that lactate dehydrogenase shows a broad specificity of substrate, since it transforms various 2-oxomonocarboxylic and 2-oxodicarboxylic acids, whereas malate dehydrogenase isoenzymes are much more specific because although they reduce oxomalonate, they are inactive with the other compounds assayed. The influence of different structural and metabolic-related substances on the activity of the mentioned dehydrogenases was also studied. Lactate dehydrogenase is specifically inhibited by oxalate and oxamate, whereas citrate and hydroxymalonate are differential inhibitors of malate dehydrogenase isoenzymes. © 1990.",,"Biological Materials--Muscle; Esters--Dehydrogenation; Lactate Dehydrogenase; Malate Dehydrogenase; Enzymes",,,,,,,,,"Banaszak, Bradshaw, (1975) The Enzymes, 11, pp. 369-396. , P.D. Boyer, 3rd edn., Academic Press, New York; Birktoft, Fernley, Bradshaw, Banaszak, (1982) Proc. Nat. Acad. Sci. U.S., 79, p. 6166; Rupley, Forster, Torikata, Johnson, O'Neal, (1980) Biochem. Biophys. Res. Commun., 93, p. 654; Frieden, Fernandez-Sousa, (1975) J. Biol. Chem., 250, p. 2106; Lodola, Shore, Parker, Holbrook, (1978) Biochem. J., 175, p. 987; Birktoft, Banaszak, (1983) J. Biol. Chem., 258, p. 472; Roderick, Banaszak, (1986) J. Biol. Chem., 261, p. 9461; Doménech, Abante, Bozal, Mazo, Cortés, Bozal, (1988) Prep. Biochem., 18, p. 17; Gelpí, Domenech, Mazo, Cortés, Bozal, (1988) Int. J. Biochem., 20, p. 989; Puig, Cortes, Bozal, (1980) Int. J. Biochem., 11, p. 229; Canela, (1984) Int. J. Biomchem. Comp., 15, p. 121; Holbrook, Liljas, Steindel, Rossmann, (1975) The Enzymes, 11, pp. 191-292. , P.D. Boyer, 3rd edn, Academic Press, New York; Yang, Scandalios, (1974) Arch. Biochem. Biophys., 161, p. 335; Mullinax, Mock, McEvily, Harrison, (1982) J. Biol. Chem., 257, p. 13233; Nisselbaum, Parker, Bodansky, (1964) J. Biol. Chem., 239, p. 2830; Raval, Wolfe, (1962) Biochemistry, 1, p. 1112; Segel, (1975) Enzyme Kinetics, pp. 779-783. , Wiley-Interscience, London, Chapt. 9; Silverstein, Sulebele, (1969) Biochemistry, 8, p. 2543; Du Val, Swaisgood, Horton, (1985) Biochemistry, 24, p. 2067; Harada, Wolfe, (1968) J. Biol. Chem., 243, p. 4123","Mazo, A.; Departement de Bioquímica i Fisiologia. Facultat de Química, Universitá de BarcelonaSpainSpain",,,,,,,,03045102,,,,"English",,Article,"Final",,Scopus,2-s2.0-0025388014
"Haro I., Gelpi J.L., Mazo A., Cortés A.","7006064539;35517522400;7007042077;7102092256;","Kinetic formulations for the reduction of ketomalonate by lactate dehydrogenase",1990,"Journal of Enzyme Inhibition and Medicinal Chemistry","3","3",,"189","193",,1,"10.3109/14756369009035836","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025157055&doi=10.3109%2f14756369009035836&partnerID=40&md5=fa6d4177747ea8b55e991d87ed2dc1b6","Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain","Haro, I., Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Gelpi, J.L., Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Mazo, A., Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain; Cortés, A., Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain","Initial rate kinetic studies of lactate dehydrogenase with ketomalonate and NADH as substrates suggest that this enzymatic system is adapted to a rapid equilibrium ordered bi-bi ternary complex mechanism. The application of the reaction product inhibition method reveals the existence of the enzyme-NADH-hydroxy-malonate and enzyme-NAD+-ketomalonate abortive complexes. This kinetic behaviour is confirmed by the differential inhibition induced by several alternate products on the pyruvate-lactate dehydrogenase-NADH and ketomalonate-lactate dehydrogenase-NADH systems. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.","Alternate product inhibition; Ketomalonate; Kinetic mechanism; Lactate dehydrogenase","lactate dehydrogenase; article; enzyme kinetics; nonhuman; Animal; Guinea Pigs; Kinetics; Lactate Dehydrogenase; Malonates; Muscles; NAD; Oxidation-Reduction; Tartronates",,"Lactate Dehydrogenase, EC 1.1.1.27; Malonates; mesoxalic acid, 473-90-5; NAD, 53-84-9; Tartronates; tartronic acid, 80-69-3",,,,,,,"Holbrook, J.J., Liljas, A., Steindel, S.J., Rossmann, M.G., (1975) The Enzymes, 11, pp. 191-292. , Ed. P.D. Boyer. Academic Press, New York1975; Birktoft, J.J., Fernley, R.T., Bradshaw, R.A., Banaszak, L.J., (1982) Proc. Natl. Acud. Sci. USA., 79, pp. 6166-6170; Roderick, S.L., Banaszak, L.J., (1986) J. Biol. Chem., 261, pp. 9461-9464; Harada, K., Wolfe, R.G., (1968) J. Biol. Chem., 243, pp. 4123-4130; Harada, K., Wolfe, R.G., (1968) J. Biol. Chem., 243, pp. 4131-4137; Puig Cort, J., Cs, A., Bozal, J., (1980) Int. J. Biochem., 11, pp. 229-236; Cleland, W.W., (1963) Biochim. Biophys. Acta., 67, pp. 104-137; Segel, I.H., (1975) Enzyme kinetics, pp. 273-345. , Wiley Interscience Publications., LondonCh. 6; Canela, E.I., (1984) Int. J. Biomed. Comp., 15, pp. 121-129; Segel, I.H., (1975) Enzyme kinetics, pp. 505-845. , Wiley Interscience Publications, LondonCh. 6","Haro, I.; Departament de Bioquimica i Fisiologia, Facultat de Quimica, Universitat de Barcelona, Martí i Franqués 1, 08028 Barcelona, Spain",,,"Informa Healthcare",,,,,14756366,,JEIMA,"2079635","English","J. Enzyme Inhib. Med. Chem.",Article,"Final",,Scopus,2-s2.0-0025157055
"Gelpí J.L., Imperial S., Mazo A., Busquets M., Cortés A.","35517522400;6701683262;7007042077;7003927984;7102092256;","Nature of artifactual bands in the electropherograms of malate dehydrogenase isoenzymes",1990,"Biochemical Education","18","4",,"200","202",,,"10.1016/0307-4412(90)90135-B","https://www.scopus.com/inward/record.uri?eid=2-s2.0-44949286663&doi=10.1016%2f0307-4412%2890%2990135-B&partnerID=40&md5=14a819413a19e704acb98b321c3cafbc","Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain","Gelpí, J.L., Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain; Imperial, S., Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain; Mazo, A., Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain; Busquets, M., Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain; Cortés, A., Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain",[No abstract available],,,,,,,,,,,"Hunter, Markert, (1957) Science, 125, pp. 1294-1295; Barnett, (1964) J Clin Pathol, 17, pp. 567-570; Graymore, (1965) Nature, 206, pp. 1360-1361; Wieme, (1983) Methods of Enzymatic Analysis, 3, pp. 54-85. , Third Edition; Falkenberg, Lehmann, Pfeiderer, (1969) Clin Chim Acta, 23, pp. 265-278; Thorne, Grossman, Kaplan, Starch-gel electrophoresis of malate dehydrogenase (1963) Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 73, pp. 193-203; Fine, Costello, (1963) Methods Enzymol, 6, pp. 958-972; Walk, Hock, (1976) Europ J Biochem, 71, pp. 25-32; Rotmans, (1978) Exptl Parasitol, 46, pp. 31-48; Aziz, Chien, Patel, Freeman, (1981) FEBS Lett, 133, pp. 127-129; Kuan, Jones, Vestling, (1979) Biochemistry, 18, pp. 4366-4373; Crow, Braggins, Batz, Hardman, (1982) J Biol Chem, 257, pp. 14217-14225; Doménech, Mazo, Artigas, Cortés, Bozal, Malate Dehydrogenase Species in the Cytosolic Fraction of Chicken Liver (1986) Biological Chemistry Hoppe-Seyler, 367, pp. 1069-1076; Hutchins, Williams, Geren, (1983) Int J Biochem, 15, pp. 1353-1359; Latner, Skillen, (1968) Isoenzymes in Biology and Medicine, pp. 146-169. , Second Edition, Academic Press, London","Gelpí, J.L.; Departament de Bioquímica i Fisiologia Facultat, Química Universitat de Barcelona Martí i Franqués 1, 08028 Barcelona, Spain",,,,,,,,03074412,,BIEDD,,"English","Biochem. Educ.",Article,"Final",,Scopus,2-s2.0-44949286663
"Mazo A., Forner A., Domènech C., Busquets M., Gelpí J.L.I., Cortés A.","7007042077;55509661800;57196812068;7003927984;35517522400;7102092256;","Comparative analysis of the reduction of oxaloacetate by human hepatoma and normal liver extracts",1990,"Tumor Biology","11","3",,"120","128",,1,"10.1159/000217646","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025035647&doi=10.1159%2f000217646&partnerID=40&md5=911e08fd1f9c01aebb78a5f387dadd5f","Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain","Mazo, A., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain; Forner, A., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain; Domènech, C., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain; Busquets, M., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain; Gelpí, J.L.I., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain; Cortés, A., Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Spain","An apparent activation of the malate dehydrogenase activity is observed in the double-reciprocal plot at high oxaloacetate concentrations when human hepatoma extracts are analyzed. This phenomenon does not occur in healthy liver samples. In hepatoma extracts, the ratio of lactate dehydrogenase to malate dehydrogenase activities becomes fivefold higher than that of normal liver. Experiments performed with mixtures of both purified enzymes and, conversely, by using oxamate, a specific inhibitor of lactate dehydrogenase, reveal that the deviation in Michaelis-Menten behavior observed is due to the oxaloacetate reductase activity of lactate dehydrogenase instead of the presence of a novel malate dehydrogenase isoenzyme. © 1990 S. Karger AG, Basel.","Hepatoma; Isoenzymes; Kinetic analysis; Lactate dehydrogenase; Malate dehydrogenase","lactate dehydrogenase; malate dehydrogenase; article; clinical article; human; kinetics; liver cell carcinoma; Carcinoma, Hepatocellular; Comparative Study; Cytosol; Electrophoresis, Polyacrylamide Gel; Human; Isoenzymes; Kinetics; Lactate Dehydrogenase; Liver; Liver Neoplasms; Malate Dehydrogenase; Oxaloacetates; Oxidation-Reduction; Support, Non-U.S. Gov't",,"lactate dehydrogenase, 9001-60-9; malate dehydrogenase, 9001-64-3; Isoenzymes; Lactate Dehydrogenase, EC 1.1.1.27; Malate Dehydrogenase, EC 1.1.1.37; Oxaloacetates",,,,,,,"Stefanini, M., Enzymes, isoenzymes and enzyme variants in the diagnosis of cancer (1985) Cancer, 55, pp. 1931-1936; Bassalyk, L.S., Pashintzeva, L.P., Lyubimova, N.V., Gorozhanskaya, E.G., Enzymes and isoenzymes in diagnosis of human malignant tumors: In Schmidt E, Schmidt FW (eds): Multiple Forms of Enzymes (1982) Adv Clin Enzymol, 2, pp. 110-116. , Basel, Karger; Weber, G., Henry, M.C., Wage, S.R., Wagle, D.S., Correlation of enzyme activites and metabolic pathways with growth rate in hepatomas (1963) Adv Enzyme Regul, 2, pp. 335-346; Weber, G., Behavior of liver enzymes during hepa-tocarcinogenesis (1961) Adv Cancer Res, 6, pp. 403-487; Felder, M.R., Mouse liver cytoplasmic malate dehydrogenase: Rapid isolation, characterization and immunochemical comparison with hepatoma enzyme (1978) Arch Biochem Biophys, 190, pp. 647-656; Grisham, M.B., Bernstein, L.H., Everse, J., The cytoplasmic malate dehydrogenase in neoplastic tissues. Presence of a novel isoenzyme? (1983) Br J Cancer, 47, pp. 727-731; Hammond, K., Balinsky, D., Isoenzyme studies of several enzymes of carbohydrate metabolism in human adult and fetal tissues, tumor tissues, and cell cultures (1978) Cancer Res, 38, pp. 1323-1328; Puig, J., Cortés, A., Bozal, J., Influence of lactate dehydrogenase on the kinetic and electrophoretic behavior of guinea-pig skeletal muscle cytoplasmic malate dehydrogenase (1980) Int J Biochem, 11, pp. 229-236; Elduque, A., Cortés, A., Bozal, J., Kinetic behavior of chicken liver mitochondrial malate dehydrogenase and lactate dehydrogenase mixtures (1981) Int J Biochem, 13, pp. 1027-1034; Carda-Abella, P., Pèrez-Cuadrado, S., Lara-Barique, L., Gil-Grande, L., Núňez-Puertas, A., LDH isoenzyme patterns in tumors, polyps, and uninvolved mucosa of human cancerous colon (1982) Cancer, 49, pp. 80-83; Lippert, M.C., Javadpour, N., Lactic dehydrogenase in the monitoring and prognosis of testicular cancer (1981) Cancer, 48, pp. 2274-2278; Domènech, C., Abante, J.J., Bozal, F.X., Mazo, A., Cortés, A., Bozal, J., An improved purification method for cytosolic malate dehydrogenase from several sources (1988) Prep Biochem, 18, pp. 17-36; Mazo, A., Gelpi, J.L.I., Cortés, A., Comparison of kinetic behaviour of lactate dehydrogenase and cytosolic and mitochondrial malate dehydrogenase from guinea-pig skeletal muscle J Mol Catal, , press; Jones, G.L., Vestling, C.S., Changes in the apparent isoelectric point of mitochondrial malate dehydrogenase caused by phospholipid binding (1979) Electrofocus, 78, pp. 55-68; Thome, C.J.R., Grossman, L.I., Kaplan, N.O., Starch gel electrophoresis of malate dehydrogenase (1963) Bio-Chim Biophys Acta, 73, pp. 193-203; Canela, E.I., A free derivative program for nonlinear regression analysis of enzyme kinetics to be used on small computers (1984) Int J Biomed Comput, 15, pp. 121-130; Elduque, A., Cortés, A., Bozal, J., Kinetic mechanism of the molecular forms of chicken liver mitochondrial malate dehydrogenase (1983) Int J Biochem, 15, pp. 539-545; Nisselbaum, J.S., Parker, D.E., Bodansky, O., Comparison of the actions of human brain, liver and heart lactic dehydrogenase variants on nucleotide analogues and on substrate analogues in the absence and in the presence of oxalate and oxamate (1964) J Biol Chem, 239, pp. 2830-2834","Mazo, A.; Departament de Bioquímica i Fisiologia, Universitat de Barcelona, Martí i Franqués 1, Barcelona, E-08028, Spain",,,,,,,,10104283,,,"2160721","English","Tumor Biol.",Article,"Final",,Scopus,2-s2.0-0025035647
"Gelpí J.L., Domènech C.","35517522400;57196812068;","KINEXP: Computer simulaton in enzyme kinetics",1988,"Biochemical Education","16","4",,"222","223",,2,"10.1016/0307-4412(88)90128-8","https://www.scopus.com/inward/record.uri?eid=2-s2.0-45549121532&doi=10.1016%2f0307-4412%2888%2990128-8&partnerID=40&md5=a189a95484f30c7281d04e063a894e59","Departament de Bioquimica i Fisiologia Facultat de Quimica Univesitat de Barcelona Marti Franques 1, 08028 Barcelona, Spain","Gelpí, J.L., Departament de Bioquimica i Fisiologia Facultat de Quimica Univesitat de Barcelona Marti Franques 1, 08028 Barcelona, Spain; Domènech, C., Departament de Bioquimica i Fisiologia Facultat de Quimica Univesitat de Barcelona Marti Franques 1, 08028 Barcelona, Spain",[No abstract available],,,,,,,,,,,,"Gelpí, J.L.; Departament de Bioquimica i Fisiologia Facultat de Quimica Univesitat de Barcelona Marti Franques 1, 08028 Barcelona, Spain",,,,,,,,03074412,,BIEDD,,"English","Biochem. Educ.",Article,"Final",,Scopus,2-s2.0-45549121532
"Gelpí J.Ll., Domènech C., Mazo A., Cortés A., Bozal J.","35517522400;57196812068;7007042077;7102092256;7006794676;","Purification of malate dehydrogenase from chicken liver mitochondria. existence of a small quantity of cytosolic isoenzyme",1988,"International Journal of Biochemistry","20","9",,"989","996",,2,"10.1016/0020-711X(88)90186-3","https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023765479&doi=10.1016%2f0020-711X%2888%2990186-3&partnerID=40&md5=b8933af8a48b35f72248653fca2f3914","Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain","Gelpí, J.Ll., Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain; Domènech, C., Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain; Mazo, A., Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain; Cortés, A., Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain; Bozal, J., Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de Barcelona, Spain","1. 1. A new purification method for chicken liver mitochondrial malate dehydrogenase is described. The application of affinity chromatography through 5'AMP-Sepharoseand Blue Sepharose permits to obtain homogeneous preparations, with good yields (47%). in a short time (48 hr). 2. 2. The 5'AMP-Sepharose chromatography reveals the presence of two malate dehydrogenase species in the mitochondrial extracts. 3. 3. A comparative study of these forms point out the cytosolic nature of the minority form and suggests that its presence could be due to a slight interaction of the cytosolic malate dehydrogenase with mitochondrial membranes. © 1988.",,"isoenzyme; malate dehydrogenase; animal cell; chicken; enzyme purification; liver mitochondrion; nonhuman; Animal; Chickens; Chromatography, Affinity; Comparative Study; Cytosol; Isoenzymes; Malate Dehydrogenase; Mitochondria, Liver; Support, Non-U.S. Gov't",,"malate dehydrogenase, 9001-64-3; Isoenzymes; Malate Dehydrogenase, EC 1.1.1.37",,,,"Acknowledgement--This work was supported in part by a research grant of the Comisi6n Asesora de Investigaci6n Cientifica y T+cnica (CAICYT).",,,"Aebi, Catalase, UV method (1983) Methods of Enzymatic Analysis, 3, pp. 277-282. , 3rd edn., H.U. Bergmeyer, M. Graβl, Chemie GmbH, Weinheim; Aziz, Chien, Patel, Freeman, A putative precursor of rat liver mitochondrial malate dehydrogenase (1981) FEBS Lett., 133, pp. 127-129; Baginski, Foà, Zak, Glucose-6-phosphalase (1974) Methods of Enzymatic Analysis, 4, pp. 876-880. , 2nd edn., H.U. Bergmeyer, M. Graβl, Chemie, Weinheim; Banaszak, Bradshaw, Malate dehydrogenases (1975) The Enzymes, 11, pp. 370-396. , 3rd edn., P.D. Boyer, Academic Press, New York; Cennamo, Montecuccoli, Konig, Inhibition of malate dehydrogenase by citrate (1967) Biochim. biophys. Acta, 139, pp. 514-516; Crémel, Filliol, Waksman, Simultaneous purification by affinity chromatography of rat liver mitochondrial aspartate aminotransferase and malate dehydrogenase and electrophoretic properties (1985) Analytical Biochemistry, 150, pp. 332-336; Dodd, The interaction of glutamate dehydrogenase and malate dehydrogenase with phospholipid membranes (1973) Eur. J. Biochem., 33, pp. 418-427; Domènech, Abante, Bozal, Mazo, Cortés, Bozal, An improved purification method for cytosolic malate dehydrogenase from several sources (1988) Prep. Biochem., 18, pp. 17-35; Dowda, Betterton, Purification and properties of malic dehydrogenase from Trichomonas gallinae (1974) Expl. Parasit., 36, pp. 415-423; D'Souza, Srere, Bincling of citrate synthase to mitochondrial inner membranes (1983) J. biol. Chem., 258, pp. 4706-4709; Dupourque, Kun, Malate dehydrogenases of ox kidney. I: isolation and properties of mitochondrial enzyme (1968) Eur. J. Biochem., 6, pp. 151-155; Edelhoch, Spectroscoplc determination of tryptophan and tyrosine in proteins (1967) Biochemistry, 6, pp. 1948-1954; Fahien, Strmecki, Gluconeogenic mitochondrial enzymes. Conversion of oxalacetate to fumarate by bovine liver malate dehydrogenase and fumarase (1969) Archs Biochem. Biophys., 130, pp. 478-483; Friedrich, Schmidt, Glutamate dehydrogenase (1983) Methods of Enzymatic Analysis, 3, pp. 216-277. , 3rd edn., H.U. Bergmeyer, M Graβl, Chemie GmbH, Weinheim; Glatthaar, Barbarash, Noyes, Banaszak, The preparation of cytosolic and mitochondrial forms of malate dehydrogenase and aspartate aminotransferase from pig heart by a single procedure (1974) Analyt. Biochem., 57, pp. 432-451; Gornall, Bardawill, David, Determination of serum proteins by means of the biuret reaction (1949) J. biol. Chem., 177, pp. 751-766; Greenawalt, The isolation of outer and inner membranes (1974) Methods in Enzymology, 31, pp. 310-323. , S. Fleischer, L. Packer, Academic Press, New York; Hagele, Neef, Mecke, The malate dehydrogenase isoenzymes of Saccaromyces cerevisiae. Purification, characterization and studies on their regulation (1978) Eur. J. Biochem., 83, pp. 67-76; Hodnett, Evans, Gray, Jr, Bartel, Isolation and partial characterization of supernatant and mitochondrial shrimp muscle malate dehydrogenase (1976) Comp. Biochem. Physiol., 54 B, pp. 271-277; Jones, Vestling, Changes in the apparent isoelectric point of mitochondrial malate dehydrogenase caused by phospholipid bincling (1978) Fedn Proc. Am. Soc. expl Biol., 37, pp. 276-279; Kuan, Jones, Vestling, Rapid preparation for malate dehlydrogenase from rat liver and heart (1979) Biochemistry, 18, pp. 4366-4373; Moss, Acid phosphatase. Fixed-time method (1974) Methods of Enzymatic Analysis, 4, pp. 495-496. , 3rd edn., H.U. Bergmeyer, M Graβl, Chemie GmbH, Weinheim; Mullinax, Mock, McEvily, Harrison, Regulation of mitochondrial malate dehydrogenase. Evidence of an allosteric citrate binding site (1982) J. biot. Chem., 257, pp. 13233-13239; Noyes, Glatthaar, Garavelli, Bradshaw, Structural and functional similarities between mitochondrial malate dehydrogenase and L-3-hydroxyacyl-CoA dehydrogenase (1974) Proc. natn. Acad. Sci. U.S.A., 71, pp. 1334-1338; Okayabashi, Nakano, Purification and properties of malate dehydrogenase from unfertilized eggs of the Sea Urchin. Anthocidaris crassipina (1984) J. Biochem., 57, pp. 432-451; Read, Northcote, Minimization of variation in the response to different proteins of the Coomassie Blue C dye-bincling assay for protein (1981) Analyt. Biochem., 116, pp. 53-64; Rotmans, Schistosoma mansoni: purification and characterization of cytosolic malate dehydrogenase (1978) Expl Parasit., 46, pp. 31-48; Silverstein, Sulebele, Modulation of heart muscle mitochondrial malate dehydrogenase activity anclinhibition by p-mercuribenzoate (1970) Biochemistry, 9, pp. 274-282; Smith, Sundaram, A facile method for the isolation of porcine heart mitochondrial malate dehydrogenase by affinity elution chromatography on Procion Red HE3B (1983) Bioscience Reports, 3, pp. 276-279; Teague, Henney, Jr, Purification and properties of mitochondrial and cytosolic malate dehydrogenase of Physarum polycephalum (1973) J. Bact., 116, pp. 673-684; Thorne, Grossman, Kaplan, Starch gel electrophoresis of malate dehydrogenase (1963) Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 73, pp. 193-203; Wali, Matoo, Malate dehydrogenase from thermophilic Humicola lanuginosa and Mucor Pusillus: purification and comparative properties of the enzymes with differing thermostabilities (1984) Can. J. Biochem. Cell Biol., 62, pp. 559-565; Walk, Hock, Separation of malate dehydrogenase isoenzymes by affinity chromatography on 5′AMP-Sepharose (1976) Eur. J. Biochem., 71, pp. 25-32; Weber, Osbom, The reliability of molecular weight determinations by dodecyl sulfate-polyaerylamide gel electrophoresis (1969) J. biol. Chem., 244, pp. 4406-4412; Yang, Scandalios, Purification and biochemical properties of genetically defined malate dehy- drogenase in maize (1974) Archives of Biochemistry and Biophysics, 161, pp. 335-353","Gelpí, J.Ll.; Departament de Bioquímica i Fisiologia, Facilitat de Quimica, Universitat de BarcelonaSpain",,,,,,,,0020711X,,IJBOB,"3197911","English","Int. J. Biochem.",Article,"Final",,Scopus,2-s2.0-0023765479
